Citrus Sinensis ID: 006593
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | 2.2.26 [Sep-21-2011] | |||||||
| Q6EU49 | 612 | Probable serine/threonine | yes | no | 0.890 | 0.929 | 0.513 | 1e-162 | |
| Q8S8Y8 | 567 | Probable serine/threonine | yes | no | 0.599 | 0.675 | 0.626 | 1e-145 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.600 | 0.689 | 0.619 | 1e-142 | |
| Q944Q0 | 563 | Serine/threonine-protein | no | no | 0.618 | 0.701 | 0.616 | 1e-134 | |
| Q8RXE5 | 524 | Probable serine/threonine | no | no | 0.596 | 0.727 | 0.626 | 1e-129 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.596 | 0.541 | 0.547 | 1e-126 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.596 | 0.541 | 0.547 | 1e-126 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.616 | 0.562 | 0.514 | 1e-121 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.557 | 0.689 | 0.538 | 1e-120 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.596 | 0.613 | 0.536 | 1e-119 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 571 bits (1472), Expect = e-162, Method: Compositional matrix adjust.
Identities = 321/625 (51%), Positives = 405/625 (64%), Gaps = 56/625 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAWS+V+ID+V+Q P +L++LYSEVHLLKSLK +NV+KFY WVDD+KK
Sbjct: 40 YKAFDEVEGIEVAWSQVEIDEVMQSPDNLERLYSEVHLLKSLKHENVMKFYNYWVDDQKK 99
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+N+ITELFTSG+LRQYR+KH VD+K IKNWARQ+L GL YLH+H PPIIHRDLKCDNI
Sbjct: 100 TINVITELFTSGSLRQYRQKHPRVDLKAIKNWARQVLRGLDYLHTHQPPIIHRDLKCDNI 159
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGNHGEVKIGDLGLA M P A+SVIGTPEFMAPELY+E Y+ELVDIYSFGMC+LEM
Sbjct: 160 FVNGNHGEVKIGDLGLATVMLTPRAKSVIGTPEFMAPELYDENYDELVDIYSFGMCMLEM 219
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
T EYPYSEC N AQIFKKV+ G+KPA+LAK+ + Q K FI+KCLVPASERLSAK+LL+D
Sbjct: 220 FTLEYPYSECTNAAQIFKKVSKGVKPAALAKITNIQAKQFIDKCLVPASERLSAKELLQD 279
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
PFL +N + K P K + + + MD+D++ + + STC ++ G PH
Sbjct: 280 PFLCSDNSS--VLVGTKFPSSLPKSVDVSLEAL-HMDVDTN-ESMCTSTCKRNDLGGPHR 335
Query: 314 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 373
VLEF R +KN E +L G K DD SVSL LRIAD G RNIHFLFYLDSDTA+SVA EM
Sbjct: 336 SVLEFTRTNKNTELKLTGEKLDDNSVSLVLRIADLCGHARNIHFLFYLDSDTAMSVAAEM 395
Query: 374 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 433
VEQL+LAD DV FIA+FID LI+ L+PG + D A+ S +G + S
Sbjct: 396 VEQLELADCDVTFIADFIDLLIVNLVPGQQLMND-----AVMSTSSESKMGESEHVITSQ 450
Query: 434 WDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQG-ENLHDNAGGGGISSPSLAKLEDQE 492
PSE +V G + + +P+ ++L + GG
Sbjct: 451 QH------PSELTHDYVLVEGMMHSKEANASPSDYIDSLLNATNLGG------------- 491
Query: 493 SQSSVASDIFVD-DTSTKNDKASEFSDYSTDRSYKDL--NGYVSELELGDLCYDECKLQG 549
SS SDI V D S+K+ S+Y D Y+ L Y +LG C+
Sbjct: 492 PNSSEGSDISVQLDGSSKS-----LSEYGVDE-YRTLECGAYKGTDKLG------CR--H 537
Query: 550 NYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVDELKMEIDAIEAQYE 609
S + ++Q + S + + +S+T ++ D L E+ IEAQYE
Sbjct: 538 PLSNGSSNFAIFQMDQASHHSELVIGASVSIT----------ENRDVLNGELGLIEAQYE 587
Query: 610 HWFQELSKMKEEALEASRKRWMAKK 634
WF+EL++M+EEALE +RK+W+ K
Sbjct: 588 QWFRELTRMREEALEGARKKWLPDK 612
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1324), Expect = e-145, Method: Compositional matrix adjust.
Identities = 253/404 (62%), Positives = 307/404 (75%), Gaps = 21/404 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW++V+IDDVLQ P L++LYSEV LLKSLK +N+++FY SW+DDK K
Sbjct: 43 YKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNK 102
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
TVN+ITELFTSG+LR YRKKH+ V++K +KNWARQIL GL YLH PPIIHRDLKCDNI
Sbjct: 103 TVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNI 162
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
F+NGNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTF+YPY ECKN AQI+KKV+SGIKPASL++V DP++K FIEKCL+PASERLSAK+LL D
Sbjct: 223 VTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLD 282
Query: 254 PFLQVENQKEPICDPLKLP-----------IQSLKMLRLPMSGPS---SMDIDSDYKQLS 299
PFLQ+ + +PL LP + L P + PS S+D+D D +
Sbjct: 283 PFLQLNGLT--MNNPLPLPDIVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDS---N 337
Query: 300 LSTCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLF 359
L T S+N C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLF
Sbjct: 338 LPIVTFSDNSGSRC--IEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLF 395
Query: 360 YLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 403
Y + DTA V+ EMVEQL+L D +V FIAE ID L++ ++P WK
Sbjct: 396 YQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWK 439
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1298), Expect = e-142, Method: Compositional matrix adjust.
Identities = 249/402 (61%), Positives = 306/402 (76%), Gaps = 18/402 (4%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+K FDE GIEVAW++V+IDD+LQ P L++LYSEV LLKSLK N+++FY SW+DDK K
Sbjct: 43 FKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNK 102
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
TVN+ITELFTSG+LRQYRKKH+ V++K +K WARQIL GL YLHS +PPIIHRD+KCDNI
Sbjct: 103 TVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNI 162
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
F+NGNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTFEYPY EC+N AQI+KKV+SGIKPASL+KV DP++ FIEKCL+PASERLSA++LL D
Sbjct: 223 VTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLD 282
Query: 254 PFLQVE----NQKEPICDPLKLPIQSLKMLRLPMS-GPS-------SMDIDSDYKQLSLS 301
FL V N P+ D + +P + R MS GP SM++D D +L
Sbjct: 283 SFLNVNGLVMNNPLPLPD-IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDN---NLP 338
Query: 302 TCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYL 361
SNN +C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLF+
Sbjct: 339 IVISSNNSGTNC--IEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQ 396
Query: 362 DSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 403
+ DTA +V+ EMVEQL+L D +V FIAE ID L++ L+P WK
Sbjct: 397 EGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWK 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 248/402 (61%), Positives = 300/402 (74%), Gaps = 7/402 (1%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW+ V I+DV+Q+PG L++LYSEVHLLK+LK +N++K + SWVD+K K
Sbjct: 44 YKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNK 103
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+NMITELFTSG+LR YRKKH+ VD K IKNWARQIL GL YLHS NPP+IHRDLKCDNI
Sbjct: 104 TINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNI 163
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN GEVKIGDLGLA +QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEM
Sbjct: 164 FVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 223
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VT EYPY+EC+N AQI+KKVTS IKP SL KV+DPQ++ FIEKCL+PAS R +A +L KD
Sbjct: 224 VTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKD 283
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
PFL + K+ L S K +R P MD+D + + SN P
Sbjct: 284 PFLARDGGKDSAL--LASSSTSSKYVRPPQLEHLPMDVDHNENK-----SVSSNEDYPWS 336
Query: 314 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 373
+E QR+ +N EFRLRG ++DD + S+ LRIAD SG+ R +HF FYL+SDTA ++A EM
Sbjct: 337 QTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEM 396
Query: 374 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALS 415
VE+L L +V IA+ ID IM+LL S+ +S L+
Sbjct: 397 VEELHLTSQEVVVIADMIDDFIMQLLSDRTSSHHNQNSPRLT 438
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-129, Method: Compositional matrix adjust.
Identities = 243/388 (62%), Positives = 288/388 (74%), Gaps = 7/388 (1%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW+ + I+DVLQ+PG L +LYSEVHLL SLK DN++K + SWVDD K
Sbjct: 31 YKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHNK 90
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
++NMITELFTSG+L YRKKH+ VD K I NWARQIL GL YLHS PP+IHRDLKCDNI
Sbjct: 91 SINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNI 150
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN G+VKIGDLGLA MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEM
Sbjct: 151 FVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 210
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VT EYPY EC+N AQI+KKVTSGIKP SL+KV+DPQ+K FIEKCL+PA R +A +LLKD
Sbjct: 211 VTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKD 270
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
L V+ K+ + K P MD++ K S+S C+ S S C
Sbjct: 271 QLLAVDGAKDSTLTASS--NTTFKPAMPPQCEYRPMDVEYK-KNTSVSICS-SAKSSQEC 326
Query: 314 PVL---EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVA 370
+L E QR+ ++ EF+L G + DD + S+ LRIA SSG+ R + F F L +DTA +V
Sbjct: 327 ALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVT 386
Query: 371 GEMVEQLDLADHDVAFIAEFIDYLIMKL 398
GEMVE+LDL+ H+V IAE ID LIMKL
Sbjct: 387 GEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 225/411 (54%), Positives = 285/411 (69%), Gaps = 30/411 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+AFDE+ G+EVAW++VK+ D LQ P DL++LY E+HLLK+LK N++KFY SWVD ++
Sbjct: 42 YRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRR 101
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+N ITE+FTSG LRQYR+KH V+I +K+W RQIL GL+YLHSH+PPIIHRDLKCDNI
Sbjct: 102 NINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNI 161
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN GEVKIGDLGLA +++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEM 221
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTFEYPYSEC +P QI+KKV SG KP +L KV DP ++ F+EKCL AS RLSA++LLKD
Sbjct: 222 VTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKD 281
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLP-----------MSGPSSMDIDSDYKQLSLST 302
PFLQV++ + P + LR P MS S ID D
Sbjct: 282 PFLQVDDL---VFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWD 338
Query: 303 CTESN---------NGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVR 353
C + + NG P+ N + ++G K++D S+ L LRIAD+ G VR
Sbjct: 339 CEDDDIKADGIDLFNGHEDEPL-------GNVDITIKGRKSEDGSIFLRLRIADNDGHVR 391
Query: 354 NIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP 404
NI+F F +++DTALSVA EMV +LD+ DH+V IAE ID + L+P W+P
Sbjct: 392 NIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 225/411 (54%), Positives = 285/411 (69%), Gaps = 30/411 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+AFDE+ G+EVAW++VK+ D LQ P DL++LY E+HLLK+LK N++KFY SWVD ++
Sbjct: 42 YRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRR 101
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+N ITE+FTSG LRQYR+KH V+I +K+W RQIL GL+YLHSH+PPIIHRDLKCDNI
Sbjct: 102 NINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNI 161
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN GEVKIGDLGLA +++ A +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEM
Sbjct: 162 FVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEM 221
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTFEYPYSEC +P QI+KKV SG KP +L KV DP ++ F+EKCL AS RLSA++LLKD
Sbjct: 222 VTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLATASRRLSARELLKD 281
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLP-----------MSGPSSMDIDSDYKQLSLST 302
PFLQV++ + P + LR P MS S ID D
Sbjct: 282 PFLQVDDL---VFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWD 338
Query: 303 CTESN---------NGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVR 353
C + + NG P+ N + ++G K++D S+ L LRIAD+ G VR
Sbjct: 339 CEDDDIKADGIDLFNGHEDEPL-------GNVDITIKGRKSEDGSIFLRLRIADNDGHVR 391
Query: 354 NIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP 404
NI+F F +++DTALSVA EMV +LD+ DH+V IAE ID + L+P W+P
Sbjct: 392 NIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRP 442
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1124), Expect = e-121, Method: Compositional matrix adjust.
Identities = 224/435 (51%), Positives = 288/435 (66%), Gaps = 41/435 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+AFDE+ GIEVAW++VK+ D LQ P DL++LY E+HLLK+LK N++KFY SWVD +
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+N +TELFTSG LRQYR +HK V+I+ +K+W RQIL GL YLHSH+PP+IHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN GEVKIGDLGLA +++ A +GTPEFMAPE+YEE YNELVDIYSFGMCILEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTF+YPYSEC +PAQI+KKV SG KP +L KV DP++K FIEKCL S R+SA++LL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 254 PFLQVEN-------------------QKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSD 294
PFL++++ Q + D P S + R +G + S
Sbjct: 279 PFLRIDDGEFDLRSVDMEDSVGPLYRQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSSL 338
Query: 295 YKQLS--LSTCTESNNGSPHCPVLEFQRMH-------KNN------------EFRLRGTK 333
+Q S ++ E NG + P E + H +NN + ++G +
Sbjct: 339 NRQYSNGYNSHHEYQNGWAYNPA-ETEETHGIELFESRNNDDQEEEKKSGNVDITIKGKR 397
Query: 334 NDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDY 393
DD + L LRIAD GRVRNI+F F +++DTALSVA EMV +LD+ DH V IA ID
Sbjct: 398 RDDGGLFLRLRIADKEGRVRNIYFPFDIETDTALSVATEMVAELDMDDHGVTKIANMIDG 457
Query: 394 LIMKLLPGWKPSYDY 408
I L+P W+P ++
Sbjct: 458 EISSLVPSWRPGPEF 472
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1115), Expect = e-120, Method: Compositional matrix adjust.
Identities = 212/394 (53%), Positives = 273/394 (69%), Gaps = 38/394 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+AFD+ GIEVAW++VK+DD DL +LYSEVHLLK+LK +++KFY SW+D +
Sbjct: 37 YRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHM 96
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+N+ITE+FTSGNLRQYRKKHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCDNI
Sbjct: 97 TINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNI 156
Query: 134 FVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 192
F+NGN GEVKIGDLGLA + + +A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE
Sbjct: 157 FINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLE 216
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252
+VTFEYPYSEC N AQI++KVTSGIKPA+L V DPQ++ FIEKC+ S+RLSAK+LL
Sbjct: 217 LVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLD 276
Query: 253 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 312
DPFL+ YK+ + + + NG
Sbjct: 277 DPFLKC------------------------------------YKENTENVSSHKENGYNG 300
Query: 313 CPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGE 372
+++ + + G + D ++ L LRI DS G++RNIHF F +++DT+ SVA E
Sbjct: 301 NGIVDKLSDSEVGLLTVEGQRKDLNTIFLKLRITDSKGQIRNIHFPFNIETDTSFSVAIE 360
Query: 373 MVEQLDLA-DHDVAFIAEFIDYLIMKLLPGWKPS 405
MVE+LDL D D++ IA+ ID I +P W PS
Sbjct: 361 MVEELDLTDDQDISTIAKMIDTEIHSHIPDWTPS 394
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1099), Expect = e-119, Method: Compositional matrix adjust.
Identities = 214/399 (53%), Positives = 278/399 (69%), Gaps = 18/399 (4%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFD+ G+EVAW+++K+ D+L+ DL++L SEV LLK+LK N++KFY SW+D K
Sbjct: 43 YKAFDQLEGLEVAWNQIKVGDILRNNDDLERLRSEVRLLKTLKHKNIIKFYNSWLDKKNN 102
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+N ITE+FTSG LRQYR KHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCDNI
Sbjct: 103 NINFITEVFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNI 162
Query: 134 FVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 192
FVNGN GEVKIGDLGLA + +A S+IGTPEFMAPELY+EEYNELVDIY+FGMC+LE
Sbjct: 163 FVNGNQGEVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLE 222
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252
+VTFEYPY EC N AQI+KKV+ G KP+SLAK+ DP+++ FIEKC+ AS+RLSA++LL
Sbjct: 223 LVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLM 282
Query: 253 DPFLQVENQKEPICDPLKLPIQS-LKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSP 311
DPFL+ + +K + P+QS K S SSM D S++ + + +
Sbjct: 283 DPFLRDDGEK------IFYPLQSNTKASDGAGSSNSSMGYKYDRDASSMAIREHTGSFAE 336
Query: 312 HCPVLEFQRMHKNNE--------FRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDS 363
P + +H + + D ++ L LRIADS+G +NIHF F +++
Sbjct: 337 EHPSDRY--IHSTMDPQAAAGRIITVESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEA 394
Query: 364 DTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGW 402
DT++SVA EMV QLDL D DV IAE ID I +P W
Sbjct: 395 DTSISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDW 433
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | ||||||
| 255564615 | 693 | kinase, putative [Ricinus communis] gi|2 | 0.973 | 0.897 | 0.652 | 0.0 | |
| 351721887 | 710 | with no lysine kinase 6 [Glycine max] gi | 0.974 | 0.877 | 0.615 | 0.0 | |
| 356560001 | 723 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.974 | 0.861 | 0.614 | 0.0 | |
| 449433018 | 663 | PREDICTED: probable serine/threonine-pro | 0.970 | 0.935 | 0.655 | 0.0 | |
| 225470964 | 625 | PREDICTED: probable serine/threonine-pro | 0.909 | 0.929 | 0.629 | 0.0 | |
| 449478217 | 713 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.945 | 0.847 | 0.644 | 0.0 | |
| 297745505 | 591 | unnamed protein product [Vitis vinifera] | 0.790 | 0.854 | 0.576 | 0.0 | |
| 356571256 | 581 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.893 | 0.982 | 0.551 | 0.0 | |
| 359474135 | 645 | PREDICTED: serine/threonine-protein kina | 0.923 | 0.914 | 0.552 | 1e-172 | |
| 224127975 | 425 | predicted protein [Populus trichocarpa] | 0.613 | 0.922 | 0.770 | 1e-170 |
| >gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 769 bits (1986), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/636 (65%), Positives = 489/636 (76%), Gaps = 14/636 (2%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YK FDE GIEVAW++V+I DVL+ P DL+KL+SEVHLL+SLK +N+++ SWVDDKKK
Sbjct: 56 YKGFDEVDGIEVAWNQVRIADVLRSPKDLEKLHSEVHLLRSLKHENIMELCNSWVDDKKK 115
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+NMITELFTSGNLRQYRKKHKNVD+K IKNWARQIL GLVYLH HNPPIIHRDLKCDNI
Sbjct: 116 TINMITELFTSGNLRQYRKKHKNVDMKAIKNWARQILQGLVYLHGHNPPIIHRDLKCDNI 175
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNG++G VKIGDLGLAI MQQPTA SVIGTPEFMA ELYEEEYNEL+DIYSFGMC+LEM
Sbjct: 176 FVNGHNGVVKIGDLGLAIIMQQPTATSVIGTPEFMATELYEEEYNELIDIYSFGMCMLEM 235
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTFEYPYSEC+NPAQI+KKVTSGIKPASL V+DPQ+K FI KCLVPASERLSAK+LLKD
Sbjct: 236 VTFEYPYSECRNPAQIYKKVTSGIKPASLGNVSDPQVKEFILKCLVPASERLSAKELLKD 295
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
PFLQ +N EP+ DPL LP Q K SGP SMDID+DYKQ+S STCT SNN
Sbjct: 296 PFLQPQNLVEPVRDPLLLPNQYPKSSSATKSGPLSMDIDADYKQISSSTCTGSNNEGTRF 355
Query: 314 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 373
PV E+QR HKN F+L+G ++DD SVSLTLRIADSSGRV NIHFLFYLDSDTALSVA EM
Sbjct: 356 PVPEYQREHKNKVFKLKGKESDDNSVSLTLRIADSSGRVWNIHFLFYLDSDTALSVASEM 415
Query: 374 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 433
V+QL+LADHDVAFIAEFID+LIMKL PGWK S +YS + SFY+ S L N S P
Sbjct: 416 VDQLELADHDVAFIAEFIDHLIMKLSPGWKLSSNYSLNELTSFYTASAALEN---SVACP 472
Query: 434 WDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKL 488
WD++ V S+ V+Q+ +SG T P + A N +DN G SSPS +
Sbjct: 473 WDSVLTTVLSQPAVEQEALSGMTTTPPEGSLQADDFNYNDNRDGAVFHINYHSSPSFGYM 532
Query: 489 EDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCYDECKLQ 548
EDQ+SQ+S S+I V+D S+K+D+ SE DY+TD + K LNGY SE EL D Y KL+
Sbjct: 533 EDQDSQTSGVSEILVEDVSSKDDRISELPDYNTDGNCKYLNGYTSEPELRD-SYSLRKLE 591
Query: 549 GNYSEDGEDILLYQFVKNSKLTFPNLSTV----LSLTSSYSSLSLTGKDVD-ELKMEIDA 603
N S GE I + + K S+ FP LS +SS SSL L GK +D ELK+E+DA
Sbjct: 592 RNDSGVGECIPMNENAKVSETPFPKLSGAPNDMSMTSSSSSSLYLVGKSMDTELKLELDA 651
Query: 604 IEAQYEHWFQELSKMKEEALEASRKRWMAKKRLPVN 639
IEAQY++WF++LS+ +EEALE+++KRW AKK+LPV+
Sbjct: 652 IEAQYQNWFRDLSRRREEALESTKKRWTAKKKLPVH 687
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721887|ref|NP_001235945.1| with no lysine kinase 6 [Glycine max] gi|225348641|gb|ACN87282.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1970), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/640 (61%), Positives = 473/640 (73%), Gaps = 17/640 (2%)
Query: 5 GLYMTPFSS---YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 61
G + T + S Y+ FDE GIEVAW++VKID ++ DL KLYSEV+LLKSLK +N++
Sbjct: 77 GAFKTVYDSDAYYRGFDEVDGIEVAWNQVKIDGLMHSVDDLAKLYSEVNLLKSLKHENII 136
Query: 62 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 121
KFY SW+DDKKKTVNMITELFTSGNLRQYRKKHK V++K IK WARQILHGLVYLHSH P
Sbjct: 137 KFYDSWIDDKKKTVNMITELFTSGNLRQYRKKHKYVEMKAIKGWARQILHGLVYLHSHKP 196
Query: 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELV 181
PIIHRDLKCDNIFVNGN GEVKIGDLGLAI MQQPTA+SVIGTPEFMAPELYEE Y ELV
Sbjct: 197 PIIHRDLKCDNIFVNGNQGEVKIGDLGLAIVMQQPTAQSVIGTPEFMAPELYEEAYTELV 256
Query: 182 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA 241
DIYSFGMCILEMVT EYPYSEC+NPAQIFKKVTSGIKPASL KV+DPQ+K FIEKCLVPA
Sbjct: 257 DIYSFGMCILEMVTLEYPYSECQNPAQIFKKVTSGIKPASLNKVSDPQLKDFIEKCLVPA 316
Query: 242 SERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLS 301
SERLSA +LLKDPFLQVEN K+PI PL+ P ++L+ SG SMD+DSDYK S+S
Sbjct: 317 SERLSADELLKDPFLQVENPKDPILYPLQPPSRTLRAYSFK-SGSLSMDMDSDYKPFSMS 375
Query: 302 TCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYL 361
+ESN +PHCP+ E QR +KNN+FRL+GTKND SVSLTLRIAD+ GRVRNIHFLFY
Sbjct: 376 IYSESNQENPHCPIFEVQRTYKNNKFRLKGTKNDVNSVSLTLRIADTCGRVRNIHFLFYP 435
Query: 362 DSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSP 421
D+DTA+SVA EMVE L+LADHDV FIAE IDYLIMKLLP WKPS D+ S G LS Y +
Sbjct: 436 DTDTAVSVATEMVEHLELADHDVDFIAELIDYLIMKLLPWWKPSPDHCSCGELSPYCTNI 495
Query: 422 ILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGG---- 477
+G+T PW ++ +PSE V+ QD SG P +D ++ ++ A
Sbjct: 496 ---DGQTLMAWPWGSVSTSIPSELVIGQDGFSGSDTTPKEDFVVSENSSVSKIANNATFE 552
Query: 478 GGISSPSLAKLEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELEL 537
G +S SL KLED+ SQ S AS++ +++TS KND + +D S EL
Sbjct: 553 GDCNSSSLVKLEDRYSQGSRASEMIIENTSMKNDNCHDSND-----DLSSKCFSSSMSEL 607
Query: 538 GDLCYDECKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD-E 596
D+ +++CKLQ GE +++ +F KNS V +L SS S +S T +D+D
Sbjct: 608 RDVYFEDCKLQQTEYCVGEGVVINEFPKNSGSVLGTSINVENLASSCSYVSSTEEDIDLG 667
Query: 597 LKMEIDAIEAQYEHWFQELSKMKEEALEASRKRWMAKKRL 636
LK ++D IEA Y+HW EL++M EALE++R+RWMAKK+L
Sbjct: 668 LKFKLDEIEAHYQHWIDELNEMMLEALESTRRRWMAKKKL 707
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560001|ref|XP_003548284.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/643 (61%), Positives = 476/643 (74%), Gaps = 20/643 (3%)
Query: 5 GLYMTPFSS---YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 61
G + T + S Y+ FDE GIEVAW++VKID ++ DL KLYSEV+LLKSLK +N++
Sbjct: 91 GAFKTVYDSDAYYRGFDEVDGIEVAWNQVKIDGLMHSVDDLAKLYSEVNLLKSLKHENII 150
Query: 62 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 121
KFY SW+DDK+KTVNMITELFTSGNLR YRKKHK V++K IK WARQILHGLVYLHSH P
Sbjct: 151 KFYDSWIDDKQKTVNMITELFTSGNLRLYRKKHKYVEMKAIKGWARQILHGLVYLHSHRP 210
Query: 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELV 181
PIIHRDLKCDNIFVNGN GEVKIGDLGLA+ MQQPTA+SVIGTPEFMAPELYEE Y ELV
Sbjct: 211 PIIHRDLKCDNIFVNGNQGEVKIGDLGLAVVMQQPTAQSVIGTPEFMAPELYEEAYTELV 270
Query: 182 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA 241
DIYSFGMCILEMVT EYPYSECKNPAQIFKKVTSGIKPASL KV+DPQ+K FIEKCLVPA
Sbjct: 271 DIYSFGMCILEMVTLEYPYSECKNPAQIFKKVTSGIKPASLNKVSDPQLKEFIEKCLVPA 330
Query: 242 SERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLS 301
SERLSA++LLKDPFLQVEN K+PI PL+ P ++L+ SG SMD+DSD K S+S
Sbjct: 331 SERLSAEELLKDPFLQVENPKDPILYPLQPPSRTLRAYSFK-SGSLSMDMDSDCKPFSMS 389
Query: 302 TCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYL 361
C+ESN +PHCPV E QR + +EFRL+GTKNDD SVSLTLRIAD+ GRVRNIHFLFYL
Sbjct: 390 ICSESNQENPHCPVFEVQRTNNKHEFRLKGTKNDDNSVSLTLRIADTCGRVRNIHFLFYL 449
Query: 362 DSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSP 421
D+DTA+SVA EMVE L+LADHDV FIAE IDYLIMKLLP WKPS D+ S G LS YS +
Sbjct: 450 DTDTAVSVATEMVEHLELADHDVDFIAELIDYLIMKLLPWWKPSPDHFSCGELSPYSTN- 508
Query: 422 ILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGG---- 477
I G PW ++ +PSE + QD SG P +D ++ ++ N
Sbjct: 509 IDGQW------PWGSVLTSIPSELAIDQDGFSGSDTTPKEDFVASEKSSVSKNDSNATFE 562
Query: 478 GGISSPSLAKLEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELEL 537
G +S SL KLED+ SQ S AS++ V++TS KND D + D S + L+ +SELE+
Sbjct: 563 GDCNSSSLVKLEDRYSQGSRASEMIVENTSMKNDNC---HDSNADVSSESLSNSMSELEI 619
Query: 538 GDLCYDECKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD-- 595
G +++CKLQ GE +++ +F KNS V + T+S S +S T +D+
Sbjct: 620 GGAYFEDCKLQPAEYCSGEGVVINEFPKNSGSVLGTSINVENPTNSCSYVSSTEEDIIDL 679
Query: 596 ELKMEIDAIEAQYEHWFQELSKMKEEALEASRKRWMAKKRLPV 638
EL+ ++D IEA Y+HW EL KM EAL+++R+ W+AKK+L V
Sbjct: 680 ELQFKLDEIEAHYQHWIDELKKMMLEALDSTRRSWVAKKKLAV 722
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449433018|ref|XP_004134295.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/633 (65%), Positives = 480/633 (75%), Gaps = 13/633 (2%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW++V+ID LQ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKKK
Sbjct: 32 YKAFDEVDGIEVAWNQVRIDGFLQSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKKK 91
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
TVNMITELFTSG+LRQYRKKHK+VD+K IKNWARQIL GLVYLHSH+PPIIHRDLK DNI
Sbjct: 92 TVNMITELFTSGSLRQYRKKHKHVDMKAIKNWARQILRGLVYLHSHDPPIIHRDLKGDNI 151
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
F+NGNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVD+YSFGMC+LEM
Sbjct: 152 FINGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCMLEM 211
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTFEYPYSECKNPAQIF+KVTSGIKPASLAKV+DP+ FI KCLVP ERLSAK+LLKD
Sbjct: 212 VTFEYPYSECKNPAQIFRKVTSGIKPASLAKVSDPRTMEFINKCLVPVHERLSAKELLKD 271
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
FLQVEN KE +PL+L Q K + LP SGP SMDID D K SLST ESN+GSP
Sbjct: 272 SFLQVENPKESARNPLQLSNQVSKSINLPKSGPISMDIDIDQKIHSLSTYAESNSGSPRF 331
Query: 314 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 373
PV+EFQ M+KNNEFRLRG KNDD SV+LTLRIADS+GRVRNIHF FYLDSDTALSVA EM
Sbjct: 332 PVVEFQTMNKNNEFRLRGNKNDDNSVALTLRIADSNGRVRNIHFTFYLDSDTALSVAAEM 391
Query: 374 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 433
EQL+L +HDV FIAEFID+LI KL+P WKP YSS+G LS +S P L + K+S S
Sbjct: 392 AEQLELINHDVDFIAEFIDFLITKLIPEWKPLSVYSSNGELSLFSAPPFLKSAKSSIGSA 451
Query: 434 WDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKL 488
W ++ G + +V QD+ SG +D ++ + + G I SSPSLA
Sbjct: 452 WGSILTG-SHDGLVAQDISSGLGCGTQKDCLQSEEDGWTTDISAGHIFDTCPSSPSLANF 510
Query: 489 EDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCY-DECKL 547
ED S +S A ++ VDD STK+ K + S+ D S K + ++ELE Y E K
Sbjct: 511 EDLNSHASFALELLVDDCSTKSAKVFDCSN--IDGSSKGSSWSIAELEHHGSSYVVEDKF 568
Query: 548 QGNYSEDGEDILLYQFVKNSKLTFP---NLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDA 603
Q N + G + F KNS ++ P S V+SLTSS SSLSLT KD+D ELKMEIDA
Sbjct: 569 QRNVGDVGIFTPMDYFAKNSVVSMPAPSEASNVMSLTSSCSSLSLTDKDLDAELKMEIDA 628
Query: 604 IEAQYEHWFQELSKMKEEALEASRKRWMAKKRL 636
IE Y F ELS+M+EEALEA+R+RW+AKK+L
Sbjct: 629 IETHYRQLFDELSRMREEALEATRRRWIAKKKL 661
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/632 (62%), Positives = 464/632 (73%), Gaps = 51/632 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIE+AW++VKIDDVL+ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKKK
Sbjct: 37 YKAFDEVDGIEIAWNQVKIDDVLRSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKKK 96
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
TVNMITELFTSG+LRQYRKKHKNVD+K IKNWARQ+L GLVYLHSHNPPIIHRDLKCDNI
Sbjct: 97 TVNMITELFTSGSLRQYRKKHKNVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCDNI 156
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEM
Sbjct: 157 FVNGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 216
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTFEYPY+ECKNPAQI+KKVTSGIKPASL KV D QIK FI KCL PASERL AK+LLKD
Sbjct: 217 VTFEYPYNECKNPAQIYKKVTSGIKPASLCKVTDLQIKEFIVKCLAPASERLPAKELLKD 276
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
PF Q EN KEPI PL+LP +S K + L SGP SMDID D+ QLS ST TE NNGSP
Sbjct: 277 PFFQSENPKEPIRVPLQLPSRSPKSIILSKSGPFSMDIDPDHPQLSSSTSTE-NNGSPDF 335
Query: 314 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 373
PVLEFQRM+K++EFRLR K +D S+SLTLR DS G V+NIHF F LD+DT SV GEM
Sbjct: 336 PVLEFQRMYKSSEFRLRAKKINDNSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVGEM 395
Query: 374 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 433
VEQL+LA+H+VAFIA+FIDY+IM+LLPGWKP D GA S + P+LGNG
Sbjct: 396 VEQLELAEHEVAFIADFIDYVIMRLLPGWKPPRDDPLGGARSPNAEPPVLGNG------- 448
Query: 434 WDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDN--AGGGGISSPSLAKLEDQ 491
N HD + G G SSP+LA EDQ
Sbjct: 449 ------------------------------------NNHDCTISHGDGNSSPNLANAEDQ 472
Query: 492 ESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLN-GYVSELELGDLCYDECKLQGN 550
+S +S D S KNDK F DY+ +YK N G+ SE E D +++ KLQ N
Sbjct: 473 DSLASAGLVTLTVDASKKNDKTVGFGDYNIGGNYKGSNGGHASEQESRDPYHEDYKLQRN 532
Query: 551 YSEDGEDILLYQFVKNSKLTFPNLSTVLSL-TSSYSSLSLTGKDVDE---LKMEIDAIEA 606
S E + +F K++ L+F +LS + ++ + + S SL+ D+D+ LK E+DAI+
Sbjct: 533 NSSIEEFTPMNKFQKSTVLSFDDLSGLSNVRSLTCSCSSLSLADIDQDPGLKQELDAIDL 592
Query: 607 QYEHWFQELSKMKEEALEASRKRWMAKKRLPV 638
QY+HWFQELS+M+ EALEA++KRWM KK+L V
Sbjct: 593 QYQHWFQELSRMRVEALEATKKRWMTKKKLAV 624
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449478217|ref|XP_004155253.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 718 bits (1853), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/633 (64%), Positives = 470/633 (74%), Gaps = 29/633 (4%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW++V+ID LQ P DL+KLYSEVHLLKSLK +N++KFY SWVDDKKK
Sbjct: 98 YKAFDEVDGIEVAWNQVRIDGFLQSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDKKK 157
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
TVNMITELFTSG+LRQYRKKHK+VD+K IKNWARQIL GLVYLHSH+PPIIHRDLK DNI
Sbjct: 158 TVNMITELFTSGSLRQYRKKHKHVDMKAIKNWARQILRGLVYLHSHDPPIIHRDLKGDNI 217
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
F+NGNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVD+YSFGMC+LEM
Sbjct: 218 FINGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDVYSFGMCMLEM 277
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTFEYPYSECKNPAQIF+KVTSGIKPASLAKV+DP+ FI KCLVP ERLSAK+LLKD
Sbjct: 278 VTFEYPYSECKNPAQIFRKVTSGIKPASLAKVSDPRTMEFINKCLVPVHERLSAKELLKD 337
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
FLQVEN KE +PL+L Q K + LP SGP SMDID D K SLST ESN+GSP
Sbjct: 338 SFLQVENPKESARNPLQLSNQVSKSINLPKSGPISMDIDIDQKIHSLSTYAESNSGSPRF 397
Query: 314 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 373
PV+EFQ M+KNNEFRLRG KNDD SV+LTLRIADS+GRVRNIHF YLDSDTALSVA EM
Sbjct: 398 PVVEFQTMNKNNEFRLRGNKNDDNSVALTLRIADSNGRVRNIHFTXYLDSDTALSVAAEM 457
Query: 374 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 433
EQL+L +HDV FIAEFID+LI KL+P WKP YSS+G L S
Sbjct: 458 AEQLELINHDVDFIAEFIDFLITKLIPEWKPLSVYSSNGELR----------------SA 501
Query: 434 WDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGI-----SSPSLAKL 488
W ++ G + +V QD+ SG +D ++ + + G I SSPSLA
Sbjct: 502 WGSILTG-SHDGLVAQDISSGLGCGTQKDCLQSEEDGWTTDISAGHIFDTCPSSPSLANF 560
Query: 489 EDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSELELGDLCY-DECKL 547
ED S +S A ++ VDD STK+ K + S+ D S K + ++ELE Y E K
Sbjct: 561 EDLNSHASFALELLVDDCSTKSAKVFDCSN--IDGSSKGSSWSIAELEHHGSSYVVEDKF 618
Query: 548 QGNYSEDGEDILLYQFVKNSKLTFP---NLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDA 603
Q N + G + F KNS ++ P S V+SLTSS SSLSLT KD+D ELKMEIDA
Sbjct: 619 QRNVGDVGIFTPMDYFAKNSVVSMPAPSEASNVMSLTSSCSSLSLTDKDLDAELKMEIDA 678
Query: 604 IEAQYEHWFQELSKMKEEALEASRKRWMAKKRL 636
IE Y F ELS+M+EEALEA+R+RW+AKK+L
Sbjct: 679 IETHYRQLFDELSRMREEALEATRRRWIAKKKL 711
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745505|emb|CBI40585.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/628 (57%), Positives = 414/628 (65%), Gaps = 123/628 (19%)
Query: 12 SSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
+ YKAFDE GIE+AW++VKIDDVL+ P DL+KLYSEVHLLKSLK +N++KFY SWVDDK
Sbjct: 43 TVYKAFDEVDGIEIAWNQVKIDDVLRSPEDLEKLYSEVHLLKSLKHENIIKFYNSWVDDK 102
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
KKTVNMITELFTSG+LRQYRKKHKNVD+K IKNWARQ+L GLVYLHSHNPPIIHRDLKCD
Sbjct: 103 KKTVNMITELFTSGSLRQYRKKHKNVDMKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCD 162
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 191
NIFVNGNHGEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+L
Sbjct: 163 NIFVNGNHGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCML 222
Query: 192 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLL 251
EMVTFEYPY+ECKNPAQI+KKVTSGIKPASL KV D QIK FI KCL PASERL AK+LL
Sbjct: 223 EMVTFEYPYNECKNPAQIYKKVTSGIKPASLCKVTDLQIKEFIVKCLAPASERLPAKELL 282
Query: 252 KDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSP 311
KDPF Q EN KEPI R+P+ P
Sbjct: 283 KDPFFQSENPKEPI--------------RVPL--------------------------HP 302
Query: 312 HCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAG 371
PVLEFQRM+K++EFRLR K +D S+SLTLR DS G V+NIHF F LD+DT SV G
Sbjct: 303 DFPVLEFQRMYKSSEFRLRAKKINDNSISLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVG 362
Query: 372 EMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTP 431
EMVEQL+LA+H+VAFIA+FIDY+IM+LLPGWKP D GA S + P+LGNG
Sbjct: 363 EMVEQLELAEHEVAFIADFIDYVIMRLLPGWKPPRDDPLGGARSPNAEPPVLGNG----- 417
Query: 432 SPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDN--AGGGGISSPSLAKLE 489
N HD + G G SSP+LA E
Sbjct: 418 --------------------------------------NNHDCTISHGDGNSSPNLANAE 439
Query: 490 DQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLN-GYVSELELGDLCYDECKLQ 548
DQ+S +S D S KNDK F DY+ +YK N G+ SE E D +++ KLQ
Sbjct: 440 DQDSLASAGLVTLTVDASKKNDKTVGFGDYNIGGNYKGSNGGHASEQESRDPYHEDYKLQ 499
Query: 549 GNYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVDELKMEIDAIEAQY 608
N S +D P LK E+DAI+ QY
Sbjct: 500 RNNSNIDQD--------------PG-----------------------LKQELDAIDLQY 522
Query: 609 EHWFQELSKMKEEALEASRKRWMAKKRL 636
+HWFQELS+M+ EALEA++KRWM KK+L
Sbjct: 523 QHWFQELSRMRVEALEATKKRWMTKKKL 550
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356571256|ref|XP_003553795.1| PREDICTED: LOW QUALITY PROTEIN: probable serine/threonine-protein kinase WNK4-like, partial [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1654), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/633 (55%), Positives = 432/633 (68%), Gaps = 62/633 (9%)
Query: 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
F SYK FDE VAW++V+ID++ Q DL KLYSEV+LLKSLK +N++KF+ SW+D
Sbjct: 1 FGSYKGFDE-----VAWNQVRIDELQQSVDDLAKLYSEVNLLKSLKHENIIKFFNSWIDG 55
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
KKKT+N+I EL T GNLRQY K+H+ VD+K IK+WA+QIL GLVYLHSHNPPIIH+DLKC
Sbjct: 56 KKKTINIIIELCTLGNLRQYCKRHRYVDMKAIKDWAKQILQGLVYLHSHNPPIIHKDLKC 115
Query: 131 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 190
DNIFVNGNHGEVKIGDLGLAI MQQPTA SVIGT EFMAP+LYEEEYNELVD+YSFGMC+
Sbjct: 116 DNIFVNGNHGEVKIGDLGLAIFMQQPTAXSVIGTLEFMAPKLYEEEYNELVDVYSFGMCL 175
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDL 250
LEMVTF+YPYSEC NPAQI+KKVTSGI+PASL KVNDPQIK FI+KCLV S+RLS K+L
Sbjct: 176 LEMVTFQYPYSECNNPAQIYKKVTSGIEPASLEKVNDPQIKEFIKKCLVSTSKRLSTKEL 235
Query: 251 LKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCT-ESNNG 309
LKDPFLQVE+ K+ I D L L +SLK++ L MS SMD+D DY+ +SLSTC ESN
Sbjct: 236 LKDPFLQVESPKQSILDHLHLSNKSLKVINLSMSDKLSMDLDVDYQFISLSTCVDESNQE 295
Query: 310 SPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSV 369
+PHC +L+ QR +KNN FRL+GTKN D SVS LRIA + NIHFLFYL++D A+SV
Sbjct: 296 NPHCSILKVQRTYKNNXFRLKGTKNGDKSVSFILRIA---KFMWNIHFLFYLETDIAISV 352
Query: 370 AGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTS 429
A EM E L+L ++DVAFI E IDYLIM+L+ GWKPS+DYSS+G LS SP L + +TS
Sbjct: 353 ASEMAENLELENNDVAFIVELIDYLIMELVLGWKPSFDYSSNGGLSQCDGSPTLIDNQTS 412
Query: 430 TPSPWDAMGAGVPSEFVVKQD--VVSGPTRNPSQDLAP-AQGENLHDNAGGGGIS-SPSL 485
PW A VPSE V+ QD T+ S P + N+ D G+S S S
Sbjct: 413 ISFPWVRALASVPSELVLDQDNCFRFNTTKKESLTTTPKSYIFNVVDKDTLEGLSCSTSE 472
Query: 486 AKLEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSYKDLNGYVSE-LELGDLCYDE 544
KL D F Y + N VS+ +E+ +L +
Sbjct: 473 IKLGDM-----------------------HFEGYKLHTT----NCNVSKSIEINELSKNS 505
Query: 545 CKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSLTSSYSSLSLTGKDVD-ELKMEIDA 603
+ + E + I S T++ SSLSLT K++D ELK ++
Sbjct: 506 HHMTSTFCETPDHI--------------------SFTNNCSSLSLTHKNIDFELKFNVEE 545
Query: 604 IEAQYEHWFQELSKMKEEALEASRKRWMAKKRL 636
IE+QY+H QEL +M+ +ALEA K+W+AKK++
Sbjct: 546 IESQYQHLSQELLRMRSKALEAVEKKWIAKKKM 578
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1577), Expect = e-172, Method: Compositional matrix adjust.
Identities = 351/635 (55%), Positives = 436/635 (68%), Gaps = 45/635 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW +V+I+D+LQ P L++LYSEVHLLKSLK DN++KFY SWVDD K
Sbjct: 38 YKAFDEVDGIEVAWGQVEIEDLLQSPQQLERLYSEVHLLKSLKHDNIIKFYNSWVDDTNK 97
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+N+ITELFTSG+LRQYRKKHKNVD+K IKNWA+QIL GL YLHSHNPPIIHRDLKCDNI
Sbjct: 98 TINLITELFTSGSLRQYRKKHKNVDLKAIKNWAKQILRGLHYLHSHNPPIIHRDLKCDNI 157
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN+GEVKIGDLGLAI MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE+
Sbjct: 158 FVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEL 217
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VT EYPY+ECKNPAQI+KKV+SGIKPASL KV+DPQ+K FIEKCLVPAS RLSA++LLKD
Sbjct: 218 VTCEYPYNECKNPAQIYKKVSSGIKPASLGKVSDPQVKQFIEKCLVPASLRLSAQELLKD 277
Query: 254 PFLQVENQKEPICDPLKL--PIQSL----KMLRLPMSGPSSMDIDSDYKQLSLSTCTESN 307
F EN KEP+ + + + +QS ++ LP MD+D +YK+LS+ST +S
Sbjct: 278 AFFATENSKEPVYNHMHVDDSLQSSNFMPNLMNLPKPELQPMDMDPNYKKLSVSTHMKSI 337
Query: 308 NGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTAL 367
+G+PH L+F+R +KNN F+LRG K DD S+S+TL IAD GR +NIHF FYLDSDTAL
Sbjct: 338 SGTPHFRALQFERFNKNNLFKLRGEKIDDNSISMTLHIADPCGRAKNIHFAFYLDSDTAL 397
Query: 368 SVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGK 427
S+AGEMVEQLDL + DVA IAE ID +I +L+P WKP+++ GA S S +L NG
Sbjct: 398 SIAGEMVEQLDLYNEDVAVIAELIDVMISELVPTWKPAFESMLCGANSSCEDSLVLHNGG 457
Query: 428 TSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQGENLHDNAGGGGISSPSLAK 487
TS P D+ A S+ V + ++S Q + G+S+
Sbjct: 458 TSLRHPSDSGSAKGTSD-AVTEHLISLSANGEEQSTV---------ESALSGMST----- 502
Query: 488 LEDQESQSSVASDIFVDDTSTKNDKASEFSD---YSTDRSYKDLNGYVSELELGDLCYDE 544
+D + +S A+DI +D+ E SD ++ DR D + E
Sbjct: 503 -KDDATVASDANDI--KSLECPDDECYEASDRCCFNGDRQVLDHER-----------HKE 548
Query: 545 CKLQGNYSEDGEDILLYQFVKN---SKLTFPNLSTVLSLTSSYSSLSLTGKD-VDELKME 600
+ GN GE + + F K+ S + + + SS SLSL KD DELK+E
Sbjct: 549 GRYNGNI---GEPVAMNGFTKDWEISCIESCSGMSNSLSLSSICSLSLADKDPSDELKLE 605
Query: 601 IDAIEAQYEHWFQELSKMKEEALEASRKRWMAKKR 635
+D I+ QY FQEL +M+EEA+E ++ RW+ K R
Sbjct: 606 VDTIDTQYHQCFQELLRMREEAIEKAKNRWITKSR 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127975|ref|XP_002320210.1| predicted protein [Populus trichocarpa] gi|222860983|gb|EEE98525.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1560), Expect = e-170, Method: Compositional matrix adjust.
Identities = 303/393 (77%), Positives = 338/393 (86%), Gaps = 1/393 (0%)
Query: 12 SSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
+ Y+AFDE GIEVAW++V+IDDVL+ P D +KLYSEV+LL+SL+ +N++KF SWVDDK
Sbjct: 33 TVYRAFDEVDGIEVAWNQVRIDDVLRSPEDFEKLYSEVYLLRSLRHENIIKFSNSWVDDK 92
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
KT+NMITELFTSGNLRQYR+KH+N+DIK IKNWARQIL GLVYLH H+PPIIHRDLKCD
Sbjct: 93 NKTINMITELFTSGNLRQYRRKHRNIDIKAIKNWARQILRGLVYLHGHSPPIIHRDLKCD 152
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 191
NIFVNGNHGEVKIGDLGLAI MQ PTA+SVIGTPEFMAPELYEEEYNELVDIYSFGMCIL
Sbjct: 153 NIFVNGNHGEVKIGDLGLAIVMQNPTAKSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 212
Query: 192 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLL 251
E+VT YPYSEC+N AQI+KKVTSGIKPASL V + QIK FIEKCL+PASERLSAK+LL
Sbjct: 213 ELVTCNYPYSECRNAAQIYKKVTSGIKPASLKTVGNTQIKEFIEKCLLPASERLSAKELL 272
Query: 252 KDPFLQVENQ-KEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGS 310
K PFLQ+E E ICDPL +P Q L LP SGP MD+D D KQLS STCT SNNGS
Sbjct: 273 KHPFLQLEIPILEQICDPLPVPDQFPISLSLPKSGPLFMDMDIDEKQLSESTCTGSNNGS 332
Query: 311 PHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVA 370
P PVLE+QR HKNNEF L+G KNDD S SLTLRI+D GRVRNIHF+FYLDSDTA+SVA
Sbjct: 333 PKSPVLEYQRAHKNNEFGLKGMKNDDNSASLTLRISDLGGRVRNIHFIFYLDSDTAISVA 392
Query: 371 GEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 403
EMVEQL+LADHDVAFIAE ID LI+KLLPGWK
Sbjct: 393 SEMVEQLELADHDVAFIAELIDSLIVKLLPGWK 425
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 639 | ||||||
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.660 | 0.749 | 0.591 | 2.4e-138 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.604 | 0.680 | 0.630 | 5.2e-136 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.600 | 0.689 | 0.619 | 7.6e-133 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.596 | 0.727 | 0.623 | 5.3e-132 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.386 | 0.352 | 0.672 | 2.6e-113 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.381 | 0.472 | 0.693 | 1.1e-112 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.608 | 0.790 | 0.518 | 1.8e-103 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.489 | 0.570 | 0.534 | 6.7e-100 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.380 | 0.425 | 0.643 | 4.2e-96 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.378 | 0.770 | 0.588 | 1.6e-77 |
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1261 (449.0 bits), Expect = 2.4e-138, Sum P(2) = 2.4e-138
Identities = 255/431 (59%), Positives = 312/431 (72%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW+ V I+DV+Q+PG L++LYSEVHLLK+LK +N++K + SWVD+K K
Sbjct: 44 YKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSEVHLLKALKHENIIKLFYSWVDEKNK 103
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+NMITELFTSG+LR YRKKH+ VD K IKNWARQIL GL YLHS NPP+IHRDLKCDNI
Sbjct: 104 TINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNI 163
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN GEVKIGDLGLA +QQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEM
Sbjct: 164 FVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 223
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VT EYPY+EC+N AQI+KKVTS IKP SL KV+DPQ++ FIEKCL+PAS R +A +L KD
Sbjct: 224 VTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLPASSRPTALELSKD 283
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
PFL + K+ L S K +R P MD+D + + S+S SN P
Sbjct: 284 PFLARDGGKDSAL--LASSSTSSKYVRPPQLEHLPMDVDHNENK-SVS----SNEDYPWS 336
Query: 314 PVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEM 373
+E QR+ +N EFRLRG ++DD + S+ LRIAD SG+ R +HF FYL+SDTA ++A EM
Sbjct: 337 QTIELQRIAENKEFRLRGERSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEM 396
Query: 374 VEQLDLADHDVAFIAEFIDYLIMKLLPGWKPSYDYSSSGALSFYSVSPILGNGKTSTPSP 433
VE+L L +V IA+ ID IM+LL S+ +S L+ N +T
Sbjct: 397 VEELHLTSQEVVVIADMIDDFIMQLLSDRTSSHHNQNSPRLTHEDHEA--ANQQTVNSKD 454
Query: 434 WDAMGAGVPSE 444
+A G + S+
Sbjct: 455 EEAAGQSMKSD 465
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 5.2e-136, Sum P(2) = 5.2e-136
Identities = 253/401 (63%), Positives = 308/401 (76%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW++V+IDDVLQ P L++LYSEV LLKSLK +N+++FY SW+DDK K
Sbjct: 43 YKAFDEVDGIEVAWNQVRIDDVLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNK 102
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
TVN+ITELFTSG+LR YRKKH+ V++K +KNWARQIL GL YLH PPIIHRDLKCDNI
Sbjct: 103 TVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNI 162
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
F+NGNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTF+YPY ECKN AQI+KKV+SGIKPASL++V DP++K FIEKCL+PASERLSAK+LL D
Sbjct: 223 VTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLD 282
Query: 254 PFLQVE----NQKEPICDPLKLPIQSLKMLRLPMS-GP------SSMDIDSDYKQLSLST 302
PFLQ+ N P+ D + +P + R MS GP ++ ID D + +L
Sbjct: 283 PFLQLNGLTMNNPLPLPD-IVMPKEGAFGDRCLMSEGPPTTRPSKTLSIDLD-EDSNLPI 340
Query: 303 CTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLD 362
T S+N C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLFY +
Sbjct: 341 VTFSDNSGSRC--IEVRRAKRGNFFVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQE 398
Query: 363 SDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 403
DTA V+ EMVEQL+L D +V FIAE ID L++ ++P WK
Sbjct: 399 GDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWK 439
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1256 (447.2 bits), Expect = 7.6e-133, Sum P(2) = 7.6e-133
Identities = 249/402 (61%), Positives = 306/402 (76%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+K FDE GIEVAW++V+IDD+LQ P L++LYSEV LLKSLK N+++FY SW+DDK K
Sbjct: 43 FKGFDEVDGIEVAWNQVRIDDLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNK 102
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
TVN+ITELFTSG+LRQYRKKH+ V++K +K WARQIL GL YLHS +PPIIHRD+KCDNI
Sbjct: 103 TVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNI 162
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
F+NGNHGEVKIGDLGLA M+Q A+SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEM
Sbjct: 163 FINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEM 222
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTFEYPY EC+N AQI+KKV+SGIKPASL+KV DP++ FIEKCL+PASERLSA++LL D
Sbjct: 223 VTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLD 282
Query: 254 PFLQVE----NQKEPICDPLKLPIQSLKMLRLPMS-GPS-------SMDIDSDYKQLSLS 301
FL V N P+ D + +P + R MS GP SM++D D +L
Sbjct: 283 SFLNVNGLVMNNPLPLPD-IVMPKEGSFGERCLMSEGPPNARNRTMSMNLDEDN---NLP 338
Query: 302 TCTESNNGSPHCPVLEFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYL 361
SNN +C +E +R + N F L+G +ND+ SVSL LRI D +GRVRNIHFLF+
Sbjct: 339 IVISSNNSGTNC--IEVRRAKRGNFFVLKGEENDENSVSLILRIVDENGRVRNIHFLFFQ 396
Query: 362 DSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWK 403
+ DTA +V+ EMVEQL+L D +V FIAE ID L++ L+P WK
Sbjct: 397 EGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNLIPNWK 438
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1213 (432.1 bits), Expect = 5.3e-132, Sum P(2) = 5.3e-132
Identities = 242/388 (62%), Positives = 289/388 (74%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFDE GIEVAW+ + I+DVLQ+PG L +LYSEVHLL SLK DN++K + SWVDD K
Sbjct: 31 YKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSEVHLLNSLKHDNIIKLFYSWVDDHNK 90
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
++NMITELFTSG+L YRKKH+ VD K I NWARQIL GL YLHS PP+IHRDLKCDNI
Sbjct: 91 SINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNI 150
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN G+VKIGDLGLA MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEM
Sbjct: 151 FVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEM 210
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VT EYPY EC+N AQI+KKVTSGIKP SL+KV+DPQ+K FIEKCL+PA R +A +LLKD
Sbjct: 211 VTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKD 270
Query: 254 PFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPHC 313
L V+ K+ + K P MD++ K S+S C+ + + S C
Sbjct: 271 QLLAVDGAKDSTLTASSNT--TFKPAMPPQCEYRPMDVEYK-KNTSVSICSSAKS-SQEC 326
Query: 314 PVL---EFQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSDTALSVA 370
+L E QR+ ++ EF+L G + DD + S+ LRIA SSG+ R + F F L +DTA +V
Sbjct: 327 ALLQTMEVQRVAESTEFKLSGERRDDVAASMALRIAGSSGQARKVDFDFNLKTDTARAVT 386
Query: 371 GEMVEQLDLADHDVAFIAEFIDYLIMKL 398
GEMVE+LDL+ H+V IAE ID LIMKL
Sbjct: 387 GEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 924 (330.3 bits), Expect = 2.6e-113, Sum P(2) = 2.6e-113
Identities = 166/247 (67%), Positives = 205/247 (82%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+AFDE+ GIEVAW++VK+ D LQ P DL++LY E+HLLK+LK N++KFY SWVD +
Sbjct: 39 YRAFDEYEGIEVAWNQVKLYDFLQSPEDLERLYCEIHLLKTLKHKNIMKFYTSWVDTANR 98
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+N +TELFTSG LRQYR +HK V+I+ +K+W RQIL GL YLHSH+PP+IHRDLKCDNI
Sbjct: 99 NINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNI 158
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
FVNGN GEVKIGDLGLA +++ A +GTPEFMAPE+YEE YNELVDIYSFGMCILEM
Sbjct: 159 FVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEM 218
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTF+YPYSEC +PAQI+KKV SG KP +L KV DP++K FIEKCL S R+SA++LL D
Sbjct: 219 VTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLATVSLRVSARELLDD 278
Query: 254 PFLQVEN 260
PFL++++
Sbjct: 279 PFLRIDD 285
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 1.1e-112, Sum P(2) = 1.1e-112
Identities = 170/245 (69%), Positives = 208/245 (84%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+AFD+ GIEVAW++VK+DD DL +LYSEVHLLK+LK +++KFY SW+D +
Sbjct: 37 YRAFDQLEGIEVAWNQVKLDDKFCSSEDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHM 96
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+N+ITE+FTSGNLRQYRKKHK VD++ +K W+RQIL GLVYLHSH+PP+IHRDLKCDNI
Sbjct: 97 TINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNI 156
Query: 134 FVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 192
F+NGN GEVKIGDLGLA + + +A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE
Sbjct: 157 FINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLE 216
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252
+VTFEYPYSEC N AQI++KVTSGIKPA+L V DPQ++ FIEKC+ S+RLSAK+LL
Sbjct: 217 LVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLD 276
Query: 253 DPFLQ 257
DPFL+
Sbjct: 277 DPFLK 281
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 1.8e-103, P = 1.8e-103
Identities = 208/401 (51%), Positives = 269/401 (67%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+ FDE+ GIEVAW++VK+ D LQ P +L++LY E+HLLK+LK +++KFY SWVD +
Sbjct: 40 YRGFDEYQGIEVAWNQVKLYDFLQSPQELERLYCEIHLLKTLKHKSIMKFYASWVDTDNR 99
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+N +TE+FTSG LRQYR KHK V+I+ +KNW RQIL GL YLH+H+PP+IHRDLKCDNI
Sbjct: 100 NINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNI 159
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEM 193
F+NGN GEVKIGDLGLA +Q A +GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEM
Sbjct: 160 FINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEM 219
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKD 253
VTF+YPYSEC +PAQI+K+V SG KP L KV DP+++GFIEKCL S RLSA +LL D
Sbjct: 220 VTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDD 279
Query: 254 PFLQV-ENQKEPICDPLKLPIQSLKMLRLPMSGPS-SMDIDSDYKQLSLSTCTESNNGSP 311
FL + E+ + L ++ LR P S S Y Q + S
Sbjct: 280 HFLCIDESDMRRVESEKGLIDEAGTPLRHSYHIPHYSNGYYSLYNQNQWDYNGDETVESH 339
Query: 312 HCPVLEFQRMHKNNE---------FRLRGTKNDD-TSVSLTLRIADSSGRVRNIHFLFYL 361
+LEFQ E ++G + D+ + L L+ + G VRNI+F F +
Sbjct: 340 EIDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDI 399
Query: 362 DSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGW 402
++DTA+SVA EMVE+L++ D DV IA ID I L+P W
Sbjct: 400 ETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASLVPNW 440
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 6.7e-100, Sum P(2) = 6.7e-100
Identities = 170/318 (53%), Positives = 226/318 (71%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKAFD+ G+EVAW++VK+++V + P LQ+LYSEVHLLK+L ++++++ SW+D ++
Sbjct: 40 YKAFDQVLGMEVAWNQVKLNEVFRSPEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRR 99
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T N ITELFTSG LR+YR+K++ VDI+ IK+WARQIL+GL YLH H+PP+IHRDLKCDNI
Sbjct: 100 TFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNI 159
Query: 134 FVNGNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 192
FVNG+ G+VKIGDLGLA ++ A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LE
Sbjct: 160 FVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLE 219
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252
M+T EYPYSEC NPAQI+KKVTSG P S + + + F+ KCL S RL AK+LL
Sbjct: 220 MLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLA 279
Query: 253 DPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDS--DYKQLSLSTCTESNNGS 310
DPFL ++++ + +LP Q L + L +G + S D + + + T N
Sbjct: 280 DPFLAATDERD-LAPLFRLP-QQLAIQNLAANGTVVEHLPSTTDPTRTTDMSITGKMNSE 337
Query: 311 PHCPVLEFQRMHKNNEFR 328
H L+ Q + + R
Sbjct: 338 DHTIFLQVQILDGDGHMR 355
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 4.2e-96, Sum P(2) = 4.2e-96
Identities = 157/244 (64%), Positives = 196/244 (80%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA DE GIEVAWS+VK+ +VL+ DLQ+LYSEVHLL +L ++++FY SW+D
Sbjct: 34 YKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSEVHLLSTLNHKSIIRFYTSWIDVHNH 93
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+N ITELFTSG LRQY+ K+ +DI+ IK+WARQIL GLVYLH H+PP+IHRDLKCDNI
Sbjct: 94 TLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNI 153
Query: 134 FVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 192
FVNG+ G+VKIGDLGLA ++ +A S+IGTPEFMAPELYEE YNEL+D+YSFGMC LE
Sbjct: 154 FVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLE 213
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252
M+T E+PYSEC +PAQI+KKV G P + +V D + + FI KCLV AS+R+SAK+LL+
Sbjct: 214 MITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQ 273
Query: 253 DPFL 256
DPFL
Sbjct: 274 DPFL 277
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 1.6e-77, P = 1.6e-77
Identities = 143/243 (58%), Positives = 187/243 (76%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+AFD+ GIEVAW++VK+ P ++LYSEV LLK+LK+ N++ YK W D++
Sbjct: 46 YRAFDQEEGIEVAWNQVKLRCFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNN 105
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
T+N ITE+ TSGNLR+YRKKH++V ++ +K W++QIL GL YLH+H+P IIHRDL C NI
Sbjct: 106 TLNFITEICTSGNLREYRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNI 165
Query: 134 FVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE 192
FVNGN G+VKIGDLGLA I + A S++GTPEFMAPELYEE Y E+VDIYS+GMC+LE
Sbjct: 166 FVNGNIGQVKIGDLGLAAIVGKNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLE 225
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252
+V+ E PYSEC + A+I+K+V+ G+KP +L KVNDP+ K FIEKC+ R SA +LL
Sbjct: 226 LVSLEIPYSECDSVAKIYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLC 285
Query: 253 DPF 255
DPF
Sbjct: 286 DPF 288
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6EU49 | WNK4_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5136 | 0.8904 | 0.9297 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00008654001 | SubName- Full=Chromosome undetermined scaffold_203, whole genome shotgun sequence; (554 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 639 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-58 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-50 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-44 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-35 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-35 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-34 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 4e-60
Identities = 83/248 (33%), Positives = 131/248 (52%), Gaps = 14/248 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y A D+ G VA +K+ ++ D +++ E+ +LK LK N+V+ Y + D+ K
Sbjct: 16 YLARDKKTGKLVA---IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDK- 71
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ ++ E G+L KK + + + RQIL L YLHS I+HRDLK +NI
Sbjct: 72 -LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG--IVHRDLKPENI 128
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 191
++ G VK+ D GLA + + +GTPE+MAPE L + Y + VDI+S G IL
Sbjct: 129 LLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VIL 186
Query: 192 -EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASERLSAK 248
E++T + P+ ++FKK+ P + + P+ K I K LV +RL+A+
Sbjct: 187 YELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE 246
Query: 249 DLLKDPFL 256
+ L+ PF
Sbjct: 247 EALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 2e-58
Identities = 91/250 (36%), Positives = 136/250 (54%), Gaps = 13/250 (5%)
Query: 14 YKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
Y A D+ G +A VK ++ +L+ L E+ +L SL+ N+V++Y S D++K
Sbjct: 17 YLALDKDTGELMA---VKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
T+N+ E + G+L KK + VI+ + RQIL GL YLHS+ I+HRD+K N
Sbjct: 74 NTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGAN 131
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFG 187
I V+ + G VK+ D G A + SV GTP +MAPE+ EEY DI+S G
Sbjct: 132 ILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLG 190
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
++EM T + P+SE NP K+ S +P + + + K F+ KCL +R +
Sbjct: 191 CTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
Query: 247 AKDLLKDPFL 256
A +LL+ PFL
Sbjct: 251 ADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-50
Identities = 75/252 (29%), Positives = 122/252 (48%), Gaps = 16/252 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA + G VA +K + Q E+ +L+ L N+V+ ++ D
Sbjct: 16 YKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDH- 72
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ ++ E G+L Y + + K A QIL GL YLHS+ IIHRDLK +NI
Sbjct: 73 -LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG--IIHRDLKPENI 129
Query: 134 FVNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMC 189
++ +G VKI D GLA + + + +GTP +MAPE L Y VD++S G+
Sbjct: 130 LLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVI 188
Query: 190 ILEMVTFEYPYSECKNPAQ--IFKKVTSGIKPASLAKVNDPQI--KGFIEKCLVP-ASER 244
+ E++T + P+S Q + +++ K + K I+KCL S+R
Sbjct: 189 LYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
Query: 245 LSAKDLLKDPFL 256
+A+++L+ P+
Sbjct: 249 PTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 8e-50
Identities = 71/247 (28%), Positives = 116/247 (46%), Gaps = 47/247 (19%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y A D+ G +VA +KI L++L E+ +LK L N+VK Y + D+
Sbjct: 10 YLARDKKTGKKVA---IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-- 64
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ ++ E G+L+ ++ + I QIL GL YLHS+ IIHRDLK +N
Sbjct: 65 HLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPEN 122
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGM 188
I ++ ++G+VK+ D GL+ + ++++GTP +MAPE+ Y+E DI+S G+
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 247
+ E+ P++K I K L +R SA
Sbjct: 183 ILYEL----------------------------------PELKDLIRKMLQKDPEKRPSA 208
Query: 248 KDLLKDP 254
K++L+
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 84/253 (33%), Positives = 136/253 (53%), Gaps = 23/253 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA D G EVA ++++ + + + +E+ ++K K N+V +Y S++
Sbjct: 36 YKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVDYYDSYLVGD-- 88
Query: 74 TVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+ ++ E G+L Q + I + R++L GL YLHS N +IHRD+K
Sbjct: 89 ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---CREVLQGLEYLHSQN--VIHRDIK 143
Query: 130 CDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 186
DNI ++ + G VK+ D G A + ++ SV+GTP +MAPE+ + ++Y VDI+S
Sbjct: 144 SDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL 202
Query: 187 GMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 244
G+ +EM E PY + P + +F T GI P + P+ K F+ KCLV +R
Sbjct: 203 GIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261
Query: 245 LSAKDLLKDPFLQ 257
SA++LL+ PFL+
Sbjct: 262 PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-44
Identities = 82/249 (32%), Positives = 133/249 (53%), Gaps = 19/249 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA + G EVA +K+ L+ +K+ +E+ +LK K N+VK+Y S++ +
Sbjct: 17 YKARHKRTGKEVA---IKVIK-LESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE- 71
Query: 74 TVNMITELFTSGNLRQYRKKHKNV----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+ ++ E + G+L+ K I + +++L GL YLHS+ IIHRD+K
Sbjct: 72 -LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV---CKELLKGLEYLHSNG--IIHRDIK 125
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE-LYEEEYNELVDIYSFG 187
NI + + GEVK+ D GL+ + AR +++GTP +MAPE + + Y+ DI+S G
Sbjct: 126 AANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLG 184
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RLS 246
+ +E+ + PYSE +FK T+G + + K F++KCL E R +
Sbjct: 185 ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244
Query: 247 AKDLLKDPF 255
A+ LLK PF
Sbjct: 245 AEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 5e-43
Identities = 84/253 (33%), Positives = 132/253 (52%), Gaps = 17/253 (6%)
Query: 12 SSYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
S Y+ + G A V + D Q +++L E+ LL L+ N+V++ + ++
Sbjct: 15 SVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE 74
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ + EL G+L + KK+ + VI+ + RQIL GL YLH N +HRD+K
Sbjct: 75 DN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKG 130
Query: 131 DNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFG 187
NI V+ N G VK+ D G+A ++ A+S G+P +MAPE+ ++ Y DI+S G
Sbjct: 131 ANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLG 189
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLAKVNDPQIKGFIEKCL-VPASE 243
+LEM T + P+S+ + A +FK S P L+ + K FI KCL S
Sbjct: 190 CTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLS----DEAKDFILKCLQRDPSL 245
Query: 244 RLSAKDLLKDPFL 256
R +A +LL+ PF+
Sbjct: 246 RPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 69/224 (30%), Positives = 121/224 (54%), Gaps = 15/224 (6%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI- 99
+ + +EV +LK L N++K+Y+S+ + K + ++ E G+L Q KK K
Sbjct: 42 EREDALNEVKILKKLNHPNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKEGKP 99
Query: 100 ---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156
+ I +W Q+ L YLHS I+HRD+K NIF+ N G VK+GD G++ +
Sbjct: 100 FPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156
Query: 157 T--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213
A++V+GTP +++PEL + + YN DI+S G + E+ T ++P+ E +N ++ K+
Sbjct: 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKI 215
Query: 214 TSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 256
G P ++ + +++ + L ER S +L+ PF+
Sbjct: 216 LKGQYPPIPSQYSS-ELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 74/251 (29%), Positives = 129/251 (51%), Gaps = 15/251 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YK + G A ++ +D + ++L E+ L+S + VVK Y ++ K+
Sbjct: 18 YKVRHKPTGKIYALKKIHVDGDEEF---RKQLLRELKTLRSCESPYVVKCYGAF--YKEG 72
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDN 132
++++ E G+L KK + V+ ARQIL GL YLH+ + IIHRD+K N
Sbjct: 73 EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSN 130
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 189
+ +N GEVKI D G++ ++ + +GT +M+PE + E Y+ DI+S G+
Sbjct: 131 LLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 190 ILEMVTFEYPYS--ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+LE ++P+ + ++ + + G P+ A+ P+ + FI CL +R S
Sbjct: 190 LLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
Query: 247 AKDLLKDPFLQ 257
A +LL+ PF++
Sbjct: 250 AAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 7e-36
Identities = 81/250 (32%), Positives = 132/250 (52%), Gaps = 14/250 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
Y +D G E+A +V D D + ++ L E+ LLK+L+ + +V++Y DD+
Sbjct: 19 YLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET 78
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++ M E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 LSIFM--EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGAN 134
Query: 133 IFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 186
I + G VK+GD G + I +SV GTP +M+PE+ E Y D++S
Sbjct: 135 ILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV 193
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERL 245
G ++EM+T + P++E + A IFK T P + V P + F+ + V A +R
Sbjct: 194 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRP 252
Query: 246 SAKDLLKDPF 255
SA++LL+ F
Sbjct: 253 SAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 80/228 (35%), Positives = 128/228 (56%), Gaps = 19/228 (8%)
Query: 42 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV 101
++++ E+ +L+ LK N+VK+Y V +K V + E + G L + + + +D V
Sbjct: 43 IKEIADEMKVLELLKHPNLVKYYGVEVHREK--VYIFMEYCSGGTLEELLEHGRILDEHV 100
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 159
I+ + Q+L GL YLHSH I+HRD+K NIF++ N G +K+GD G A+ ++ T
Sbjct: 101 IRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMG 157
Query: 160 ----SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 211
S+ GTP +MAPE+ + + DI+S G +LEM T + P+SE N QI
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF 217
Query: 212 KVTSGIKPASLAKVN-DPQIKGFIEKCLV--PASERLSAKDLLKDPFL 256
V +G KP + P+ K F+++CL P +R +A +LL+ PF+
Sbjct: 218 HVGAGHKPPIPDSLQLSPEGKDFLDRCLESDP-KKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 85/258 (32%), Positives = 128/258 (49%), Gaps = 32/258 (12%)
Query: 12 SSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
S YKA + G VA V ++ DLQ++ E+ +LK +VK+Y S+ K
Sbjct: 18 SVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYF--K 69
Query: 72 KKTVNMITELFTSGN----LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 127
+ ++ E +G+ ++ K +I I Q L GL YLHS+ IHRD
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI---LYQTLKGLEYLHSNK--KIHRD 124
Query: 128 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIY 184
+K NI +N G+ K+ D G++ + A+ +VIGTP +MAPE+ +E YN DI+
Sbjct: 125 IKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183
Query: 185 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PASLAKVND--PQIKGFIEKCLV 239
S G+ +EM + PYS+ IF I P +L+ P+ F++KCLV
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFNDFVKKCLV 238
Query: 240 -PASERLSAKDLLKDPFL 256
ER SA LL+ PF+
Sbjct: 239 KDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 78/247 (31%), Positives = 127/247 (51%), Gaps = 13/247 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YK + G VA ++ ++ + + L+ + E+ LLK+LK N+VK+ S
Sbjct: 17 YKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKHPNIVKYIGSIET--SD 72
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
++ +I E +G+LRQ KK ++ + Q+L GL YLH +IHRD+K NI
Sbjct: 73 SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANI 130
Query: 134 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 190
+ G VK+ D G+A + SV+GTP +MAPE+ E + DI+S G +
Sbjct: 131 LTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTV 189
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 249
+E++T PY + A +F+ V P L + P++K F+ +C + R +AK
Sbjct: 190 IELLTGNPPYYDLNPMAALFRIVQDDHPP--LPEGISPELKDFLMQCFQKDPNLRPTAKQ 247
Query: 250 LLKDPFL 256
LLK P++
Sbjct: 248 LLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 82/252 (32%), Positives = 137/252 (54%), Gaps = 11/252 (4%)
Query: 14 YKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
Y +D G E+A +V+ D + + ++ L E+ LLK+L+ + +V++Y D +
Sbjct: 19 YLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
KT+ + E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGAN 136
Query: 133 IFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 186
I + + G VK+GD G + I M RSV GTP +M+PE+ E Y D++S
Sbjct: 137 ILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL 195
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLS 246
G ++EM+T + P++E + A IFK T P + +++ + F+ V A R S
Sbjct: 196 GCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFLGCIFVEARHRPS 254
Query: 247 AKDLLKDPFLQV 258
A++LL+ PF Q+
Sbjct: 255 AEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 69/225 (30%), Positives = 121/225 (53%), Gaps = 14/225 (6%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVD 98
Q+L SEV++L+ LK N+V++Y +D +T+ ++ E G+L ++ +K+ K ++
Sbjct: 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE 103
Query: 99 IKVIKNWARQILHGLVYLHSHNPP---IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155
+ I Q+L L H+ + P ++HRDLK NIF++ N+ VK+GD GLA +
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGH 162
Query: 156 PT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 212
+ A++ +GTP +M+PE L Y+E DI+S G I E+ P+ +N Q+ K
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASK 221
Query: 213 VTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 256
+ G + ++ I+ L V +R S ++LL+ P +
Sbjct: 222 IKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 80/251 (31%), Positives = 135/251 (53%), Gaps = 11/251 (4%)
Query: 14 YKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
Y +D G E+A +V+ D + + ++ L E+ LLK+L + +V++Y D +
Sbjct: 19 YLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+T+++ E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGAN 136
Query: 133 IFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 186
I + + G VK+GD G + I + +SV GTP +M+PE+ E Y DI+S
Sbjct: 137 ILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV 195
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLS 246
G ++EM+T + P++E + A IFK T P V+D + F+++ V A R S
Sbjct: 196 GCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFLKRIFVEAKLRPS 254
Query: 247 AKDLLKDPFLQ 257
A +LL+ F+
Sbjct: 255 ADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 82/276 (29%), Positives = 133/276 (48%), Gaps = 28/276 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA D+ VA +K+ D+ + +++ + E+ L + + K+Y S++ K
Sbjct: 18 YKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ M E G+ K K +D I R++L GL YLH IHRD+K NI
Sbjct: 75 WIIM--EYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGK--IHRDIKAANI 129
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY-EEEYNELVDIYSFGMCI 190
++ G+VK+ D G++ + ++ + +GTP +MAPE+ + Y+E DI+S G+
Sbjct: 130 LLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITA 188
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVN-DPQIKGFIEKCLV--PASER 244
+E+ E P S+ +P +V I P SL K F+ CL P ER
Sbjct: 189 IELAKGEPPLSD-LHPM----RVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPK-ER 242
Query: 245 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 280
SAK+LLK F ++ K+ L L I+ +K +
Sbjct: 243 PSAKELLKHKF--IKKAKKT--SYLTLLIERIKKWK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 48/279 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA D+ G VA ++++D+ + G E+ LLK LK N+VK ++K
Sbjct: 16 YKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK- 72
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ ++ E + +L++Y K+ + +IK+ Q+L GL Y HSH I+HRDLK N
Sbjct: 73 -LYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQN 128
Query: 133 IFVNGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSF 186
I +N + G +K+ D GLA I ++ T V T + APE+ + Y+ VDI+S
Sbjct: 129 ILINRD-GVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHYSTAVDIWSV 185
Query: 187 GMCILEMVTF--------------------------EYP-YSECKNPAQIFKKVTSGIKP 219
G EM+T +P ++ + F K
Sbjct: 186 GCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP-PKDL 244
Query: 220 ASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL 256
+ DP+ + K L PA +R+SAK+ LK P+
Sbjct: 245 EKVLPRLDPEGIDLLSKMLQYNPA-KRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 73/239 (30%), Positives = 125/239 (52%), Gaps = 15/239 (6%)
Query: 11 FSS-YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 69
FS YKA G VA +V+I +++ Q E+ LLK L NV+K+ S+++
Sbjct: 15 FSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIE 73
Query: 70 DKKKTVNMITELFTSGNLRQ----YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 125
+ + +N++ EL +G+L + ++K+ + + + I + Q+ L ++HS I+H
Sbjct: 74 NNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMH 129
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPE-LYEEEYNELVD 182
RD+K N+F+ G VK+GDLGL T A S++GTP +M+PE ++E YN D
Sbjct: 130 RDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188
Query: 183 IYSFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 240
I+S G + EM + P Y + N + KK+ P A +++ + +C+ P
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 81/249 (32%), Positives = 134/249 (53%), Gaps = 11/249 (4%)
Query: 14 YKAFDEFAGIEVAWSRVKID-DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
Y +D G E+A +V D D + ++ L E+ LLK+L+ D +V++Y D ++
Sbjct: 19 YLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
K +++ E G+++ K + + V + + RQIL G+ YLHS+ I+HRD+K N
Sbjct: 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGAN 136
Query: 133 IFVNGNHGEVKIGDLGLA-----IAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSF 186
I + + G VK+GD G + I M +SV GTP +M+PE+ E Y D++S
Sbjct: 137 ILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV 195
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLS 246
++EM+T + P++E + A IFK T KP V+D + F+++ V R +
Sbjct: 196 ACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRDFLKQIFVEEKRRPT 254
Query: 247 AKDLLKDPF 255
A+ LL+ PF
Sbjct: 255 AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 73/243 (30%), Positives = 116/243 (47%), Gaps = 24/243 (9%)
Query: 30 VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR- 88
+K D+ + + +L EV + NVVK+Y S+V + + M + G+L
Sbjct: 31 IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM--PYLSGGSLLD 88
Query: 89 --QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 146
+ +D +I +++L GL YLHS+ IHRD+K NI + G G VKI D
Sbjct: 89 IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILL-GEDGSVKIAD 145
Query: 147 LGLAIAMQQPTARS------VIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEY 198
G++ ++ R+ +GTP +MAPE+ E+ Y+ DI+SFG+ +E+ T
Sbjct: 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205
Query: 199 PYSECKNPAQIFKKVTSGIKPASL-----AKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 252
PYS+ P ++ P SL K + I CL S+R +A++LLK
Sbjct: 206 PYSKYP-PMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
Query: 253 DPF 255
F
Sbjct: 264 HKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
+++ E +++ L N+VK +++ + ++ E G+L Y +K++ ++
Sbjct: 44 QIEEFLREARIMRKLDHPNIVKLL-GVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPKELS 101
Query: 101 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
+ ++A QI G+ YL S N IHRDL N V N VKI D GL+ +
Sbjct: 102 LSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDY 158
Query: 159 RSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
V G +MAPE L E ++ D++SFG+ + E+ T E PY N A++ + +
Sbjct: 159 YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYL 217
Query: 214 TSGIK-------PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 252
G + P L K+ + +C +R + +L++
Sbjct: 218 KKGYRLPKPPNCPPELYKL--------MLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 58/215 (26%), Positives = 110/215 (51%), Gaps = 15/215 (6%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
E ++L + +VK + ++ ++K + ++ E G L + K + + +A
Sbjct: 43 ERNILSRINHPFIVKLHYAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAA 100
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP 165
+I+ L YLHS II+RDLK +NI ++ G +K+ D GLA ++ + + GTP
Sbjct: 101 EIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 166 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 224
E++APE L + Y + VD +S G+ + EM+T + P+ ++ +I++K+ P +
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPE 214
Query: 225 VNDPQIKGFIEKCLVP-ASERL---SAKDLLKDPF 255
P+ + I L ++RL A+++ PF
Sbjct: 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 66/215 (30%), Positives = 118/215 (54%), Gaps = 13/215 (6%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
E +L L ++++Y+S++D K +N++ E +G+L + K + + + W
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRF 106
Query: 108 --QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 163
QIL GL +LHS I+HRD+K N+F++ VKIGDLG+A + T A +++G
Sbjct: 107 FIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVG 163
Query: 164 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 222
TP +++PEL E++ YNE D+++ G+ + E T ++P+ + N + K+ G+ P
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFPPVS 222
Query: 223 AKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 256
+ Q+ I++CL +R LL++P L
Sbjct: 223 QMYS-QQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 72/228 (31%), Positives = 123/228 (53%), Gaps = 20/228 (8%)
Query: 41 DLQK------LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH 94
DL+K L++EV +++ + N+V+ Y S++ + V M E G L H
Sbjct: 53 DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM--EFLEGGALTDI-VTH 109
Query: 95 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 152
++ + I +L L +LH+ +IHRD+K D+I + + G VK+ D G ++
Sbjct: 110 TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVS 166
Query: 153 MQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 211
+ P +S++GTP +MAPE+ Y VDI+S G+ ++EMV E PY + P Q K
Sbjct: 167 KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMK 225
Query: 212 KVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256
++ + P L KV+ P+++ F+++ LV ++R +A +LL PFL
Sbjct: 226 RIRDNLPPKLKNLHKVS-PRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 82/230 (35%), Positives = 117/230 (50%), Gaps = 23/230 (10%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 99
+Q L+ E+ L LK N+V++ S D + + E G+L R K +
Sbjct: 48 YVQPLHEEIALHSYLKHRNIVQYLGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKD 105
Query: 100 K--VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQ 155
I + +QIL GL YLH + I+HRD+K DN+ VN G VKI D G + +A
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163
Query: 156 PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFK 211
P + GT ++MAPE+ ++ Y DI+S G I+EM T + P+ E P A +FK
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK 223
Query: 212 ----KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 256
K+ I P SL+ + K FI +C P +R SA DLL+DPFL
Sbjct: 224 VGMFKIHPEI-PESLSA----EAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 64/256 (25%), Positives = 108/256 (42%), Gaps = 37/256 (14%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
K +EVA VK L+ +++ E +++ L NVVK +
Sbjct: 20 LKGKGGKKKVEVA---VK---TLKEDASEQQIEEFLREARIMRKLDHPNVVKLL-GVCTE 72
Query: 71 KKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
++ ++ E G+L Y RK + + + ++A QI G+ YL S N IHRDL
Sbjct: 73 EEPLY-IVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN--FIHRDLA 129
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE---FMAPE-LYEEEYNELVDIYS 185
N V N VKI D GL+ + G +MAPE L E ++ D++S
Sbjct: 130 ARNCLVGENLV-VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWS 188
Query: 186 FGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-------PASLAKVNDPQIKGFIEKC 237
FG+ + E+ T E PY N ++ + + +G + P L + + +C
Sbjct: 189 FGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPELYDL--------MLQC 239
Query: 238 LVP-ASERLSAKDLLK 252
+R + +L++
Sbjct: 240 WAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 40/227 (17%)
Query: 59 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS 118
++K Y ++ D++ + + E +G L QY +K+ ++D K + +A +IL L YLHS
Sbjct: 63 GIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 119 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----------------------QQP 156
IIHRDLK +NI ++ + +KI D G A + +
Sbjct: 121 KG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 157 TARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVT 214
S +GT E+++PEL E+ + D+++ G CI+ +M+T + P+ N F+K+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFR-GSNEYLTFQKIL 235
Query: 215 SGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKD----LLKDPF 255
S P K IEK LV P +RL + L PF
Sbjct: 236 KL--EYSFPPNFPPDAKDLIEKLLVLDP-QDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 13/215 (6%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKN-VDIKVIK 103
E+ +L S+ N++ + ++++D K + M E G+L + RKK + + + I
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVM--EYAPFGDLSKAISKRKKKRKLIPEQEIW 106
Query: 104 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 163
Q+L GL LH I+HRDLK NI + N VKIGDLG++ +++ A++ IG
Sbjct: 107 RIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKNMAKTQIG 163
Query: 164 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 222
TP +MAPE+++ Y+ DI+S G + EM TF P+ E ++ + KV G P +
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPP-I 221
Query: 223 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 256
+ ++ FI L R + +L P +
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
K E +VA +K + + ++ E ++K L N+V+ V + +
Sbjct: 20 LKGDGEGTETKVAVKTLKEGASEE---EREEFLEEASIMKKLSHPNIVRLLG--VCTQGE 74
Query: 74 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ ++TE G+L + +KH + +K + A QI G+ YL S N +HRDL N
Sbjct: 75 PLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN--FVHRDLAARN 132
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF-----MAPELYEE-EYNELVDIYSF 186
V N VKI D GL+ + MAPE ++ ++ D++SF
Sbjct: 133 CLVTEN-LVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSF 190
Query: 187 GMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
G+ + E+ T E PY N ++ + + G
Sbjct: 191 GVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 75/234 (32%), Positives = 117/234 (50%), Gaps = 24/234 (10%)
Query: 33 DDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 89
DDV D+Q+ EV LL L+ N+ K+Y S++ + +I E G++R
Sbjct: 41 DDV----SDIQR---EVALLSQLRQSQPPNITKYYGSYLKGP--RLWIIMEYAEGGSVRT 91
Query: 90 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149
K + K I R++L L Y+H +IHRD+K NI V N G VK+ D G+
Sbjct: 92 LMKAGP-IAEKYISVIIREVLVALKYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGV 147
Query: 150 AIAMQQPTAR--SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN 205
A + Q +++ + +GTP +MAPE+ E Y+ DI+S G+ I EM T PYS+ +
Sbjct: 148 AALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VD 206
Query: 206 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQ 257
+ + P ++ F+ CL P ERLSA++LLK +++
Sbjct: 207 AFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPK-ERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 113 bits (282), Expect = 5e-27
Identities = 70/310 (22%), Positives = 115/310 (37%), Gaps = 33/310 (10%)
Query: 42 LQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH---KNV 97
+++ E+ +L SL N+VK Y + D+ + ++ E G+L KK +
Sbjct: 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGS--LYLVMEYVDGGSLEDLLKKIGRKGPL 98
Query: 98 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM---- 153
QIL L YLHS IIHRD+K +NI ++ + VK+ D GLA +
Sbjct: 99 SESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156
Query: 154 ----QQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPY---SE 202
+ +GTP +MAPE+ + DI+S G+ + E++T P+
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 203 CKNPAQIFKKVTSGIKPASLAKVN-------DPQIKGFIEKCLVP-ASERLSAKDLLKDP 254
+Q K + P+ + ++ ++K L RLS+ L
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 255 FLQVENQKE--PICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSPH 312
L KE L++ P ++S S +SN
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
Query: 313 CPVLEFQRMH 322
P H
Sbjct: 337 APNGVSSSPH 346
|
Length = 384 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 68/232 (29%), Positives = 117/232 (50%), Gaps = 19/232 (8%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWA 106
E+ +L K N+V Y+++ + K ++ E G L + + + I+
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLW--ILIEFCDGGALDSIMLELERGLTEPQIRYVC 109
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGT 164
RQ+L L +LHSH +IHRDLK NI + G+VK+ D G++ + + + IGT
Sbjct: 110 RQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGT 166
Query: 165 PEFMAPELYEEE------YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 218
P +MAPE+ E Y+ DI+S G+ ++E+ E P+ E NP ++ K+ +
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKS-E 224
Query: 219 PASLAKVN--DPQIKGFIEKCLVPASE-RLSAKDLLKDPFLQVENQKEPICD 267
P +L + + F++ CLV + R +A +LLK PF+ ++ + I D
Sbjct: 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKD 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 14/222 (6%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 102
+ L E+ L+ L ++++ + +D N+ E G++ K+ VI
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATCEDSH--FNLFVEWMAGGSVSHLLSKYGAFKEAVI 105
Query: 103 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-- 160
N+ Q+L GL YLH + IIHRD+K N+ ++ ++I D G A + +
Sbjct: 106 INYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 161 ----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYS--ECKNPAQIFKKV 213
++GT FMAPE L E+Y D++S G I+EM T + P++ + N + K+
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223
Query: 214 TSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDP 254
S S+ + P ++ +CL + +R +++LLK P
Sbjct: 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 77/254 (30%), Positives = 121/254 (47%), Gaps = 23/254 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
YKA D G VA +K++ PGD + + E+ +LK + N+V ++ S++ K
Sbjct: 20 YKARDIATGELVAIKVIKLE-----PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDK 74
Query: 73 KTVNMITELFTSGNLRQ-YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ M E G+L+ Y+ + I R+ L GL YLH IHRD+K
Sbjct: 75 LWIVM--EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGA 130
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE----YNELVDIYS 185
NI + G+VK+ D G++ + A+ S IGTP +MAPE+ E Y+ DI++
Sbjct: 131 NILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWA 189
Query: 186 FGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVN--DPQIKGFIEKCLVPA- 241
G+ +E+ + P + +P + +F S P L P FI+KCL
Sbjct: 190 LGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDP 248
Query: 242 SERLSAKDLLKDPF 255
+R +A LL+ PF
Sbjct: 249 KKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 79/260 (30%), Positives = 135/260 (51%), Gaps = 22/260 (8%)
Query: 12 SSYKAFDEFAGIEVAWSRVKIDDVLQLPGD-----LQKLYSEVHLLKSLKDDNVVKFYKS 66
S Y + +G +A +V++ V D L L E+ LLK L+ +N+V++ S
Sbjct: 15 SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS 74
Query: 67 WVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
+D +N+ E G++ + + +++N+ RQIL GL YLH+ IIHR
Sbjct: 75 SLDADH--LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHR 130
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTAR-SVIGTPEFMAPELYEEE-Y 177
D+K NI V+ N G +KI D G++ ++ + AR S+ G+ +MAPE+ ++ Y
Sbjct: 131 DIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY 189
Query: 178 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237
DI+S G ++EM+T ++P+ +C IF K+ P + ++ + F+EK
Sbjct: 190 TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISS-EAIDFLEKT 247
Query: 238 LVP-ASERLSAKDLLKDPFL 256
++R +A +LLK PFL
Sbjct: 248 FEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 74/245 (30%), Positives = 120/245 (48%), Gaps = 19/245 (7%)
Query: 25 VAWSRVKID--DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 82
+A +V++D +VL + +KL EV LLKSLK N+V++ + +DD T+++ E
Sbjct: 27 IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISIFMEFV 84
Query: 83 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 142
G++ + + V + +QIL G+ YLH++ ++HRD+K +N+ + N G +
Sbjct: 85 PGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GII 141
Query: 143 KIGDLGLA--IAM------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEM 193
K+ D G A +A +S+ GTP +MAPE+ E Y DI+S G + EM
Sbjct: 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 251
T + P + A +F + + L F+ CL ER SA LL
Sbjct: 202 ATGKPPLASMDRLAAMF-YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260
Query: 252 KDPFL 256
+ FL
Sbjct: 261 RHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 23/230 (10%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-- 96
+ + E ++K L NVV+ +++ ++ E G+L Y +K +
Sbjct: 37 EEERKDFLKEARVMKKLGHPNVVRLL-GVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVF 94
Query: 97 -------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149
+ +K + ++A QI G+ YL S +HRDL N V G VKI D GL
Sbjct: 95 PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFGL 151
Query: 150 AIAMQQPT-ARSVIGTPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSEC 203
+ + R G +MAPE L + + D++SFG+ + E+ T PY
Sbjct: 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211
Query: 204 KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 252
N ++ + + G + D ++ + C +R + +L++
Sbjct: 212 SN-EEVLEYLRKGYRLPKPEYCPD-ELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 62/236 (26%), Positives = 122/236 (51%), Gaps = 16/236 (6%)
Query: 29 RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 88
R++I++ +Q +++ E+ +L +V FY ++ ++ +++ E G+L
Sbjct: 35 RLEINEAIQ-----KQILRELDILHKCNSPYIVGFYGAFYNNG--DISICMEYMDGGSLD 87
Query: 89 QYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147
+ K+ + +++ A +L GL YLH IIHRD+K NI VN + G++K+ D
Sbjct: 88 KILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDF 145
Query: 148 GLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSEC--- 203
G++ + A++ +GT +MAPE + +Y+ DI+S G+ ++E+ T +PY
Sbjct: 146 GVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP 205
Query: 204 -KNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
++ + + + P + P + F+ CL+ ER S K+LL+ PF++
Sbjct: 206 PDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 70/239 (29%), Positives = 126/239 (52%), Gaps = 14/239 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+A G+ VA +V+I D++ E+ LLK L NV+K+Y S+++D +
Sbjct: 19 YRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKYYASFIEDNE- 76
Query: 74 TVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+N++ EL +G+L + ++K+ + + K + + Q+ L ++HS ++HRD+K
Sbjct: 77 -LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIK 133
Query: 130 CDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 186
N+F+ G VK+GDLGL + + A S++GTP +M+PE ++E YN DI+S
Sbjct: 134 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 187 GMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASER 244
G + EM + P Y + N + KK+ P + +++ + C+ P E+
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 66/240 (27%), Positives = 126/240 (52%), Gaps = 19/240 (7%)
Query: 41 DLQK-LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHK 95
DLQK + E+ + KS K +VK+Y +++D+ ++ + E G+L ++ +K+
Sbjct: 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG 100
Query: 96 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155
+ KV+ A +L GL YLHS IIHRD+K NI + G+VK+ D G++ +
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN 157
Query: 156 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY-SECKNPAQIFKKV 213
A + GT +MAPE + + Y+ D++S G+ +LE+ +P+ E + P + +
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217
Query: 214 TSGIKPASLAKVNDP--------QIKGFIEKCL-VPASERLSAKDLLKDPFLQVENQKEP 264
+ + + ++P + K FI++CL + R + D+L+ P+++ + +K+
Sbjct: 218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 102
++ +E +L + VVK Y S+ K + ++ E G+L + ++D V
Sbjct: 38 DQVLTERDILSQAQSPYVVKLYYSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVA 95
Query: 103 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL--------AIAMQ 154
+ + +I+ L YLHS+ IIHRDLK DNI ++ N G +K+ D GL I +
Sbjct: 96 RIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLN 152
Query: 155 QPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 211
++GTP+++APE + + +++ VD +S G + E + P+ + P +IF+
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQ 211
Query: 212 KVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RL---SAKDLLKDPFL 256
+ +G + I K LVP E RL S +++ PF
Sbjct: 212 NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 73/218 (33%), Positives = 120/218 (55%), Gaps = 14/218 (6%)
Query: 45 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 104
L++EV +++ + +NVV+ Y S++ + V M E G L H ++ + I
Sbjct: 64 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM--EFLEGGALTDI-VTHTRMNEEQIAA 120
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 162
+L L LH+ +IHRD+K D+I + + G VK+ D G ++ + P +S++
Sbjct: 121 VCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLV 177
Query: 163 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 219
GTP +MAPEL Y VDI+S G+ ++EMV E PY + P + K + + P
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKL 236
Query: 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256
+L KV+ P +KGF+++ LV ++R +A +LLK PFL
Sbjct: 237 KNLHKVS-PSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 16/223 (7%)
Query: 45 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 104
++SE +L+ +VK Y+++ D KK + M+ E G L + D +
Sbjct: 40 IFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARF 97
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-ARSVIG 163
+ ++ YLH+ II+RDLK +N+ ++ N G VK+ D G A ++ + G
Sbjct: 98 YIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCG 154
Query: 164 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPAS 221
TPE++APE+ + Y+ VD +S G+ + E++T P+ E +P +I+ + G
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE 214
Query: 222 LAKVNDPQIKGFIEK--CLVPASERL-----SAKDLLKDPFLQ 257
D K I++ P ERL KD+ K +
Sbjct: 215 FPNYIDKAAKDLIKQLLRRNPE-ERLGNLKGGIKDIKKHKWFN 256
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 52/158 (32%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT---SGNLRQYRKKHKNVDIKVIKN 104
E+ LL+ L+ N+V+ + K ++ M+ E +G L K IK
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKC 104
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS---- 160
+ +Q+L GL YLHS+ I+HRD+K NI +N N G +K+ D GLA + +
Sbjct: 105 YMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 161 VIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 195
VI T + PEL Y VD++S G CIL E+
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVG-CILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 64/217 (29%), Positives = 115/217 (52%), Gaps = 11/217 (5%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDIK 100
+E +LK L N++++Y+++++DK + M E G L +Y +K N +D
Sbjct: 44 LAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM--EYAPGGTLAEYIQKRCNSLLDED 101
Query: 101 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTAR 159
I ++ QIL L ++H+ I+HRDLK NI ++ + VKIGD G++ I + A
Sbjct: 102 TILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159
Query: 160 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 218
+V+GTP +++PEL E + YN+ DI++ G + E+ + + + PA + K+ SG
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL-KIMSG-T 217
Query: 219 PASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDP 254
A ++ P ++ I L + S+R ++ P
Sbjct: 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 72/217 (33%), Positives = 115/217 (52%), Gaps = 12/217 (5%)
Query: 45 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 104
L++EV +++ + NVV+ YKS++ ++ V M E G L + + ++ + I
Sbjct: 65 LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM--EFLQGGALTDIVSQTR-LNEEQIAT 121
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 162
+L L YLHS +IHRD+K D+I + + G VK+ D G I+ P +S++
Sbjct: 122 VCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLV 178
Query: 163 GTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-A 220
GTP +MAPE+ Y VDI+S G+ ++EMV E PY +P Q K++ P
Sbjct: 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKL 237
Query: 221 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256
A P ++ F+E+ L ER +A++LL PFL
Sbjct: 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-23
Identities = 68/220 (30%), Positives = 119/220 (54%), Gaps = 14/220 (6%)
Query: 45 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 104
L++EV +++ +NVV Y S++ + V M E G L H ++ + I
Sbjct: 66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM--EFLEGGALTDI-VTHTRMNEEQIAT 122
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 162
+L L YLH+ +IHRD+K D+I + + G +K+ D G ++ + P +S++
Sbjct: 123 VCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLV 179
Query: 163 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 219
GTP +MAPE+ Y VDI+S G+ ++EM+ E PY + P Q +++ + P
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRV 238
Query: 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258
KV+ ++GF++ LV S+R +A++LL+ PFL++
Sbjct: 239 KDSHKVSS-VLRGFLDLMLVREPSQRATAQELLQHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 45 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 104
L SE+ LK L N+V++ + ++ +++ E G++ + + + ++++
Sbjct: 55 LRSEIETLKDLDHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL----AIAMQQPTARS 160
+ Q+L GL YLHS I+HRDLK DN+ V+ + G KI D G+ S
Sbjct: 113 FTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMS 169
Query: 161 VIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK----KV 213
+ G+ +MAPE Y + Y+ VDI+S G +LEM P+S+ + A +FK +
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS 229
Query: 214 TSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPF 255
I P ++ + + R +A++LL+ PF
Sbjct: 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 65/235 (27%), Positives = 122/235 (51%), Gaps = 14/235 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+A VA +V+I +++ Q E+ LLK L NV+K+ S+++D +
Sbjct: 19 YRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIKYLDSFIEDNE- 76
Query: 74 TVNMITELFTSGNLRQ----YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+N++ EL +G+L Q ++K+ + + + + + Q+ + ++HS ++HRD+K
Sbjct: 77 -LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIK 133
Query: 130 CDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 186
N+F+ G VK+GDLGL + + A S++GTP +M+PE ++E YN DI+S
Sbjct: 134 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 192
Query: 187 GMCILEMVTFEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 240
G + EM + P Y + N + +K+ P + +++ + C+ P
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 78/252 (30%), Positives = 129/252 (51%), Gaps = 16/252 (6%)
Query: 12 SSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
+ Y A D G EVA ++ + Q +L + +E+ +++ K N+V + S++
Sbjct: 34 TVYTAIDVATGQEVAIKQMNLQQ--QPKKEL--IINEILVMRENKHPNIVNYLDSYLVGD 89
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ V M E G+L + +D I R+ L L +LHS+ +IHRD+K D
Sbjct: 90 ELWVVM--EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSD 144
Query: 132 NIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGM 188
NI + G G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 145 NILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 189 CILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLS 246
+EMV E PY +NP + ++ T+G + + F+ +CL + +R S
Sbjct: 204 MAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS 262
Query: 247 AKDLLKDPFLQV 258
AK+LL+ PFL++
Sbjct: 263 AKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 79/250 (31%), Positives = 130/250 (52%), Gaps = 16/250 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ A D G EVA ++ LQ + + +E+ ++K LK+ N+V F S++ +
Sbjct: 36 FTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
V M E G+L + +D I R+ L L +LH++ +IHRD+K DN+
Sbjct: 92 FVVM--EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNV 146
Query: 134 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 190
+ G G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 191 LEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAK 248
+EMV E PY +NP + ++ T+G + P + F+ +CL + +R SAK
Sbjct: 206 IEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAK 264
Query: 249 DLLKDPFLQV 258
+LL+ PFL++
Sbjct: 265 ELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ--YRKKHKNVDIKVIKNW 105
E+ +L L+ N++ +Y ++DD + M E G L R+K + + +++ +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 163
QI+ + Y+H I+HRD+K NIF+ G +K+GD G++ + A +V+G
Sbjct: 107 LFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVG 163
Query: 164 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 222
TP +M+PEL + +YN DI++ G + E++T + + + NP + K+ G
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNY---- 218
Query: 223 AKVNDPQIKGFIE---KCL-VPASERLSAKDLLKDPFL 256
V I L +R +A ++L P L
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 16/222 (7%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 102
+ + +E +L+ L +V + S+ D++ + ++ +L G+LR + + + +
Sbjct: 45 RNVLNERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQV 102
Query: 103 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARSV 161
K W +I+ L YLHS IIHRD+K DNI ++ G V I D +A + S
Sbjct: 103 KFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTST 159
Query: 162 IGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGI 217
GTP +MAPE+ + Y+ VD +S G+ E + + PY S K+ T+ +
Sbjct: 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV 219
Query: 218 K-PASLAKVNDPQIKGFIEKCLVPASERLS--AKDLLKDPFL 256
PA+ + I +E +RL KDL P+
Sbjct: 220 LYPATWSTEAIDAINKLLE---RDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 9e-22
Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 72/323 (22%)
Query: 15 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK-- 72
A D+ G +VA KI +V D +++ E+ LL+ L+ +N++
Sbjct: 18 SAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75
Query: 73 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
V ++TEL + +L + K + + I+ + QIL GL YLHS N +IHRDLK
Sbjct: 76 FNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPS 132
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE--LYEEEYNE 179
NI VN N ++KI D GLA + F+ APE L Y +
Sbjct: 133 NILVNSN-CDLKICDFGLARGVDPDED-----EKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 180 LVDIYSFGMCIL-EMVT----F----------------------EYPYSECKNPAQIFKK 212
+DI+S G CI E++T F + + + A+ + K
Sbjct: 187 AIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK-ARNYLK 244
Query: 213 VTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKEPI 265
L+K+ P+ +EK LV P +R++A + L P+L + + EP+
Sbjct: 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK-KRITADEALAHPYLAQLHDPEDEPV 303
Query: 266 CDPL---------KLPIQSLKML 279
P +L + LK L
Sbjct: 304 AKPPFDFDFFDDDELTEEELKEL 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 44/270 (16%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK-LYSEVHLLKSLKD-DNVVKFYKSWVDDK 71
YKA + G VA +KI D++ D ++ + E ++L+ + N+ FY +++ K
Sbjct: 23 YKARHKKTGQLVA---IKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFI--K 74
Query: 72 KKTVN------MITELFTSGNLRQYRKKHKNVDIKVIKNW----ARQILHGLVYLHSHNP 121
K ++ EL G++ K + ++ + W R+ L GL YLH +
Sbjct: 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK- 133
Query: 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPEL------Y 173
+IHRD+K NI + N EVK+ D G++ + R + IGTP +MAPE+
Sbjct: 134 -VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQP 191
Query: 174 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA----QIFKKVTSGIKPASL--AKVND 227
+ Y+ D++S G+ +E+ + P + +P +I + +K K ND
Sbjct: 192 DASYDARSDVWSLGITAIELADGKPPLCD-MHPMRALFKIPRNPPPTLKSPENWSKKFND 250
Query: 228 PQIKGFIEKCLVP-ASERLSAKDLLKDPFL 256
FI +CL+ +R ++LL+ PF+
Sbjct: 251 -----FISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 12/215 (5%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDIKVIKNW 105
E LL LK N+V + +SW + + + ++ G+L K+ K + + W
Sbjct: 49 EAQLLSQLKHPNIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVIG 163
QI L YLH + I+HRDLK N+F+ + +K+GDLG+A + Q A ++IG
Sbjct: 108 FVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIG 164
Query: 164 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 222
TP +M+PEL+ + YN D+++ G C+ EM T ++ ++ + +++ + + P +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--M 222
Query: 223 AKVNDPQIKGFIEKCLVPASE-RLSAKDLLKDPFL 256
K P++ I L E R S K +L+ P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 14/216 (6%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK--VIKNW 105
EV LL +K N+V F+ S+ ++ + + M E G+L + + + V I +W
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVM--EYCDGGDLMKRINRQRGVLFSEDQILSW 106
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 163
QI GL H H+ I+HRD+K NIF++ N K+GD G+A + A + +G
Sbjct: 107 FVQISLGLK--HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 164 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IKPAS 221
TP +++PE+ + YN DI+S G + E+ T ++P+ E N Q+ K+ G P S
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGYFAPIS 223
Query: 222 LAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 256
D ++ I + V +R S +LK PFL
Sbjct: 224 PNFSRD--LRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 74/261 (28%), Positives = 110/261 (42%), Gaps = 58/261 (22%)
Query: 43 QKLYS--------EVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK 93
+K YS EV L+ L + N+VK + + + + + E + GNL Q K
Sbjct: 34 KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE-YMEGNLYQLMKD 90
Query: 94 HKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151
K VI++ QIL GL ++H H HRDLK +N+ V+G VKI D GLA
Sbjct: 91 RKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAR 147
Query: 152 AMQ-QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTFE--YP-YSECK 204
++ +P + T + APE L Y+ VDI++ G CI+ E+ T +P SE
Sbjct: 148 EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYTLRPLFPGSSEID 206
Query: 205 NPAQIFKKVT-----------SGIKPASLAKVNDPQIKG----------------FIEKC 237
Q++K + G K AS PQ I+
Sbjct: 207 ---QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDM 263
Query: 238 LV--PASERLSAKDLLKDPFL 256
L P +R +A L+ P+
Sbjct: 264 LRWDPK-KRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 73/231 (31%), Positives = 120/231 (51%), Gaps = 12/231 (5%)
Query: 30 VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 89
+KI D+ + +++ + E+ +L V K+Y S++ D K + +I E G+
Sbjct: 34 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALD 91
Query: 90 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149
+ +D I R+IL GL YLHS IHRD+K N+ ++ HGEVK+ D G+
Sbjct: 92 LLEPGP-LDETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGV 147
Query: 150 A--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNP 206
A + Q + +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P+SE +P
Sbjct: 148 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HP 206
Query: 207 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFL 256
++ + P + P +K F+E CL S R +AK+LLK F+
Sbjct: 207 MKVLFLIPKNNPPTLEGNYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 55/173 (31%), Positives = 97/173 (56%), Gaps = 12/173 (6%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 106
+E +L+S++ +V Y S+ DD + ++ E G L + +K V + +A
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYA 107
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
Q++ L YLHS + I++RDLK +N+ + + G +KI D G A ++ T ++ GTPE
Sbjct: 108 AQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTPE 163
Query: 167 FMAPELYEEE-YNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSG 216
++APE+ + Y + VD ++ G+ I EM+ YP + + NP QI++K+ G
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDD--NPIQIYEKILEG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 78/254 (30%), Positives = 129/254 (50%), Gaps = 24/254 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y A D G EVA ++ LQ + + +E+ +++ K+ N+V + S++ +
Sbjct: 36 YTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
V M E G+L + +D I R+ L L +LHS+ +IHRD+K DNI
Sbjct: 92 WVVM--EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNI 146
Query: 134 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 190
+ G G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 147 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 205
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ-----IKGFIEKCL-VPASER 244
+EMV E PY +NP + + + P ++ +P+ + F+ +CL + R
Sbjct: 206 IEMVEGEPPYLN-ENPLRALYLIATNGTP----ELQNPERLSAVFRDFLNRCLEMDVDRR 260
Query: 245 LSAKDLLKDPFLQV 258
SAK+LL+ PFL++
Sbjct: 261 GSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 57/225 (25%), Positives = 113/225 (50%), Gaps = 21/225 (9%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
E+ ++ + +V FY +++++ + M E G+L + KK + ++++ A
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENN--ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAV 110
Query: 108 QILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
++ GL YL++ H I+HRD+K NI VN G++K+ D G++ + A + +GT
Sbjct: 111 AVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTST 167
Query: 167 FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-------- 217
+M+PE + +Y D++S G+ I+E+ ++P++ N + GI
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIV 226
Query: 218 --KPASLAKVNDPQI-KGFIEKCLV-PASERLSAKDLLK-DPFLQ 257
P L + P+ + F++ CL+ +ER + + L PF+Q
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 67/255 (26%), Positives = 124/255 (48%), Gaps = 20/255 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA+ +A + +D ++L +++ SE+ +L ++ FY ++ + +
Sbjct: 18 YKAYHLLTRRILAVKVIPLDITVELQ---KQIMSELEILYKCDSPYIIGFYGAFFVENR- 73
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+++ TE G+L YRK + V+ A ++ GL YL S I+HRD+K N+
Sbjct: 74 -ISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNM 126
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 192
VN G+VK+ D G++ + A++ +GT +MAPE + E+Y D++S G+ +E
Sbjct: 127 LVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
Query: 193 MVTFEYPYSEC-KN-----PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERL 245
+ +PY + KN P Q+ + + P + FI +C+ ER
Sbjct: 186 LALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERP 245
Query: 246 SAKDLLKDPFLQVEN 260
+ ++L+ PF+ N
Sbjct: 246 APENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 21/224 (9%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF---TSGNLRQYRKKHKNVDI 99
Q + EV L+ L+ N +++ ++ ++ T ++ E S L ++K + V+I
Sbjct: 60 QDIIKEVRFLQQLRHPNTIEYKGCYL--REHTAWLVMEYCLGSASDILEVHKKPLQEVEI 117
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
I L GL YLHSH IHRD+K NI + G VK+ D G A ++ P A
Sbjct: 118 AAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSA-SLVSP-AN 169
Query: 160 SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 215
S +GTP +MAPE+ E +Y+ VD++S G+ +E+ + P + ++ +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 216 GIKPASLAKVNDPQ-IKGFIEKCLV-PASERLSAKDLLKDPFLQ 257
+L+ + + F++ CL +R S+++LLK F+
Sbjct: 230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 57/176 (32%), Positives = 98/176 (55%), Gaps = 13/176 (7%)
Query: 45 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIK 103
L E+ +L++L +N+VK+ +D + +I E SG+L++Y ++KN +++K
Sbjct: 53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL 112
Query: 104 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TAR 159
+A QI G+ YL S +HRDL N+ V + +VKIGD GL A++ T +
Sbjct: 113 KYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVK 169
Query: 160 SVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213
+ +P F APE L + ++ D++SFG+ + E++T Y SE +P +F K+
Sbjct: 170 DDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT--YCDSES-SPMTLFLKM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 77/284 (27%), Positives = 118/284 (41%), Gaps = 53/284 (18%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL----YSEVHLLKSLKD---DNVVKFYK- 65
YKA D G VA +V++ P + + E+ LLK L+ N+V+
Sbjct: 16 YKARDLNTGRFVALKKVRV------PLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDV 69
Query: 66 --SWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNP 121
D++ + ++ E +L Y K + + IK+ RQ+L G+ +LHSH
Sbjct: 70 CHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR- 127
Query: 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNE 179
I+HRDLK NI V + G+VKI D GLA I + SV+ T + APE L + Y
Sbjct: 128 -IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYAT 185
Query: 180 LVDIYSFGMCIL-EMVTFE---YPYSECKNPAQIFKKV---------------------T 214
VD++S G CI E+ SE +IF +
Sbjct: 186 PVDMWSVG-CIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSY 244
Query: 215 SGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL 256
+ S + ++K L P R+SA + L+ P+
Sbjct: 245 TPRSFKSFVPEICEEGLDLLKKMLTFNPHK-RISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIK 103
E LL L +VKF+ S+++ + +ITE +L + + K + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLE--RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC 109
Query: 104 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSV 161
W Q+L G+ Y+H I+HRDLK NIF+ N +KIGD G++ + A +
Sbjct: 110 EWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTF 165
Query: 162 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA 220
GTP +M+PE L + Y+ DI+S G + EM + + E +N + ++ G P
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP- 223
Query: 221 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFL 256
SL + Q+ ++ L S R SA ++L++PF+
Sbjct: 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 70/246 (28%), Positives = 110/246 (44%), Gaps = 44/246 (17%)
Query: 52 LKSLKDDN---VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQ 108
LK L + N +V FY ++ D + ++ M E G+L Q KK + ++ +
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIA 107
Query: 109 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 168
+L GL YL I+HRD+K NI VN GE+K+ D G++ + A S +GT +M
Sbjct: 108 VLRGLTYLRE-KHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYM 165
Query: 169 APE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--SECKNPAQIFKKVTSGIK------- 218
+PE L Y DI+S G+ ++EM YP + K +F + S +
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225
Query: 219 --------PASLA-------KVNDP-----------QIKGFIEKCLVP-ASERLSAKDLL 251
P +A VN+P + + F++KCL ER K+L
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285
Query: 252 KDPFLQ 257
K PF++
Sbjct: 286 KHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 54/182 (29%), Positives = 92/182 (50%), Gaps = 9/182 (4%)
Query: 88 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147
++ K + ++ A I+ L YLHS +IHRD+K N+ +N +G+VK+ D
Sbjct: 91 KKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDF 148
Query: 148 GLAIAMQQPTARSV-IGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTFEYPYS 201
G++ + A+++ G +MAPE E Y+ D++S G+ ++E+ T +PY
Sbjct: 149 GISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
Query: 202 ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVEN 260
K P Q K+V P A+ P+ + F+ KCL ER + +LL+ PF ++
Sbjct: 209 SWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
Query: 261 QK 262
K
Sbjct: 269 SK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 57/172 (33%), Positives = 91/172 (52%), Gaps = 16/172 (9%)
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 159
I+ +Q L L YLH + IIHRDLK NI + G++K+ D G++ + R
Sbjct: 105 IRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD 161
Query: 160 SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213
S IGTP +MAPE+ + Y+ D++S G+ ++EM E P+ E NP ++ K+
Sbjct: 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKI 220
Query: 214 TSGIKPASLAKVN--DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 262
+P +LA+ + + K F++KCL R + LL+ PF+ V + K
Sbjct: 221 AKS-EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 57/166 (34%), Positives = 89/166 (53%), Gaps = 20/166 (12%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ-----YRKKHKNVDIKVI 102
E+ LL+ LK +NVV + +++ K+V ++ + + +L Q + K ++ ++
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 103 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIAMQQP--- 156
K+ QIL+G+ YLHS+ ++HRDLK NI V G G VKIGDLGLA P
Sbjct: 111 KSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 157 --TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFE 197
V+ T + APEL Y + +DI++ G CI E++T E
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 76/254 (29%), Positives = 129/254 (50%), Gaps = 24/254 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y A D G EVA ++ LQ + + +E+ +++ K+ N+V + S++ +
Sbjct: 37 YTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
V M E G+L + +D I R+ L L +LHS+ +IHRD+K DNI
Sbjct: 93 WVVM--EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 134 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 190
+ G G VK+ D G I +Q +++GTP +MAPE+ + Y VDI+S G+
Sbjct: 148 LL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ-----IKGFIEKCL-VPASER 244
+EM+ E PY +NP + + + P ++ +P+ + F+ +CL + +R
Sbjct: 207 IEMIEGEPPYLN-ENPLRALYLIATNGTP----ELQNPEKLSAIFRDFLNRCLDMDVEKR 261
Query: 245 LSAKDLLKDPFLQV 258
SAK+LL+ FL++
Sbjct: 262 GSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 63/229 (27%), Positives = 117/229 (51%), Gaps = 15/229 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ D + A + I +V++L Q +++E +LK + +++ + + D +
Sbjct: 18 HLVRDRISEHYYALKVMAIPEVIRLK-QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR-- 74
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ M+ E G L Y + +A +I+ L YLHS I++RDLK +NI
Sbjct: 75 FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENI 132
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 192
++ G +K+ D G A ++ T ++ GTPE++APE+ + + +N+ VD ++ G+ I E
Sbjct: 133 LLD-KEGHIKLTDFGFAKKLRDRTW-TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYE 190
Query: 193 MVTFEYPYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLV 239
M+ P+ + NP I++K+ +G ++ P L D K I+K LV
Sbjct: 191 MLVGYPPFFD-DNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 69/232 (29%), Positives = 116/232 (50%), Gaps = 17/232 (7%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKV 101
Q + EV L+ LK N +++ ++ + + M L ++ +L + KK + V+I
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 125
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161
I + A L GL YLHSHN +IHRD+K NI + G+VK+ D G A + P A S
Sbjct: 126 ITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSA-SKSSP-ANSF 177
Query: 162 IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 217
+GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N +
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQND 236
Query: 218 KPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 267
P + +GF++ CL +P ER ++ +LL+ F++ + + D
Sbjct: 237 SPTLQSNEWTDSFRGFVDYCLQKIP-QERPASAELLRHDFVRRDRPARVLID 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 12/195 (6%)
Query: 58 DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 117
V K Y + K + ++ E G+ K + K + +++ G+ LH
Sbjct: 57 PYVAKLY--YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH 114
Query: 118 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EE 176
IIHRD+K +N+ ++ G +K+ D GL+ + + +GTP+++APE
Sbjct: 115 QRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETILGVG 169
Query: 177 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFI 234
+++ D +S G I E + F YP + P +F + S P + + P+ I
Sbjct: 170 DDKMSDWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228
Query: 235 EKCLVP-ASERLSAK 248
+ L ++RL A
Sbjct: 229 NRLLCMDPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 16/151 (10%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV--IKNW 105
E+ LL+ LK N++ + K +N++ E F +L + K K++ + IK++
Sbjct: 52 EIKLLQELKHPNIIGLLDVFG--HKSNINLVFE-FMETDLEKVIKD-KSIVLTPADIKSY 107
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVI 162
L GL YLHS+ I+HRDLK +N+ + + G +K+ D GLA + P + V+
Sbjct: 108 MLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVV 164
Query: 163 GTPEFMAPELY--EEEYNELVDIYSFGMCIL 191
T + APEL Y VD++S G CI
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 71/247 (28%), Positives = 121/247 (48%), Gaps = 15/247 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YK D VA +KI D+ + +++ + E+ +L + ++Y S++ K
Sbjct: 21 YKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK- 76
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ +I E G+ K ++ I R+IL GL YLHS IHRD+K N+
Sbjct: 77 -LWIIMEYLGGGSALDLLKPGP-LEETYIATILREILKGLDYLHSERK--IHRDIKAANV 132
Query: 134 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 190
++ G+VK+ D G+A + Q + +GTP +MAPE+ ++ Y+ DI+S G+
Sbjct: 133 LLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITA 191
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RLSAKD 249
+E+ E P S+ +P ++ + P + + P K F+E CL R +AK+
Sbjct: 192 IELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEGQYSKP-FKEFVEACLNKDPRFRPTAKE 249
Query: 250 LLKDPFL 256
LLK F+
Sbjct: 250 LLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 73/252 (28%), Positives = 119/252 (47%), Gaps = 20/252 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
YKA + G A +K++ PG D + E+ ++K K N+V ++ S++ K
Sbjct: 26 YKARNVNTGELAAIKVIKLE-----PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK 80
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ M E G+L+ + I +R+ L GL YLHS +HRD+K N
Sbjct: 81 LWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--MHRDIKGAN 136
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE----YNELVDIYSF 186
I + N G VK+ D G++ + A+ S IGTP +MAPE+ E YN+L DI++
Sbjct: 137 ILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV 195
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA-KVN-DPQIKGFIEKCLVP-ASE 243
G+ +E+ + P + +F S +P L K+ F++ L +
Sbjct: 196 GITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKK 255
Query: 244 RLSAKDLLKDPF 255
R +A+ LL+ PF
Sbjct: 256 RPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 44 KLYSEVHLLK-SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY----RKKHKNVD 98
+ SEV ++K L+ N+V++YK+++++ + + M +L L ++ ++K +
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVM--DLIEGAPLGEHFNSLKEKKQRFT 111
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
+ I N Q++ L YLH I+HRDL +NI + G +V I D GLA +QP +
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQPES 168
Query: 159 R--SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 215
+ SV+GT + PE+ + E Y E D+++FG + +M T + P+ N + K+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVE 227
Query: 216 GIKPASLAKVNDPQIKGFIEKCLVPASE 243
+ + + I CL P +E
Sbjct: 228 AVYEPLPEGMYSEDVTDVITSCLTPDAE 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 43/277 (15%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA D+ G VA ++K+ + G + E+ LLK L N++K V K
Sbjct: 16 YKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLLD--VFRHKG 71
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ ++ E + + + + + + +IK++ Q+L GL + HSH I+HRDLK +N+
Sbjct: 72 DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENL 129
Query: 134 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMC 189
+N G +K+ D GLA + T + APEL ++ Y+ VDI+S G C
Sbjct: 130 LINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVG-C 187
Query: 190 IL-EMVTFEYPYSECKN--------------PAQ-IFKKVTS-------------GIKPA 220
I E+++ P K+ P ++ K TS G+
Sbjct: 188 IFAELLSRR-PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLP 246
Query: 221 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256
L PQ + + L +R++A+ L P+
Sbjct: 247 KLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 70/245 (28%), Positives = 121/245 (49%), Gaps = 27/245 (11%)
Query: 30 VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM-------ITELF 82
+KI D+ + +++ + E+ +L V K+Y S++ K + M +L
Sbjct: 34 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL 93
Query: 83 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 142
+G +++ I ++IL GL YLHS IHRD+K N+ ++ G+V
Sbjct: 94 RAGPFDEFQ----------IATMLKEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDV 140
Query: 143 KIGDLGLA--IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYP 199
K+ D G+A + Q + +GTP +MAPE+ ++ Y+ DI+S G+ +E+ E P
Sbjct: 141 KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
Query: 200 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPFLQV 258
S+ +P ++ + P +L K FI+ CL S R +AK+LLK F+ V
Sbjct: 201 NSD-MHPMRVLFLIPK-NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI-V 257
Query: 259 ENQKE 263
+N K+
Sbjct: 258 KNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 67/256 (26%), Positives = 124/256 (48%), Gaps = 25/256 (9%)
Query: 20 FAGIEVAWSRVKIDDVLQLPGDLQK-LYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVN- 76
+ G V ++ V+ + GD ++ + E+++LK N+ +Y +++ ++
Sbjct: 23 YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82
Query: 77 ---MITELFTSGNLRQYRKKHKNVDIKVIKNW----ARQILHGLVYLHSHNPPIIHRDLK 129
++ E +G++ K K +K + W R+IL GL +LH H +IHRD+K
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIAYICREILRGLSHLHQHK--VIHRDIK 138
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELV 181
N+ + N EVK+ D G++ + + R + IGTP +MAPE+ + Y+
Sbjct: 139 GQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 197
Query: 182 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA 241
D++S G+ +EM P + +P + + P +K + + FIE CLV
Sbjct: 198 DLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKN 256
Query: 242 -SERLSAKDLLKDPFL 256
S+R + + L+K PF+
Sbjct: 257 HSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-- 159
I+ RQ+L L YLHS IIHRDLK N+ + + G++K+ D G++ + R
Sbjct: 112 IQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRD 168
Query: 160 SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213
S IGTP +MAPE + + Y+ DI+S G+ ++EM E P+ E NP ++ K+
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKI 227
Query: 214 TSGIKPASLAKVN-DPQIKGFIEKCLVPASE-RLSAKDLLKDPFLQVENQKEPI 265
P + + F++ L E R SA LL+ PF+ P+
Sbjct: 228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 17/198 (8%)
Query: 22 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK-KKTVNMITE 80
G +VA + Q D ++ E+ +L++L +N+VK YK + +++ +I E
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHENIVK-YKGVCEKPGGRSLRLIME 88
Query: 81 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
SG+LR Y ++H+ +++K + ++ QI G+ YL S IHRDL NI V
Sbjct: 89 YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESED 146
Query: 140 GEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEM 193
VKI D GLA + + + +P F APE L +++ D++SFG+ + E+
Sbjct: 147 -LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
Query: 194 VTFEYPYSECKNPAQIFK 211
F Y PA+ +
Sbjct: 206 --FTYGDPSQSPPAEFLR 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 16/189 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA D+ G VA +++++ + G E+ LLK L N+V+ + K
Sbjct: 16 YKARDKLTGEIVALKKIRLET--EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK- 72
Query: 74 TVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ ++ E F +L++Y +D +IK++ Q+L G+ Y HSH ++HRDLK
Sbjct: 73 -LYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQ 128
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 187
N+ ++ G +K+ D GLA A P T + T + APE L +Y+ VDI+S G
Sbjct: 129 NLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG 187
Query: 188 MCIL-EMVT 195
CI EMV
Sbjct: 188 -CIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 23 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 82
I VA +K D + + D K E ++ SL +N+++ Y + M+TEL
Sbjct: 24 IPVAVKCLKSDKLSDIMDDFLK---EAAIMHSLDHENLIRLYGVVLTHPLM---MVTELA 77
Query: 83 TSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 140
G+L +K I + ++A QI +G+ YL S IHRDL NI + +
Sbjct: 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDD- 134
Query: 141 EVKIGDLGLAIAMQQ-------------PTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 186
+VKIGD GL A+ Q P A + APE L ++ D++ F
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFA--------WCAPESLRTRTFSHASDVWMF 186
Query: 187 GMCILEMVTF-EYPYSECKNPAQIFKKV 213
G+ + EM T+ E P++ + +QI KK+
Sbjct: 187 GVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 69/232 (29%), Positives = 114/232 (49%), Gaps = 17/232 (7%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKV 101
Q + EV L+ L+ N +++ ++ + + M L ++ +L + KK + V+I
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161
+ + A L GL YLHSHN +IHRD+K NI ++ G VK+GD G A M A
Sbjct: 120 VTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXF 171
Query: 162 IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 217
+GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNE 230
Query: 218 KPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 267
PA + + F++ CL +P +R +++ LLK F+ E I D
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIP-QDRPTSEVLLKHRFVLRERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 70/247 (28%), Positives = 114/247 (46%), Gaps = 25/247 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
YKA + G A +K++ PGD + E+ ++K K N+V ++ S++ +K
Sbjct: 26 YKARNLHTGELAAVKIIKLE-----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK 80
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ M E G+L+ + I R+ L GL YLHS +HRD+K N
Sbjct: 81 LWICM--EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--MHRDIKGAN 136
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE----YNELVDIYSF 186
I + ++G+VK+ D G+A + A+ S IGTP +MAPE+ E YN+L DI++
Sbjct: 137 ILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV 195
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN--DPQIKGFIEKCLV----- 239
G+ +E+ + P + +F S +P L F++ L
Sbjct: 196 GITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKK 255
Query: 240 -PASERL 245
P +ERL
Sbjct: 256 RPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 81/290 (27%), Positives = 125/290 (43%), Gaps = 48/290 (16%)
Query: 16 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75
A D+ G VA KI P ++ Y E+ LLK L+ +N++ ++ + +
Sbjct: 29 ARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLEDI 85
Query: 76 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 135
+TEL + R + ++ + I+ + QIL GL Y+HS ++HRDLK NI +
Sbjct: 86 YFVTELLGTDLHRLL--TSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILI 141
Query: 136 NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEM 193
N N ++KI D GLA +Q P + T + APE L ++Y+ VDI+S G EM
Sbjct: 142 NEN-CDLKICDFGLA-RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
Query: 194 VTFEYPYSECKNPAQIFKKVTS--GIKP---------------------------ASLAK 224
+ + P K+ F +T G P + K
Sbjct: 200 LEGK-PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFK 258
Query: 225 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEPICDPLKLPI 273
DP +EK LV +R+SA + L P+L P DP P+
Sbjct: 259 NADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA------PYHDPTDEPV 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 61/188 (32%), Positives = 94/188 (50%), Gaps = 14/188 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA ++ G VA ++++D + G E+ LLK L N+VK V +
Sbjct: 17 YKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVKLLD--VIHTEN 72
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKV--IKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ ++ E F +L+++ I + IK++ Q+L GL + HSH ++HRDLK
Sbjct: 73 KLYLVFE-FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQ 129
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 187
N+ +N G +K+ D GLA A P T + T + APE L + Y+ VDI+S G
Sbjct: 130 NLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 188
Query: 188 MCILEMVT 195
EMVT
Sbjct: 189 CIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 41/99 (41%), Positives = 62/99 (62%), Gaps = 6/99 (6%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVI 162
+ QI+ GL +LH II+RDLK +N+ ++ N G V+I DLGLA+ ++ Q +
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 163 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPY 200
GTP FMAPEL + EEY+ VD ++ G+ + EM+ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 10/184 (5%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VD 98
++ E LL +K N+V F +S+ D + M E G+L Q K +
Sbjct: 41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM--EYCDGGDLMQKIKLQRGKLFP 98
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
I W Q+ G+ H H ++HRD+K NIF+ N G+VK+GD G A + P A
Sbjct: 99 EDTILQWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA 155
Query: 159 RSV--IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS 215
+ +GTP ++ PE++E YN DI+S G + E+ T ++P+ I K
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215
Query: 216 GIKP 219
KP
Sbjct: 216 SYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 53/177 (29%), Positives = 92/177 (51%), Gaps = 11/177 (6%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNW 105
EV +L ++K N+V++ +S+ ++ + ++ + G+L + + V I +W
Sbjct: 49 EVAVLSNMKHPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIG 163
QI L H H+ I+HRD+K NIF+ G +K+GD G+A + AR+ IG
Sbjct: 107 FVQICLALK--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIG 163
Query: 164 TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 219
TP +++PE+ E YN DI++ G + EM T ++ + E N + K+ G P
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVI 162
+A QI+ GL H H I++RDLK +N+ ++ +HG V+I DLGLA+ + +
Sbjct: 100 YAAQIICGL--EHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155
Query: 163 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP---YSECKNPAQIFKKVTSGIK 218
GTP +MAPE L E Y+ VD ++ G + EM+ P E ++ ++
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--M 213
Query: 219 PASLAKVNDPQIKGFIEKCLVP-ASERL-----SAKDLLKDPFLQ 257
P+ K E L +RL SA ++ + P +
Sbjct: 214 AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 68/232 (29%), Positives = 117/232 (50%), Gaps = 17/232 (7%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKV 101
Q + EV L+ +K N +++ ++ + + M L ++ +L + KK + V+I
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 129
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161
I + A L GL YLHSHN +IHRD+K NI + G+VK+ D G A ++ P A S
Sbjct: 130 ITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSA-SIASP-ANSF 181
Query: 162 IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 217
+GTP +MAPE+ E +Y+ VD++S G+ +E+ + P N +
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNE 240
Query: 218 KPASLAKVNDPQIKGFIEKCL--VPASERLSAKDLLKDPFLQVENQKEPICD 267
P + + F++ CL +P +R ++++LLK F+ E + + D
Sbjct: 241 SPTLQSNEWSDYFRNFVDSCLQKIP-QDRPTSEELLKHMFVLRERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 62/188 (32%), Positives = 103/188 (54%), Gaps = 19/188 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+KA + VA RV++DD + G E+ LLK LK N+V+ Y DKK
Sbjct: 17 FKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74
Query: 74 TVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
T ++ E + +L++Y + ++D +++K++ Q+L GL + HSHN ++HRDLK N
Sbjct: 75 T--LVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQN 129
Query: 133 IFVNGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSF 186
+ +N N GE+K+ D GLA I ++ +A V T + P+ + Y+ +D++S
Sbjct: 130 LLINKN-GELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWSA 186
Query: 187 GMCIL-EM 193
G CI E+
Sbjct: 187 G-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 72/262 (27%), Positives = 124/262 (47%), Gaps = 29/262 (11%)
Query: 12 SSYKAFDEFAGIEVAWS--RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 69
S YK G+ +A R+++D+ ++ E+ +L +V FY ++
Sbjct: 16 SVYKVLHRPTGVTMAMKEIRLELDE-----SKFNQIIMELDILHKAVSPYIVDFYGAFF- 69
Query: 70 DKKKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIH 125
+ V M E +G+L + + + V++ ++ GL +L HN IIH
Sbjct: 70 -IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE-------YN 178
RD+K N+ VNGN G+VK+ D G++ + A++ IG +MAPE + Y
Sbjct: 127 RDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYT 185
Query: 179 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEK 236
D++S G+ ILEM YPY + A IF ++++ + P +L + F+ K
Sbjct: 186 VQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAK 244
Query: 237 CL--VPASERLSAKDLLKDPFL 256
CL +P + R + LL+ P+L
Sbjct: 245 CLNKIP-NRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 54/156 (34%), Positives = 87/156 (55%), Gaps = 14/156 (8%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
E+++LK+L +N+VK+ + K + +I E G+LR Y KH +++ + +A+
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQ 114
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA------RSV 161
QI G+ YLHS + IHRDL N+ ++ N VKIGD GLA A+ P R
Sbjct: 115 QICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PEGHEYYRVRED 169
Query: 162 IGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 195
+P F A E L E +++ D++SFG+ + E++T
Sbjct: 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 50/249 (20%)
Query: 48 EVHLLKSLKDDNVVKF---YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 104
EV +L+ L+ +N+V ++ K + ++ E L + +++
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRR-----KGRLYLVFEYVERTLLELLEASPGGLPPDAVRS 104
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SV 161
+ Q+L + Y HSHN IIHRD+K +NI V+ G +K+ D G A A++ A
Sbjct: 105 YIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDY 161
Query: 162 IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFE--YP----------------- 199
+ T + APEL + Y + VD+++ G CI+ E++ E +P
Sbjct: 162 VATRWYRAPELLVGDTNYGKPVDVWAIG-CIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220
Query: 200 ------YSECKNPAQIFKKVTSGIKPASL-----AKVNDPQIKGFIEKCLVP-ASERLSA 247
NP +P SL KV+ P + F++ CL ERL+
Sbjct: 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL-DFLKACLRMDPKERLTC 279
Query: 248 KDLLKDPFL 256
+LL+ P+
Sbjct: 280 DELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 69/248 (27%), Positives = 122/248 (49%), Gaps = 32/248 (12%)
Query: 30 VKIDDVLQLPGDLQKLYSEVHLLKSLKDD-NVVKFYKSWV-------DDKKKTVNMITEL 81
+K+ DV + + +++ E+++LK N+ +Y +++ DD+ + ++ E
Sbjct: 46 IKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ---LWLVMEF 100
Query: 82 FTSGNLRQYRKKHKNVDIKVIKNW----ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137
+G++ K K +K ++W R+IL GL +LH+H +IHRD+K N+ +
Sbjct: 101 CGAGSVTDLVKNTKGNALK--EDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTE 156
Query: 138 NHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIYSFGMC 189
N EVK+ D G++ + + R + IGTP +MAPE+ + Y+ DI+S G+
Sbjct: 157 N-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT 215
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPAS-ERLSAK 248
+EM P + +P + + P +K + FIE CLV R S +
Sbjct: 216 AIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTE 274
Query: 249 DLLKDPFL 256
LLK PF+
Sbjct: 275 QLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 29/242 (11%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
E+ +L+ + NVVK + + D + ++ E G+L + + + + AR
Sbjct: 122 EIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE----QFLADVAR 175
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---PTARSVIGT 164
QIL G+ YLH + I+HRD+K N+ +N VKI D G++ + Q P SV GT
Sbjct: 176 QILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV-GT 231
Query: 165 PEFMAPELYEEEYNELV------DIYSFGMCILE--MVTFEYPYSECKNPAQIFKKVTSG 216
+M+PE + N DI+S G+ ILE + F + + A + +
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS 291
Query: 217 IKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFL----QVENQKEPICDPLK 270
P + A + + + FI CL PA +R SA LL+ PF+ + Q P L
Sbjct: 292 QPPEAPATAS-REFRHFISCCLQREPA-KRWSAMQLLQHPFILRAQPGQGQGGPNLHQLL 349
Query: 271 LP 272
P
Sbjct: 350 PP 351
|
Length = 353 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 56/177 (31%), Positives = 90/177 (50%), Gaps = 15/177 (8%)
Query: 42 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIK 100
L+ E+ +LKSL+ DN+VK+ ++ + ++ E G+LR Y +KH+ +D +
Sbjct: 49 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR 108
Query: 101 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160
+ +A QI G+ YL S +HRDL NI V + VKIGD GL + Q
Sbjct: 109 KLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYY 165
Query: 161 VIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSE-CKNPAQIF 210
+ P + APE L E +++ D++SFG+ + E+ T YS+ +P F
Sbjct: 166 KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YSDKSCSPPAEF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNW 105
E ++K L+ +++ Y V ++ + ++TEL G+L +Y + + + + +
Sbjct: 51 EAQIMKKLRHPKLIQLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 163
A Q+ G+ YL + N IHRDL N+ V G + K+ D GLA I AR
Sbjct: 109 AAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAK 165
Query: 164 TP-EFMAPELYEEEYNELV---DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
P ++ APE YN D++SFG+ + E+VT+ PY N A++ ++V G
Sbjct: 166 FPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 41/244 (16%)
Query: 46 YSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIK 103
E+ L+ L N+++ + D K + ++ EL NL + K K + K +K
Sbjct: 45 LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVK 103
Query: 104 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSV 161
++ Q+L L ++H + I HRD+K +NI + + +K+ D G I + P
Sbjct: 104 SYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYT-EY 158
Query: 162 IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-QIFK------- 211
I T + APE L + Y +DI++ G E+++ +P N QI K
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL-FPLFPGTNELDQIAKIHDVLGT 217
Query: 212 ---KVTSGIKPASLAKVNDPQIKGF-IEKCLVPAS----------------ERLSAKDLL 251
+V + + N P KG + K L AS ER++AK L
Sbjct: 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
Query: 252 KDPF 255
+ P+
Sbjct: 278 RHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 40/101 (39%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSV 161
+A ++ GL YLH + I++RDLK DN+ ++ G VKI D GL + T+ +
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTS-TF 161
Query: 162 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYS 201
GTPEF+APE L E Y VD + G+ I EM+ E P+
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 49/162 (30%), Positives = 85/162 (52%), Gaps = 5/162 (3%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 98
P ++ E+ +L +V FY ++ D + ++ M E G+L Q K+ K +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIP 101
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
+++ + +L GL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 159 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP 199
S +GT +M+PE L Y+ DI+S G+ ++E+ YP
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 68/191 (35%), Positives = 95/191 (49%), Gaps = 22/191 (11%)
Query: 15 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVDD 70
AFD G +VA K+ Q ++ Y E+ LLK + +NV+ F + +
Sbjct: 33 SAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ V ++T L + +L K K D I+ QIL GL Y+HS IIHRDLK
Sbjct: 91 DFQDVYLVTHLMGA-DLNNIVKCQKLSD-DHIQFLVYQILRGLKYIHSAG--IIHRDLKP 146
Query: 131 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG---TPEFMAPE--LYEEEYNELVDIYS 185
NI VN + E+KI D GLA + T + G T + APE L YN+ VDI+S
Sbjct: 147 SNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201
Query: 186 FGMCIL-EMVT 195
G CI+ E++T
Sbjct: 202 VG-CIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 41/129 (31%), Positives = 72/129 (55%), Gaps = 6/129 (4%)
Query: 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137
+ E G+L + + D + +A +I+ GL +LH II+RDLK DN+ ++
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDK 131
Query: 138 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 194
+ G +KI D G+ + A + GTP+++APE+ + ++YNE VD +SFG+ + EM+
Sbjct: 132 D-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
Query: 195 TFEYPYSEC 203
+ P+
Sbjct: 191 IGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 40/206 (19%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA D+ G VA +V++D+ + G E+ +L+ L N+V K V DK+
Sbjct: 24 YKARDKDTGELVALKKVRLDN--EKEGFPITAIREIKILRQLNHRNIVNL-KEIVTDKQD 80
Query: 74 TVNMITE-----------------LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 116
++ + L SG L + + H IK++ +Q+L GL Y
Sbjct: 81 ALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKSFMKQLLEGLNYC 132
Query: 117 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPEL 172
H N +HRD+KC NI +N N G++K+ D GLA +P VI T + PEL
Sbjct: 133 HKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPEL 188
Query: 173 Y--EEEYNELVDIYSFGMCIL-EMVT 195
EE Y +D++S G CIL E+ T
Sbjct: 189 LLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 51/154 (33%), Positives = 81/154 (52%), Gaps = 9/154 (5%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
E+ +LK L+ +N+V + V +KK + ++ E L K +D ++ +
Sbjct: 50 EIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF 107
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTP 165
QIL G+ + HSHN IIHRD+K +NI V+ + G VK+ D G A +A + T
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 166 EFMAPELY--EEEYNELVDIYSFGMCILEMVTFE 197
+ APEL + +Y VDI++ G + EM+T E
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 25/201 (12%)
Query: 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 64
G Y T YK + G VA + +D P + E+ L+K LK +N+V+ +
Sbjct: 11 GTYAT---VYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVRLH 64
Query: 65 KSWVDDKKKTVNMITELF--TSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSH 119
D T N + +F +L++Y H +D +K++ Q+L G+ + H +
Sbjct: 65 -----DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 120 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEE 175
++HRDLK N+ +N GE+K+ D GLA A P T + + T + AP+ L
Sbjct: 120 R--VLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 176 EYNELVDIYSFGMCIL-EMVT 195
Y+ +DI+S G CI+ EM+T
Sbjct: 177 TYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 8/197 (4%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 98
P ++ E+ +L +V FY ++ D + ++ M E G+L Q KK +
Sbjct: 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIP 101
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
+++ + ++ GL YL + I+HRD+K NI VN + GE+K+ D G++ + A
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159
Query: 159 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--SECKNPAQIFKKVTS 215
S +GT +M+PE L Y+ DI+S G+ ++EM YP + K +F
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVE 219
Query: 216 GIKPASLAKVNDPQIKG 232
G PA P+ G
Sbjct: 220 G-DPAESETSPRPRPPG 235
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 1e-14
Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 32/234 (13%)
Query: 44 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL-RQYRKKHK---NVDI 99
+L EV++++ LK N+V++ +++ + + ++ E +G+L R +K +K ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 100 KVIKNWARQILHGLVYLHS-----HNPPIIHRDLKCDNIFV--------------NGNHG 140
I + RQ+LH L Y H+ + ++HRDLK NIF+ N +G
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 141 E--VKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMV 194
KIGD GL+ + + A S +GTP + +PEL E Y++ D+++ G I E+
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 195 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSA 247
+ + P+ + N +Q+ ++ G P K ++ I+ L + A ER SA
Sbjct: 238 SGKTPFHKANNFSQLISELKRG--PDLPIKGKSKELNILIKNLLNLSAKERPSA 289
|
Length = 1021 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 40/242 (16%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
E+ +LK LK N+V + V +K+ ++++ E L + K + V +IK
Sbjct: 50 EIRMLKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTP 165
Q L + + H HN IHRD+K +NI + G++K+ D G A + P + T
Sbjct: 108 QTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 166 EFMAPELY--EEEYNELVDIYSFGMCILEMVTFE--YPYSE---------------CKNP 206
+ APEL + +Y VD+++ G E++T + +P
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224
Query: 207 AQIFK--KVTSGIK----------PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 253
QIF + G+ + ++ P + F++ CL +ERLS ++LL+
Sbjct: 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALS-FLKGCLQMDPTERLSCEELLEH 283
Query: 254 PF 255
P+
Sbjct: 284 PY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 23 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 82
+ VA +K DD+L+ D QK EV LK L+ +++ + V + V +ITEL
Sbjct: 31 VRVAIKILKSDDLLKQ-QDFQK---EVQALKRLRHKHLISLFA--VCSVGEPVYIITELM 84
Query: 83 TSGNLRQYRK--KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 140
G+L + + + + + + + + A Q+ G+ YL N IHRDL NI V G
Sbjct: 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILV-GEDL 141
Query: 141 EVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 196
K+ D GLA +++ + ++ APE ++ D++SFG+ + EM T+
Sbjct: 142 VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG 201
Query: 197 EYPYSECKNPAQIFKKVTSG 216
+ PY N +++ ++T+G
Sbjct: 202 QVPY-PGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 73 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
V +IT+L G L Y + HK N+ + + NW QI G+ YL ++HRDL
Sbjct: 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAAR 138
Query: 132 NIFVNG-NHGEVKIGDLGLAIAMQQPTARSVIGT----P-EFMAPE-LYEEEYNELVDIY 184
N+ V H VKI D GLA + + P ++MA E + Y D++
Sbjct: 139 NVLVKTPQH--VKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVW 195
Query: 185 SFGMCILEMVTF-EYPY 200
S+G+ + E++TF PY
Sbjct: 196 SYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 17/161 (10%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 162
+A +I+ GL +LH II+RDLK DN+ ++ G +KI D G+ T +
Sbjct: 101 YAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC 157
Query: 163 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 219
GTP+++APE L + Y VD ++ G+ + EM+ + P+ E + ++F+ + P
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYP 216
Query: 220 ASLAKVNDPQIKGFIEKCLVPASERLSA-----KDLLKDPF 255
L+K +K F+ K +RL +D+ PF
Sbjct: 217 RWLSKEAKSILKSFLTK---NPEKRLGCLPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 10/98 (10%)
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161
+K++ R +L G+ Y+H++ I+HRDLK N+ + G +KI D GLA + R
Sbjct: 101 VKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLY 157
Query: 162 ---IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EM 193
+ T + APEL +Y+ VD+++ G CI E+
Sbjct: 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 58/179 (32%), Positives = 82/179 (45%), Gaps = 44/179 (24%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVD------DKKKTVNMIT-----ELFTSGNLRQYRKKHKN 96
E+ +LK LK NVV V+ K+ +V M+T +L SG L +N
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDL--SGLL-------EN 107
Query: 97 VDIKV----IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI- 151
+K+ IK + Q+L G+ YLH ++ I+HRD+K NI ++ N G +KI D GLA
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARP 164
Query: 152 ---AMQQPTARSVIGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 195
P GT ++ PEL E Y VDI+ G C+ EM T
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 48/283 (16%)
Query: 14 YKAFDEFAGIEVAW--SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDD 70
YKA D+ G VA +R+++D+ P L+ E+ LL+ L + +V+ +
Sbjct: 18 YKARDKNTGKLVALKKTRLEMDEEGIPPTALR----EISLLQMLSESIYIVRLLDVEHVE 73
Query: 71 KKKTVNMITELFT--SGNLRQY-----RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 123
+K + +F +L+++ R + + K IK++ Q+L G+ + H H +
Sbjct: 74 EKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--V 131
Query: 124 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV--IGTPEFMAPE--LYEEEYNE 179
+HRDLK N+ V+ G +KI DLGL A P I T + APE L Y+
Sbjct: 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYST 191
Query: 180 LVDIYSFGMCILEMVTFEYPY---SECKNPAQIFK-------KVTSGI------------ 217
VDI+S G EM + + SE + IFK +V G+
Sbjct: 192 PVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQW 251
Query: 218 KPASLAKVN---DPQIKGFIEKCLV--PASERLSAKDLLKDPF 255
KP L++ P+ ++K L PA +R+SAK L P+
Sbjct: 252 KPQDLSRAVPDLSPEGLDLLQKMLRYDPA-KRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 44/158 (27%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 109 ILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-VIGTPE 166
I+ L YL H +IHRD+K NI ++ + G VK+ D G++ + A++ G
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 167 FMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA- 220
+MAPE + +Y+ D++S G+ ++E+ T ++PY CK ++ K+ P+
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 221 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
+ P F++ CL +R ++LL+ PF++
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-14
Identities = 52/233 (22%), Positives = 95/233 (40%), Gaps = 45/233 (19%)
Query: 60 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 119
+VK Y S+ D++ + ++ E G+L + + + + +++ L +H
Sbjct: 63 IVKLYYSFQDEEH--LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 120 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM-------------------------- 153
IHRD+K DNI + G +K+ D GL M
Sbjct: 121 G--FIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 154 ---QQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKN 205
+Q A S +GTP+++APE L Y D +S G+ + EM+ + +P YS+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFYSD--T 234
Query: 206 PAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVPASERL-SAKDLLKDPF 255
+ + K+ + + P+ I + L +RL S +++ PF
Sbjct: 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 11/147 (7%)
Query: 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
++ EL G L +Y KK + + + +K A Q+ G+ YL S + +HRDL N+ +
Sbjct: 72 LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV 129
Query: 137 GNHGEVKIGDLGLAIAM----QQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 190
H + KI D G++ A+ A + P ++ APE + +++ D++S+G+ +
Sbjct: 130 NRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188
Query: 191 LEMVTF-EYPYSECKNPAQIFKKVTSG 216
E ++ PY E K ++ + SG
Sbjct: 189 WEAFSYGAKPYGEMKGA-EVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
E LL+++ +V++ + V M+ ++S K+ + + I +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPE 166
QIL GL YLH+ IIHRD+K +NIF+N + +V IGDLG A + P + GT E
Sbjct: 165 QILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221
Query: 167 FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNP 206
APE L ++YN DI+S G+ + EM+ YP + ++P
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 44/137 (32%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 162
+A +I GL +LHS II+RDLK DN+ ++ G +KI D G+ T R+
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFC 162
Query: 163 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SGIKP 219
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ + ++ ++F+ + + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYP 221
Query: 220 ASLAKVNDPQIKGFIEK 236
SL+K KG + K
Sbjct: 222 KSLSKEAVSICKGLLTK 238
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 48/247 (19%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYR---KKHKNVDIKVIKN 104
E+ LLK L+ N+V + + + + +I E F S +L++Y K + +D +++K+
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESR--LYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKS 105
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARS 160
+ QIL G+++ HS ++HRDLK N+ ++ N G +K+ D GLA A P T
Sbjct: 106 YLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 161 VIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPY----SECKNPAQIFKKV- 213
V T + APE L Y+ VDI+S G EM T + P SE +IF+ +
Sbjct: 163 V--TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILG 219
Query: 214 --TSGIKP---------ASLAKVNDPQIKGF-----------IEKCLV--PASERLSAKD 249
T + P + K ++ +EK L+ PA +R+SAK
Sbjct: 220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPA-KRISAKK 278
Query: 250 LLKDPFL 256
L P+
Sbjct: 279 ALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 31 KIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV---KFYKSWVDDKKKTVNMITELFTSGNL 87
KI +P ++ E+ +L+ K DN++ + D K V ++ +L S +L
Sbjct: 37 KIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK-DVYVVMDLMES-DL 94
Query: 88 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147
+ + + I+ + Q+L GL Y+HS N +IHRDLK N+ VN + E++IGD
Sbjct: 95 HHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDF 151
Query: 148 GLA-IAMQQPTARSV-----IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMV 194
G+A PT + T + APEL EY +D++S G CI EM+
Sbjct: 152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 102
Q + E +L L +V S+ D+ + V + E G L + +K V
Sbjct: 63 QHVAQEKSILMELSHPFIVNMMCSFQDENR--VYFLLEFVVGGELFTHLRKAGRFPNDVA 120
Query: 103 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 162
K + +++ YLHS + II+RDLK +N+ ++ N G VK+ D G A + T ++
Sbjct: 121 KFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF-TLC 176
Query: 163 GTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 221
GTPE++APE+ + + + + VD ++ G+ + E + P+ + P +I++K+ +G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG----- 230
Query: 222 LAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQK 262
+ P A+DL+K LQ ++ K
Sbjct: 231 --------------RLKFPNWFDGRARDLVKG-LLQTDHTK 256
|
Length = 329 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 54/167 (32%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NW 105
E ++K L+ D +V+ Y V +++ + ++TE + G+L + K + +++ + +
Sbjct: 51 EAQIMKKLRHDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 163
A QI G+ YL S N IHRDL NI V G + KI D GLA I + TAR
Sbjct: 109 AAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAK 165
Query: 164 TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNP 206
P ++ APE Y + D++SFG+ + E+VT+ PY N
Sbjct: 166 FPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 46 YSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKV-- 101
+E ++K +VV+ V + T+ ++ EL G+L+ Y + + +
Sbjct: 57 LNEASVMKEFNCHHVVRLL-GVVSTGQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLG 114
Query: 102 ------IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155
A +I G+ YL + +HRDL N V + VKIGD G+ + +
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYE 171
Query: 156 -----PTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPA 207
+ ++ P +MAPE L + + D++SFG+ + EM T E PY N
Sbjct: 172 TDYYRKGGKGLL--PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-E 228
Query: 208 QIFKKVTSG 216
++ K V G
Sbjct: 229 EVLKFVIDG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 55/301 (18%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD---D 70
+ A D VA ++ + D P ++ E+ +++ L DN+VK Y+ D
Sbjct: 22 FSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD 77
Query: 71 KKKTVNMITELFTSGNLRQYRK-------KHKNVDIKVIKNWARQILHGLVYLHSHNPPI 123
+ V +TEL + +++Y + + + + + + Q+L GL Y+HS N +
Sbjct: 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--V 135
Query: 124 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-----VIGTPEFMAPE--LYEEE 176
+HRDLK N+F+N +KIGD GLA + + + T + +P L
Sbjct: 136 LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN 195
Query: 177 YNELVDIYSFGMCIL-EMVT------------------------FEYPYSECKNPAQIFK 211
Y + +D+++ G CI EM+T E +E N F
Sbjct: 196 YTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFV 254
Query: 212 KVTSGIKPASLAKV---NDPQIKGFIEKCLVPA-SERLSAKDLLKDPFLQVEN--QKEPI 265
+ G L + +P+ F+E+ L +RL+A++ L P++ + EP+
Sbjct: 255 RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPV 314
Query: 266 C 266
Sbjct: 315 S 315
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 63/236 (26%), Positives = 116/236 (49%), Gaps = 30/236 (12%)
Query: 43 QKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVN---MITELFTSGNL----RQYRKKH 94
+++ +E ++LK+L D NVVKFY + K + ++ EL G++ + + K+
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118
Query: 95 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154
+ ++ +I + L GL +LH IHRD+K +NI + G VK+ D G++ +
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLT 175
Query: 155 QPTAR--SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNP 206
R + +GTP +MAPE+ + Y+ D++S G+ +E+ + P ++ +P
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HP 234
Query: 207 AQIFKKVTSGIKPASLAKVNDPQI-----KGFIEKCLVPASE-RLSAKDLLKDPFL 256
+ K+ P ++ P++ FI KCL E R + DLL+ F+
Sbjct: 235 MRALFKIPRNPPP----TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 10/150 (6%)
Query: 123 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-IGTPEFMAPELYEEE----Y 177
IIHRD+K NI ++ +G +K+ D G++ + A++ G +MAPE + Y
Sbjct: 129 IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 178 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---IKPASLAKVNDPQIKGFI 234
+ D++S G+ + E+ T ++PY + + +V G I S + P FI
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 235 EKCLVPASE-RLSAKDLLKDPFLQVENQKE 263
CL+ R K+LL+ PF++ ++
Sbjct: 248 NLCLIKDESKRPKYKELLEHPFIKDYEERN 277
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 13/188 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA D +A +++++ + G E+ LLK ++ N+V+ V +K
Sbjct: 19 YKARDRVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVRLQD--VVHSEK 74
Query: 74 TVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ ++ E + +L+++ + + ++IK + QIL G+ Y HSH ++HRDLK
Sbjct: 75 RLYLVFE-YLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQ 131
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 187
N+ ++ +K+ D GLA A P T + T + APE L Y+ VDI+S G
Sbjct: 132 NLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191
Query: 188 MCILEMVT 195
EMV
Sbjct: 192 CIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 45/179 (25%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 23 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 82
I VA K P +K E ++++ ++VK ++ V ++ EL
Sbjct: 35 IAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPHIVKLIGVITENP---VWIVMELA 88
Query: 83 TSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141
G LR Y + +K +D+ + ++ Q+ L YL S +HRD+ N+ V+
Sbjct: 89 PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDC- 145
Query: 142 VKIGDLGLAIAMQQPT--ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 196
VK+GD GL+ ++ + S P ++MAPE + + D++ FG+C+ E++
Sbjct: 146 VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 35/205 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDV-LQLPGDLQK---------LYSEVHLLKSLKDDNVVKF 63
KA+D G VA +VKI ++ + D Q E+ ++ +K +N++
Sbjct: 26 EKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85
Query: 64 YKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 123
+V + +N++ ++ + +L++ + + +K QIL+GL LH
Sbjct: 86 VDVYV--EGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--F 140
Query: 124 IHRDLKCDNIFVNGNHGEVKIGDLGLA-----------IAMQQPTARSVIGTPE-----F 167
+HRDL NIF+N + G KI D GLA ++ + R T + +
Sbjct: 141 MHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199
Query: 168 MAPELY--EEEYNELVDIYSFGMCI 190
APEL E+Y+ VD++S G CI
Sbjct: 200 RAPELLMGAEKYHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 56/189 (29%), Positives = 95/189 (50%), Gaps = 15/189 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
Y+A D+ G VA ++K++ + P + L E+++L L+ N+V + V
Sbjct: 22 YRARDKKTGEIVALKKLKMEKEKEGFP--ITSL-REINILLKLQHPNIVTVKEVVVGSNL 78
Query: 73 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ M+ E + +L+ + K +K Q+L G+ +LH + I+HRDLK
Sbjct: 79 DKIYMVME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTS 135
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFG 187
N+ +N N G +KI D GLA P ++ T + APEL +EY+ +D++S G
Sbjct: 136 NLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG 194
Query: 188 MCIL-EMVT 195
CI E++T
Sbjct: 195 -CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 66/235 (28%), Positives = 114/235 (48%), Gaps = 26/235 (11%)
Query: 43 QKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKT---VNMITELFTSGNLRQYRKKHKNVD 98
+++ +E ++L+SL + NVVKFY + K + ++ EL G++ + K
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 99 IKVIKNWARQILHG--LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156
++ + IL+G L H HN IIHRD+K +NI + G VK+ D G++ +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTST 181
Query: 157 TAR--SVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 208
R + +GTP +MAPE+ Y+ Y+ D++S G+ +E+ + P + +P +
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVK 240
Query: 209 IFKKVTSGIKPASLAKVNDPQ-----IKGFIEKCLVPASE-RLSAKDLLKDPFLQ 257
K+ P L P+ FI +CL+ E R S LL+ PF++
Sbjct: 241 TLFKIPRNPPPTLL----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 84/304 (27%), Positives = 131/304 (43%), Gaps = 51/304 (16%)
Query: 16 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 72
AFD G+ VA K+ Q ++ Y E+ LLK +K +NV+ + +
Sbjct: 36 AFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93
Query: 73 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
V ++T L +L K K D V + QIL GL Y+HS + IIHRDLK
Sbjct: 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHV-QFLIYQILRGLKYIHSAD--IIHRDLKPS 149
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG---TPEFMAPELYEE--EYNELVDIYSF 186
N+ VN + E+KI D GLA + T + G T + APE+ YN+ VDI+S
Sbjct: 150 NLAVNED-CELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 204
Query: 187 GMCILEMVTFE--YPYSECKNPAQIFKKVTSGIKPASLAKVN------------------ 226
G + E++T +P ++ + ++ ++ L K++
Sbjct: 205 GCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMN 264
Query: 227 --------DPQIKGFIEKCLVPASE-RLSAKDLLKDP-FLQVEN-QKEPICDPLKLPIQS 275
+P +EK LV S+ R++A L F Q + EP+ DP +S
Sbjct: 265 FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFES 324
Query: 276 LKML 279
+L
Sbjct: 325 RDLL 328
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 22/188 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKID---DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
Y+A D +G VA +V++D D + + E+ LL +L+ N+V+ + V
Sbjct: 24 YRARDTTSGEIVALKKVRMDNERDGIPISS-----LREITLLLNLRHPNIVELKEVVVGK 78
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
++ ++ E + +L +K Q+L GL YLH + IIHRDLK
Sbjct: 79 HLDSIFLVME-YCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLK 135
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELY--EEEYNELVDI 183
N+ + G +KI D GLA P T + V T + APEL Y +D+
Sbjct: 136 VSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDM 192
Query: 184 YSFGMCIL 191
++ G CIL
Sbjct: 193 WAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 43/132 (32%), Positives = 74/132 (56%), Gaps = 6/132 (4%)
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
K+ + + E G+L + + D+ +A +I+ GL +LHS I++RDLK D
Sbjct: 68 KENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLD 125
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGM 188
NI ++ + G +KI D G+ A++ GTP+++APE L ++YN VD +SFG+
Sbjct: 126 NILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGV 184
Query: 189 CILEMVTFEYPY 200
+ EM+ + P+
Sbjct: 185 LLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 37/102 (36%), Positives = 60/102 (58%), Gaps = 5/102 (4%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 163
+A +I GL LH I++RDLK +NI ++ ++G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163
Query: 164 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 204
T +MAPE+ + E Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 40/129 (31%), Positives = 70/129 (54%), Gaps = 5/129 (3%)
Query: 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137
I +L G+L + +H K ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 138 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 195
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191
Query: 196 FEYPYSECK 204
P+ + K
Sbjct: 192 GHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 41/140 (29%), Positives = 80/140 (57%), Gaps = 9/140 (6%)
Query: 70 DKKKTVNMITELFTSGNLRQ--YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 127
+ K + ++ L G+L+ Y + ++++ + +++ QI G+++LHS + I++RD
Sbjct: 63 ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRD 120
Query: 128 LKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIY 184
+K +N+ ++ G ++ DLGLA+ ++ + + GT +MAPE L EE Y+ VD +
Sbjct: 121 MKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPYSYPVDWF 178
Query: 185 SFGMCILEMVTFEYPYSECK 204
+ G I EMV P+ + K
Sbjct: 179 AMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 14/176 (7%)
Query: 39 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 96
PG + Q E +L+K+L+ D +V+ Y V K++ + +ITE G+L + K +
Sbjct: 40 PGTMSVQAFLEEANLMKTLQHDKLVRLYA--VVTKEEPIYIITEYMAKGSLLDFLKSDEG 97
Query: 97 VDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 152
+ + K +++ QI G+ Y+ N IHRDL+ N+ V+ KI D GLA I
Sbjct: 98 GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIE 154
Query: 153 MQQPTARSVIGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKN 205
+ TAR P ++ APE + D++SFG+ + E+VT+ + PY N
Sbjct: 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 13/170 (7%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--N 104
+E +L+K L+ +V+ Y ++ + +ITE +G+L + K + + + + K +
Sbjct: 50 AEANLMKQLQHPRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVI 162
A QI G+ ++ N IHRDL+ NI V+ KI D GLA I + TAR
Sbjct: 107 MAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 163 GTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 209
P ++ APE + + D++SFG+ + E+VT+ PY NP I
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 56/204 (27%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 167
Q+L GL Y+HS N ++HRDLK N+ +N N ++KI D GL AR+ +F
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGL--------ARTTSEKGDF 164
Query: 168 M----------APELY--EEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKNPAQIFKK 212
M APEL EY +D++S G CI E++ + +P + + ++ +
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITE 223
Query: 213 VTSGIKPASLAKVNDPQIKGFI--------------------------EKCLV-PASERL 245
+ L + + + + +I EK LV S+R+
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI 283
Query: 246 SAKDLLKDPFLQV--ENQKEPICD 267
+ ++ L P+L + EP+C
Sbjct: 284 TVEEALAHPYLASLHDPSDEPVCQ 307
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 21/194 (10%)
Query: 36 LQLPGDLQKLY--SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL----RQ 89
+ L + Q Y SE+H L + +VK + + D K + +I E + G+L +Q
Sbjct: 101 VMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK--LLLIMEYGSGGDLNKQIKQ 158
Query: 90 YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149
K+H + QI+ L +HS ++HRDLK NIF+ G +K+GD G
Sbjct: 159 RLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGF 215
Query: 150 AI----AMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 204
+ ++ A S GTP ++APEL+E + Y++ D++S G+ + E++T P+ K
Sbjct: 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---K 272
Query: 205 NPAQ--IFKKVTSG 216
P+Q I ++V G
Sbjct: 273 GPSQREIMQQVLYG 286
|
Length = 478 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 66/193 (34%), Positives = 95/193 (49%), Gaps = 22/193 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKI---DDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYK-- 65
YKA D +G VA V++ +D L L EV LLK L+ N+V+
Sbjct: 17 YKARDPHSGHFVALKSVRVQTNEDGLPL-----STVREVALLKRLEAFDHPNIVRLMDVC 71
Query: 66 -SWVDDKKKTVNMITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPP 122
+ D++ V ++ E +LR Y K + + IK+ RQ L GL +LH++
Sbjct: 72 ATSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC-- 128
Query: 123 IIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNEL 180
I+HRDLK +NI V + G+VK+ D GLA I Q V+ T + APE L + Y
Sbjct: 129 IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATP 187
Query: 181 VDIYSFGMCILEM 193
VD++S G EM
Sbjct: 188 VDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 47/164 (28%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137
+ E G+L ++ + D + +A ++ L++LH H +I+RDLK DNI ++
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDA 131
Query: 138 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 194
G K+ D G+ + T + GTP+++APE L E EY VD ++ G+ + EM+
Sbjct: 132 E-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM 190
Query: 195 TFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEK 236
+ P+ E N +F+ + + P L+K +K F+ K
Sbjct: 191 AGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 41/132 (31%), Positives = 72/132 (54%), Gaps = 6/132 (4%)
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
K+ + + E G+L + + D+ +A +I+ GL +LHS II+RDLK D
Sbjct: 68 KEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLD 125
Query: 132 NIFVNGNHGEVKIGDLGLAI--AMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 188
N+ ++ + G +KI D G+ A + GTP+++APE+ + +Y VD +SFG+
Sbjct: 126 NVMLDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 189 CILEMVTFEYPY 200
+ EM+ + P+
Sbjct: 185 LLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 106
EV LLK LK N+V + + +K++ ++ E + +L+QY N +++ +K +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFL 110
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGT 164
Q+L GL Y H ++HRDLK N+ +N GE+K+ D GLA A PT + + T
Sbjct: 111 FQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 165 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 195
+ P+ L +Y+ +D++ G EM T
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 106
EV LLK+LK N+V + + ++ + ++ E S +L+QY N+ + +K +
Sbjct: 53 EVSLLKNLKHANIVTLHD--IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGT 164
Q+L GL Y H I+HRDLK N+ +N GE+K+ D GLA A PT + + T
Sbjct: 110 FQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 165 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 195
+ P+ L EY+ +D++ G + EM T
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 13/189 (6%)
Query: 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137
I +L G+L + +H ++ +A +I+ GL H HN +++RDLK NI ++
Sbjct: 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD- 131
Query: 138 NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT 195
HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G + +++
Sbjct: 132 EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191
Query: 196 FEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERL-----SAK 248
P+ + K + ++T + L P+++ +E L + RL A+
Sbjct: 192 GHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 250
Query: 249 DLLKDPFLQ 257
++ + PF +
Sbjct: 251 EVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137
+ E G+L + +K + D + +A +I L++LH II+RDLK DN+ ++
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD- 130
Query: 138 NHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 194
+ G K+ D G+ T + GTP+++APE L E Y VD ++ G+ + EM+
Sbjct: 131 HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190
Query: 195 TFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEK 236
P+ E +N +F+ + + + P L++ +K F+ K
Sbjct: 191 CGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 47/153 (30%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 106
E LLK LK N+V + + KKT+ ++ E + +L+QY + + ++ +
Sbjct: 53 EASLLKDLKHANIVTLHD--IIHTKKTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFL 109
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGT 164
Q+L GL Y H ++HRDLK N+ ++ GE+K+ D GLA A P T + + T
Sbjct: 110 FQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVT 166
Query: 165 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 195
+ P+ L EY+ +D++ G EM T
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 119 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEY 177
H IHRDLK +N F+ G +K+ D GL+ + A SV+G+P++MAPE L + Y
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGY 175
Query: 178 NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK------ 231
+ VD +S G C+L +P P + ++ + + +DP+
Sbjct: 176 DFTVDYWSLG-CMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234
Query: 232 GFIEKCLVPASERL-SAKDLLKDPF 255
I K + S R S +D+ PF
Sbjct: 235 DLITKLINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 11/188 (5%)
Query: 14 YKAFD-EFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
+KA D + G VA RV++ + +P + + + L++ + NVV+ + +
Sbjct: 18 FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77
Query: 72 KKTVNMITELF--TSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 127
+T +F +L Y K V + IK+ Q+L GL +LHSH ++HRD
Sbjct: 78 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRD 135
Query: 128 LKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYS 185
LK NI V + G++K+ D GLA I Q SV+ T + APE L + Y VD++S
Sbjct: 136 LKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWS 194
Query: 186 FGMCILEM 193
G EM
Sbjct: 195 VGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 11/153 (7%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 106
EV LLK LK N+V + + K++ ++ E + +L+QY N+ + +K +
Sbjct: 54 EVSLLKDLKHANIVTLHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFL 110
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGT 164
QIL GL Y H ++HRDLK N+ +N GE+K+ D GLA A PT + + T
Sbjct: 111 YQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVT 167
Query: 165 PEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 195
+ P+ L EY+ +D++ G EM +
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 59/292 (20%)
Query: 31 KIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 89
KI D + D Q+ + E+ L+ L D N+VK + K + ++ E + +L
Sbjct: 39 KIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHA 97
Query: 90 YRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147
+ + ++V + I Q+L L Y+HS N +IHRDLK NI +N + VK+ D
Sbjct: 98 VIRANILEDVHKRYI---MYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADF 151
Query: 148 GLA-------IAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTFE 197
GLA + P + T + APE L Y + VD++S G CIL EM+ +
Sbjct: 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLGK 210
Query: 198 --YPYSECKNPAQIFKKVTSGIKPAS--------------LAKVNDPQIKG--------- 232
+P + N Q+ K + P++ L + K
Sbjct: 211 PLFPGTSTLN--QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKAS 268
Query: 233 -----FIEKCLV--PASERLSAKDLLKDPFLQ--VENQKEPICD-PLKLPIQ 274
++K LV P ++RL+A++ L+ P++ EP+ P+ +P+
Sbjct: 269 DDALDLLKKLLVFNP-NKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 40 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT---SGNLRQYRKKHKN 96
G +E H+L+++ ++++ ++ T N T L +L Y +N
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTF------TYNKFTCLILPRYKTDLYCYLAAKRN 178
Query: 97 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAM 153
+ I I R +L + YLH IIHRD+K +NIF+N + G+V +GD G A + +
Sbjct: 179 IAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDI 235
Query: 154 QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVT 195
GT APEL + Y VDI+S G+ + EM T
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 39 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 96
PG + + E ++K L+ D +V+ Y ++ + ++TE + G+L + K +
Sbjct: 40 PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKDGEG 96
Query: 97 VDIKV--IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 152
+K+ + + A Q+ G+ Y+ N IHRDL+ NI V G+ KI D GLA I
Sbjct: 97 RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIE 153
Query: 153 MQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQ 208
+ TAR P ++ APE LY + D++SFG+ + E+VT PY N +
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-RE 211
Query: 209 IFKKVTSGIK-------PASLAKV 225
+ ++V G + P SL ++
Sbjct: 212 VLEQVERGYRMPCPQDCPISLHEL 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 6/99 (6%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 162
+ +I+ L YLHS + +++RD+K +N+ ++ G +KI D GL T ++
Sbjct: 100 YGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 163 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 200
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-11
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 24/114 (21%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----------PT 157
+I + Y+HS ++HRDLK DNI + G GEV I D G AI +
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 158 ARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 200
++GTP++MAPE L +E DIY+ G+ + +M+T +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 25/260 (9%)
Query: 16 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75
A D G +VA KI+DV + D ++ E+ LL+ L+ ++V+ + ++
Sbjct: 19 AIDTHTGEKVAIK--KINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREF 76
Query: 76 N---MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++ EL S +L Q K + ++ + + + Q+L L Y+H+ N + HRDLK N
Sbjct: 77 KDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKN 133
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTARSV-----IGTPEFMAPEL---YEEEYNELVDIY 184
I N + ++KI D GLA T ++ + T + APEL + +Y +DI+
Sbjct: 134 ILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 192
Query: 185 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI----EKC 237
S G CI V P KN +T + P ++++V + + + ++ +K
Sbjct: 193 SIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQ 251
Query: 238 LVPASERLSAKDLLKDPFLQ 257
VP S++ D L L+
Sbjct: 252 PVPFSQKFPNADPLALRLLE 271
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 10/153 (6%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 162
+A +I L YLHS N II+RDLK +NI ++ + G V + D GL + T +
Sbjct: 101 YAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFC 157
Query: 163 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 221
GTPE++APE L ++ Y+ VD + G + EM+ + P ++ A+++ + + KP
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLR 214
Query: 222 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKD 253
L + +E L ++RL AKD +
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLE 247
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 30 VKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWV-DDKKKTVN-----MITELF 82
VK+ D+ + D + +EV L + ++VK ++ + D + N ++ +
Sbjct: 62 VKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYA 121
Query: 83 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-------HSHNPPIIHRDLKCDNIFV 135
+G+LRQ K + ++ A GL+++ H H+ +IHRD+K NI +
Sbjct: 122 NAGDLRQEIKSRAKTNRTFREHEA-----GLLFIQVLLAVHHVHSKHMIHRDIKSANILL 176
Query: 136 NGNHGEVKIGDLGL----AIAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCI 190
N G VK+GD G A + R+ GTP ++APE++ + Y++ D++S G+ +
Sbjct: 177 CSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLL 235
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSG 216
E++T + P+ + +N ++ K +G
Sbjct: 236 YELLTLKRPF-DGENMEEVMHKTLAG 260
|
Length = 496 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 63/260 (24%)
Query: 48 EVHLLKSLKDDNVVKFY------KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKV 101
E+ +L+ LK +NVV + + K + ++ E K+ +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----- 156
IK + +L+GL Y+H + I+HRD+K NI + + G +K+ D GLA A
Sbjct: 121 IKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKP 177
Query: 157 ---TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTFEYP----------- 199
T R V T + PEL E +Y +D++ G CI+ EM T P
Sbjct: 178 NRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWT-RSPIMQGNTEQHQL 233
Query: 200 -----------------------YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236
+ + + P +KV +KP V DP I+K
Sbjct: 234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALDLIDK 289
Query: 237 CLV-PASERLSAKDLLKDPF 255
LV ++R+ A L F
Sbjct: 290 LLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 43/137 (31%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 162
+A +I GL +LHS II+RDLK DN+ ++ + G +KI D G+ T ++
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 163 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 219
GTP+++APE+ + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 221
Query: 220 ASLAKVNDPQIKGFIEK 236
S++K KG + K
Sbjct: 222 KSMSKEAVAICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
DL+ L E+ + L+ N++ + S++ D + + +++ L G+ K H +
Sbjct: 42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDLLKTHFPEGLP 99
Query: 101 --VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQP 156
I + +L+ L Y+HS IHR +K +I ++G+ G+V + L +++M
Sbjct: 100 ELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGK 156
Query: 157 TARSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSE 202
R V P+ ++PE+ ++ YNE DIYS G+ E+ P+ +
Sbjct: 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 42/137 (30%), Positives = 77/137 (56%), Gaps = 9/137 (6%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 162
+A +I GL +LH II+RDLK DN+ ++ + G +KI D G+ + T R+
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFC 162
Query: 163 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP 219
GTP+++APE+ + Y + VD +++G+ + EM+ + P+ + ++ ++F+ + P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYP 221
Query: 220 ASLAKVNDPQIKGFIEK 236
SL+K KG + K
Sbjct: 222 KSLSKEAVSICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 49/161 (30%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVI 162
+A +I L YLHS N I++RDLK +NI ++ + G + + D GL + T +
Sbjct: 101 YAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFC 157
Query: 163 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 221
GTPE++APE L+++ Y+ VD + G + EM+ + P +N A+++ + + KP
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN--KPLQ 214
Query: 222 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ 261
L + +E L ++RL A KD F++++N
Sbjct: 215 LKPNITNSARHLLEGLLQKDRTKRLGA----KDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 35/113 (30%), Positives = 65/113 (57%), Gaps = 9/113 (7%)
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSV--IG 163
+Q+L + Y+H +IHRD+K +NIF+N + G++ +GD G A+ ++ A +G
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY-PYSE-CKNPAQIFKKV 213
T +PE L + Y E+ DI+S G+ +L+M++ ++ P + P + K+
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ------Q 155
+++ QIL GL Y+HS N ++HRDLK N+ VN + E+KI D GLA
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENA 163
Query: 156 PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL 191
+ T + APE L + Y + +D++S G CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 42/130 (32%), Positives = 71/130 (54%), Gaps = 11/130 (8%)
Query: 74 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
T+ ++T+L G L Y +HK N+ +++ NW QI G++YL ++HRDL N
Sbjct: 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARN 139
Query: 133 IFVNG-NHGEVKIGDLGLAIAMQ----QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 186
+ V NH VKI D GLA ++ + A ++MA E ++ ++ D++S+
Sbjct: 140 VLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY 197
Query: 187 GMCILEMVTF 196
G+ I E++TF
Sbjct: 198 GVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 49/167 (29%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 42 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDI 99
+++ E ++K +K N+V+ V ++ +ITE T GNL Y + V+
Sbjct: 46 VEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 103
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
V+ A QI + YL N IHRDL N V G + VK+ D GL+ M T
Sbjct: 104 VVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYT 160
Query: 160 SVIGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 199
+ G ++ APE L +++ D+++FG+ + E+ T+ YP
Sbjct: 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 36/102 (35%), Positives = 61/102 (59%), Gaps = 5/102 (4%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 163
+A +I GL LH I++RDLK +NI ++ +HG ++I DLGLA+ + + T + +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 164 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK 204
T +MAPE+ + E Y D ++ G + EM+ + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 36/98 (36%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 163
+A +IL GL LH N ++RDLK +NI ++ ++G ++I DLGLA+ + + + R +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY 200
T +MAPE L + Y D + G I EM+ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 52/160 (32%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL-----FTSGNLRQYRKKHKNV 97
++ Y E+ LLK +K +NV+ + D +++ + F +L + KH+ +
Sbjct: 59 KRAYRELRLLKHMKHENVIGLLDVFTPDL--SLDRFHDFYLVMPFMGTDLGKL-MKHEKL 115
Query: 98 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157
I+ Q+L GL Y+H+ IIHRDLK N+ VN E+KI D GLA
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEM 172
Query: 158 ARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 195
V+ T + APE L Y + VDI+S G + EM+T
Sbjct: 173 TGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 48/174 (27%), Positives = 88/174 (50%), Gaps = 8/174 (4%)
Query: 45 LYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 104
++SE +L + V Y S+ D+ + ++ E G + +++K V
Sbjct: 78 VFSERKILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT 164
+A QI+ YL S N I++RDLK +N+ ++ + G +K+ D G A + T ++ GT
Sbjct: 136 YAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRT-YTLCGT 191
Query: 165 PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI 217
PE++APE L + + D ++ G+ I E++ P+ P I++K+ GI
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGI 244
|
Length = 340 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 18/214 (8%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVD--DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNW 105
E+ L+ + +N++K Y +D D +++I E T G LR+ K K++ K +
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDM 127
Query: 106 ARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT 164
A GL L+ N P +++L + V N ++KI GL + P ++V
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN-YKLKIICHGLEKILSSPPFKNV--- 181
Query: 165 PEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 218
FM Y+ EY DIYS G+ + E+ T + P+ E +I+ + +
Sbjct: 182 -NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLIINKNN 239
Query: 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 251
L +IK +E C + +R + K++L
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 54/180 (30%), Positives = 92/180 (51%), Gaps = 15/180 (8%)
Query: 39 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 96
PG + + +E +++K+L+ D +VK + K+ + +ITE G+L + K +
Sbjct: 40 PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEG 96
Query: 97 VDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 152
+ K +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA I
Sbjct: 97 SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIE 153
Query: 153 MQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 209
+ TAR P ++ APE + + D++SFG+ ++E+VT+ PY NP I
Sbjct: 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 40/96 (41%), Positives = 56/96 (58%), Gaps = 12/96 (12%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSV----I 162
QIL GL Y+HS N ++HRDLK N+ +N N ++KI D GLA IA + +
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 163 GTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 195
T + APE L + Y + +DI+S G CIL EM++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 51 LLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQIL 110
LLK+LK +V + S+ +K + + + G L + ++ + + +A ++
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEK--LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106
Query: 111 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFM 168
+ YLHS N II+RDLK +NI ++ + G V + D GL +P T + GTPE++
Sbjct: 107 SAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYL 163
Query: 169 APE-LYEEEYNELVDIYSFGMCILEMV 194
APE L +E Y+ VD + G + EM+
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 11/152 (7%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 106
E LLK LK N+V + + K+T+ ++ E + +L QY KH + + +K +
Sbjct: 53 EASLLKGLKHANIVLLHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLFL 109
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGT 164
Q+L GL Y+H I+HRDLK N+ ++ + GE+K+ D GLA A P T + + T
Sbjct: 110 FQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 165 PEFMAPE--LYEEEYNELVDIYSFGMCILEMV 194
+ P+ L EY+ +D++ G +EM+
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 52/191 (27%), Positives = 95/191 (49%), Gaps = 24/191 (12%)
Query: 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
ELFT R++ + + ++ + +I+ L +LH II+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTESE------VRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 140 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 193
G V + D GL+ +A ++ A S GT E+MAPE+ +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 194 VTFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE-RL---S 246
+T P++ E + ++I +++ P K + + FI+K L + RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 247 AKDLLKDPFLQ 257
A ++ PF Q
Sbjct: 260 ADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 71/270 (26%), Positives = 116/270 (42%), Gaps = 52/270 (19%)
Query: 31 KIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD-------DKKKTVNMITELFT 83
K+ +V Q ++++ E+ +L K DNV+ S +D D + + ++TEL
Sbjct: 32 KMPNVFQNLVSCKRVFRELKMLCFFKHDNVL----SALDILQPPHIDPFEEIYVVTELMQ 87
Query: 84 SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
S +L + + + +K + QIL GL YLHS I+HRD+K N+ VN N +K
Sbjct: 88 S-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLK 143
Query: 144 IGDLGLAIAMQQPTARSV---IGTPEFMAPELY--EEEYNELVDIYSFGMCI-------- 190
I D GLA + ++ + + T + APE+ Y VDI+S G CI
Sbjct: 144 ICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG-CIFAELLGRR 202
Query: 191 -----------LEMVT-------FEYPYSECKNP-AQIFKKVTSGIKPASLAKVNDP--- 228
L+++T E S C+ A I + L ++
Sbjct: 203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATH 262
Query: 229 QIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257
+ + + LV +R+SA D L P+L
Sbjct: 263 EAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 21/175 (12%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE--------LFTSGNLRQYRKKHKNVDI 99
E+ LL+ LK NV+ K ++ + V ++ + + + KK +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQP 156
++K+ QIL G+ YLH++ ++HRDLK NI V G G VKI D+G A P
Sbjct: 108 SMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 157 TA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYPYSECK 204
V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 23/179 (12%)
Query: 42 LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------- 94
+ EV +L L D N+ + D + MI E +G+L Q+ +KH
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 95 ----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150
K++ + A QI G+ YL S N +HRDL N V N+ +KI D G++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFGMS 177
Query: 151 IAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF--EYPYSE 202
+ V G +MA E + ++ D+++FG+ + E++T E PY
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 12/177 (6%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 106
E ++ L N+V+ Y V K++ + ++TE +G L Y ++ K + + +
Sbjct: 49 EAKVMMKLSHPNLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP- 165
+ + YL S+ IHRDL N V G VK+ D GLA + S GT
Sbjct: 107 SDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKF 163
Query: 166 --EFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 218
++ PE+++ ++ D++SFG+ + E+ + + PY N +++ + V++G +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYR 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL-------RQYRKKHKNVDIK 100
E+ LL+ LK NV+ K ++ + V ++ + + +L R + K V +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 101 --VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQ 155
++K+ QIL G+ YLH++ ++HRDLK NI V G G VKI D+G A
Sbjct: 107 RGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 156 PTA-----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTFEYPYSECK 204
P V+ T + APEL Y + +DI++ G E++T E P C+
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 106
E LLK LK N+V + + K+T+ + E + +L QY +H + ++ +
Sbjct: 53 EASLLKGLKHANIVLLHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFM 109
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGT 164
Q+L GL Y+H + I+HRDLK N+ ++ GE+K+ D GLA A P T S + T
Sbjct: 110 FQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVT 166
Query: 165 PEFMAPE--LYEEEYNELVDIYSFGMCILEMV 194
+ P+ L +Y+ +DI+ G +EM+
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 35/121 (28%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
++T+ + G L + +K K + +++ L +LH ++ I++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 137 GNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILE 192
G + + D GL+ A T + GT E++APE+ +E Y + VD +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 193 M 193
M
Sbjct: 190 M 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 31/206 (15%)
Query: 33 DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRK 92
D L D Q+ E LL +L+ +++VKFY D + M+ E G+L ++ +
Sbjct: 45 DPTLAARKDFQR---EAELLTNLQHEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLR 99
Query: 93 KH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
H + + + + A QI G+VYL S + +HRDL N V
Sbjct: 100 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV- 156
Query: 137 GNHGEVKIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCIL 191
G + VKIGD G++ + V G +M PE + ++ D++SFG+ +
Sbjct: 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216
Query: 192 EMVTF-EYPYSECKNPAQIFKKVTSG 216
E+ T+ + P+ + + ++ + +T G
Sbjct: 217 EIFTYGKQPWFQL-SNTEVIECITQG 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 38/135 (28%), Positives = 74/135 (54%), Gaps = 10/135 (7%)
Query: 74 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++ ++T+L G+L + ++H+ ++D + + NW QI G+ YL H ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARN 139
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTP-EFMAPE-LYEEEYNELVDIYSFG 187
I + + V+I D G+A + + S TP ++MA E + Y D++S+G
Sbjct: 140 ILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 188 MCILEMVTF-EYPYS 201
+ + EM+++ PY+
Sbjct: 199 VTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 43 QKLYSEVHLLKSLKDDNVVK----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 98
++ Y E+ LLK +K +NV+ F + + V ++T L +L K K D
Sbjct: 59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSD 117
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
+ ++ Q+L GL Y+HS IIHRDLK N+ VN + E++I D GLA
Sbjct: 118 -EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLARQADDEMT 173
Query: 159 RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFE--YPYSECKNPAQIFKKVT 214
+ T + APE L YN+ VDI+S G + E++ + +P ++ + + +V
Sbjct: 174 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232
Query: 215 SGIKPASLAKVNDPQIKGFIE 235
P L K++ + +I+
Sbjct: 233 GTPSPEVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 37/127 (29%), Positives = 68/127 (53%), Gaps = 6/127 (4%)
Query: 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
++ E G+L + ++ + + + + +A +I L +LH II+RDLK DN+ ++
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD 130
Query: 137 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 193
+ G +K+ D G+ P T + GTP ++APE+ EEY VD ++ G+ + EM
Sbjct: 131 AD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 194 VTFEYPY 200
+ P+
Sbjct: 190 MAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 49/167 (29%), Positives = 90/167 (53%), Gaps = 11/167 (6%)
Query: 51 LLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQIL 110
LLK++K +V + S+ +K + + + G L + ++ ++ + +A +I
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEK--LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA 106
Query: 111 HGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL---AIAMQQPTARSVIGTPEF 167
L YLHS N I++RDLK +NI ++ + G V + D GL IA Q T + GTPE+
Sbjct: 107 SALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEY 162
Query: 168 MAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213
+APE + ++ Y+ VD + G + EM+ + P C++ A+++ +
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----QPTARSV 161
ARQ+L + Y+H IIHRD+K +N+ VNG ++ +GD G A + P +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 162 IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 192
GT + APE L + Y VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 39 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-- 94
PG + + E ++K L+ D +V Y ++ + ++TE G+L + K+
Sbjct: 40 PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDG 96
Query: 95 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 152
K + + + + A QI G+ Y+ N IHRDL+ NI V G++ KI D GLA I
Sbjct: 97 KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIE 153
Query: 153 MQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 195
+ TAR P ++ APE LY + D++SFG+ + E+VT
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 45/177 (25%), Positives = 87/177 (49%), Gaps = 12/177 (6%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWA 106
E ++ L + +V+ Y V K++ + ++TE ++G L Y ++H K +
Sbjct: 49 EAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP- 165
+ + G+ YL S IHRDL N V+ G VK+ D GL+ + S +G+
Sbjct: 107 KDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTSSVGSKF 163
Query: 166 --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 218
+ PE L +++ D+++FG+ + E+ + + PY N ++ +KV+ G++
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 21 AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80
EVA + P +K E +LK N+VK V K+ + ++ E
Sbjct: 18 GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVME 72
Query: 81 LFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
L G+L + RKK + +K + + G+ YL S N IHRDL N V N+
Sbjct: 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENN 130
Query: 140 GEVKIGDLGLAIAMQQPTARSVIGTPE----FMAPE-LYEEEYNELVDIYSFGMCILEMV 194
+KI D G++ + G + + APE L Y D++S+G+ + E
Sbjct: 131 -VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF 189
Query: 195 TF-EYPYSECKNPAQIFKKVTSG 216
+ + PY N Q +++ SG
Sbjct: 190 SLGDTPYPGMSN-QQTRERIESG 211
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 22/190 (11%)
Query: 44 KLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN------- 96
+ E HL+ + N+VK + ++ +I EL G+L Y + +
Sbjct: 45 EFLKEAHLMSNFNHPNIVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPL 102
Query: 97 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE----VKIGDLGLAIA 152
+ +K + + + G VYL + IHRDL N V+ + VKIGD GLA
Sbjct: 103 LTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
Query: 153 MQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNP 206
+ + G +MAPE L + ++ D++SFG+ + E++T + PY N
Sbjct: 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN- 219
Query: 207 AQIFKKVTSG 216
++ + VT+G
Sbjct: 220 QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 106
E+ +LK++ ++ ++ K TV M+ + +L Y + + ++
Sbjct: 135 REIDILKTISHRAIINLIHAY--RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----QQPTARSVI 162
R++L L YLH IIHRD+K +NIF++ +GD G A + P
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 163 GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 193
GT E +PEL + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
K + + E G L + + + + + +I+ L YLHS I++RDLK +
Sbjct: 67 KDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLE 124
Query: 132 NIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGM 188
N+ ++ + G +KI D GL T ++ GTPE++APE+ E+ +Y VD + G+
Sbjct: 125 NLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 189 CILEMVTFEYPY 200
+ EM+ P+
Sbjct: 184 VMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 9/138 (6%)
Query: 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
+ E G+L + ++ + + + + ++ +I L YLH II+RDLK DN+ ++
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD 130
Query: 137 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEM 193
+ G +K+ D G+ +P T + GTP ++APE+ E+Y VD ++ G+ + EM
Sbjct: 131 -SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 194 VTFEYPYS---ECKNPAQ 208
+ P+ NP Q
Sbjct: 190 MAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 6/96 (6%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVIGTP 165
+I+ L YLHS + +++RDLK +N+ ++ + G +KI D GL T ++ GTP
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTP 159
Query: 166 EFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 200
E++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 5/99 (5%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQQPTARSVI 162
+ +I+ L YLHS +++RDLK +N+ ++ + G +KI D GL T ++
Sbjct: 100 YGAEIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFC 157
Query: 163 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPY 200
GTPE++APE+ E+ +Y VD + G+ + EM+ P+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 46/135 (34%), Positives = 70/135 (51%), Gaps = 12/135 (8%)
Query: 74 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
TV +IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL N
Sbjct: 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARN 139
Query: 133 IFVNG-NHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE-LYEEEYNELVDIYSF 186
+ V H VKI D GLA + + + G P ++MA E + Y D++S+
Sbjct: 140 VLVKTPQH--VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 197
Query: 187 GMCILEMVTF-EYPY 200
G+ + E++TF PY
Sbjct: 198 GVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 77 MITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 134
+ITE G+L + RK+ + ++ + +++ Q+ G+ +L S N IHRDL N+
Sbjct: 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVL 173
Query: 135 VNGNHGEV-KIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGM 188
+ HG++ KI D GLA + + V G ++MAPE ++ Y D++S+G+
Sbjct: 174 LT--HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231
Query: 189 CILEMVTF-EYPYSECKNPAQIFKKVTSGIKPAS 221
+ E+ + PY ++ +K + G + A
Sbjct: 232 LLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 23/173 (13%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------N 96
E+ ++ LKD N+++ + + MITE +G+L Q+ +H+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDP--LCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 97 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156
+ + A QI G+ YL S N +HRDL N V N+ +KI D G++ +
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSG 183
Query: 157 -----TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTF--EYPYSE 202
R+V+ + ++ D+++FG+ + E++T E PYS+
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 32/87 (36%), Positives = 50/87 (57%), Gaps = 4/87 (4%)
Query: 117 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTARSVIGTPEFMAPELYE 174
H H+ II+RDLK +NI ++ G +K+ D GL+ + A S GT E+MAPE+
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 175 EE-YNELVDIYSFGMCILEMVTFEYPY 200
+ + D +SFG+ + EM+T P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWV-----DDKKKTVNMITELFTSGNLRQYRKKHKNV 97
++ Y E+ LLK ++ +NV+ + D+ + ++ + T +L++ +
Sbjct: 59 KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT--DLQKIMGHPLSE 116
Query: 98 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157
D ++ Q+L GL Y+HS IIHRDLK N+ VN + E+KI D GLA
Sbjct: 117 D--KVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLARHADAEM 171
Query: 158 ARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--KV 213
V+ T + APE L YN+ VDI+S G + EM+T + + Q+ + KV
Sbjct: 172 TGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230
Query: 214 TSGIKPASLAKVNDPQIKGFIE 235
T P + K+ D K +I+
Sbjct: 231 TGVPGPEFVQKLEDKAAKSYIK 252
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 41 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
DL L SE+ ++K + K N++ + D + +I E + GNLR+Y + + +
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGM 120
Query: 100 KVIKNWAR----------------QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
+ + AR Q+ G+ YL S IHRDL N+ V N+ +K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMK 177
Query: 144 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 196
I D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236
Query: 197 --EYPYSECKNPAQIFKKVTSGIKPAS 221
YP + ++ K+ KPA+
Sbjct: 237 GSPYPGIPVEELFKLLKEGHRMDKPAN 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 31/203 (15%)
Query: 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
+ E + G+L + ++ + + + + ++ +I L +LH II+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 137 GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 193
G +K+ D G+ +P T + GTP ++APE L E+Y VD ++ G+ + EM
Sbjct: 131 AE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 194 VTFEYPY---SECKNPAQ---------IFKKVTSGIK-PASLAKVNDPQIKGFIEKCLVP 240
+ P+ NP Q I +K I+ P SL+ +KGF+ K P
Sbjct: 190 MAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---IRIPRSLSVKASSVLKGFLNK--DP 244
Query: 241 ASERLSAK------DLLKDPFLQ 257
ERL D+ PF +
Sbjct: 245 K-ERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 85 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144
G+L KK + +K RQ++ L LH HN IIH D+K +N+ + + +
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYL 151
Query: 145 GDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY--- 200
D GL + P+ GT ++ +PE + Y+ D ++ G+ E++T ++P+
Sbjct: 152 CDYGLCKIIGTPSCYD--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209
Query: 201 -SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPA-SERLSA-KDLLKDPFLQ 257
E + + K+ K K F++ L + RL+ +++K PFL+
Sbjct: 210 EDEELDLESLLKRQQ---KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266
Query: 258 V 258
+
Sbjct: 267 I 267
|
Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 40/149 (26%), Positives = 78/149 (52%), Gaps = 14/149 (9%)
Query: 60 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 119
VV+ + ++ DDK + M+ E G+L + +V K K + +++ L +HS
Sbjct: 105 VVQLFCAFQDDKY--LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 161
Query: 120 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEEE 176
+IHRD+K DN+ ++ HG +K+ D G + M + + +GTP++++PE+ + +
Sbjct: 162 G--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 177 -----YNELVDIYSFGMCILEMVTFEYPY 200
Y D +S G+ + EM+ + P+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 47/166 (28%), Positives = 83/166 (50%), Gaps = 16/166 (9%)
Query: 39 PGDL--QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN 96
PG + + E ++K L+ + +V+ Y ++ + ++TE + G+L + K
Sbjct: 40 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMG 96
Query: 97 VDIKV--IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IA 152
+++ + + A QI G+ Y+ N +HRDL+ NI V G + K+ D GLA I
Sbjct: 97 KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIE 153
Query: 153 MQQPTARSVIGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 195
+ TAR P ++ APE LY + D++SFG+ + E+ T
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 72/258 (27%), Positives = 115/258 (44%), Gaps = 19/258 (7%)
Query: 16 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 72
AFD GI VA K+ Q ++ Y E+ LLK + N++ + K
Sbjct: 40 AFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97
Query: 73 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ V ++ EL + NL Q H +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 98 FQDVYLVMELMDA-NLCQV--IHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 152
Query: 132 NIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 189
NI V + +KI D GLA A + T + APE + Y E VDI+S G
Sbjct: 153 NIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 211
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN--DPQIKGFIEKCLVPASERLSA 247
+ E+V + + Q + KV + S +N P ++ ++E P +S
Sbjct: 212 MGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMNRLQPTVRNYVEN--RPQYPGISF 268
Query: 248 KDLLKDPFLQVENQKEPI 265
++L D E++++ +
Sbjct: 269 EELFPDWIFPSESERDKL 286
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 32/185 (17%)
Query: 41 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----- 94
DL L SE+ ++K + K N++ + V + E GNLR + +
Sbjct: 58 DLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV--VVEYAAHGNLRDFLRARRPPGE 115
Query: 95 -----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
+ + K + ++A Q+ G+ +L S IHRDL N+ V +H +K
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMK 172
Query: 144 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 196
I D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 173 IADFGLARDIHHIDYYRKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231
Query: 197 --EYP 199
YP
Sbjct: 232 GSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIG 163
+A ++ GL L I++RDLK +NI ++ + G ++I DLGLA+ + + T R +G
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECK 204
T +MAPE + E+Y D + G I EM+ + P+ + K
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 23/175 (13%)
Query: 116 LHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM---QQPTARSVIGTPEFMAPE 171
+HS H +HRD+K +N+ ++ G +K+ D G A + + ++ +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 172 LYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPAS 221
+ Y D +S G+ EM+ P+ E A+ + + + +K
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPE 232
Query: 222 LAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL------QVENQKEPICDPLK 270
KV+ I+ L ERL + L PF + N P LK
Sbjct: 233 DPKVSS-DFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLK 286
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 102
Q E LL L+ ++V+FY V + + + M+ E G+L ++ + H D K++
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYG--VCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKIL 108
Query: 103 KNW----------------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 146
A QI G+VYL S + +HRDL N V G VKIGD
Sbjct: 109 AGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGD 165
Query: 147 LGLAIAMQQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYP 199
G++ + V G +M PE LY + E DI+SFG+ + E+ T+ + P
Sbjct: 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQP 224
Query: 200 YSECKNPAQI 209
+ + N I
Sbjct: 225 WYQLSNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 29/179 (16%)
Query: 41 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK---- 95
DL L SE+ ++K + K N++ + D V I E + GNLR+Y + +
Sbjct: 66 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGM 123
Query: 96 ------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
+ K + + A Q+ G+ YL S IHRDL N+ V ++ +K
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMK 180
Query: 144 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 196
I D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 47/188 (25%), Positives = 94/188 (50%), Gaps = 19/188 (10%)
Query: 19 EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78
++ G +VA +K D Q +E ++ L+ N+V+ V++K + ++
Sbjct: 26 DYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-GLYIV 78
Query: 79 TELFTSGNLRQY-RKKHKNV-DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
TE G+L Y R + ++V + ++ + + YL ++N +HRDL N+ V+
Sbjct: 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS 136
Query: 137 GNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 193
++ K+ D GL + Q T + + ++ APE L E++++ D++SFG+ + E+
Sbjct: 137 EDN-VAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEI 192
Query: 194 VTF-EYPY 200
+F PY
Sbjct: 193 YSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 38/132 (28%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 85 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144
G L + ++ D+ + + ++L L LH N +I+RDLK +NI ++ G + +
Sbjct: 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIAL 134
Query: 145 GDLGLA-IAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYS 201
D GL + M+ + GTPE++APEL Y + VD ++ G+ + EM+T P+
Sbjct: 135 CDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
Query: 202 ECKNPAQIFKKV 213
+ +N ++++K+
Sbjct: 195 D-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 26/196 (13%)
Query: 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
ELFT + R+ K+ + ++ ++ +I+ L +LH II+RD+K +NI ++ N
Sbjct: 91 ELFTHLSQRERFKEQE------VQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN- 141
Query: 140 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEM 193
G V + D GL+ + A S GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 194 VTFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL---- 245
+T P++ E + A+I +++ P + K I++ L+ +RL
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGP 259
Query: 246 -SAKDLLKDPFLQVEN 260
A ++ K PF Q N
Sbjct: 260 SDADEIKKHPFFQKIN 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 14/100 (14%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGL--------AIAMQQPT 157
Q+L L +HN I+HRDLK NI V+ K+ D G+ + T
Sbjct: 87 QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 158 ARS-VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 195
+ V+GTP + APE L E D+Y++G+ LE +T
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 17/190 (8%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 102
Q SE ++ N+++ V K K +ITE +G L +Y + H +
Sbjct: 51 QDFLSEASIMGQFSHHNIIRL--EGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSY 107
Query: 103 K--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160
+ R I G+ YL N +HRDL NI VN N E K+ D GL+ ++ +
Sbjct: 108 QLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGT 164
Query: 161 VIGTP-----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
+ + APE + ++ D++SFG+ + E+++F E PY + N ++ K +
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAI 223
Query: 214 TSGIK-PASL 222
G + PA +
Sbjct: 224 NDGFRLPAPM 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 24/199 (12%)
Query: 36 LQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK 95
L L +Q+++ E +L ++ VV + S+ + K+ + M+ E G+ K
Sbjct: 39 LILRNQIQQVFVERDILTFAENPFVVSMFCSF--ETKRHLCMVMEYVEGGDCATLLKNIG 96
Query: 96 NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQ 154
+ + + + + + + L YLH++ I+HRDLK DN+ + + G +K+ D GL+ I +
Sbjct: 97 ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLM 153
Query: 155 QPTA----------------RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFE 197
T + V GTPE++APE + + Y + VD ++ G+ + E +
Sbjct: 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213
Query: 198 YPYSECKNPAQIFKKVTSG 216
P+ P ++F +V S
Sbjct: 214 VPFFG-DTPEELFGQVISD 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 41/130 (31%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 74 TVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
TV ++T+L G L Y +++K+ + + + NW QI G+ YL ++HRDL N
Sbjct: 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARN 139
Query: 133 IFV-NGNHGEVKIGDLGLA----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 186
+ V + NH VKI D GLA I + A ++MA E + + D++S+
Sbjct: 140 VLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY 197
Query: 187 GMCILEMVTF 196
G+ + E++TF
Sbjct: 198 GVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 37/193 (19%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 98
+L+ L SE +LLK + +V+K Y + D + +I E G+LR + ++ + V
Sbjct: 44 SSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPLLLIVEYAKYGSLRSFLRESRKVG 101
Query: 99 ------------------------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 134
+ + ++A QI G+ YL ++HRDL N+
Sbjct: 102 PSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVL 159
Query: 135 VNGNHGEVKIGDLGLAIAMQQPTA---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMC 189
V ++KI D GL+ + + + RS P ++MA E L++ Y D++SFG+
Sbjct: 160 V-AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 218
Query: 190 ILEMVTF---EYP 199
+ E+VT YP
Sbjct: 219 LWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 28/191 (14%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--------------RKK 93
E LL + + +N+VKFY + M+ E G+L ++
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115
Query: 94 HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153
+ + + A QI G+VYL S + +HRDL N V G VKIGD G++ +
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDV 172
Query: 154 QQPTARSVIGTP----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNP 206
V G +M PE +Y + E D++SFG+ + E+ T+ + P+ N
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN- 230
Query: 207 AQIFKKVTSGI 217
++ + +T G
Sbjct: 231 EEVIECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 47/189 (24%), Positives = 87/189 (46%), Gaps = 21/189 (11%)
Query: 19 EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78
++ G +VA +K DD Q +E ++ +L+ N+V+ + + ++
Sbjct: 26 DYRGQKVAVKCLK-DDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN--PLYIV 78
Query: 79 TELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 135
TE G+L Y R + + +A + G+ YL N +HRDL N+ V
Sbjct: 79 TEYMAKGSLVDYLRSRGRAVIT-LAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLV 135
Query: 136 NGNHGEVKIGDLGLAIAMQ--QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 192
+ K+ D GLA Q + + + ++ APE L E++++ D++SFG+ + E
Sbjct: 136 S-EDLVAKVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 193 MVTF-EYPY 200
+ +F PY
Sbjct: 192 IYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 35/201 (17%)
Query: 116 LHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS--VIGTPEFMAPE 171
+HS H +HRD+K DN+ ++ N G +++ D G + M Q T +S +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 172 LYEE------EYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASL 222
+ + +Y D +S G+C+ EM+ E P+ S + +I P+ +
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
Query: 223 AKVNDPQIKGFIEKCLVPASERLSA---KDLLKDPFLQ------VENQKEPICDPLKLPI 273
V++ + K I++ + RL +D K F + + N + P + P
Sbjct: 234 TDVSE-EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSP- 291
Query: 274 QSLKMLRLPMSGPSSMDIDSD 294
S S+ D+D D
Sbjct: 292 ----------SDTSNFDVDDD 302
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 34/197 (17%)
Query: 119 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA-MQQPTARS--VIGTPEFMAPELYEE 175
H +HRD+K DNI ++ N G +++ D G + M+ T +S +GTP++++PE+ +
Sbjct: 119 HQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 176 ------EYNELVDIYSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVN 226
+Y D +S G+C+ EM+ E P+ S + +I PA + V+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237
Query: 227 DPQIKGFIEKCLVPASERLSA---KDLLKDPFL------QVENQKEPICDPLKLPIQSLK 277
+ K I + + RL +D + PF + N + P + P +
Sbjct: 238 E-DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDT-- 294
Query: 278 MLRLPMSGPSSMDIDSD 294
S+ D+D D
Sbjct: 295 ---------SNFDVDDD 302
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 117 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL---AIAMQQPTARSVIGTPEFMAPE-L 172
H H II+RDLK +NI ++ G VK+ D GL +I T + GT E+MAPE L
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT-HTFCGTIEYMAPEIL 172
Query: 173 YEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQI 230
+ + VD +S G + +M+T P++ +N + K+ G P L P+
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPYLT----PEA 227
Query: 231 KGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKEPICDPLKLPIQ 274
+ ++K L S RL A ++ PF + N + + ++ P +
Sbjct: 228 RDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFK 277
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 25/193 (12%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-------- 94
+ + E LL +L+ +++VKFY V+ + M+ E G+L ++ + H
Sbjct: 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDP--LIMVFEYMKHGDLNKFLRAHGPDAVLMA 109
Query: 95 -----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149
+ + + A+QI G+VYL S + +HRDL N V G + VKIGD G+
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGM 166
Query: 150 AIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSEC 203
+ + V G +M PE + ++ D++S G+ + E+ T+ + P+ +
Sbjct: 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
Query: 204 KNPAQIFKKVTSG 216
N ++ + +T G
Sbjct: 227 SN-NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 44/192 (22%)
Query: 60 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 119
VVK + S+ D K+ + +I E G++ K + + + + + + + +H
Sbjct: 63 VVKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 120 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--------------PT-------- 157
IHRD+K DN+ ++ G VK+ D GL +++ P+
Sbjct: 121 G--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 158 ---------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYS 201
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPPF 236
Query: 202 ECKNPAQIFKKV 213
+ P + ++KV
Sbjct: 237 CSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 59/190 (31%), Positives = 89/190 (46%), Gaps = 24/190 (12%)
Query: 16 AFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--- 72
A+D G VA K+ Q ++ Y E+ L+K + N++ + K
Sbjct: 35 AYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92
Query: 73 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ V ++ EL + NL Q ++D + + Q+L G+ +LHS IIHRDLK
Sbjct: 93 FQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPS 147
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYS 185
NI V + +KI D GLA + S + TP + APE + Y E VDI+S
Sbjct: 148 NIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 202
Query: 186 FGMCIL-EMV 194
G CI+ EM+
Sbjct: 203 VG-CIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 44/192 (22%)
Query: 60 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 119
VVK + S+ D K + +I E G++ K + + + + + + + +H
Sbjct: 63 VVKMFYSFQD--KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 120 NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--------------PT-------- 157
IHRD+K DN+ ++ + G VK+ D GL +++ P+
Sbjct: 121 G--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 158 ---------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYS 201
A S +GTP+++APE++ + YN+L D +S G+ + EM+ YP
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-IGYPPF 236
Query: 202 ECKNPAQIFKKV 213
+ P + +KKV
Sbjct: 237 CSETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 31/183 (16%)
Query: 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
E+FT R + + ++ ++ +I+ L +LH I++RD+K +NI ++ +
Sbjct: 91 EMFTHLYQRDNFSEDE------VRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 140 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMV 194
G V + D GL+ ++ ++ S GT E+MAPE+ + + + VD +S G+ I E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 195 TFEYPYS---ECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLL 251
T P++ E +++ +++ DP FI P ++ L K L
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILK----------CDPPFPSFIG----PEAQDLLHKLLR 247
Query: 252 KDP 254
KDP
Sbjct: 248 KDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 39/197 (19%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD--------- 98
EV +L LKD N+++ VD+ + MITE +G+L Q+ H D
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDP--LCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 99 ----------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148
+ + A QI G+ YL S N +HRDL N V N +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADFG 183
Query: 149 LAIAM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF--EYPY 200
++ + + R+V+ +MA E + ++ D+++FG+ + E++ E PY
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPI-RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242
Query: 201 SE------CKNPAQIFK 211
E +N + F+
Sbjct: 243 GELTDEQVIENAGEFFR 259
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 45/191 (23%), Positives = 74/191 (38%), Gaps = 55/191 (28%)
Query: 119 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 153
H IHRD+K DNI ++ G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 154 --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 192
Q+ A S++GTP ++APE+ Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 193 MVTFEYPYSECKNPAQIFKKVT---SGIKPASLAKVNDPQIKGFIEKCLVPASERL---S 246
M+ + P+ PA+ KV + + S AK++ + I + A +RL
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS-REASDLILRLCCGAEDRLGKNG 294
Query: 247 AKDLLKDPFLQ 257
A ++ PF +
Sbjct: 295 ADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 41 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--------- 90
DL L SE+ ++K + K N++ + D V + E + GNLR+Y
Sbjct: 60 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV--LVEYASKGNLREYLRARRPPGM 117
Query: 91 -------RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
+ + + K + + A Q+ G+ YL S IHRDL N+ V ++ +K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMK 174
Query: 144 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 196
I D GLA I + T + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233
Query: 197 --EYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC--LVPASERLSAKDLLK 252
YP + ++ K+ KPA+ ++ + +C VP S+R + K L++
Sbjct: 234 GSPYPGIPVEELFKLLKEGHRMDKPANCTH----ELYMIMRECWHAVP-SQRPTFKQLVE 288
Query: 253 D 253
D
Sbjct: 289 D 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 32/185 (17%)
Query: 41 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--------- 90
DL L SE+ L+K + K N++ + V I E GNLR++
Sbjct: 60 DLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGP 117
Query: 91 -------RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
+ + + K + + A Q+ G+ YL S IHRDL N+ V ++ +K
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMK 174
Query: 144 IGDLGLA-----IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF- 196
I D GLA I + T+ + ++MAPE L++ Y D++SFG+ + E+ T
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG 233
Query: 197 --EYP 199
YP
Sbjct: 234 GSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 59 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLH 117
N+++ V K + V +ITE +G+L ++ R+ + + R I G+ YL
Sbjct: 66 NIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 118 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM--------- 168
N +HRDL NI VN ++ K+ D GL+ T
Sbjct: 124 EMN--YVHRDLAARNILVN-SNLVCKVSDFGLS-----RRLEDSEATYTTKGGKIPIRWT 175
Query: 169 APE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
APE + ++ D++SFG+ + E++++ E PY + N + K V G
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 22/185 (11%)
Query: 29 RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV----KFYKSWVDDKKKTV--NMITELF 82
+V I VLQ P Q E+ ++K+L N++ +Y +K + N++ E
Sbjct: 93 KVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI 149
Query: 83 ---TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
++ Y + + + + ++K ++ Q+ L Y+HS I HRDLK N+ ++ N
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNT 207
Query: 140 GEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 194
+K+ D G A +A Q+ S I + + APEL Y +D++S G I EM+
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSV--SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
Query: 195 TFEYP 199
YP
Sbjct: 266 -LGYP 269
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 39/153 (25%), Positives = 77/153 (50%), Gaps = 22/153 (14%)
Query: 60 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR----QILHGLVY 115
VV+ + ++ DD+ + M+ E G+L + V + WAR +++ L
Sbjct: 105 VVQLFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDA 157
Query: 116 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPEL 172
+HS IHRD+K DN+ ++ + G +K+ D G + M + + +GTP++++PE+
Sbjct: 158 IHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214
Query: 173 YEEE-----YNELVDIYSFGMCILEMVTFEYPY 200
+ + Y D +S G+ + EM+ + P+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 19/172 (11%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---------RKKHKNVD 98
E+ + + L NVV+ + + MI E G+L+Q+ + K +
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQ 155
K QI G+ +L + +HRDL N V+ EVK+ L L+ +
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEY 172
Query: 156 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 205
R+ + ++APE + E++++ D++SFG+ + E+ T E P+ +
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 58/190 (30%)
Query: 116 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL------------------------AI 151
+H IHRD+K DN+ ++ G +K+ D GL
Sbjct: 117 IHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 152 AMQQPT----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMV 194
+ +P A S +GTP+++APE++ + YN+ D +S G+ + EM+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 195 TFEYP--YSECKNPAQIFKKVTSGIKPASLAKVND----PQIKGFIEKCLVPASERL--- 245
YP S+ NP + ++K+ + + +L ++ P+ K I++ A RL
Sbjct: 234 V-GYPPFCSD--NPQETYRKIINWKE--TLQFPDEVPLSPEAKDLIKRLCCEAERRLGNN 288
Query: 246 SAKDLLKDPF 255
++ PF
Sbjct: 289 GVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
++ EL G L ++ +K+K+V K I Q+ G+ YL N +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 137 GNHGEVKIGDLGLAIAMQQP----TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCI 190
H KI D GL+ A+ A++ P ++ APE + +++ D++SFG+ +
Sbjct: 130 TQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 191 LEMVTF-EYPYSECK 204
E ++ + PY K
Sbjct: 189 WEAFSYGQKPYKGMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 19/133 (14%)
Query: 85 GNLRQYRKKHKNVDIKVIK--------NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
GNL+ + ++ + + + + A QI G+ YLH +IH+D+ N ++
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID 151
Query: 137 GNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCI 190
+VKI D L+ + P +G E +MA E L +EY+ D++SFG+ +
Sbjct: 152 -EELQVKITDNALSRDLF-PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209
Query: 191 LEMVTF-EYPYSE 202
E++T + PY E
Sbjct: 210 WELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 33/117 (28%), Positives = 59/117 (50%), Gaps = 17/117 (14%)
Query: 96 NVDIKVIKNWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151
N DI + WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G +
Sbjct: 136 NYDIP--EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCM 190
Query: 152 AMQ---QPTARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPY 200
M + +GTP++++PE+ + Y D +S G+ + EM+ + P+
Sbjct: 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 19 EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78
E+ G +VA +K D Q E ++ L N+V+ + + + ++
Sbjct: 26 EYTGQKVAVKNIKCDVTAQ------AFLEETAVMTKLHHKNLVRLLGVILHNG---LYIV 76
Query: 79 TELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
EL + GNL + + + VI+ ++ + G+ YL S ++HRDL NI V+
Sbjct: 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS 134
Query: 137 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 195
+ G K+ D GLA S + ++ APE L ++++ D++S+G+ + E+ +
Sbjct: 135 ED-GVAKVSDFGLARVGSMGVDNSKLPV-KWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
Query: 196 F-EYPYSECKNPAQIFKKVTSGIK 218
+ PY P K+V ++
Sbjct: 193 YGRAPY-----PKMSLKEVKECVE 211
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 105
SE ++ N++ V K + V +ITE +G L + R+ + +
Sbjct: 54 SEASIMGQFDHPNIIHL--EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM 111
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----PTARSV 161
R I G+ YL N +HRDL NI VN N K+ D GL+ ++ PT S
Sbjct: 112 LRGIAAGMKYLSEMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 162 IGTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 205
+G + APE + ++ D++S+G+ + E++++ E PY + N
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIK--NWARQILHGLVYLHSHNPPIIHRDL 128
K K V ++TE +G+L + +KH + VI+ R I G+ YL +HRDL
Sbjct: 76 KSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDL 132
Query: 129 KCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVD 182
NI VN N K+ D GL+ ++ T R + APE + ++ D
Sbjct: 133 AARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASD 191
Query: 183 IYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-PASL 222
++S+G+ + E++++ E PY E N + K + G + PA +
Sbjct: 192 VWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPM 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 37/149 (24%), Positives = 74/149 (49%), Gaps = 21/149 (14%)
Query: 124 IHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS--VIGTPEFMAPELYEE----- 175
+HRD+K DN+ ++ +G +++ D G + + T +S +GTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 176 -EYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIFKKVTSGIK----PASLAKVNDPQ 229
Y D +S G+C+ EM+ E P Y+E + + + K+ + + P + V++ +
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQFPPDVTDVSE-E 239
Query: 230 IKGFIEKCLVPASERL---SAKDLLKDPF 255
K I + + RL +D PF
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 43/175 (24%), Positives = 90/175 (51%), Gaps = 12/175 (6%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWA 106
E ++ L +V+ Y V ++K + ++TE +G L Y R++ + ++ +
Sbjct: 49 EAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT 164
+ + G+ YL ++ IHRDL N V+ + G VK+ D G+ + + T+ S
Sbjct: 107 QDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKF 163
Query: 165 P-EFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 216
P ++ PE++ +Y+ D++SFG+ + E+ T + P+ E K+ ++ + ++ G
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 27/56 (48%), Positives = 35/56 (62%), Gaps = 3/56 (5%)
Query: 98 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153
DI VIK RQ+L GL LH I+HRD+K +N+ V + G+VKI D G A+ M
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDM 359
|
Length = 507 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 12/137 (8%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIAMQQPTARSVIGTP- 165
Q+ +G+ +L S N +HRDL N+ + G+ VKI D GLA + + + G+
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 166 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 220
++MAPE ++ Y L D++SFG+ + E+ T PY E Q + + G + A
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 221 SLAKVNDPQIKGFIEKC 237
A +D +I ++KC
Sbjct: 363 KPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 50/180 (27%), Positives = 81/180 (45%), Gaps = 36/180 (20%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNV-- 97
Q+ E L+ L+ N+V V K++ M+ E G+L ++ H +V
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110
Query: 98 --DIKVIK---------NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 146
+ +K + A QI G+ YL SH+ +HRDL N V G VKI D
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISD 167
Query: 147 LGLA--------IAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTF 196
GL+ +Q ++S++ +M PE LY + E DI+SFG+ + E+ ++
Sbjct: 168 FGLSRDIYSADYYRVQ---SKSLLPV-RWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 20/162 (12%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVD 98
++ Y E+ L+K + N++ + K + V ++ EL + NL Q + +D
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LD 124
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
+ + Q+L G+ +LHS IIHRDLK NI V + +KI D GLA +
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAG 177
Query: 159 RSVIGTPE-----FMAPE-LYEEEYNELVDIYSFGMCILEMV 194
S + TP + APE + Y E VDI+S G + EM+
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 20/162 (12%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNMITELFTSGNLRQYRKKHKNVD 98
++ Y E+ L+K + N++ + K + V ++ EL + NL Q + +D
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--LD 117
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
+ + Q+L G+ +LHS IIHRDLK NI V + +KI D GLA +
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTAG 170
Query: 159 RSVIGTP-----EFMAPE-LYEEEYNELVDIYSFGMCILEMV 194
S + TP + APE + Y E VDI+S G + EMV
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 20/156 (12%)
Query: 77 MITELFTSGNLRQY----RKKHKN------VDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
+I EL T G+L+ Y R + +N +K + A +I G+ YL+++ +HR
Sbjct: 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHR 143
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP----EFMAPE-LYEEEYNELV 181
DL N V + VKIGD G+ + + G +M+PE L + +
Sbjct: 144 DLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 202
Query: 182 DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
D++SFG+ + E+ T E PY N Q+ + V G
Sbjct: 203 DVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFVMEG 237
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 38/170 (22%), Positives = 61/170 (35%), Gaps = 25/170 (14%)
Query: 105 WA--RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 162
WA Q L L LH L + + + G +R
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLKLD---------GSVAFKTPEQSR--- 65
Query: 163 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-- 219
P FMAPE+ + Y E DIYS G+ + E + +E PY+E + + I + + +G+
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD 125
Query: 220 ----ASLAKVND-PQIKGFIEKCLVPAS-ERLSAKDLLKDPFLQVENQKE 263
++L V+ + F+ C R +A L E
Sbjct: 126 PRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLE 175
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 58/263 (22%), Positives = 91/263 (34%), Gaps = 68/263 (25%)
Query: 119 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 153
H IHRD+K DNI ++ + G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 154 ------------------------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 188
Q+ A S++GTP ++APE L + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVT---SGIKPASLAKVNDPQIKGFIEKCLVPASERL 245
+ EM+ + P+ P + KV + + K++ P+ I K A ERL
Sbjct: 237 ILFEMLVGQPPFL-APTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERL 294
Query: 246 ---SAKDLLKDPFLQ-------VENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDY 295
A D+ PF + Q P + P+ + P+ S + S
Sbjct: 295 GRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNF--DPVEEESPWNDASGD 352
Query: 296 KQLSLSTCTESNNGSPHCPVLEF 318
+ T N P EF
Sbjct: 353 STRTWDTLCSPNGKHPEHAFYEF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 36/129 (27%), Positives = 66/129 (51%), Gaps = 11/129 (8%)
Query: 97 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV-KIGDLGLAIAMQQ 155
+D + + +++ Q+ G+ +L S N IHRDL NI + HG + KI D GLA ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRN 266
Query: 156 PTARSVIGTP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 209
+ V G ++MAPE ++ Y D++S+G+ + E+ + PY ++
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 210 FKKVTSGIK 218
+K + G +
Sbjct: 327 YKMIKEGYR 335
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 35/149 (23%), Positives = 84/149 (56%), Gaps = 12/149 (8%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 106
E+ +L++LK +N+V+ +++ ++ + ++ E + N+ + ++ N V + ++++
Sbjct: 50 ELKMLRTLKQENIVELKEAF--RRRGKLYLVFE-YVEKNMLELLEEMPNGVPPEKVRSYI 106
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS---VIG 163
Q++ + + H ++ I+HRD+K +N+ ++ N +K+ D G A + + + + +
Sbjct: 107 YQLIKAIHWCHKND--IVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVA 163
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCIL 191
T + +PE L Y + VD++S G CIL
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVG-CIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 77 MITELFTSGNLRQYRKKHKNV-----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
++ E G+L+ Y + ++ + V++ A ++ GL++LH + IH DL
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALR 129
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV------ 181
N + + VKIGD GLA+ T ++APEL E +L+
Sbjct: 130 NCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTK 188
Query: 182 --DIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
+I+S G+ + E+ T + PY + + Q+ K+V
Sbjct: 189 KSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 36/182 (19%)
Query: 40 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKN 96
G+ Q+ E L+ L N+V V +++ V M+ E G+L ++ R H +
Sbjct: 52 GEFQQ---EASLMAELHHPNIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSD 106
Query: 97 V--------------DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 142
V D + A QI G+ YL SH +H+DL NI + G V
Sbjct: 107 VGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHV 163
Query: 143 KIGDLGLAIAMQ-------QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 194
KI DLGL+ + QP + I +M PE + +++ DI+SFG+ + E+
Sbjct: 164 KISDLGLSREIYSADYYRVQPKSLLPI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220
Query: 195 TF 196
+F
Sbjct: 221 SF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 30/79 (37%), Positives = 40/79 (50%), Gaps = 9/79 (11%)
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----- 154
K+I+ RQIL L LHS I+HRD+K NI + G KI DLG A ++
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312
Query: 155 QPTARSVIGTPEFMAPELY 173
P + + P + APE Y
Sbjct: 313 IP--KEFLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 42/197 (21%)
Query: 87 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 146
L Q R+ K + +V + +A ++L L YLH I++RDLK +NI ++ + G + + D
Sbjct: 91 LLQ-RQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHES-GHIMLSD 146
Query: 147 LGLA-----------------------------IAMQQPTAR--SVIGTPEFMAPELYEE 175
L+ ++P+ R S +GT E++APE+
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
Query: 176 E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA-KVNDP-QIKG 232
+ + VD ++ G+ + EM+ P+ + N + F + K + +
Sbjct: 207 DGHGSAVDWWTLGILLYEMLYGTTPF-KGSNRDETFSNILK--KEVTFPGSPPVSSSARD 263
Query: 233 FIEKCLVP-ASERLSAK 248
I K LV S+RL +K
Sbjct: 264 LIRKLLVKDPSKRLGSK 280
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 35/120 (29%), Positives = 61/120 (50%), Gaps = 11/120 (9%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIAMQQPTARSVIGTP- 165
Q+ G+ +L S N +HRDL N+ + G+ VKI D GLA + + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 166 ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 220
++MAPE +++ Y L D++S+G+ + E+ + PY + + K+ SG + A
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWA 106
E ++ L +V+ Y V ++ + ++ E G L Y R + + +
Sbjct: 49 EAQVMMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP- 165
+ G+ YL S N +IHRDL N V G + VK+ D G+ + S GT
Sbjct: 107 LDVCEGMAYLESSN--VIHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 166 --EFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP 206
++ +PE++ +Y+ D++SFG+ + E+ +SE K P
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 85 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144
L Q + +N + +++ A +I G+ ++H HN +H DL N F+ + VK+
Sbjct: 84 SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKV 140
Query: 145 GDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV--------DIYSFGMCILE 192
GD G+ + + T ++APEL E + L+ ++++ G+ + E
Sbjct: 141 GDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200
Query: 193 MVTFE---YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASER 244
+ FE PYS + ++ V + D Q+K F + +P SER
Sbjct: 201 L--FENAAQPYSHLSD-REVLNHV-----------IKDQQVKLFKPQLELPYSER 241
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 23/199 (11%)
Query: 20 FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79
+G A VK V + K E +SL+ N+++ + ++
Sbjct: 17 NSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL--LVM 74
Query: 80 ELFTSGNLRQYRKKHKNV-----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 134
E G+L+ Y + + D ++ A +I GL++LH +N IH DL N
Sbjct: 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCL 132
Query: 135 VNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEEEYNELV--------D 182
+ + VKIGD GL+ + T + ++APEL +E + L+ +
Sbjct: 133 LTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 183 IYSFGMCILEMVTF-EYPY 200
++S G+ I E+ PY
Sbjct: 192 VWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 32/132 (24%), Positives = 50/132 (37%), Gaps = 51/132 (38%)
Query: 119 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM------------------------- 153
H IHRD+K DNI ++ + G +K+ D GL
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 154 ------------------------QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 188
Q+ A S++GTP ++APE L Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 189 CILEMVTFEYPY 200
+ EM+ + P+
Sbjct: 237 ILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 27/108 (25%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 167
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229
Query: 168 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF---EYP 199
MAPE ++++ Y D++SFG+ + E+ + YP
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 26/144 (18%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 167
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230
Query: 168 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
MAPE ++++ Y D++SFG+ + E+ + PY + + +++
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL 290
Query: 214 TSGIKPASLAKVNDPQIKGFIEKC 237
G + + + P+I + C
Sbjct: 291 KDGTRMRA-PENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 20/38 (52%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 113 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150
L YLH H IIHRDLK DN+ ++ N G +K+ D GL+
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 11/119 (9%)
Query: 85 GNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
G+LR + R + N +K + + Q+ G+ YL S +HRDL N ++ + VK
Sbjct: 82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESF-TVK 138
Query: 144 IGDLGLAIAMQQPTARSV-----IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 195
+ D GLA + SV P ++MA E L +++ D++SFG+ + E++T
Sbjct: 139 VADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 35/125 (28%), Positives = 58/125 (46%), Gaps = 25/125 (20%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 167
Q+ G+ +L S IHRDL NI ++ N+ VKI D GL AR + P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235
Query: 168 ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
MAPE +++ Y D++SFG+ + E+ + PY K + +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295
Query: 214 TSGIK 218
G +
Sbjct: 296 KEGTR 300
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 34/160 (21%)
Query: 80 ELFTSGNLRQYRKKHKN-------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
EL G+L+ + ++++ + +K + AR + G YL ++ IHRD+ N
Sbjct: 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARN 146
Query: 133 IFVN--GNHGEVKIGDLGLAIAMQQPTARSVIGTP------------EFMAPELYEEE-Y 177
+ G KI D G+A R + ++M PE + + +
Sbjct: 147 CLLTCKGPGRVAKIADFGMA--------RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF 198
Query: 178 NELVDIYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSG 216
D++SFG+ + E+ + Y PY N ++ + VT G
Sbjct: 199 TSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.86 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.83 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.34 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.34 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.2 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.04 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.7 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.66 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.6 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.31 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.21 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.09 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.94 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.85 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.52 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.51 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.34 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.28 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.15 | |
| PLN02236 | 344 | choline kinase | 95.88 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.82 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.45 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.43 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.35 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.04 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.98 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.62 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.82 | |
| PTZ00384 | 383 | choline kinase; Provisional | 90.39 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 88.83 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 88.66 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 87.39 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 87.35 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 86.9 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 82.03 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-86 Score=721.31 Aligned_cols=397 Identities=59% Similarity=0.932 Sum_probs=341.5
Q ss_pred cccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCC
Q 006593 6 LYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSG 85 (639)
Q Consensus 6 GfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gG 85 (639)
|.|.+++||+|+|..+|.+|||+++++.++.+++..+++|+.|+++|+.|+|||||+||++|++..++++.||||++++|
T Consensus 49 GrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSG 128 (632)
T KOG0584|consen 49 GRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSG 128 (632)
T ss_pred ccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCC
Confidence 45566699999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccccCCC
Q 006593 86 NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 165 (639)
Q Consensus 86 sL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~GTp 165 (639)
+|+.|+++++.++.++++.|++|||+||.|||++.||||||||||+||||+|+.|.|||||+|||+.++...+..++|||
T Consensus 129 tLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTP 208 (632)
T KOG0584|consen 129 TLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTP 208 (632)
T ss_pred cHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcCCCCCCC
Q 006593 166 EFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERL 245 (639)
Q Consensus 166 ~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~dP~~Rp 245 (639)
.|||||+|+..|++.+||||||||++||+|+++||++|.++++||++|++|++|..+.++.+|++++||++||...++||
T Consensus 209 EFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~~~~R~ 288 (632)
T KOG0584|consen 209 EFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLATKSERL 288 (632)
T ss_pred cccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcCchhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHhcCcccccccCCCCcCCCCC----------CchhhhhhccCCCCC--CCCccCCccccccccccccCCCCC--CC
Q 006593 246 SAKDLLKDPFLQVENQKEPICDPLK----------LPIQSLKMLRLPMSG--PSSMDIDSDYKQLSLSTCTESNNG--SP 311 (639)
Q Consensus 246 Sa~ELL~Hpff~~~~~~~~~~~~~~----------~~~~~~~~~~~~~s~--~~~~~~~~d~~~~~~s~~~~~~~~--~~ 311 (639)
|+.|||+||||+...... ...+.. ...........+... ...+++..|. ....+.++... -.
T Consensus 289 sa~eLL~d~Ff~~d~g~~-~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~---~e~v~~em~~~~~~~ 364 (632)
T KOG0584|consen 289 SAKELLKDPFFDEDGGIV-ELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDE---SEEVAQEMVEEEIVS 364 (632)
T ss_pred CHHHHhhChhhccccccc-cccchhhcccccccccccccchhhcCCcccccccceeecCCCc---hhHHHHHHHHhccCC
Confidence 999999999999875531 111110 111111111111111 1111221110 11111000000 01
Q ss_pred CCCchhhhhcccCcceeeccccCCCC-ceEEEEEecCCCCCcceeeecccCCCCCHHHHHHHHHhcccCCCccHHHHHHH
Q 006593 312 HCPVLEFQRMHKNNEFRLRGTKNDDT-SVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEF 390 (639)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~g~~~~~~-~i~L~Lri~d~~~~~~~i~F~f~~~~DTa~~vA~EmV~~~~i~~~d~~~iA~~ 390 (639)
.....+..+...+..+.++|+.+++. .++|.|||+|..|+.|||+|||++..|||.+||.|||+++.++++++..||+|
T Consensus 365 edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~v~~ia~m 444 (632)
T KOG0584|consen 365 EDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQPVVNIAEM 444 (632)
T ss_pred cchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccchhhHHHH
Confidence 11224456667788899999999876 99999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 006593 391 IDYLIMKLLPGWKPSY 406 (639)
Q Consensus 391 i~~~i~~l~~~~~~~~ 406 (639)
||.+|.+|+|.|+...
T Consensus 445 id~~i~~L~p~~~~~~ 460 (632)
T KOG0584|consen 445 IDGEISALVPNWKAST 460 (632)
T ss_pred HhchhhhcCCccCCCC
Confidence 9999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=431.73 Aligned_cols=250 Identities=28% Similarity=0.482 Sum_probs=225.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|..| +||++.|+.|++.+|+|.+... ..+...+++.+|+++++.++|||||+||+.|..+.. .++|+|||
T Consensus 87 lG~G~gG---~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEY 159 (364)
T KOG0581|consen 87 LGSGNGG---TVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEY 159 (364)
T ss_pred cccCCCc---EEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhh
Confidence 5555555 9999999999999999999543 246777889999999999999999999999998765 69999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|.+|+|.++++..++++|..+..++++|++||.|||. ++ ||||||||.|||++ ..|.|||||||.++.+.+..+.+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS~a~t 236 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNSIANT 236 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhhhccc
Confidence 9999999999999999999999999999999999995 78 99999999999998 56899999999999998888899
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCC----CCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSE----CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~----~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
+.||..|||||.+.+ .|+.++||||||+.++||++|++||.. .....+++..|..+.+|.......++++++||.
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 999999999998875 699999999999999999999999976 346778888898887776555569999999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.||+ ||.+||+++|||.|||++....
T Consensus 317 ~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999 8999999999999999985543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=429.60 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=219.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP---GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~---~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
||+|+|| .|.+|+.+.||+.||||+++........ .....+.+|+++|++|+|||||+++++|..+ .+.|||
T Consensus 180 LGsGafg---~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~--ds~YmV 254 (475)
T KOG0615|consen 180 LGSGAFG---LVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP--DSSYMV 254 (475)
T ss_pred ecCCcee---EEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC--CceEEE
Confidence 7888888 8899999999999999999887654321 2334578999999999999999999998766 458999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhccC-
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQ- 155 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~~- 155 (639)
|||+.||+|.+++-.++.+.+..-+.+++|++.|+.|||++| |+||||||+|||+..+ .-.+||+|||+|+....
T Consensus 255 lE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~ 332 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG 332 (475)
T ss_pred EEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhccccc
Confidence 999999999999999999999999999999999999999999 9999999999999633 24699999999998864
Q ss_pred CCCccccCCCCcCCccccccc----CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--ccCCCChH
Q 006593 156 PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQ 229 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~~~----ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~~~~s~~ 229 (639)
...++.||||.|.|||++... |..++||||+||++|.+++|.+||++...+..+.+.|.+|..+.. .+...+.+
T Consensus 333 sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Isee 412 (475)
T KOG0615|consen 333 SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEE 412 (475)
T ss_pred eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHH
Confidence 356789999999999998642 566999999999999999999999987777768889999876543 44556889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+++||.+||. ||++|||+.|+|+||||+...
T Consensus 413 a~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 413 ALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 9999999998 999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=433.63 Aligned_cols=246 Identities=33% Similarity=0.502 Sum_probs=223.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|||. +||.+.+..+|..||+|+|.+..+. ...+.+++.+||++.++|+|||||+||++|.|.+ ++|||.|
T Consensus 25 ~LGkGgFA---~cYe~~~~~tge~~A~KvVpk~~l~-k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~--nVYivLE 98 (592)
T KOG0575|consen 25 FLGKGGFA---RCYEARDLDTGEVVAVKVVPKKLLK-KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN--NVYIVLE 98 (592)
T ss_pred eeccCcce---EEEEEEEcCCCcEEEEEEeehHHhc-CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC--ceEEEEE
Confidence 58999998 8999999999999999999987653 4678899999999999999999999999997764 5999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+|..|+|..++++++.++|.+++.+++||+.||.|||+++ |||||||..|+|++++. +|||||||||+.+..+ ..
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcC-cEEecccceeeeecCccccc
Confidence 9999999999999999999999999999999999999999 99999999999998664 8999999999988643 45
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
.+.||||.|.|||++. .+++..+||||+||++|.|++|++||.. .+..+++.+|..... .+|...++++++||.++
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKL 252 (592)
T ss_pred ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCHHHHHHHHHH
Confidence 6889999999999886 4699999999999999999999999986 567888988887644 34557789999999999
Q ss_pred cC-CCCCCCCHHHHhcCccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~ 258 (639)
|. +|.+|||++++|.|+||..
T Consensus 253 L~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred hcCCcccCCCHHHHhcCHhhhC
Confidence 99 8999999999999999943
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=416.72 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=213.5
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCC
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 84 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 84 (639)
.|.|..++||+|++..+++.||||++.++++. .....+.+|++.|+.++||||+++|.+|+.++ .+|+||.||.+
T Consensus 34 IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--~LWvVmpfMa~ 108 (516)
T KOG0582|consen 34 IGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--ELWVVMPFMAG 108 (516)
T ss_pred EeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc--eeEEeehhhcC
Confidence 34555579999999999999999999999874 34788999999999999999999999999875 59999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-----C
Q 006593 85 GNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-----T 157 (639)
Q Consensus 85 GsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-----~ 157 (639)
|++.++++.. ..++|..|+.+++++++||.|||.+| .||||||+.||||+ .+|.|||+|||.+..+... .
T Consensus 109 GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 109 GSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred CcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCceeeeeecccCceeeE
Confidence 9999999874 45999999999999999999999999 99999999999997 5689999999988655322 1
Q ss_pred C-ccccCCCCcCCccccc---ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC-------CCcccCCC
Q 006593 158 A-RSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-------PASLAKVN 226 (639)
Q Consensus 158 ~-~~~~GTp~ymAPE~l~---~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-------p~~l~~~~ 226 (639)
. .++.|||+|||||++. .+|+.|+|||||||++.||++|..||........+...+....+ +....+..
T Consensus 186 rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~ 265 (516)
T KOG0582|consen 186 RFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKF 265 (516)
T ss_pred eeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhh
Confidence 2 5678999999999954 36999999999999999999999999986655555555544332 12222344
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCCC
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~~ 263 (639)
+..++.||..||+ ||.+||||++||+|+||+......
T Consensus 266 ~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 266 SKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred cHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 6689999999999 899999999999999998766543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=407.84 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=229.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||.++.+.+|+.+|+|++++..+... .+.+....|..+|.+++||.||+++.+|.+..+ +|||+|
T Consensus 32 viGkG~fG---kV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k--LylVld 105 (357)
T KOG0598|consen 32 VIGKGSFG---KVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK--LYLVLD 105 (357)
T ss_pred eeeccCCc---eEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe--EEEEEe
Confidence 58999999 788888889999999999998886543 567889999999999999999999999987754 999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~ 158 (639)
|+.||.|+-.|++.+.++|..++.|+.+|+.||.|||+.| ||||||||+|||++ .+|+|+|+||||++.... ...
T Consensus 106 ~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 106 YLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred ccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCCcc
Confidence 9999999999999999999999999999999999999999 99999999999998 669999999999985433 355
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
.++|||+.|||||++. ..|+..+|+||||+++|||++|.+||.+ .+...++++|..+.. ...+...++++++||.++
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~~L 260 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEARDLLKKL 260 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHHHHHHHH
Confidence 6789999999999775 5799999999999999999999999987 677888888888763 234566789999999999
Q ss_pred cC-CCCCCC----CHHHHhcCcccccccCCCCcCCCC
Q 006593 238 LV-PASERL----SAKDLLKDPFLQVENQKEPICDPL 269 (639)
Q Consensus 238 L~-dP~~Rp----Sa~ELL~Hpff~~~~~~~~~~~~~ 269 (639)
|. +|.+|. ++.++-+||||...+|+......+
T Consensus 261 L~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 261 LKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred hccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCC
Confidence 98 899996 699999999999999876544433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=400.80 Aligned_cols=251 Identities=26% Similarity=0.474 Sum_probs=220.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| +||+|+++.+|.+||||.+....+ .+...+.+..|+.+|+.++|||||.++++.... +++||||||
T Consensus 18 iG~Gsfa---vVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~--~~i~lVMEy 90 (429)
T KOG0595|consen 18 IGSGSFA---VVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD--DFIYLVMEY 90 (429)
T ss_pred ccCcceE---EEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC--CeEEEEEEe
Confidence 5666666 899999999999999999998765 567788899999999999999999999987665 479999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--C---CcEEEeecchhhhccCC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--H---GEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~---g~VKL~DFGlA~~l~~~ 156 (639)
|.||+|.+|+++++.+++..++.++.||+.||++||+++ ||||||||+|||++.. . -.+||+|||+|+.+...
T Consensus 91 C~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999999999999999999999999999999999999 9999999999999753 1 35899999999998754
Q ss_pred -CCccccCCCCcCCcccc-cccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCcccCCCChHHHHH
Q 006593 157 -TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIKGF 233 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l-~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~s~~l~~L 233 (639)
...+.||+|.|||||++ .++|+.|+|+||+|+++|+|++|+.||.. .++.+++..+..+.. ...++...+....++
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~L 247 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNPLREL 247 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCchhhh
Confidence 46688999999999988 57899999999999999999999999987 567888777776644 344555566777888
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+...|+ +|..|.+..+-+.|+|+......
T Consensus 248 l~~ll~~~~~~~~~~~~~~~~~~l~~~p~~ 277 (429)
T KOG0595|consen 248 LISLLQRNPKDRISFEDFFDHPFLAANPQD 277 (429)
T ss_pred hhHHHhcCccccCchHHhhhhhhcccCccc
Confidence 888887 89999999999999999765533
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=397.78 Aligned_cols=251 Identities=30% Similarity=0.508 Sum_probs=211.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|.|| +||+|.+..+|...|+|.+...+ .+. .+.+.+|+.+|++|+|||||++++.........++++||
T Consensus 24 ~lG~Gs~G---~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 24 LLGRGSFG---SVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred cccCccce---EEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 36777777 89999999999999999998773 222 677999999999999999999999633322247899999
Q ss_pred cCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC----
Q 006593 81 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---- 155 (639)
Q Consensus 81 y~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~---- 155 (639)
|+++|+|.+++++.+ .+++..++++.+||++||.|||++| ||||||||+|||++...|.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 999999999999987 7999999999999999999999999 999999999999985358999999999987662
Q ss_pred -CCCccccCCCCcCCcccccccCC--ccccccchhhhhhhhhhccCCCCCC-CCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 156 -PTARSVIGTPEFMAPELYEEEYN--ELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 156 -~~~~~~~GTp~ymAPE~l~~~ys--~ksDIwSlGiil~ELltG~~Pf~~~-~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
.....+.|||.|||||++...+. .++|||||||+++||+||..||.+. .....++...... ..+.++...+++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLPEIPDSLSDEAK 253 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCCCCCcccCHHHH
Confidence 22346789999999999985433 4999999999999999999999873 3334444444444 33377888899999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||.+|+. +|.+||||.+||.|||++....
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999 9999999999999999976543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=386.45 Aligned_cols=239 Identities=28% Similarity=0.459 Sum_probs=212.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|.|| +||++.+..+|..||+|.++...+ .....+.+..|+.+|++|+|||||+||+.-..+++..++|||||
T Consensus 27 IG~GsFg---~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 27 IGRGSFG---EVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HcCCcch---heEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHh
Confidence 6777777 899999999999999999996654 45778889999999999999999999994445555679999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPP--IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gpp--IIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
|.+|+|.++++. ++.++|+.+|+++.|++.||..+|+.-|. |+||||||.|||++ ..|.|||+||||++.+..
T Consensus 102 c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhHhcc
Confidence 999999999874 45799999999999999999999995444 99999999999998 558999999999998875
Q ss_pred C--CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 156 P--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 156 ~--~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
. .+.+++|||.||+||.+. .+|+.++||||+||++|||+....||.+ .+..++.++|..|..|+.....++..++.
T Consensus 181 ~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~l~~ 259 (375)
T KOG0591|consen 181 KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTDLRE 259 (375)
T ss_pred hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhHHHH
Confidence 5 356789999999999776 5799999999999999999999999998 48899999999997776666888999999
Q ss_pred HHHHhcC-CCCCCCCH
Q 006593 233 FIEKCLV-PASERLSA 247 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa 247 (639)
+|..|+. ||..||+.
T Consensus 260 li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 260 LINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHccCCcccCCCc
Confidence 9999998 99999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=382.27 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=231.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| +|.+++++.+|.-+|+|++.+.++.. ..+.+....|..+|+.+.||++++++++|.+.+ .+||||||
T Consensus 52 lGtGSFG---rV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~--~lymvmey 125 (355)
T KOG0616|consen 52 LGTGSFG---RVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS--NLYMVMEY 125 (355)
T ss_pred eccCccc---eEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeeccCC--eEEEEEec
Confidence 6777777 89999999999999999999888644 467788999999999999999999999997764 59999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 161 (639)
++||.|+.++++.+++++..++.++.||+.||+|||+++ |++|||||+|||+| ..|.+||+|||+|+..... ..+.
T Consensus 126 v~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~Tl 201 (355)
T KOG0616|consen 126 VPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TWTL 201 (355)
T ss_pred cCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EEEe
Confidence 999999999999999999999999999999999999999 99999999999998 5689999999999887765 5678
Q ss_pred cCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-
Q 006593 162 IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 239 (639)
Q Consensus 162 ~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~- 239 (639)
||||.|+|||++. .+|+.++|+|+|||++|||+.|.+||.. .++.+++.+|..+.. .+|...++++++||.++|+
T Consensus 202 CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhh
Confidence 9999999999886 4699999999999999999999999987 678999999999865 3577788999999999998
Q ss_pred CCCCC-----CCHHHHhcCcccccccCCCCcCCCCCCch
Q 006593 240 PASER-----LSAKDLLKDPFLQVENQKEPICDPLKLPI 273 (639)
Q Consensus 240 dP~~R-----pSa~ELL~Hpff~~~~~~~~~~~~~~~~~ 273 (639)
|-.+| ....++..||||+...|.......+..|.
T Consensus 279 D~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~ 317 (355)
T KOG0616|consen 279 DLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPF 317 (355)
T ss_pred hhHhhhcCcCCCccccccCcccccccHHHHhhccccCCC
Confidence 88888 46889999999999888765444444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=409.28 Aligned_cols=245 Identities=31% Similarity=0.528 Sum_probs=215.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|.-| .||.|....+++.||||++.+... .-.+-+..|+.+|+.++|+|||+|+++|...+ .+|+||||
T Consensus 281 igqgaSG---~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--eLWVVMEy 351 (550)
T KOG0578|consen 281 IGQGATG---GVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--ELWVVMEY 351 (550)
T ss_pred hcccccc---ceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccc--eeEEEEee
Confidence 4555555 899999999999999999998763 33456899999999999999999999998774 59999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 159 (639)
+.||+|.+.+.. -.++|..|+.+|++++.||+|||.+| |||||||.+|||+. .+|.|||+|||++..+.. ..+.
T Consensus 352 m~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred cCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeeeccccccCccc
Confidence 999999998875 44999999999999999999999999 99999999999997 668999999999987753 3566
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
+.+|||+|||||++.. .|++++||||||++++||+-|++||-.......++..-..|.+....+...++.+++|+.+||
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL 507 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL 507 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence 7899999999999875 699999999999999999999999986444455566667777777888889999999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+ |+.+|++|.|||.||||+..
T Consensus 508 ~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 508 VVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred hcchhcCCCHHHHhcChhhhhc
Confidence 9 99999999999999999543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=400.90 Aligned_cols=248 Identities=24% Similarity=0.485 Sum_probs=217.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh-hhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~-~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|.+..+|..||+|++......... ...+.+.+|+.+++++. ||||++++.++....+ +|+||
T Consensus 25 lG~Gsfg---kV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~--~~ivm 99 (370)
T KOG0583|consen 25 LGSGSFG---KVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK--IYIVM 99 (370)
T ss_pred ecCCCCe---eEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe--EEEEE
Confidence 6777777 8999999999999999987765332122 34567789999999998 9999999998876654 99999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc--cCCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l--~~~~ 157 (639)
|||.||+|.+++.+.+++.|..++++++||+.|++|||++| |+||||||+|||++++.+.+||+|||++... ....
T Consensus 100 Ey~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~ 177 (370)
T KOG0583|consen 100 EYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGL 177 (370)
T ss_pred EecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCc
Confidence 99999999999999999999999999999999999999999 9999999999999866489999999999887 3456
Q ss_pred CccccCCCCcCCcccccc-c-C-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCC-ChHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-E-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGF 233 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~-y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~-s~~l~~L 233 (639)
..+.||||.|+|||++.+ . | +.++||||+|+++|.|++|.+||.+ .+...++.++..+... ++... +++++.|
T Consensus 178 l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~--~p~~~~S~~~~~L 254 (370)
T KOG0583|consen 178 LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFK--IPSYLLSPEARSL 254 (370)
T ss_pred ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCcc--CCCCcCCHHHHHH
Confidence 778999999999999975 4 6 4789999999999999999999998 6677777788776543 34444 8999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|.+||. +|.+|+++.+++.||||+..
T Consensus 255 i~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 255 IEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHcCCCcccCCCHHHHhhChhhccC
Confidence 999999 89999999999999999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=401.04 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=223.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||.|+|. +|++|.++.++++||||++.+.-+.. +....-+..|-.+|.+| .||.|+++|..|.|+.. +|||+
T Consensus 80 ~lGeGSYS---tV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s--LYFvL 153 (604)
T KOG0592|consen 80 ILGEGSYS---TVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES--LYFVL 153 (604)
T ss_pred eeccccce---eEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc--eEEEE
Confidence 57888888 89999999999999999998766543 33446688899999999 89999999999988765 99999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
||+++|+|.++|++.+.|++...+.++.||+.||+|||++| ||||||||+|||+++ +|++||+|||-|+.+...
T Consensus 154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~-dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDK-DGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcC-CCcEEEeeccccccCChhhcc
Confidence 99999999999999999999999999999999999999999 999999999999985 479999999999876421
Q ss_pred ----------C--CccccCCCCcCCccccccc-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 006593 157 ----------T--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 223 (639)
Q Consensus 157 ----------~--~~~~~GTp~ymAPE~l~~~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 223 (639)
. +.+++||-.|.+||++... .++.+|||+|||++|+|+.|.+||.+ .|.-.++++|..- .-.++
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l--~y~fp 307 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQAL--DYEFP 307 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHh--cccCC
Confidence 1 1458999999999999865 68899999999999999999999998 6788889998873 33456
Q ss_pred CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCCCC
Q 006593 224 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 224 ~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~~~ 264 (639)
...++.+++||+++|+ ||++|+|+.+|.+||||...+|...
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 6677999999999999 9999999999999999999988763
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=398.45 Aligned_cols=256 Identities=22% Similarity=0.393 Sum_probs=225.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|||| .||+|+-+.||..+|+|++++.... ...+++.+..|-.+|...++|+|||+|.+|.+. .++|||||
T Consensus 148 ~IgkGAfG---eVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--~~LYLiME 221 (550)
T KOG0605|consen 148 VIGKGAFG---EVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--EYLYLIME 221 (550)
T ss_pred eeccccce---eEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--CeeEEEEE
Confidence 58999999 8999999999999999999998864 467889999999999999999999999999776 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----- 155 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~----- 155 (639)
|++||++..+|.+.+.+++..++.|+.+++.|+..||++| +|||||||+|+||+ ..|++||.||||++.+..
T Consensus 222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhhh
Confidence 9999999999999999999999999999999999999999 99999999999998 669999999999853211
Q ss_pred --------------------CC------------------------CccccCCCCcCCcccccc-cCCccccccchhhhh
Q 006593 156 --------------------PT------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCI 190 (639)
Q Consensus 156 --------------------~~------------------------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil 190 (639)
.. +.+.+|||.|||||++.+ +|+..+|+||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 00 114579999999998865 599999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--CCCChHHHHHHHHhcCCCCCCCC---HHHHhcCcccccccCCCCc
Q 006593 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKEPI 265 (639)
Q Consensus 191 ~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~l~~LI~kcL~dP~~RpS---a~ELL~Hpff~~~~~~~~~ 265 (639)
|||+.|.+||.. .++.+.+.+|........++ ...++++++||.+||.||..|.. ++||.+||||+..+|....
T Consensus 379 yEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 379 YEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLR 457 (550)
T ss_pred HHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhh
Confidence 999999999987 78999999998876433333 33468999999999999999985 9999999999999998754
Q ss_pred C
Q 006593 266 C 266 (639)
Q Consensus 266 ~ 266 (639)
.
T Consensus 458 ~ 458 (550)
T KOG0605|consen 458 E 458 (550)
T ss_pred c
Confidence 3
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=404.18 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=223.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+-| .|.+|++..||+.+|||+|.+.. .........+.+||-+|+.+.||||+++|++|... ..+|+|.||
T Consensus 20 LG~Gstg---~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~--~~lylvlEy 93 (786)
T KOG0588|consen 20 LGKGSTG---CVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK--QHLYLVLEY 93 (786)
T ss_pred ccCCCCc---eehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeeccC--ceEEEEEEe
Confidence 6777777 89999999999999999998774 23456678899999999999999999999999654 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc-CCCCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~-~~~~~~ 160 (639)
++||.|++|+.+++++++..++++++||+.|+.|||..+ |+||||||+|+|++.+ +.|||+|||.|.... .....+
T Consensus 94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeecccCCccccc
Confidence 999999999999999999999999999999999999999 9999999999999855 569999999997543 445678
Q ss_pred ccCCCCcCCcccccc-cC-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
.||.|+|.|||++.+ .| +.++||||+|||||.|+||++||.+ .|...++.+|.+|... ++...++++++||.+||
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQDLLRRML 247 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHHHHHHHHh
Confidence 899999999998875 45 6889999999999999999999996 7899999999999764 56788999999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccccCCC
Q 006593 239 V-PASERLSAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~~~~ 263 (639)
. ||.+|+|.+|+++|||+.......
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred ccCccccccHHHHhhCchhhcCCCCC
Confidence 8 999999999999999998765443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=397.37 Aligned_cols=246 Identities=29% Similarity=0.496 Sum_probs=217.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|.|| .||+|.|..+++.||+|++..+. ..++.+.+++|+.+|.+++++||.++|++|+.... +|++||
T Consensus 20 ~IgrGsfG---~Vyk~~d~~t~k~vAiKii~Le~---~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~--LwiiMe 91 (467)
T KOG0201|consen 20 LIGRGSFG---EVYKAIDNKTKKVVAIKIIDLEE---AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK--LWIIME 91 (467)
T ss_pred hccccccc---eeeeeeeccccceEEEEEechhh---cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc--HHHHHH
Confidence 36777777 89999999999999999999876 56788999999999999999999999999998865 999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
||.||++.+.++..+.+++..+..++++++.||.|||+++ .+|||||+.|||+..+ |.|||+|||++..+... ..
T Consensus 92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecceeeeeechhhcc
Confidence 9999999999998888899999999999999999999999 9999999999999855 99999999999877543 34
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
.+++|||.|||||++.+ .|+.++||||||++++||++|++||.++..+ .....|.+ ..|+.+...+++.+++||..|
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-rvlflIpk-~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-RVLFLIPK-SAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-eEEEeccC-CCCCccccccCHHHHHHHHHH
Confidence 68999999999999886 6999999999999999999999999986542 22222333 345566668899999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|. +|..||+|.+||+|+|++..
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhc
Confidence 99 89999999999999999873
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=376.89 Aligned_cols=252 Identities=21% Similarity=0.385 Sum_probs=215.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|+++.... ........+.+|+.+|++++||||+++++++... ..+|+|||
T Consensus 2 ~lG~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~e 75 (323)
T cd05571 2 LLGKGTFG---KVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH--DRLCFVME 75 (323)
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC--CEEEEEEe
Confidence 58999998 899999999999999999986543 2234566788999999999999999999988665 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~ 158 (639)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++.... ...
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcc
Confidence 9999999999998889999999999999999999999999 99999999999997 557999999999875322 223
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...+...+..+.. .++...++++++||.+|
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~ 229 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLSPEAKSLLAGL 229 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45689999999998864 589999999999999999999999976 455566666655432 34556788999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCcccccccCCCC
Q 006593 238 LV-PASERL-----SAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 238 L~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~~ 264 (639)
|. ||.+|| ++.++++||||....+...
T Consensus 230 L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~ 262 (323)
T cd05571 230 LKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262 (323)
T ss_pred ccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 99 899999 8999999999987665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=380.43 Aligned_cols=241 Identities=31% Similarity=0.487 Sum_probs=207.3
Q ss_pred cccccccCcEEEEEEEecCCCeE-EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIE-VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~-VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|... |.. ||+|.+...+.. ....+.+.+|+.+|.+|+|||||+|++++..... .+++|||
T Consensus 49 iG~G~~g---~V~~~~~~--g~~~vavK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtE 120 (362)
T KOG0192|consen 49 LGSGSFG---TVYKGKWR--GTDVVAVKIISDPDFD--DESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTE 120 (362)
T ss_pred cccCCce---eEEEEEeC--CceeEEEEEecchhcC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEE
Confidence 6788888 89999875 555 999999876642 2337899999999999999999999998766542 5899999
Q ss_pred cCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--C
Q 006593 81 LFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--P 156 (639)
Q Consensus 81 y~~gGsL~d~lkk--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~ 156 (639)
|+++|+|.+++.+ .+.++...+..|+.||+.|+.|||+++| ||||||||+|||++.+.-++||+|||+++.... .
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 9999999999987 5789999999999999999999999996 999999999999985423999999999987654 3
Q ss_pred CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... .++...+..+.....++..+++.+..+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 3444789999999999985 399999999999999999999999998665 666666665556566677788999999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
|++||. +|..||+..+++.
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHH
Confidence 999999 8999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=389.23 Aligned_cols=245 Identities=29% Similarity=0.469 Sum_probs=218.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||||+.+.+++.||+|.+.+.. +...+++.+.+|+++++.|+|||||.++++|... ..+|+|+|
T Consensus 9 ~iG~Gsfg---~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~--~~~~vVte 81 (808)
T KOG0597|consen 9 MIGEGSFG---RVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETS--AHLWVVTE 81 (808)
T ss_pred HhcCCccc---eeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc--ceEEEEeh
Confidence 47888888 89999999999999999998766 3668899999999999999999999999988544 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
||.| +|+.++...+.++|+.++.++.|++.||.|||+++ |+|||+||+|||+. ..|.+|+||||+|+.+... ..
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccCceee
Confidence 9987 99999999999999999999999999999999999 99999999999997 5589999999999988654 34
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
....|||.|||||++++ .|+..+|+||+||++|||++|++||.. ....++.+.|... |..++...+..++.|++.+
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFLQGL 234 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHHHHH
Confidence 56789999999999875 599999999999999999999999976 4566777777664 3344557788999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|. ||.+|.++.+||.|||.+..
T Consensus 235 L~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 235 LIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhcChhhcccHHHHhcChHHhhh
Confidence 98 89999999999999999743
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.59 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=215.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|+.||+|+++..... .....+.+.+|+.+|++++||||+++++++.+. ..+|+||||
T Consensus 26 lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 99 (329)
T PTZ00263 26 LGTGSFG---RVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE--NRVYFLLEF 99 (329)
T ss_pred EEecCCe---EEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC--CEEEEEEcC
Confidence 6788887 8999999999999999999865432 234557789999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 161 (639)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ....
T Consensus 100 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~-~~~~ 175 (329)
T PTZ00263 100 VVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR-TFTL 175 (329)
T ss_pred CCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC-ccee
Confidence 999999999999889999999999999999999999999 99999999999998 5589999999999765433 2356
Q ss_pred cCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-
Q 006593 162 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 239 (639)
Q Consensus 162 ~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~- 239 (639)
+||+.|+|||++.. .++.++|||||||++|+|++|..||.+ .++..++..+..+.. .++...++.+++||.+||.
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVKGLLQT 252 (329)
T ss_pred cCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHHHHhhc
Confidence 89999999998864 588999999999999999999999986 456777777777643 3455678899999999998
Q ss_pred CCCCCCC-----HHHHhcCcccccccCC
Q 006593 240 PASERLS-----AKDLLKDPFLQVENQK 262 (639)
Q Consensus 240 dP~~RpS-----a~ELL~Hpff~~~~~~ 262 (639)
||.+||+ +++|+.||||....+.
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 8999997 7999999999876554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=365.21 Aligned_cols=246 Identities=26% Similarity=0.434 Sum_probs=202.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
+|+|+|| .||+++++.||+.||||.+.-++ ..+...+-..+||++|++|+|||+|.+..+| ..++.+++|+||
T Consensus 10 vGEGSYG---vV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklhLVFE~ 82 (396)
T KOG0593|consen 10 VGEGSYG---VVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLHLVFEY 82 (396)
T ss_pred cccCcce---EEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeEEEeee
Confidence 5666666 89999999999999999987654 2345566788999999999999999999987 445679999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
|...-|.++-.....++.+.++.+++|++.|+.|||+++ +|||||||+|||++ .+|.+||||||+|+.+..+ ...
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCCcchhh
Confidence 987545444333456999999999999999999999999 99999999999998 5689999999999988743 334
Q ss_pred cccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-------------------CCC
Q 006593 160 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------------GIK 218 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-------------------g~~ 218 (639)
.++.|.+|+|||++-+ +|+..+|||++||++.||++|++-|.+.++..+++..... |..
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 5788999999998764 6999999999999999999999999998888887653321 111
Q ss_pred C------Cccc---CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 219 P------ASLA---KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 219 p------~~l~---~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
. ..+. ...+..+.+|+++||. ||.+|++.+|||.||||+
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 0 1111 1123468899999999 999999999999999995
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=369.51 Aligned_cols=248 Identities=21% Similarity=0.366 Sum_probs=212.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..++..||+|+++..... .......+..|+.+|++++||||+++++++... ..+++||||
T Consensus 1 lg~G~~g---~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFG---KVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP--EKLYLVLAF 74 (312)
T ss_pred CCcCCCe---EEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC--CeEEEEEcC
Confidence 7899998 8999999999999999999865432 335567788999999999999999999988654 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~~ 159 (639)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..... ....
T Consensus 75 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 75 INGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCccc
Confidence 999999999998889999999999999999999999999 99999999999997 557999999999875432 2234
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+ +..++...++++++||.+||
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L 228 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLL 228 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHc
Confidence 5679999999998864 589999999999999999999999986 4566666666654 33455667889999999999
Q ss_pred C-CCCCCC---CHHHHhcCcccccccC
Q 006593 239 V-PASERL---SAKDLLKDPFLQVENQ 261 (639)
Q Consensus 239 ~-dP~~Rp---Sa~ELL~Hpff~~~~~ 261 (639)
. +|.+|| ++.|+|.||||....+
T Consensus 229 ~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 229 SRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred CCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 9 899997 5899999999987543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=368.48 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=214.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|++...... .....+.+.+|+.+|++++||||+++++++.+. ..+++|||
T Consensus 8 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e 81 (291)
T cd05612 8 TVGTGTFG---RVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ--RFLYMLME 81 (291)
T ss_pred eeecCCCe---EEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC--CeEEEEEe
Confidence 37888887 8999999999999999999865432 224556789999999999999999999987654 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~-~~~ 157 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR-TWT 157 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC-ccc
Confidence 9999999999999889999999999999999999999999 99999999999997 5689999999999766543 335
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...++..+..+.. .++...++.+++||.+||.
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHcC
Confidence 679999999998864 588999999999999999999999987 456677777766543 3455568899999999999
Q ss_pred -CCCCCCC-----HHHHhcCcccccccCC
Q 006593 240 -PASERLS-----AKDLLKDPFLQVENQK 262 (639)
Q Consensus 240 -dP~~RpS-----a~ELL~Hpff~~~~~~ 262 (639)
||.+||+ +.++++||||+...+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 8999995 9999999999865554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=383.31 Aligned_cols=253 Identities=27% Similarity=0.342 Sum_probs=211.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
|++.|-|++|.||+|..+.+|..||||+++..-. +.++.- =.+|++.|++|+ |||||+++.++.+.++ .+|||||
T Consensus 15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~-~L~fVfE 90 (538)
T KOG0661|consen 15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYFVFE 90 (538)
T ss_pred HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCc-eEeeeHH
Confidence 4556666666999999999999999999986543 233333 368999999998 9999999999887764 8999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CC
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
||. .+|.++++.+ +.|++..++.|+.||++||+|+|.+| +.||||||+|||+.++ ..|||+|||+|+..... ..
T Consensus 91 ~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 91 FMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLAREVRSKPPY 166 (538)
T ss_pred hhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccccccccccCCCc
Confidence 996 5999999865 56999999999999999999999999 9999999999999865 48999999999988754 44
Q ss_pred ccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-C-------------------
Q 006593 159 RSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------------- 216 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g------------------- 216 (639)
..++.|.+|+|||++- +.|+.++|+|++||+++|+++.++.|.+.....++++...- |
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 5678999999999764 45999999999999999999999999998888888875421 0
Q ss_pred -------CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 217 -------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 217 -------~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
.....+....++++.++|.+||. ||.+||||.|+|+||||+.....
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 01111222357899999999999 99999999999999999866543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=376.77 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=211.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|+++..... .......+..|+.++++++||||+++++++.+. ..+|+|||
T Consensus 8 ~LG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~--~~~~lv~E 81 (363)
T cd05628 8 VIGRGAFG---EVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQDK--LNLYLIME 81 (363)
T ss_pred EEEeCCCE---EEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CeEEEEEc
Confidence 37888887 8999999999999999999865432 234556789999999999999999999988765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
||+||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCccccccccccc
Confidence 9999999999998899999999999999999999999999 99999999999997 45899999999986542110
Q ss_pred ----------------------------------CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCC
Q 006593 158 ----------------------------------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSE 202 (639)
Q Consensus 158 ----------------------------------~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~ 202 (639)
....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 12457999999999876 4589999999999999999999999986
Q ss_pred CCCHHHHHHHHHcCCCCCccc--CCCChHHHHHHHHhcCCC---CCCCCHHHHhcCcccccccCCCC
Q 006593 203 CKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPA---SERLSAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 203 ~~~~~~i~~~i~~g~~p~~l~--~~~s~~l~~LI~kcL~dP---~~RpSa~ELL~Hpff~~~~~~~~ 264 (639)
.++...+..+........++ ...++++++||.+++.+| ..||+++||++||||+...+...
T Consensus 239 -~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~ 304 (363)
T cd05628 239 -ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHI 304 (363)
T ss_pred -CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHH
Confidence 45667777776543222222 235789999999977643 45789999999999998776544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=393.09 Aligned_cols=260 Identities=23% Similarity=0.408 Sum_probs=228.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|.|| +|++|..+.+++.+|||++++..+.+ .++.+.++.|.+|+... +||.++.+|.+|... .++|+||
T Consensus 375 vLGkGsFG---kV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~l~fvm 448 (694)
T KOG0694|consen 375 VLGRGSFG---KVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EHLFFVM 448 (694)
T ss_pred EeccCcCc---eEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC--CeEEEEE
Confidence 58999999 89999999999999999999999876 47888999999999999 599999999999765 5699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.||++..+ ++.+.|++..++.|+..|+.||.|||++| |||||||.+|||+| ..|.+||+|||+++... ...
T Consensus 449 ey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 449 EYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCCCc
Confidence 99999995443 34478999999999999999999999999 99999999999998 56899999999998653 345
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
..++||||.|||||++.+ .|+.++|+|||||++|||++|++||.+ ++.++++..|... ....|...+.++..++++
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAIAIMRR 601 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHHHHHHH
Confidence 678999999999998875 699999999999999999999999998 6788999988874 334567778999999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCcccccccCCCCcCCCCCCch
Q 006593 237 CLV-PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPI 273 (639)
Q Consensus 237 cL~-dP~~RpS-----a~ELL~Hpff~~~~~~~~~~~~~~~~~ 273 (639)
+|. +|.+|+. +.+|.+||||+..+|.......+++|.
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf 644 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPF 644 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCC
Confidence 998 8999996 589999999999998766555454443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=373.71 Aligned_cols=252 Identities=22% Similarity=0.420 Sum_probs=211.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|+++..... .......+.+|+.+|+.++||||++++++|.+. ..+|+|||
T Consensus 8 ~lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~E 81 (364)
T cd05599 8 VIGRGAFG---EVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDE--NYLYLIME 81 (364)
T ss_pred EEEecCCE---EEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CeEEEEEC
Confidence 47888888 8999999999999999999865432 234556788999999999999999999988765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
||.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceecccccccc
Confidence 9999999999998888999999999999999999999999 99999999999997 5589999999998654211
Q ss_pred ------------------------------------CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCC
Q 006593 157 ------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYP 199 (639)
Q Consensus 157 ------------------------------------~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~P 199 (639)
.....+||+.|+|||++. ..|+.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 011346999999999876 4589999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCcccC--CCChHHHHHHHHhcCCCCCCCC---HHHHhcCcccccccCC
Q 006593 200 YSECKNPAQIFKKVTSGIKPASLAK--VNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQK 262 (639)
Q Consensus 200 f~~~~~~~~i~~~i~~g~~p~~l~~--~~s~~l~~LI~kcL~dP~~RpS---a~ELL~Hpff~~~~~~ 262 (639)
|.. .++.+.+..+........++. ..++++++||.+||.+|.+|++ +.++|.||||+...+.
T Consensus 239 f~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 239 FCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 987 445666666665433322222 3578999999999999999997 9999999999876553
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=367.95 Aligned_cols=250 Identities=20% Similarity=0.381 Sum_probs=213.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|+++.... ........+..|+.+++.++||||++++++|... ..+|+|||
T Consensus 2 ~lG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~E 75 (323)
T cd05595 2 LLGKGTFG---KVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVME 75 (323)
T ss_pred eeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CEEEEEEe
Confidence 58999998 899999999999999999986533 2234566788999999999999999999988765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~ 158 (639)
|+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++|.+||+|||++..... ...
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcc
Confidence 9999999999998888999999999999999999999999 99999999999997 557999999999875322 223
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+.......+..... .++...++++++||.+|
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~ 229 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL 229 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence 4567999999999886 4589999999999999999999999976 345555555554322 34556789999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCcccccccCC
Q 006593 238 LV-PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 238 L~-dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
|. +|.+|+ ++.++++||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred ccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99 899998 89999999999876554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.73 Aligned_cols=250 Identities=22% Similarity=0.390 Sum_probs=213.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|++..... ........+.+|+.+|+.++||||+++++++... ..+|+|||
T Consensus 2 ~lG~G~~g---~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~E 75 (328)
T cd05593 2 LLGKGTFG---KVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK--DRLCFVME 75 (328)
T ss_pred eeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC--CEEEEEEe
Confidence 58999998 899999999999999999986543 2345567788999999999999999999988655 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~ 158 (639)
|+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..... ...
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccc
Confidence 9999999999998888999999999999999999999999 99999999999998 557999999999875322 223
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...+.+.+..+. ..++...++++++||.+|
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMED--IKFPRTLSADAKSLLSGL 229 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCC--ccCCCCCCHHHHHHHHHH
Confidence 4568999999999886 4589999999999999999999999976 34555555554432 234556788999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCcccccccCC
Q 006593 238 LV-PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 238 L~-dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
|. +|.+|+ ++.++++||||....+.
T Consensus 230 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred cCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99 899997 89999999999876554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=367.35 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=210.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|+++..... .......+..|+.+|+.++||||+++++++... ..+|+||||
T Consensus 9 ig~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~e~ 82 (333)
T cd05600 9 VGQGGYG---QVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD--EYLYLAMEY 82 (333)
T ss_pred EeecCCe---EEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC--CEEEEEEeC
Confidence 6777777 8999999999999999999865432 234566789999999999999999999988655 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 161 (639)
+.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..... .....
T Consensus 83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~-~~~~~ 158 (333)
T cd05600 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT-YANSV 158 (333)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-ccCCc
Confidence 999999999998889999999999999999999999999 99999999999997 568999999999976544 33456
Q ss_pred cCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc------CCCChHHHHHH
Q 006593 162 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA------KVNDPQIKGFI 234 (639)
Q Consensus 162 ~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~------~~~s~~l~~LI 234 (639)
+||+.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+.+..+.........+ ...++++.+||
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 89999999998764 589999999999999999999999986 45666666555432211111 13478999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.+||. +|.+||++.++++||||....+
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 99999 6899999999999999986544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=364.79 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=209.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|+.||+|++....... ......+..|.. +++.++||||+++++++... ..+++||
T Consensus 2 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~--~~~~lv~ 75 (323)
T cd05575 2 VIGKGSFG---KVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA--DKLYFVL 75 (323)
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC--CEEEEEE
Confidence 58999999 89999999999999999998654322 233345555555 56889999999999988665 4689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ++|.+||+|||++.... ...
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCc
Confidence 99999999999998889999999999999999999999999 99999999999997 55899999999986532 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.. .++...++.+.+||.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 229 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPL--RLKPNISVSARHLLEG 229 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998764 589999999999999999999999986 456677777766533 2344558899999999
Q ss_pred hcC-CCCCCCCH----HHHhcCcccccccCCC
Q 006593 237 CLV-PASERLSA----KDLLKDPFLQVENQKE 263 (639)
Q Consensus 237 cL~-dP~~RpSa----~ELL~Hpff~~~~~~~ 263 (639)
||+ +|.+||++ .+++.||||....+..
T Consensus 230 ~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 230 LLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred HhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999 89999987 6999999998765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.37 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=211.1
Q ss_pred CcccccccCcEEEEEEEe---cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d---~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+ ..+|..||+|+++.............+..|+.+|+.++||||++++++|..+ ..+|+
T Consensus 3 ~lg~G~~g---~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~l 77 (323)
T cd05584 3 VLGKGGYG---KVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG--GKLYL 77 (323)
T ss_pred eeeecCCe---EEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC--CeEEE
Confidence 48999999 5666654 4689999999998765433445566788999999999999999999988765 46999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--C
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~ 155 (639)
||||+.+|+|.+++.+.+.+.+..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.... .
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCC
Confidence 9999999999999999888999999999999999999999999 99999999999997 55899999999986432 2
Q ss_pred CCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 156 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
......+||+.|+|||++.. .++.++|||||||++|||++|..||.. .+.......+..+.. .++...++.+++||
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 231 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLL 231 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence 22345679999999998864 588999999999999999999999987 445555666665533 34556688999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCcccccccCC
Q 006593 235 EKCLV-PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 235 ~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
.+||. +|.+|| ++.+++.||||....+.
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~ 265 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99999 899999 89999999999866543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.02 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=213.2
Q ss_pred cccccccCcEEEEEEEecCCC-eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG-~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| .||+|.+..++ ..||+|++...... .....+.+.+|+.+++.++||||+++++++.+. ..+|+|||
T Consensus 38 ig~G~~g---~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~lv~E 111 (340)
T PTZ00426 38 LGTGSFG---RVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--SYLYLVLE 111 (340)
T ss_pred EeecCCe---EEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC--CEEEEEEe
Confidence 7888887 89999876665 78999999765432 234566789999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..+... ...
T Consensus 112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~~-~~~ 187 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTR-TYT 187 (340)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecCCC-cce
Confidence 9999999999999889999999999999999999999999 99999999999997 5689999999999765432 345
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
.+||+.|||||++.+ .++.++|||||||++|+|++|..||.+ .++..+++.+..+.. .++...++.++++|++||.
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~ 264 (340)
T PTZ00426 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLMKKLLS 264 (340)
T ss_pred ecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcc
Confidence 689999999998864 588999999999999999999999986 456677777776643 2455668899999999999
Q ss_pred -CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 240 -PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 240 -dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
+|.+|+ +++++++||||....+..
T Consensus 265 ~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 265 HDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred cCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 899995 899999999998766543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.20 Aligned_cols=254 Identities=22% Similarity=0.394 Sum_probs=212.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|+++..... .......+..|+.++.+++||||++++++|.+. ..+|+|||
T Consensus 8 ~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~~lv~E 81 (360)
T cd05627 8 VIGRGAFG---EVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDK--RNLYLIME 81 (360)
T ss_pred EEeeCCCE---EEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEEe
Confidence 37888888 8999999999999999999865432 234567889999999999999999999988655 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
|++||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCcccccccccc
Confidence 9999999999998889999999999999999999999999 99999999999997 5689999999998644211
Q ss_pred ---------------------------------CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCC
Q 006593 157 ---------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSE 202 (639)
Q Consensus 157 ---------------------------------~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~ 202 (639)
.....+||+.|+|||++. ..|+.++|||||||++|||+||..||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 012457999999999876 4589999999999999999999999986
Q ss_pred CCCHHHHHHHHHcCCCCCccc--CCCChHHHHHHHHhcCCCCCCC---CHHHHhcCcccccccCCCC
Q 006593 203 CKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 203 ~~~~~~i~~~i~~g~~p~~l~--~~~s~~l~~LI~kcL~dP~~Rp---Sa~ELL~Hpff~~~~~~~~ 264 (639)
.++...+..+........++ ...++++++||.+|+.+|.+|+ ++.+++.||||+..+|...
T Consensus 239 -~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~ 304 (360)
T cd05627 239 -ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHI 304 (360)
T ss_pred -CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence 45666666666543222222 2357899999999888888888 5899999999998776543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=372.12 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=208.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|++...... .....+.+..|+++|++++||||++++++|.+. ..+|+|||
T Consensus 8 ~lG~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~--~~~~lv~E 81 (377)
T cd05629 8 VIGKGAFG---EVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA--QYLYLIME 81 (377)
T ss_pred EEeecCCE---EEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CeeEEEEe
Confidence 37888888 8999999999999999998765432 234567789999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
|+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccccccc
Confidence 9999999999998889999999999999999999999999 99999999999997 5689999999998532110
Q ss_pred ---------------------------------------------CCccccCCCCcCCccccc-ccCCccccccchhhhh
Q 006593 157 ---------------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 190 (639)
Q Consensus 157 ---------------------------------------------~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil 190 (639)
.....+||+.|+|||++. ..|+.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 001257999999999876 4589999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccC--CCChHHHHHHHHhcCCCCC---CCCHHHHhcCcccccccCC
Q 006593 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDPQIKGFIEKCLVPASE---RLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 191 ~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~--~~s~~l~~LI~kcL~dP~~---RpSa~ELL~Hpff~~~~~~ 262 (639)
|||++|.+||.. .+....+..+........++. ..++++++||.+||.+|.+ |+++.|+|.||||+...+.
T Consensus 239 ~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~ 314 (377)
T cd05629 239 FECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWD 314 (377)
T ss_pred hhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 999999999976 345566666655433223332 3578999999999986554 5699999999999865543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.82 Aligned_cols=252 Identities=21% Similarity=0.388 Sum_probs=212.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|+.||+|+++..... .......+..|+.+|+.++||||++++++|.+. ..+++|||
T Consensus 8 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 81 (350)
T cd05573 8 VIGRGAFG---EVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDE--EHLYLVME 81 (350)
T ss_pred EEEeCCcE---EEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecC--CeEEEEEc
Confidence 36777777 8999999999999999999866532 224567789999999999999999999988665 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCccc
Confidence 9999999999998888999999999999999999999999 99999999999997 55799999999997654322
Q ss_pred ----------------------------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHH
Q 006593 158 ----------------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 208 (639)
Q Consensus 158 ----------------------------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~ 208 (639)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||... +...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD-TLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC-CHHH
Confidence 234579999999998864 5899999999999999999999999874 4555
Q ss_pred HHHHHHcCCCCCcccC--CCChHHHHHHHHhcCCCCCCCC-HHHHhcCcccccccCC
Q 006593 209 IFKKVTSGIKPASLAK--VNDPQIKGFIEKCLVPASERLS-AKDLLKDPFLQVENQK 262 (639)
Q Consensus 209 i~~~i~~g~~p~~l~~--~~s~~l~~LI~kcL~dP~~RpS-a~ELL~Hpff~~~~~~ 262 (639)
.+..+........++. ..++++++||.+||.+|.+||+ ++++|+||||+...+.
T Consensus 238 ~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred HHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHH
Confidence 6666665222222222 2589999999999999999999 9999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=364.94 Aligned_cols=250 Identities=21% Similarity=0.377 Sum_probs=212.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|+++.... ........+..|+++++.++||||+++++++... ..+|+|||
T Consensus 2 ~lG~G~~g---~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~--~~~~lv~E 75 (325)
T cd05594 2 LLGKGTFG---KVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCFVME 75 (325)
T ss_pred eeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC--CEEEEEEe
Confidence 58999998 899999999999999999986543 2334566788999999999999999999988655 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
|+.+|+|..++.+.+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+|.+||+|||++.... ...
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcc
Confidence 99999999999988899999999999999999999998 68 99999999999997 55799999999986532 222
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|||||++. ..++.++|||||||++|+|+||..||.+ .+...+...+.... ..++...++++++||.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~ 229 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLSG 229 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHH
Confidence 34567999999999886 4589999999999999999999999976 34556666655432 23455678999999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCcccccccCC
Q 006593 237 CLV-PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
||+ +|.+|+ ++.++|+||||....+.
T Consensus 230 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999 899997 89999999999875543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=370.91 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=206.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|++...... .....+.+..|+.+|+.++||||+++++++.+. ..+|+|||
T Consensus 8 ~LG~G~~g---~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~--~~~~lv~E 81 (381)
T cd05626 8 TLGIGAFG---EVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFVMD 81 (381)
T ss_pred EEeecCCE---EEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC--CEEEEEEe
Confidence 36777777 8999999999999999999876542 234567899999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
|++||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccccc
Confidence 9999999999999889999999999999999999999999 99999999999997 5589999999997532100
Q ss_pred ---------------------------------------------CCccccCCCCcCCccccc-ccCCccccccchhhhh
Q 006593 157 ---------------------------------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 190 (639)
Q Consensus 157 ---------------------------------------------~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil 190 (639)
.....+||+.|||||++. ..|+.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 012457999999999876 4589999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--cCCCChHHHHHHHHhcC---CCCCCCCHHHHhcCcccccccCC
Q 006593 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKGFIEKCLV---PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 191 ~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~s~~l~~LI~kcL~---dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
|||+||..||... ++......+......... ....++++++||.+||. +|..|+++.+++.||||+...+.
T Consensus 239 ~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 239 FEMLVGQPPFLAP-TPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHHhCCCCCcCC-CHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 9999999999874 344444444432221122 22467899999999664 35569999999999999876554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=364.24 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=213.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.++.+|..||+|+++..... .....+.+..|..+++.+ +||||+++++++... ..+|+||
T Consensus 2 ~lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~ 75 (320)
T cd05590 2 VLGKGSFG---KVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVM 75 (320)
T ss_pred eeeeCCCe---EEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEE
Confidence 58999998 8999999999999999999865432 234566778899999877 799999999988655 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... ...
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCc
Confidence 99999999999998889999999999999999999999999 99999999999997 55799999999986532 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.. ..+...++++++||.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 229 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKA 229 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998864 589999999999999999999999986 456677777766533 2445578899999999
Q ss_pred hcC-CCCCCCCH------HHHhcCcccccccCC
Q 006593 237 CLV-PASERLSA------KDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa------~ELL~Hpff~~~~~~ 262 (639)
||. +|.+||++ +++++||||+...+.
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999 89999998 999999999876553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=366.70 Aligned_cols=248 Identities=31% Similarity=0.484 Sum_probs=213.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.|+++|..||||++..+ .+++.+.+|+.+|.+|+.|+||+||++|..... +|+||||
T Consensus 41 LGEGSYG---SV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD--LWIVMEY 109 (502)
T KOG0574|consen 41 LGEGSYG---SVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD--LWIVMEY 109 (502)
T ss_pred hcCCcch---HHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc--eEeehhh
Confidence 5666666 8999999999999999999865 467889999999999999999999999876654 9999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|..|++.+.++. ++.++++.+..+++.-++||+|||-.. -||||||..|||++ ..|..||+|||.|..+... .+
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccchhhhhHHhh
Confidence 999999999874 578999999999999999999999998 89999999999998 4589999999999877654 45
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
.+++|||.|||||++.. +|+.++||||||++..||+.|++||.+......++-.-+...+...-+..++.++.+||++|
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C 266 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC 266 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence 68899999999999975 69999999999999999999999999865444444332333333344556688999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccccCCC
Q 006593 238 LV-PASERLSAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~~~~~ 263 (639)
|. .|.+|-||.+|++|||++......
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 99 799999999999999998765543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=370.84 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=208.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..++..||+|++...... .....+.+..|+.+|++++||||++++++|.+. ..+|+|||
T Consensus 8 ~LG~G~~g---~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~--~~~~lv~E 81 (382)
T cd05625 8 TLGIGAFG---EVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDK--DNLYFVMD 81 (382)
T ss_pred EEEeCCCE---EEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC--CEEEEEEe
Confidence 37778777 8999999999999999999865432 234567889999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----- 155 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~----- 155 (639)
||.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+..
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999997 568999999999753210
Q ss_pred --------------------------------------------CCCccccCCCCcCCccccc-ccCCccccccchhhhh
Q 006593 156 --------------------------------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 190 (639)
Q Consensus 156 --------------------------------------------~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil 190 (639)
......+||+.|+|||++. ..|+.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0012357999999999876 4699999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--cCCCChHHHHHHHHhcCCCCCCCC---HHHHhcCcccccccCC
Q 006593 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQK 262 (639)
Q Consensus 191 ~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~s~~l~~LI~kcL~dP~~RpS---a~ELL~Hpff~~~~~~ 262 (639)
|||++|..||... ++.+....+......... ....++++++||.+|+.+|.+|++ +.++++||||+...+.
T Consensus 239 ~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 239 YEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999999999873 455555555443222222 234578999999998889999987 9999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.26 Aligned_cols=251 Identities=25% Similarity=0.294 Sum_probs=208.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
|.+.|.|+++.||+|++..+|+.||+|.|+++.. .+....-..+||.||++|+||||+++.+...+.....+|||+||
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence 3445555555999999999999999999998864 34556678899999999999999999998877766789999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
|.. +|.-++... -.|++..|+.+++||+.||+|||++| |+|||||+.||||| +.|.+||+|||||+......
T Consensus 200 Mdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 200 MDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred ccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCCcc
Confidence 986 888887763 37999999999999999999999999 99999999999998 67999999999998665332
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCCC--------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPA-------------- 220 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~-------------- 220 (639)
....+-|.+|+|||++-+ .|+.++|+||.|||+.||++|++.|.+....+|+.+.+.- |.+..
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 344567999999997754 5999999999999999999999999987777766543321 11100
Q ss_pred -----------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 221 -----------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 221 -----------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
......++.+.+|+..+|. ||.+|.||.+.|+|+||..
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 0012336778899999999 9999999999999999953
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.39 Aligned_cols=247 Identities=26% Similarity=0.451 Sum_probs=206.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|.+.... .....+++.+|+++|++++||||+++++++... ..+++||||
T Consensus 13 lg~G~~g---~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 84 (331)
T cd06649 13 LGAGNGG---VVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEH 84 (331)
T ss_pred ecCCCCE---EEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEEeec
Confidence 6777777 89999999999999999987642 345567899999999999999999999998765 458999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
+.+|+|.+++...+.+++..++.++.||+.||.|||+. + |+||||||+|||++ ..|.+||+|||++..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 161 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 161 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEc-CCCcEEEccCccccccccccccc
Confidence 99999999999888899999999999999999999985 5 99999999999998 55799999999997765555556
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHH---------------------------
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK--------------------------- 212 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~--------------------------- 212 (639)
..||+.|+|||++.+ .++.++|||||||++|+|++|+.||... ....+...
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 789999999998864 5899999999999999999999999653 22222211
Q ss_pred -------------------HHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 213 -------------------VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 213 -------------------i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+.....+.......++++++||.+||+ +|.+|||+.+||+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 111111222223457889999999999 999999999999999998544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=362.59 Aligned_cols=250 Identities=20% Similarity=0.339 Sum_probs=209.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||+|+++.... ........+..|..+++.+ +||||+++++++... ..+|+||
T Consensus 2 ~lG~G~~g---~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~ 75 (329)
T cd05588 2 VIGRGSYA---KVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVI 75 (329)
T ss_pred eEeeCCCe---EEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEE
Confidence 58999998 899999999999999999986543 2234566788999999999 799999999988665 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++... ...
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCc
Confidence 99999999999988889999999999999999999999999 99999999999997 55799999999986432 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC--------CHHHHHHHHHcCCCCCcccCCCCh
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--------NPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~--------~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ....+.+.+.... ..++...++
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~ 230 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSV 230 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCH
Confidence 345689999999998864 58999999999999999999999995311 1223344444432 234556788
Q ss_pred HHHHHHHHhcC-CCCCCCC------HHHHhcCcccccccC
Q 006593 229 QIKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQ 261 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpS------a~ELL~Hpff~~~~~ 261 (639)
.+.++|.+||+ +|.+|++ +.++++||||....+
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999999999 8999987 799999999976544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=360.89 Aligned_cols=250 Identities=21% Similarity=0.336 Sum_probs=213.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||+|+++..... .....+.+..|..++..+ +||||++++++|... ..+|+||
T Consensus 2 ~lG~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~ 75 (321)
T cd05591 2 VLGKGSFG---KVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVM 75 (321)
T ss_pred ccccCCCe---EEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEE
Confidence 58999998 8999999999999999999865432 234556778899999876 899999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... ...
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcc
Confidence 99999999999998889999999999999999999999999 99999999999997 55799999999986532 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.. .|+.++|||||||++|+|++|..||.. .+....+..+..+.. ..+...++++.+||.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~ 229 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKA 229 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998864 589999999999999999999999987 456677777766533 2344567899999999
Q ss_pred hcC-CCCCCC-------CHHHHhcCcccccccCC
Q 006593 237 CLV-PASERL-------SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~Rp-------Sa~ELL~Hpff~~~~~~ 262 (639)
||. +|.+|| ++.++++||||....+.
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 999 899999 99999999999876554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=368.83 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=206.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||+|++...... .....+.+.+|+.+|+.++||||+++++.|.+. ..+|+||||
T Consensus 9 lG~G~~g---~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~E~ 82 (376)
T cd05598 9 IGIGAFG---EVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDK--DNLYFVMDY 82 (376)
T ss_pred EEeCCCe---EEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CEEEEEEeC
Confidence 6777777 8999999999999999998765432 123456788999999999999999999988765 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-----
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~----- 156 (639)
|++|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+|..+...
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccccccc
Confidence 999999999999888999999999999999999999999 99999999999997 5579999999997532100
Q ss_pred ----------------------------------------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh
Q 006593 157 ----------------------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT 195 (639)
Q Consensus 157 ----------------------------------------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt 195 (639)
.....+||+.|||||++.+ .++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 0123579999999998864 58999999999999999999
Q ss_pred ccCCCCCCCCHHHHHHHHHcCCCCCcc--cCCCChHHHHHHHHhcCCCCCCC---CHHHHhcCcccccccC
Q 006593 196 FEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKGFIEKCLVPASERL---SAKDLLKDPFLQVENQ 261 (639)
Q Consensus 196 G~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~s~~l~~LI~kcL~dP~~Rp---Sa~ELL~Hpff~~~~~ 261 (639)
|..||.+. ++......+......... ....++++.+||.+|+.+|.+|+ ++.++++||||+...+
T Consensus 240 G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 240 GQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred CCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 99999873 444444444433222122 23457899999999888999999 9999999999986544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=354.26 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=207.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|.+....... ......+.+|+.+|++++|+||++++++|.+. ..+++|||
T Consensus 7 ~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~--~~~~lv~e 80 (285)
T cd05631 7 VLGKGGFG---EVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETK--DALCLVLT 80 (285)
T ss_pred EEecCCCE---EEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC--CeEEEEEE
Confidence 47888888 89999999999999999988655422 23345678999999999999999999988665 46999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~ 157 (639)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +.+.+||+|||++...... .
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCCe
Confidence 99999999888653 36899999999999999999999999 99999999999997 5579999999999765432 2
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH---HHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~---~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.....||+.|||||++.. .|+.++|||||||++|+|++|+.||...... ..+...+.. ....++...++++.+|
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~l 235 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSI 235 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHH
Confidence 345679999999998864 6899999999999999999999999764322 223333322 2223455568899999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCcccccccCCCC
Q 006593 234 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 234 I~kcL~-dP~~RpS-----a~ELL~Hpff~~~~~~~~ 264 (639)
|.+||. +|.+||+ ++++++||||+..++...
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence 999999 8999997 999999999987766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=351.71 Aligned_cols=249 Identities=24% Similarity=0.437 Sum_probs=217.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|.|+ .||++.+..+|+.+|+|++....+.+ ...+++.+|+.|-+.|+|||||++++++... .+.|+|+|
T Consensus 18 ~igkG~FS---vVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--~~~ylvFe 90 (355)
T KOG0033|consen 18 ELGKGAFS---VVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLVFD 90 (355)
T ss_pred HHccCchH---HHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhccc--ceeEEEEe
Confidence 47888887 79999999999999999998777643 3778899999999999999999999987544 57899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~~~-~ 157 (639)
++.||+|..-+.++-.++|..+..+++||+.||.|||.++ |||||+||.|+++-. +...|||+|||+|..+... .
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 9999999877776677899999999999999999999999 999999999999942 3357999999999887633 4
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFI 234 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~LI 234 (639)
...+.|||.|||||++. ..|+..+|||+.|+++|-|+.|.+||.+ .+...+++.|..|.. +...+...++++++||
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 56678999999999887 5699999999999999999999999987 568899999998854 3334556689999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
++||. ||.+|+|+.|.|+|||++..
T Consensus 248 rrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHhccChhhhccHHHHhCCchhcch
Confidence 99998 99999999999999999754
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=361.08 Aligned_cols=255 Identities=21% Similarity=0.346 Sum_probs=207.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|+||.+..|+.+.+..+|..||+|+++...........+.+..|+.+|+.+ +||||+++++++... ..+++||
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~~lv~ 84 (332)
T cd05614 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--AKLHLIL 84 (332)
T ss_pred EEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--CEEEEEE
Confidence 3788888854444444445689999999998655433445567789999999999 599999999987654 4689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
||+.+|+|.+++.+++.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 85 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 85 DYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCccccccCCC
Confidence 99999999999998888999999999999999999999999 99999999999997 4579999999998764322
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCC---CCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~---~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
.....+||+.|||||++.+ .++.++|||||||++|+|+||..||... .....+...+.... ..++...++.++
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 239 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIGPEAQ 239 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHH
Confidence 2234679999999998864 3788999999999999999999999642 22334444444332 234556788999
Q ss_pred HHHHHhcC-CCCCCC-----CHHHHhcCcccccccCC
Q 006593 232 GFIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 232 ~LI~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
+||.+||. +|.+|| ++.++++||||+...+.
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99999999 899999 88999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=360.65 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=209.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+||.+..|+.+.+..+|..||+|+++.... .......+..|+++|++++||||+++++++... ..+|+|||
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 78 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE--GKLYLILD 78 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CEEEEEEc
Confidence 48999999555444444567899999999986543 123445678899999999999999999988665 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++...... ..
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCce
Confidence 9999999999988888999999999999999999999999 99999999999997 5579999999998765432 23
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+||+.|+|||++.. .++.++|||||||++|+|++|+.||.. .+..+....+..... .++...++.+++||.+|
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRAL 232 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 45689999999998864 588999999999999999999999986 345566666655432 34555688999999999
Q ss_pred cC-CCCCCCC-----HHHHhcCcccccccCC
Q 006593 238 LV-PASERLS-----AKDLLKDPFLQVENQK 262 (639)
Q Consensus 238 L~-dP~~RpS-----a~ELL~Hpff~~~~~~ 262 (639)
|+ +|.+||+ ..+++.||||+...+.
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 98 8999999 7889999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=380.84 Aligned_cols=251 Identities=31% Similarity=0.524 Sum_probs=223.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
|||+|.|| +||.|+|..+...+|||.+...+ ....+.+..||.+-++|+|.|||+|.|++ ..+.++-|.||
T Consensus 582 VLGKGTYG---~VYA~RD~~tqvrIaIKEIpekd----sr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYG---TVYAARDMDTQVRIAIKEIPEKD----SREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFME 652 (1226)
T ss_pred EeecCcee---EEEeeccccceeEEEeeeccccc----chhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEee
Confidence 58999998 89999999999999999987554 35678899999999999999999999986 33457889999
Q ss_pred cCCCCCHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--C
Q 006593 81 LFTSGNLRQYRKK-HKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 155 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l--~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~ 155 (639)
-++||+|..+++. .+++ +|.++..|.+||++||.|||.+. |+|||||-+|+|++.-.|.+||.|||-++.+- +
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 9999999999874 6777 89999999999999999999999 99999999999999888999999999998774 4
Q ss_pred CCCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 156 PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
+...++-||..|||||++.. +|+.++|||||||++.||+||++||.+..+|...+-++.--...+.+|...+.+++.
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~ 810 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKN 810 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHH
Confidence 56678999999999999974 599999999999999999999999999888877766665555556677777899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
||.+|+. +|.+||+|.+||.+||++..+.+
T Consensus 811 FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 811 FILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred HHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 9999999 89999999999999999987544
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=372.72 Aligned_cols=249 Identities=29% Similarity=0.509 Sum_probs=221.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
++|+|+|| .+++.+++..+..||||.+..... +....+...+|+.++++++|||||.|+++|+.++ .+++|||+
T Consensus 11 ~iG~GafG---~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~Ivm~ 84 (426)
T KOG0589|consen 11 QVGRGAFG---SALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCIVME 84 (426)
T ss_pred hcCccccc---hhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEEEEe
Confidence 47888888 788889999999999999998875 4455568899999999999999999999998764 46999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
||.||+|.+.+++.+ .++++.+..|+.||+.|+.|||+.. |+|||||+.|||++.+ +.|||+|||+|+.+...
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcccc-CceeecchhhhhhcCCchh
Confidence 999999999998654 6999999999999999999999888 9999999999999854 68899999999998765
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
...++.|||.||.||++.+ .|+.++||||||||+|||++.+.+|.. .+...+..+|..+. -..++..++.+++.+|+
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHHHHHHH
Confidence 5678899999999999986 699999999999999999999999987 67777777777776 34467778899999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.||. +|..||++.+||.+|.++..-
T Consensus 240 ~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHhhcCCccCCCHHHHhhChhhhhHH
Confidence 9999 899999999999999887543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=360.19 Aligned_cols=252 Identities=18% Similarity=0.309 Sum_probs=211.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|+++.... ......+.+..|+.+++.++||||+++++++.+. ..+++|||
T Consensus 8 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~--~~~~lv~e 81 (330)
T cd05601 8 LVGRGHFG---EVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDK--DNLYLVME 81 (330)
T ss_pred EEEeccCE---EEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC--CeEEEEEC
Confidence 36788887 899999999999999999986543 1234566788999999999999999999988665 46999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|+.+|+|.+++.+. +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCCce
Confidence 99999999999886 67999999999999999999999999 99999999999997 55899999999997654322
Q ss_pred -CccccCCCCcCCccccc-------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccC--CCC
Q 006593 158 -ARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VND 227 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~-------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~--~~s 227 (639)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||... +....+..+........++. ..+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCCC
Confidence 23357999999999875 34788999999999999999999999873 45556666655433222222 357
Q ss_pred hHHHHHHHHhcCCCCCCCCHHHHhcCcccccccCC
Q 006593 228 PQIKGFIEKCLVPASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 228 ~~l~~LI~kcL~dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+.+++||.+||.+|.+||++.+++.||||....+.
T Consensus 238 ~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 238 SDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred HHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHH
Confidence 89999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.72 Aligned_cols=251 Identities=19% Similarity=0.350 Sum_probs=209.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|++...... .....+.+..|+.+++.++||||+++++++.+. ..+|+|||
T Consensus 50 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~--~~~~lv~E 123 (370)
T cd05596 50 VIGRGAFG---EVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD--KYLYMVME 123 (370)
T ss_pred EEeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEEEEEEc
Confidence 37788877 8999999999999999999765432 223445678999999999999999999988655 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---C
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~ 157 (639)
|++||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++...... .
T Consensus 124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccCCCccc
Confidence 99999999998764 5899999999999999999999999 99999999999997 5689999999999765432 2
Q ss_pred CccccCCCCcCCcccccc-----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccC--CCChHH
Q 006593 158 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDPQI 230 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~--~~s~~l 230 (639)
....+||+.|||||++.. .++.++|||||||++|||++|..||.+ .+....+..+..+.....++. ..+.++
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 235679999999998753 378999999999999999999999987 455667777766543333333 357899
Q ss_pred HHHHHHhcC-CCCC--CCCHHHHhcCcccccccCC
Q 006593 231 KGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 231 ~~LI~kcL~-dP~~--RpSa~ELL~Hpff~~~~~~ 262 (639)
++||.+||. +|.+ |++++++++||||+...+.
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 999999998 6776 9999999999999876554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=358.26 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=208.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+++.||+|+++.... ........+..|+.++.++ +||||+++++++... ..+++||
T Consensus 2 ~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ 75 (329)
T cd05618 2 VIGRGSYA---KVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVI 75 (329)
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEE
Confidence 58999999 899999999999999999986543 2335566788999999887 899999999988765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~ 157 (639)
||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..... ..
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCc
Confidence 99999999999998889999999999999999999999999 99999999999997 557999999999875322 22
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC--------CCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+.+.+.... ..++...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~ 230 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSV 230 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCH
Confidence 345689999999998864 5899999999999999999999999521 11222344444332 235566788
Q ss_pred HHHHHHHHhcC-CCCCCCC------HHHHhcCcccccccC
Q 006593 229 QIKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQ 261 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpS------a~ELL~Hpff~~~~~ 261 (639)
.+++||.+||+ +|.+||+ +.++++||||+...+
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999999999 8999998 589999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.50 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=207.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEV-HLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei-~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..++..||+|++........ .....+..|. .+++.++||||+++++++... ..+|+||
T Consensus 2 ~lg~G~fg---~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--~~~~lv~ 75 (325)
T cd05602 2 VIGKGSFG---KVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVL 75 (325)
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC--CeEEEEE
Confidence 48999998 899999999999999999986543222 2233444444 457889999999999988665 4689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... ...
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCC
Confidence 99999999999998888999999999999999999999999 99999999999997 55799999999987543 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|||||++.+ .++.++|||||||++|+|++|..||.+ .+..+.+..+..... .+....++.++++|.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 229 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEG 229 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHH
Confidence 345689999999998864 589999999999999999999999986 456666666655422 3344567899999999
Q ss_pred hcC-CCCCCCCHH----HHhcCcccccccCCC
Q 006593 237 CLV-PASERLSAK----DLLKDPFLQVENQKE 263 (639)
Q Consensus 237 cL~-dP~~RpSa~----ELL~Hpff~~~~~~~ 263 (639)
||+ +|.+|+++. ++++|+||....+..
T Consensus 230 ~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 230 LLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred HcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 999 899999875 899999998766543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=379.92 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=218.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
|||..|-|.||.||+|..+.++...|-|++... +.++++.+.-||+||..|+||+||++|+.|+.+++ +||+.|
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk--LwiliE 109 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK--LWILIE 109 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc--eEEEEe
Confidence 577777777789999999999999999988754 56889999999999999999999999999888766 889999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CC
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~ 157 (639)
||.||-....+-. ...+.+..|..+|+|++.||.|||+++ |||||||+.|||++ -+|.|+|+|||.+..... ..
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccchhHHhh
Confidence 9999999887755 457999999999999999999999999 99999999999998 558999999999865432 23
Q ss_pred CccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHH
Q 006593 158 ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQI 230 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l 230 (639)
..+++|||+|||||++. ..|+.++||||||++|.||+.+++|.++ .++..++-+|....+| ..-+..++..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 56799999999999763 3599999999999999999999999988 4566555556554444 34567778899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCcccccccCCC
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~~ 263 (639)
++|+.+||. +|..||++.+||+|||++....+.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccCCcch
Confidence 999999999 899999999999999998665543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=348.76 Aligned_cols=245 Identities=19% Similarity=0.304 Sum_probs=198.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..++..||+|+++.... .....+.+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 9 lg~g~~~---~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 81 (287)
T cd07848 9 VGEGAYG---VVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRR--GKLYLVFEY 81 (287)
T ss_pred ecccCCE---EEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecC--CEEEEEEec
Confidence 6777777 899999999999999999986542 234556788999999999999999999988654 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~~ 158 (639)
+.++.+..+......+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||++...... ..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCcccccccccccc
Confidence 999888777666677999999999999999999999999 99999999999997 5579999999999765432 22
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH--cCC------------------
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SGI------------------ 217 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~--~g~------------------ 217 (639)
....||+.|+|||++.+ .++.++|||||||++|+|++|++||.............. ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 34578999999998764 589999999999999999999999986443332221110 000
Q ss_pred CCC---------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 218 KPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 218 ~p~---------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.+. ......++++++||.+||+ +|.+|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112346789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=349.59 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=206.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||++.+..+|..||+|.+...... .....+.+..|+.+|+.++||||+++++++... ..+++||||
T Consensus 1 lg~G~~g---~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFG---EVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK--TDLCLVMTI 74 (280)
T ss_pred CCCCCce---eEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC--CeEEEEEeC
Confidence 7899998 8999999999999999998865432 223456778999999999999999999987654 468999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++..+...
T Consensus 75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~ 151 (280)
T cd05608 75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQ 151 (280)
T ss_pred CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCC
Confidence 999999988743 356899999999999999999999999 99999999999997 5679999999998765432
Q ss_pred -CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH---HHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~---~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+...+... +...+...++.++
T Consensus 152 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 229 (280)
T cd05608 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASK 229 (280)
T ss_pred ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHH
Confidence 2234579999999998864 5889999999999999999999999753322 2222233222 2334455788999
Q ss_pred HHHHHhcC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 232 GFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 232 ~LI~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
+|+.+||+ +|.+|| +++++++||||+...+..
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 99999998 899999 899999999998765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=356.76 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=209.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..++..||+|+++..... .....+.+..|..++..+ +||||+++++++... ..+++||
T Consensus 2 ~lG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~ 75 (316)
T cd05592 2 VLGKGSFG---KVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK--EHLFFVM 75 (316)
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEE
Confidence 58999998 8999999999999999999865432 234455567777777755 899999999988654 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~ 157 (639)
||+.||+|.++++..+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCc
Confidence 99999999999998889999999999999999999999999 99999999999997 557999999999975432 23
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+++..+.... ..++...++++++||.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~ 229 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSK 229 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHH
Confidence 345689999999998864 589999999999999999999999987 45566666665543 23455678899999999
Q ss_pred hcC-CCCCCCCH-HHHhcCcccccccCC
Q 006593 237 CLV-PASERLSA-KDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa-~ELL~Hpff~~~~~~ 262 (639)
||. +|.+||++ .+++.||||....+.
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCCCHH
Confidence 999 89999986 589999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.36 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=207.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||+|++....... ......+..|.. +++.++||||+++++++... ..+|+||
T Consensus 2 ~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~--~~~~lv~ 75 (325)
T cd05604 2 VIGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT--EKLYFVL 75 (325)
T ss_pred ceeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC--CEEEEEE
Confidence 58999998 89999999999999999998654322 233445556655 57789999999999988665 4689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ +.|.+||+|||++.... ...
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCC
Confidence 99999999999998889999999999999999999999999 99999999999997 55799999999986532 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|||||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.. .+....+..+.++|.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPL--VLRPGASLTAWSILEE 229 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCc--cCCCCCCHHHHHHHHH
Confidence 345689999999998864 589999999999999999999999986 456666666665432 2333467889999999
Q ss_pred hcC-CCCCCCCH----HHHhcCcccccccC
Q 006593 237 CLV-PASERLSA----KDLLKDPFLQVENQ 261 (639)
Q Consensus 237 cL~-dP~~RpSa----~ELL~Hpff~~~~~ 261 (639)
||. +|.+||++ .++++||||....+
T Consensus 230 ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 230 LLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred HhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 998 89999876 69999999986554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.84 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=208.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||+|++....... ......+..|.. +++.++||||+++++++.+. ..+|+||
T Consensus 2 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~ 75 (321)
T cd05603 2 VIGKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA--EKLYFVL 75 (321)
T ss_pred eeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CEEEEEE
Confidence 58999998 89999999999999999998654322 233445555654 67889999999999988655 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~ 157 (639)
||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCc
Confidence 99999999999988888999999999999999999999999 99999999999997 557999999999875322 22
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+..+++..+.... ..++...+..+.++|.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~ 229 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKP--LQLPGGKTVAACDLLVG 229 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHH
Confidence 345679999999998864 589999999999999999999999987 45666666666543 34455667899999999
Q ss_pred hcC-CCCCCCCH----HHHhcCcccccccCC
Q 006593 237 CLV-PASERLSA----KDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa----~ELL~Hpff~~~~~~ 262 (639)
||+ +|.+||++ .++++||||....+.
T Consensus 230 ~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 230 LLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred HccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 999 89999875 599999999866553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=355.45 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=200.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC---ceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~---~~l~l 77 (639)
.||+|+|| .||+|.+..+|..||+|+++... .......++.+|+.+|+.++||||+++++++..... ..+|+
T Consensus 7 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 7 VIGKGSYG---VVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred EEeecCCe---EEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 36778877 89999999999999999987432 122345678899999999999999999998865432 35899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
|||||. ++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCcccccccccc
Confidence 999995 699999998888999999999999999999999999 99999999999997 5589999999999754321
Q ss_pred ----CCccccCCCCcCCccccc---ccCCccccccchhhhhhhhhhccCCCCCCCCHHHH--------------HHHHHc
Q 006593 157 ----TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--------------FKKVTS 215 (639)
Q Consensus 157 ----~~~~~~GTp~ymAPE~l~---~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i--------------~~~i~~ 215 (639)
......||+.|+|||++. ..++.++|||||||++|+|+||++||.+......+ ...+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 123457999999999875 36899999999999999999999999764322111 011100
Q ss_pred -----------CCCCCc---ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 216 -----------GIKPAS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 216 -----------g~~p~~---l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
...+.. .....++.+.+||.+||. +|.+||+++|+|+||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 001110 112346789999999999 9999999999999999975443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=364.80 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=217.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||.|.|| .||++.++.+|..+|+|.+.+..... ....+.+.+|+++|++|. |||||.++++|.+.. .+++||
T Consensus 42 ~lG~G~Fg---~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--~~~lvm 115 (382)
T KOG0032|consen 42 ELGRGQFG---VVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--SVYLVM 115 (382)
T ss_pred hhCCCCce---EEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC--eEEEEE
Confidence 36666666 89999999999999999999887643 235678999999999998 999999999997764 699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC---CCcEEEeecchhhhccC-
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAIAMQQ- 155 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~---~g~VKL~DFGlA~~l~~- 155 (639)
|+|.||.|.+.+.+. .+++..+..+++||+.|+.|||+.| |+||||||+|+|+... .+.+|++|||++.....
T Consensus 116 EL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 999999999999877 5999999999999999999999999 9999999999999643 25899999999987764
Q ss_pred CCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHH
Q 006593 156 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKG 232 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~ 232 (639)
......+|||.|+|||++. ..|+..+||||+|+++|.|++|..||.+ .+....+..+..+.. +.......+..+++
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~~~~~f~~~~w~~is~~akd 271 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILRGDFDFTSEPWDDISESAKD 271 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence 3456789999999999998 6899999999999999999999999987 455666667877754 33344455789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||.+||. ||.+|+||.++|+|||++...
T Consensus 272 ~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 272 FIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 9999999 999999999999999998653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.70 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=196.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| +||+|.+..+|..||+|+++.... ......+.+|+.+++.++||||+++++++.+. ..+++||||
T Consensus 13 lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 84 (303)
T cd07869 13 LGEGSYA---TVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTLVFEY 84 (303)
T ss_pred EEecCCE---EEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecC--CeEEEEEEC
Confidence 6777776 899999999999999999876542 22334577899999999999999999988665 469999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+. ++|.+++.++ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++...... ..
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccCCCccC
Confidence 96 6788877654 56899999999999999999999999 99999999999997 5579999999998654322 23
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCC---------------C
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK---------------P 219 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~---------------p 219 (639)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..+.......+.. +.. +
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 34678999999998753 4889999999999999999999999875555443333211 000 0
Q ss_pred Cccc-------------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 220 ASLA-------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 220 ~~l~-------------~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
..+. ...++.+++||.+||+ +|.+|||+.|+|.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0000 0123578999999999 89999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=356.77 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=212.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..++..||+|+++..... .......+..|+.+++.+ +||||+++++++... ..+|+||
T Consensus 2 ~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~ 75 (318)
T cd05570 2 VLGKGSFG---KVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVM 75 (318)
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEE
Confidence 58999998 8999999999999999999865432 234566788999999988 799999999988655 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.... ...
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCc
Confidence 99999999999998889999999999999999999999999 99999999999997 55799999999986432 222
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..... .++...++.+++||.+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 229 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKS 229 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHH
Confidence 345679999999998864 589999999999999999999999976 456666666665433 3445668899999999
Q ss_pred hcC-CCCCCCCH-----HHHhcCcccccccCC
Q 006593 237 CLV-PASERLSA-----KDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa-----~ELL~Hpff~~~~~~ 262 (639)
||. +|.+||++ .+++.||||+...+.
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999 89999999 999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.14 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=210.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||+|+++..... .....+.+..|..++..+ +||||+++++++.+. ..+|+||
T Consensus 2 ~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~ 75 (316)
T cd05620 2 VLGKGSFG---KVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVM 75 (316)
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEE
Confidence 58999998 8999999999999999999865322 123456677888888765 899999999988665 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... ...
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCc
Confidence 99999999999998888999999999999999999999999 99999999999997 45799999999986432 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...+++.+..+. ..++...++++++||.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ 229 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEK 229 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHH
Confidence 345789999999998864 589999999999999999999999976 45566666665543 23455678899999999
Q ss_pred hcC-CCCCCCCH-HHHhcCcccccccCC
Q 006593 237 CLV-PASERLSA-KDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa-~ELL~Hpff~~~~~~ 262 (639)
||. +|.+||++ .++++||||+...+.
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 998 89999997 589999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.56 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=217.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
|-..|.|..|+||+|....++..+|+|++.+..+. ....+.+++.|-+||+.++||.++.+|..|..+ +++|++|||
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~--~~~cl~mey 158 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASFETD--KYSCLVMEY 158 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhheeecc--ceeEEEEec
Confidence 44567788889999999999999999999987764 356778999999999999999999999998554 689999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC----
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---- 155 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~---- 155 (639)
|+||+|..+++++ +.+++..++.|+.+|+.||+|||-.| ||+|||||+||||. ++|+|.|.||.|+.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCCCee
Confidence 9999999999875 57999999999999999999999999 99999999999997 669999999988732100
Q ss_pred -----------------------------C-C------------------------CccccCCCCcCCcccccc-cCCcc
Q 006593 156 -----------------------------P-T------------------------ARSVIGTPEFMAPELYEE-EYNEL 180 (639)
Q Consensus 156 -----------------------------~-~------------------------~~~~~GTp~ymAPE~l~~-~ys~k 180 (639)
. . ..+++||-+|.|||++.+ +.+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 114679999999999985 58999
Q ss_pred ccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCC----HHHHhcCcc
Q 006593 181 VDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS----AKDLLKDPF 255 (639)
Q Consensus 181 sDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpS----a~ELL~Hpf 255 (639)
+|+|+|||++|||+.|..||.+..+.+.+...+.+...-+..+ ..+..+++||+++|+ ||.+|.. |.||.+|||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 9999999999999999999999666666655555543333322 446789999999999 8999998 999999999
Q ss_pred cccccCCC
Q 006593 256 LQVENQKE 263 (639)
Q Consensus 256 f~~~~~~~ 263 (639)
|+..+|.-
T Consensus 395 F~gVnWaL 402 (459)
T KOG0610|consen 395 FEGVNWAL 402 (459)
T ss_pred ccCCChhh
Confidence 99999973
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=362.51 Aligned_cols=250 Identities=20% Similarity=0.367 Sum_probs=206.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..++..||+|++...... .....+.+..|+.+++.++||||++++++|.++ ..+|+|||
T Consensus 50 ~lG~G~fg---~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~lv~E 123 (370)
T cd05621 50 VIGRGAFG---EVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD--KYLYMVME 123 (370)
T ss_pred EEEecCCe---EEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEEc
Confidence 36778877 8999999999999999999764432 223456688999999999999999999988665 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
|+.+|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.......
T Consensus 124 y~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 124 YMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecccCCcee
Confidence 99999999999765 5899999999999999999999999 99999999999997 56899999999997654322
Q ss_pred CccccCCCCcCCcccccc-----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccC--CCChHH
Q 006593 158 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--VNDPQI 230 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~--~~s~~l 230 (639)
....+||+.|||||++.. .++.++|||||||++|+|++|..||.. .+....+..+........++. ..+..+
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 278 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEISKHA 278 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence 245689999999998853 278899999999999999999999986 455566666665433222332 347889
Q ss_pred HHHHHHhcCC-C--CCCCCHHHHhcCcccccccC
Q 006593 231 KGFIEKCLVP-A--SERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 231 ~~LI~kcL~d-P--~~RpSa~ELL~Hpff~~~~~ 261 (639)
+++|.+||.+ + ..|+++.|+++||||+...+
T Consensus 279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 9999999984 3 34899999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=349.40 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=195.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| +||+|.+..++..||+|+++.... ......+.+|+.++++++||||+++++++... ..+++||||
T Consensus 13 lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 84 (288)
T cd07871 13 LGEGTYA---TVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTE--RCLTLVFEY 84 (288)
T ss_pred EecCCCE---EEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEEEEeC
Confidence 6777777 899999999999999999976532 22345678999999999999999999988654 468999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+ +|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... ..
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccCCCccc
Confidence 975 9999987654 5799999999999999999999999 99999999999997 5579999999998654322 23
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CC----------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK---------------- 218 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~---------------- 218 (639)
....||+.|+|||++.+ .++.++|||||||++|+|+||.+||.+.. ..+....+... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST-VKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 34578999999998753 58999999999999999999999998643 33322222110 00
Q ss_pred ---C-------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 219 ---P-------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 219 ---p-------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+ .......++++++||.+||. +|.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0 00112346789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=356.90 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=207.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCCceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
||+|+|| +||+|.+..+|..||+|++....... .........|..++..+ +||||++++++|... ..+|+|
T Consensus 1 lG~G~~g---~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv 74 (330)
T cd05586 1 IGKGTFG---QVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLV 74 (330)
T ss_pred CCCCCce---EEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEE
Confidence 7899998 89999999999999999997654322 23344566677777766 699999999988665 469999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CC
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QP 156 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~ 156 (639)
|||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.... ..
T Consensus 75 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 75 TDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred EcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCC
Confidence 999999999999998889999999999999999999999999 99999999999997 55799999999986532 22
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.....+||+.|||||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+.... .....++++++||
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li 229 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFV 229 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHH
Confidence 3345789999999998753 489999999999999999999999976 45667777776654322 1234578999999
Q ss_pred HHhcC-CCCCCC----CHHHHhcCcccccccC
Q 006593 235 EKCLV-PASERL----SAKDLLKDPFLQVENQ 261 (639)
Q Consensus 235 ~kcL~-dP~~Rp----Sa~ELL~Hpff~~~~~ 261 (639)
.+||. +|.+|| ++.++++||||....+
T Consensus 230 ~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 230 KGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred HHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 99999 899998 7999999999986543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=357.17 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=207.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCc---eEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK---TVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~---~l~l 77 (639)
++|.|+|| .||+|...++++.||||.+..+.... .+|+++|+.++|||||++..+|...... ++++
T Consensus 31 liG~GsFg---~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 31 LIGSGSFG---VVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEeecccc---eEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 47888888 89999999999999999998766433 4799999999999999999988765444 6779
Q ss_pred EEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 78 ITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
||||++. +|.++++. +..++.-.++-+.+||++||.|||++| |+||||||+|+|+|.+.|.+||||||.|+.+
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 9999974 99998884 577999999999999999999999999 9999999999999988899999999999887
Q ss_pred cC-CCCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-C-------------
Q 006593 154 QQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------- 216 (639)
Q Consensus 154 ~~-~~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g------------- 216 (639)
.. ....++..|..|+|||++-+ .|+.+.||||.||++.||+-|++-|.+.+...|+...+.- |
T Consensus 177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 53 33456788999999997754 6999999999999999999999999986655555432210 0
Q ss_pred --------CCC----CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 217 --------IKP----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 217 --------~~p----~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
..+ ..+....++++.+|+.++|+ +|.+|.++.|+|.||||+....
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 001 11344568999999999999 9999999999999999985443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=355.09 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=210.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp-NIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|+|| .||+|.+..++..||+|+++..... .....+.+..|+.++..+.|+ +|+++++++... ..+|+||
T Consensus 7 ~lg~G~~g---~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (324)
T cd05587 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFVM 80 (324)
T ss_pred EEeeccCe---EEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEEEE
Confidence 37888887 8999999999999999999865432 234567788999999999765 588898887655 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCCc
Confidence 99999999999998888999999999999999999999999 99999999999997 45799999999986432 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.. .++.++|||||||++|+|+||..||.+ .+..+.+..+..... .++...++++++||.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 234 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICKG 234 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 345679999999998864 589999999999999999999999986 456667777765433 3455678899999999
Q ss_pred hcC-CCCCCCCH-----HHHhcCcccccccCC
Q 006593 237 CLV-PASERLSA-----KDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa-----~ELL~Hpff~~~~~~ 262 (639)
||. +|.+|+++ .++++||||....+.
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999 89999976 899999999876654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=363.05 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=208.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC----------hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL----------PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~----------~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~ 71 (639)
||+|.|| .|.+|++..+|+.||||++.+...... ....+++++||.+|++|.|||||+++.+.-+..
T Consensus 105 iG~G~yG---kVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~ 181 (576)
T KOG0585|consen 105 IGSGQYG---KVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE 181 (576)
T ss_pred hcCCccc---eEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence 6777777 899999999999999999987554311 123578999999999999999999999876666
Q ss_pred CceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 72 ~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
.+.+|||+|||..|.+...-.....+++.+++.|++.++.||+|||.+| ||||||||.|+|+++ .|+|||+|||.+.
T Consensus 182 s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~-~g~VKIsDFGVs~ 258 (576)
T KOG0585|consen 182 SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSS-DGTVKISDFGVSN 258 (576)
T ss_pred cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcC-CCcEEeeccceee
Confidence 7789999999999998653322223899999999999999999999999 999999999999984 4899999999986
Q ss_pred hccCCC-------CccccCCCCcCCcccccc---c--CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC
Q 006593 152 AMQQPT-------ARSVIGTPEFMAPELYEE---E--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 219 (639)
Q Consensus 152 ~l~~~~-------~~~~~GTp~ymAPE~l~~---~--ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p 219 (639)
...... .....|||.|||||+... . -+.+.||||+|++||.|+.|++||.+ .....++.+|......
T Consensus 259 ~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~pL~ 337 (576)
T KOG0585|consen 259 EFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDPLE 337 (576)
T ss_pred ecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCccc
Confidence 542211 123579999999998764 2 36789999999999999999999987 5567788888875443
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
..........+++||.++|. ||.+|.+..++..|||.....
T Consensus 338 fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 338 FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 33333457899999999999 899999999999999997553
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=355.31 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=206.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL---KSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iL---k~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+..+|..||+|+++..... .....+.+.+|+.++ +.++||||+++++++... ..+|+
T Consensus 6 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--~~~~l 79 (324)
T cd05589 6 VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE--DHVCF 79 (324)
T ss_pred EEeecCCE---EEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC--CEEEE
Confidence 37788777 8999999999999999999865432 234556777777765 566899999999988655 46999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--C
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--Q 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~ 155 (639)
||||+.+|+|..++.. +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCCCC
Confidence 9999999999988864 56999999999999999999999999 99999999999997 55799999999986532 2
Q ss_pred CCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 156 PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
......+||+.|||||++.+ .++.++|||||||++|+|++|..||.+ .+..++...+..+.. ..+...++.+.+||
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 232 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAISIM 232 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHH
Confidence 23345689999999998864 589999999999999999999999986 455666666665433 24455688999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCcccccccCC
Q 006593 235 EKCLV-PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 235 ~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
.+||. +|.+|| ++.++++||||+...+.
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 99999 899999 79999999999875543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.05 Aligned_cols=246 Identities=25% Similarity=0.454 Sum_probs=204.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|.+.... .......+.+|+++|++++||||+++++++... ..+++||||
T Consensus 13 lg~g~~g---~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 84 (333)
T cd06650 13 LGAGNGG---VVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEH 84 (333)
T ss_pred ccCCCCE---EEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC--CEEEEEEec
Confidence 6777777 89999999999999999987642 234567789999999999999999999998775 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||+. + |+||||||+|||++ +.|.+||+|||++..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhhhhcccc
Confidence 99999999999888899999999999999999999974 6 99999999999997 55799999999997665554556
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHH-----------------------------
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF----------------------------- 210 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~----------------------------- 210 (639)
..||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ..++.
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence 689999999998864 58899999999999999999999996422 22211
Q ss_pred ---------------HHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 211 ---------------KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 211 ---------------~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
..+.....+.......+.++++||.+||+ +|.+|||+.|||.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11112212222222356789999999999 99999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.40 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=210.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..++..||+|+++..... .....+....|..+++.+ +||||+++++++... ..+++||
T Consensus 2 ~lG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ 75 (316)
T cd05619 2 MLGKGSFG---KVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVM 75 (316)
T ss_pred eeeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEE
Confidence 48999998 8999999999999999999865321 123445677788888765 999999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.... ...
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCc
Confidence 99999999999998888999999999999999999999999 99999999999997 45799999999986432 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+.. .++...+.++++||.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 229 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNP--CYPRWLTREAKDILVK 229 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHH
Confidence 345679999999998864 589999999999999999999999986 456666666654432 2445578899999999
Q ss_pred hcC-CCCCCCCHH-HHhcCcccccccCC
Q 006593 237 CLV-PASERLSAK-DLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa~-ELL~Hpff~~~~~~ 262 (639)
||. +|.+||++. +++.||||+...+.
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 999 899999996 99999999876553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=354.05 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=211.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..++..||+|+++..... .....+.+..|..++..+ +|++|+++++++... ..+|+||
T Consensus 7 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (323)
T cd05616 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYFVM 80 (323)
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEEEE
Confidence 47888888 8999999999999999999865432 234455677888888887 689999999988655 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCCCc
Confidence 99999999999998889999999999999999999999999 99999999999997 55799999999986543 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.. .++.++|||||||++|||+||..||.+ .+...++..+..... .++...++++++||.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 234 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKG 234 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHHHH
Confidence 345689999999998864 589999999999999999999999987 456667777766433 3455678899999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCcccccccCCC
Q 006593 237 CLV-PASERLS-----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 237 cL~-dP~~RpS-----a~ELL~Hpff~~~~~~~ 263 (639)
||+ +|.+|++ ..++++||||+..++..
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~ 267 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999 8999998 48999999998766544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=354.38 Aligned_cols=250 Identities=29% Similarity=0.426 Sum_probs=208.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEe---CCCceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD---DKKKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~---~~~~~l~lV 78 (639)
||+|+|| .|..|.++.+|..||||.+... .+..-..++..+|+.+|+.++|+||+.+++.+.. +.-+-+|+|
T Consensus 30 iG~GAyG---vVcsA~~~~t~~~VAIKKi~~~--F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV 104 (359)
T KOG0660|consen 30 IGRGAYG---VVCSAKDKRTGEKVAIKKILNP--FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLV 104 (359)
T ss_pred ccCccee---eEEEEEEcCCCCEeehhhhhhh--hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEe
Confidence 7888888 7888999999999999987622 2356778999999999999999999999998866 223569999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc----
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ---- 154 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~---- 154 (639)
+|+|. -+|.+.++..+.+++..++.++.|||.||.|+|+.+ |+||||||.|+|++.+ ..+||||||+|+...
T Consensus 105 ~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 105 FELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLARYLDKFFE 180 (359)
T ss_pred hhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEeccccceeeccccCc
Confidence 99994 599999999888999999999999999999999999 9999999999999855 689999999998874
Q ss_pred CCCCccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHH--------------HHH----
Q 006593 155 QPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--------------KVT---- 214 (639)
Q Consensus 155 ~~~~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~--------------~i~---- 214 (639)
......++-|.+|+|||++. ..|+.++||||+|||+.||++|++-|.+.....|+.. .+.
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 34446678899999999775 4699999999999999999999999987555444421 111
Q ss_pred -----c-CCCC----CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 215 -----S-GIKP----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 215 -----~-g~~p----~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+ +..| ..+....+|.+.+|+++||. ||.+|+|++|.|.||||....
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 0 1111 12223568899999999999 999999999999999997543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=353.43 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=210.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..++..||+|+++.... ......+.+..|+.++.++ +||||+++++++... ..+|+||
T Consensus 2 ~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~ 75 (327)
T cd05617 2 VIGRGSYA---KVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVI 75 (327)
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEE
Confidence 58999998 899999999999999999986543 2234567789999999998 699999999988665 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.+|+|..++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.... ...
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCc
Confidence 99999999999998889999999999999999999999999 99999999999998 55799999999987532 223
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCC------CCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~------~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....+++.+... +..++...++.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~ 230 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKA 230 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHH
Confidence 34578999999999886 45899999999999999999999999532 1223344444443 334566678899
Q ss_pred HHHHHHhcC-CCCCCCC------HHHHhcCcccccccCC
Q 006593 231 KGFIEKCLV-PASERLS------AKDLLKDPFLQVENQK 262 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpS------a~ELL~Hpff~~~~~~ 262 (639)
+++|.+||. +|.+|++ ..+++.||||....+.
T Consensus 231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 999999999 8999998 5799999999876654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=358.39 Aligned_cols=249 Identities=19% Similarity=0.343 Sum_probs=207.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+. ..+|+||||
T Consensus 51 lG~G~fg---~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~--~~~~lv~Ey 124 (371)
T cd05622 51 IGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMVMEY 124 (371)
T ss_pred EeecCCe---EEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEEEEEcC
Confidence 6777777 8999999999999999999764432 223456688999999999999999999988654 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~~ 158 (639)
++||+|.++++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+... ..
T Consensus 125 ~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~~~~~~ 200 (371)
T cd05622 125 MPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRC 200 (371)
T ss_pred CCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcCCcccc
Confidence 9999999999764 5899999999999999999999999 99999999999997 5589999999999765432 22
Q ss_pred ccccCCCCcCCcccccc-----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--CCCChHHH
Q 006593 159 RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIK 231 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~l~ 231 (639)
...+||+.|||||++.. .++.++|||||||++|||++|..||.. .+....+..+........++ ...++.++
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCCCHHHH
Confidence 35689999999998853 278999999999999999999999986 56667777777654332233 34678999
Q ss_pred HHHHHhcCCCC---CCCCHHHHhcCcccccccC
Q 006593 232 GFIEKCLVPAS---ERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 232 ~LI~kcL~dP~---~RpSa~ELL~Hpff~~~~~ 261 (639)
+||.+||.+|. .|++++++++||||+...+
T Consensus 280 ~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 280 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 99999998543 3789999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.02 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=215.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||-|+|..+.+.||||.+..... ++.+..+.+.+|+..|++|+|||+|.|.++|..+. +.|+||||
T Consensus 34 IGHGSFG---AVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--TaWLVMEY 107 (948)
T KOG0577|consen 34 IGHGSFG---AVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--TAWLVMEY 107 (948)
T ss_pred hcCCccc---eeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccc--hHHHHHHH
Confidence 7888888 799999999999999999987764 45677788999999999999999999999998775 48899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|- |+..|++.-+ +++.+-.|..|+.+.+.||.|||+++ .||||||..|||++ +.|.|||+|||.|.... .+.+
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~--PAns 181 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSASIMA--PANS 181 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccccchhhcC--chhc
Confidence 95 6999998765 57999999999999999999999999 99999999999998 56899999999997654 3578
Q ss_pred ccCCCCcCCcccc----cccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 161 VIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 161 ~~GTp~ymAPE~l----~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
++|||+|||||++ ++.|+-++|||||||+..||+-.++|+... |.......|..+..|......++..++.||..
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 9999999999976 367999999999999999999999998764 44444445666666665566678899999999
Q ss_pred hcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
||+ -|.+|||+++||+|+|.......
T Consensus 261 CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 261 CLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred HHhhCcccCCcHHHHhhcchhccCCCc
Confidence 999 59999999999999999765543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=343.97 Aligned_cols=249 Identities=25% Similarity=0.344 Sum_probs=208.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
|+.|.|| .||+|+|+.|++.||+|+++.+.- .....-.-.+||.+|.+++|||||.+-.+.+..+-+.+||||||
T Consensus 84 I~EGtyG---iVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 84 IEEGTYG---VVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred cccCcce---eEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 4556666 899999999999999999997752 22333346899999999999999999999888777789999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--C
Q 006593 82 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~ 158 (639)
|+. +|+.++...+ +|...+++.++.|+|.||.|||.+. |+|||||++|+|++ +.|.+||+|||+|+....+. .
T Consensus 159 ~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 159 VEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCcccC
Confidence 986 9999998876 8999999999999999999999999 99999999999998 77999999999999887652 3
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCCC---------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPA--------------- 220 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~--------------- 220 (639)
...+-|.+|+|||++-+ .|++++|+||+|||+.||+++++-|.+.....|+.+.+.. |.+..
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 34567999999997754 5999999999999999999999999987777776654421 11100
Q ss_pred ------------cccCC-CChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 221 ------------SLAKV-NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 221 ------------~l~~~-~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.+... .+....+|+..+|. ||.+|.||.|.|+|.||...
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 01111 23567899999999 99999999999999999754
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=369.76 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=197.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD------KKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~------~~~~ 74 (639)
+||+|+|| +||+|.+..+|..||+|++.... ....+|+.+|+.++|||||+++++|... ...+
T Consensus 73 ~LG~G~fg---~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 73 IIGNGSFG---VVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred EEEeCCCE---EEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 37888888 89999999999999999886432 1245799999999999999999987542 2236
Q ss_pred EEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 75 VNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lk----k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
+++||||+++ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||+|
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccc
Confidence 7899999975 7777665 3467999999999999999999999999 9999999999999866568999999999
Q ss_pred hhccCC-CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCC--------
Q 006593 151 IAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK-------- 218 (639)
Q Consensus 151 ~~l~~~-~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~-------- 218 (639)
+.+... ......||+.|||||++.+ .|+.++|||||||++|||++|.+||.+.....++.+.+.. +..
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 866432 2345678999999998753 5899999999999999999999999875554444333211 000
Q ss_pred ---------C--------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 219 ---------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 219 ---------p--------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+ ..++...++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0 01223356789999999999 999999999999999997543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=334.88 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=202.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|.|| .||+|.|.+||+.||||.++..+.. ........+||+.|+.++|+||+.+.++|-..+ .+.+|+||
T Consensus 10 lGEG~~g---vVyka~d~~t~~~VAIKKIkl~~~k--dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~--~l~lVfEf 82 (318)
T KOG0659|consen 10 LGEGTYG---VVYKARDTETGKRVAIKKIKLGNAK--DGINRTALREIKLLQELKHPNIIELIDVFPHKS--NLSLVFEF 82 (318)
T ss_pred hcCcceE---EEEEEEecCCCcEEEEEEeeccccc--cCccHHHHHHHHHHHHccCcchhhhhhhccCCC--ceEEEEEe
Confidence 4555555 9999999999999999999988653 234456889999999999999999999986554 59999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc-
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR- 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~- 159 (639)
++. +|...++.. ..++...++.|+.|+++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+....+...
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCCCCccc
Confidence 975 999988754 46899999999999999999999999 99999999999997 5689999999999987654322
Q ss_pred -cccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CC-CCCc-------------
Q 006593 160 -SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI-KPAS------------- 221 (639)
Q Consensus 160 -~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~-~p~~------------- 221 (639)
..+-|.+|+|||++- ..|+..+|+||.||++.||+-|.+-|.+.++.+|+...+.. |. .+..
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 236799999999764 46999999999999999999999888887777776543321 10 0111
Q ss_pred ----------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 222 ----------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 222 ----------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
+....+.++.+|+.+||. +|.+|+++.|+|+|+||..
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 112235678999999999 9999999999999999985
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=337.66 Aligned_cols=246 Identities=22% Similarity=0.402 Sum_probs=220.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|-|| .||+|+.+.++-.||+|++.++.+.+. ...+.+.+|+++-..|+||||+++|++|.+.. ++|+++|
T Consensus 29 ~LgkgkFG---~vYlarekks~~IvalKVlfKsqi~~~-~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~--riyLilE 102 (281)
T KOG0580|consen 29 PLGKGKFG---NVYLAREKKSLFIVALKVLFKSQILKT-QVEHQLRREIEIQSHLRHPNILRLYGYFHDSK--RIYLILE 102 (281)
T ss_pred cccCCccc---cEeEeeeccCCcEEEEeeeeHHHHHHh-cchhhhhheeEeecccCCccHHhhhhheeccc--eeEEEEE
Confidence 47888888 899999999999999999998876543 44577999999999999999999999998774 5999999
Q ss_pred cCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRK--KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lk--k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|.+.|+|...|+ +.+++++...+.+++|++.||.|+|..+ ||||||||+|+|+. ..|.+||+|||-+.......+
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~kR 179 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSNKR 179 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCCCc
Confidence 999999999999 6778999999999999999999999999 99999999999996 668999999999977766677
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
.+.|||..|.|||+.++ .++..+|+|++|++.||++.|.+||... +..+.+++|..-. ..++...+.+++++|.+|
T Consensus 180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~-~~~etYkrI~k~~--~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ-SHSETYKRIRKVD--LKFPSTISGGAADLISRL 256 (281)
T ss_pred eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh-hhHHHHHHHHHcc--ccCCcccChhHHHHHHHH
Confidence 88999999999999986 5999999999999999999999999863 4778888887642 234567788999999999
Q ss_pred cC-CCCCCCCHHHHhcCccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~ 258 (639)
|. +|.+|.+..|++.|||+..
T Consensus 257 l~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hccCccccccHHHHhhhHHHHh
Confidence 99 8999999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=341.22 Aligned_cols=241 Identities=22% Similarity=0.278 Sum_probs=204.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD--DKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~--~~~~~l~lV 78 (639)
+||+||+| .||+|.. +|..||+|.++.... ......+.+.+|+.+|++++||||+++++++.+ ....++++|
T Consensus 27 ~i~~g~~~---~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 27 LIKENDQN---SIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred EEeeCCce---EEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 36778887 7999987 689999999876542 223345778899999999999999999999877 445678999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
|||+.+|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+|||++ ++|.+||+|||++..+....
T Consensus 101 ~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 101 LEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred EEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhcccc
Confidence 99999999999999888899999999999999999999985 7 88999999999998 55899999999997654332
Q ss_pred CccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..+..+.....++...++.+++||
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 255 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCCCCCCcCcHHHHHHH
Confidence 34578999999998864 689999999999999999999999987 4566677776555444445556788999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||+ +|.+|||+.|++.
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 99999 9999999999986
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=332.05 Aligned_cols=247 Identities=31% Similarity=0.536 Sum_probs=207.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||.|++| .||+|.+..+|..||+|.+....... .......+.+|+.++++++||||+++++++... ..+++|+
T Consensus 9 ~lg~g~~~---~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 83 (263)
T cd06625 9 LLGQGAFG---RVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD--ETLSIFM 83 (263)
T ss_pred eecCCCce---EEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC--CeEEEEE
Confidence 47788887 79999999999999999987654321 123456789999999999999999999998765 4799999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
||+++++|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||+|+||+++ .++.++|+|||++........
T Consensus 84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceeccccccc
Confidence 99999999999998888999999999999999999999999 99999999999997 557999999999865532211
Q ss_pred ----ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 159 ----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 159 ----~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....|++.|+|||++.+ .++.++||||||+++|+|++|+.||......... ..+........++...+..+.+|
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 239 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQPTNPQLPSHVSPDARNF 239 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-HHHhccCCCCCCCccCCHHHHHH
Confidence 34568899999998864 4889999999999999999999999875443333 34444434445666778899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
|.+||. +|.+||++.++|+||||
T Consensus 240 i~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 240 LRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.30 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=210.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|..||+|++...... .....+.+..|..+++.+. |++|+++++++... ..+|+||
T Consensus 7 ~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~ 80 (323)
T cd05615 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYFVM 80 (323)
T ss_pred EEEecCCe---EEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEEEE
Confidence 47888888 8999999999999999999865432 2345567888999999885 57788899887665 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~ 157 (639)
||+++|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCcc
Confidence 99999999999998889999999999999999999999999 99999999999998 557999999999875432 22
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.. .++.++|||||||++|+|++|..||.+ .+...+++.+..... ..+...++++++|+.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 234 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICKG 234 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHH
Confidence 345679999999998864 589999999999999999999999987 456667777665433 3455667899999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCcccccccCCC
Q 006593 237 CLV-PASERLS-----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 237 cL~-dP~~RpS-----a~ELL~Hpff~~~~~~~ 263 (639)
||. +|.+|++ ..++++||||+...+..
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~ 267 (323)
T cd05615 235 LMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK 267 (323)
T ss_pred HcccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence 999 8999997 58999999998766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.24 Aligned_cols=250 Identities=22% Similarity=0.396 Sum_probs=211.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP----GDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~----~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l 75 (639)
+||.|+.+ +|.++.++.+|.++|+|++....-..+. ...+.-.+|+.+|+++ .||||+++.++|... ..+
T Consensus 24 ilgrgvss---~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~--sF~ 98 (411)
T KOG0599|consen 24 ILGRGVSS---VVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD--AFV 98 (411)
T ss_pred Hhcccchh---hhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc--chh
Confidence 35555554 7899999999999999998765432222 3345567899999999 799999999988544 578
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 76 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
++|+|+|+-|.|+||+...-.++++..+++++|++.|++|||..+ |+||||||+|||++++ -.+||.|||+|+.+..
T Consensus 99 FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-MNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-cceEEeccceeeccCC
Confidence 999999999999999999889999999999999999999999999 9999999999999865 4899999999988864
Q ss_pred C-CCccccCCCCcCCccccc-------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--CC
Q 006593 156 P-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KV 225 (639)
Q Consensus 156 ~-~~~~~~GTp~ymAPE~l~-------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~ 225 (639)
. ..+..||||.|.|||.+. .+|+..+|+|++|++||.|+.|.+||-. ...-.+...|..|......+ ..
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH-RkQmlMLR~ImeGkyqF~speWad 254 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH-RKQMLMLRMIMEGKYQFRSPEWAD 254 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH-HHHHHHHHHHHhcccccCCcchhh
Confidence 4 456789999999999775 2589999999999999999999999964 22344567788887654433 34
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 226 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 226 ~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.+...++||.+||+ ||.+|.|++|+|.||||...
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 56789999999999 99999999999999999643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.69 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=205.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|++...... .......+.+|+.+++.++||||+++++.+... ..+++|||
T Consensus 7 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 80 (285)
T cd05605 7 VLGKGGFG---EVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVLT 80 (285)
T ss_pred EEecCCCe---EEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC--CeEEEEEe
Confidence 47888888 8999999999999999998765432 123345678899999999999999999988654 46999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~ 157 (639)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ +.+.++|+|||++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCCc
Confidence 99999999888653 46899999999999999999999999 99999999999997 5579999999998765432 2
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHH---HHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~---~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.....|++.|+|||++. ..++.++||||||+++|+|++|..||.+..... .+...+... +...+...++.+++|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 235 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAARSI 235 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHHHH
Confidence 23457899999999886 458899999999999999999999998643221 222222221 223445567899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 234 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 234 I~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
|.+||. +|.+|| ++++|++||||....++.
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 999999 899999 999999999998766553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=351.30 Aligned_cols=244 Identities=26% Similarity=0.431 Sum_probs=197.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|+.||+|++.... .......+.+|+++|+.++|+||++++++|... ..+++|||
T Consensus 81 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 152 (353)
T PLN00034 81 RIGSGAGG---TVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN--GEIQVLLE 152 (353)
T ss_pred hccCCCCe---EEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC--CeEEEEEe
Confidence 37788877 89999999999999999986442 234567789999999999999999999988654 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+.+|+|... ...++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++..+... ..
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceecccccccc
Confidence 9999998653 34678889999999999999999999 99999999999998 5579999999999765432 22
Q ss_pred ccccCCCCcCCcccccc-----c-CCccccccchhhhhhhhhhccCCCCCCC--CHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 159 RSVIGTPEFMAPELYEE-----E-YNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-----~-ys~ksDIwSlGiil~ELltG~~Pf~~~~--~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
....||+.|+|||++.. . ++.++|||||||++|||++|+.||.... ........+.... +...+...++++
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 304 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASREF 304 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHHH
Confidence 45679999999998742 2 3568999999999999999999997422 1222233332222 233445667899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
++||.+||. +|.+||++.|+|+||||....
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999 899999999999999998653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.52 Aligned_cols=252 Identities=16% Similarity=0.332 Sum_probs=205.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..++..||+|++...... .....+.+..|+.+++.++|+||+++++++.++ ..+|+|||
T Consensus 8 ~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 81 (331)
T cd05597 8 VIGRGAFG---EVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDE--NNLYLVMD 81 (331)
T ss_pred EEEecCCe---EEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC--CeEEEEEe
Confidence 37888888 8999999999999999999864432 234556788999999999999999999988655 46999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|+.||+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCCCCc
Confidence 9999999999986 457999999999999999999999999 99999999999997 55799999999986554322
Q ss_pred -CccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc---cCCCC
Q 006593 158 -ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL---AKVND 227 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l---~~~~s 227 (639)
....+||+.|||||++. ..++.++|||||||++|+|++|..||.+ .+..+.+..+........+ ....+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~ 237 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVTDVS 237 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccCCCC
Confidence 12346999999999885 3478899999999999999999999986 3455566666543221111 22357
Q ss_pred hHHHHHHHHhcCC---CCCCCCHHHHhcCcccccccCC
Q 006593 228 PQIKGFIEKCLVP---ASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 228 ~~l~~LI~kcL~d---P~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+.+++||.+||.. +..|+++.++|+||||....+.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 8999999999973 3348899999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=338.27 Aligned_cols=250 Identities=21% Similarity=0.340 Sum_probs=202.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|||| .||++.+..+|..||+|.+....... ......+..|++++++++||||+++++++... ..+++||||
T Consensus 1 lg~G~~g---~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~--~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFG---EVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESK--THLCLVMSL 74 (277)
T ss_pred CCCCCce---EEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecC--CeEEEEEec
Confidence 7999998 89999999999999999997644322 22334566799999999999999999988654 569999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.||+|.+++...+ .+++..+..++.||+.||.|||+.| |+||||||+||+++ +.+.++|+|||++...... ..
T Consensus 75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCcee
Confidence 99999999886543 5889999999999999999999999 99999999999997 5579999999998765432 22
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCC---HHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....||+.|+|||++.. .++.++|||||||++|+|++|..||..... ..++.........+. .....++++++||
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li 230 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDIC 230 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHH
Confidence 34578999999998764 589999999999999999999999975332 223333333322221 1234678999999
Q ss_pred HHhcC-CCCCCCCH----HHHhcCcccccccC
Q 006593 235 EKCLV-PASERLSA----KDLLKDPFLQVENQ 261 (639)
Q Consensus 235 ~kcL~-dP~~RpSa----~ELL~Hpff~~~~~ 261 (639)
.+||+ +|.+||++ .++++||||+..++
T Consensus 231 ~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred HHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 99999 89999999 77889999986554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=337.64 Aligned_cols=245 Identities=30% Similarity=0.427 Sum_probs=192.9
Q ss_pred cccccccCcEEEEEEEecC-CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceEEEEEEe---CCCce
Q 006593 2 VLTGLYMTPFSSYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVD---DKKKT 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~-tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~~~~---~~~~~ 74 (639)
||+|+|| +||+|.+.. .|..||+|.++..... ......+.+|+.+++.+ +||||+++++++.. .....
T Consensus 9 lg~G~~g---~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 9 IGEGAYG---KVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred eccCCCe---EEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 7788877 899999854 4788999998865432 22334466788777766 69999999998753 22346
Q ss_pred EEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 75 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 84 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARI 159 (290)
T ss_pred EEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccccceEe
Confidence 899999996 6999999764 45899999999999999999999999 99999999999997 457999999999976
Q ss_pred ccCC-CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC---CC-------
Q 006593 153 MQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PA------- 220 (639)
Q Consensus 153 l~~~-~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---p~------- 220 (639)
.... ......||+.|+|||++. ..++.++|||||||++|||++|.+||.+.... +.+..+..... +.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhchhhhc
Confidence 5432 234567899999999875 46899999999999999999999999874433 33333322110 00
Q ss_pred ---------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 221 ---------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 221 ---------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.+....++.+++||.+||+ +|.+|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112346788999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=345.06 Aligned_cols=249 Identities=21% Similarity=0.384 Sum_probs=199.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|++| +++||++.+..+|+.||+|+++.... .....+.+..|+++++.++||||++++++|..++ .+++|||
T Consensus 5 ~ig~G~~~-~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e 79 (327)
T cd08227 5 VIGRGFED-LMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTS 79 (327)
T ss_pred hccccccc-eEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC--EEEEEEe
Confidence 58888543 66899999999999999999876543 2345567889999999999999999999997764 5899999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|+++|+|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.++++||+.+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccccc
Confidence 99999999999764 45899999999999999999999999 99999999999998 4579999999865433211
Q ss_pred -------CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC------
Q 006593 157 -------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA------ 220 (639)
Q Consensus 157 -------~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~------ 220 (639)
......++..|+|||++.. .|+.++|||||||++|+|++|..||............ ..+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-LNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-hcCCccccccccc
Confidence 1122356788999998863 4899999999999999999999999764333222222 2111110
Q ss_pred --------------------------------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 221 --------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 221 --------------------------------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
......++.+++||.+||+ ||.+|||+.|||+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 0112236789999999999 9999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.57 Aligned_cols=244 Identities=21% Similarity=0.438 Sum_probs=215.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|.|| .|.+|.+...|+.||||.++++.+. .+.++-.+.+||+||..|+||||+.+|.+|...+ .+.|||||
T Consensus 61 LGkGTYG---KVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVFENkd--KIvivMEY 134 (668)
T KOG0611|consen 61 LGKGTYG---KVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD--KIVIVMEY 134 (668)
T ss_pred hcCCccc---ceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc--eEEEEEEe
Confidence 6777777 7888999999999999999988864 5677888999999999999999999999986554 59999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-CCCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~-~~~~~ 160 (639)
..+|.|.+|+...+.+++..++.+++||+.|+.|||.++ ++|||||.+|||++. ++++||+||||+-.+.. ....+
T Consensus 135 aS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~-N~NiKIADFGLSNly~~~kfLqT 211 (668)
T KOG0611|consen 135 ASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQ-NNNIKIADFGLSNLYADKKFLQT 211 (668)
T ss_pred cCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecC-CCCeeeeccchhhhhccccHHHH
Confidence 999999999999999999999999999999999999999 999999999999985 47999999999987654 45678
Q ss_pred ccCCCCcCCccccccc-C-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~~-y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
+||+|-|.+||++.+. | ++.+|.||||++||.|+.|..||.+ .+-..+.+.|.+|..... ..+..+..||+.||
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYREP---ETPSDASGLIRWML 287 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccCC---CCCchHHHHHHHHH
Confidence 9999999999999864 5 6889999999999999999999998 456777888888755321 12346899999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~ 258 (639)
. +|.+|.|..++-.|=|+.-
T Consensus 288 mVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred hcCcccchhHHHHhhhheeec
Confidence 7 9999999999999999864
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.84 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=214.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++..||+|++...... .....+.+.+|+.+++.++||||+++++++.++ ..+++||||
T Consensus 1 lg~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFG---RVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK--KYIYMLMEY 74 (262)
T ss_pred CCCCCce---EEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC--CccEEEEec
Confidence 6888888 8999999999999999999865532 234557899999999999999999999988655 458999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ....
T Consensus 75 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 75 CLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCccccccc
Confidence 999999999998888999999999999999999999999 99999999999997 4579999999999766543 2334
Q ss_pred ccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCC-CHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~-~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
..|++.|+|||.+. ..++.++|+||||+++|+|++|..||.... ++...+..+..+......+...++++++||.+||
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 231 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHc
Confidence 57899999999875 458899999999999999999999997643 3566666666554555555555889999999999
Q ss_pred C-CCCCCCC-----HHHHhcCcccccccC
Q 006593 239 V-PASERLS-----AKDLLKDPFLQVENQ 261 (639)
Q Consensus 239 ~-dP~~RpS-----a~ELL~Hpff~~~~~ 261 (639)
. +|.+||+ ++|+++||||+...|
T Consensus 232 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 232 RRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred cCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 8 8999999 999999999986554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.16 Aligned_cols=252 Identities=16% Similarity=0.326 Sum_probs=206.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||++.+..++..||+|++...... .......+..|+.++..++|+||+++++++.+. ..+|+|||
T Consensus 8 ~lG~G~fg---~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 81 (332)
T cd05623 8 VIGRGAFG---EVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDE--NNLYLVMD 81 (332)
T ss_pred EEEeCCCe---EEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CEEEEEEe
Confidence 47888887 8999999999999999998754322 223455688999999999999999999988655 46999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
|+.+|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCCcc
Confidence 9999999999987 467999999999999999999999999 99999999999997 5579999999998654322
Q ss_pred CCccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc---cCCCC
Q 006593 157 TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL---AKVND 227 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l---~~~~s 227 (639)
.....+||+.|||||++. ..++.++|||||||++|||++|+.||.. .+..+.+..+........+ ....+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccCC
Confidence 122357999999999874 3488999999999999999999999986 4566666666554322222 23457
Q ss_pred hHHHHHHHHhcC-C--CCCCCCHHHHhcCcccccccCC
Q 006593 228 PQIKGFIEKCLV-P--ASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 228 ~~l~~LI~kcL~-d--P~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+++++||.+||. + +..|++++++++||||+...+.
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 899999999997 3 3347899999999999876654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.41 Aligned_cols=244 Identities=26% Similarity=0.409 Sum_probs=190.2
Q ss_pred CcccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.||+|+|| +||+|.+. .++..||+|.+..... ...+.+|+.+|++++||||++++++|.......+|++
T Consensus 8 ~lG~G~~g---~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 8 KVGRGTYG---HVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccCCCe---EEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 37888888 89999965 4778999999875432 2346789999999999999999999987766789999
Q ss_pred EecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe---CCCCcEEEee
Q 006593 79 TELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKIGD 146 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~---------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~---~~~g~VKL~D 146 (639)
|||+. ++|.+++... ..+++..++.+++||+.||.|||++| |+||||||+|||++ ...+.+||+|
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99996 5898887632 25899999999999999999999999 99999999999994 2447899999
Q ss_pred cchhhhccCC-----CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCH--------HHHHH
Q 006593 147 LGLAIAMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP--------AQIFK 211 (639)
Q Consensus 147 FGlA~~l~~~-----~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~--------~~i~~ 211 (639)
||++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...... .....
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHH
Confidence 9999765432 1234678999999998754 4899999999999999999999999642210 01111
Q ss_pred HHHc--CCC-----------C-----------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 212 KVTS--GIK-----------P-----------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 212 ~i~~--g~~-----------p-----------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
.+.. +.. + .......+..+.+||.+||. ||.+|||++|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp 315 (317)
T cd07868 236 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315 (317)
T ss_pred HHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence 1100 000 0 00011224578999999999 999999999999999
Q ss_pred cc
Q 006593 255 FL 256 (639)
Q Consensus 255 ff 256 (639)
||
T Consensus 316 ~f 317 (317)
T cd07868 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=329.50 Aligned_cols=249 Identities=33% Similarity=0.556 Sum_probs=207.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEeccccc-CChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||+|.+...... ........+.+|+.++++++||||+++++++.......+++++
T Consensus 9 ~lg~g~~g---~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 9 LLGQGAFG---RVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred eecCCCCE---EEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 47888888 8999999999999999998765432 1234567789999999999999999999988766566889999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||++..+...
T Consensus 86 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 86 EYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCcccccccccc
Confidence 99999999999998888999999999999999999999999 99999999999997 5579999999998755321
Q ss_pred --CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 157 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........+.+... ......++...++.+++|
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-CCCCCCCchhcCHHHHHH
Confidence 1223468899999998864 488999999999999999999999987554444444333 323344556678889999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
|. ||. +|.+||+++|+++||||+
T Consensus 242 i~-~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 LG-CIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HhcCChhhCcCHHHHhcCcccc
Confidence 95 555 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.76 Aligned_cols=246 Identities=28% Similarity=0.387 Sum_probs=195.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~l 77 (639)
||+|+|| .||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++..... ..+|+
T Consensus 29 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 29 IGSGAQG---IVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred eecCCCE---EEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 6778887 899999999999999999875532 33456678899999999999999999998865432 35799
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||||+.+ +|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 104 v~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 104 VMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNF 177 (359)
T ss_pred EEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCccccccCc
Confidence 9999975 6666664 35889999999999999999999999 99999999999997 5589999999999755332
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHH---------------------H
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV---------------------T 214 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i---------------------~ 214 (639)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..........+ .
T Consensus 178 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV 257 (359)
T ss_pred cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 2345678999999998864 58999999999999999999999998643322211110 0
Q ss_pred cCC--CC----------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 215 SGI--KP----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 215 ~g~--~p----------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
... .+ .......++.+++||.+||. ||.+|||+.|+|.||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred hhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 00 00112235689999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.86 Aligned_cols=250 Identities=31% Similarity=0.535 Sum_probs=208.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEeccccc-CChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||+|++...... ......+.+.+|++++++++||||++++++|.+.....++++|
T Consensus 9 ~l~~g~~g---~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 9 LLGQGAFG---RVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EEecCCce---EEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 47888887 7999999999999999998754321 2234567899999999999999999999998776556789999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
||+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||||+||+++ ..+.++|+|||++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~ 162 (265)
T cd06652 86 EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLS 162 (265)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCcccccccccccc
Confidence 99999999999998888999999999999999999999999 99999999999997 5679999999998755321
Q ss_pred --CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 157 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
......|+..|+|||++. ..++.++||||||+++|+|++|+.||........+. .+.........+...+..+.++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (265)
T cd06652 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPVLPPHVSDHCRDF 241 (265)
T ss_pred ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhcCCCCCCCchhhCHHHHHH
Confidence 223456899999999875 458899999999999999999999998754444443 3333333333455567789999
Q ss_pred HHHhcCCCCCCCCHHHHhcCcccc
Q 006593 234 IEKCLVPASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 234 I~kcL~dP~~RpSa~ELL~Hpff~ 257 (639)
|.+||.+|.+||+++++++|||+.
T Consensus 242 i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 242 LKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHhcChhhCCCHHHHhcCcccC
Confidence 999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.68 Aligned_cols=253 Identities=16% Similarity=0.326 Sum_probs=206.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..++..||+|++...... .......+..|+.+++.++|+||+++++++.+. ..+|+|||
T Consensus 8 ~lG~G~fg---~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~--~~~~lv~E 81 (331)
T cd05624 8 VIGRGAFG---EVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQDE--NYLYLVMD 81 (331)
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CEEEEEEe
Confidence 37888888 8999999999999999999764322 234456688999999999999999999988655 56999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|+.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.......
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccCCCce
Confidence 9999999999987 467999999999999999999999999 99999999999997 55799999999987654322
Q ss_pred -CccccCCCCcCCcccccc------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc---CCCC
Q 006593 158 -ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA---KVND 227 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~~------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~---~~~s 227 (639)
....+||+.|||||++.. .++.++|||||||++|+|++|+.||.. .+..+.+..+........++ ...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCccccCC
Confidence 123579999999998763 478899999999999999999999986 45556666665543222222 2346
Q ss_pred hHHHHHHHHhcCC-CC--CCCCHHHHhcCcccccccCCC
Q 006593 228 PQIKGFIEKCLVP-AS--ERLSAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 228 ~~l~~LI~kcL~d-P~--~RpSa~ELL~Hpff~~~~~~~ 263 (639)
.++++||.+||.. +. .|++++++++||||+...+..
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 8999999999984 33 257999999999998766543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=329.42 Aligned_cols=243 Identities=28% Similarity=0.482 Sum_probs=201.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..++..||+|.++... ......+.+|+.+++.++||||+++++++... ..+++|||
T Consensus 16 ~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~--~~~~lv~e 86 (267)
T cd06645 16 RIGSGTYG---DVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR--DKLWICME 86 (267)
T ss_pred HhCCCCCe---EEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC--CEEEEEEe
Confidence 37888888 79999999999999999987653 23445688999999999999999999998765 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+++++|.+++...+.+++..++.++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++..+... ..
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCccccc
Confidence 9999999999998889999999999999999999999999 99999999999997 5579999999998655432 12
Q ss_pred ccccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--CCCChHHHH
Q 006593 159 RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKG 232 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~l~~ 232 (639)
....|++.|+|||++. ..++.++|+|||||++|+|++|..||........+.........+.... ...+..+++
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 3457899999999873 3488999999999999999999999976443333333333332222222 134678999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
||.+||. +|.+||++.+|+.|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.36 Aligned_cols=245 Identities=30% Similarity=0.420 Sum_probs=193.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeC---CCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDD---KKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~~~~~---~~~~l 75 (639)
||+|+|| +||+|.+..+|..||+|.++..... ......+.+|+.+++.+ +||||+++++++... ....+
T Consensus 8 lg~g~~g---~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 8 IGVGAYG---TVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred EeecCCe---EEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 6778777 8999999999999999998865321 12223456677777666 799999999987653 23468
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 76 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ +.|.+||+|||++...
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCccccc
Confidence 99999997 5899998764 35899999999999999999999999 99999999999997 5579999999999766
Q ss_pred cCC-CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--C-C----C-----
Q 006593 154 QQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--I-K----P----- 219 (639)
Q Consensus 154 ~~~-~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~-~----p----- 219 (639)
... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+......+ .++... . . +
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH-HHHHHHhCCCChhhCcccccc
Confidence 433 223457899999999875 45899999999999999999999999764433322 222110 0 0 0
Q ss_pred -------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 220 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 220 -------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.......+..+++||.+||+ ||.+|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01112345678999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.31 Aligned_cols=251 Identities=29% Similarity=0.442 Sum_probs=206.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----CceEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDK----KKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~~~~~~----~~~l~ 76 (639)
||.|.|| +||+|+++.+|+.||+|+++...-. +.......+|+.+|+.|+|+| ||++++++...+ ...++
T Consensus 19 lGeGtyg---~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 19 LGEGTYG---VVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred hCCCCce---EEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 5666666 9999999999999999999987531 234556789999999999999 999999987654 23689
Q ss_pred EEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 77 MITELFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~----~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+|+||+. -+|..|+...+ .++...++.+++||+.||+|||+++ |+||||||+||||+ +.|.+||+|||+|+.
T Consensus 94 lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGLARA 169 (323)
T ss_pred EEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccchHHH
Confidence 9999996 59999998765 5888999999999999999999999 99999999999998 579999999999987
Q ss_pred ccCCC--CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCC---------
Q 006593 153 MQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK--------- 218 (639)
Q Consensus 153 l~~~~--~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~--------- 218 (639)
..-+. ....++|.+|+|||++-+ .|+..+||||+||+++||+++++-|.+.....++...... |.+
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 65332 345688999999997753 5999999999999999999999999987776666543321 110
Q ss_pred --------------CCccc---CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 219 --------------PASLA---KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 219 --------------p~~l~---~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+..+. ...++...+++.+||+ +|.+|.||+..|.||||+....
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 00000 1123589999999999 9999999999999999986543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.69 Aligned_cols=245 Identities=25% Similarity=0.475 Sum_probs=203.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..++..||+|.+.... .......+..|+.++++++||||+++++++... ...++|||
T Consensus 8 ~lg~g~~~---~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 79 (279)
T cd06619 8 ILGHGNGG---TVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICTE 79 (279)
T ss_pred eeccCCCe---EEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 36777777 89999999999999999987542 344556789999999999999999999998775 45889999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+++|+|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++ ..|.+||+|||++..........
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccccC
Confidence 9999999765 35789999999999999999999999 99999999999997 56899999999997766555556
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCC------HHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN------PAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~------~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
..||+.|+|||++.. .++.++|+||||+++|+|++|..||..... +....+.+.....+.......++++++|
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 789999999998864 589999999999999999999999964221 2233344443333333334467899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
|.+||+ +|.+||+++|++.||||+..+
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCccccccc
Confidence 999998 899999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.91 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=202.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL---KSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iL---k~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+..+|..||+|.+........ ........|..++ ...+||||+++++++..+ +.+++
T Consensus 1 ~lg~G~~g---~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~l 74 (279)
T cd05633 1 IIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCF 74 (279)
T ss_pred CcccCCCe---EEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEE
Confidence 58999999 899999999999999999876543221 2222334444433 445799999999988665 45899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+.+|+|.+++..++.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.++|+|||++.......
T Consensus 75 v~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 75 ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccC
Confidence 9999999999999998889999999999999999999999999 99999999999997 55799999999987655444
Q ss_pred CccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCC--HHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.....||+.|+|||.+. ..++.++|||||||++|+|++|..||..... ...+.. ... ..+..++...++++++|
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~l 229 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTL-TVNVELPDSFSPELKSL 229 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-Hhh-cCCcCCccccCHHHHHH
Confidence 44567999999999875 3488999999999999999999999975322 222211 111 12334455678899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 234 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 234 I~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
|.+||. +|.+|| ++.++++||||+..++..
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 999999 899999 699999999998866543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=336.89 Aligned_cols=247 Identities=26% Similarity=0.450 Sum_probs=204.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..+|..||+|.++... ......++.+|++++++++||||+++++++... ..+++|||
T Consensus 8 ~lg~G~~g---~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 79 (308)
T cd06615 8 ELGAGNGG---VVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD--GEISICME 79 (308)
T ss_pred eccCCCCe---EEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CEEEEEee
Confidence 37888887 89999999999999999987542 244566789999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+.+|+|.+++++.+.+++..++.++.||+.||.|||+ ++ ++||||||+|||++ +++.+||+|||++.........
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCcccccccccc
Confidence 99999999999988899999999999999999999997 57 99999999999998 4579999999998766555556
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH------------------------
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT------------------------ 214 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~------------------------ 214 (639)
...|++.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 6789999999998864 48899999999999999999999986422 222222111
Q ss_pred ------------cCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 215 ------------SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 215 ------------~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
....+.......++++++||.+||. +|.+||++.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111111112356789999999998 89999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=323.44 Aligned_cols=245 Identities=29% Similarity=0.506 Sum_probs=210.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+|..||+|++..... .....+++..|+++++.++||||+++++++.......++++|||
T Consensus 8 lg~g~~~---~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 8 IGKGSFG---TVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eccCCCe---EEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 6777777 899999999999999999886653 34566788999999999999999999998887766788999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLH-----SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLH-----s~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+.+++|.+++.. ...+++..++.++.||+.||.||| +.+ ++||||||+||+++ +.+.+||+|||++..
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~~~ 159 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLAKI 159 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEeccccccc
Confidence 999999999976 357899999999999999999999 777 99999999999998 558999999999987
Q ss_pred ccCCC--CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 153 MQQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 153 l~~~~--~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
..... .....|++.|+|||++.. .++.++|+||||+++|+|++|..||... +...+.+.+..+..+ .++...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 237 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRYSSE 237 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCccccCHH
Confidence 65433 345678999999998864 5788999999999999999999999874 466666666665443 445566789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+.+++.+||. +|.+||++.+||+|||+
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=361.43 Aligned_cols=244 Identities=26% Similarity=0.400 Sum_probs=205.7
Q ss_pred CcccccccCcEEEEEEEecCC-CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA-GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t-G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+||+| .||+|.+..+ +..||+|.+...+ ......+..|+.+|+.++|||||+++++|... ..+|+||
T Consensus 74 ~lg~G~~g---~vy~a~~~~~~~~~vv~K~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--~~~~lv~ 144 (478)
T PTZ00267 74 LVGRNPTT---AAFVATRGSDPKEKVVAKFVMLND----ERQAAYARSELHCLAACDHFGIVKHFDDFKSD--DKLLLIM 144 (478)
T ss_pred EEEeCCCc---EEEEEEEcCCCCeEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--CEEEEEE
Confidence 37888888 7899998887 7889999765442 34556788999999999999999999998765 4699999
Q ss_pred ecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 80 ELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 80 Ey~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
||+.||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCceecCC
Confidence 99999999988754 356899999999999999999999999 99999999999998 557999999999976543
Q ss_pred C----CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 156 P----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 156 ~----~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
. .....+||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+..+++..+..+..+ ..+...++++
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~s~~~ 299 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PFPCPVSSGM 299 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CCCccCCHHH
Confidence 2 2345679999999998864 589999999999999999999999976 4556666666655443 2344567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
++||.+||. +|.+||++.++|.|+|++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999 8999999999999999964
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=331.85 Aligned_cols=245 Identities=30% Similarity=0.551 Sum_probs=201.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..++..||+|++..... ..........|+.++++++||||+++++++.+. ..+++||||
T Consensus 7 lg~G~~g---~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~v~~~ 79 (260)
T PF00069_consen 7 LGSGGFG---TVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDD--NYLYIVMEY 79 (260)
T ss_dssp EEEESSE---EEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES--SEEEEEEEE
T ss_pred EEeCCCE---EEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccc--ccccccccc
Confidence 6777777 899999999999999999997753 122333445699999999999999999998774 568899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc--cCCCCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l--~~~~~~ 159 (639)
+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.++|+|||++... ......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccccccccccc
Confidence 999999999998888999999999999999999999999 99999999999998 6689999999998753 233344
Q ss_pred cccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCC--CHHHHHHHHHcCCCCCccc--CCCChHHHHH
Q 006593 160 SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLA--KVNDPQIKGF 233 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~--~~~~i~~~i~~g~~p~~l~--~~~s~~l~~L 233 (639)
...+|+.|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ....+.++++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence 567899999999987 568999999999999999999999998741 2222333222211111111 1112789999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
|.+||. +|.+||++.++++||||
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHccCChhHCcCHHHHhcCCCC
Confidence 999999 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=323.65 Aligned_cols=244 Identities=27% Similarity=0.514 Sum_probs=207.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|++| .||+|.+..+|..|++|.+..... .......+..|+++++.++||||+++++++... ..+++|||
T Consensus 7 ~l~~g~~~---~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd08529 7 KIGKGSFG---VVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDK--GKLNIVME 79 (256)
T ss_pred EecCCCCe---EEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccC--CEEEEEEE
Confidence 37788887 899999999999999999986653 245667899999999999999999999988765 56899999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|+++++|.+++... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++ ..+.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCccc
Confidence 99999999999774 57899999999999999999999999 99999999999998 4579999999998765432
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
......|++.|+|||++.. .++.++|+||||+++++|++|..||... +.......+..+..+. ++...++.++++|.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 234 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQLID 234 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHHHHH
Confidence 2234578999999998864 5889999999999999999999999763 4556666666654433 34466789999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+||+ +|.+||++.++++|||+
T Consensus 235 ~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 235 QCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHccCCcccCcCHHHHhhCCCC
Confidence 9998 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=327.96 Aligned_cols=244 Identities=27% Similarity=0.500 Sum_probs=200.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC----CceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK----KKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~----~~~l 75 (639)
.||+|+|| .||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++.... ...+
T Consensus 13 ~lg~g~~g---~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 13 LVGNGTYG---QVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred heeecCCe---EEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 37888887 89999999999999999987543 2345688999999999 7999999999987643 2468
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 76 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEccCCCceec
Confidence 9999999999999999864 35899999999999999999999999 99999999999998 4579999999998765
Q ss_pred cCC--CCccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCC
Q 006593 154 QQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 225 (639)
Q Consensus 154 ~~~--~~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 225 (639)
... ......|++.|+|||++. ..|+.++|||||||++|+|++|..||.... +......+.....+......
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhcCCCCCCCCCC
Confidence 432 234567999999999874 248889999999999999999999997643 33333333333233333345
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 226 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 226 ~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.+..+++||.+||. +|.+|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 57899999999999 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.35 Aligned_cols=238 Identities=28% Similarity=0.356 Sum_probs=189.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+++.||+|.... ..+.+|+++|++|+|||||+++++|... ...++|+|+
T Consensus 100 lg~G~~g---~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~ 164 (391)
T PHA03212 100 FTPGAEG---FAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYN--KFTCLILPR 164 (391)
T ss_pred EcCCCCe---EEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEEC--CeeEEEEec
Confidence 5677776 899999999999999996432 2367899999999999999999998765 458899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC---CCC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---PTA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~---~~~ 158 (639)
+. ++|..++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+|..... ...
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCccccccccccccc
Confidence 95 799999988888999999999999999999999999 99999999999997 557999999999965322 223
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC-------CHHHHHHHHH-cCCC-----------
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-------NPAQIFKKVT-SGIK----------- 218 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~-------~~~~i~~~i~-~g~~----------- 218 (639)
...+||+.|+|||++.. .|+.++|||||||++|||++|..||.+.. ...++...+. .+..
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 35689999999998864 58999999999999999999998764321 1111111110 0000
Q ss_pred ---------------CCccc-----CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 219 ---------------PASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 219 ---------------p~~l~-----~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
+...+ ...+.++++||.+||. +|.+||||+|+|+||||+.
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00000 1124578999999999 9999999999999999975
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=333.83 Aligned_cols=249 Identities=26% Similarity=0.429 Sum_probs=211.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+++.||+|++...... .....+.+.+|+++|++++||||+++++++.+. ..+++|||
T Consensus 8 ~ig~g~~~---~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 81 (290)
T cd05580 8 TLGTGSFG---RVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD--SNLYLVME 81 (290)
T ss_pred EeecCCCe---EEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC--CeEEEEEe
Confidence 36777777 8999999999999999998765432 234567889999999999999999999988665 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+.+++|.+++.+.+.+++..++.++.||+.||.|||+.| ++||||+|.|||++ .+|.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~-~~~ 157 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR-TYT 157 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC-CCC
Confidence 9999999999999889999999999999999999999999 99999999999997 4579999999998766544 345
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
..|++.|+|||.+.. .++.++||||||+++|+|++|..||... ......+.+..+.. .++...++.++++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKV--RFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCc--cCCccCCHHHHHHHHHHcc
Confidence 678999999997754 5788999999999999999999999764 35556666655433 2445568899999999998
Q ss_pred -CCCCCC-----CHHHHhcCcccccccCC
Q 006593 240 -PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 240 -dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
+|.+|+ +++||++||||....+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 899999 99999999999766544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=328.08 Aligned_cols=247 Identities=26% Similarity=0.485 Sum_probs=209.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+++.||+|++.... .......+.+|++++++++||||+++++.+... ..+++++||
T Consensus 9 ig~g~~~---~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 80 (265)
T cd06605 9 LGAGNSG---VVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICMEY 80 (265)
T ss_pred hcCCCCe---EEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEEEe
Confidence 6777777 79999999999999999988653 235567789999999999999999999988765 569999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
+.+++|.+++... ..+++..++.++.||+.||.|||+ .+ ++||||||+||+++ +.|.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHHhh
Confidence 9999999999876 789999999999999999999999 88 99999999999998 4689999999998766543333
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC----CCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~----~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
...+++.|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+..+..+.......++++++||
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 4788999999998764 5889999999999999999999999754 2344455555555444433333788999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.+||. +|.+||++.+++.||||+..
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHcCCCchhCcCHHHHhhCchhhcc
Confidence 99998 89999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.08 Aligned_cols=250 Identities=27% Similarity=0.473 Sum_probs=206.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
+||+|+|| .||+|.+..+|..||+|++........ ....+.+.+|+.+|++++||||+++++++.+. ..+++|
T Consensus 7 ~lg~g~~~---~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v 81 (268)
T cd06630 7 QLGTGAFS---SCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED--SHFNLF 81 (268)
T ss_pred eecCcCce---EEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC--CeEEEE
Confidence 47888888 899999999999999999875442211 23467899999999999999999999988655 458999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
+||+.+++|.+++.+.+.+++..++.|+.||+.||.|||++| ++||||+|+||+++.+...+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999999998888999999999999999999999999 99999999999997554579999999987654321
Q ss_pred -----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCC--HHHHHHHHHcCCCCCcccCCCChH
Q 006593 158 -----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 158 -----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.....|+..|+|||++. ..++.++|+||||+++|+|++|..||..... .......+.........+...+++
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 12346889999999876 4588999999999999999999999964322 223333333333444555667889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
+++||.+||. +|.+||++.+|++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999998 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.94 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=201.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC---ceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~---~~l~l 77 (639)
.||+|+|| .||+|.+..+|..||+|++.... .......++.+|+.+|+.++||||+++++++..... ..+|+
T Consensus 7 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 7 PIGYGAFG---VVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred eeeeCCCE---EEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 37888887 89999999999999999886432 223455678999999999999999999998865531 26899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||||+. ++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 82 v~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred Eeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccCc
Confidence 999996 689999988888999999999999999999999999 99999999999997 5589999999999754322
Q ss_pred --CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-----------------
Q 006593 157 --TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS----------------- 215 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~----------------- 215 (639)
......+|+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.. +.+....+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~ 236 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS-PIQQLDLITDLLGTPSLEAMRSACEGA 236 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence 1233568999999998764 47899999999999999999999997643 3333222211
Q ss_pred -------CCCCC------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 216 -------GIKPA------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 216 -------g~~p~------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
...+. .+....++++.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11111 1223346789999999999 999999999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=362.70 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=210.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC------ce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK------KT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~------~~ 74 (639)
+||+|+|| +||+|.+..+|..||+|++..... .......+.+|+.+|..++|+||++++..+..... ..
T Consensus 39 ~LG~G~fG---~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 39 VLGSGATG---TVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEecCCCE---EEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 47888888 899999999999999999987654 34667788999999999999999999988754332 24
Q ss_pred EEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 75 VNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
+++||||+.+|+|.++++.+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCCEEEEecccC
Confidence 78999999999999998753 46899999999999999999999999 99999999999998 4579999999998
Q ss_pred hhccC----CCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCC
Q 006593 151 IAMQQ----PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 225 (639)
Q Consensus 151 ~~l~~----~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 225 (639)
+.+.. ......+||+.|+|||++.. .|+.++|||||||++|||++|..||.+ .+...++..+..+..+ .++..
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~ 268 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYD-PLPPS 268 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC-CCCCC
Confidence 76532 22345689999999998874 589999999999999999999999986 4566677776665443 34556
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 226 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 226 ~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
.++++++||.+||. +|.+||++.++|+|||++.
T Consensus 269 ~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 78899999999999 8999999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=343.42 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=197.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~ 76 (639)
.||+|+|| +||+|.+..++..||+|++..... .....+.+.+|+.+|++++||||++++++|.... ...+|
T Consensus 22 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 22 PVGSGAYG---SVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred ecccCCCe---EEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 36777777 899999999999999999875431 2234566889999999999999999999876432 13578
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
++++++ +++|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 97 ~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 97 LVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADDE 171 (343)
T ss_pred EEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccceecCCC
Confidence 999998 7899988764 56999999999999999999999999 99999999999997 5579999999999765433
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CC--------------
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK-------------- 218 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~-------------- 218 (639)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+... ..
T Consensus 172 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 172 -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND-YIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred -cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 345679999999998764 58899999999999999999999997633 22222222110 00
Q ss_pred ----------CC---cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 219 ----------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 219 ----------p~---~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.. ......++.+.+||.+||. +|.+|||+.|+|.||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 0112345678999999999 99999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.34 Aligned_cols=241 Identities=23% Similarity=0.348 Sum_probs=195.3
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
+||+|||| .||+|.+ ..++..||+|+++... .......+.+|+.+|+.+ +||||+++++++... ...
T Consensus 14 ~lG~G~fg---~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~ 86 (338)
T cd05102 14 VLGHGAFG---KVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTKP-NGP 86 (338)
T ss_pred EeccCCcc---eEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-CCc
Confidence 47899998 7888864 3456789999987432 234556789999999999 899999999987644 346
Q ss_pred EEEEEecCCCCCHHHHHHhC------------------------------------------------------------
Q 006593 75 VNMITELFTSGNLRQYRKKH------------------------------------------------------------ 94 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~------------------------------------------------------------ 94 (639)
+++||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 88999999999999999753
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCcC
Q 006593 95 --KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFM 168 (639)
Q Consensus 95 --~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ym 168 (639)
..+++..+..|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+++...... .....+++.||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 23778889999999999999999999 99999999999998 45799999999997653221 12345678899
Q ss_pred Cccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCC
Q 006593 169 APELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERL 245 (639)
Q Consensus 169 APE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~Rp 245 (639)
|||++. ..|+.++|||||||++|||++ |..||.+......+...+..+..+ ..+...++.+++||.+||. +|.+||
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCc
Confidence 999775 458999999999999999997 999998755445555555555433 3455667899999999999 899999
Q ss_pred CHHHHhc
Q 006593 246 SAKDLLK 252 (639)
Q Consensus 246 Sa~ELL~ 252 (639)
|+.||++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=325.38 Aligned_cols=247 Identities=30% Similarity=0.469 Sum_probs=203.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEeccccc--CChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL--QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~--~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
+||+|+|| .||+|.+ .+|..||+|.++..... ........+.+|+++|++++|+||+++++++.+. ..+++|
T Consensus 7 ~ig~g~~~---~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 80 (265)
T cd06631 7 VLGKGAYG---TVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD--NTISIF 80 (265)
T ss_pred eEeccCCe---EEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC--CeEEEE
Confidence 37788888 7999987 47899999998765321 1234456799999999999999999999988665 579999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC---
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--- 155 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--- 155 (639)
+||+.+++|.+++.+.+.+++..++.++.||+.||.|||+.+ |+|+||+|+||+++ ..+.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhccc
Confidence 999999999999998888999999999999999999999999 99999999999997 557999999999875421
Q ss_pred -----CCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 -----PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 -----~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.......|++.|+|||++.. .++.++|+||||+++|+|++|..||......................+...+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 11234568999999998864 588999999999999999999999976544443333222212223355567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+.+||.+||. +|.+||++.++|.||||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999998 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=333.91 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=204.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+++.||+|.+...... .......+..|+.++++++|+||+++++.+.+. ..+++|||
T Consensus 7 ~ig~G~~g---~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e 80 (285)
T cd05630 7 VLGKGGFG---EVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVLT 80 (285)
T ss_pred EeecCCCe---EEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC--CEEEEEEE
Confidence 48999999 7999999999999999998765432 223345677899999999999999999988655 46999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~ 157 (639)
|+.+|+|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||+++ ..+.++|+|||++...... .
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCcc
Confidence 999999999986543 5899999999999999999999999 99999999999997 4578999999998654322 2
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCH--HHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~--~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.....||+.|+|||++. ..++.++||||||+++|+|++|..||...... ......+.... +...+...++++++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHHHH
Confidence 23457999999999886 45899999999999999999999999763321 11222222211 2234455678999999
Q ss_pred HHhcC-CCCCCCC-----HHHHhcCcccccccCC
Q 006593 235 EKCLV-PASERLS-----AKDLLKDPFLQVENQK 262 (639)
Q Consensus 235 ~kcL~-dP~~RpS-----a~ELL~Hpff~~~~~~ 262 (639)
.+||+ +|.+||| ++|+++||||+...+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 99999 8999999 9999999999865443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=377.45 Aligned_cols=252 Identities=24% Similarity=0.430 Sum_probs=211.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| +||+|.+..++..||+|.+..... .......+..|+.+|++|+|||||+++++|.+.....+||||||
T Consensus 21 LG~GgFG---tVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY 95 (1021)
T PTZ00266 21 IGNGRFG---EVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEF 95 (1021)
T ss_pred EecCCCe---EEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeC
Confidence 6777777 899999999999999999986653 33556789999999999999999999999988777789999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeeeeccCCCcEEEeCC--------------
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHN-----PPIIHRDLKCDNIFVNGN-------------- 138 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~g-----ppIIHRDLKp~NILl~~~-------------- 138 (639)
+.+|+|.++|.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 96 ~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 96 CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 999999999875 357999999999999999999999854 249999999999999531
Q ss_pred --CCcEEEeecchhhhccCC-CCccccCCCCcCCccccc---ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHH
Q 006593 139 --HGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 212 (639)
Q Consensus 139 --~g~VKL~DFGlA~~l~~~-~~~~~~GTp~ymAPE~l~---~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~ 212 (639)
.+.+||+|||++..+... .....+||+.|+|||++. ..++.++|||||||++|+|+||..||.......+++..
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~ 255 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHH
Confidence 235899999999766432 234568999999999874 34889999999999999999999999876667777666
Q ss_pred HHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 213 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 213 i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+..+... .....++++.+||..||. +|.+||++.|+|.||||+...
T Consensus 256 lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 256 LKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 6654322 223457899999999999 899999999999999997543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=329.95 Aligned_cols=252 Identities=21% Similarity=0.364 Sum_probs=203.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSE---VHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~E---i~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+..+|+.||+|.+........ ........| +.+++...||||+++++++... ..+++
T Consensus 1 ~ig~g~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~ 74 (278)
T cd05606 1 IIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSF 74 (278)
T ss_pred CcccCCCe---EEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEE
Confidence 58999999 899999999999999999886543221 111223333 3445556899999999988655 46899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+.||+|.+++.+.+.+++..++.|+.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||++.......
T Consensus 75 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 75 ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccC
Confidence 9999999999999988888999999999999999999999999 99999999999997 45799999999987665444
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCC--HHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.....|++.|+|||++.. .++.++||||||+++|+|++|..||.+... .......... .+..++...++.+.++
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~l 229 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSL 229 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHH
Confidence 456689999999998863 488999999999999999999999976422 2222222222 2233455568899999
Q ss_pred HHHhcC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 234 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 234 I~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
|.+||. +|.+|| ++.++++||||....+..
T Consensus 230 i~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 999999 899999 999999999998776554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.89 Aligned_cols=247 Identities=28% Similarity=0.372 Sum_probs=195.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~l 77 (639)
||+|+|| .||+|.+..++..||+|++..... ......++.+|+.+++.++||||++++++|.... ...+++
T Consensus 25 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 25 IGSGAQG---IVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eeecCCE---EEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 6788887 799999999999999999875432 3345677889999999999999999999886543 235799
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 100 v~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 173 (355)
T cd07874 100 VMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSF 173 (355)
T ss_pred Ehhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcccccCCCcc
Confidence 9999975 67777653 5889999999999999999999999 99999999999997 5579999999999765433
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--------------------
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------------- 215 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-------------------- 215 (639)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..........+..
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T cd07874 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_pred ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHH
Confidence 2345679999999998764 5899999999999999999999999764322221111100
Q ss_pred -C-CC------C-----------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 216 -G-IK------P-----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 216 -g-~~------p-----------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
. .. + .......+..+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred hcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 00 0 00112234578999999999 99999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=325.84 Aligned_cols=245 Identities=31% Similarity=0.477 Sum_probs=202.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++... ..+++|+|
T Consensus 15 ~lg~g~~g---~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 85 (268)
T cd06624 15 VLGKGTYG---IVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN--GFFKIFME 85 (268)
T ss_pred EEecCCce---EEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC--CEEEEEEe
Confidence 47888888 79999999999999999887543 34567789999999999999999999987655 56899999
Q ss_pred cCCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 81 LFTSGNLRQYRKKH-KNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l--~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
|+.+++|.+++... ..+ ++..+..++.||+.||.|||+.+ |+||||||.||+++.+.+.++|+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 99999999999864 455 88999999999999999999999 9999999999999765679999999998655322
Q ss_pred -CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 157 -TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
......|++.|+|||++.. .++.++||||||+++|+|++|..||.....................++...++++++
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 2233468999999998753 378999999999999999999999976544333322222212233455567789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
|+.+||. +|.+||++.|++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999998 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=324.46 Aligned_cols=246 Identities=30% Similarity=0.529 Sum_probs=204.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC-----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL-----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~-----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
+||+|++| .||+|.+..++..||+|.+........ ....+.+.+|+.++++++||||+++++++... .++
T Consensus 7 ~ig~g~~~---~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 81 (267)
T cd06628 7 LIGSGSFG---SVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA--DHL 81 (267)
T ss_pred eeecCCCe---EEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--Ccc
Confidence 47888887 899999999999999999876543221 22346788999999999999999999988765 468
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 76 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
++||||+++++|.+++...+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ +.+.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCccccc
Confidence 899999999999999999888999999999999999999999999 99999999999997 557999999999876642
Q ss_pred CC--------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCC
Q 006593 156 PT--------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 226 (639)
Q Consensus 156 ~~--------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 226 (639)
.. .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||.+......+ ..+..... ..++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~ 236 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENAS-PEIPSNI 236 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCC-CcCCccc
Confidence 11 123468899999998864 5888999999999999999999999875444333 33333322 2344556
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+..++++|.+||+ +|.+||++.++++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 7899999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=343.01 Aligned_cols=246 Identities=28% Similarity=0.388 Sum_probs=196.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~ 76 (639)
.||+|+|| .||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++.... ...+|
T Consensus 31 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 31 PIGSGAQG---IVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred EeecCCCe---EEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 37788887 89999999999999999987543 23345567889999999999999999999875432 23589
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+||||+.+ +|.+++.. .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 106 IVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 179 (364)
T ss_pred EEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCccccCCC
Confidence 99999965 78777753 5889999999999999999999999 99999999999997 5579999999999765433
Q ss_pred -CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC----------------
Q 006593 157 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---------------- 218 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---------------- 218 (639)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ....+..+.....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258 (364)
T ss_pred CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence 2345679999999998864 58999999999999999999999997643 3333222221100
Q ss_pred -----C-------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 219 -----P-------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 219 -----p-------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
+ .......+..+++||.+||+ ||.+|||+.|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00111234578999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.36 Aligned_cols=245 Identities=27% Similarity=0.517 Sum_probs=204.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|++| .||+|.+..+++.||+|.+..... .....+.+..|+.++++++|+||+++++.+... ...+++|||
T Consensus 7 ~lg~g~~~---~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e 80 (257)
T cd08223 7 VVGKGSYG---EVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVMG 80 (257)
T ss_pred EecCCCCe---EEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEec
Confidence 36777777 899999999999999999976543 234556789999999999999999999987533 346899999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|+++++|.+++... ..+++..++.++.||+.||.|||+.| ++||||||+||+++ ..+.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecccCC
Confidence 99999999999763 45899999999999999999999999 99999999999997 5579999999998765422
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
......|++.|+|||++.. .++.++||||||+++++|++|+.||... +.......+..+..+ ..+...++.+.+||.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 235 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELGELIA 235 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHHHHHH
Confidence 2334578999999998764 5889999999999999999999999763 445555555555433 244567789999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+||+ +|.+||++.++++||||
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHhccCcccCCCHHHHhcCCCC
Confidence 9999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.95 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=212.1
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCC
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 84 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 84 (639)
.|.|-|+.|.+|+|..||..||||++.+.++ .......+++|++.|+.++|||||++|.+. +.+..+|+|+|+-.+
T Consensus 26 lG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLiLELGD~ 101 (864)
T KOG4717|consen 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLILELGDG 101 (864)
T ss_pred hcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEEEEecCC
Confidence 3455556899999999999999999998876 334556799999999999999999999964 344569999999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc-CCCCcccc
Q 006593 85 GNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTARSVI 162 (639)
Q Consensus 85 GsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~-~~~~~~~~ 162 (639)
|+|++||-+| ..+.|..+++|++||+.|+.|||+.. ++||||||+|+.+-...|.|||.|||++-.+. .....+.|
T Consensus 102 GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsC 179 (864)
T KOG4717|consen 102 GDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSC 179 (864)
T ss_pred chHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhccc
Confidence 9999999876 57999999999999999999999998 99999999999888888999999999996654 34567899
Q ss_pred CCCCcCCcccccc-cCC-ccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-
Q 006593 163 GTPEFMAPELYEE-EYN-ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 239 (639)
Q Consensus 163 GTp~ymAPE~l~~-~ys-~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~- 239 (639)
|+..|.|||++-+ .|+ +++||||||+|||-|++|++||.+. |..+.+-+|+.-.. ..|...+.++++||..||+
T Consensus 180 GSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA-NDSETLTmImDCKY--tvPshvS~eCrdLI~sMLvR 256 (864)
T KOG4717|consen 180 GSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA-NDSETLTMIMDCKY--TVPSHVSKECRDLIQSMLVR 256 (864)
T ss_pred chhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc-cchhhhhhhhcccc--cCchhhhHHHHHHHHHHHhc
Confidence 9999999997654 575 7899999999999999999999884 44444455555322 3566678899999999999
Q ss_pred CCCCCCCHHHHhcCcccccccC
Q 006593 240 PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 240 dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
||.+|.+.+||..|+|++....
T Consensus 257 dPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 257 DPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred CchhhccHHHHhccccccCCCC
Confidence 9999999999999999997654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=335.63 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=196.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..++..||+|+++.... ......+.+|+.++++++||||+++++++..+ ..+++||||
T Consensus 14 lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 85 (309)
T cd07872 14 LGEGTYA---TVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSLTLVFEY 85 (309)
T ss_pred ecccCCE---EEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeEEEEEeC
Confidence 6777777 899999999999999999986542 22334577899999999999999999988765 458999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++...... ..
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCCCcccc
Confidence 975 888888764 45899999999999999999999999 99999999999998 4579999999998654332 22
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC---C----------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---I---------------- 217 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g---~---------------- 217 (639)
....+|+.|+|||++.+ .++.++|||||||++|+|+||..||.+.. ..+....+... .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST-VEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 34568999999998753 58899999999999999999999997643 22222222110 0
Q ss_pred --CCC-------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 218 --KPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 218 --~p~-------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.+. ......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 0112346789999999999 999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.87 Aligned_cols=246 Identities=27% Similarity=0.483 Sum_probs=203.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++..+|+|.+.... ....+.+..|+++++.++||||+++++++... ...++|+||
T Consensus 13 lg~g~~g---~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~~v~e~ 83 (282)
T cd06643 13 LGDGAFG---KVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE--NNLWILIEF 83 (282)
T ss_pred cccCCCe---EEEEEEECCCCeEEEEEEeCCCC----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC--CEEEEEEEe
Confidence 5666666 89999999999999999986442 35567789999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+|+|..++.+ ...+++..+..++.||+.||.|||+.| ++||||||+||+++ ..+.+||+|||++...... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEcccccccccccccccc
Confidence 999999998765 467999999999999999999999999 99999999999997 5579999999998654322 22
Q ss_pred ccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCcccCCCChHHH
Q 006593 159 RSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIK 231 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~s~~l~ 231 (639)
....|++.|+|||++. ..++.++|||||||++|+|++|..||.... +.+....+..... ....+...+..++
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 3457899999999873 237789999999999999999999998743 4444444443332 2233445678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||.+||. +|.+||++.++++||||....
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999998 899999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=356.68 Aligned_cols=244 Identities=18% Similarity=0.270 Sum_probs=190.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC------CCcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD------DNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H------pNIVkl~~~~~~~~~~~l 75 (639)
||+|+|| +||+|.+..++..||+|+++... .....+..|+.+++.++| ++|++++++|... ...+
T Consensus 137 lG~G~fg---~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~~~ 207 (467)
T PTZ00284 137 LGEGTFG---KVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TGHM 207 (467)
T ss_pred EEeccCE---EEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-CceE
Confidence 7788887 89999999999999999986432 223445667777777755 4588999887654 3578
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCC---------------
Q 006593 76 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNH--------------- 139 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~--------------- 139 (639)
|+||+++ |++|.+++.+++.+++..++.++.||+.||.|||+ .| ||||||||+|||++...
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9999998 77999999888899999999999999999999998 58 99999999999997432
Q ss_pred CcEEEeecchhhhccCCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--C
Q 006593 140 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--G 216 (639)
Q Consensus 140 g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g 216 (639)
+.+||+|||++..... .....+||+.|||||++.+ .|+.++|||||||++|||++|++||.+..+...+ ..+.. +
T Consensus 285 ~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~i~~~~g 362 (467)
T PTZ00284 285 CRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL-HLMEKTLG 362 (467)
T ss_pred ceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHcC
Confidence 1499999998754322 2345789999999998764 5999999999999999999999999764433222 11111 1
Q ss_pred CCCCc--------------------------------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 217 IKPAS--------------------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 217 ~~p~~--------------------------------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
..|.. .....++.+.+||.+||+ ||.+|||++|+|+||||+
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence 00000 001124668899999999 999999999999999998
Q ss_pred cc
Q 006593 258 VE 259 (639)
Q Consensus 258 ~~ 259 (639)
..
T Consensus 443 ~~ 444 (467)
T PTZ00284 443 KY 444 (467)
T ss_pred cc
Confidence 54
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.75 Aligned_cols=249 Identities=30% Similarity=0.529 Sum_probs=210.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccc-cCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDV-LQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~-~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||+|++..... .........+.+|++++++++||||+++++++.+.....+++++
T Consensus 9 ~lg~g~~g---~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 9 LLGRGAFG---EVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eEccCCCe---EEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence 47888888 899999999999999999865421 12345667899999999999999999999998776666789999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
||+.+++|.+++...+.+++..++.|+.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~ 162 (264)
T cd06653 86 EYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMS 162 (264)
T ss_pred EeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcccccccccccccc
Confidence 99999999999988888999999999999999999999999 99999999999997 4579999999999765321
Q ss_pred --CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 157 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
......|++.|+|||++.+ .++.++|+|||||++|+|++|+.||.+......+. .+.....+..++...++.+++|
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHHcCCCCCCCCcccCHHHHHH
Confidence 1224568999999998864 58899999999999999999999998754444444 3333334445666778899999
Q ss_pred HHHhcCCCCCCCCHHHHhcCccc
Q 006593 234 IEKCLVPASERLSAKDLLKDPFL 256 (639)
Q Consensus 234 I~kcL~dP~~RpSa~ELL~Hpff 256 (639)
|.+||++|..||++.++|.|||.
T Consensus 242 i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 242 LKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHhcCcccCccHHHHhcCCCC
Confidence 99999988999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.35 Aligned_cols=244 Identities=27% Similarity=0.474 Sum_probs=201.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC----CCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD----KKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~----~~~~l 75 (639)
.||+|+|| .||+|.+..++..||+|++.... .....+..|+.+++++ +||||++++++|... ....+
T Consensus 23 ~lg~g~~~---~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 23 VVGNGTYG---QVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred eeccCCCe---EEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 36777777 89999999999999999986542 3445688999999999 799999999998643 24578
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 76 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
+++|||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCcchhhh
Confidence 9999999999999999764 35889999999999999999999999 99999999999997 5579999999998765
Q ss_pred cCC--CCccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCC
Q 006593 154 QQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 225 (639)
Q Consensus 154 ~~~--~~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 225 (639)
... ......|++.|+|||++. ..++.++||||||+++|+|++|..||........+ ..+.....+......
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 250 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-FLIPRNPPPKLKSKK 250 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-hhHhhCCCCCCcccc
Confidence 422 234567899999999874 34888999999999999999999999775433333 333333333334445
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 226 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 226 ~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.+.++.+||.+||. +|.+||++.|||+||||
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 67899999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.57 Aligned_cols=247 Identities=28% Similarity=0.500 Sum_probs=208.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+|..||+|++.... .......+.+|+.+++.++||||+++++++.+. ..+++|+||
T Consensus 9 lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~ 80 (274)
T cd06609 9 IGKGSFG---EVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIMEY 80 (274)
T ss_pred hcCCCCe---EEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEEEe
Confidence 6777777 89999999999999999987653 234556788999999999999999999998766 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+++|.+++... .+++..++.++.||+.||.|||+++ ++||||+|+||+++ +.|.++|+|||++..+... ...
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeecccccccc
Confidence 9999999999875 7899999999999999999999999 99999999999998 4679999999999776543 233
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...|++.|+|||++.+ .++.++||||||+++|+|+||..||... ++......+..+..+.......++.+.++|.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 4578999999998764 5899999999999999999999999763 3455555555554433222226789999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccccC
Q 006593 239 V-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
. +|.+||+++++++||||+....
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCCCc
Confidence 8 8999999999999999986544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=330.79 Aligned_cols=244 Identities=28% Similarity=0.474 Sum_probs=195.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|+++.... .......+.+|++++++++||||+++++++.+. ..+++|+||
T Consensus 8 l~~g~~~---~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 80 (284)
T cd07839 8 IGEGTYG---TVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSD--KKLTLVFEY 80 (284)
T ss_pred ecccCCe---EEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccC--CceEEEEec
Confidence 6777777 899999999999999999986542 223345678899999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||++...... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCCCCCc
Confidence 97 588887765 567999999999999999999999999 99999999999998 4579999999998765432 22
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC------------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------------------ 218 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~------------------ 218 (639)
....+++.|+|||++.+ .++.++|||||||++|+|+||..||....+....+..+.....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999998754 3789999999999999999999886543444433333221100
Q ss_pred -C--------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 219 -P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 219 -p--------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+ .......++++++||.+||. +|.+|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 00112346789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.17 Aligned_cols=244 Identities=27% Similarity=0.388 Sum_probs=189.1
Q ss_pred CcccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.||+|+|| +||+|.+. .++..||+|.+.... ....+.+|+.+|+.++||||+++++++.......+++|
T Consensus 8 ~lG~G~~g---~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 8 KVGRGTYG---HVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred EeccCCCe---eEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 37888888 79999864 467899999887443 12357889999999999999999999987767789999
Q ss_pred EecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe---CCCCcEEEee
Q 006593 79 TELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKIGD 146 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~---------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~---~~~g~VKL~D 146 (639)
|||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...|.+||+|
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99996 5888887532 24889999999999999999999999 99999999999994 2457899999
Q ss_pred cchhhhccCCC-----CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCH---------HHHH
Q 006593 147 LGLAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------AQIF 210 (639)
Q Consensus 147 FGlA~~l~~~~-----~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~---------~~i~ 210 (639)
||+++...... .....||+.|+|||++.+ .++.++|||||||++|||+||.+||...... .++.
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 99997654321 234578999999998754 4889999999999999999999999642210 1111
Q ss_pred HHHHc-C--------------------------CC-C-------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 211 KKVTS-G--------------------------IK-P-------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 211 ~~i~~-g--------------------------~~-p-------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
+.+.. + .. . .......+..+++||.+||+ ||.+|||+.|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 10000 0 00 0 00011234568899999999 999999999999999
Q ss_pred cc
Q 006593 255 FL 256 (639)
Q Consensus 255 ff 256 (639)
||
T Consensus 316 ~f 317 (317)
T cd07867 316 YF 317 (317)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.44 Aligned_cols=247 Identities=32% Similarity=0.488 Sum_probs=207.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEeccccc-CChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL-QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..++..||+|.+...... ...+..+.+..|+.+++.++||||+++++++... ..+++++
T Consensus 7 ~ig~g~~~---~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~ 81 (258)
T cd06632 7 LLGSGSFG---SVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE--DNLYIFL 81 (258)
T ss_pred eeeecCCc---eEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC--CeEEEEE
Confidence 47888888 8999999989999999998765432 2345667899999999999999999999987654 4689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-C
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-A 158 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-~ 158 (639)
||+++++|.+++.+.+.+++..++.++.||+.||.|||+.+ ++|+||+|+||+++ ..+.+||+|||++....... .
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceeccccccc
Confidence 99999999999998888999999999999999999999999 99999999999997 45799999999987654332 3
Q ss_pred ccccCCCCcCCcccccc-c-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....|++.|+|||.+.. . ++.++|+||||+++|+|++|..||......... ..+........++...++.+++||.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-FKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-HHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 45678999999997753 3 789999999999999999999999875433333 33333223334556678899999999
Q ss_pred hcC-CCCCCCCHHHHhcCccc
Q 006593 237 CLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff 256 (639)
||. +|.+||++.++|.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 998 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=325.98 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=205.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|.+... .....+.+..|+.+++.++||||+++++++... ..+++||||
T Consensus 20 lg~g~~g---~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 90 (292)
T cd06644 20 LGDGAFG---KVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--GKLWIMIEF 90 (292)
T ss_pred ecCCCCe---EEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--CeEEEEEec
Confidence 6667666 8999999999999999998754 345677889999999999999999999988765 468999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+++|..++.+ ...+++..++.++.||+.||.|||+++ ++||||||+||+++ ..|.+||+|||++...... ..
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccceecccccccc
Confidence 999999988764 456899999999999999999999999 99999999999997 4579999999998654322 22
Q ss_pred ccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHHH
Q 006593 159 RSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIK 231 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l~ 231 (639)
....+++.|+|||++. ..++.++|||||||++|+|++|..||... ++...+..+.....+ ...+...+.++.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 3457899999999874 23688999999999999999999999764 344444444444332 223445677899
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCcccccccCCC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~~ 263 (639)
+||.+||. +|.+||++.++++||||....+..
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 99999999 899999999999999998666544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.95 Aligned_cols=244 Identities=28% Similarity=0.437 Sum_probs=195.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+|..||+|.++.... .......+.+|+.++++++||||+++++++.++ ..+++||||
T Consensus 8 l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~ 80 (285)
T cd07861 8 IGEGTYG---VVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQE--SRLYLIFEF 80 (285)
T ss_pred ecccCce---EEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC--CeEEEEEec
Confidence 6777777 899999999999999999876542 223446688999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 82 FTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~---~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
+. ++|.+++... +.+++..++.++.||+.||.|||+++ ++||||||+||+++ ++|.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCCCcc
Confidence 97 6899888653 46899999999999999999999999 99999999999997 5689999999998654322
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC-----------------
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----------------- 217 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~----------------- 217 (639)
......+++.|+|||++.+ .++.++|||||||++|+|+||..||.+...............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 1223467899999998753 478899999999999999999999986544333322211100
Q ss_pred ---------CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 218 ---------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 218 ---------~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.........++++++||.+||. +|.+|||+.+|+.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0001122357889999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.65 Aligned_cols=246 Identities=29% Similarity=0.528 Sum_probs=205.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++..||+|++... .....+.+..|+.++++++||||+++++++... ..+++||||
T Consensus 13 l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 83 (280)
T cd06611 13 LGDGAFG---KVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE--NKLWILIEF 83 (280)
T ss_pred hcCCCCc---eEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC--CeEEEEeec
Confidence 5677776 8999999999999999998754 345667789999999999999999999988754 468999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+|+|.+++.+. +.+++..++.++.||+.||.|||+.+ |+||||||+||+++ ..+.++|+|||++...... ..
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhccccccc
Confidence 9999999998764 56999999999999999999999999 99999999999997 4579999999998655432 22
Q ss_pred ccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHHH
Q 006593 159 RSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIK 231 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l~ 231 (639)
....|++.|+|||++. ..++.++||||||+++|+|++|..||... ........+..+..+ ...+...+.++.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 3457899999999864 23678999999999999999999999864 444555555554332 223445678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||.+||. +|.+||++.++|+||||....
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 99999998 899999999999999997553
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.37 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=202.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL-KSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iL-k~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||.|+|| .||+|.+..+|..||+|+++...... ......+..|..++ ..++||||+++++++... ..+|+|||
T Consensus 4 l~~g~~~---~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e 77 (260)
T cd05611 4 ISKGAFG---SVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK--DYLYLVME 77 (260)
T ss_pred CCcCCCe---eEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC--CeEEEEEe
Confidence 6788888 89999999999999999987654321 22333445555544 455899999999988654 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+.+++|.++++..+.+++..+..++.||+.||.|||+.+ ++||||+|.||+++ +.+.+||+|||++..... ...
T Consensus 78 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~ 152 (260)
T cd05611 78 YLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKK 152 (260)
T ss_pred ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--ccc
Confidence 9999999999998888999999999999999999999999 99999999999997 557999999999865433 334
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHHHHHHh
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~LI~kc 237 (639)
..|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .+....+..+..+.. +.......++.+.+||.+|
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 578999999998764 478999999999999999999999976 345555555554432 3333445678999999999
Q ss_pred cC-CCCCCCC---HHHHhcCcccccccC
Q 006593 238 LV-PASERLS---AKDLLKDPFLQVENQ 261 (639)
Q Consensus 238 L~-dP~~RpS---a~ELL~Hpff~~~~~ 261 (639)
|. +|.+||+ ++|+|.||||...+|
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 98 8999995 479999999987655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=317.53 Aligned_cols=245 Identities=25% Similarity=0.448 Sum_probs=206.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..++..||+|.+..... .......+..|+++|++++||||+++++.+... ..+++|||
T Consensus 7 ~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd08220 7 VVGRGAFG---IVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLED--KALMIVME 79 (256)
T ss_pred EecccCce---EEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC--CEEEEEEe
Confidence 37888888 799999999999999999986653 335567899999999999999999999988654 56899999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||+|+||+++.+.+.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999999764 35899999999999999999999999 99999999999998666678999999997665332
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
.....|++.|+|||.+.. .++.++||||||+++|+|++|..||... +.......+..+... .++...++.+++||.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFA-PISDRYSPDLRQLILS 235 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-chHHHHHHHHhcCCC-CCCCCcCHHHHHHHHH
Confidence 234578999999998864 4788999999999999999999999774 444455555444332 3444567899999999
Q ss_pred hcC-CCCCCCCHHHHhcCccc
Q 006593 237 CLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff 256 (639)
||. +|.+|||+.|+|.||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.23 Aligned_cols=242 Identities=29% Similarity=0.506 Sum_probs=201.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++..+|+|.+..... ...+.+.+|+.++++++||||+++++++... ..+|++|||
T Consensus 11 l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~l~~e~ 81 (262)
T cd06613 11 IGSGTYG---DVYKARDIATGELVAIKVIKLEPG----DDFEIIQQEISMLKECRHPNIVAYFGSYLRR--DKLWIVMEY 81 (262)
T ss_pred ecCCCce---EEEEeEecCCCCEEEEEEEEcCch----hhHHHHHHHHHHHHhCCCCChhceEEEEEeC--CEEEEEEeC
Confidence 6777777 899999999999999999986542 3567899999999999999999999988765 469999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+++|.+++... ..+++..++.++.||+.||.|||+++ ++||||+|+||+++ +.|.+||+|||++...... ..
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchhhhhhhhcc
Confidence 9999999999876 78999999999999999999999999 99999999999998 5679999999998765432 23
Q ss_pred ccccCCCCcCCcccccc----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--ccCCCChHHHH
Q 006593 159 RSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIKG 232 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~~~~s~~l~~ 232 (639)
....+++.|+|||.+.. .++.++||||||+++|+|+||..||.+................+.. .....+.++++
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 34578999999998753 5888999999999999999999999875544333333222222211 12234578999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
||.+||. +|.+||++.+++.|+|
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999998 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.99 Aligned_cols=249 Identities=27% Similarity=0.440 Sum_probs=208.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+|..||+|++..... ......+.+..|+.++++++||||+++++.+... ..+|+++||
T Consensus 1 lg~g~~~---~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYG---RVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEY 74 (265)
T ss_pred CCCCCce---EEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC--cEEEEEEec
Confidence 6888888 799999999999999999876543 2235667899999999999999999999987654 568999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-----
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~----- 156 (639)
+.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 75 LPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCccccc
Confidence 999999999998888999999999999999999999999 99999999999998 4579999999998654322
Q ss_pred -----CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 157 -----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 157 -----~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
......+++.|+|||.+.. .++.++||||||+++|+|++|..||.. ..+...+..+..+..+.......++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSDEA 230 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCcCCCccccCCHHH
Confidence 2234568899999997754 488899999999999999999999976 456666666665443322222237899
Q ss_pred HHHHHHhcC-CCCCCCCH---HHHhcCccccccc
Q 006593 231 KGFIEKCLV-PASERLSA---KDLLKDPFLQVEN 260 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa---~ELL~Hpff~~~~ 260 (639)
.+||.+||+ +|.+||++ .++|+||||...+
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999999999 89999999 9999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=325.35 Aligned_cols=247 Identities=29% Similarity=0.510 Sum_probs=205.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..+|..||+|.++... .......+.+|+.++++++||||+++++++... ..+++|||
T Consensus 8 ~ig~g~~g---~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 79 (286)
T cd06622 8 ELGKGNYG---SVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE--GAVYMCME 79 (286)
T ss_pred hhcccCCe---EEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC--CeEEEEEe
Confidence 36777777 89999999999999999987542 334557789999999999999999999988664 56999999
Q ss_pred cCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~---~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|+++++|..++... ..+++..++.++.||+.||.|||+ ++ |+||||||+||+++. .+.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECC-CCCEEEeecCCcccccCC
Confidence 99999999998763 379999999999999999999996 57 999999999999984 679999999999776555
Q ss_pred CCccccCCCCcCCcccccc-------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHH---HHHHcCCCCCcccCCC
Q 006593 157 TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF---KKVTSGIKPASLAKVN 226 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~---~~i~~g~~p~~l~~~~ 226 (639)
......|++.|+|||.+.. .++.++|||||||++|+|++|..||.... ....+ ..+..+. +...+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 234 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGD-PPTLPSGY 234 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcC-CCCCCccc
Confidence 5556678999999998743 25789999999999999999999997532 22222 2333333 33345557
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
++++++||.+||. +|.+||++.+++.||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 8899999999998 899999999999999997554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=329.93 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=206.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|.+....... ....+.+..|+++|+.++||||+++++.+... ..+++||||
T Consensus 9 ig~g~~g---~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~ 82 (316)
T cd05574 9 LGKGDVG---RVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTE--TYLCLVMDY 82 (316)
T ss_pred ecCCccE---EEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecC--CEEEEEEEe
Confidence 6777777 89999999999999999998765422 23567799999999999999999999987654 568999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
+.+++|.+++.+. ..+++..++.++.||+.||.|||+.| ++||||||+||+++ .+|.++|+|||++......
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhcccccccc
Confidence 9999999999864 56899999999999999999999999 99999999999997 4579999999998644211
Q ss_pred ----------------------------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHH
Q 006593 157 ----------------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPA 207 (639)
Q Consensus 157 ----------------------------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~ 207 (639)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~-~ 238 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR-D 238 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch-H
Confidence 1123468999999998764 588899999999999999999999987443 3
Q ss_pred HHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCC----HHHHhcCcccccccCCC
Q 006593 208 QIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 208 ~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpS----a~ELL~Hpff~~~~~~~ 263 (639)
..+..+.............++.+++||.+||. +|.+||+ ++++|.||||+...+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 44444443322222222257899999999998 8999999 99999999998766543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.36 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=204.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|+.||+|.+...... .......+.+|+++|++++|+||+++++.+..+ ..+++|||
T Consensus 7 ~lg~G~~g---~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~--~~~~lv~e 80 (285)
T cd05632 7 VLGKGGFG---EVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETK--DALCLVLT 80 (285)
T ss_pred EEecCCCe---EEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC--CEEEEEEE
Confidence 47889988 8999999999999999998765432 223345678899999999999999999988655 46999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~ 157 (639)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCCc
Confidence 99999999888653 36999999999999999999999999 99999999999997 4579999999998654322 2
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHH---HHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~---~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.....|++.|+|||++. ..++.++|+||||+++|+|++|..||....... .+...+..+ ....+...++.+.+|
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 235 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKSI 235 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHHH
Confidence 23457999999999875 458999999999999999999999998643322 122222222 123344567889999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCcccccccCC
Q 006593 234 IEKCLV-PASERLS-----AKDLLKDPFLQVENQK 262 (639)
Q Consensus 234 I~kcL~-dP~~RpS-----a~ELL~Hpff~~~~~~ 262 (639)
+.+||+ +|.+||+ +.+++.|+||+...++
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 999999 8999999 8999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=322.93 Aligned_cols=242 Identities=28% Similarity=0.474 Sum_probs=197.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++.... ......+.+|+.++++++||||+++++++... ..+++||||
T Consensus 17 lg~g~~g---~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~--~~~~iv~e~ 87 (267)
T cd06646 17 VGSGTYG---DVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR--EKLWICMEY 87 (267)
T ss_pred eecCCCe---EEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CEEEEEEeC
Confidence 6777777 89999999999999999987543 23445688999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~~ 159 (639)
+.+|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++ +.+.+||+|||++....... ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccceeecccccccC
Confidence 999999999988888999999999999999999999999 99999999999997 55789999999997654322 23
Q ss_pred cccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--cCCCChHHHHH
Q 006593 160 SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKGF 233 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~s~~l~~L 233 (639)
...|++.|+|||.+. ..++.++|||||||++|+|++|..||..................+... ....+..+++|
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 457899999999873 347889999999999999999999997543222222111122222211 12346789999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
|.+||. +|.+||+++++|+|+|
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcCCC
Confidence 999998 8999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=318.52 Aligned_cols=243 Identities=30% Similarity=0.493 Sum_probs=201.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| +||+|.+..++..||+|++..... ......+.+|+.+|+.++|+||+++++.+... ..+++|||+
T Consensus 9 lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~e~ 80 (267)
T cd06610 9 IGVGATA---VVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG--DELWLVMPY 80 (267)
T ss_pred ecCCCCe---EEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC--CEEEEEEec
Confidence 6788877 899999999999999999876543 23667899999999999999999999988765 468999999
Q ss_pred CCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 82 FTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~---~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
+.+++|.+++... ..+++..++.++.||+.||.|||++| ++||||+|+||+++. .+.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGE-DGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcC-CCCEEEcccchHHHhccCcc
Confidence 9999999999764 45899999999999999999999999 999999999999984 5799999999997665332
Q ss_pred -----CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc----cCCC
Q 006593 158 -----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL----AKVN 226 (639)
Q Consensus 158 -----~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l----~~~~ 226 (639)
.....|++.|+|||.+.. .++.++|+||||+++|+|++|+.||..... ...+..+.....+... ....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKVLMLTLQNDPPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhhHHHHhcCCCCCcCCccccccc
Confidence 133568999999998764 488999999999999999999999987443 3344444333222111 1244
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
++.+++||.+||. +|.+||++.+|++||||
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 6789999999999 89999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=319.79 Aligned_cols=243 Identities=26% Similarity=0.476 Sum_probs=198.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC----CceEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK----KKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~----~~~l~ 76 (639)
||+|+|| .||+|.+..++..|++|++.... ...+.+.+|+.+++++ +|+||+++++++.... ...++
T Consensus 14 l~~g~~~---~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 14 IGEGTYG---KVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred ecCCCCe---EEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 6667666 89999999999999999987553 2346789999999999 7999999999987643 45689
Q ss_pred EEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 77 MITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||+|+||+++. .+.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~-~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTK-NAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEcc-CCeEEECCCcccee
Confidence 99999999999999875 357999999999999999999999999 999999999999984 57999999999865
Q ss_pred ccCC--CCccccCCCCcCCcccccc------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-cc
Q 006593 153 MQQP--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LA 223 (639)
Q Consensus 153 l~~~--~~~~~~GTp~ymAPE~l~~------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-l~ 223 (639)
.... ......|++.|+|||++.. .++.++||||||+++|+|++|..||........+ ..+..+..+.. .+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 241 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-FKIPRNPPPTLKSP 241 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-HHhhccCCCCCCch
Confidence 4322 2234578999999998742 3778999999999999999999999764333333 33444333221 22
Q ss_pred CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 224 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 224 ~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
...+..+++||.+||. +|.+|||+.++++|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2356789999999998 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.65 Aligned_cols=248 Identities=23% Similarity=0.430 Sum_probs=204.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|++.... .......+.+|+++++.++||||+++++++... ..+++|||
T Consensus 12 ~ig~g~~g---~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 83 (284)
T cd06620 12 DLGAGNGG---SVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCME 83 (284)
T ss_pred HcCCCCCe---EEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEEEe
Confidence 36778877 89999999999999999987543 234567789999999999999999999998766 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+++|+|.+++.+.+.+++..++.++.|++.||.|||+ ++ ++||||||+||+++ +.+.++|+|||++.........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhccC
Confidence 99999999999988889999999999999999999997 57 99999999999997 5679999999998765444445
Q ss_pred cccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCH-------H---HHHHHHHcCCCCCcccCCCCh
Q 006593 160 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP-------A---QIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~-------~---~i~~~i~~g~~p~~l~~~~s~ 228 (639)
...|+..|+|||++. ..++.++|||||||++|+|+||..||...... . .....+.....+.......+.
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 568999999999775 46889999999999999999999999753321 1 222333332222222223567
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.+.+||.+||+ +|.+||++.|+++||||...
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 89999999999 89999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.93 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=206.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|.+...... .......+..|+.+|++++||||+++++++... ..+|+||||
T Consensus 1 lg~g~~g---~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFG---EVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETK--DDLCLVMTL 74 (277)
T ss_pred CCCCCce---eEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC--CeEEEEEec
Confidence 6888888 8999999999999999998764432 223456678899999999999999999988654 468999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+++++|.+++.+.+ .+++..++.++.||+.||.|||+++ ++||||+|+||+++ +.+.+||+|||++...... ..
T Consensus 75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCcc
Confidence 99999999998765 7999999999999999999999999 99999999999997 5579999999998765432 22
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCC---HHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....+++.|+|||++. ..++.++||||||+++|+|++|+.||..... ...+...+.. .+...+...++.+++||
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li 229 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLC 229 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHH
Confidence 3456788999999875 3588899999999999999999999975332 2222222221 23334555688999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCcccccccCCCC
Q 006593 235 EKCLV-PASERL-----SAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 235 ~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~~ 264 (639)
.+||+ +|.+|| ++.+|+.||||...++...
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 230 EALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred HHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 99998 899999 8999999999987666443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=313.66 Aligned_cols=248 Identities=37% Similarity=0.587 Sum_probs=214.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|++| .||+|.+..+|..|++|++..... .....+.+.+|+.++++++||||+++++.+.......+++++|
T Consensus 7 ~i~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 7 LLGRGSFG---SVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred EeeecCce---EEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 37888888 899999999999999999886653 2456788999999999999999999999887664467899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
|+.+++|.+++.+.+.+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. .+.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcC-CCCEEEcccccEEecccccccc
Confidence 9999999999998889999999999999999999999999 999999999999984 5799999999987665443
Q ss_pred -CccccCCCCcCCccccccc-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~~~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
.....+++.|+|||.+... ++.++||||||+++|+|++|..||....+.......+..+.....++...+..+++||.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 3456789999999988654 88999999999999999999999987655555555555444445566666889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+||. +|.+||++.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=323.90 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=205.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|++| .||+|.+..++..||+|.+.... ......++.+|++++++++||||+++++++.+.....+++||||
T Consensus 9 lg~g~~~---~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 9 LGEGAGG---SVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eccCCce---EEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 6777777 89999999999999999988653 23456779999999999999999999999887766789999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeeccccccccccc
Confidence 999999998754 345899999999999999999999999 99999999999997 45789999999987655444
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCC----CCHHHHHHHHHcCCCCCc---cc--CCCC
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC----KNPAQIFKKVTSGIKPAS---LA--KVND 227 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~----~~~~~i~~~i~~g~~p~~---l~--~~~s 227 (639)
.....++..|+|||.+. ..++.++||||||+++|+|++|..||... ..+.+....+.....+.. .. ...+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239 (287)
T ss_pred cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchH
Confidence 44567889999999776 45899999999999999999999999754 233444444443222111 11 1235
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 228 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+.+++||.+||. +|.+|||+.|+++||||+...
T Consensus 240 ~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 689999999998 899999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.26 Aligned_cols=247 Identities=27% Similarity=0.461 Sum_probs=198.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL-LKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| .||+|.+..+|..||+|+++.... .....++..|+.+ ++.++||||+++++++.... .+|++||
T Consensus 9 ig~g~~g---~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~--~~~lv~e 80 (283)
T cd06617 9 LGRGAYG---VVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG--DVWICME 80 (283)
T ss_pred ecccCCe---EEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--cEEEEhh
Confidence 6777777 899999999999999999876532 2233455666665 67779999999999987654 5899999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 81 LFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 81 y~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
|+. |+|.+++.. ...+++..++.++.||+.||.|||++ + ++||||||+|||++ ..+.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeeccccccccc
Confidence 996 688888764 24689999999999999999999997 7 99999999999997 457999999999876543
Q ss_pred CCC-ccccCCCCcCCcccccc-----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PTA-RSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~~-~~~~GTp~ymAPE~l~~-----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
... ....|++.|+|||++.+ .++.++|+|||||++|+|++|..||....+..+....+..+..+.......+.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 322 23568999999998753 478899999999999999999999976444444444444443333333446789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+++||.+||. +|.+||++.+++.||||+...
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999998 899999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=327.33 Aligned_cols=245 Identities=28% Similarity=0.487 Sum_probs=203.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+|..||+|.+..... ...+.+.+|+.+++.+.||||+++++.|... ..+++||||
T Consensus 28 lg~g~~~---~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~--~~~~lv~e~ 98 (296)
T cd06654 28 IGQGASG---TVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVMEY 98 (296)
T ss_pred ecCCCCe---EEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC--CEEEEeecc
Confidence 6777777 899999999999999999886543 3346788999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~~ 159 (639)
+.+|+|.+++.. ..+++..+..++.||+.||.|||+.| |+||||||+||+++ .++.+||+|||++....... ..
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccccchhccccccccC
Confidence 999999999865 45899999999999999999999999 99999999999997 55799999999987654322 23
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...|++.|+|||.+.. .++.++|||||||++|+|++|..||.........+.....+..+...+...++.+.+||.+||
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 4578999999998764 478999999999999999999999976443333433333333333334456788999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
. +|.+||++.+++.||||...
T Consensus 255 ~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 255 DMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cCCcccCcCHHHHhhChhhhcc
Confidence 9 89999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=326.76 Aligned_cols=246 Identities=29% Similarity=0.516 Sum_probs=204.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| +||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..+++|+||
T Consensus 27 lg~g~~g---~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 97 (296)
T cd06655 27 IGQGASG---TVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVG--DELFVVMEY 97 (296)
T ss_pred EecCCCe---EEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecC--ceEEEEEEe
Confidence 6777777 89999999999999999987543 23456788999999999999999999988765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~~ 159 (639)
+.+++|..++... .+++..+..++.||+.||.|||++| ++||||||+||+++ ..|.+||+|||++....... ..
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchhcccccccCC
Confidence 9999999998754 5899999999999999999999999 99999999999997 56899999999987654322 23
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...|++.|+|||.+.. .++.++|||||||++|+|++|..||...............+..+...+...++.+++||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence 4578999999998764 588999999999999999999999987443333333323333333345556789999999999
Q ss_pred C-CCCCCCCHHHHhcCccccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. +|.+||++.+++.||||+...
T Consensus 254 ~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 254 EMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hcChhhCCCHHHHhhChHhhhcc
Confidence 8 899999999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=315.65 Aligned_cols=244 Identities=24% Similarity=0.468 Sum_probs=207.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||.|+|| .||.+.+..+|..|++|.+..... .......+.+|+.++++++|+||+++++++.+. ..++++||
T Consensus 7 ~ig~g~~g---~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~~~e 79 (256)
T cd08221 7 VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDD--NTLLIEME 79 (256)
T ss_pred EecccCCc---eEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC--CeEEEEEE
Confidence 47888888 788899999999999999886653 335567789999999999999999999998765 56899999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++ ..+.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcccccc
Confidence 99999999999875 46899999999999999999999999 99999999999998 45799999999987654322
Q ss_pred -CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
.....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+..+..+. .....+.++.++|.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 234 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELISLVH 234 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHHH
Confidence 345678999999998764 478899999999999999999999976 45566666666554433 33556789999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+||. +|.+||++.++|+|||+
T Consensus 235 ~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHcccCcccCCCHHHHhhCcCC
Confidence 9998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=334.24 Aligned_cols=254 Identities=22% Similarity=0.390 Sum_probs=222.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|.|| .|.+++.+.+|+.+|+|+++++-+. ..++...-..|-++|+.++||.+..+..+|... +++|+|||
T Consensus 175 vLGkGTFG---KVIL~rEKat~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~--drlCFVMe 248 (516)
T KOG0690|consen 175 VLGKGTFG---KVILCREKATGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ--DRLCFVME 248 (516)
T ss_pred HhcCCccc---eEEEEeecccCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC--ceEEEEEE
Confidence 57888777 8999999999999999999877654 456777788999999999999999998888655 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~~ 158 (639)
|..||.|.-.+.+.+.+++...+.+...|+.||.|||+++ ||+||||.+|+|++ .+|+|||+|||+++.-. ....
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhccccccee
Confidence 9999999999999999999999999999999999999999 99999999999998 56899999999997543 3456
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
.++||||.|.|||++.. .|+.++|+|.+|+++|||++|++||.. .+...++..|.-. ...++...+++++.|+..+
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~e--d~kFPr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILME--DLKFPRTLSPEAKTLLSGL 402 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhh--hccCCccCCHHHHHHHHHH
Confidence 78999999999999985 599999999999999999999999986 3455666666553 2346777899999999999
Q ss_pred cC-CCCCCCC-----HHHHhcCcccccccCCCCcC
Q 006593 238 LV-PASERLS-----AKDLLKDPFLQVENQKEPIC 266 (639)
Q Consensus 238 L~-dP~~RpS-----a~ELL~Hpff~~~~~~~~~~ 266 (639)
|. ||.+|.. |.|+.+|+||...+|.....
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~ 437 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYR 437 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHH
Confidence 98 8999985 89999999999988865433
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=317.39 Aligned_cols=248 Identities=29% Similarity=0.505 Sum_probs=211.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||.||+| .||+|.+..+|..||+|++..... ......+..|+..+.+++|+||+++++++... ..+++|||
T Consensus 8 ~i~~g~~~---~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 79 (264)
T cd06623 8 VLGQGSSG---VVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE--GEISIVLE 79 (264)
T ss_pred eeeecCCe---EEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC--CeEEEEEE
Confidence 47788877 899999999999999999876542 25567899999999999999999999988765 56899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+.+++|.+++.....+++..++.++.||+.||.|||+ .+ ++||||+|+||+++ ..+.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCCCc
Confidence 99999999999988889999999999999999999999 99 99999999999997 4579999999998766543322
Q ss_pred --cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC--CHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 160 --SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 160 --~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~--~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
...+++.|+|||.+.. .++.++|+||||+++|+|+||..||.... ...+..+.+.....+.......+..+.++|
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 4578999999998764 57889999999999999999999997754 555666666655444333332678999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.+||. +|.+||++.+++.||||+..
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHccCChhhCCCHHHHHhCHHHHhc
Confidence 99998 89999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.16 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=206.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||.|+|| .||+|.+..+|..||+|++..... ......+.+.+|++++++++||||+++++++... ..+++|+|
T Consensus 7 ~i~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 80 (258)
T cd05578 7 VIGKGAFG---KVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE--ENMYLVVD 80 (258)
T ss_pred EeccCCCc---eEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC--CeEEEEEe
Confidence 37888888 899999999999999999986543 2234567899999999999999999999987554 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~ 159 (639)
|+.|++|.+++.+...+++..++.|+.||+.||.|||.++ ++|+||+|+||+++ +++.++|+|||++...... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCcccc
Confidence 9999999999988878999999999999999999999999 99999999999998 5579999999998765443 234
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCC--HHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
...|+..|+|||++.. .++.++|+||||+++|+|++|..||..... ...+.+.... .....+...+..+.++|.+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINK 235 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHH
Confidence 5678999999998764 478999999999999999999999986543 3444333332 2333445567899999999
Q ss_pred hcC-CCCCCCCH--HHHhcCccc
Q 006593 237 CLV-PASERLSA--KDLLKDPFL 256 (639)
Q Consensus 237 cL~-dP~~RpSa--~ELL~Hpff 256 (639)
||. +|.+||++ .|++.||||
T Consensus 236 ~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HccCChhHcCCccHHHHhcCCCC
Confidence 998 89999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.39 Aligned_cols=246 Identities=26% Similarity=0.414 Sum_probs=197.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++..||+|.++.... ......+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 14 lg~g~~g---~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--~~~~lv~e~ 85 (301)
T cd07873 14 LGEGTYA---TVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVFEY 85 (301)
T ss_pred eccCcCE---EEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecC--CeEEEEEec
Confidence 6777777 899999999999999999976542 22344577899999999999999999998655 468999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCCCcc
Confidence 97 5899988764 56899999999999999999999999 99999999999997 5579999999998754322 22
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC---C----------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---I---------------- 217 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g---~---------------- 217 (639)
....+++.|+|||++.+ .++.++||||||+++|+|+||.+||..... ......+... .
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 34467999999998753 478899999999999999999999986433 2222221110 0
Q ss_pred --CCC-------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 218 --KPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 218 --~p~-------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.+. ......++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0112346789999999999 899999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=370.86 Aligned_cols=254 Identities=20% Similarity=0.346 Sum_probs=223.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .|.+.+++.|++.||+|++.+.+... ..+..-|..|-.+|-..+.+-|++++..|.|+ +++|+|||
T Consensus 82 vIGrGaFG---EV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--~~LYlVMd 155 (1317)
T KOG0612|consen 82 VIGRGAFG---EVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQDE--RYLYLVMD 155 (1317)
T ss_pred Hhcccccc---eeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--cceEEEEe
Confidence 58999999 67888899999999999998866543 24556688999999999999999999999776 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-CC--
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~-~~-- 157 (639)
|++||+|-.++.+..+++++.+++|+..|+.||.-||+.| +|||||||+|||++ ..|+|||+|||.+..+.. +.
T Consensus 156 Y~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V~ 232 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTVR 232 (1317)
T ss_pred cccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcEE
Confidence 9999999999999999999999999999999999999999 99999999999998 669999999999977763 33
Q ss_pred CccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--CCCChH
Q 006593 158 ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQ 229 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~ 229 (639)
....+|||.|.+||++. +.|++.+|+||+|||+|||+.|..||.. .+....|.+|++......+| ...+.+
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 23468999999999884 3599999999999999999999999987 57788899998875555555 446899
Q ss_pred HHHHHHHhcCCCCCCCC---HHHHhcCcccccccCCCC
Q 006593 230 IKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 230 l~~LI~kcL~dP~~RpS---a~ELL~Hpff~~~~~~~~ 264 (639)
+++||.+.|.+|..|.+ ++++..||||....|...
T Consensus 312 akdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~i 349 (1317)
T KOG0612|consen 312 AKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNI 349 (1317)
T ss_pred HHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhh
Confidence 99999999999999888 999999999999999543
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=322.95 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=198.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC---CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK---KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~---~~~l~l 77 (639)
||+|+|| .||+|.+..+|..||+|++.... .....+..|+.+++++ +||||+++++++...+ ...+++
T Consensus 30 l~~g~~~---~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 30 IGKGTYG---KVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred eecCCCe---EEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 6777777 89999999999999999986432 2345678899999999 8999999999987543 246899
Q ss_pred EEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 78 ITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
||||+.+|+|.++++. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++...
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEeecccchhc
Confidence 9999999999998863 457899999999999999999999999 99999999999997 5578999999998765
Q ss_pred cCCC--CccccCCCCcCCcccccc------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccC
Q 006593 154 QQPT--ARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAK 224 (639)
Q Consensus 154 ~~~~--~~~~~GTp~ymAPE~l~~------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~ 224 (639)
.... .....|++.|+|||++.. .++.++|||||||++|+|++|.+||........+ ..+..+..+ ...+.
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 257 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRNPPPTLLHPE 257 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcCCCCCCCccc
Confidence 4322 234578999999998753 2688999999999999999999999874433333 334333222 12233
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 225 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 225 ~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
.....+++||.+||+ +|.+||++.|++.||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 445789999999999 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=322.65 Aligned_cols=243 Identities=26% Similarity=0.443 Sum_probs=196.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC---CCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD---KKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~---~~~~l~l 77 (639)
||+|+|| .||+|.+..+|..||+|++.... .....+..|+.+++.+ +||||+++++++... ....+++
T Consensus 26 lg~g~~~---~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 26 IGKGTYG---KVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred eccCCCc---EEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 6777777 89999999999999999875432 2235678899999999 799999999987542 3357899
Q ss_pred EEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 78 ITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
||||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEEccCCceeec
Confidence 9999999999998753 356899999999999999999999999 99999999999997 4578999999998765
Q ss_pred cCC--CCccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCcccC
Q 006593 154 QQP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAK 224 (639)
Q Consensus 154 ~~~--~~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~ 224 (639)
... ......|++.|+|||++. ..++.++|||||||++|+|++|..||........+. .+..+.. ....+.
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 253 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPPTLHQPE 253 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccccCCCcccCCC
Confidence 432 223457999999999874 347889999999999999999999998754333333 2322222 222344
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 225 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 225 ~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
..+..+++||.+||. +|.+||++.|+|+|+||
T Consensus 254 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 557789999999998 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=321.70 Aligned_cols=245 Identities=25% Similarity=0.406 Sum_probs=198.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++..... .....+.+..|+.++++++||||+++++++... ..+++||||
T Consensus 9 l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~e~ 81 (286)
T cd07847 9 IGEGSYG---VVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK--RKLHLVFEY 81 (286)
T ss_pred ecccCCe---EEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC--CEEEEEEec
Confidence 6777777 899999999999999999875432 223345678999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~~ 159 (639)
+++++|..++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ ..|.+||+|||++....... ..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCCccccc
Confidence 999999988877778999999999999999999999999 99999999999997 55799999999997664432 23
Q ss_pred cccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CC------------------
Q 006593 160 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI------------------ 217 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~------------------ 217 (639)
...++..|+|||++.+ .++.++||||||+++|+|++|+.||.+..+...+...... ..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 4568899999998753 4789999999999999999999999875544433322110 00
Q ss_pred CCC--------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 218 KPA--------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 218 ~p~--------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.+. ......+..+.+||.+||. +|.+||++.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0012236789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.06 Aligned_cols=231 Identities=28% Similarity=0.415 Sum_probs=198.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+.| .||+|+. .++.||||.|+.- -..+|+-|++|+||||+.|.+++ .....+||||||
T Consensus 132 lGSGaQG---AVF~Grl--~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEf 193 (904)
T KOG4721|consen 132 LGSGAQG---AVFLGRL--HNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEF 193 (904)
T ss_pred hccCccc---ceeeeec--cCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeee--cCCceeEEeeec
Confidence 6777777 7999975 4778999987632 24689999999999999999966 455689999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
|..|-|...|+....+....+..|..+|+.|+.|||.+. |||||||.-||||+.+ ..|||+|||-++..... +.-.
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhh
Confidence 999999999999999999999999999999999999999 9999999999999855 48999999999876543 4557
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
++||..|||||+++. ..++|+|||||||+||||+||+.||.+... ..|+--+-.+......+..++..++-||+.||.
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 899999999999975 589999999999999999999999987433 334444555555556677778889999999998
Q ss_pred -CCCCCCCHHHHhcCc
Q 006593 240 -PASERLSAKDLLKDP 254 (639)
Q Consensus 240 -dP~~RpSa~ELL~Hp 254 (639)
+|..||+..++|.|-
T Consensus 350 sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHL 365 (904)
T ss_pred cCCCCCccHHHHHHHH
Confidence 899999999999983
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=321.22 Aligned_cols=250 Identities=22% Similarity=0.401 Sum_probs=214.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||..|.|+.|.|++++...+|...|||++.... +.++.+++...+.++... +.|+||+.|++|+.+.. +++.||
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~IcMe 171 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFICME 171 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHHHH
Confidence 566677777799999999999999999999776 567888999999988777 49999999999988765 778889
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
+|. .-+..++++ .++++|..+-++...+++||.||.. |+ |||||+||.|||+| ..|.|||||||++..+-...+
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEc-cCCCEEeecccccceeecccc
Confidence 994 466666654 4679999999999999999999976 46 99999999999998 568999999999988876655
Q ss_pred cc-ccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCC-CChHHHH
Q 006593 159 RS-VIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV-NDPQIKG 232 (639)
Q Consensus 159 ~~-~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~-~s~~l~~ 232 (639)
++ ..|-+.|||||.+. ..|+.++||||||+.++||+||.+||.+|....+.+-+|....+|...... .++.+++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~ 327 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQS 327 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHH
Confidence 44 47899999999886 359999999999999999999999999999988988888886554333222 6899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
|+..||. |+.+||...+||+|||+....
T Consensus 328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 328 FVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999 899999999999999997544
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=380.74 Aligned_cols=248 Identities=30% Similarity=0.449 Sum_probs=219.0
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCC
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS 84 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~g 84 (639)
+|-|++|.||.|.+..+|+..|+|.+++.+.. ......+..|..+|..|+|||+|+||++=++.+ .++|.||||.+
T Consensus 1243 Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--kv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1243 IGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--KVYIFMEYCEG 1318 (1509)
T ss_pred cCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHH--HHHHHHHHhcc
Confidence 45566669999999999999999999988753 345566889999999999999999999765554 48899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC------C
Q 006593 85 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT------A 158 (639)
Q Consensus 85 GsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~------~ 158 (639)
|+|.++++..+..+|...+.+..|++.|+.|||++| ||||||||.|||++ ..|.+|++|||.|..+.... .
T Consensus 1319 GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1319 GSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred CcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCchhcCCHHH
Confidence 999999998888999999999999999999999999 99999999999998 55899999999997765442 2
Q ss_pred ccccCCCCcCCcccccc----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....|||.|||||++.+ +...++|||||||+++||+||+.||...++..+|+-+|..|..|... ...+++.++||
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P-~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP-ERLSSEGRDFL 1474 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc-hhhhHhHHHHH
Confidence 35689999999999864 46789999999999999999999999999999999999999888654 44789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+.||. ||.+|.++.|||.|.|-+...
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHhhcccccc
Confidence 99998 999999999999999876543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=326.64 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=208.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++..||+|.+..... ........+..|+.+++.++||||+++++++... ..+++||||
T Consensus 9 l~~g~~~---~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 82 (305)
T cd05609 9 ISNGAYG---AVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETK--RHLCMVMEY 82 (305)
T ss_pred eecCCCe---eEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC--CEEEEEEec
Confidence 6777777 899999999999999999876542 2234566788999999999999999999988654 568999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-----
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~----- 156 (639)
++||+|.++++..+.+++..+..++.||+.||.|||+++ ++||||||.||+++ ..|.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccccc
Confidence 999999999998888999999999999999999999999 99999999999997 5689999999988531100
Q ss_pred ------------CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-Ccc
Q 006593 157 ------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASL 222 (639)
Q Consensus 157 ------------~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l 222 (639)
......|++.|+|||.+. ..++.++||||||+++|+|++|..||.+ ..+.++...+..+..+ ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~ 238 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEG 238 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCCCCc
Confidence 011246788999999775 4689999999999999999999999986 3556666666554322 222
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCC---HHHHhcCcccccccCCC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLS---AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpS---a~ELL~Hpff~~~~~~~ 263 (639)
....++++++||.+||+ +|.+||+ +.++|.||||....+..
T Consensus 239 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 23467889999999999 8999998 89999999998766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.72 Aligned_cols=244 Identities=24% Similarity=0.395 Sum_probs=198.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+|..||+|++..... .......+.+|+.++++++||||+++++++... ..+++||||
T Consensus 8 l~~g~~~---~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 80 (286)
T cd07832 8 IGEGAHG---IVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHG--SGFVLVMEY 80 (286)
T ss_pred cccCCCc---EEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC--CeeEEEecc
Confidence 6777777 799999999999999999987653 234456789999999999999999999998764 568999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ ++|+||||+||+++. .+.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISA-DGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcC-CCcEEEeeeeecccccCCCCCc
Confidence 9 9999999865 456999999999999999999999999 999999999999984 5799999999987665432
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC-C---------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-P--------------- 219 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p--------------- 219 (639)
.....|++.|+|||.+.. .++.++||||||+++|+|++|.+||....+... +..+..... +
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ-LAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH-HHHHHHHcCCCChHHHhhccCcchhh
Confidence 234578999999998753 468999999999999999999888876443332 222211100 0
Q ss_pred ------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 220 ------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 220 ------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
.......+..+.+||.+||. +|.+||+++++|+||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00112345789999999999 899999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=315.13 Aligned_cols=240 Identities=34% Similarity=0.552 Sum_probs=199.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++..||+|.+.... ..+.+.+|+++++.++||||+++++++... ..+|+++||
T Consensus 11 i~~g~~~---~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~ 79 (256)
T cd06612 11 LGEGSYG---SVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDLWIVMEY 79 (256)
T ss_pred hcCCCCe---EEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcEEEEEec
Confidence 6777777 89999999989999999987542 267799999999999999999999988765 568999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--C
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~ 158 (639)
+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++ +.+.+||+|||++....... .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchhcccCcccc
Confidence 999999999976 456899999999999999999999999 99999999999998 45799999999997665432 2
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC-CCCcccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~-~p~~l~~~~s~~l~~LI~k 236 (639)
....|++.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+.... .....+...+..+.+||.+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP-MRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch-hhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 34568999999998764 588999999999999999999999976433 22222222221 1222233456789999999
Q ss_pred hcC-CCCCCCCHHHHhcCccc
Q 006593 237 CLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff 256 (639)
||. +|.+||++.|+|.||||
T Consensus 236 ~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 236 CLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHhcChhhCcCHHHHhcCCCC
Confidence 998 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.65 Aligned_cols=245 Identities=34% Similarity=0.591 Sum_probs=205.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..++..||+|.++..... ....+.+..|+.+++.++|+||+++++++... ..+++|+|
T Consensus 7 ~lg~G~~~---~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~lv~e 79 (264)
T cd06626 7 KIGGGTFG---KVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHR--EKVYIFME 79 (264)
T ss_pred EeecCCCc---EEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecC--CEEEEEEe
Confidence 37888888 8999999999999999999876532 45778899999999999999999999976544 56899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC--
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-- 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~-- 158 (639)
|+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++|+||+|+||+++ +.+.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCcc
Confidence 9999999999998878999999999999999999999999 99999999999998 468999999999876543211
Q ss_pred ----ccccCCCCcCCcccccc-c---CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCC--CCh
Q 006593 159 ----RSVIGTPEFMAPELYEE-E---YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV--NDP 228 (639)
Q Consensus 159 ----~~~~GTp~ymAPE~l~~-~---ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~--~s~ 228 (639)
....+++.|+|||++.. . ++.++||||||+++|+|++|..||....+.......+..+.. ..++.. .++
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK-PPIPDSLQLSP 235 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCC-CCCCcccccCH
Confidence 13568899999998763 2 788999999999999999999999875555544444444322 223333 378
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.+.+||.+||+ +|.+||++.+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 89999999998 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=326.61 Aligned_cols=247 Identities=28% Similarity=0.491 Sum_probs=203.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+|..||+|.+..... ...+.+..|+.+++.++||||+++++++... ..+++||||
T Consensus 27 lg~g~~g---~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 97 (297)
T cd06656 27 IGQGASG---TVYTAIDIATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVMEY 97 (297)
T ss_pred eccCCCe---EEEEEEECCCCCEEEEEEEecCcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CEEEEeecc
Confidence 6777777 899999999999999999875542 3346688999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++ ..|.++|+|||++...... ...
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCccceEccCCccCcC
Confidence 999999999875 45899999999999999999999999 99999999999997 5689999999998655432 223
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...|++.|+|||.+.+ .++.++|+||||+++|+|++|..||........+......+..+...+...++.+++||.+||
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence 4578999999998764 588999999999999999999999976433333332222333333344556788999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccccC
Q 006593 239 V-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
. +|.+||++.++|+||||+....
T Consensus 254 ~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 254 EMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred cCChhhCcCHHHHhcCchhccccc
Confidence 9 8999999999999999985543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.98 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=202.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-D-----DNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-H-----pNIVkl~~~~~~~~~~~ 74 (639)
+||+|.|| .|-+|.|..|++.||||+++-. +....+...|+.+|..|+ | -|||++|++|...+ +
T Consensus 193 ~LGkGtFG---QVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~--H 262 (586)
T KOG0667|consen 193 VLGKGSFG---QVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN--H 262 (586)
T ss_pred Eecccccc---eeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc--c
Confidence 58888888 7899999999999999999844 456677889999999996 4 48999999998764 5
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC-CCCcEEEeecchhh
Q 006593 75 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAI 151 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~-~~g~VKL~DFGlA~ 151 (639)
+|||+|++. -+|.+|++.++ .++...++.++.||+.||.+||+.+ |||+||||+|||+.. ....|||+|||.|+
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999999995 69999999864 6899999999999999999999999 999999999999953 23479999999998
Q ss_pred hccCCCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH----------------
Q 006593 152 AMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---------------- 214 (639)
Q Consensus 152 ~l~~~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~---------------- 214 (639)
....... +++-+..|+|||++- ..|+.+.||||||||++||++|.+.|.+.....++...+.
T Consensus 340 ~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 340 FESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred ccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 7765544 888999999999775 5799999999999999999999988988655555433220
Q ss_pred -----c--CC------------------------------CC-------CcccCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 006593 215 -----S--GI------------------------------KP-------ASLAKVNDPQIKGFIEKCLV-PASERLSAKD 249 (639)
Q Consensus 215 -----~--g~------------------------------~p-------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~E 249 (639)
. +. .| ..+....+..+.+||.+||. ||.+|+|+.+
T Consensus 419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q 498 (586)
T KOG0667|consen 419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ 498 (586)
T ss_pred ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence 0 00 00 00011224568999999999 9999999999
Q ss_pred HhcCcccccccC
Q 006593 250 LLKDPFLQVENQ 261 (639)
Q Consensus 250 LL~Hpff~~~~~ 261 (639)
.|+||||.....
T Consensus 499 al~Hpfl~~~~~ 510 (586)
T KOG0667|consen 499 ALNHPFLTGTSL 510 (586)
T ss_pred HhcCcccccccc
Confidence 999999985443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=321.08 Aligned_cols=244 Identities=29% Similarity=0.471 Sum_probs=196.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|++| .||+|.+..+|..||+|+++.... .......+.+|++++++++||||+++++++.+. ..+++||||
T Consensus 8 l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~ 80 (284)
T cd07860 8 IGEGTYG---VVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLYLVFEF 80 (284)
T ss_pred ecCCCce---EEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccC--CcEEEEeec
Confidence 6777777 899999999999999999876542 223446788999999999999999999988654 468999999
Q ss_pred CCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 82 FTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
+. ++|..++.. ...+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.+||+|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccCccc
Confidence 96 689998865 356899999999999999999999999 99999999999998 5579999999998765432 2
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC----------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP---------------- 219 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p---------------- 219 (639)
.....+++.|+|||++.+ .++.++||||||+++|+|+||+.||..........+.+.....+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 233457899999998764 36888999999999999999999997754444443322211110
Q ss_pred ----------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 220 ----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 220 ----------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.......++++++||.+||. +|.+||+++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01112356789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=325.16 Aligned_cols=247 Identities=27% Similarity=0.531 Sum_probs=204.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.+... ...++|||
T Consensus 29 ~lg~g~~g---~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~--~~~~lv~e 99 (292)
T cd06658 29 KIGEGSTG---IVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVG--DELWVVME 99 (292)
T ss_pred cccCCCCe---EEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecC--CeEEEEEe
Confidence 37888887 89999999999999999986542 34566789999999999999999999988765 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+.+++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++...... ..
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccC
Confidence 9999999998864 56899999999999999999999999 99999999999997 4579999999998755332 22
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC-cccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~~~s~~l~~LI~k 236 (639)
....|++.|+|||++.. .++.++||||||+++|||++|..||... .+...+..+.....+. ......+..+++||.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 34578999999998764 5889999999999999999999999763 4444444444332221 1223457789999999
Q ss_pred hcC-CCCCCCCHHHHhcCcccccccC
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
||. +|.+|||++++|+||||+....
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCC
Confidence 998 8999999999999999985543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.87 Aligned_cols=248 Identities=23% Similarity=0.412 Sum_probs=198.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|+|| .||++.+..+|..||+|++..... ......+..|+.++.++. ||||+++++++..+. ..+++|
T Consensus 11 ~lg~G~~g---~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--~~~~~~ 82 (288)
T cd06616 11 EIGRGAFG---TVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--DCWICM 82 (288)
T ss_pred HhCCCCce---EEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC--cEEEEE
Confidence 37888887 899999999999999999886542 245667899999999996 999999999887653 478999
Q ss_pred ecCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 80 ELFTSGNLRQYRK-----KHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 80 Ey~~gGsL~d~lk-----k~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
||+.. +|.++.. ..+.+++..+..++.|++.||+|||+. + ++||||||+||+++ ..+.+||+|||++..+
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHh
Confidence 99864 6655432 246799999999999999999999974 7 99999999999997 4579999999999765
Q ss_pred cCCC-CccccCCCCcCCcccccc----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc---cCC
Q 006593 154 QQPT-ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL---AKV 225 (639)
Q Consensus 154 ~~~~-~~~~~GTp~ymAPE~l~~----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l---~~~ 225 (639)
.... .....|++.|+|||++.. .++.++|||||||++|+|++|+.||.......+....+..+..+... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 4332 234568999999998864 48899999999999999999999998755333333344333332221 223
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 226 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 226 ~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.++++.+||.+||. +|.+||+++++++||||+...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 67889999999999 899999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.99 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=199.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|+++..... ......+.+|+.++++++|+||+++++++.......+++||||
T Consensus 15 ig~g~~~---~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 15 IGEGTYG---IVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eeecCCE---EEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 6777777 8999999999999999998865421 1222345689999999999999999999887665678999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+. ++|.+++... ..+++..++.++.||+.||.|||++| ++||||||+||+++ +.+.+||+|||++...... ..
T Consensus 90 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~ 165 (309)
T cd07845 90 CE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPM 165 (309)
T ss_pred CC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeecCCccCCC
Confidence 96 5898888763 67899999999999999999999999 99999999999997 5579999999999766432 22
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--C---------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P--------------- 219 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p--------------- 219 (639)
....+++.|+|||++.+ .++.++||||||+++|+|++|.+||... +..+.+..+..... .
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK-SEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 23356888999998753 4789999999999999999999999864 34444433322100 0
Q ss_pred Ccc-----------cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 ASL-----------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 ~~l-----------~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
... ....++.+.+||.+||+ ||.+|||+.++|.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 000 01246789999999999 999999999999999997443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.49 Aligned_cols=243 Identities=22% Similarity=0.323 Sum_probs=192.3
Q ss_pred cccccccCcEEEEEEEe--cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d--~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||.|+|| .||+|.. ..++..||+|.+.... ...+|+.+|++|+||||++++++|... ..+|+||
T Consensus 100 Lg~G~~g---~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~--~~~~lv~ 165 (392)
T PHA03207 100 LTPGSEG---EVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWK--STVCMVM 165 (392)
T ss_pred ecCCCCe---EEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeC--CEEEEEe
Confidence 6777777 7888875 3467889999876432 246799999999999999999988655 4689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|++. ++|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++..+....
T Consensus 166 e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccCccccc
Confidence 9996 689999987888999999999999999999999999 99999999999997 55799999999997654322
Q ss_pred --CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH--HHHHHHHHc-----------------
Q 006593 158 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTS----------------- 215 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~--~~i~~~i~~----------------- 215 (639)
.....||+.|+|||++.. .|+.++|||||||++|||++|..||.+.... ...+..+..
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 234679999999998864 5899999999999999999999999653321 111111111
Q ss_pred ---------CCCC-Cccc-----CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 216 ---------GIKP-ASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 216 ---------g~~p-~~l~-----~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
...+ ...+ ...+.++++||.+||. +|.+|||+.|+|.||||+...+.
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 0000 0011 1235678999999999 99999999999999999865543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.25 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=199.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|+|| .||+|.+..+|..||+|.++..... ......+.+|+.++++++||||+++++++...+...+|+|||
T Consensus 12 ~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 12 RIEEGTYG---VVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhcCCCCe---EEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 36778777 8999999999999999999866532 233445778999999999999999999988776578999999
Q ss_pred cCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 81 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
|+. ++|.+++.... .+++..++.++.||+.||.|||+++ ++||||||+|||++ +.|.+||+|||++...... .
T Consensus 87 ~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 87 YVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred hcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCccc
Confidence 997 59999987654 5899999999999999999999999 99999999999998 5589999999998765443 2
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC------------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI------------------ 217 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~------------------ 217 (639)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|..||....... ...++....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhccchhc
Confidence 234567899999998754 36889999999999999999999998644332 222221100
Q ss_pred -----------CCCcccCC-CChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 218 -----------KPASLAKV-NDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 218 -----------~p~~l~~~-~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
....++.. .++.+++||.+||+ +|.+|||+.|+|.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00112222 46789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.55 Aligned_cols=244 Identities=24% Similarity=0.470 Sum_probs=205.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||++.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++... ...++|||
T Consensus 7 ~lg~g~~g---~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd08218 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEEN--GNLYIVMD 79 (256)
T ss_pred EeccCCce---EEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC--CeEEEEEe
Confidence 37888888 799999999999999999986543 234556789999999999999999999987554 56899999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+.+++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||+|+||+++ ..+.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCcchh
Confidence 999999999987643 5789999999999999999999999 99999999999997 45799999999987554321
Q ss_pred -CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
.....|++.|+|||++.. .++.++|+||||+++++|++|..||.. .+.......+..+..+. .+...+.++.++|.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 234 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP-VSSHYSYDLRNLVS 234 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCC-CcccCCHHHHHHHH
Confidence 234568999999998764 578899999999999999999999976 34555666665554433 34456789999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+||+ +|.+||++.++|+||||
T Consensus 235 ~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 235 QLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHhhCChhhCcCHHHHhhCcCC
Confidence 9998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.40 Aligned_cols=248 Identities=28% Similarity=0.481 Sum_probs=201.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccC------ChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ------LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~------~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~ 74 (639)
+||.|+|| .||+|.+..+|..||+|+++...... .....+.+..|+.+++.++||||+++++++... ..
T Consensus 8 ~lg~g~~~---~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 82 (272)
T cd06629 8 LIGKGTYG---RVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE--EY 82 (272)
T ss_pred eecccCce---EEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC--Cc
Confidence 37788887 89999999999999999987542211 112345788999999999999999999987654 56
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 75 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ ..+.++|+|||++....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccccccc
Confidence 8999999999999999998888999999999999999999999999 99999999999997 55899999999987554
Q ss_pred CC----CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC---CCCcccC
Q 006593 155 QP----TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAK 224 (639)
Q Consensus 155 ~~----~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~---~p~~l~~ 224 (639)
.. ......|+..|+|||++.. .++.++|+||||+++|+|++|..||........+........ .+.....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 22 1233568899999998753 378899999999999999999999976444433333222211 1222333
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 225 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 225 ~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
..+..+++||.+||. +|.+||+++++|+||||
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 457899999999998 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=335.51 Aligned_cols=238 Identities=26% Similarity=0.386 Sum_probs=185.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++..||+|...... ...|+.+|++++||||+++++++... ...++||||
T Consensus 74 lg~G~~g---~Vy~~~~~~~~~~valK~~~~~~----------~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 138 (357)
T PHA03209 74 LTPGSEG---RVFVATKPGQPDPVVLKIGQKGT----------TLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMVLPH 138 (357)
T ss_pred ecCCCCe---EEEEEEECCCCceEEEEeCCccc----------cHHHHHHHHhCCCCCCcChhheEEeC--CeeEEEEEc
Confidence 5677776 89999999999999999743221 35699999999999999999998765 458899999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-CCCc
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~-~~~~ 159 (639)
+. |+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..... ....
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCccccccccCcccc
Confidence 95 588888765 467999999999999999999999999 99999999999997 557999999999875432 2334
Q ss_pred cccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCC-CCCCCH---------HHHHHHHHc-CCCCCccc----
Q 006593 160 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPY-SECKNP---------AQIFKKVTS-GIKPASLA---- 223 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf-~~~~~~---------~~i~~~i~~-g~~p~~l~---- 223 (639)
...||+.|+|||++. ..|+.++|||||||++|||+++..|+ ...... ..+...+.. +..+..++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 567999999999876 46899999999999999999865444 321111 111111111 11111111
Q ss_pred --------------------------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 224 --------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 224 --------------------------~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
...+..+.+||.+||+ ||.+|||+.|+|+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1234567889999999 9999999999999999974
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.26 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=199.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+| +|.+++||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||++++++|... ..+++|+||
T Consensus 6 ig~g-~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~~v~e~ 80 (328)
T cd08226 6 IGRG-FCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG--SWLWVISPF 80 (328)
T ss_pred hCCc-ccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC--CceEEEEec
Confidence 6786 67777999999999999999999886543 335567899999999999999999999998765 458999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
+.+|+|.+++++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.++++||+.+...... .
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCcc
Confidence 9999999999875 35899999999999999999999999 99999999999997 4579999999865433211 0
Q ss_pred C-------ccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC-C-------
Q 006593 158 A-------RSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-P------- 219 (639)
Q Consensus 158 ~-------~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p------- 219 (639)
. ....++..|||||++.. .++.++|||||||++|+|++|..||............+..... +
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 11234667999998864 3789999999999999999999999875544443333221100 0
Q ss_pred ------------------------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 ------------------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 ------------------------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.......++.+++||.+||. +|.+|||+.|+|+||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00112235678999999998 999999999999999997544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.66 Aligned_cols=246 Identities=32% Similarity=0.541 Sum_probs=202.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||.|+|| .||+|.+..+|..||+|.++... .......+.+|+.+++.++ ||||+++++++... ..+++
T Consensus 8 ~l~~g~~g---~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--~~~~l 79 (277)
T cd06917 8 LIGRGAYG---AVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG--PRLWI 79 (277)
T ss_pred heeccCCc---eEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--CEEEE
Confidence 37888888 89999999999999999987543 2345667889999999996 99999999988765 46899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+.+++|.++++. +.+++..++.++.||+.||.|||+.| |+||||+|+||+++ ..+.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCCCc
Confidence 9999999999999876 47899999999999999999999999 99999999999998 46899999999987654332
Q ss_pred --CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccC-CCChHHHH
Q 006593 158 --ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK-VNDPQIKG 232 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~-~~s~~l~~ 232 (639)
.....|++.|+|||.+.. .++.++|+||||+++|+|++|..||.+.. .......+... .+..+.. ..+.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKS-KPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccC-CCCCCCcccCCHHHHH
Confidence 234578999999998753 36889999999999999999999997643 33332222222 2222322 36789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||.+||. +|.+||++.++++||||+...
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 9999998 899999999999999996543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.34 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=200.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~-~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||.|+|| .||+|.+..+|..||||.++....... ......+..|+++++.++|+||+++++++.+. ..+++||
T Consensus 7 ~lg~g~~~---~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~ 81 (298)
T cd07841 7 KLGEGTYA---VVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK--SNINLVF 81 (298)
T ss_pred eeeecccc---EEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC--CEEEEEE
Confidence 36788877 899999999999999999987654311 23345678899999999999999999998764 5699999
Q ss_pred ecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 80 ELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
||+ +|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.++|+|||++......
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccCCCc
Confidence 999 899999998766 7999999999999999999999999 99999999999998 4589999999999765433
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC----------------
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---------------- 218 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---------------- 218 (639)
......+++.|+|||.+.. .++.++|||||||++|+|++|.+||.+.... ..+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccccccc
Confidence 2223457889999998753 4789999999999999999998888764433 22333221100
Q ss_pred ----------CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 219 ----------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 219 ----------p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
........+..+++||.+||. +|.+|||+.|+|.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 000112335789999999999 899999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.60 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=199.3
Q ss_pred CcccccccCcEEEEEEEecCCC-----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG-----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|+|| .||+|.+...+ ..||+|.++... .......+.+|+.++++++||||+++++++... ..+
T Consensus 12 ~lg~G~~g---~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--~~~ 83 (283)
T cd05048 12 ELGEGAFG---KVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--QPT 83 (283)
T ss_pred cccCccCC---cEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC--Cce
Confidence 37888888 78888876555 789999887443 345567789999999999999999999988655 458
Q ss_pred EEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC
Q 006593 76 NMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~ 139 (639)
+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ ++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-EG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-CC
Confidence 8999999999999999865 45788999999999999999999999 99999999999997 55
Q ss_pred CcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHH
Q 006593 140 GEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 140 g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i 213 (639)
+.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+ .+..++...+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 799999999987543221 22345688999999775 568999999999999999998 9999987 4566777777
Q ss_pred HcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 214 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 214 ~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+..+. .+...++++.+|+.+||. +|.+||++.|++++
T Consensus 240 ~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6665443 455667899999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=308.82 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=205.0
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+... +..||+|.++.... ....+.+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 2 ~ig~g~~g---~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 73 (262)
T cd00192 2 KLGEGAFG---EVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYL 73 (262)
T ss_pred ccccCCce---EEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEE
Confidence 48999998 7999999866 99999999886542 2256789999999999999999999998876 456999
Q ss_pred EEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 78 ITELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~---------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
||||+.+|+|.++++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++. ++.+||+|||
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~-~~~~~l~dfg 150 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGE-DLVVKISDFG 150 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECC-CCcEEEcccc
Confidence 99999999999999885 77999999999999999999999999 999999999999984 4799999999
Q ss_pred hhhhccCCC----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 149 LAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 149 lA~~l~~~~----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
.+....... .....+++.|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~ 228 (262)
T cd00192 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PK 228 (262)
T ss_pred cccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CC
Confidence 997665432 334567899999998764 68999999999999999999 59999874 566677777765433 34
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+...++++.+++.+||. +|.+|||+.+++++
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 45558899999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.49 Aligned_cols=243 Identities=22% Similarity=0.313 Sum_probs=192.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| .||+|.+..++..||+|+++.... . .......+|+.+++++. |+||+++++++.+.....+++|||
T Consensus 7 lg~g~~~---~v~~~~~~~~~~~~aik~~~~~~~--~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 7 IGEGTFS---EVLKAQSRKTGKYYAIKCMKKHFK--S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred ccccccc---eEEEEEEcCCCcEEEEEEehhccC--C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6777777 899999999999999998875421 1 12233467999999995 999999999998775567999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-C
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-A 158 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-~ 158 (639)
|+. |+|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||+|+||+++. |.+||+|||++..+.... .
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccCCCc
Confidence 997 578877765 457899999999999999999999999 999999999999985 899999999997664332 2
Q ss_pred ccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--C--------------CCC
Q 006593 159 RSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--I--------------KPA 220 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~--------------~p~ 220 (639)
....+++.|+|||++. ..++.++|||||||++|+|++|..||.+. +....+..+... . ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT-NELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC-CHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 3456899999999764 34788999999999999999999999763 333322222110 0 000
Q ss_pred c-----------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 221 S-----------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 221 ~-----------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
. +....+..+++||.+||. +|.+||++.++|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0 112346889999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=322.53 Aligned_cols=245 Identities=30% Similarity=0.527 Sum_probs=203.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++... ..+++|+||
T Consensus 29 ig~g~~g---~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--~~~~iv~e~ 99 (297)
T cd06659 29 IGEGSTG---IVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVG--EELWVLMEF 99 (297)
T ss_pred cCCCCce---eEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeC--CeEEEEEec
Confidence 7888887 799999999999999999875432 3346688999999999999999999988765 458999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+++++|..++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++...... ...
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhccccccccc
Confidence 999999998765 56899999999999999999999999 99999999999997 5589999999998765432 233
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l~~LI~kc 237 (639)
...|++.|+|||++.. .++.++|||||||++|+|++|+.||... .+......+.....+ .......++.+.+||.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 4678999999998764 5889999999999999999999999763 344444444433221 122334567899999999
Q ss_pred cC-CCCCCCCHHHHhcCccccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
|+ +|.+||++.+++.||||....
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCC
Confidence 99 899999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.28 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=196.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCC---ceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK---KTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~---~~l~ 76 (639)
+||.|+|| .||+|.+..+|..||+|+++.... .......+.+|+.+++.+ +||||+++++++..... ..+|
T Consensus 8 ~lg~g~~g---~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 8 KIGEGTYG---KVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred EecccCCe---EEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 36778877 899999999999999999876532 223445688899999999 56999999998865432 2478
Q ss_pred EEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 77 MITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+.+.+||+|||++.
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccce
Confidence 99999985 898888642 35799999999999999999999999 99999999999998647899999999987
Q ss_pred hccCCC--CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--------
Q 006593 152 AMQQPT--ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-------- 219 (639)
Q Consensus 152 ~l~~~~--~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-------- 219 (639)
...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+........+....-..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543221 223357899999997753 47899999999999999999999998755444433222110000
Q ss_pred -----------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 220 -----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 220 -----------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
.......++.+.+||.+||. +|.+||++.|+|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00112356789999999999 899999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.89 Aligned_cols=246 Identities=28% Similarity=0.526 Sum_probs=205.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|++| .||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++... .+.++|+|
T Consensus 26 ~lg~g~~g---~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~--~~~~~v~e 96 (285)
T cd06648 26 KIGEGSTG---IVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG--DELWVVME 96 (285)
T ss_pred EeccCCCe---EEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcC--CeEEEEEe
Confidence 37788777 89999999999999999986543 23456688999999999999999999988765 45899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+.+++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||+|.||+++ .++.++|+|||++...... ..
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhhccCCccc
Confidence 9999999999987 67899999999999999999999999 99999999999997 4579999999988654332 22
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-ccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-l~~~~s~~l~~LI~k 236 (639)
....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.. .++......+..+..+.. .....+..+.+||.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 34578999999998764 588999999999999999999999976 445555556655532221 122356789999999
Q ss_pred hcC-CCCCCCCHHHHhcCccccccc
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||. +|.+||++.+++.||||+...
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HcccChhhCcCHHHHccCcccccCC
Confidence 998 899999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=314.48 Aligned_cols=239 Identities=18% Similarity=0.279 Sum_probs=195.2
Q ss_pred CcccccccCcEEEEEEEec---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+. ..+..||+|.++... .......+.+|+.+|++++||||+++++++... ..+++
T Consensus 12 ~ig~G~fg---~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 83 (266)
T cd05064 12 ILGTGRFG---ELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG--NTMMI 83 (266)
T ss_pred eecccCCC---eEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--CCcEE
Confidence 48999998 67777654 567899999987542 334556789999999999999999999988654 46899
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+|||++ .++.+||+|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCccccccccc
Confidence 99999999999999874 57899999999999999999999999 99999999999997 4579999999987543221
Q ss_pred C---CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 ~---~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
. .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+. +...+.+.+..+..+. .+...+..+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRLP-APRNCPNLLH 238 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCCC-CCCCCCHHHH
Confidence 1 11234567899999875 568999999999999999775 99999863 4555666666654432 4556678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006593 232 GFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+++.+||+ +|.+||++.+|++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 99999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.61 Aligned_cols=245 Identities=26% Similarity=0.456 Sum_probs=203.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+... ..+++|+|
T Consensus 7 ~l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e 79 (257)
T cd08225 7 KIGEGSFG---KIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQEN--GRLFIVME 79 (257)
T ss_pred EecCCCcc---eEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccC--CeEEEEEe
Confidence 37888888 899999999999999999987543 223456788999999999999999999987554 56899999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+.+++|.+++.... .+++..++.|+.||+.||.|||+++ ++|+||||.||+++.+...+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999997654 4799999999999999999999999 99999999999998654567999999987665332
Q ss_pred -CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
.....|++.|+|||++. ..++.++|+||||+++++|++|..||... +.......+..+..+. .....+..++++|.
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~ 235 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP-ISPNFSRDLRSLIS 235 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCCC-CCCCCCHHHHHHHH
Confidence 23356899999999876 45889999999999999999999999763 4444444444443322 23345678999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+||. +|.+|||+.++++||||
T Consensus 236 ~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 236 QLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHhccChhhCcCHHHHhhCCCC
Confidence 9998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.93 Aligned_cols=246 Identities=27% Similarity=0.494 Sum_probs=204.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|.+.... .....+.+.+|+.++++++||||+++++++... ..+++||||
T Consensus 12 l~~g~~~---~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 83 (277)
T cd06642 12 IGKGSFG---EVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG--TKLWIIMEY 83 (277)
T ss_pred hcCCCCe---eEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccC--CceEEEEEc
Confidence 6777777 89999999999999999987553 234567899999999999999999999988665 458999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~~ 159 (639)
+++++|.+++.. +.+++..++.++.||+.||.|||+++ ++|+||+|+||+++ +.+.++|+|||++..+.... ..
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCcchhhh
Confidence 999999999865 56899999999999999999999999 99999999999997 55799999999987654322 22
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...|+..|+|||.+.. .++.++|+||||+++|+|++|..||... .+......+..+. +..+....+..+.+||.+||
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHc
Confidence 3568899999998864 5888999999999999999999999763 3333333333333 23344456778999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccccC
Q 006593 239 V-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
. +|.+||++.++++||||.....
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHHhh
Confidence 9 8999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.12 Aligned_cols=252 Identities=28% Similarity=0.406 Sum_probs=218.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
++++.|-|.+++|.+|.+..+|.+||||.+.+... ....++++.+|+++|+.|+||||||+|.+.... ..+|+|||
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~--~~lylV~e 135 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE--ATLYLVME 135 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec--ceeEEEEE
Confidence 35666667777999999999999999999988765 446667799999999999999999999977554 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc-CCCCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-QPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~-~~~~~ 159 (639)
|+.+|.+++|+.+++++.+..++.++.|++.|++|||+++ |+|||||++|||++.+. .+||+|||++..+. .....
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENM-NIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccccccc-ceeeeccccceeeccccccc
Confidence 9999999999999999999999999999999999999999 99999999999998664 79999999998776 34567
Q ss_pred cccCCCCcCCccccccc-C-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~~-y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
++||+|.|.|||++.+. | ++.+|+||+|+++|-|+.|.+||.+ .+...+...+..+... ++...+.+++++|.++
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSCDCEDLLRKF 289 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--ccceeechhHHHHHHh
Confidence 89999999999999864 4 6889999999999999999999987 4555555556555443 3444567899999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccccCC
Q 006593 238 LV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
|. +|.+|++.+++.+|.|.......
T Consensus 290 lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hccCccccCCHHHhhhhcccchhhhh
Confidence 99 99999999999999999765544
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=319.87 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=201.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+ ..++|||
T Consensus 22 ~lg~g~~g---~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 95 (307)
T cd06607 22 EIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH--TAWLVME 95 (307)
T ss_pred eecCCCCe---EEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC--eEEEEHH
Confidence 37788777 899999999999999999875542 23445567899999999999999999999987654 5889999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+. |+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||+|+||+++ ++|.+||+|||++..... ..
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~--~~ 169 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVSP--AN 169 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeecCcceecCC--CC
Confidence 997 577777654 456999999999999999999999999 99999999999997 557999999999865432 23
Q ss_pred cccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 160 SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
...|++.|+|||++. ..++.++||||||+++|+|+||..||... +.......+.....+.......+..++++|.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLSSNDWSDYFRNFVD 248 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcCCCCCCCchhhCHHHHHHHH
Confidence 467899999999763 45889999999999999999999999764 3333333444333333333446778999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||. +|.+||++.+++.||||....
T Consensus 249 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 249 SCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHhcCChhhCcCHHHHhcChhhcccC
Confidence 9998 899999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.91 Aligned_cols=238 Identities=23% Similarity=0.316 Sum_probs=188.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++..||+|.... ..+.+|+++|++|+|+|||++++++... ...++|||+
T Consensus 177 Lg~G~~G---~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~lv~e~ 241 (461)
T PHA03211 177 LTPGSEG---CVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCLVLPK 241 (461)
T ss_pred EccCCCe---EEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEEEEc
Confidence 5667776 899999999999999996432 2256899999999999999999988765 458899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
+. ++|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceecccccccc
Confidence 95 6888888764 46999999999999999999999999 99999999999997 45799999999997654321
Q ss_pred -CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC-------CHHHHHHHHHcCCCC-Cc------
Q 006593 158 -ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-------NPAQIFKKVTSGIKP-AS------ 221 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~-------~~~~i~~~i~~g~~p-~~------ 221 (639)
.....||+.|||||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+...... ..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 224579999999998864 58999999999999999999876542211 123343333321110 00
Q ss_pred -----------------------cc--CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 222 -----------------------LA--KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 222 -----------------------l~--~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
+. ...++.+++||.+||. ||.+|||+.|||+||||+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 1235689999999999 9999999999999999974
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=306.41 Aligned_cols=244 Identities=28% Similarity=0.514 Sum_probs=208.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|+|| .||+|.+..++..||+|++..... .......+..|+++++.++|||++++++.+... ..+++|+|
T Consensus 7 ~l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~e 79 (258)
T cd08215 7 QIGKGSFG---KVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVME 79 (258)
T ss_pred eeccCCCe---EEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEEE
Confidence 36788887 899999999999999999987653 235667789999999999999999999988765 56899999
Q ss_pred cCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|+++++|.+++... ..+++..+..++.||+.||.|||++| ++|+||+|+||+++ +.+.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeecccC
Confidence 99999999999864 67999999999999999999999999 99999999999998 4579999999998765443
Q ss_pred --CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 157 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
......|++.|+|||.+. ..++.++|+||||+++++|++|..||... +...+...+.... ...++...+..+.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ-YPPIPSQYSSELRNL 234 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC-CCCCCCCCCHHHHHH
Confidence 234457899999999775 45889999999999999999999999763 4566666665543 333455667899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
|.+||. +|.+||++.++|.||||
T Consensus 235 i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 235 VSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.65 Aligned_cols=241 Identities=22% Similarity=0.328 Sum_probs=195.4
Q ss_pred CcccccccCcEEEEEEE-----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~-----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
.||+|||| +||+|. +..++..||+|+++... .....+.+.+|+.+|+.+ +||||+++++++.... .
T Consensus 42 ~LG~G~fG---~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~--~ 113 (375)
T cd05104 42 TLGAGAFG---KVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG--P 113 (375)
T ss_pred eecCCccc---eEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC--c
Confidence 47999998 677775 35567899999987543 234456789999999999 8999999999886654 5
Q ss_pred EEEEEecCCCCCHHHHHHhCC-----------------------------------------------------------
Q 006593 75 VNMITELFTSGNLRQYRKKHK----------------------------------------------------------- 95 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~----------------------------------------------------------- 95 (639)
.++|||||++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 889999999999999986532
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 96 ----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 96 ----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
.+++..+..|+.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceeccCcccc
Confidence 3678889999999999999999999 99999999999998 457899999999976543221
Q ss_pred ---ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 159 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 159 ---~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....+++.|+|||++. ..++.++|||||||++|||++ |..||..........+.+..+..+ ..+...+.++++|
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 349 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAPSEMYDI 349 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCCHHHHHH
Confidence 1233466799999876 468999999999999999998 899998755555666666655433 2344567899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcC
Q 006593 234 IEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~H 253 (639)
|.+||+ +|.+||++.|+++.
T Consensus 350 i~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 350 MKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.62 Aligned_cols=246 Identities=28% Similarity=0.496 Sum_probs=205.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++..||+|++.... .......+.+|+.+++++.||||+++++++.+. ..+++||||
T Consensus 12 lg~g~~~---~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 83 (277)
T cd06640 12 IGKGSFG---EVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG--TKLWIIMEY 83 (277)
T ss_pred cccCCCe---EEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEEec
Confidence 6778877 89999999999999999987553 345567899999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~~ 159 (639)
+.+|+|.+++.. +.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++ ..+.++|+|||++....... ..
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceeccCCccccc
Confidence 999999999875 56899999999999999999999999 99999999999997 55799999999986654322 23
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...++..|+|||++.. .++.++|+||||+++|+|+||..||.+. ++......+..+. +..+....+..+.+||.+||
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHc
Confidence 3468899999998764 5789999999999999999999999864 3444444333332 33444556788999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccccC
Q 006593 239 V-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
. +|.+||++.++++||||.....
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhcch
Confidence 8 8999999999999999975544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=309.04 Aligned_cols=239 Identities=20% Similarity=0.330 Sum_probs=195.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..+|..||+|.+.... ..+....+.+|++++++++||||+++++++... ..+++|||
T Consensus 2 ~lg~g~~g---~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 73 (252)
T cd05084 2 RIGRGNFG---EVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVME 73 (252)
T ss_pred ccCcccCc---cEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC--CCeEEEEe
Confidence 48999998 79999999999999999876432 345567799999999999999999999987655 45899999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.........
T Consensus 74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccc
Confidence 99999999999764 46899999999999999999999999 99999999999997 5579999999998754432111
Q ss_pred c----ccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 160 S----VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 160 ~----~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
. ..++..|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+.. ...+...+..+.+|
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 228 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVR-LPCPELCPDAVYRL 228 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCC-CCCcccCCHHHHHH
Confidence 1 12245699999876 458899999999999999998 88998753 34444444544433 23455667899999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+||+ +|.+||++.++++
T Consensus 229 i~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.09 Aligned_cols=235 Identities=23% Similarity=0.387 Sum_probs=195.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|-|| .||.|....+ ..||+|.++.... ..+.+.+|+++|++|+|+|||++|+++..+. .+||||||
T Consensus 214 LG~G~FG---~V~~g~~~~~-~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~ 282 (468)
T KOG0197|consen 214 LGSGQFG---EVWLGKWNGS-TKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEY 282 (468)
T ss_pred hcCCccc---eEEEEEEcCC-CcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEe
Confidence 5666666 8999998543 4799999986542 2355779999999999999999999876543 69999999
Q ss_pred CCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 82 FTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
++.|+|.+||+. ++.+.......++.||++|++||++++ +|||||.+.||||+ +++.+||+|||+|+........
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccCCCcee
Confidence 999999999997 567999999999999999999999999 99999999999997 5579999999999954332211
Q ss_pred ccc---CCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 160 SVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 160 ~~~---GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
... -...|.|||.+. +.|+.++|||||||+||||+| |+.||.+ .+..+....+.+|...+ -|..+++++.+++
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp-~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLP-RPEGCPDEVYELM 437 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCC-CCCCCCHHHHHHH
Confidence 111 234699999886 679999999999999999998 7899887 45677888888886644 3556788999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
..||. +|.+|||.+.|..
T Consensus 438 ~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHhhCCcccCCCHHHHHH
Confidence 99999 8999999986653
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=311.55 Aligned_cols=244 Identities=27% Similarity=0.437 Sum_probs=202.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||.|+|| .||+|.+..+|..||+|.++..... .......+.+|+.+++.++||||+++++++.+. ..+++|+|
T Consensus 9 ~l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 82 (267)
T cd08228 9 KIGRGQFS---EVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNIVLE 82 (267)
T ss_pred eeccCCCe---eEEEEEEeCCCCEEEEEEeeccccC-CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEEEEE
Confidence 36788887 7999999999999999998765432 345566789999999999999999999998765 46889999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccceeccch
Confidence 9999999998853 345899999999999999999999999 99999999999997 5579999999998765432
Q ss_pred C--CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCC-CCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 157 T--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 157 ~--~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~-~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
. .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||... .+...+...+.....+.......+..+++
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 1 23457899999999875 45888999999999999999999998643 23455666666555554444556788999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcC
Q 006593 233 FIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~H 253 (639)
||.+||. +|.+||++.++|+.
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHH
Confidence 9999999 89999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.28 Aligned_cols=245 Identities=24% Similarity=0.398 Sum_probs=199.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++..||+|.++.... .....+.+.+|++++++++|+||+++++++... ..+++||||
T Consensus 9 i~~g~~~---~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~iv~e~ 81 (288)
T cd07833 9 VGEGAYG---VVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRK--GRLYLVFEY 81 (288)
T ss_pred ecccCCe---eEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEEC--CEEEEEEec
Confidence 6777777 899999999999999999876432 234557789999999999999999999998764 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~~ 158 (639)
+.++.+..+..+...+++..++.++.||+.||.|||.++ ++||||+|+||+++ +.+.+||+|||++...... ..
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCccccc
Confidence 999888877777777999999999999999999999999 99999999999998 4689999999998766543 22
Q ss_pred ccccCCCCcCCccccc-c-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH--cCCC----------------
Q 006593 159 RSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SGIK---------------- 218 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~--~g~~---------------- 218 (639)
....+++.|+|||++. . .++.++||||||+++|+|++|..||.+......+..... ....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 3467899999999875 3 578999999999999999999999986544433322111 0000
Q ss_pred ---C--------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 219 ---P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 219 ---p--------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+ ...+...++++++||.+||. +|.+||+++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01122346789999999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.11 Aligned_cols=241 Identities=33% Similarity=0.562 Sum_probs=201.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|++| .||+|.+..+|..|++|++..... .....+.+|+++++.++||||+++++++... ...++++||
T Consensus 8 l~~g~~~---~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~e~ 78 (253)
T cd05122 8 IGKGGFG---EVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVMEF 78 (253)
T ss_pred eccCCce---EEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEec
Confidence 6777777 899999999999999999876542 4567899999999999999999999988765 458899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-Cc
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-AR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-~~ 159 (639)
+.+++|.+++... +.+++..++.++.|++.||.|||.++ ++||||+|+||+++ +.+.++|+|||.+....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeecccccccccccccc
Confidence 9999999999876 67999999999999999999999999 99999999999998 45799999999987665433 34
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-ccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-l~~~~s~~l~~LI~kc 237 (639)
...|+..|+|||.+.. .++.++|+||||+++|+|++|..||........+..... ...+.. .....+..+.+||.+|
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHH
Confidence 5678999999998764 478899999999999999999999987543333333222 222221 1222378899999999
Q ss_pred cC-CCCCCCCHHHHhcCcc
Q 006593 238 LV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpf 255 (639)
|. +|.+|||+.++|+|||
T Consensus 235 l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 235 LQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ccCChhhCCCHHHHhcCCC
Confidence 99 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=308.45 Aligned_cols=241 Identities=26% Similarity=0.439 Sum_probs=202.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||.|+|| .||++.+..++..||+|.++... .....+.+..|+.+++.++||||+++++++.+. ..++++||
T Consensus 7 ~lg~g~~g---~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 78 (255)
T cd08219 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD--GHLYIVME 78 (255)
T ss_pred EeeccCCe---EEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEEe
Confidence 36777777 89999999999999999987653 234567789999999999999999999998665 46999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|+++|+|.+++... ..+++..++.|+.||+.||.|||+++ |+|+||||+||+++ ..+.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeeccccc
Confidence 99999999998753 45899999999999999999999999 99999999999997 5579999999998765432
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
......|++.|+|||++.. .++.++|+||||+++|+|++|..||.. .+.......+..+..+ ..+...+..+++||.
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 233 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSLIK 233 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHHHH
Confidence 2234678999999998864 588999999999999999999999986 4555555566555433 234556788999999
Q ss_pred HhcC-CCCCCCCHHHHhcCc
Q 006593 236 KCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hp 254 (639)
+||. +|.+||++.+++.--
T Consensus 234 ~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 234 QMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHhCCcccCCCHHHHhhcc
Confidence 9998 899999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=333.56 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=193.4
Q ss_pred CcccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
+||+|+|| .||+|.+.. ++..||+|.++... .....+.+.+|+.+|+.+ +|||||++++++... ..
T Consensus 45 ~LG~G~fg---~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--~~ 116 (374)
T cd05106 45 TLGAGAFG---KVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTHG--GP 116 (374)
T ss_pred eecCCCcc---cEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--CC
Confidence 48899998 688887544 34579999987553 234567789999999999 899999999988665 45
Q ss_pred EEEEEecCCCCCHHHHHHhC------------------------------------------------------------
Q 006593 75 VNMITELFTSGNLRQYRKKH------------------------------------------------------------ 94 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~------------------------------------------------------------ 94 (639)
+++|||||.+|+|.+++.+.
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 89999999999999998642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc----c
Q 006593 95 ----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR----S 160 (639)
Q Consensus 95 ----------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~----~ 160 (639)
..+++..++.++.||+.||.|||++| |+||||||+|||++ +.+.+||+|||+++........ .
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeeccC
Confidence 23678889999999999999999999 99999999999998 5579999999999765433221 2
Q ss_pred ccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
..+++.|||||++. ..|+.++|||||||++|+|++ |..||..........+.+..+. ....+...+++++++|.+||
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-QMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-CccCCCCCCHHHHHHHHHHc
Confidence 33567899999775 468999999999999999997 9999987544444444444443 22344556789999999999
Q ss_pred C-CCCCCCCHHHHhc
Q 006593 239 V-PASERLSAKDLLK 252 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~ 252 (639)
+ +|.+||++.++++
T Consensus 353 ~~dp~~RPs~~~l~~ 367 (374)
T cd05106 353 NLEPTERPTFSQISQ 367 (374)
T ss_pred CCChhhCcCHHHHHH
Confidence 9 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.34 Aligned_cols=243 Identities=27% Similarity=0.436 Sum_probs=192.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++..... ......+.+|+.+|+.++|+||+++++++... ...|+||||
T Consensus 13 ig~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e~ 84 (291)
T cd07870 13 LGEGSYA---TVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTK--ETLTFVFEY 84 (291)
T ss_pred EEecCCE---EEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC--CeEEEEEec
Confidence 6777777 899999999999999999876542 22334567899999999999999999988654 468999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+. ++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++...... ..
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccCCCCCCC
Confidence 96 677777654 356888999999999999999999999 99999999999997 5579999999998654322 22
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCC----------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK---------------- 218 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~---------------- 218 (639)
....+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+....+.. +.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 34467999999998854 4788999999999999999999999765444333222211 000
Q ss_pred -------CCccc-----CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 219 -------PASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 219 -------p~~l~-----~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+..+. ...++.+.+||.+||. +|.+|||+.|+|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 0125689999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=327.22 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=195.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~ 76 (639)
.||+|+|| .||+|.+..+|..||+|.+..... .......+.+|+.++++++||||++++++|..... ..+|
T Consensus 23 ~lg~g~~g---~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 23 PIGSGAQG---IVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred EeccCCCE---EEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 36788877 899999999999999999864421 23455678899999999999999999998864432 3579
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+||||+. ++|.+++... +++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++......
T Consensus 98 lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 98 LVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 171 (353)
T ss_pred EEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccceeCCCC
Confidence 9999996 5898888654 899999999999999999999999 99999999999998 4579999999999765433
Q ss_pred C-CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CC--------------
Q 006593 157 T-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK-------------- 218 (639)
Q Consensus 157 ~-~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~-------------- 218 (639)
. .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+..+... ..
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 2 234568999999998764 5899999999999999999999999764322 222222110 00
Q ss_pred -----C------------Cc-c-------cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 219 -----P------------AS-L-------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 219 -----p------------~~-l-------~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+ .. . ....++.+++||.+||+ +|.+|||+.|+|.||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0 00 0 11235578999999999 99999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.29 Aligned_cols=240 Identities=23% Similarity=0.318 Sum_probs=188.1
Q ss_pred CcccccccCcEEEEEEEec----------------CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE----------------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 64 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~----------------~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~ 64 (639)
.||+|||| .||+|.+. .++..||+|+++... .......+.+|+.+|++++||||++++
T Consensus 12 ~lg~G~fg---~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 12 KLGEGQFG---EVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred EecccCCe---EEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 37888888 78888753 245679999987542 344566789999999999999999999
Q ss_pred EEEEeCCCceEEEEEecCCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006593 65 KSWVDDKKKTVNMITELFTSGNLRQYRKKHK-------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIH 125 (639)
Q Consensus 65 ~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~-------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIH 125 (639)
+++.+.+ .+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+|
T Consensus 86 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH 161 (304)
T cd05096 86 GVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVH 161 (304)
T ss_pred EEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--ccc
Confidence 9987664 4899999999999999986532 3677889999999999999999999 999
Q ss_pred eccCCCcEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh--ccC
Q 006593 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEY 198 (639)
Q Consensus 126 RDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt--G~~ 198 (639)
|||||+|||++ ..+.+||+|||++..+.... .....+++.|||||++. ..++.++||||||+++|+|++ +..
T Consensus 162 ~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 99999999998 55799999999997654322 12334578899999775 568999999999999999987 567
Q ss_pred CCCCCCCHHHHHHHHHc----C--CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 199 PYSECKNPAQIFKKVTS----G--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 199 Pf~~~~~~~~i~~~i~~----g--~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
||.+.. ..+....+.. . ......+...+..+.+||.+||. +|.+|||+.+|.+
T Consensus 241 p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 887643 3333332221 1 11112233456789999999999 8999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.01 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=198.9
Q ss_pred CcccccccCcEEEEEEEe--cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d--~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.||+|+|| .||+|.+ ..++..||+|+++.... .....+.+..|+.+++.++||||+++++++.. ...++|
T Consensus 2 ~lg~G~~g---~v~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv 73 (257)
T cd05116 2 ELGSGNFG---TVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLV 73 (257)
T ss_pred cCCCcCCc---ceEEeEEecCCCceEEEEEEccCCCC--cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEE
Confidence 48999998 7898864 56789999999875532 34556778999999999999999999997643 347899
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|||+.+|+|.+++.+.+.+++..+..++.||+.||.|||++| |+||||||.||+++ +.+.+||+|||++..+.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 74 MELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCC
Confidence 999999999999998888999999999999999999999999 99999999999998 457999999999976543221
Q ss_pred -----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 159 -----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 159 -----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .+...+...+..+..+ ..+...+++++
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~ 228 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMY 228 (257)
T ss_pred eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 1223467899999876 458889999999999999998 9999976 4556677777766543 34556788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006593 232 GFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+||.+||+ +|.+||++.+|..
T Consensus 229 ~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 229 DLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHhccCchhCcCHHHHHH
Confidence 99999999 8999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=313.87 Aligned_cols=235 Identities=23% Similarity=0.357 Sum_probs=190.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||.|+|| .||++.+..+|..+|+|.+....... .|+.....+ +||||+++++++...+ .+++|||
T Consensus 24 lg~g~~g---~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e 89 (267)
T PHA03390 24 LIDGKFG---KVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMD 89 (267)
T ss_pred ecCCCce---EEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCC--eeEEEEE
Confidence 4777777 89999999999999999987654311 122222222 7999999999987664 6999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+++|+|.+++...+.+++..++.|+.||+.||.|||+.+ ++||||||+||+++.+.+.++|+|||++...... ..
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~ 165 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SC 165 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--cc
Confidence 9999999999998888999999999999999999999999 9999999999999855448999999998765432 34
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH----HHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP----AQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~----~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
..|++.|+|||++.. .++.++||||||+++|+|++|..||...... ..+.... ..+.......++.+++||.
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~ 242 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQ 242 (267)
T ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHHH
Confidence 568999999998864 5889999999999999999999999753221 1222222 2233344567899999999
Q ss_pred HhcC-CCCCCCC-HHHHhcCcccc
Q 006593 236 KCLV-PASERLS-AKDLLKDPFLQ 257 (639)
Q Consensus 236 kcL~-dP~~RpS-a~ELL~Hpff~ 257 (639)
+||+ +|.+||+ ++++|+||||+
T Consensus 243 ~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 243 SMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHhccChhhCCchHHHHhcCCccc
Confidence 9999 8999996 59999999996
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=321.76 Aligned_cols=251 Identities=22% Similarity=0.385 Sum_probs=199.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|-. ..+.||++.+..+|..||+|+++.... .......+..|+.+++.++||||++++++|... ...+++|||
T Consensus 6 i~~~~~-~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--~~~~~~~e~ 80 (314)
T cd08216 6 IGKCFE-DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD--SELYVVSPL 80 (314)
T ss_pred hhHhhc-CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecC--CeEEEEEec
Confidence 555532 234678888888999999999987532 345677899999999999999999999998765 458999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
+.+|+|.+++.+. ..+++..++.+++||+.||.|||+++ |+||||||+||+++ ..|.+||+|||.+..+...
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeecccccc
Confidence 9999999999864 45899999999999999999999999 99999999999998 5589999999988644221
Q ss_pred ------CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--------
Q 006593 157 ------TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-------- 219 (639)
Q Consensus 157 ------~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-------- 219 (639)
......++..|+|||++.. .|+.++|||||||++|+|++|..||............+......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 1123457888999998864 48899999999999999999999998755444444433211100
Q ss_pred -----------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 -----------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 -----------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.......+.++.+||.+||. +|.+|||++++|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00011123578899999999 999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=311.90 Aligned_cols=239 Identities=22% Similarity=0.353 Sum_probs=197.5
Q ss_pred CcccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|+|| .||+|.+. .++..||+|.++... ..+..+.+.+|+++|+.++||||+++++++... ..+
T Consensus 12 ~lg~g~~~---~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 83 (280)
T cd05049 12 ELGEGAFG---KVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--DPP 83 (280)
T ss_pred hccccCCc---eEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--CCe
Confidence 47888888 78988874 446889999987543 233567899999999999999999999998766 458
Q ss_pred EEEEecCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc
Q 006593 76 NMITELFTSGNLRQYRKKHK--------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~--------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~ 141 (639)
++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG-YDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-CCCe
Confidence 99999999999999997643 3788999999999999999999999 99999999999997 4589
Q ss_pred EEEeecchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHc
Q 006593 142 VKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 215 (639)
Q Consensus 142 VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~ 215 (639)
+||+|||++...... ......+++.|+|||++. ..++.++||||||+++|+|++ |..||.+. +.......+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHc
Confidence 999999998754322 122345678999999876 458999999999999999998 99999764 45566666666
Q ss_pred CCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 216 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 216 g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+..+. .+...+..+++||.+||. +|.+||++.|++.
T Consensus 240 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 65433 344567899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.16 Aligned_cols=246 Identities=34% Similarity=0.586 Sum_probs=205.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..++..||+|++..... ..+.+..|+++++.++|+||+++++++... ...++|+|
T Consensus 26 ~l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 95 (286)
T cd06614 26 KIGEGASG---EVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWVVME 95 (286)
T ss_pred hccCCCCe---EEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEEEEe
Confidence 36778877 799999998999999999876532 456788999999999999999999998876 46899999
Q ss_pred cCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 81 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
|+.+++|.+++..++ .++...+..++.||+.||.|||+.| ++|+||+|+||+++ ..|.++|+|||++...... .
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchhhhhccchhh
Confidence 999999999999877 8999999999999999999999999 99999999999998 5579999999998655432 2
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCCCcccCCCChHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~~l~~~~s~~l~~LI~ 235 (639)
.....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... ++......+.. +..+.......+..+++||.
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCCHHHHHHHH
Confidence 234568899999998764 5889999999999999999999999864 34333333333 22222223336788999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||. +|.+||++.++|.||||....
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhccC
Confidence 9999 899999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=313.22 Aligned_cols=242 Identities=28% Similarity=0.478 Sum_probs=195.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|++| .||+|.+..+|..||+|+++.... ......+..|+.++++++||||+++++++.+.+ .+++||||
T Consensus 8 l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 79 (284)
T cd07836 8 LGEGTYA---TVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTEN--KLMLVFEY 79 (284)
T ss_pred eccCCce---EEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC--cEEEEEec
Confidence 5667666 899999999999999999986542 233456788999999999999999999987764 58999999
Q ss_pred CCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 82 FTSGNLRQYRKKH---KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~---~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
+.+ +|.+++... ..+++..+..++.||+.||.|||+.| ++||||||+||+++ +.+.++|+|||++......
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCCcc
Confidence 985 899888754 35899999999999999999999999 99999999999997 5579999999999765432
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC-CC--------------
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KP-------------- 219 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~-~p-------------- 219 (639)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+...... ...+.... .+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchh
Confidence 2234567899999998753 478899999999999999999999987544332 22221110 00
Q ss_pred ------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 220 ------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 220 ------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
..+....++.++++|.+||+ +|.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00112346789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.81 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=197.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|++| +||+|.+..+|..||+|.+..... .......+.+|++++++++||||+++++++.+. ..+++||||
T Consensus 10 l~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 82 (294)
T PLN00009 10 IGEGTYG---VVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE--KRLYLVFEY 82 (294)
T ss_pred ecCCCCE---EEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecC--CeEEEEEec
Confidence 5666666 899999999999999999876542 223445688999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 82 FTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~--l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
+. ++|.+++..... +++..++.++.||+.||.|||+++ ++||||+|+||+++..++.+||+|||++...... .
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 96 588888766443 588899999999999999999999 9999999999999865568999999999754322 2
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCC---------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP--------------- 219 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p--------------- 219 (639)
.....+++.|+|||++.+ .++.++||||||+++|+|+||.+||........+.+.+.. +...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 234467899999998754 4788999999999999999999999764444443332211 0000
Q ss_pred -------C---cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 -------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 -------~---~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. ......++.+++||.+||. +|.+||++.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0 0112346789999999998 899999999999999997543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=315.24 Aligned_cols=243 Identities=27% Similarity=0.435 Sum_probs=191.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| +||+|.+..+|..||+|.+..... ......+.+|+.++++++||||+++++++... ..+++||||
T Consensus 13 lg~g~~~---~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 84 (291)
T cd07844 13 LGEGSYA---TVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHTK--KTLTLVFEY 84 (291)
T ss_pred EeecCCe---EEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEecC--CeEEEEEec
Confidence 6777777 899999999999999999876432 12223467899999999999999999988654 569999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+ +|.+++.+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++ ..|.+||+|||++...... ..
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCCCCccc
Confidence 974 999998764 46899999999999999999999999 99999999999997 5579999999998654322 22
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC---CC---------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG---IK--------------- 218 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g---~~--------------- 218 (639)
....+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.....+..+.+... ..
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 23357889999998753 48899999999999999999999997654333322222110 00
Q ss_pred -------CCc---ccCCCC--hHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 219 -------PAS---LAKVND--PQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 219 -------p~~---l~~~~s--~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+.. .....+ ..+.++|.+||. +|.+|||+.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 001122 678899999999 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.68 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=198.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh----------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP----------GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~----------~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~ 70 (639)
+||.|+|| +||+|.+..+|..||+|.++........ .....+.+|+.++++++||||+++++++...
T Consensus 16 ~ig~G~~g---~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 16 HLGEGTYG---KVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred cccCCCce---eEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 47778777 8999999999999999998765432111 0112478999999999999999999998765
Q ss_pred CCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 71 ~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
.++++||||+. |+|.+++.....+++..+..++.||+.||.|||++| |+||||+|+||+++ ..+.+||+|||++
T Consensus 93 --~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~~kl~dfg~~ 166 (335)
T PTZ00024 93 --DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLA 166 (335)
T ss_pred --CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCCEEECCccce
Confidence 46899999996 699999988888999999999999999999999999 99999999999997 5579999999998
Q ss_pred hhccCC----------------CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHH
Q 006593 151 IAMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 212 (639)
Q Consensus 151 ~~l~~~----------------~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~ 212 (639)
...... ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||........ +..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~ 245 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-LGR 245 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence 655411 1122356889999998754 378999999999999999999999986443332 222
Q ss_pred HHc---CCCCC-----------------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 213 VTS---GIKPA-----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 213 i~~---g~~p~-----------------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+.. ..... ......+..+.+||.+||. +|.+||+++|+|.||||+...
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 211 00000 0112336779999999999 899999999999999998543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=315.65 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=205.2
Q ss_pred CcccccccCcEEEEEEEe---cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d---~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|+|| .||+|.+ ..+|..||+|+++...........+.+..|+.+|+++ +|+||+++++.+... ..++
T Consensus 7 ~lg~G~~g---~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~~~~ 81 (290)
T cd05613 7 VLGTGAYG---KVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--TKLH 81 (290)
T ss_pred eeccCCcc---eEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC--CeEE
Confidence 37888888 5676665 3589999999998654433344567788999999999 699999999987654 4689
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+||||+.+++|.+++...+.+++..+..++.||+.||.|||+.+ ++||||+|+|||++ .++.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceecccc
Confidence 99999999999999998888999999999999999999999999 99999999999997 4579999999998765432
Q ss_pred ---CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCC---CHHHHHHHHHcCCCCCcccCCCC
Q 006593 157 ---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVND 227 (639)
Q Consensus 157 ---~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~~l~~~~s 227 (639)
......|++.|+|||.+.. .++.++||||||+++|+|++|..||.... ....+...+..... ..+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCC
Confidence 1234578999999998753 47889999999999999999999996321 22334444443322 2345567
Q ss_pred hHHHHHHHHhcC-CCCCCC-----CHHHHhcCcccccccCC
Q 006593 228 PQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
+.+.+|+.+||. +|.+|| ++.+++.||||+..++.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 277 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence 899999999999 899997 89999999999887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.69 Aligned_cols=243 Identities=28% Similarity=0.456 Sum_probs=206.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||++.+..+|..+|+|.+..... .......+..|+.++++++||||+++++++.+. ...++|+||
T Consensus 8 i~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~ 80 (256)
T cd08530 8 LGKGSYG---SVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDG--NKLCIVMEY 80 (256)
T ss_pred ecCCCce---eEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC--CEEEEEehh
Confidence 6777776 799999999999999999886653 235567788999999999999999999988765 568999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
+++++|.+++.+ ...+++..++.++.||+.||.|||+.| ++||||+|.||+++. .+.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVA-NDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEec-CCcEEEeeccchhhhccCC
Confidence 999999999876 356899999999999999999999999 999999999999984 5799999999998776554
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
.....|++.|+|||.+.. .++.++|+||||+++|+|++|..||... +...+...+..+..+. .+...+.+++++|.+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 235 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQNFIRS 235 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHHHHHHH
Confidence 455678999999998764 4888999999999999999999999864 4555555555554433 334667899999999
Q ss_pred hcC-CCCCCCCHHHHhcCccc
Q 006593 237 CLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff 256 (639)
||. +|.+||++.++|+||++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 236 MLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HcCCCcccCCCHHHHhcCCCC
Confidence 998 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=318.29 Aligned_cols=248 Identities=32% Similarity=0.470 Sum_probs=193.8
Q ss_pred cccccccCcEEEEEEEecC--CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~--tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| .||+|.+.. +|..||+|.+..... ......+.+.+|+.++++++||||+++++++.+.....+++||
T Consensus 8 ig~g~~g---~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 83 (316)
T cd07842 8 IGRGTYG---RVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF 83 (316)
T ss_pred eccCCcE---EEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence 5666666 899999988 899999999986432 2233446678999999999999999999999877567899999
Q ss_pred ecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC---CCCcEEEeecchhh
Q 006593 80 ELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDLGLAI 151 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~-----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~---~~g~VKL~DFGlA~ 151 (639)
||+.+ +|.+++..+ ..+++..++.++.||+.||.|||+.+ |+||||||+||+++. ..|.+||+|||++.
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99975 777776532 36899999999999999999999999 999999999999974 15799999999987
Q ss_pred hccCCC-----CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHH--------HHHHHHHc-
Q 006593 152 AMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPA--------QIFKKVTS- 215 (639)
Q Consensus 152 ~l~~~~-----~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~--------~i~~~i~~- 215 (639)
...... .....+|+.|+|||++.+ .++.++||||||+++|+|++|.+||....... .....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 654322 234578999999997753 47899999999999999999999997432211 00000000
Q ss_pred -----------------------CCCCCccc-----------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 216 -----------------------GIKPASLA-----------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 216 -----------------------g~~p~~l~-----------~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.......+ ...+..+.++|.+||. +|.+|||+.|++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000000 1456789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.66 Aligned_cols=244 Identities=30% Similarity=0.513 Sum_probs=204.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++..||+|++.... .......+.+|+.++++++||||+++++++... ..+++||||
T Consensus 12 ig~G~~~---~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 83 (277)
T cd06641 12 IGKGSFG---EVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIMEY 83 (277)
T ss_pred EeecCCe---EEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC--CeEEEEEEe
Confidence 6788887 89999999999999999886543 234567789999999999999999999998765 458999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+|+|.+++.. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ +.|.++|+|||++..+... ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhhhc
Confidence 999999999875 46899999999999999999999999 99999999999997 5579999999998655432 223
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...|+..|+|||.+.. .++.++|+|||||++|+|++|..||.. .........+..+. +..+....+.++.++|.+||
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHc
Confidence 4568999999998764 578899999999999999999999976 34444444444433 33345566789999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
. +|.+||++.++++||||...
T Consensus 238 ~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 238 NKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred cCChhhCcCHHHHHhCHHHhhh
Confidence 8 89999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=313.36 Aligned_cols=244 Identities=29% Similarity=0.453 Sum_probs=195.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|++| .||+|.+..+|..||+|++..... .......+..|+++++.++||||+++++++.+. ...+++|||
T Consensus 7 l~~g~~~---~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--~~~~iv~e~ 79 (283)
T cd07835 7 IGEGTYG---VVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE--NKLYLVFEF 79 (283)
T ss_pred ecCCCCe---EEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccC--CeEEEEEec
Confidence 5666666 899999999999999999886542 223345678899999999999999999988655 568999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
+. ++|.+++...+ .+++..++.++.||+.||.|||+++ ++||||+|+||+++. ++.++|+|||++...... .
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcC-CCcEEEeecccccccCCCccc
Confidence 95 69999998766 7899999999999999999999999 999999999999984 689999999998655322 1
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC------------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI------------------ 217 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~------------------ 217 (639)
.....+++.|+|||++.+ .++.++||||||+++|+|++|..||.......+..+.+....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 223456899999997754 478899999999999999999999976443333322211100
Q ss_pred --------CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 218 --------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 218 --------~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.........+..+.++|.+||+ +|.+||+++|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011123345789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.51 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=197.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|++..... .....+.+.+|+++++.++||||+++++++... ..+++|||
T Consensus 8 ~lg~g~~~---~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 80 (286)
T cd07846 8 LVGEGSYG---MVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK--KRLYLVFE 80 (286)
T ss_pred eeccCCCe---EEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccC--CeEEEEEe
Confidence 37888888 899999999999999998765442 223456688999999999999999999988654 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+.+++|..+......+++..++.++.||+.||.|||+.+ ++||||+|+||+++ .++.++|+|||++..+... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCcccc
Confidence 9999999988877777999999999999999999999999 99999999999997 5579999999998765432 22
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH--c-----------------CC
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--S-----------------GI 217 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~--~-----------------g~ 217 (639)
....+++.|+|||++.+ .++.++||||||+++|+|++|.+||.............. . +.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 34568899999998753 478899999999999999999999975433222221110 0 00
Q ss_pred CCC---------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 218 KPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 218 ~p~---------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
... ......+..+++||.+||. +|.+||++.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 0112346789999999998 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=341.07 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=230.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||-||||.|-.|... .....+|+|++++..+-. ..+.+.++.|-++|..++.|.||++|..|.+. +++||+||-
T Consensus 428 LGvGgFGRVELV~~~---~~~~~fAlKilkK~hIVd-tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~--kyvYmLmEa 501 (732)
T KOG0614|consen 428 LGVGGFGRVELVKVN---SQKATFALKILKKKHIVD-TKQQEHVFSERNIMMECRSDFIVRLYRTFRDS--KYVYMLMEA 501 (732)
T ss_pred cccCccceEEEEEec---ccchHHHHHHHhHhhccc-hhHHHHHHhHHHHHHhcCchHHHHHHHHhccc--hhhhhhHHh
Confidence 788999976655443 333358999988776543 46778899999999999999999999998654 679999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
|-||.|+..++.++.|++.+.+.++.-+++|++|||++| ||+|||||+|.+++ +.|.+||.|||+|+.+... ...+
T Consensus 502 ClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwT 578 (732)
T KOG0614|consen 502 CLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWT 578 (732)
T ss_pred hcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceee
Confidence 999999999999999999999999999999999999999 99999999999997 6699999999999988754 4568
Q ss_pred ccCCCCcCCcccc-cccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l-~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
+||||+|.|||++ ..+.+.++|.||||+++|||+||.+||++ .+|...|..|.+|+....+|......+.+||+++..
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence 9999999999965 56799999999999999999999999998 688999999999999999999999999999999887
Q ss_pred -CCCCCCC-----HHHHhcCcccccccCCCCcCCCCCCch
Q 006593 240 -PASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPI 273 (639)
Q Consensus 240 -dP~~RpS-----a~ELL~Hpff~~~~~~~~~~~~~~~~~ 273 (639)
.|.+|.. ..++-+|.||..-+|.......++.|+
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi 697 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPI 697 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCc
Confidence 7999986 899999999999888766544444443
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.17 Aligned_cols=238 Identities=22% Similarity=0.367 Sum_probs=196.6
Q ss_pred CcccccccCcEEEEEEEecCCC---eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG---~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|+|| .||+|.+..++ ..||+|.+..... ....+.+..|+.+++.++||||+++++++.. ..+++
T Consensus 2 ~ig~G~~g---~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~ 72 (257)
T cd05060 2 ELGHGNFG---SVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLML 72 (257)
T ss_pred ccCccCce---eEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEE
Confidence 48999998 78888775554 8899999876543 2455678999999999999999999997643 34789
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+.+|+|.+++.+.+.+++..+..|+.||+.||.|||.++ ++||||||+|||++ ..+.+||+|||++..+....
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 73 VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCC
Confidence 9999999999999998888999999999999999999999999 99999999999997 55799999999997664322
Q ss_pred Cc-----cccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 158 AR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 158 ~~-----~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
.. ...++..|+|||.+. ..++.++||||||+++|+|++ |.+||... +..++...+..+.. ...+...++.+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l 227 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEI 227 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHH
Confidence 11 112346799999876 458999999999999999998 99999874 45566666655533 33455567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+++|.+||. +|.+||++.+|++
T Consensus 228 ~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 228 YSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.72 Aligned_cols=243 Identities=32% Similarity=0.544 Sum_probs=206.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|++| .||+|.+..++..||+|.+..... .....+.+.+|++++++++|||++++++++... ..++++|||
T Consensus 8 l~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~ 80 (254)
T cd06627 8 IGRGAFG---VVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS--DSLYIILEY 80 (254)
T ss_pred EcccCCe---EEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC--CEEEEEEec
Confidence 6777777 899999999999999999987653 235667899999999999999999999987654 568999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC--c
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA--R 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~--~ 159 (639)
+.+++|.+++...+.+++..++.++.|++.||.|||+.| |+||||+|+||+++ ..+.++|+|||++........ .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCccccc
Confidence 999999999998889999999999999999999999999 99999999999998 468999999999976654332 3
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...+++.|+|||.+.. .++.++||||||+++|+|++|..||..........+.. .. ....++...+..+++||.+||
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~i~~~l 235 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QD-DHPPLPEGISPELKDFLMQCF 235 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cc-CCCCCCCCCCHHHHHHHHHHH
Confidence 4578999999998753 47889999999999999999999997644333333332 22 223345566789999999999
Q ss_pred C-CCCCCCCHHHHhcCccc
Q 006593 239 V-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff 256 (639)
. +|.+||++.+++.||||
T Consensus 236 ~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 236 QKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred hCChhhCcCHHHHhcCCCC
Confidence 8 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.77 Aligned_cols=239 Identities=25% Similarity=0.404 Sum_probs=194.6
Q ss_pred CcccccccCcEEEEEEEecCCCeE----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~----VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|+|| +||+|.+..+|.. ||+|.++... .....+.+..|+.+++.++||||+++++++... ..+
T Consensus 14 ~lg~G~~g---~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~~~ 84 (316)
T cd05108 14 VLGSGAFG---TVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQ 84 (316)
T ss_pred eeecCCCc---eEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---Cce
Confidence 37888888 8999988666654 8999886432 345567889999999999999999999988653 367
Q ss_pred EEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+|++|+.+|+|.+++..+. .++...+..++.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||+++.+..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEccccccccccC
Confidence 8999999999999998754 6889999999999999999999999 99999999999997 557999999999986643
Q ss_pred CCC----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~~----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
... ....+++.|+|||++. ..++.++||||||+++|||++ |..||.+ ....++...+..+..+ ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTID 239 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhCCCCC-CCCCCCCHH
Confidence 211 1223467899999876 468999999999999999997 9999976 3445555555444333 234456788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.++|.+||. +|.+||++.+++.+
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999998 89999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=317.22 Aligned_cols=246 Identities=28% Similarity=0.498 Sum_probs=200.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++..||+|.+.... ....+.+..|+.+++.++||||+++++++.... ..|+|+||
T Consensus 27 lg~g~~g---~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~ 97 (293)
T cd06647 27 IGQGASG---TVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVGD--ELWVVMEY 97 (293)
T ss_pred ecCCCCe---EEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC--cEEEEEec
Confidence 6777777 89999999999999999986543 233567899999999999999999999987654 58999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+|+|.+++.+. .+++..+..++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++...... ...
T Consensus 98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcceecccccccccc
Confidence 9999999998764 5889999999999999999999999 99999999999997 5579999999988654322 223
Q ss_pred cccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...|++.|+|||.+. ..++.++|+||||+++|+|++|..||.......++......+......+...+..+++||.+||
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence 456899999999875 4588999999999999999999999976433333222222222222233345678999999999
Q ss_pred C-CCCCCCCHHHHhcCccccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. +|.+||++.+++.||||+..+
T Consensus 254 ~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 254 EMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred cCChhhCcCHHHHhcCHHHhcCc
Confidence 8 899999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.67 Aligned_cols=243 Identities=29% Similarity=0.489 Sum_probs=201.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|.+...+.. .......+.+|+.+++.++||||+++++++... ..++++||
T Consensus 9 ~ig~g~~g---~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v~e 82 (267)
T cd08229 9 KIGRGQFS---EVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNIVLE 82 (267)
T ss_pred hhcccCCe---EEEEEeecCCCceEEEEeeeehhhh-hHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEEEEE
Confidence 47888887 7999999999999999998765432 234556788999999999999999999998765 46889999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|+.+++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||||+||+++ ..+.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhccccC
Confidence 9999999999874 356899999999999999999999999 99999999999997 4579999999998765432
Q ss_pred C--CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC-CHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 157 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK-NPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 157 ~--~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~-~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
. .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||.+.. ......+.+.....+.......++.+++
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 2 234578999999998854 58889999999999999999999996532 2344555555554444444567789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006593 233 FIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~ 252 (639)
||.+||. +|.+|||+.+++.
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHH
Confidence 9999998 8999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=306.71 Aligned_cols=243 Identities=19% Similarity=0.306 Sum_probs=197.4
Q ss_pred CcccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----c
Q 006593 1 MVLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----K 73 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~ 73 (639)
+||+|+|| .||+|.+.. ++..||+|.++.... .......+.+|+.+++.++||||+++++++..... .
T Consensus 6 ~lg~G~~g---~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 6 ILGEGEFG---SVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred ccCcCCCc---eEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 47899998 678887654 458899999886543 34556789999999999999999999998765432 3
Q ss_pred eEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeec
Q 006593 74 TVNMITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DF 147 (639)
..++++||+.+|+|..++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ +.+.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECCc
Confidence 478999999999999998542 35899999999999999999999999 99999999999997 4579999999
Q ss_pred chhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006593 148 GLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 221 (639)
Q Consensus 148 GlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 221 (639)
|+++...... .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+. ...++++.+..+..+ .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~ 235 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL-K 235 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-C
Confidence 9997654322 11223567899999876 458999999999999999999 88999764 455666666665433 3
Q ss_pred ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 222 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 222 l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+...++.+.++|.+||+ +|.+||++.|++++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 455677899999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=341.68 Aligned_cols=236 Identities=30% Similarity=0.455 Sum_probs=202.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|.|| +||+|++-.+ ||||.++.... .+++++.|+.|+.+|++-+|.||+-|.|++.... +.||+-+
T Consensus 400 IGsGsFG---tV~Rg~whGd---VAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIiTqw 468 (678)
T KOG0193|consen 400 IGSGSFG---TVYRGRWHGD---VAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAIITQW 468 (678)
T ss_pred ecccccc---ceeecccccc---eEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeeeehh
Confidence 6777777 8999998654 99999998875 5679999999999999999999999999886543 5899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc----CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----QP 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~----~~ 156 (639)
|+|-+|..++.-. .+|+......|++||++|+.|||.++ |||||||..|||+. +++.|||+||||+..-. ..
T Consensus 469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeecccc
Confidence 9999999998643 46889999999999999999999999 99999999999997 55899999999996432 22
Q ss_pred CCccccCCCCcCCcccccc----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC---CCcccCCCChH
Q 006593 157 TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK---PASLAKVNDPQ 229 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~---p~~l~~~~s~~ 229 (639)
......|...|||||+++. .|++.+||||||||+|||+||.+||. ..+.++++-.+.+|.. .......+..+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~ 624 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKA 624 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHH
Confidence 2334567889999998863 49999999999999999999999999 6889999999999843 33334445569
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+++|+..||. ++.+||...+||.
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999 8999999999987
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.38 Aligned_cols=243 Identities=20% Similarity=0.302 Sum_probs=197.4
Q ss_pred CcccccccCcEEEEEEEecCCCe--EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----Cce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~--~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~ 74 (639)
+||+|+|| .||+|.+..++. .||+|.++... ......+.+..|+.+++.++||||+++++++.... ...
T Consensus 6 ~ig~G~~g---~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 6 TLGEGEFG---SVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccCcccCc---eEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 47889998 799999877765 69999887653 24456778999999999999999999999765432 235
Q ss_pred EEEEEecCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 75 VNMITELFTSGNLRQYRKK------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk------~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
.++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCCC
Confidence 7899999999999998742 234889999999999999999999999 99999999999997 55799999999
Q ss_pred hhhhccCCC----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 149 LAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 149 lA~~l~~~~----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
++....... .....+++.|+|||.+.. .++.++||||||+++|+|++ |..||.. ....++...+..+..+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~ 235 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK-Q 235 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-C
Confidence 997654321 122346778999998864 58999999999999999999 7899976 45566777776654432 2
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+...+..++++|.+||. +|.+|||+.+|+++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 33456789999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.23 Aligned_cols=243 Identities=24% Similarity=0.410 Sum_probs=207.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||++.+..+|..||+|++...... .......+..|+.++++++||||+++++.+... ..+++||||
T Consensus 1 lg~G~~~---~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFG---KVLLVRKKDTGKLYAMKVLKKKKII-KRKEVEHTLTERNILSRINHPFIVKLHYAFQTE--EKLYLVLEY 74 (250)
T ss_pred CCCCCce---EEEEEEECCCCcEEEEEEeehhhhc-chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC--CeeEEEEec
Confidence 6888888 8999999989999999998866532 234567899999999999999999999987554 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+++|.+++...+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ +.+.++|+|||++...... ...
T Consensus 75 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 75 APGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCccc
Confidence 999999999998888999999999999999999999999 99999999999997 5579999999998765442 234
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...++..|+|||.... .++.++|+||||+++|+|++|..||... ........+.... ..++...+..+.+||.+||
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l 228 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILKDP--LRFPEFLSPEARDLISGLL 228 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHh
Confidence 5678999999998764 4788999999999999999999999763 3455556655532 3345555789999999999
Q ss_pred C-CCCCCCCH---HHHhcCccc
Q 006593 239 V-PASERLSA---KDLLKDPFL 256 (639)
Q Consensus 239 ~-dP~~RpSa---~ELL~Hpff 256 (639)
. +|.+||++ ++++.||||
T Consensus 229 ~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 229 QKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred cCCHhhCCCcccHHHHHhCCCC
Confidence 8 89999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.30 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=191.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------CceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK------KKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~------~~~l 75 (639)
||+|+|| .||+|.+..+|..||+|.+..... .......+.+|+.++++++||||+++++++.... ...+
T Consensus 20 lg~g~~~---~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 94 (310)
T cd07865 20 IGQGTFG---EVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF 94 (310)
T ss_pred eecCCCE---EEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence 6677666 899999999999999999875532 2223345678999999999999999999876543 2357
Q ss_pred EEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 76 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++....
T Consensus 95 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 95 YLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFS 170 (310)
T ss_pred EEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEEECcCCCccccc
Confidence 99999996 5888887654 36899999999999999999999999 99999999999997 55799999999997654
Q ss_pred CCC------CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHH--HHHHHcCCCCC----
Q 006593 155 QPT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--FKKVTSGIKPA---- 220 (639)
Q Consensus 155 ~~~------~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i--~~~i~~g~~p~---- 220 (639)
... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||......... ...+.....+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 321 123467889999997754 3788999999999999999999999764322211 11111110000
Q ss_pred -----------------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 221 -----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 221 -----------------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
......++.+++||.+||. +|.+|||++++|.||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0012235678899999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=315.81 Aligned_cols=246 Identities=27% Similarity=0.459 Sum_probs=201.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|.+..... ......+.+..|+++++.++|||++++++++.+. ...|+||||
T Consensus 29 lg~g~~g---~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 102 (313)
T cd06633 29 IGHGSFG---AVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVMEY 102 (313)
T ss_pred eccCCCe---EEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEEec
Confidence 5777776 899999999999999999876543 2334556789999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
+. |+|.+++.. ...+++..+..++.||+.||.|||++| ++||||+|+||+++ ..+.+||+|||++.... ....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~~--~~~~ 176 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PANS 176 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecCCCcccC--CCCC
Confidence 96 577777765 456899999999999999999999999 99999999999997 55799999999885432 2235
Q ss_pred ccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 161 VIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 161 ~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
..|++.|+|||++. ..++.++||||||+++|+|++|..||......... ..+.....+.......+..+++||.+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCccccCHHHHHHHHH
Confidence 67899999999873 45888999999999999999999999874433333 33443334433444556789999999
Q ss_pred hcC-CCCCCCCHHHHhcCccccccc
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||+ +|.+||++.++++||||+...
T Consensus 256 ~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 256 CLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HccCChhhCcCHHHHhcCcccCCCc
Confidence 998 899999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=313.28 Aligned_cols=238 Identities=27% Similarity=0.477 Sum_probs=192.1
Q ss_pred cccccccCcEEEEEEEec----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDE----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||.|.|| .||+|... ..+..|+||.++.. ......+.+.+|++.|++++||||+++++++.... .+++
T Consensus 7 ig~G~fg---~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~~l 78 (259)
T PF07714_consen 7 IGEGSFG---KVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PLFL 78 (259)
T ss_dssp EEEESSE---EEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SEEE
T ss_pred EccCCCc---EEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccc--cccc
Confidence 5666666 89999887 56788999998543 23456788999999999999999999999998443 3899
Q ss_pred EEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 78 ITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ ++|+||++.|||++. ++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~-~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDS-NGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEET-TTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccc-ccccccccccccccccc
Confidence 99999999999999987 67999999999999999999999999 999999999999984 57999999999976522
Q ss_pred C----CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 P----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~----~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
. ......+...|+|||.+.. .++.++||||||+++|||++ |..||.+. +..++...+..+..+ ..+...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRL-PIPDNCPKD 233 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEET-TSBTTSBHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc-eeccchhHH
Confidence 1 1223456778999998864 58999999999999999999 68999875 667777777665443 345566788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.++|.+||. +|.+||++.+|++
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999998 8999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.75 Aligned_cols=239 Identities=26% Similarity=0.372 Sum_probs=197.7
Q ss_pred CcccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+.. +...||+|.+...... ...+.+.+|+.++++++||||+++++++.+ ..+++
T Consensus 2 ~ig~g~~~---~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~ 72 (257)
T cd05040 2 KLGDGSFG---VVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMM 72 (257)
T ss_pred cCCccCcc---cEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEE
Confidence 58999999 789998755 2346999998866532 567789999999999999999999998876 56899
Q ss_pred EEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 78 ITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
||||+.+|+|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||++..+..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLAS-DDKVKIGDFGLMRALPQ 149 (257)
T ss_pred EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEec-CCEEEeccccccccccc
Confidence 999999999999998764 6899999999999999999999999 999999999999984 47999999999976543
Q ss_pred CC-----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 156 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 156 ~~-----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
.. .....++..|+|||.+. ..++.++|||||||++|+|++ |..||... +..++.+.+.........+...+.
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQ 228 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCH
Confidence 21 11345778899999876 468999999999999999998 99999764 455566655543333333445578
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.+.+++.+||. +|.+||++.+++.
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHH
Confidence 99999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=304.52 Aligned_cols=243 Identities=29% Similarity=0.475 Sum_probs=201.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|+|| .||+|.+..+|..||+|.++..... .....+.+.+|++++++++|+||+++++++... ...++|||
T Consensus 9 ~lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 82 (267)
T cd08224 9 KIGKGQFS---VVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN--NELNIVLE 82 (267)
T ss_pred eeccCCce---EEEEEEEcCCCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEEEEe
Confidence 36788887 8999999999999999999865432 234567899999999999999999999998765 46899999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|+++|+|..++.. ...+++..++.|+.||+.||.|||++| |+||||+|+||+++ ..|.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeeeccCC
Confidence 9999999999864 245899999999999999999999999 99999999999997 4579999999998765432
Q ss_pred --CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCC-CCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 157 --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~-~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
......|++.|+|||.+. ..++.++||||||+++|+|++|..||... .+.......+..+..+.......+..+++
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence 223457899999999775 45889999999999999999999999643 23445555555555444333356778999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006593 233 FIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+|.+||. +|.+||++.+|+.
T Consensus 240 ~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 240 LVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 9999998 8999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=311.33 Aligned_cols=244 Identities=28% Similarity=0.446 Sum_probs=204.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|+|| .||+|.+..+|..||+|++...... .......+..|+.++++++ ||||+++++++... ..+++||
T Consensus 8 ~lg~g~~~---~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~lv~ 81 (280)
T cd05581 8 IIGEGSFS---TVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE--ENLYFVL 81 (280)
T ss_pred eecCCCce---EEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC--ceEEEEE
Confidence 37888888 8999999999999999998765432 2344567899999999998 99999999987554 4689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
||+.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++|+||+|+||+++ .+|.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCcccc
Confidence 99999999999999889999999999999999999999999 99999999999997 56899999999987654322
Q ss_pred --------------------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC
Q 006593 158 --------------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 216 (639)
Q Consensus 158 --------------------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g 216 (639)
.....|++.|+|||.+.. .++.++||||||+++++|++|..||.... ....++.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhc
Confidence 123467899999997764 57889999999999999999999998643 44444554432
Q ss_pred CCCCcccCCCChHHHHHHHHhcC-CCCCCCCH----HHHhcCccc
Q 006593 217 IKPASLAKVNDPQIKGFIEKCLV-PASERLSA----KDLLKDPFL 256 (639)
Q Consensus 217 ~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa----~ELL~Hpff 256 (639)
.. .++...++.+.+||.+||. +|.+||++ ++||+||||
T Consensus 238 ~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 22 2344557899999999998 89999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=318.98 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=212.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||.|+|+ .|..+....+|.++|||++.+.. .....++.+|++++.++ .|+||++++++|.++. .+|+||
T Consensus 85 ~LGeGAya---sVqtcv~i~t~~EYAVKiidKq~----gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVf 155 (463)
T KOG0607|consen 85 LLGEGAYA---SVQTCVSIQTGKEYAVKIIDKQP----GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVF 155 (463)
T ss_pred HhcCccce---eeeeeeeeccchhhhhhhhhcCC----chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEE
Confidence 58999998 67778899999999999987653 46678999999999999 5999999999997765 499999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC--CcEEEeecchhhhccC--
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQQ-- 155 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~--g~VKL~DFGlA~~l~~-- 155 (639)
|-+.||+|...|.+++.|+|.++.++.+.|+.||.|||.+| |.||||||+|||....+ ..||||||.|+..+..
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 99999999999999999999999999999999999999999 99999999999995322 3589999998754321
Q ss_pred -------CCCccccCCCCcCCccccc---c---cCCccccccchhhhhhhhhhccCCCCCCC--------------CHHH
Q 006593 156 -------PTARSVIGTPEFMAPELYE---E---EYNELVDIYSFGMCILEMVTFEYPYSECK--------------NPAQ 208 (639)
Q Consensus 156 -------~~~~~~~GTp~ymAPE~l~---~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~--------------~~~~ 208 (639)
+...+.+|+..|||||+.. + .|+.+.|.|||||++|.|+.|.+||.+.- -...
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 1234568889999999764 2 48999999999999999999999995411 1345
Q ss_pred HHHHHHcCCC--CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 209 IFKKVTSGIK--PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 209 i~~~i~~g~~--p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
++..|..|.. |..-+...+.+++++|.++|. ++..|.++.++|+|||++.....
T Consensus 314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 7888888865 444455668899999999998 89999999999999999865543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=316.96 Aligned_cols=245 Identities=20% Similarity=0.276 Sum_probs=205.7
Q ss_pred cccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe--CCCceEEEEEecC
Q 006593 6 LYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVD--DKKKTVNMITELF 82 (639)
Q Consensus 6 GfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~--~~~~~l~lV~Ey~ 82 (639)
|.|..|.|-.+.++.||+.+|+|++.-. .+..+|+++--.. .|||||.++++|.. ...+++.+|||.+
T Consensus 71 G~GinGkV~~C~~k~T~ekfALKvL~Ds---------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 71 GAGINGKVVQCVHKRTQEKFALKVLLDS---------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred ccccCCceEEEEeccchhhhHHHHHhcC---------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 4556668999999999999999987632 4578899886666 79999999998854 3456899999999
Q ss_pred CCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhcc-CCC
Q 006593 83 TSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ-QPT 157 (639)
Q Consensus 83 ~gGsL~d~lkk~~~--l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~-~~~ 157 (639)
+||.|+.-++.++. ++|+.+..|++||..|+.|||+.+ |.||||||+|+|+.+ .+..+||+|||+|+... ...
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~ 219 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD 219 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCCcc
Confidence 99999999988764 999999999999999999999999 999999999999963 34579999999998765 345
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCC---CHHHHHHHHHcCCC--CCcccCCCChHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIK--PASLAKVNDPQIK 231 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~--p~~l~~~~s~~l~ 231 (639)
..+.|-||.|.|||++. ++|+...|+||+|+++|.|++|.+||.... -...+-.+|..|.. |..-+...+..++
T Consensus 220 L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aK 299 (400)
T KOG0604|consen 220 LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAK 299 (400)
T ss_pred ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHH
Confidence 56788999999999997 569999999999999999999999996422 23455667777654 3344455678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
++|+++|. +|.+|.|..+++.|||+.....
T Consensus 300 dlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 300 DLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 99999998 9999999999999999986554
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.76 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=190.6
Q ss_pred CcccccccCcEEE-EEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSS-YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tV-ykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+||.+..+ |.+....++..||+|.++... .......+.+|+++|+.++||||+++++++.......+++||
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred ecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 4788998843321 334455678899999987543 234456788999999999999999999988776666789999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
||+.+|+|.+++... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++........
T Consensus 88 e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 88 EYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred cCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccccccCCcchh
Confidence 999999999999764 5999999999999999999999999 99999999999997 457999999999876543221
Q ss_pred ----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHH--------------HHHHHHHcCCCC
Q 006593 159 ----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA--------------QIFKKVTSGIKP 219 (639)
Q Consensus 159 ----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~--------------~i~~~i~~g~~p 219 (639)
....++..|+|||.+. ..++.++||||||+++|+|+||..||....... .+...+..+..
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR- 242 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC-
Confidence 2234567799999876 458999999999999999999999986422110 01111111111
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
...+...+.++++|+.+||. +|++||++++++.
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 12234456899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.47 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=200.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~--~~~~l~lV 78 (639)
+||.|+|| .||+|.+..+|..||+|++..... .......+.+|+.+|++++||||+++++++... ....+++|
T Consensus 12 ~lg~g~~g---~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 12 NIGSGAYG---VVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeecCCCe---EEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 37888887 799999999999999999875432 223456788899999999999999999987543 23478999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.......
T Consensus 87 ~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 87 MDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred Eehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceeecccCc
Confidence 99995 699999988888999999999999999999999999 99999999999998 56899999999986553221
Q ss_pred -----CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCC----------
Q 006593 158 -----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK---------- 218 (639)
Q Consensus 158 -----~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~---------- 218 (639)
.....|++.|+|||.+.. .++.++||||||+++|+|++|..||.+.....++ ..+.. +..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-KLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-HHHHHHhCCChhHhhhhhch
Confidence 123578999999998753 4889999999999999999999999764332221 11110 000
Q ss_pred --------------CC---cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 219 --------------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 219 --------------p~---~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+. ......++.+++||.+||+ +|.+||++.+++.||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 00 0112347889999999999 8999999999999999985443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.15 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=198.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC---ceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~---~~l~l 77 (639)
.||+|+|| +||+|.+..+|..||+|.+..... .......+..|+.+++.++||||+++++++..... ..+++
T Consensus 12 ~lg~G~~~---~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 12 PIGRGAYG---IVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred EeccCCCe---EEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 36788777 899999999999999999875421 22345567889999999999999999998765432 35899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
|+||+. ++|.++++..+.+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++......
T Consensus 87 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccccCCCc
Confidence 999995 799999998889999999999999999999999999 99999999999997 4579999999999765432
Q ss_pred -CCccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH---cC--------------
Q 006593 157 -TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---SG-------------- 216 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~---~g-------------- 216 (639)
......++..|+|||.+. ..++.++|||||||++|+|++|..||.+.. .......+. ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD-YVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 223457899999999775 358899999999999999999999997532 211111110 00
Q ss_pred ----------CCC--CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 217 ----------IKP--ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 217 ----------~~p--~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
..+ .......++.+++||.+||+ +|.+|||++++|+||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000 01123457889999999999 89999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.57 Aligned_cols=241 Identities=20% Similarity=0.300 Sum_probs=188.6
Q ss_pred CcccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.||+|+|| .||+|.+. .++..+|+|.++... .......+.+|+.++++++||||+++++++.+. ..+++|
T Consensus 2 ~lg~G~~g---~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 73 (269)
T cd05087 2 EIGNGWFG---KVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV--TPYLLV 73 (269)
T ss_pred cccccCCc---eEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CCcEEE
Confidence 48999999 78988753 456789999887553 223445688999999999999999999987654 458899
Q ss_pred EecCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 79 TELFTSGNLRQYRKKHK-----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~-----~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
|||+++|+|.+++...+ ..++..++.++.||+.||.|||+.+ ++||||||+||+++ ..+.+||+|||++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~ 150 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNK 150 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccc
Confidence 99999999999997532 4567788899999999999999999 99999999999998 4579999999998654
Q ss_pred cCCC----CccccCCCCcCCcccccc--------cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC--
Q 006593 154 QQPT----ARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK-- 218 (639)
Q Consensus 154 ~~~~----~~~~~GTp~ymAPE~l~~--------~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~-- 218 (639)
.... .....|++.|+|||++.. .++.++||||||+++|||++ |..||............+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (269)
T cd05087 151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230 (269)
T ss_pred cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCC
Confidence 3221 123457889999998753 25789999999999999996 99999875444333222322211
Q ss_pred -CCcccCCCChHHHHHHHHhcCCCCCCCCHHHHhc
Q 006593 219 -PASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252 (639)
Q Consensus 219 -p~~l~~~~s~~l~~LI~kcL~dP~~RpSa~ELL~ 252 (639)
...+....+..+++++.+|+.+|.+|||++||++
T Consensus 231 ~~~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 231 PKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CCCccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1222334567899999999989999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=310.45 Aligned_cols=238 Identities=24% Similarity=0.375 Sum_probs=195.9
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|||| .||++.+ ..++..||+|.+... .......+.+|+.++++++||||+++++++... ..+
T Consensus 12 ~lg~G~~~---~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 82 (288)
T cd05093 12 ELGEGAFG---KVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DPL 82 (288)
T ss_pred ccCCcCCe---eEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--Ccc
Confidence 47888888 7788875 345677999988643 234567799999999999999999999988665 458
Q ss_pred EEEEecCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcE
Q 006593 76 NMITELFTSGNLRQYRKKHK-------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 142 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~-------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~V 142 (639)
++||||+.+|+|.+++..++ .+++..++.++.||+.||+|||++| ++||||||+||+++ +.+.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCCcE
Confidence 99999999999999997654 3899999999999999999999999 99999999999997 55799
Q ss_pred EEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcC
Q 006593 143 KIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 216 (639)
Q Consensus 143 KL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g 216 (639)
||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||... +.......+..+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcC
Confidence 999999987553221 12334578899999886 458999999999999999998 89999764 455666777766
Q ss_pred CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 217 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 217 ~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+ ..+...++++.+|+.+||+ +|.+|||+.+++.
T Consensus 239 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 239 RVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 543 2344567899999999999 8999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=305.32 Aligned_cols=237 Identities=25% Similarity=0.388 Sum_probs=197.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|+|| .||+|.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++... ..+++|||
T Consensus 13 ~ig~g~~~---~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 82 (263)
T cd05052 13 KLGGGQYG---EVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIITE 82 (263)
T ss_pred ecCCcccc---eEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEEEE
Confidence 37788887 79999999999999999887432 3356688999999999999999999987655 45889999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|+.+|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ +++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCcccccccccee
Confidence 99999999999764 35899999999999999999999999 99999999999997 567999999999876654321
Q ss_pred c---cccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 159 R---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 159 ~---~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
. ...+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ ......+..+..+..+ ..+...++++.++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 237 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVYEL 237 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 1 123466899999876 458899999999999999998 8999976 4566666777665433 3455667899999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
|.+||. +|.+||++.++++
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 999999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.71 Aligned_cols=240 Identities=23% Similarity=0.311 Sum_probs=196.4
Q ss_pred CcccccccCcEEEEEEEe----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFD----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|||| +||+|.+ ...+..||+|.+.... .......+.+|+.+++.++||||+++++++.... ..|
T Consensus 12 ~lg~g~~g---~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 83 (283)
T cd05090 12 ELGECAFG---KIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--PVC 83 (283)
T ss_pred eccccCCc---ceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC--ceE
Confidence 47888888 7888885 4466889999987433 3345567899999999999999999999876654 589
Q ss_pred EEEecCCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC
Q 006593 77 MITELFTSGNLRQYRKKH-----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~ 139 (639)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++ +.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~-~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG-EQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-CC
Confidence 999999999999998633 23788889999999999999999999 99999999999998 55
Q ss_pred CcEEEeecchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHH
Q 006593 140 GEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 140 g~VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i 213 (639)
+.+||+|||+++..... ......++..|+|||++. ..++.++||||||+++|||++ |..||.+ .++..+...+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 78999999999765322 123345677899999876 458999999999999999998 8999976 3455666666
Q ss_pred HcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 214 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 214 ~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+..+ ..+...++.++++|.+||+ +|.+||++.+|+++
T Consensus 240 ~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 655433 3455668899999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.91 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=198.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..+|..||+|++.... ........+..|+.+++.++||||+++++++.+.....+++|+||
T Consensus 7 l~~g~~~---~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 7 IGEGTYG---QVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eccCCCe---EEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 6777766 89999999999999999998764 223445668899999999999999999999876634679999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
+. ++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++ ++|.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCccc
Confidence 97 4899988765 57999999999999999999999999 99999999999998 56899999999997665432
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC---CCC------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPA------------ 220 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~---~p~------------ 220 (639)
.....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.....+ .....+.... .+.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchhhh
Confidence 233467889999997653 4789999999999999999999999874433 3323222110 000
Q ss_pred --------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 221 --------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 221 --------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0111236789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.28 Aligned_cols=242 Identities=22% Similarity=0.346 Sum_probs=194.8
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
+||+|+|| .||+|.+ ..+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++...+ ..
T Consensus 14 ~lG~G~fg---~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~-~~ 86 (337)
T cd05054 14 PLGRGAFG---KVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG-GP 86 (337)
T ss_pred ccccCcCc---eEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-CC
Confidence 48999998 7888864 3456889999987442 234556788999999999 8999999999876543 46
Q ss_pred EEEEEecCCCCCHHHHHHhC------------------------------------------------------------
Q 006593 75 VNMITELFTSGNLRQYRKKH------------------------------------------------------------ 94 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~------------------------------------------------------------ 94 (639)
++++|||+.+|+|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998642
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCcCC
Q 006593 95 -KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMA 169 (639)
Q Consensus 95 -~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymA 169 (639)
..+++..+..++.||+.||.|||+++ |+||||||.||+++. .+.+||+|||++..+.... .....+++.|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25788999999999999999999999 999999999999984 5799999999997654321 123456778999
Q ss_pred ccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCC
Q 006593 170 PELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS 246 (639)
Q Consensus 170 PE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpS 246 (639)
||++. ..++.++|||||||++|||++ |..||.+..........+..+..+ ..+...++++.+++.+||+ +|.+||+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcC
Confidence 99775 569999999999999999998 999997643334444444444332 3345567899999999999 8999999
Q ss_pred HHHHhcC
Q 006593 247 AKDLLKD 253 (639)
Q Consensus 247 a~ELL~H 253 (639)
+.||++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.11 Aligned_cols=249 Identities=25% Similarity=0.335 Sum_probs=199.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|+|| .||+|.+..+|..||+|++.... ........+.+|+.+++++ +||||+++++++...+...+++||
T Consensus 14 ~lg~g~~~---~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 14 KLGKGAYG---IVWKAIDRRTKEVVALKKIFDAF--RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred hhcCCCCe---eEEEEEEcCCCeEEEEEeecccc--CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 37888887 79999999999999999886432 1234456688999999999 999999999998766666789999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
||+. ++|..++... .+++..++.++.||+.||.|||+.| |+||||||+|||++ .+|.+||+|||++......
T Consensus 89 e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 89 EYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred cccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhcccccccc
Confidence 9997 5999998875 7889999999999999999999999 99999999999997 5589999999999765432
Q ss_pred ----CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--------------
Q 006593 157 ----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-------------- 216 (639)
Q Consensus 157 ----~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g-------------- 216 (639)
....+.||+.|+|||.+.. .++.++||||||+++|+|++|..||.+........+.+...
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 1223568999999997743 47889999999999999999999997644333222111110
Q ss_pred --------------CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 217 --------------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 217 --------------~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
..........+.++.+||.+||+ +|.+|||+.++++||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00111122257789999999999 89999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=308.11 Aligned_cols=241 Identities=19% Similarity=0.328 Sum_probs=195.3
Q ss_pred CcccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
+||+|+|| .||+|.+.. ++..||+|.+.... .......+..|+.+++.++|+||+++++++.... ..
T Consensus 13 ~lg~g~~g---~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 84 (277)
T cd05036 13 ALGHGAFG---EVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL--PR 84 (277)
T ss_pred ECCCCCCC---cEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC--Cc
Confidence 47888888 799999987 78899999876432 2344466899999999999999999999886654 47
Q ss_pred EEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEee
Q 006593 76 NMITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGD 146 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~-------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~D 146 (639)
++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++.+ ...+||+|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEecc
Confidence 89999999999999997653 4899999999999999999999999 9999999999999743 23699999
Q ss_pred cchhhhccCCCC----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCC
Q 006593 147 LGLAIAMQQPTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 220 (639)
Q Consensus 147 FGlA~~l~~~~~----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 220 (639)
||+++.+..... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+. ....+...+..+..+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~~~~~~~~~~~~~~~- 240 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-TNQEVMEFVTGGGRL- 240 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCcC-
Confidence 999976532211 1223356899999875 459999999999999999997 99999864 444555555544332
Q ss_pred cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 221 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 221 ~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+...++.+.+|+.+||+ +|.+||++.++|+|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3345567899999999999 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=309.39 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=196.6
Q ss_pred CcccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|+|| .||+|.++ ..+..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 13 ~lg~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 84 (288)
T cd05061 13 ELGQGSFG---MVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--QPT 84 (288)
T ss_pred eecCCCCc---EEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCc
Confidence 47888888 78988764 246689999876443 233445688999999999999999999987655 458
Q ss_pred EEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEe
Q 006593 76 NMITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 145 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~----------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~ 145 (639)
++||||+.+|+|.+++.+. ..++...+..++.||+.||.|||+++ |+||||||+||+++ .++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCCcEEEC
Confidence 9999999999999999753 23466788999999999999999999 99999999999998 45799999
Q ss_pred ecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006593 146 DLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 219 (639)
Q Consensus 146 DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p 219 (639)
|||+++...... .....++..|+|||.+. ..++.++|||||||++|||++ |..||.+ ....+..+.+..+..+
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 999987543221 12234577899999876 458999999999999999998 7889976 4455666666554333
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc------Cccccccc
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK------DPFLQVEN 260 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~------Hpff~~~~ 260 (639)
. .+...++.++++|.+||+ +|.+|||+.++++ ||||....
T Consensus 241 ~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 241 D-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred C-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 2 334456889999999998 8999999999987 89887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.17 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=196.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC---------
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--------- 72 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~--------- 72 (639)
||.|+|| .||+|.+..+|..||+|++...+. ...+.+.+|+++++.++||||+++++++.....
T Consensus 13 Lg~g~~g---~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 13 LGCGSNG---LVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ecCCCCE---EEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 6777777 899999999999999999876643 445678899999999999999999987654332
Q ss_pred ---ceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 73 ---KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 73 ---~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
..+++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++..++.+||+|||+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCccc
Confidence 35789999997 599988864 46899999999999999999999999 999999999999976667899999999
Q ss_pred hhhccCCC-----CccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC-----
Q 006593 150 AIAMQQPT-----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI----- 217 (639)
Q Consensus 150 A~~l~~~~-----~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~----- 217 (639)
+..+.... .....|++.|+|||++. ..++.++|||||||++|+|++|..||.+.... .....+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 240 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQLILESVPVVRE 240 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCh
Confidence 87653221 12236788999999764 34788999999999999999999999764332 2222221110
Q ss_pred ------------------CC-----CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 218 ------------------KP-----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 218 ------------------~p-----~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.. ..+....+.++++||.+||+ +|.+|||+.++|.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00 01112356789999999999 89999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=348.49 Aligned_cols=242 Identities=22% Similarity=0.361 Sum_probs=197.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEE-EEeC---C-CceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKS-WVDD---K-KKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~-~~~~---~-~~~l 75 (639)
|-+|||+ .||+|.+...|..||+|++-.. .+..++.+.+||.+|++|. |||||.|+++ .... . .-.+
T Consensus 45 LAEGGFa---~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 45 LAEGGFA---QVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EccCCcE---EEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 5678888 8999999998899999997755 3678899999999999995 9999999994 3221 1 2367
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 76 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
+|+||||.||.|-|++.++ .+|++.+|.+|+.|+++|+.+||...|||||||||-+||||+ ++|..||||||.|+..
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcccccccc
Confidence 8999999999999999853 569999999999999999999999999999999999999997 5589999999999654
Q ss_pred cCCCCc-----------cccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC
Q 006593 154 QQPTAR-----------SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK 218 (639)
Q Consensus 154 ~~~~~~-----------~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~ 218 (639)
...... ...-||.|+|||++. ...++|+|||+|||+||-||....||.+... . .|..+..
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-l----aIlng~Y 271 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-L----AILNGNY 271 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-e----eEEeccc
Confidence 322111 124699999999774 2589999999999999999999999976322 1 2344433
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.......++..+++||..||+ +|.+||++-+++.+-|.
T Consensus 272 ~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 272 SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 332334566789999999999 89999999999876553
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.38 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=194.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---CceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~---~~~l~l 77 (639)
+||+|+|| .||+|.+..+|..||+|++.... ......++..|+.++++++||||+++++++.... ...+++
T Consensus 12 ~lg~G~~g---~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 12 YIGEGAYG---MVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred EEEecCCe---EEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 37788877 89999999999999999986432 2344566889999999999999999999875443 235899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
|+||+. ++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.......
T Consensus 86 v~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 86 VQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEH 160 (336)
T ss_pred Eehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceeeccccc
Confidence 999996 588888754 56999999999999999999999999 99999999999997 55899999999986553221
Q ss_pred -----CccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH---------------c
Q 006593 158 -----ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---------------S 215 (639)
Q Consensus 158 -----~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~---------------~ 215 (639)
.....||+.|+|||.+. ..++.++||||||+++|+|++|+.||.+..... ....+. .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhc
Confidence 12357899999999764 358899999999999999999999997633211 111110 0
Q ss_pred --------CC---CCC---cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 216 --------GI---KPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 216 --------g~---~p~---~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.. ... ......++++.+||.+||. +|.+||++.|++.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 000 0112346789999999999 89999999999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=305.47 Aligned_cols=241 Identities=20% Similarity=0.334 Sum_probs=187.4
Q ss_pred CcccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.||+|+|| .||+|... .....+|+|.+.... .......+.+|+.+++.++||||+++++++... ..+++|
T Consensus 2 ~lg~G~fg---~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~--~~~~lv 73 (269)
T cd05042 2 EIGNGWFG---KVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES--IPYLLV 73 (269)
T ss_pred cCCccCCc---eEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC--CceEEE
Confidence 47899999 68887542 345678888765432 234456688999999999999999999988654 458999
Q ss_pred EecCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 79 TELFTSGNLRQYRKKHK-----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~-----~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
|||+++|+|.+++...+ ..++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++...
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~ 150 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTA-DLSVKIGDYGLALEQ 150 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecC-CCcEEEecccccccc
Confidence 99999999999997643 2467888999999999999999999 999999999999984 579999999998653
Q ss_pred cCC----CCccccCCCCcCCccccc--------ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC--
Q 006593 154 QQP----TARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK-- 218 (639)
Q Consensus 154 ~~~----~~~~~~GTp~ymAPE~l~--------~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~-- 218 (639)
... ......+++.|+|||++. ..++.++|||||||++|||++ |..||....+...+...+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 230 (269)
T cd05042 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL 230 (269)
T ss_pred ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC
Confidence 221 112234577899999864 246789999999999999999 78899875444433333333321
Q ss_pred -CCcccCCCChHHHHHHHHhcCCCCCCCCHHHHhc
Q 006593 219 -PASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252 (639)
Q Consensus 219 -p~~l~~~~s~~l~~LI~kcL~dP~~RpSa~ELL~ 252 (639)
........++.+.+++..|+.+|.+||++++|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 PKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred CCCcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 2233445678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=311.90 Aligned_cols=246 Identities=29% Similarity=0.505 Sum_probs=202.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..+|..||+|++.... ......+.+|+.+++.++|+||+++++++... ...++|||
T Consensus 27 ~lg~g~~g---~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 97 (292)
T cd06657 27 KIGEGSTG---IVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVME 97 (292)
T ss_pred HcCCCCCe---EEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeC--CEEEEEEe
Confidence 37888888 89999999999999999876432 34456789999999999999999999998765 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+++++|.+++.. +.+++..++.++.||+.||.|||+.| ++||||+|.||+++ .++.++|+|||++...... ..
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccccc
Confidence 9999999998764 56899999999999999999999999 99999999999997 4579999999988655432 22
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC-cccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~~~s~~l~~LI~k 236 (639)
....|++.|+|||.+. ..++.++|+||||+++|+|++|..||... ........+..+..+. ......++.+.+||.+
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence 3457899999999875 45788999999999999999999999763 3344444444333221 1223457889999999
Q ss_pred hcC-CCCCCCCHHHHhcCccccccc
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||. +|.+||++.++|.||||....
T Consensus 253 ~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 253 LLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHhCCcccCcCHHHHhcChHHhccC
Confidence 999 899999999999999998655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=303.39 Aligned_cols=237 Identities=18% Similarity=0.344 Sum_probs=194.0
Q ss_pred cccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| .||+|.+. ..+..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..+++||
T Consensus 3 ig~G~~g---~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~ 73 (257)
T cd05115 3 LGSGNFG---CVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVM 73 (257)
T ss_pred cCCCCcc---cEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEE
Confidence 7899998 78888764 456779999886542 34455678999999999999999999997632 3588999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 80 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 80 Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++........
T Consensus 74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCcc
Confidence 99999999999975 457899999999999999999999999 99999999999997 557999999999875533211
Q ss_pred -----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 159 -----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 159 -----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+. ....+...+..+..+ ..+...++++.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~ 228 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMY 228 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 1122357899999876 458899999999999999996 99999874 455566666665443 34556678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006593 232 GFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
++|.+||. +|.+||++.++++
T Consensus 229 ~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 229 ALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 99999999 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.08 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=192.5
Q ss_pred CcccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|||| .||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 13 ~ig~G~~g---~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~--~~~ 84 (277)
T cd05062 13 ELGQGSFG---MVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--QPT 84 (277)
T ss_pred eeccccCC---eEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCe
Confidence 37888888 78888764 346789999876432 234456688999999999999999999987544 468
Q ss_pred EEEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEe
Q 006593 76 NMITELFTSGNLRQYRKKHK----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 145 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~----------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~ 145 (639)
++||||+++|+|.+++.+.+ .++...+..++.|++.||.|||+.+ ++||||||+||+++ ..+.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CCCCEEEC
Confidence 89999999999999997532 2567889999999999999999998 99999999999998 45799999
Q ss_pred ecchhhhccCCC----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006593 146 DLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 219 (639)
Q Consensus 146 DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p 219 (639)
|||++....... .....+++.|||||.+.. .++.++||||||+++|||++ |..||.+ .+.....+.+..+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999987553221 112345788999998864 58999999999999999999 6889976 3455555555554332
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+...+..+++||.+||+ +|.+||++.|++++
T Consensus 241 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 -DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3345567889999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.06 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=203.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..+|..||+|.+...... ..+....+.+|++++++++|||++++++++.... ..++|||
T Consensus 32 ~lg~G~~~---~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 105 (317)
T cd06635 32 EIGHGSFG---AVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH--TAWLVME 105 (317)
T ss_pred eeccCCCe---EEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--eEEEEEe
Confidence 36778777 8999999999999999998765432 3455677899999999999999999999887654 5889999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+.| +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++ +.+.+||+|||++..... ..
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~--~~ 179 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIASP--AN 179 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCCCccccCC--cc
Confidence 9975 77777754 456899999999999999999999999 99999999999997 457999999998865432 23
Q ss_pred cccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 160 SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
...|++.|+|||++. +.++.++||||||+++|+|++|..||.... .......+..+..+.......++.+++||.
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 457899999999863 458899999999999999999999997743 333344444443443344456788999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||+ +|.+||++.++++|+|+.....
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccCc
Confidence 9998 8999999999999999965443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=308.55 Aligned_cols=240 Identities=25% Similarity=0.379 Sum_probs=196.3
Q ss_pred CcccccccCcEEEEEEEecCC-----CeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA-----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t-----G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
.||+|+|| .||+|.+... ...||+|.+.... .......+.+|+.+++++ +||||+++++++... ..
T Consensus 19 ~ig~g~~g---~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~ 90 (293)
T cd05053 19 PLGEGAFG---QVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE--GP 90 (293)
T ss_pred Eecccccc---cEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--CC
Confidence 37888888 7888887643 3789999887542 234556789999999999 899999999987654 45
Q ss_pred EEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC
Q 006593 75 VNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 138 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~ 138 (639)
+++||||+.+|+|..++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ +
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~-~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT-E 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc-C
Confidence 89999999999999999642 45889999999999999999999999 99999999999997 5
Q ss_pred CCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHH
Q 006593 139 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKK 212 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~ 212 (639)
.+.+||+|||++..+.... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.. ....+.++.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHHHH
Confidence 6899999999997654321 11223467899999775 458999999999999999997 8999976 455667777
Q ss_pred HHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 213 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 213 i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus 247 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66664433 344567899999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=304.80 Aligned_cols=239 Identities=21% Similarity=0.359 Sum_probs=195.2
Q ss_pred CcccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|+|| .||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+++++++... ..+
T Consensus 13 ~lg~g~~g---~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~ 84 (277)
T cd05032 13 ELGQGSFG---MVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--QPT 84 (277)
T ss_pred EecCCCCc---eEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--CCc
Confidence 37888888 788888764 34889999976442 234456788999999999999999999988665 458
Q ss_pred EEEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEe
Q 006593 76 NMITELFTSGNLRQYRKKHK----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 145 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~----------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~ 145 (639)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+|||++ ..+.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCCCEEEC
Confidence 89999999999999997532 3678899999999999999999999 99999999999998 45899999
Q ss_pred ecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006593 146 DLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 219 (639)
Q Consensus 146 DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p 219 (639)
|||+++...... .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+.....+.+..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~- 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGH- 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCCC-
Confidence 999987654321 22345678999999775 458899999999999999998 8999976 456666666664433
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
...+...+..+.+||.+||+ +|.+|||+.+|+.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 23445568899999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=305.96 Aligned_cols=238 Identities=22% Similarity=0.363 Sum_probs=194.3
Q ss_pred CcccccccCcEEEEEEEecCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+|.+..+|. .||+|+++... .....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 14 ~lg~G~~g---~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~ 84 (279)
T cd05109 14 VLGSGAFG---TVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---TVQ 84 (279)
T ss_pred ecCCCCCc---eEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---CcE
Confidence 47888888 899998877766 48999887543 345567789999999999999999999987643 367
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
++++|+++|+|.+++..+ +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ +.+.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceeeccc
Confidence 899999999999999764 56999999999999999999999999 99999999999997 557899999999976543
Q ss_pred CCC----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~~----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+ ..+...++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERL-PQPPICTID 239 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCccCCHH
Confidence 221 1223467899999875 458999999999999999998 8999975 3445555555554333 234456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.++|.+||. +|.+||++.+++.
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.07 Aligned_cols=245 Identities=27% Similarity=0.375 Sum_probs=190.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC------ceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK------KTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~------~~l 75 (639)
||.|+|| .||+|.+..+|..||+|++...... ......+.+|+++++.++||||+++++++..... ..+
T Consensus 16 lg~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 16 LGEGTFG---EVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred eccCCCE---EEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 6777777 8999999999999999998765421 1223456789999999999999999998765432 357
Q ss_pred EEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 76 NMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
++|+||+.+ +|..++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++ +.+.+||+|||++....
T Consensus 91 ~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYD 166 (311)
T ss_pred EEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCccchhcc
Confidence 999999975 67766654 457999999999999999999999999 99999999999997 55899999999997553
Q ss_pred CCC-------------CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc---C
Q 006593 155 QPT-------------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---G 216 (639)
Q Consensus 155 ~~~-------------~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~---g 216 (639)
... .....|++.|+|||++.+ .++.++|||||||++|+|++|.+||.+..... ....+.. .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~~ 245 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFKLCGT 245 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence 221 122357889999997753 47899999999999999999999997643332 2222211 0
Q ss_pred CCC----------------------Cc---ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 217 IKP----------------------AS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 217 ~~p----------------------~~---l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
..+ .. ......+.+.+||.+||. +|.+|||+.|++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 00 001223678899999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.97 Aligned_cols=236 Identities=20% Similarity=0.375 Sum_probs=193.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|... .+..||+|.+..... ....+..|+.+|+.++||||+++++++... ..+++|||
T Consensus 11 ~lg~G~~~---~vy~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~iv~e 79 (256)
T cd05114 11 ELGSGQFG---VVHLGKWR-AQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--KPLYIVTE 79 (256)
T ss_pred EecCCcCc---eEEEEEec-cCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccC--CCEEEEEE
Confidence 37888888 78998875 456799998764432 235688899999999999999999987554 45899999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
|+++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCcee
Confidence 99999999999754 46899999999999999999999999 99999999999998 457999999999876533221
Q ss_pred --ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 --~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....++..|+|||++. ..++.++||||||+++|+|++ |+.||.. .+..+....+..+..+ ..+...+..+.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li 234 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMISRGFRL-YRPKLASMTVYEVM 234 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 1223566899999886 458899999999999999999 8999976 3455666677665443 23455678899999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||. +|.+||++.++++
T Consensus 235 ~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 99999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.06 Aligned_cols=240 Identities=20% Similarity=0.358 Sum_probs=196.1
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|||| +||+|.+... ...||+|.++... .......+.+|+.++++++||||+++++++... ..+++
T Consensus 11 ~lg~g~~g---~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~i 82 (266)
T cd05033 11 VIGGGEFG---EVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS--RPVMI 82 (266)
T ss_pred EecCCccc---eEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC--CceEE
Confidence 47899998 7999987644 5679999886543 344566788999999999999999999987654 45899
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++ ..+.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhccccc
Confidence 99999999999999764 46899999999999999999999999 99999999999998 4579999999999876421
Q ss_pred C----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 157 T----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 157 ~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
. .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+. ....+...+..+... ..+...++.+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l 237 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAVEDGYRL-PPPMDCPSAL 237 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHH
Confidence 1 11223467899999886 458999999999999999998 99999764 345555666554332 2334567899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+|+.+||+ +|.+||++.+++++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 238 YQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.90 Aligned_cols=245 Identities=27% Similarity=0.434 Sum_probs=201.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++..||+|.+...... ......++.+|+++++.++|+|++++++++... ...++||||
T Consensus 23 lg~g~~g---~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 96 (308)
T cd06634 23 IGHGSFG---AVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEY 96 (308)
T ss_pred eeeCCCE---EEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC--CeeEEEEEc
Confidence 6777777 8999999999999999998754322 234556788999999999999999999998765 458899999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
+. |+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||+|.||+++ ..+.+||+|||++...... ..
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~--~~ 170 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA--NX 170 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccceeecCc--cc
Confidence 96 588777754 456899999999999999999999999 99999999999997 4579999999998655432 34
Q ss_pred ccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 161 VIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 161 ~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
..|++.|+|||.+. ..++.++|||||||++|+|++|..||.... .......+..+..+.......+..+++||.+
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence 57899999999863 357889999999999999999999997643 3333334444444444455677889999999
Q ss_pred hcC-CCCCCCCHHHHhcCcccccc
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
||. +|.+||++.++++|||+...
T Consensus 250 cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HhhCCcccCCCHHHHhhCcccccc
Confidence 998 89999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.70 Aligned_cols=238 Identities=24% Similarity=0.381 Sum_probs=194.4
Q ss_pred CcccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|||| .||+|.+. .++..|++|.+.... ....+.+.+|++++++++||||+++++++... ..+
T Consensus 12 ~lg~g~~g---~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 82 (291)
T cd05094 12 ELGEGAFG---KVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPL 82 (291)
T ss_pred eecccCCC---eEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC--Cce
Confidence 47888888 78888753 456779999876442 34456789999999999999999999988654 458
Q ss_pred EEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC
Q 006593 76 NMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~ 139 (639)
++||||+.+++|.+++..++ .+++..++.++.||+.||.|||+++ |+||||||+|||++ +.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~-~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG-AN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cC
Confidence 99999999999999997643 3789999999999999999999999 99999999999998 45
Q ss_pred CcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHH
Q 006593 140 GEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 140 g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i 213 (639)
+.+||+|||++....... .....+++.|+|||.+. ..++.++||||||+++|+|+| |..||... +.......+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH
Confidence 799999999987553321 22345688999999776 458899999999999999999 99999763 455555666
Q ss_pred HcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 214 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 214 ~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+..+. .+...+..+.+||.+||+ +|.+||++.++++
T Consensus 239 ~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 5554432 345567889999999999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.90 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=202.9
Q ss_pred CcccccccCcEEEEEEEe---cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d---~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|+|| .||+|.+ ..++..||+|+++...........+.+..|+.++.++ +||||+++++.+... ..++
T Consensus 7 ~ig~G~~~---~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--~~~~ 81 (288)
T cd05583 7 VLGTGAYG---KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--TKLH 81 (288)
T ss_pred EeccCCCc---eEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC--CEEE
Confidence 37888888 5676664 4578899999998655433344566788999999999 699999999987554 4689
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+||||+.+|+|.+++.+...+++..++.|+.|++.||.|||+.+ ++||||||.||+++ .++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECccccccccc
Confidence 99999999999999988788999999999999999999999998 99999999999997 4579999999998765432
Q ss_pred C---CccccCCCCcCCccccccc---CCccccccchhhhhhhhhhccCCCCCCC---CHHHHHHHHHcCCCCCcccCCCC
Q 006593 157 T---ARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVND 227 (639)
Q Consensus 157 ~---~~~~~GTp~ymAPE~l~~~---ys~ksDIwSlGiil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~~l~~~~s 227 (639)
. .....|++.|+|||.+... ++.++||||||+++|+|++|..||.... ....+.+.+..... ..+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccC
Confidence 1 2235689999999987542 6889999999999999999999996322 12333344433322 2344567
Q ss_pred hHHHHHHHHhcC-CCCCCCC---HHHHhcCcccccccCC
Q 006593 228 PQIKGFIEKCLV-PASERLS---AKDLLKDPFLQVENQK 262 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~RpS---a~ELL~Hpff~~~~~~ 262 (639)
+.+++||.+||. +|.+||| +.++|+||||+...+.
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 899999999998 8999998 6788999999877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=327.95 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=210.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||.|-|| +||-|++..+|+.||||++.+..+-. .+...+..|+.||.++.||.||.+--.|.. .+++++|||
T Consensus 571 vLGSGQFG---~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVME 643 (888)
T KOG4236|consen 571 VLGSGQFG---TVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVME 643 (888)
T ss_pred hccCCcce---eeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEeh
Confidence 47787777 89999999999999999998877633 445789999999999999999999886644 456999999
Q ss_pred cCCCCCHHHHH-H-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYR-K-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~l-k-k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~~~ 156 (639)
-+.| ++.+.+ . ..+++++..-+.++.||+.||.|||-.+ |+|+||||+|||+... --.+||||||+|+.+.+.
T Consensus 644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 9965 555554 3 3578999999999999999999999999 9999999999999643 347999999999988754
Q ss_pred -CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCCCCcccCCCChHHHH
Q 006593 157 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPASLAKVNDPQIKG 232 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p~~l~~~~s~~l~~ 232 (639)
.+++++|||.|.|||++.. +|+..-|+||.|+|+|.-+.|.+||.+..+ +...|.+ ...|...+...++++.+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---IndQIQNAaFMyPp~PW~eis~~Aid 797 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---INDQIQNAAFMYPPNPWSEISPEAID 797 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---hhHHhhccccccCCCchhhcCHHHHH
Confidence 6778999999999999874 699999999999999999999999987544 3444443 34566667778899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||..+|+ +-.+|.|.+..|.|||+|...
T Consensus 798 lIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 798 LINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 9999999 899999999999999998654
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=311.92 Aligned_cols=241 Identities=22% Similarity=0.327 Sum_probs=192.2
Q ss_pred CcccccccCcEEEEEEEecCCCeE--EEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIE--VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~--VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+..+|.. +|+|.++.. ........+.+|+.++.++ +||||+++++++... ..+|+
T Consensus 14 ~lg~G~~g---~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--~~~~l 85 (303)
T cd05088 14 VIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYL 85 (303)
T ss_pred eecCCCCc---eEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC--CCceE
Confidence 47888888 7999998887765 466665422 2345567788999999999 899999999987654 46899
Q ss_pred EEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc
Q 006593 78 ITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~ 141 (639)
||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||++| ++||||||+|||++ ..+.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CCCc
Confidence 999999999999997543 4789999999999999999999999 99999999999997 4579
Q ss_pred EEEeecchhhhccCCC-CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 006593 142 VKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 218 (639)
Q Consensus 142 VKL~DFGlA~~l~~~~-~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~ 218 (639)
+||+|||++....... .....+++.|+|||.+.. .++.++|||||||++|+|+| |..||.. .+..+.+..+..+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~ 241 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYR 241 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhcCCc
Confidence 9999999985432111 111234667999998764 47899999999999999998 9999976 344556666555432
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
+ ..+...++.+.+||.+||+ +|.+||++.++|.+.
T Consensus 242 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 242 L-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2 2334457899999999999 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=309.74 Aligned_cols=240 Identities=21% Similarity=0.331 Sum_probs=194.0
Q ss_pred CcccccccCcEEEEEEEecCCCe--EEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~--~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|||| .||+|.+..+|. .+++|.++... .....+.+..|+++++++ +||||+++++++... ..+++
T Consensus 9 ~lg~g~~g---~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~l 80 (297)
T cd05089 9 VIGEGNFG---QVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLYI 80 (297)
T ss_pred eecCCCcc---eEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--CcceE
Confidence 58999999 799998877765 46888776321 234567789999999999 799999999987655 45899
Q ss_pred EEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc
Q 006593 78 ITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~ 141 (639)
+|||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++ .++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-ENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CCCe
Confidence 999999999999997643 4788999999999999999999999 99999999999997 4579
Q ss_pred EEEeecchhhhccCCCCcc-ccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 006593 142 VKIGDLGLAIAMQQPTARS-VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 218 (639)
Q Consensus 142 VKL~DFGlA~~l~~~~~~~-~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~ 218 (639)
+||+|||++.......... ...+..|+|||++.. .++.++|||||||++|+|++ |..||.. .........+..+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~~ 236 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYR 236 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCC
Confidence 9999999986433221111 223457999998764 58999999999999999997 9999976 455666666665543
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+ ..+...++.+++||.+||. +|.+||+++++++.
T Consensus 237 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 M-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 3345567899999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.86 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=195.3
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
.||+|+|| .||+|.+ ..++..||+|.++... .....+.+..|+.+++++ +||||+++++++... ..
T Consensus 42 ~ig~G~~g---~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~ 113 (302)
T cd05055 42 TLGAGAFG---KVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTIG--GP 113 (302)
T ss_pred eeeccCCe---eEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--Cc
Confidence 37888888 6888875 4456789999887543 234567789999999999 899999999988665 45
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 75 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCccccc
Confidence 899999999999999997643 3899999999999999999999999 99999999999997 557999999999976
Q ss_pred ccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCC
Q 006593 153 MQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVN 226 (639)
Q Consensus 153 l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 226 (639)
..... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||..........+.+..+..+ ..+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 269 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHA 269 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCCC
Confidence 54322 12234678899999775 458999999999999999998 999998755444555555554333 334456
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
++.+++|+.+||. +|.+||++.||+.
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7899999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.19 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=203.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---CceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~---~~~l~l 77 (639)
+||.|+|| .||+|.+..+|..||+|++.... ......+.+.+|+.+++.++||||+++++++.... ...+|+
T Consensus 7 ~ig~g~~~---~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 7 PIGSGAYG---VVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred eecCCCCe---EEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 36777777 89999999999999999987542 12455677999999999999999999999886653 236899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+. ++|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++. .+.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~-~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNS-NCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC-CCCEEEcccCceEeecccc
Confidence 999997 589999988888999999999999999999999999 999999999999984 4899999999997665432
Q ss_pred -----CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CC--------
Q 006593 158 -----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PA-------- 220 (639)
Q Consensus 158 -----~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~-------- 220 (639)
.....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... ....+..+..... +.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhhccc
Confidence 334568999999998764 58899999999999999999999998643 3333333332110 00
Q ss_pred -------------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 221 -------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 221 -------------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
......++.+.+||.+||. +|.+||++.++|.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0112246789999999999 899999999999999998544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.38 Aligned_cols=237 Identities=20% Similarity=0.370 Sum_probs=193.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+. .+..+|+|.+..... ....+..|+.++++++||||+++++++... ..+++|||
T Consensus 11 ~lg~G~~~---~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 79 (256)
T cd05059 11 ELGSGQFG---VVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--RPIFIVTE 79 (256)
T ss_pred hhccCCCc---eEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC--CceEEEEe
Confidence 36788887 79999875 466899998764332 234578899999999999999999987544 46899999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+++++|.+++..+ +.+++..++.++.||+.||.|||+.+ ++||||||+|||++ +.|.+||+|||+++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccccccc
Confidence 99999999999764 46899999999999999999999999 99999999999997 5579999999998765433222
Q ss_pred ccc---CCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 160 SVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 160 ~~~---GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
... ++..|+|||.+. ..++.++||||||+++|+|++ |..||... ...+....+..+..+ ..+...++.+.+++
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 234 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL-YRPKLAPTEVYTIM 234 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHH
Confidence 222 345799999876 468999999999999999999 79999763 455666666655332 33456788999999
Q ss_pred HHhcC-CCCCCCCHHHHhcC
Q 006593 235 EKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~H 253 (639)
.+||. +|.+||++.++++.
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHhcCChhhCcCHHHHHHH
Confidence 99998 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.26 Aligned_cols=238 Identities=24% Similarity=0.392 Sum_probs=194.0
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|||| .||+|.. ..++..||+|.+... .....+.+.+|+++++.++|+||+++++++... ..+
T Consensus 12 ~lg~g~~g---~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 82 (280)
T cd05092 12 ELGEGAFG---KVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG--RPL 82 (280)
T ss_pred ccCCccCC---eEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--Cce
Confidence 47899999 6777753 346778999987643 245567899999999999999999999988665 458
Q ss_pred EEEEecCCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC
Q 006593 76 NMITELFTSGNLRQYRKKHK---------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 140 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~---------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g 140 (639)
+++|||+.+|+|.+++..++ .+++..+..++.||+.||.|||+++ ++||||||+|||++ +.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-QGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-CCC
Confidence 99999999999999998653 4789999999999999999999999 99999999999997 567
Q ss_pred cEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHH
Q 006593 141 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 214 (639)
Q Consensus 141 ~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~ 214 (639)
.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |.+||... ........+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-CHHHHHHHHH
Confidence 99999999986543221 12234578899999776 458999999999999999998 89999764 3445555555
Q ss_pred cCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 215 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 215 ~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.+..+ ..+...++.+++||.+||. +|.+||++.+|+.
T Consensus 239 ~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 QGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 55433 3345567899999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.91 Aligned_cols=241 Identities=19% Similarity=0.296 Sum_probs=192.6
Q ss_pred CcccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+.. .+..||+|.+.... .....+.+..|+.+++.++||||+++++++...+ ...++
T Consensus 2 ~lg~g~~g---~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~l 74 (262)
T cd05058 2 VIGKGHFG---CVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLV 74 (262)
T ss_pred cccccCCc---eEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEE
Confidence 58999999 688887643 45679999875322 3455678899999999999999999999765433 45789
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++.+. ...++..+..++.||+.||.|||+.+ ++||||||+|||++ +.+.+||+|||++......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCC
Confidence 99999999999999764 45678888999999999999999999 99999999999997 5579999999998755322
Q ss_pred C------CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhc-cCCCCCCCCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 157 T------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 157 ~------~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG-~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
. .....+++.|+|||.+. ..++.++|||||||++|||++| .+||.. .+...+...+..+..+. .+...++
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRLL-QPEYCPD 229 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 1 12335677899999875 4688999999999999999995 556654 45556666666554332 3344567
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+.+++.+||. +|.+||++.++++.
T Consensus 230 ~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 230 PLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 89999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.85 Aligned_cols=239 Identities=23% Similarity=0.340 Sum_probs=192.7
Q ss_pred CcccccccCcEEEEEEEecCCCe--EEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI--EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~--~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|||| .||+|.+..+|. .+|+|.++... .....+.+..|+++++++ +||||+++++++... ..+++
T Consensus 2 ~lg~g~~g---~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~l 73 (270)
T cd05047 2 VIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYL 73 (270)
T ss_pred cCCCCCCc---eEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceE
Confidence 58999999 799999988775 46888776321 234556789999999999 899999999988655 45899
Q ss_pred EEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc
Q 006593 78 ITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~ 141 (639)
+|||+++|+|.+++...+ .+++..++.++.||+.||+|||+++ ++||||||+||+++ ..+.
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~ 150 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYV 150 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCe
Confidence 999999999999997643 4788999999999999999999999 99999999999997 4579
Q ss_pred EEEeecchhhhccCCC-CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 006593 142 VKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 218 (639)
Q Consensus 142 VKL~DFGlA~~l~~~~-~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~ 218 (639)
+||+|||++....... ......++.|+|||++. ..++.++||||||+++|+|++ |..||.+ .+....+..+..+..
T Consensus 151 ~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~ 229 (270)
T cd05047 151 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYR 229 (270)
T ss_pred EEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCC
Confidence 9999999985332211 11223456799999875 458899999999999999997 9999976 345556666655433
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
. ..+...+.++.+++.+||. +|.+||++.+++.
T Consensus 230 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 230 L-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred C-CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2 2344567889999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.85 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=200.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
|++.|.|..+.||++.....+. ||+|.+.... .....+.-+..|+.+|.+| .|.+||++|+|-+.+ .++|||||
T Consensus 366 lk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~lYmvmE 440 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYLYMVME 440 (677)
T ss_pred HHhhcCCCcceeeeeecCCCcc-hhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceEEEEee
Confidence 5555666666899998765544 5666555443 2456788899999999999 699999999987664 57999999
Q ss_pred cCCCCCHHHHHHhCCCCCH-HHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 81 LFTSGNLRQYRKKHKNVDI-KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e-~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|=. -+|..+|++.+...+ -.++.|..|+|.|+.++|.+| |||.||||.|+|+- .|.+||+|||+|..+...+
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhcccCccccc
Confidence 875 599999998765443 588999999999999999999 99999999999985 3899999999998876554
Q ss_pred --CccccCCCCcCCcccccc------------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 006593 158 --ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 223 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~~------------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 223 (639)
..+-+||+.||+||.+.. +.++++||||||||+|+|+.|+.||....+....+..|+.......++
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 335689999999997631 156899999999999999999999987666666666666654444555
Q ss_pred CCCChH-HHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 224 KVNDPQ-IKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 224 ~~~s~~-l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
...... +.++++.||. ||.+||+..+||+|||++.
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 555444 9999999999 9999999999999999985
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.98 Aligned_cols=249 Identities=28% Similarity=0.385 Sum_probs=199.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~l 77 (639)
||+|+|| .||+|.+..+|..||+|++.... ........+..|+.+|+.++||||+++++++..... ..+++
T Consensus 23 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 23 VGSGAYG---TVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred eeecCCe---EEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 6777777 79999999999999999986532 233445678899999999999999999998865432 25689
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+ +++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++ +.|.+||+|||++......
T Consensus 98 v~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~- 171 (343)
T cd07880 98 VMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSE- 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccccccccC-
Confidence 99999 7799988874 56999999999999999999999999 99999999999997 5579999999998765432
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC------------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI------------------ 217 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~------------------ 217 (639)
.....+++.|+|||++.. .++.++|+||||+++|+|++|..||.+........+.+....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07880 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251 (343)
T ss_pred ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHH
Confidence 234568999999998764 488999999999999999999999986543322222111000
Q ss_pred -------C---CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 218 -------K---PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 218 -------~---p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
. ...+....++.+.++|.+||. +|.+|||+.+++.||||+....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0 001123456789999999999 8999999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.91 Aligned_cols=234 Identities=22% Similarity=0.361 Sum_probs=195.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||.|+|| .||+|.+. |..||+|.++... ...+++.+|+.+++.++|+||+++++++.+. ...++|||
T Consensus 13 ~ig~g~~g---~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 80 (256)
T cd05039 13 TIGKGEFG---DVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPLYIVTE 80 (256)
T ss_pred eeecCCCc---eEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCC--CCeEEEEE
Confidence 47888887 78999874 8899999987543 2567799999999999999999999988664 45899999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|+++++|.++++... .+++..++.++.|++.||.|||+++ ++||||||+||+++ .+|.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEcccccccccccccc
Confidence 999999999998765 6999999999999999999999999 99999999999998 557999999999976643322
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
...++..|+|||.+. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.++|.+
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 234 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYKVMKD 234 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHHHHHH
Confidence 334466799999775 468889999999999999997 9999976 3556666666555332 3445567899999999
Q ss_pred hcC-CCCCCCCHHHHhc
Q 006593 237 CLV-PASERLSAKDLLK 252 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~ 252 (639)
||. +|.+||++.+|+.
T Consensus 235 ~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 235 CWELDPAKRPTFKQLRE 251 (256)
T ss_pred HhccChhhCcCHHHHHH
Confidence 999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.42 Aligned_cols=237 Identities=25% Similarity=0.397 Sum_probs=196.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|+|| .||+|.+.. +..||+|.+.... ......+..|+.+++.++||||+++++++... ..+++|||
T Consensus 13 ~ig~g~~~---~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 82 (261)
T cd05148 13 KLGSGYFG---EVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--EPVYIITE 82 (261)
T ss_pred hhccCCCc---cEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEecC--CCeEEEEe
Confidence 37888888 799999987 8999999987553 23456688999999999999999999987655 45899999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+.+|+|.+++... ..+++..++.|+.||+.||.|||++| ++||||||+||+++ +++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcCCccc
Confidence 99999999999863 46899999999999999999999999 99999999999998 55799999999997664332
Q ss_pred -CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.. .+..+++..+..+..+ ..+...++.+.++|
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i 237 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIYKIM 237 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHHHHH
Confidence 12334577899999876 458899999999999999998 8999976 3455666666655333 33456678999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||+ +|.+|||+.+|+.
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 99998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.02 Aligned_cols=240 Identities=22% Similarity=0.298 Sum_probs=192.8
Q ss_pred CcccccccCcEEEEEEEecCCC----------------eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG----------------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 64 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG----------------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~ 64 (639)
.||+|+|| .||+|.+...+ ..||+|.+.... .....+.+.+|+++|++++||||++++
T Consensus 12 ~lg~G~~g---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 12 KLGEGQFG---EVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred cccCCCCc---cEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 37888887 78888776543 568999887553 235667889999999999999999999
Q ss_pred EEEEeCCCceEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcE
Q 006593 65 KSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133 (639)
Q Consensus 65 ~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~-----------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NI 133 (639)
+++... ..++++|||+.+++|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 86 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Ni 161 (296)
T cd05051 86 GVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNC 161 (296)
T ss_pred EEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhce
Confidence 988765 45899999999999999998766 6899999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh--ccCCCCCCCCH
Q 006593 134 FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT--FEYPYSECKNP 206 (639)
Q Consensus 134 Ll~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt--G~~Pf~~~~~~ 206 (639)
+++ +.+.++|+|||++..+.... .....+++.|||||++.. .++.++|||||||++|+|++ +..||.... .
T Consensus 162 li~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~ 239 (296)
T cd05051 162 LVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-D 239 (296)
T ss_pred eec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-h
Confidence 997 44799999999987553321 223456788999998764 68999999999999999998 678887643 3
Q ss_pred HHHHHHHHcC------CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 207 AQIFKKVTSG------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 207 ~~i~~~i~~g------~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.+++..+... ......+...+.++.++|.+||+ +|.+||++.||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 4444444322 11112233456789999999999 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.24 Aligned_cols=238 Identities=21% Similarity=0.352 Sum_probs=191.6
Q ss_pred CcccccccCcEEEEEEEecCCCeE----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~----VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|||| +||+|.+..+|.. |++|.+... ........+..|+.++++++||||+++++++.. ..++
T Consensus 14 ~lg~G~~~---~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~~ 84 (279)
T cd05111 14 LLGSGVFG---TVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASLQ 84 (279)
T ss_pred ccCccCCc---ceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---CccE
Confidence 47888888 7999998777764 666665422 123445678889999999999999999998643 3477
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+++||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceeccC
Confidence 899999999999999764 56899999999999999999999999 99999999999997 457999999999976532
Q ss_pred CC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. .....++..|+|||.+. ..++.++||||||+++|||++ |..||.+. .+..+...+..+..+ ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERL-AQPQICTID 239 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcC-CCCCCCCHH
Confidence 21 12345677899999876 468999999999999999998 99999763 445555555555433 334456678
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+++.+||. +|.+|||+.|+++
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999998 8999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.72 Aligned_cols=239 Identities=25% Similarity=0.375 Sum_probs=194.5
Q ss_pred CcccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
+||+|||| .||+|.+.. ....||+|.+.... .....+.+.+|+.+++.++||||+++++.+... ...
T Consensus 7 ~lg~g~~g---~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 78 (290)
T cd05045 7 TLGEGEFG---KVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--GPL 78 (290)
T ss_pred cccCcCCc---ceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--CCc
Confidence 48899998 688888743 33578888876442 234567899999999999999999999987655 458
Q ss_pred EEEEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCC
Q 006593 76 NMITELFTSGNLRQYRKKH------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~------------------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~ 131 (639)
++++||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~ 156 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAAR 156 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhh
Confidence 8999999999999998653 24788899999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCC
Q 006593 132 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKN 205 (639)
Q Consensus 132 NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~ 205 (639)
|||++ +.+.+||+|||++....... .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+ ..
T Consensus 157 nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~ 234 (290)
T cd05045 157 NVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IA 234 (290)
T ss_pred eEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-CC
Confidence 99997 55799999999987553221 12234577899999765 458999999999999999998 9999976 45
Q ss_pred HHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 206 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 206 ~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+..+...+..+..+. .+...+..+++||.+||+ +|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 677777666654332 345567899999999998 8999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=307.42 Aligned_cols=247 Identities=23% Similarity=0.439 Sum_probs=197.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| .||+|.+..+|..||+|+++.... ......+..|+.++..+ .||||+++++++.+. ..++++||
T Consensus 23 lg~g~~~---~v~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e 94 (296)
T cd06618 23 IGSGTCG---QVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVFICME 94 (296)
T ss_pred eeccCCe---EEEEEEECCCCeEEEEEEEeccCC---hHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEEEEee
Confidence 5667666 899999999999999999976532 23455677788777777 599999999998765 45899999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+. ++|.+++.. ...+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ +++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccCCCc
Confidence 985 578887765 4578999999999999999999997 57 99999999999997 56899999999987654322
Q ss_pred CccccCCCCcCCcccccc-----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-ccCCCChHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQIK 231 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-l~~~~s~~l~ 231 (639)
.....+++.|+|||.+.. .++.++||||||+++|+|++|+.||.......+....+.....+.. .....+.+++
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence 223457889999998753 3788999999999999999999999764444455555554433221 2223578899
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||.+||. +|.+||++.+++.||||+...
T Consensus 251 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 251 SFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 99999999 899999999999999998544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.70 Aligned_cols=235 Identities=23% Similarity=0.411 Sum_probs=191.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+. .+..||+|.+.... ...+.+..|+.++++++|+||+++++++.+. ...+++|||
T Consensus 14 lg~g~~g---~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 82 (261)
T cd05072 14 LGAGQFG---EVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--EPIYIITEY 82 (261)
T ss_pred cCCcCCc---eEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--CCcEEEEec
Confidence 6777777 79999874 56679999876433 2356789999999999999999999987554 458999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
+.+|+|.+++++. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++ +.+.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecCCCcee
Confidence 9999999999763 56889999999999999999999999 99999999999998 55799999999997654322
Q ss_pred -CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.....++..|+|||++. ..++.++||||||+++|+|+| |..||.. .........+..+.... .....+.++.++|
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li 237 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSALQRGYRMP-RMENCPDELYDIM 237 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHH
Confidence 12234567899999876 458889999999999999998 9999976 34555666666554332 2344678899999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||. +|.+||+++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 99999 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.58 Aligned_cols=238 Identities=24% Similarity=0.416 Sum_probs=199.0
Q ss_pred cccccccCcEEEEEEEecCCC----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||.|+|| .||+|.+...+ ..||+|+++... .....+.+..|+.+++.++|+||+++++++.+. ...++
T Consensus 7 lg~g~~g---~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~ 78 (258)
T smart00219 7 LGEGAFG---EVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPLMI 78 (258)
T ss_pred eccCCCc---ceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--CeeEE
Confidence 6788888 78999998766 999999986543 233667899999999999999999999988665 46899
Q ss_pred EEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 78 ITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~--l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+|||+.+++|.+++..... +++..+..++.||+.||.|||+.+ ++||||||+||+++ +.+.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceeccc
Confidence 9999999999999987554 999999999999999999999999 99999999999997 557999999999876543
Q ss_pred CCCc---cccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 156 PTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 156 ~~~~---~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
.... ...+++.|+|||.+. ..++.++||||||+++++|++ |..||.. .+...+...+..+..+. .+...+.++
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPPEI 233 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCHHH
Confidence 3111 123678999999875 458999999999999999998 7888876 45666677776665443 344467899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.+++.+||. +|.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999 8999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.66 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=193.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--------Cc
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--------KK 73 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~--------~~ 73 (639)
||.|+|| .||+|.+..+|..||+|+++.... .......+.+|++++++++||||+++++++.+.. ..
T Consensus 15 lg~g~~g---~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 89 (302)
T cd07864 15 IGEGTYG---QVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG 89 (302)
T ss_pred ecccCCE---EEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence 6777766 899999999999999999986542 2233456788999999999999999999886543 33
Q ss_pred eEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 74 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
.+++|+||+.+ +|..++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++ +.+.+||+|||++..
T Consensus 90 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~ 165 (302)
T cd07864 90 AFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARL 165 (302)
T ss_pred cEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCccccccc
Confidence 78999999986 777777654 46899999999999999999999999 99999999999997 557999999999976
Q ss_pred ccCCCC---ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc---CCCCCc---
Q 006593 153 MQQPTA---RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPAS--- 221 (639)
Q Consensus 153 l~~~~~---~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~---g~~p~~--- 221 (639)
...... ....+++.|+|||++.. .++.++|||||||++|+|++|.+||....... ....+.. +..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCGSPCPAVWPD 244 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhccc
Confidence 543321 22346888999998753 47889999999999999999999997643322 2222211 111100
Q ss_pred ----------------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 222 ----------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 222 ----------------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.....++.+.+||.+||. +|.+||++.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 112346789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=299.04 Aligned_cols=234 Identities=22% Similarity=0.367 Sum_probs=193.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|||| .||+|... |..||+|.++.. ...+.+..|+.++++++|+||+++++++.... ..+++|||
T Consensus 13 ~lg~g~~~---~v~~~~~~--~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv~e 80 (256)
T cd05082 13 TIGKGEFG---DVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTE 80 (256)
T ss_pred eecccCCC---eEEEEEEc--CCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceEEEEE
Confidence 47888888 78988764 788999987633 23456889999999999999999999765443 45889999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|+.+|+|.+++++.+ .+++..+..++.||+.||.|||++| ++||||||+||+++ +++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceeccccC-
Confidence 999999999998654 4889999999999999999999999 99999999999997 55799999999987543322
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....++..|+|||++.. .++.++|||||||++|+|++ |+.||.. .+..++...+..+..+ ..+...++.++++|.+
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 234 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVMKQ 234 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHH
Confidence 23445678999998764 58899999999999999997 9999975 4566676766665443 3455668899999999
Q ss_pred hcC-CCCCCCCHHHHhc
Q 006593 237 CLV-PASERLSAKDLLK 252 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~ 252 (639)
||. +|.+|||+.++++
T Consensus 235 ~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPSFLQLRE 251 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.58 Aligned_cols=236 Identities=22% Similarity=0.399 Sum_probs=192.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+. .+..||+|.++.... ..+.+.+|+.++++++||||+++++++... ..+++|||
T Consensus 13 ~lg~g~~~---~v~~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 81 (261)
T cd05068 13 KLGAGQFG---EVWEGLWN-NTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--EPIYIVTE 81 (261)
T ss_pred EecccCCc---cEEEEEec-CCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecC--CCeeeeee
Confidence 37888888 79999875 457899999875432 245688999999999999999999987655 45899999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|+.+++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++ ..+.+||+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEccCCcc
Confidence 999999999997654 6899999999999999999999999 99999999999998 557999999999976653322
Q ss_pred ccccC---CCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 159 RSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 159 ~~~~G---Tp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....| +..|+|||++. ..++.++||||||+++|+|++ |+.||.+. +...+...+..+... ..+...+..+.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 236 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYRM-PCPPGCPKELYDI 236 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 22223 45799999876 458899999999999999999 99999863 455566666554332 2344567889999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+||. +|.+||++.+|++
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHhhcCcccCCCHHHHHH
Confidence 999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.57 Aligned_cols=238 Identities=23% Similarity=0.355 Sum_probs=195.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+.. +..||+|.+..... ....+.+..|+.++++++||||+++++++... ...++|||
T Consensus 2 ~lg~g~~g---~v~~~~~~~-~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 72 (251)
T cd05041 2 KIGKGNFG---DVYKGVLKG-NTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVME 72 (251)
T ss_pred ccccCCCc---eEEEEEEeC-CCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEE
Confidence 48899999 799999877 99999998876542 24567899999999999999999999988665 45889999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
|+.+++|.+++.+ ...+++..+..++.|++.||.|||+++ ++||||||+|||++ ..+.+||+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcce
Confidence 9999999999976 356899999999999999999999999 99999999999997 557999999999875542211
Q ss_pred ---ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 159 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 159 ---~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....++..|+|||.+. +.++.++||||||+++|+|+| |..||... ........+..+. ....+...+.++.+|
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 227 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGY-RMPAPQLCPEEIYRL 227 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCC-CCCCCccCCHHHHHH
Confidence 1223356799999776 458999999999999999999 88999763 3445555555442 223345567899999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
|.+||. +|.+||++.|+|+
T Consensus 228 i~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 228 MLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.19 Aligned_cols=243 Identities=23% Similarity=0.394 Sum_probs=192.8
Q ss_pred CcccccccCcEEEEEEEe----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFD----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|+|| .||+|.. ..++..||+|.++... .......+.+|+.+|+.++||||+++++++...+...++
T Consensus 11 ~lg~g~~g---~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 11 DLGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred ecCCCCce---eEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 37888888 7888863 5678999999986443 244567799999999999999999999998776556789
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+||||++|++|.+++.+. ..+++..+..++.||+.||.|||++| ++||||||+||+++ +++.+||+|||++..+..
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCcccccccc
Confidence 999999999999999765 35899999999999999999999999 99999999999997 457999999999976543
Q ss_pred CC-----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCC--------------CHHHHHHHHHc
Q 006593 156 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK--------------NPAQIFKKVTS 215 (639)
Q Consensus 156 ~~-----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~--------------~~~~i~~~i~~ 215 (639)
.. .....++..|+|||++. ..++.++||||||+++|+|+|+..|+.... ........+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 21 12345677899999775 458899999999999999999876642210 11112222223
Q ss_pred CCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 216 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 216 g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+... ..+...+..+.+||.+||+ +|.+||++.+++++
T Consensus 242 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 3222 2344567899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=304.96 Aligned_cols=244 Identities=28% Similarity=0.454 Sum_probs=196.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|++| .||+|.+..+|..||+|++..... .......+..|+.+|++++|+||+++++++.+. ..+++|+||
T Consensus 7 i~~g~~~---~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~ 79 (283)
T cd05118 7 IGEGTYG---VVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHK--GDLYLVFEF 79 (283)
T ss_pred eecCCCc---eEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccC--CCEEEEEec
Confidence 5666666 899999999999999999876543 224557788999999999999999999988665 458999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--C
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~ 158 (639)
+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++ ..+.+||+|||.+....... .
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcccc
Confidence 975 88888776 467999999999999999999999999 99999999999998 45799999999987665432 2
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--C---------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P--------------- 219 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p--------------- 219 (639)
....++..|+|||.+.. .++.++|+||||+++|+|+||+.||.......++.+....... +
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 23468889999998753 5789999999999999999999999764443333222211000 0
Q ss_pred ----------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 220 ----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 220 ----------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.......+.++++||.+||. +|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01112346789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=300.25 Aligned_cols=236 Identities=22% Similarity=0.390 Sum_probs=192.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+.. +..||+|.+..... ....+.+|+.++++++||||+++++++... ..+++||||
T Consensus 12 lg~G~~~---~vy~~~~~~-~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 80 (256)
T cd05113 12 LGTGQFG---VVKYGKWRG-QYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVTEY 80 (256)
T ss_pred ecCcccc---eEEEEEecC-CCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccC--CCcEEEEEc
Confidence 6777777 789997754 45699998874432 235688999999999999999999987554 458999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++|+||||.|||++ .++.+||+|||.+..........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCceee
Confidence 9999999999864 46899999999999999999999999 99999999999997 45799999999987554322111
Q ss_pred ---ccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 161 ---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 161 ---~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
..++..|+|||++. ..++.++|||||||++|+|++ |..||... +.......+..+..+ ..+...+..+++++.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 235 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVSQGLRL-YRPHLASEKVYAIMY 235 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHH
Confidence 23456799999886 468999999999999999998 99999764 445566666665443 234456789999999
Q ss_pred HhcC-CCCCCCCHHHHhcC
Q 006593 236 KCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~H 253 (639)
+||. +|.+||++.+|+.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.08 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=213.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
|||+|||| .||-+....||+-+|.|.+.+..+.. ..-......|-++|.+++.+.||.+-..|... +.+|+|+.
T Consensus 192 vlGkGGFG---EV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTk--d~LClVLt 265 (591)
T KOG0986|consen 192 VLGKGGFG---EVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETK--DALCLVLT 265 (591)
T ss_pred EEeccccc---ceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCC--CceEEEEE
Confidence 69999999 57778888999999999887655433 33445678999999999999999998888555 55999999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
+|.||+|.-.|-+++ .|+++.+..|+.+|+.||++||..+ ||+|||||+|||+| +.|+|+|.|+|||..+....
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecCCCCc
Confidence 999999998887776 7999999999999999999999999 99999999999998 66999999999998876543
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCH---HHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~---~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....+||..|||||++. +.|+..+|+|||||++|||+.|+.||...... +++-+.+.. .+..++...++++++|
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAKSL 420 (591)
T ss_pred cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHHHH
Confidence 34459999999999886 46999999999999999999999999653221 123233332 3455667789999999
Q ss_pred HHHhcC-CCCCCCC-----HHHHhcCcccccccCCCC
Q 006593 234 IEKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 234 I~kcL~-dP~~RpS-----a~ELL~Hpff~~~~~~~~ 264 (639)
.+.+|. ||++|.. +.++..||||+..+|...
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 999998 8999875 789999999999888754
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=295.17 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=194.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|||| .||+|.+. .+..||+|.+.... .......+.+|+++++.++||||+++++++... ..+++|||
T Consensus 2 ~ig~g~~g---~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 72 (250)
T cd05085 2 LLGKGNFG---EVFKGTLK-DKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVME 72 (250)
T ss_pred ccCCCCCc---eEEEEEec-CCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEE
Confidence 58999999 78999864 68899999876432 234455788999999999999999999987655 45899999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
|+.+|+|.+++... ..+++..+..++.||+.||.|||++| ++||||||+||+++ ..+.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccc
Confidence 99999999998754 46899999999999999999999999 99999999999997 557999999999865432211
Q ss_pred --ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 --~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....+++.|+|||++. ..++.++||||||+++|+|++ |..||... +.......+..+... ..+...+..+.+|+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 227 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVM 227 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 1224467799999876 458899999999999999998 99999874 455555555554332 33445678999999
Q ss_pred HHhcC-CCCCCCCHHHHhcC
Q 006593 235 EKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~H 253 (639)
.+||. +|.+||++.++++.
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 228 QRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHHcccCcccCCCHHHHHHH
Confidence 99999 89999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.20 Aligned_cols=239 Identities=19% Similarity=0.239 Sum_probs=195.3
Q ss_pred cccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| .||+|.+.. .+..||+|+++... .....+.+..|+.+++.++||||+++++++.... .++
T Consensus 13 lg~G~~g---~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--~~~ 84 (283)
T cd05091 13 LGEDRFG---KVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--PLS 84 (283)
T ss_pred hCCCCCC---eEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC--ceE
Confidence 7888888 789998754 36889999987443 2344567899999999999999999999876554 588
Q ss_pred EEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC
Q 006593 77 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 140 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g 140 (639)
+++||+.+++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||+++ +++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-CCC
Confidence 999999999999998632 34788899999999999999999999 99999999999997 457
Q ss_pred cEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHH
Q 006593 141 EVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 214 (639)
Q Consensus 141 ~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~ 214 (639)
.+||+|||+++.+.... .....+++.|+|||.+. ..++.++|||||||++|||++ |..||.+ ....++...+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 89999999987653221 12335678999999775 568999999999999999998 8889876 45566777776
Q ss_pred cCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 215 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 215 ~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+... ..+...+..+.+|+.+||+ +|.+||++.+|+..
T Consensus 241 ~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 65433 2345567889999999998 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.09 Aligned_cols=232 Identities=22% Similarity=0.358 Sum_probs=187.3
Q ss_pred CcccccccCcEEEEEEEecCCC----------eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG----------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG----------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~ 70 (639)
.||+|+|| .||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 2 ~lg~G~~~---~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (259)
T cd05037 2 HLGQGTFT---NIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR- 72 (259)
T ss_pred cccccccc---eEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec-
Confidence 48999998 78999998777 457888766443 115778899999999999999999998876
Q ss_pred CCceEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC-------cE
Q 006593 71 KKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------EV 142 (639)
Q Consensus 71 ~~~~l~lV~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g-------~V 142 (639)
...++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ + .+
T Consensus 73 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~-~~~~~~~~~~ 147 (259)
T cd05037 73 --DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARY-GLNEGYVPFI 147 (259)
T ss_pred --CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecC-ccccCCceeE
Confidence 34789999999999999998766 7999999999999999999999999 9999999999999743 4 69
Q ss_pred EEeecchhhhccCCCCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 006593 143 KIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 218 (639)
Q Consensus 143 KL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~ 218 (639)
||+|||++..... .....+++.|+|||++.. .++.++||||||+++|+|++ |..||.... ...........
T Consensus 148 kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~-- 222 (259)
T cd05037 148 KLSDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ-- 222 (259)
T ss_pred EeCCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC--
Confidence 9999999876543 234457788999998864 48899999999999999999 588887643 32222222211
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
...+......+.+||.+||. +|.+||++.++++
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 -HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11222223789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=301.46 Aligned_cols=227 Identities=19% Similarity=0.247 Sum_probs=186.6
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCH
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL 87 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL 87 (639)
|.++.||+|.+..+|+.||+|+++.... ...|...+....||||+++++++... ..+++||||+.+|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---------~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---------YSRERLTIIPHCVPNMVCLHKYIVSE--DSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---------hhhHHHHHHhcCCCceeehhhheecC--CeEEEEEecCCCCCH
Confidence 5666899999999999999999876531 23455556667899999999988655 568999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCc
Q 006593 88 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEF 167 (639)
Q Consensus 88 ~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~y 167 (639)
.+++.+...+++..+..|+.||+.||.|||+.+ |+||||||+||+++ ..+.++|+|||++..+... .....+++.|
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~-~~~~~~~~~y 148 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDS-CDGEAVENMY 148 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhccccc-cccCCcCccc
Confidence 999988888999999999999999999999999 99999999999998 4578999999988655433 2334567889
Q ss_pred CCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCC
Q 006593 168 MAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERL 245 (639)
Q Consensus 168 mAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~Rp 245 (639)
+|||.+. ..++.++|+||||+++|+|++|..|+.... ..+ .......++...++.+++||.+||+ ||.+||
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP--SGI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCc--hhc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 9999886 458899999999999999999998875421 111 1111123445567899999999998 899999
Q ss_pred CH-----HHHhcCccc
Q 006593 246 SA-----KDLLKDPFL 256 (639)
Q Consensus 246 Sa-----~ELL~Hpff 256 (639)
++ +++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.12 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=196.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~ 76 (639)
.||+|+|| .||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++..... ..++
T Consensus 22 ~ig~g~~g---~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 22 QVGSGAYG---SVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred EeeecCCe---EEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 36778877 899999999999999999875431 22344568899999999999999999998865432 3578
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+|+||+. ++|..++ ...+++..++.++.||+.||.|||+++ ++||||||+||+++ ..|.+||+|||++.....
T Consensus 97 lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 97 LVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADA- 169 (342)
T ss_pred EEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCcCCCC-
Confidence 9999996 4787765 346899999999999999999999999 99999999999998 458999999999875433
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC--C--------------
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--K-------------- 218 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~--~-------------- 218 (639)
......+++.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.. ....+..+.... .
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 2234578999999998754 48899999999999999999999998643 222222221100 0
Q ss_pred ------C----Cc---ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 219 ------P----AS---LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 219 ------p----~~---l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+ .. .....++.+.+||.+||+ +|.+||++.++|.||||+.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0 00 012346789999999999 89999999999999999876543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.24 Aligned_cols=244 Identities=27% Similarity=0.387 Sum_probs=194.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||.|+|| +||+|.+..++..||+|++..... . .......+|+..+++++ ||||+++++++.+. ...++||
T Consensus 6 ~ig~g~~g---~v~~~~~~~~~~~~~ik~~~~~~~--~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~ 77 (283)
T cd07830 6 QLGDGTFG---SVYLARNKETGELVAIKKMKKKFY--S-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN--DELYFVF 77 (283)
T ss_pred eeccCCce---EEEEEEECCCCcEEEEEEehhhcc--c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC--CcEEEEE
Confidence 36778877 899999999999999999875432 1 22334567999999998 99999999988764 5689999
Q ss_pred ecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 80 ELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||+ +|+|.+++.... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++ ..+.++|+|||++......
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 78 EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccCCC
Confidence 999 789999988764 7899999999999999999999999 99999999999998 5589999999999766533
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC---------------
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--------------- 219 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--------------- 219 (639)
......++..|+|||++.. .++.++|+||||+++++|++|++||..........+.......+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 2234568999999998743 47899999999999999999999997654433333222100000
Q ss_pred ------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 220 ------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 220 ------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
.......+..+++||.+||+ +|.+||+++|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00111225789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=318.05 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=199.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~l 77 (639)
||+|+|| .||+|.+..++..||+|++.... ......+.+.+|+.+++.++||||+++++++..... ..+++
T Consensus 23 ig~g~~g---~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 23 VGSGAYG---QVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred eccCCce---EEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 6777777 89999999999999999886542 123455678899999999999999999987754432 35889
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||+++ +.|.+||+|||++......
T Consensus 98 v~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 98 VTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEcccccccccccc-
Confidence 99999 6799999875 56999999999999999999999999 99999999999997 5589999999999765433
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--C--------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--P-------------- 219 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p-------------- 219 (639)
.....+++.|+|||.+.. .++.++|||||||++|+|++|+.||.+... ...+..+..... +
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07851 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISSESARN 250 (343)
T ss_pred ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence 345678999999998754 578999999999999999999999976433 333333322110 0
Q ss_pred ----------C---cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 220 ----------A---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 220 ----------~---~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
. ......++.+.+||.+||. +|.+|||+.+||.||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0 0112347889999999999 8999999999999999986543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.48 Aligned_cols=240 Identities=23% Similarity=0.347 Sum_probs=194.0
Q ss_pred CcccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~ 74 (639)
+||+|||| .||+|.+.. .+..||+|+++... .....+.+.+|+++|++|. ||||++++++|... ..
T Consensus 44 ~LG~G~fG---~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~--~~ 115 (400)
T cd05105 44 ILGSGAFG---KVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS--GP 115 (400)
T ss_pred eecCCCCc---eEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--Cc
Confidence 47899998 789888643 34579999987543 2345577999999999996 99999999998654 45
Q ss_pred EEEEEecCCCCCHHHHHHhC------------------------------------------------------------
Q 006593 75 VNMITELFTSGNLRQYRKKH------------------------------------------------------------ 94 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~------------------------------------------------------------ 94 (639)
+|+|||||.+|+|.+++.+.
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 89999999999999998642
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC
Q 006593 95 ------------------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 138 (639)
Q Consensus 95 ------------------------------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~ 138 (639)
..+++..+..++.||+.||.|||+.+ |+||||||+|||++ +
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~-~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA-Q 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe-C
Confidence 23677888999999999999999999 99999999999998 4
Q ss_pred CCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHH
Q 006593 139 HGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKK 212 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~ 212 (639)
.+.+||+|||++....... .....+++.|+|||++. ..++.++|||||||++|+|++ |..||.........+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 5789999999997653321 22345678899999775 458999999999999999997 89999765444555566
Q ss_pred HHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 213 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 213 i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+..+..+ ..+...++.++++|.+||. +|.+||++.+|.+
T Consensus 353 ~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 6655433 3344567899999999999 8999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.13 Aligned_cols=240 Identities=18% Similarity=0.306 Sum_probs=186.3
Q ss_pred CcccccccCcEEEEEEEecC--CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF--AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~--tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.||+|+|| +||+|.... ....+++|.+.... .....+.+.+|+.+++.++||||+++++.+... ..+++|
T Consensus 2 ~lg~G~~g---~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~~~~lv 73 (268)
T cd05086 2 EIGNGWFG---KVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA--IPYLLV 73 (268)
T ss_pred cCCCCcCc---eEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCC--CccEEE
Confidence 48999999 788886533 23446666655432 334567899999999999999999999988755 458999
Q ss_pred EecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 79 TELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
|||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRY 150 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccC
Confidence 9999999999999764 34677888999999999999999999 99999999999997 45799999999985432
Q ss_pred CC----CCccccCCCCcCCcccccc--------cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCC----
Q 006593 155 QP----TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI---- 217 (639)
Q Consensus 155 ~~----~~~~~~GTp~ymAPE~l~~--------~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~---- 217 (639)
.. .....+|++.|+|||++.. .++.++||||||+++|||++ |..||.... ....+..+..+.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~~~~ 229 (268)
T cd05086 151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNHVIKDQQVKL 229 (268)
T ss_pred cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhhccccc
Confidence 11 1234568899999998742 35788999999999999997 577887644 334444333221
Q ss_pred CCCcccCCCChHHHHHHHHhcCCCCCCCCHHHHhc
Q 006593 218 KPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLK 252 (639)
Q Consensus 218 ~p~~l~~~~s~~l~~LI~kcL~dP~~RpSa~ELL~ 252 (639)
....+....++.+.+++..||.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 230 FKPQLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred CCCccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 12333445678899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=302.89 Aligned_cols=236 Identities=19% Similarity=0.309 Sum_probs=187.4
Q ss_pred CcccccccCcEEEEEEEecCCCe-------EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCc
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI-------EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~-------~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~ 73 (639)
.||+|||| .||+|.+...+. .||+|.+.... ....+.+..|+.+++.++||||+++++++....
T Consensus 2 ~lg~G~~~---~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-- 72 (258)
T cd05078 2 SLGQGTFT---KIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-- 72 (258)
T ss_pred CCCcccch---hheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC--
Confidence 48999999 788888755443 48888875432 345567889999999999999999999987754
Q ss_pred eEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC-------cEEEe
Q 006593 74 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------EVKIG 145 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g-------~VKL~ 145 (639)
..++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||+++.+.. .++++
T Consensus 73 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 73 ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEec
Confidence 4789999999999999998654 5899999999999999999999999 999999999999974422 37999
Q ss_pred ecchhhhccCCCCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhc-cCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 146 DLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 146 DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG-~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
|||++..... .....+++.|+|||++.. .++.++||||||+++|+|++| ..||... .+......... ...+
T Consensus 151 d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~~~~~~~~~---~~~~ 224 (258)
T cd05078 151 DPGISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQKKLQFYED---RHQL 224 (258)
T ss_pred ccccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHHHHHHHHHc---cccC
Confidence 9999865432 234578899999998874 478999999999999999998 5666543 33322222222 1223
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+...+.++.+||.+||+ +|.+|||++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 44456789999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.63 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=194.8
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
.||+|+|| .||+|.+ ..+++.||+|+++... .......+.+|+.+|.++ +||||+++++++.... ..
T Consensus 14 ~lG~G~fg---~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~ 86 (343)
T cd05103 14 PLGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GP 86 (343)
T ss_pred cccCCccc---eEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-Cc
Confidence 47888888 7898874 4568899999987543 234456788999999999 7899999999876543 46
Q ss_pred EEEEEecCCCCCHHHHHHhC------------------------------------------------------------
Q 006593 75 VNMITELFTSGNLRQYRKKH------------------------------------------------------------ 94 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~------------------------------------------------------------ 94 (639)
+++|||||.+|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 88999999999999998642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC----CccccC
Q 006593 95 -------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIG 163 (639)
Q Consensus 95 -------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~G 163 (639)
..++...+..|+.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||++....... .....+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcCCCCC
Confidence 23677888899999999999999999 99999999999997 45799999999987653221 122345
Q ss_pred CCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-C
Q 006593 164 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-P 240 (639)
Q Consensus 164 Tp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-d 240 (639)
++.|+|||.+. ..++.++||||||+++|+|++ |..||............+..+..+ ..+...++.+.+++.+||+ +
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHccCC
Confidence 67899999775 458999999999999999997 899998755555555555554433 2344567899999999999 8
Q ss_pred CCCCCCHHHHhcC
Q 006593 241 ASERLSAKDLLKD 253 (639)
Q Consensus 241 P~~RpSa~ELL~H 253 (639)
|.+||++.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=349.62 Aligned_cols=246 Identities=30% Similarity=0.514 Sum_probs=205.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---------
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--------- 71 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~--------- 71 (639)
+||+|||| .||+++++-.|+.||||++.... +.....++.+|+.+|.+|+|||||+||.+|+...
T Consensus 486 lLGkGGFG---~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 486 LLGKGGFG---SVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred HhcCCCCc---eEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence 58999999 79999999999999999998764 4567789999999999999999999997764300
Q ss_pred --------------------------------------------------------------------------------
Q 006593 72 -------------------------------------------------------------------------------- 71 (639)
Q Consensus 72 -------------------------------------------------------------------------------- 71 (639)
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence
Q ss_pred --------------------C--------ceEEEEEecCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCC
Q 006593 72 --------------------K--------KTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWARQILHGLVYLHSHNPP 122 (639)
Q Consensus 72 --------------------~--------~~l~lV~Ey~~gGsL~d~lkk~~~l-~e~~i~~i~~QIl~aL~yLHs~gpp 122 (639)
. .++||=||||+.-+|++++..+... ....+|++++||+.||.|+|+.|
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g-- 717 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG-- 717 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--
Confidence 0 3578999999998888888876554 57889999999999999999999
Q ss_pred eeeeccCCCcEEEeCCCCcEEEeecchhhhcc----C----------------CCCccccCCCCcCCcccccc----cCC
Q 006593 123 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ----Q----------------PTARSVIGTPEFMAPELYEE----EYN 178 (639)
Q Consensus 123 IIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~----~----------------~~~~~~~GTp~ymAPE~l~~----~ys 178 (639)
||||||||.|||++ ..+.|||+|||+|+... . ......+||--|+|||++.. .|+
T Consensus 718 iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999998 45699999999997621 0 01235689999999999863 599
Q ss_pred ccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcc
Q 006593 179 ELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 179 ~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
.|+|+|||||+++||+. ||.-....+.+...+..+..|.. +....-+.-..+|.+||+ ||++||||.|||++-|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 99999999999999985 78765666677777777776655 222233567889999999 9999999999999999
Q ss_pred ccc
Q 006593 256 LQV 258 (639)
Q Consensus 256 f~~ 258 (639)
|.+
T Consensus 874 lpp 876 (1351)
T KOG1035|consen 874 LPP 876 (1351)
T ss_pred CCc
Confidence 974
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.75 Aligned_cols=246 Identities=30% Similarity=0.407 Sum_probs=193.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCC---ce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDDKK---KT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~~~~~~~---~~ 74 (639)
+||+|+|| .||+|.+..+|..||+|.++.... .......+.+|+.+++++ +||||+++++++..... ..
T Consensus 6 ~l~~g~~~---~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 6 EIGEGAYG---TVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred EecccCce---EEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 36777777 899999998999999999986542 222344566788887766 59999999999876542 24
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 75 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
++++|||+. ++|.+++.+.+ .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.+ +.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCccee
Confidence 889999997 48999887643 4899999999999999999999999 9999999999999855 8999999999876
Q ss_pred ccCC-CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC------------
Q 006593 153 MQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------------ 218 (639)
Q Consensus 153 l~~~-~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~------------ 218 (639)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|.+||.+.. ..+.+.++.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhcCCCcc
Confidence 6433 2234467899999998764 58899999999999999999999998644 3333333322100
Q ss_pred ----------C---CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 219 ----------P---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 219 ----------p---~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+ .......++.+.+||.+||+ +|.+||++.++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 00011234678899999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.85 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=194.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~l 77 (639)
||+|+|| .||+|.+..+|..||+|++..... .....+.+.+|+.++++++||||+++++++.... ...+++
T Consensus 25 lg~G~~g---~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 25 VGSGAYG---SVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred eeecCCe---EEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence 6777777 799999999999999999875421 2334567889999999999999999999876432 234778
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
+++++ +++|.++++. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +.|.+||+|||++......
T Consensus 100 v~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 100 VTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDE- 173 (345)
T ss_pred Eehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEeccccccccccc-
Confidence 88887 7899988865 46999999999999999999999999 99999999999997 5579999999998765432
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC-------------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG------------------- 216 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g------------------- 216 (639)
.....|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... .....+...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T cd07877 174 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISSESARN 252 (345)
T ss_pred ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence 234578999999998754 4788999999999999999999999753322 222221110
Q ss_pred -------CCCC---cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 217 -------IKPA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 217 -------~~p~---~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.... ......++.+++||.+||+ +|.+||++.++|.||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0000 0111346789999999999 89999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.59 Aligned_cols=239 Identities=27% Similarity=0.393 Sum_probs=193.8
Q ss_pred cccccccCcEEEEEEEecC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCc
Q 006593 2 VLTGLYMTPFSSYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 73 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~ 73 (639)
||+|+|| .||+|.+.. ++..||+|.++... .......+..|+.+++.+ +||||+++++++... .
T Consensus 26 lg~G~~g---~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~ 97 (307)
T cd05098 26 LGEGCFG---QVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD--G 97 (307)
T ss_pred eccCCCe---eEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--C
Confidence 7888888 788887643 34579999887542 234566788999999999 799999999988655 4
Q ss_pred eEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC
Q 006593 74 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~ 137 (639)
.+|+||||+.+|+|.+++..++ .++...+..++.||+.||.|||++| ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~- 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT- 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEc-
Confidence 5899999999999999997642 3788999999999999999999999 99999999999998
Q ss_pred CCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHH
Q 006593 138 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 211 (639)
Q Consensus 138 ~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~ 211 (639)
.++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.. .+..++.+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~ 253 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFK 253 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHH
Confidence 45799999999987554211 11223457899999776 458999999999999999998 8889876 45666666
Q ss_pred HHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 212 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 212 ~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+..+..+ ..+...+.++++||.+||. +|.+||++.+++.+
T Consensus 254 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 254 LLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66655432 3455667899999999998 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.63 Aligned_cols=242 Identities=26% Similarity=0.400 Sum_probs=187.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|||| +||+|.... |..||||++...... . ...|.+|+.+|.+++|||+|+++|||.+.+. ..++|+|
T Consensus 82 ~ig~Ggfg---~VYkG~l~~-~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYE 152 (361)
T KOG1187|consen 82 LIGEGGFG---TVYKGVLSD-GTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYE 152 (361)
T ss_pred ceecCCCe---EEEEEEECC-CCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEE
Confidence 58999988 899999854 489999977654321 1 3449999999999999999999999987653 5889999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-C
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-P 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~-~ 156 (639)
|+++|+|.++|.... .+++....+|+.++++||+|||.. .|||||||||+.|||+| .+...||+|||+|+.... .
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccc
Confidence 999999999997655 889999999999999999999995 45899999999999998 457999999999966543 2
Q ss_pred CC-ccc-cCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCC-----CHHHHH-HHHHcCCC----CCccc
Q 006593 157 TA-RSV-IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECK-----NPAQIF-KKVTSGIK----PASLA 223 (639)
Q Consensus 157 ~~-~~~-~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~-----~~~~i~-~~i~~g~~----p~~l~ 223 (639)
.. .+. .||..|+|||++. +..+.++||||||++++||+||+.|..... +..... ..+..+.. ...+.
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~ 311 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLK 311 (361)
T ss_pred cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCcc
Confidence 22 222 8999999999886 579999999999999999999998775321 111211 22222211 11111
Q ss_pred -CCCC--hH---HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 224 -KVND--PQ---IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 224 -~~~s--~~---l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
...+ .+ +..+..+|++ +|.+||++.|+++
T Consensus 312 ~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 312 EGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 2222 23 4455678998 7999999999754
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=305.26 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=195.2
Q ss_pred CcccccccCcEEEEEEEe-------cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCC
Q 006593 1 MVLTGLYMTPFSSYKAFD-------EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 72 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-------~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~ 72 (639)
.||+|||| .||+|.+ ...+..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~lg~G~~g---~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 93 (304)
T cd05101 22 PLGEGCFG---QVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-- 93 (304)
T ss_pred eeeccCCc---eEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchheeEEEecC--
Confidence 37889988 7888864 2345689999876432 235567899999999999 899999999988655
Q ss_pred ceEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe
Q 006593 73 KTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136 (639)
Q Consensus 73 ~~l~lV~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~ 136 (639)
..+++||||+.+|+|.+++.+. ..++...+..++.||+.||.|||++| ++||||||+||+++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~ 171 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT 171 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEc
Confidence 4689999999999999999764 24678889999999999999999999 99999999999997
Q ss_pred CCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHH
Q 006593 137 GNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 210 (639)
Q Consensus 137 ~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~ 210 (639)
..+.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+ .+..++.
T Consensus 172 -~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~ 249 (304)
T cd05101 172 -ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELF 249 (304)
T ss_pred -CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHH
Confidence 45799999999997654321 12234577899999775 458999999999999999998 7888876 4566777
Q ss_pred HHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 211 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 211 ~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.+..+... ..+...+..+++||.+||. +|.+||++.|+++.
T Consensus 250 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 777665433 3345567899999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=301.13 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=189.2
Q ss_pred CcccccccCcEEEEEEE----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||.|+|| +||+|. +..++..||+|.+.... ....+.+.+|+++|++++||||+++++++...+...++
T Consensus 11 ~lg~g~~g---~v~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 11 QLGKGNFG---SVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred eccCCCCc---eEEEEEecCCcCCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888888 677776 56789999999987542 45567889999999999999999999987666656789
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++..+..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCcccccccC
Confidence 999999999999999764 46899999999999999999999999 99999999999997 457999999999976543
Q ss_pred CCC-----ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH---------------HHHHHHHH
Q 006593 156 PTA-----RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------------AQIFKKVT 214 (639)
Q Consensus 156 ~~~-----~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~---------------~~i~~~i~ 214 (639)
... ....++..|+|||++.+ .++.++||||||+++|||++|..|+...... ..+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 221 11223456999998764 5889999999999999999987665321100 01111122
Q ss_pred cCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 215 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 215 ~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.+.. ...+...+.++.+||.+||. +|.+|||+.+|++
T Consensus 241 ~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 NNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2211 12234456789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=300.24 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=197.7
Q ss_pred CcccccccCcEEEEEEEecC----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| .||+|.+.. ++..||+|.+... ......+.+.+|+.+++.++||||+++++++... ....+
T Consensus 13 ~i~~g~~g---~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~~ 85 (280)
T cd05043 13 LLQEGTFG---RIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEPPF 85 (280)
T ss_pred eecccCCc---eEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCCE
Confidence 47889998 799999876 3688999987632 2345677889999999999999999999987654 34678
Q ss_pred EEEecCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 77 MITELFTSGNLRQYRKKH--------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~--------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
++++|+.+|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEECCCC
Confidence 999999999999999764 35889999999999999999999999 99999999999997 45799999999
Q ss_pred hhhhccCCC----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 149 LAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 149 lA~~l~~~~----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
+++.+.... .....++..|+|||++.. .++.++||||||+++|+|++ |+.||.. .++..+...+..+..+. .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~ 240 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRLA-Q 240 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHcCCCCC-C
Confidence 997653321 122345678999998764 58999999999999999999 9999986 46667777666654433 2
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
....++++.+++.+||. +|++|||+.+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 241 PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 34457889999999998 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=305.72 Aligned_cols=239 Identities=25% Similarity=0.379 Sum_probs=193.1
Q ss_pred CcccccccCcEEEEEEEec-------CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCC
Q 006593 1 MVLTGLYMTPFSSYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 72 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~-------~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~ 72 (639)
.||+|+|| .||+|.+. ..+..||+|.++... .......+..|+.+++++ +||||+++++++...
T Consensus 19 ~lg~G~~g---~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 90 (314)
T cd05099 19 PLGEGCFG---QVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE-- 90 (314)
T ss_pred eecCCCcc---cEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC--
Confidence 37888888 78888753 235679999877432 245567789999999999 699999999987654
Q ss_pred ceEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe
Q 006593 73 KTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136 (639)
Q Consensus 73 ~~l~lV~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~ 136 (639)
..++++|||+.+|+|.+++... ..++...+..++.||+.||.|||++| ++||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~ 168 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVT 168 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEc
Confidence 4689999999999999999763 24788999999999999999999999 99999999999997
Q ss_pred CCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHH
Q 006593 137 GNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 210 (639)
Q Consensus 137 ~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~ 210 (639)
+++.+||+|||+++...... .....+++.|||||++. ..++.++||||||+++|+|++ |..||.. .....++
T Consensus 169 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~ 246 (314)
T cd05099 169 -EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELF 246 (314)
T ss_pred -CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHH
Confidence 55799999999997654321 11223456899999875 458999999999999999999 8899976 4566667
Q ss_pred HHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 211 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 211 ~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+..+... ..+...+.+++++|.+||. +|.+||++.+++.
T Consensus 247 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 666665432 2344556789999999998 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.79 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=208.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP---GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~---~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|||. .||+|+|....+.||+|+-...+-...+ ...+..-+|..|-+.|+||.||++|++|.-+ .+.+|-
T Consensus 470 LLGrGGFS---EVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-tdsFCT 545 (775)
T KOG1151|consen 470 LLGRGGFS---EVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-TDSFCT 545 (775)
T ss_pred HhccccHH---HHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-ccccee
Confidence 58999999 7999999999999999987654422111 1234567999999999999999999998543 356999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe-C-CCCcEEEeecchhhhccC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-G-NHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~-~-~~g~VKL~DFGlA~~l~~ 155 (639)
|+|||+|.+|.-||+.++.++++.++.|+.||+.||.||....|||||-||||.|||+- | .-|.|||.||||++.+..
T Consensus 546 VLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred eeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 99999999999999999999999999999999999999999999999999999999984 2 237899999999998865
Q ss_pred CCC---------ccccCCCCcCCccccc-----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH--cC-CC
Q 006593 156 PTA---------RSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT--SG-IK 218 (639)
Q Consensus 156 ~~~---------~~~~GTp~ymAPE~l~-----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~--~g-~~ 218 (639)
... ....||.+|++||.+- .+.+.++||||+|+|+|.++.|+.||........+++..+ .. ..
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEV 705 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEV 705 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceec
Confidence 432 2357999999999763 2478899999999999999999999987555555554322 11 11
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
......+.++++++||++||+ .-.+|....+|-.||+|.+
T Consensus 706 qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 706 QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 122234567899999999999 7889999999999999975
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=297.60 Aligned_cols=239 Identities=21% Similarity=0.358 Sum_probs=193.8
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|+|| .||+|.+..+ +..||+|.++... .....+.+..|+.++++++||||+++++++... ..+++
T Consensus 11 ~lg~g~~g---~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 82 (267)
T cd05066 11 VIGAGEFG---EVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--KPVMI 82 (267)
T ss_pred eecccCCC---ceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC--CccEE
Confidence 47888888 6888887644 3479999886432 234567889999999999999999999988654 46899
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+++|+|.+++.+. +.+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCcccccccc
Confidence 99999999999999865 46899999999999999999999999 99999999999997 4579999999998765432
Q ss_pred CC-----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 157 TA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 157 ~~-----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. ....+++.|+|||.+. ..++.++|+||||+++|+|++ |..||.+. ...+....+..+..+. .+...++.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 237 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKAIEEGYRLP-APMDCPAA 237 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHHHhCCCcCC-CCCCCCHH
Confidence 11 1122356899999886 468999999999999999886 99999764 3455666666654322 23445788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+++++.+||+ +|.+||++.++++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=296.86 Aligned_cols=239 Identities=22% Similarity=0.370 Sum_probs=194.1
Q ss_pred CcccccccCcEEEEEEEecCCCe---EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~---~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+..++. .||+|.++... .....+.+..|++++++++||||+++++++... ..+++
T Consensus 12 ~lg~g~~g---~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 83 (268)
T cd05063 12 VIGAGEFG---EVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KPAMI 83 (268)
T ss_pred EecCCCCc---cEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CCcEE
Confidence 48999998 799998876554 79999876442 234567789999999999999999999988655 45889
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+++|.+++..+ +.+++..+..++.|++.||.|||+.+ ++||||||+||+++ +.+.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceecccc
Confidence 99999999999999764 57899999999999999999999999 99999999999997 4579999999998755432
Q ss_pred CCc-----cccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 157 TAR-----SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 157 ~~~-----~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
... ....++.|+|||++. ..++.++|||||||++|+|++ |..||... +...+...+..+... ......+..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~ 238 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL-PAPMDCPSA 238 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC-CCCCCCCHH
Confidence 211 112345799999876 458999999999999999997 99999763 455566666654332 223345788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+|+.+||. +|.+||++.++++
T Consensus 239 ~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 239 VYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999998 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.14 Aligned_cols=245 Identities=28% Similarity=0.457 Sum_probs=199.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|+|| .||+|.+..++..+++|.++...... .......+..|+.+++.++||||+++++++.+.. .+++||
T Consensus 7 ~ig~g~~g---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 81 (260)
T cd08222 7 RLGKGSFG---TVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD--AFCIIT 81 (260)
T ss_pred eecCCCCc---eEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC--ceEEEE
Confidence 47888888 89999998888778777766433221 2234456778999999999999999999886654 588999
Q ss_pred ecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 80 ELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 80 Ey~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
||+.+++|.+++.. ...+++..++.++.|++.||.|||++| ++|+||+|+||+++. +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCceeecCC
Confidence 99999999998864 356899999999999999999999999 999999999999963 5799999999866543
Q ss_pred C--CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 156 P--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 156 ~--~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
. ......|++.|+|||.+.. .++.++|+||||+++|+|++|..||.. .........+..+..+ ..+...+.++.+
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQLNS 235 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHHHHH
Confidence 2 2234568999999997753 578899999999999999999999975 3444454555554333 345566789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
+|.+||. +|.+||++.++++||||
T Consensus 236 li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 236 IMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999998 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=309.49 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=195.9
Q ss_pred CcccccccCcEEEEEEEecCC--CeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--CCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA--GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDD--KKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t--G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~--~~~~l 75 (639)
.||+|+|| .||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... ....+
T Consensus 7 ~lg~G~~g---~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 7 ELGQGAYG---IVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred EccccCCe---EEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 37888887 8999999888 9999999986432 1223456788999999999 599999999875432 23457
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 76 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+++++|+. ++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++..+..
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceeccc
Confidence 88999986 699999988888999999999999999999999999 99999999999997 457999999999975542
Q ss_pred CC------CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc------------
Q 006593 156 PT------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------------ 215 (639)
Q Consensus 156 ~~------~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~------------ 215 (639)
.. .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+..+..
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHHHHHHHHhCCCCHHHHHh
Confidence 21 223578999999997653 588999999999999999999999976332 111111110
Q ss_pred --------------CCCC---CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 216 --------------GIKP---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 216 --------------g~~p---~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.... .......++.+++||.+||+ +|.+|||+.+++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0000 11122346789999999999 89999999999999999644
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=300.79 Aligned_cols=238 Identities=20% Similarity=0.282 Sum_probs=192.3
Q ss_pred cccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|||| .||+|.+. .++..||+|++.... .......+.+|+.++++++||||+++++++.+.. .++
T Consensus 13 lg~g~~g---~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~--~~~ 84 (288)
T cd05050 13 IGQGAFG---RVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK--PMC 84 (288)
T ss_pred ccccccc---cEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--ccE
Confidence 6888887 78888874 367899999887443 2345567889999999999999999999876554 588
Q ss_pred EEEecCCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEE
Q 006593 77 MITELFTSGNLRQYRKKHK----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 134 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~----------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NIL 134 (639)
+||||+.+|+|.+++.... .+++..++.++.||+.||.|||.++ ++||||||.|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil 162 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCL 162 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhheE
Confidence 9999999999999997532 3678889999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHH
Q 006593 135 VNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQ 208 (639)
Q Consensus 135 l~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~ 208 (639)
++ ..+.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+ .+..+
T Consensus 163 ~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~-~~~~~ 240 (288)
T cd05050 163 VG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG-MAHEE 240 (288)
T ss_pred ec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHH
Confidence 97 45799999999986543221 12233467799999776 468999999999999999997 7889876 34566
Q ss_pred HHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 209 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 209 i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+...+..+... ..+...+.++.+||.+||+ +|.+||++.|+++
T Consensus 241 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 66666655433 2234557899999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=296.77 Aligned_cols=239 Identities=23% Similarity=0.410 Sum_probs=193.2
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|+|| .||+|.+... ...||+|...... .....+.+..|+.++++++||||+++++++.+. ..++
T Consensus 13 ~lg~g~~g---~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~l 83 (270)
T cd05056 13 CIGEGQFG---DVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---PVWI 83 (270)
T ss_pred eeCCccce---eEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---CcEE
Confidence 37888888 7999987544 4578999876443 245667899999999999999999999987543 3679
Q ss_pred EEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+++|+|.+++.+.+ .+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeecccc
Confidence 999999999999998754 5899999999999999999999999 99999999999998 4579999999998765432
Q ss_pred CC---ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 TA---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 ~~---~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
.. ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+... ......+..+..+ ..+...++.++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL-PMPPNCPPTLY 238 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCcC-CCCCCCCHHHH
Confidence 11 1223456899999876 458899999999999999996 9999987544 3444555554333 33455678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
++|.+||. +|.+|||+.+++..
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=334.25 Aligned_cols=244 Identities=27% Similarity=0.461 Sum_probs=206.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC---CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK---KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~---~~~l~l 77 (639)
||+|-|| .||++++..+|+.+|+|+..... +.-+.+..|.++|+.+ .|||++.||++|.-.+ .+.+||
T Consensus 27 ig~Gtyg---kv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 27 IGNGTYG---KVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred Eeeccce---eEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 5565555 89999999999999999876543 3445578899999988 7999999999986532 357999
Q ss_pred EEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 78 ITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
|||||.||+..|++++- .++.|..|..|++.++.||.+||.+. +||||||-.|||++. .|.|||+|||++..+..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~-e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEec-cCcEEEeeeeeeeeeec
Confidence 99999999999999864 56899999999999999999999999 999999999999984 58999999999987754
Q ss_pred C--CCccccCCCCcCCcccccc------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc-cCCC
Q 006593 156 P--TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL-AKVN 226 (639)
Q Consensus 156 ~--~~~~~~GTp~ymAPE~l~~------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l-~~~~ 226 (639)
. ...+++|||+|||||++.. .|+..+|+||||+++.||.-|.+|+.+.. |...+-.|.++.+|... +..+
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-PmraLF~IpRNPPPkLkrp~kW 254 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPPPKLKRPKKW 254 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-hhhhhccCCCCCCccccchhhH
Confidence 3 4567899999999998853 37889999999999999999999998854 44444444444444433 6777
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
+.++.+||..||. |-.+||+..++|+|||+.
T Consensus 255 s~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 255 SKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred HHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 8999999999998 899999999999999998
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=298.22 Aligned_cols=240 Identities=20% Similarity=0.317 Sum_probs=195.0
Q ss_pred cccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||.|||| .||+|+++. ....||+|.+.... .....+.+.+|+++|++++||||+++++++.+. ...+
T Consensus 13 lg~g~~g---~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 84 (275)
T cd05046 13 LGRGEFG---EVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA--EPHY 84 (275)
T ss_pred eccccee---EEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--Ccce
Confidence 6777777 899998654 35678888775432 233567799999999999999999999987554 4689
Q ss_pred EEEecCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeec
Q 006593 77 MITELFTSGNLRQYRKKHK---------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~---------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DF 147 (639)
+||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ ..+.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcEEEccc
Confidence 9999999999999998765 6899999999999999999999999 99999999999997 4579999999
Q ss_pred chhhhccCC---CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 148 GLAIAMQQP---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 148 GlA~~l~~~---~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
|++...... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ........+..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGKLELPV 240 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcCCcCCCC
Confidence 998654322 122345678899999775 457889999999999999998 78899763 345555666555444444
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+...+..+.++|.+||. +|.+||++.+++.+
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55667899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=344.24 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=191.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|||| .||+|.+..+|..||+|+++... .......+++.+|++++++++||||+++++++.+. ...++|||
T Consensus 9 ~LGkGgfG---~VYlA~d~~tg~~VAIK~I~~~l-~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~--~~lyLVME 82 (932)
T PRK13184 9 LIGKGGMG---EVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG--DPVYYTMP 82 (932)
T ss_pred EEecCCCE---EEEEEEECCCCcEEEEEEECccc-ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC--CEEEEEEE
Confidence 37888888 89999999999999999987532 23345567899999999999999999999987655 46899999
Q ss_pred cCCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 81 LFTSGNLRQYRKKH-----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 81 y~~gGsL~d~lkk~-----------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
|++||+|.+++... ..++...+..++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEEecCc
Confidence 99999999998642 23556778899999999999999999 99999999999997 557999999999
Q ss_pred hhhccCC--------------------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHH
Q 006593 150 AIAMQQP--------------------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 208 (639)
Q Consensus 150 A~~l~~~--------------------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~ 208 (639)
+...... .....+||+.|||||++.+ .++.++|||||||++|||+||..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9755110 0113569999999998764 589999999999999999999999976332222
Q ss_pred HHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 209 IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 209 i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..................++.+.+++.+||. +|.+|++..+.|.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222111111111123456889999999999 89999887666554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.73 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=225.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .|.+|..+.+.+.+|||+++++-+.+. ++.+--..|-++|... +-|.+++++..|..-+ ++|+||
T Consensus 356 VlGKGSFG---KVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmD--RLyFVM 429 (683)
T KOG0696|consen 356 VLGKGSFG---KVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD--RLYFVM 429 (683)
T ss_pred EeccCccc---eeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhh--heeeEE
Confidence 68999999 899999999999999999998776654 4445556788888777 5678899999886654 599999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc--cCCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM--QQPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l--~~~~ 157 (639)
||+.||+|--.+++.+++.|..+..|+.+|+-||-|||++| ||+||||.+||+++. .|.|||+|||+++.- ...+
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~-eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEecc-CCceEeeecccccccccCCcc
Confidence 99999999999999999999999999999999999999999 999999999999984 589999999999753 3456
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
.+++||||.|+|||++. +.|+..+|+||||++||||+.|++||.+ .+..++++.|+.... ..++..+.++.++++.
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehnv--syPKslSkEAv~ickg 583 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHNV--SYPKSLSKEAVAICKG 583 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHccC--cCcccccHHHHHHHHH
Confidence 78899999999999775 6799999999999999999999999988 677889998887533 4567778999999999
Q ss_pred hcC-CCCCCCCH-----HHHhcCcccccccCCCCcCCCCCCchh
Q 006593 237 CLV-PASERLSA-----KDLLKDPFLQVENQKEPICDPLKLPIQ 274 (639)
Q Consensus 237 cL~-dP~~RpSa-----~ELL~Hpff~~~~~~~~~~~~~~~~~~ 274 (639)
.|. .|.+|..+ .++-.||||+...|.......+++|..
T Consensus 584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfk 627 (683)
T KOG0696|consen 584 LLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFK 627 (683)
T ss_pred HhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCC
Confidence 998 79999864 789999999998887655555555443
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.09 Aligned_cols=245 Identities=32% Similarity=0.460 Sum_probs=196.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|+|| .||+|.+..+|..||+|.+..... .....+.+..|+.++++++|+||+++++++.+. ..+++|||
T Consensus 6 ~ig~g~~~---~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~~v~e 78 (282)
T cd07829 6 KLGEGTYG---VVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHTE--RKLYLVFE 78 (282)
T ss_pred cccccCcc---eEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--CceEEEec
Confidence 36777776 899999999999999999986541 233456678999999999999999999988655 56899999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||+|+||+++ +.+.+||+|||++.......
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCccc
Confidence 997 5999999886 57999999999999999999999999 99999999999997 45899999999987654332
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-------------------C
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------------G 216 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-------------------g 216 (639)
.....+++.|+|||.+.. .++.++|||||||++|+|++|.+||........+.+.... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 223456788999997753 5889999999999999999999999764433322211110 0
Q ss_pred CCCC-------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 217 IKPA-------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 217 ~~p~-------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
..+. ......+..+.+||.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0011226789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=308.38 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=195.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|+|| .||+|.+..+|..||+|++..... .....+.+..|+.+++.++||||++++++|.... ..+++|+|
T Consensus 17 ~ig~g~~g---~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~lv~e 90 (328)
T cd07856 17 PVGMGAFG---LVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL-EDIYFVTE 90 (328)
T ss_pred eecccCCe---EEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-CcEEEEee
Confidence 36777777 899999999999999998865432 2344567889999999999999999999886543 46889999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+ +++|..+++. ..+++..+..++.||+.||.|||+.+ |+||||+|+||+++ ..+.+||+|||++...... ...
T Consensus 91 ~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~~-~~~ 164 (328)
T cd07856 91 LL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQDPQ-MTG 164 (328)
T ss_pred hh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccCCC-cCC
Confidence 99 5699988864 45889999999999999999999999 99999999999997 5579999999998754332 234
Q ss_pred ccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH---------------cC-------
Q 006593 161 VIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---------------SG------- 216 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~---------------~g------- 216 (639)
..+++.|+|||.+.. .++.++||||||+++|+|++|..||.... ....+..+. .+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 567899999998754 58999999999999999999999997532 221111110 00
Q ss_pred --C-----CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 217 --I-----KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 217 --~-----~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. .........++.++++|.+||+ +|.+||++.+++.||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0 0001112346789999999998 899999999999999997443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.44 Aligned_cols=236 Identities=19% Similarity=0.266 Sum_probs=185.0
Q ss_pred CcccccccCcEEEEEEEecC------------------------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC
Q 006593 1 MVLTGLYMTPFSSYKAFDEF------------------------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK 56 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~------------------------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~ 56 (639)
.||+|+|| .||+|.... ....||+|.+.... ......+..|+.+++.++
T Consensus 2 ~lG~G~~~---~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~ 74 (274)
T cd05076 2 HLGQGTRT---NIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVS 74 (274)
T ss_pred CcCccccc---ceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCC
Confidence 48999999 688887432 23568888876432 244567889999999999
Q ss_pred CCCcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEE
Q 006593 57 DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV 135 (639)
Q Consensus 57 HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl 135 (639)
||||+++++++.... ..++||||+++|+|..++.+ .+.+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 75 h~niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill 150 (274)
T cd05076 75 HIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILL 150 (274)
T ss_pred CCCeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEE
Confidence 999999999987654 58899999999999999875 467899999999999999999999998 9999999999999
Q ss_pred eCC------CCcEEEeecchhhhccCCCCccccCCCCcCCcccccc--cCCccccccchhhhhhhhh-hccCCCCCCCCH
Q 006593 136 NGN------HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMV-TFEYPYSECKNP 206 (639)
Q Consensus 136 ~~~------~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELl-tG~~Pf~~~~~~ 206 (639)
+.. .+.+||+|||++...... ....+++.|+|||.+.. .++.++||||||+++|||+ +|..||.... +
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~ 227 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-P 227 (274)
T ss_pred eccCcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-h
Confidence 732 224899999987543221 23457889999998753 4899999999999999995 6899997643 3
Q ss_pred HHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 207 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 207 ~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+....+.... ..+....+.+.++|.+||. +|.+||++.++|++
T Consensus 228 ~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 228 SEKERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 33222222211 1223345789999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.31 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=201.1
Q ss_pred CcccccccCcEEEEEEEecCCCe---E-EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI---E-VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~---~-VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|.|| .||+|..+..+. . ||+|..+.... ...++...+..|.++|++++|||||+|||+..... .++
T Consensus 164 kLGeGaFG---eV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--Pl~ 237 (474)
T KOG0194|consen 164 KLGEGAFG---EVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--PLM 237 (474)
T ss_pred eeeccccc---EEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ccE
Confidence 47888888 788888766422 3 89999886332 35678889999999999999999999999877664 599
Q ss_pred EEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~-l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+|||+|.||+|.+||++.+. ++......++.+.+.||+|||+++ +|||||-..|+|++ ..+.+||+|||+++.-..
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcc
Confidence 99999999999999999874 999999999999999999999999 99999999999997 445789999999865431
Q ss_pred C-CCc-cccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 156 P-TAR-SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 156 ~-~~~-~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
. ... ...-...|+|||.+.. .|++++|||||||++||+++ |..||.+ ....++..+|.....+...+...+..+.
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~~~~r~~~~~~~p~~~~ 393 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVKNGYRMPIPSKTPKELA 393 (474)
T ss_pred eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence 1 111 1123568999998874 59999999999999999998 7889998 4566777888554455555667778899
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc
Q 006593 232 GFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.++.+|+. +|..||++.++.+
T Consensus 394 ~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 394 KVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHhccCChhhccCHHHHHH
Confidence 99999998 9999999999876
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.52 Aligned_cols=239 Identities=19% Similarity=0.339 Sum_probs=193.1
Q ss_pred CcccccccCcEEEEEEEecCCCe---EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~---~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|+|| .||+|.+..+|. .||+|.++... .....+.+..|+.+++.++||||+++++++... ..+++
T Consensus 11 ~lg~g~~g---~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l 82 (269)
T cd05065 11 VIGAGEFG---EVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS--RPVMI 82 (269)
T ss_pred EecCCCCC---eEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC--CceEE
Confidence 47889999 799999877664 69999886432 345667899999999999999999999987554 45889
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++... +.+++..++.++.|++.||.|||++| ++||||||+||+++ ..+.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccccccC
Confidence 99999999999999764 56899999999999999999999999 99999999999997 4579999999998755332
Q ss_pred CC----cccc---CCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCC
Q 006593 157 TA----RSVI---GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 227 (639)
Q Consensus 157 ~~----~~~~---GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 227 (639)
.. .... .+..|+|||.+. ..++.++|||||||++|||++ |..||... +.......+..... ...+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~-~~~~~~~~ 237 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYR-LPPPMDCP 237 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCc-CCCcccCC
Confidence 11 1111 245799999886 468999999999999999886 99999763 44555566654422 22234456
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 228 PQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+.+++.+||. +|.+||++.+++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.46 Aligned_cols=238 Identities=25% Similarity=0.399 Sum_probs=196.3
Q ss_pred CcccccccCcEEEEEEEecCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+|.+..+|. .||+|.+.... .......+.+|+.++++++||||+++++++.. ..++
T Consensus 14 ~ig~g~~g---~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 84 (279)
T cd05057 14 VLGSGAFG---TVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQVQ 84 (279)
T ss_pred eecCCCCc---cEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---CceE
Confidence 37888888 799999876664 58988876553 24566788999999999999999999998865 4588
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++..+..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCcccccccC
Confidence 999999999999999874 46899999999999999999999998 99999999999997 457999999999976543
Q ss_pred CCC----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PTA----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~~----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
... ....+++.|+|||.+. ..++.++||||||+++|||++ |..||... ...++...+..+... ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERL-PQPPICTID 239 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCC-CCCCCCCHH
Confidence 211 1122356899999775 468899999999999999998 99999874 566677777665332 334556789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+++.+||. +|.+||++.++++
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999998 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=317.96 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=195.3
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~ 74 (639)
.||+|+|| .||+|.+ ..++..||+|+++... .....+.+.+|+.+|.++. |||||+++++|... ..
T Consensus 44 ~lG~G~fG---~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~--~~ 115 (401)
T cd05107 44 TLGSGAFG---RVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG--GP 115 (401)
T ss_pred hccCCCce---eEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--CC
Confidence 47889988 7899985 3456789999997543 2344567899999999997 99999999998665 45
Q ss_pred EEEEEecCCCCCHHHHHHhCC-----------------------------------------------------------
Q 006593 75 VNMITELFTSGNLRQYRKKHK----------------------------------------------------------- 95 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~----------------------------------------------------------- 95 (639)
+++|||||.+|+|.+++.+.+
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 899999999999999996532
Q ss_pred ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe
Q 006593 96 ---------------------------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136 (639)
Q Consensus 96 ---------------------------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~ 136 (639)
.+++..+..++.||+.||.|||+.+ ++||||||+|||++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~ 273 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEe
Confidence 2566778889999999999999998 99999999999998
Q ss_pred CCCCcEEEeecchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHH
Q 006593 137 GNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 210 (639)
Q Consensus 137 ~~~g~VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~ 210 (639)
+.+.+||+|||+++..... ......+++.|||||.+. ..++.++||||||+++|||++ |..||..........
T Consensus 274 -~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 -EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred -CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 4579999999999754321 122345788999999876 458899999999999999998 899998755555555
Q ss_pred HHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 211 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 211 ~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+..+..+ ..+...+.++.+||.+||. +|.+||++++|++.
T Consensus 353 ~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555555433 3445567899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=296.97 Aligned_cols=239 Identities=25% Similarity=0.401 Sum_probs=192.7
Q ss_pred CcccccccCcEEEEEEEecCCC------eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~ 74 (639)
+||+|+|| .||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 2 ~lg~g~~g---~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 73 (269)
T cd05044 2 FLGSGAFG---EVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN--EP 73 (269)
T ss_pred ccccccce---eEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC--CC
Confidence 58999998 78999876544 789999876432 234556788999999999999999999988655 45
Q ss_pred EEEEEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC-----cE
Q 006593 75 VNMITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-----EV 142 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~-------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g-----~V 142 (639)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++. .+ .+
T Consensus 74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~-~~~~~~~~~ 150 (269)
T cd05044 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSE-KGYDADRVV 150 (269)
T ss_pred eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEec-CCCCCCcce
Confidence 89999999999999999743 34788999999999999999999999 999999999999974 34 79
Q ss_pred EEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcC
Q 006593 143 KIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 216 (639)
Q Consensus 143 KL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g 216 (639)
+|+|||++....... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... +..+....+..+
T Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~ 229 (269)
T cd05044 151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAG 229 (269)
T ss_pred EECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcC
Confidence 999999987653321 12234578899999876 458999999999999999998 99999763 445555555544
Q ss_pred CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 217 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 217 ~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+ ..+...+..+.+||.+||. +|.+||++.++++
T Consensus 230 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 GRL-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred Ccc-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 332 2334557889999999998 8999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.19 Aligned_cols=235 Identities=23% Similarity=0.380 Sum_probs=190.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|||| .||+|.+. .+..||+|.+..... ..+.+.+|+.++++++|+||+++++++.. ..++++||
T Consensus 13 ~ig~g~~~---~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e 80 (260)
T cd05070 13 KLGNGQFG---EVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVTE 80 (260)
T ss_pred eeccccCc---eEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEEEE
Confidence 37888888 89999875 566799999875442 23568899999999999999999997632 34789999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.++|+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeeccCccc
Confidence 99999999999763 35899999999999999999999999 99999999999997 557999999999976543221
Q ss_pred ---ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 159 ---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 159 ---~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....++..|+|||++. ..++.++||||||+++|+|++ |.+||.+. +.......+..+..+ ..+...+..+++|
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 235 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCPISLHEL 235 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 1233556799999775 458899999999999999999 89999763 455555666554332 3345567899999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
|.+||. +|.+|||+.+++.
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 999998 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.09 Aligned_cols=235 Identities=23% Similarity=0.385 Sum_probs=191.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++.. ..++++||
T Consensus 13 ~ig~G~~g---~v~~~~~~-~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05067 13 KLGAGQFG---EVWMGYYN-GHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYIITE 80 (260)
T ss_pred eeccCccc---eEEeeecC-CCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEEEEE
Confidence 36777777 79999864 578899999875432 24568899999999999999999997632 35889999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ +.+.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceeecCCCCc
Confidence 99999999998764 46899999999999999999999999 99999999999997 55799999999987654221
Q ss_pred --CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.....++..|+|||++. ..++.++||||||+++|+|++ |+.||.+. +.....+.+..+..+ ..+...+.++++|
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 235 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEELYEL 235 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 12234567899999886 458899999999999999999 99999874 445555555555333 3344567899999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
|.+||. +|.+||++++++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=297.04 Aligned_cols=235 Identities=18% Similarity=0.311 Sum_probs=184.5
Q ss_pred CcccccccCcEEEEEEEecC------------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF------------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 68 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~------------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~ 68 (639)
.||+|+|| .||+|.... ....||+|.+.... ......+..|+.+++.++||||+++++++.
T Consensus 2 ~lg~G~~~---~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~ 74 (262)
T cd05077 2 HLGRGTRT---QIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCV 74 (262)
T ss_pred ccccCCcc---eEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 47999998 788887432 34468888765432 344567889999999999999999999886
Q ss_pred eCCCceEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC-------
Q 006593 69 DDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG------- 140 (639)
Q Consensus 69 ~~~~~~l~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g------- 140 (639)
... ..++||||+.+|+|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 75 ~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~-~~~~~~~~~ 149 (262)
T cd05077 75 RDV--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAR-EGIDGECGP 149 (262)
T ss_pred cCC--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEec-CCccCCCCc
Confidence 553 578999999999999998764 56899999999999999999999999 999999999999963 23
Q ss_pred cEEEeecchhhhccCCCCccccCCCCcCCccccc--ccCCccccccchhhhhhhhh-hccCCCCCCCCHHHHHHHHHcCC
Q 006593 141 EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMV-TFEYPYSECKNPAQIFKKVTSGI 217 (639)
Q Consensus 141 ~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELl-tG~~Pf~~~~~~~~i~~~i~~g~ 217 (639)
.+|++|||++..... .....|++.|+|||.+. ..++.++|||||||++|+|+ +|..||... ...+.. ....+.
T Consensus 150 ~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~-~~~~~~ 225 (262)
T cd05077 150 FIKLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-RFYEGQ 225 (262)
T ss_pred eeEeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHH-HHHhcC
Confidence 389999999865432 23456889999999875 45889999999999999998 588888753 222222 222222
Q ss_pred CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 218 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 218 ~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.. ......+++++||.+||. +|.+||++.+||++
T Consensus 226 ~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11 222335689999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.04 Aligned_cols=240 Identities=24% Similarity=0.339 Sum_probs=187.9
Q ss_pred CcccccccCcEEEEEEEecCC--------------CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA--------------GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKS 66 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t--------------G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 66 (639)
.||+|||| .||+|.+..+ ...||+|.++... .....+.+.+|+++|++++||||++++++
T Consensus 12 ~lg~G~~g---~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 12 KLGEGQFG---EVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred ccCCCCCc---eEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 47888888 7888877543 3458999887432 34556679999999999999999999998
Q ss_pred EEeCCCceEEEEEecCCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEE
Q 006593 67 WVDDKKKTVNMITELFTSGNLRQYRKKHK------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 134 (639)
Q Consensus 67 ~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NIL 134 (639)
+... ..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+||+
T Consensus 86 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil 161 (295)
T cd05097 86 CVSD--DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCL 161 (295)
T ss_pred EcCC--CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEE
Confidence 8655 45899999999999999986532 3688899999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh--ccCCCCCCCCHH
Q 006593 135 VNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECKNPA 207 (639)
Q Consensus 135 l~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt--G~~Pf~~~~~~~ 207 (639)
++ +++.+||+|||++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ +..||... +..
T Consensus 162 l~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~-~~~ 239 (295)
T cd05097 162 VG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL-SDE 239 (295)
T ss_pred Ec-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc-ChH
Confidence 97 55799999999987653321 12234567899999765 568999999999999999988 67888763 333
Q ss_pred HHHHHHHc------CCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 208 QIFKKVTS------GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 208 ~i~~~i~~------g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
++...+.. .......+...++.+++||.+||. +|.+||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 33333221 111122334457889999999999 8999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=293.61 Aligned_cols=234 Identities=22% Similarity=0.364 Sum_probs=189.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|+|| .||+|.+..++ .||+|.+..... ..+.+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 14 ig~g~~~---~v~~~~~~~~~-~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~ 81 (260)
T cd05069 14 LGQGCFG---EVWMGTWNGTT-KVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIVTEF 81 (260)
T ss_pred ecCcCCC---eEEEEEEcCCc-eEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEEEEc
Confidence 6778877 79999886654 599998764432 23568899999999999999999987632 347899999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
+.+|+|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++ +.+.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEccCCccc
Confidence 99999999997643 4789999999999999999999999 99999999999997 557999999999976543221
Q ss_pred --ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 --~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....++..|+|||... ..++.++||||||+++|+|+| |..||.+. ........+..+..+ ..+...+..+++||
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 236 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGCPESLHELM 236 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcccCHHHHHHH
Confidence 1234567899999776 458899999999999999999 89999874 444555555554332 23445678899999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||. +|.+||+++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 99999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=336.88 Aligned_cols=141 Identities=26% Similarity=0.382 Sum_probs=126.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|+++..... .......+..|+.+++.++||||+++++++... ..+|+||||
T Consensus 12 LG~G~fg---~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~lVmEy 85 (669)
T cd05610 12 ISRGAFG---KVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSA--NNVYLVMEY 85 (669)
T ss_pred EecCCCe---EEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC--CEEEEEEeC
Confidence 6777777 8999999999999999999866542 345567899999999999999999999887655 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+.||+|.+++...+.+++..++.|+.||+.||.|||.++ |+||||||+|||++ ..|.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 999999999998888999999999999999999999999 99999999999997 55899999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.27 Aligned_cols=234 Identities=21% Similarity=0.356 Sum_probs=189.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++ .||+|.++.... ..+.+.+|+++++.++||||+++++.+.. ...++||||
T Consensus 14 lg~g~~~---~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e~ 81 (262)
T cd05071 14 LGQGCFG---EVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEY 81 (262)
T ss_pred cCCCCCC---cEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEEEEEc
Confidence 6778887 78999887664 599999875432 23568899999999999999999997632 347899999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++ +++.+||+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCceeeccccccc
Confidence 9999999999864 35889999999999999999999999 99999999999997 557999999999976543221
Q ss_pred --ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 --~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....++..|+|||++. ..++.++||||||+++|+|+| |..||.+. ....+...+..+... ......+..+.+||
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 236 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPESLHDLM 236 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccccCHHHHHHH
Confidence 1234567899999775 468999999999999999999 88899764 445555555554332 22345678899999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||. +|.+||++.+++.
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 99999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=298.84 Aligned_cols=245 Identities=20% Similarity=0.245 Sum_probs=196.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC---CCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD---KKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~---~~~~l~l 77 (639)
.||.|||. -||++.+..++..+|+|++.... .++.+..++|++..++++||||++++++.+.+ .+...|+
T Consensus 28 ~LgeGGfs---fv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 28 LLGEGGFS---FVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred eecCCCce---eeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 37889988 68889999999999999998764 47788999999999999999999999986543 3457999
Q ss_pred EEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 78 ITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
+++|+..|+|.+.+... ..++|..+..|+.+|++||.+||+..||++||||||.|||+.+ .+.++|.|||.++..
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCceEEEeccCcccc
Confidence 99999999999998753 3699999999999999999999999999999999999999974 689999999998654
Q ss_pred cCCC-----------CccccCCCCcCCcccccc----cCCccccccchhhhhhhhhhccCCCCCCCCH-HHHHHHHHcCC
Q 006593 154 QQPT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFKKVTSGI 217 (639)
Q Consensus 154 ~~~~-----------~~~~~GTp~ymAPE~l~~----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~-~~i~~~i~~g~ 217 (639)
.-.. ...-..|..|+|||++.- ..++++|||||||++|.|+.|..||...... ..+.-.+.++.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q 259 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ 259 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence 3211 012235889999999873 3789999999999999999999999531100 00001112221
Q ss_pred CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 218 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 218 ~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
........++..+.+||+.||+ ||.+||++.+|+.+
T Consensus 260 ~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 260 ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111223367889999999999 99999999999874
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.24 Aligned_cols=236 Identities=23% Similarity=0.385 Sum_probs=191.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+. .+..||+|.+..... ..+.+..|+.++++++||||+++++++... ..+++|||
T Consensus 13 ~ig~g~~~---~v~~~~~~-~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 81 (261)
T cd05034 13 KLGAGQFG---EVWMGTWN-GTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--EPIYIVTE 81 (261)
T ss_pred eeccCcce---EEEEEEEc-CCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecC--CceEEEEe
Confidence 36777777 89999975 457799999875432 345688999999999999999999987554 45899999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+.+++|.+++.... .+++..+..|+.||+.||.|||+++ ++||||||+||+++ +++.+||+|||++..+....
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccceeccchhh
Confidence 999999999997653 6899999999999999999999999 99999999999997 55899999999987654321
Q ss_pred --CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.....++..|+|||.+.+ .++.++||||||+++|+|++ |..||.+. ........+..+... ..+...+..++++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRM-PRPPNCPEELYDL 236 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 112234578999998764 58899999999999999998 99999764 455556666554332 2233447789999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+||. +|.+||++++++.
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 999999 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=291.39 Aligned_cols=237 Identities=18% Similarity=0.379 Sum_probs=193.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||.|+|| .||+|.+. .+..+|+|.+..... ....+..|++++++++||||+++++++... ..+++|||
T Consensus 11 ~ig~g~~g---~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e 79 (256)
T cd05112 11 EIGSGQFG---LVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTER--SPICLVFE 79 (256)
T ss_pred eecCcccc---eEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccC--CceEEEEE
Confidence 37888888 79999885 467899998864432 234588899999999999999999987654 45899999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+.+|+|.+++... +.++++.++.++.|++.||.|||+++ ++||||||+||+++ ..+.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCccc
Confidence 99999999999764 46899999999999999999999999 99999999999997 5579999999998654332211
Q ss_pred ---cccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 160 ---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 160 ---~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
...++..|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...+..+.+|+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 234 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYELM 234 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHHH
Confidence 223467899999876 468899999999999999998 8999976 4455666666655333 23445678999999
Q ss_pred HHhcC-CCCCCCCHHHHhcC
Q 006593 235 EKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~H 253 (639)
.+||. +|.+||++.+++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHcccChhhCCCHHHHHHh
Confidence 99999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=303.04 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=208.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+.|.|.+|+|++..++.+|+..|||+++.... ..+.+++..|.....+- +.||||+||+....+.. -||.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eeeeHH
Confidence 3444555555899999999999999999987653 45667888888865554 89999999998877654 788999
Q ss_pred cCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 81 LFTSGNLRQYRK-----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 81 y~~gGsL~d~lk-----k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+|. -+|..+.+ +...++|..+-.+..-.+.||.||-..- .|||||+||+|||++ ..|.|||||||++..+..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHH
Confidence 995 58877654 3467999999999999999999997652 299999999999998 558999999999988877
Q ss_pred CCCccc-cCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCC----CC
Q 006593 156 PTARSV-IGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV----ND 227 (639)
Q Consensus 156 ~~~~~~-~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~----~s 227 (639)
..+.+. .|-..|||||.+.. +|+-++|+||||++|||++||.+||.+..+..+....+..|-+|...... .+
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 655543 68889999998863 49999999999999999999999999887766666677777666544322 47
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 228 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
..++.||..||. |.+.||...+|+++||++.....
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 889999999998 89999999999999999865443
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.06 Aligned_cols=241 Identities=26% Similarity=0.381 Sum_probs=193.3
Q ss_pred CcccccccCcEEEEEEEecC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCC
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKK 72 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~ 72 (639)
.||+|+|| .||+|.+.. .+..||+|.++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 19 ~ig~G~~g---~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 90 (334)
T cd05100 19 PLGEGCFG---QVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-- 90 (334)
T ss_pred eeccccCC---cEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC--
Confidence 37889998 577776532 23479999876432 334567899999999999 899999999988654
Q ss_pred ceEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe
Q 006593 73 KTVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136 (639)
Q Consensus 73 ~~l~lV~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~ 136 (639)
..+++++||+.+|+|.+++.+.. .++...+..++.||+.||.|||++| ++||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~ 168 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT 168 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc
Confidence 45899999999999999997642 3677888999999999999999999 99999999999997
Q ss_pred CCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHH
Q 006593 137 GNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 210 (639)
Q Consensus 137 ~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~ 210 (639)
..+.+||+|||+++...... .....+++.|+|||++. ..++.++||||||+++|||++ |..||.+ .+....+
T Consensus 169 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~ 246 (334)
T cd05100 169 -EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELF 246 (334)
T ss_pred -CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHH
Confidence 45799999999987654321 11223456799999875 458899999999999999998 8899976 4566666
Q ss_pred HHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 211 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 211 ~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
..+..+..+ ..+...+.++.+||.+||. +|.+||++.|++.+-
T Consensus 247 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 247 KLLKEGHRM-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 666665433 2344556789999999999 899999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.66 Aligned_cols=242 Identities=23% Similarity=0.386 Sum_probs=192.7
Q ss_pred CcccccccCcEEEEEEEec----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|+|| .||+|... .++..||+|+++.... ....+.+.+|+.+++.++||||+++++++.......++
T Consensus 11 ~ig~g~~~---~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 11 QLGEGHFG---KVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred eeccCCCe---eEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 37888887 78999854 4589999999875542 13567899999999999999999999988776666799
Q ss_pred EEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+||||+.+++|.+++...+ .+++..+..++.||+.||.|||++| ++||||||+||+++ .++.++|+|||++.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEccccccccccc
Confidence 9999999999999998765 6899999999999999999999999 99999999999998 458999999999976652
Q ss_pred CCC-----ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCH--------------HHHHHHHHc
Q 006593 156 PTA-----RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP--------------AQIFKKVTS 215 (639)
Q Consensus 156 ~~~-----~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~--------------~~i~~~i~~ 215 (639)
... ....++..|+|||.+. ..++.++||||||+++|+|+||..|+...... ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 211 1223456799999775 45889999999999999999999998643211 111222222
Q ss_pred CCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 216 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 216 g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+. ....+...+.++.+|+.+||. +|.+||++.|++.
T Consensus 242 ~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 GE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 222234456789999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.15 Aligned_cols=240 Identities=22% Similarity=0.342 Sum_probs=186.5
Q ss_pred CcccccccCcEEEEEEEec----------------CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE----------------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY 64 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~----------------~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~ 64 (639)
.||.|||| .||+|.+. .++..||+|.++... .......+..|+.+|+.++|+||++++
T Consensus 12 ~lg~G~~g---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 12 KLGEGQFG---EVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred eccCCCCC---eEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 37888888 67877543 245579999887542 334567789999999999999999999
Q ss_pred EEEEeCCCceEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcE
Q 006593 65 KSWVDDKKKTVNMITELFTSGNLRQYRKKHK-----------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133 (639)
Q Consensus 65 ~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~-----------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NI 133 (639)
+++...+ .+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++| ++||||||+||
T Consensus 86 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Ni 161 (296)
T cd05095 86 AVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNC 161 (296)
T ss_pred EEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheE
Confidence 9887654 5899999999999999997643 3667789999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh--ccCCCCCCCCH
Q 006593 134 FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--FEYPYSECKNP 206 (639)
Q Consensus 134 Ll~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt--G~~Pf~~~~~~ 206 (639)
|++ ..+.++|+|||++..+.... .....+++.|+|||... +.++.++|||||||++|||++ |..||... +.
T Consensus 162 li~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~-~~ 239 (296)
T cd05095 162 LVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL-SD 239 (296)
T ss_pred EEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc-Ch
Confidence 997 45799999999987654322 12234467899999654 568999999999999999998 77898763 33
Q ss_pred HHHHHHHHc----C--CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 207 AQIFKKVTS----G--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 207 ~~i~~~i~~----g--~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.++...... . ......+...++.+++||.+||+ +|.+||++.+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 333322211 0 01111233456889999999999 8999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.49 Aligned_cols=239 Identities=25% Similarity=0.407 Sum_probs=191.9
Q ss_pred CcccccccCcEEEEEEEecCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| .||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 14 ~lg~G~~g---~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~~ 84 (303)
T cd05110 14 VLGSGAFG---TVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TIQ 84 (303)
T ss_pred ccccCCCc---cEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Cce
Confidence 47888888 799999877776 46888776432 234445688999999999999999999987643 356
Q ss_pred EEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+++||+++|+|.+++..++ .+++..+..|+.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||++.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccccccccC
Confidence 8999999999999998754 5899999999999999999999999 99999999999997 457899999999976543
Q ss_pred CC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. .....+++.|+|||.+. ..++.++||||||+++|||++ |..||.+. ........+..+..+ ..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL-PQPPICTID 239 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCCCHH
Confidence 21 12234577899999876 458899999999999999997 89999763 344444444444332 234456788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+++++.+||. +|.+||++++|++.
T Consensus 240 ~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 240 VYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999998 89999999999884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=291.71 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=192.7
Q ss_pred CcccccccCcEEEEEEEe---cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCc----
Q 006593 1 MVLTGLYMTPFSSYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK---- 73 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d---~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~---- 73 (639)
+||+|||| .||+|.+ ..+|..||+|++..... .....+.+.+|+++|+.++||||+++++++......
T Consensus 6 ~ig~g~~g---~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 6 MLGKGEFG---SVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred cccCCCCC---CEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 48999999 5666664 45789999999875432 345567789999999999999999999988654321
Q ss_pred eEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeec
Q 006593 74 TVNMITELFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DF 147 (639)
..+++++|+.+|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++ +.+.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEECcc
Confidence 346889999999999887532 24789999999999999999999999 99999999999997 4579999999
Q ss_pred chhhhccCCC----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006593 148 GLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 221 (639)
Q Consensus 148 GlA~~l~~~~----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 221 (639)
|++....... .....+++.|++||.+.. .++.++||||||+++|+|++ |..||.+ .+...++..+..+... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~ 235 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL-K 235 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC-C
Confidence 9987654221 123345678999998764 47889999999999999999 8899876 4455566655554332 2
Q ss_pred ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 222 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 222 l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+...+..+.+++.+||. +|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233456799999999998 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=328.30 Aligned_cols=215 Identities=25% Similarity=0.397 Sum_probs=164.8
Q ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHH
Q 006593 40 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLV 114 (639)
Q Consensus 40 ~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~-----~~l~e~~i~~i~~QIl~aL~ 114 (639)
.....+.+|+.+|++++|||||++++++...+ ..|+|++++. ++|..++... .......++.|+.||+.||.
T Consensus 205 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~ 281 (501)
T PHA03210 205 RAAIQLENEILALGRLNHENILKIEEILRSEA--NTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVE 281 (501)
T ss_pred HHHHHHHHHHHHHHhCCCCCcCcEeEEEEECC--eeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999987664 5889999995 5787776532 23446778899999999999
Q ss_pred HHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---CCccccCCCCcCCcccccc-cCCccccccchhhhh
Q 006593 115 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCI 190 (639)
Q Consensus 115 yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil 190 (639)
|||++| ||||||||+|||++ ..|.+||+|||++..+... .....+||+.|+|||++.+ .|+.++|||||||++
T Consensus 282 yLH~~g--IiHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 358 (501)
T PHA03210 282 YIHDKK--LIHRDIKLENIFLN-CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358 (501)
T ss_pred HHHhCC--eecCCCCHHHEEEC-CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHH
Confidence 999999 99999999999997 5579999999999766432 2234689999999998864 599999999999999
Q ss_pred hhhhhccCC-CCCC-CCH-HHHHHHHHcCC-CCC-----------------------cc-----cCCCChHHHHHHHHhc
Q 006593 191 LEMVTFEYP-YSEC-KNP-AQIFKKVTSGI-KPA-----------------------SL-----AKVNDPQIKGFIEKCL 238 (639)
Q Consensus 191 ~ELltG~~P-f~~~-~~~-~~i~~~i~~g~-~p~-----------------------~l-----~~~~s~~l~~LI~kcL 238 (639)
|||++|.++ |... .++ .++.+.+.... ... .+ ....+..+.++|.+||
T Consensus 359 ~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL 438 (501)
T PHA03210 359 LDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKML 438 (501)
T ss_pred HHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHh
Confidence 999998754 4322 122 22222221100 000 00 0123456788899999
Q ss_pred C-CCCCCCCHHHHhcCccccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. ||.+|||+.|+|.||||....
T Consensus 439 ~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 439 TFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred ccCcccCcCHHHHhhChhhhcCC
Confidence 9 999999999999999997654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.44 Aligned_cols=244 Identities=23% Similarity=0.407 Sum_probs=197.4
Q ss_pred CcccccccCcEEEEEEEecC-CCeEEEEEEEeccccc------CChhhHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCC
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-AGIEVAWSRVKIDDVL------QLPGDLQKLYSEVHLLKS-LKDDNVVKFYKSWVDDKK 72 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-tG~~VAIK~v~~~~~~------~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~~~~~~~ 72 (639)
.||+|+|| .||+|.+.. .+..||+|.+...... .......++..|+.++++ ++||||+++++++...
T Consensus 7 ~ig~G~~~---~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-- 81 (269)
T cd08528 7 HLGSGAFG---CVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN-- 81 (269)
T ss_pred hhcCCCCc---eEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC--
Confidence 37888887 899999987 7889999998754321 223456678889998875 7999999999988654
Q ss_pred ceEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeec
Q 006593 73 KTVNMITELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147 (639)
Q Consensus 73 ~~l~lV~Ey~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DF 147 (639)
..+++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+ .+ ++||||+|.|||++ ..+.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEecc
Confidence 569999999999999998743 3468999999999999999999996 66 99999999999997 5579999999
Q ss_pred chhhhccCC-CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCC
Q 006593 148 GLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 225 (639)
Q Consensus 148 GlA~~l~~~-~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~ 225 (639)
|++...... ......|+..|+|||.+.. .++.++|+||||+++|+|++|..||.. .+.......+..+.........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCccc
Confidence 998765433 2345578999999998764 488999999999999999999999976 3444555555555444333345
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 226 NDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 226 ~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.++.+.+||.+||. +|.+||++.|+..+
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 67899999999998 89999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=289.91 Aligned_cols=232 Identities=21% Similarity=0.382 Sum_probs=190.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|||| .||++. .++..||+|.++... ..+.+.+|+.+++.++||||+++++++... ..++|||
T Consensus 13 ~lg~g~~g---~v~~~~--~~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v~e 78 (254)
T cd05083 13 IIGEGEFG---AVLQGE--YTGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIVME 78 (254)
T ss_pred eeccCCCC---ceEecc--cCCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEEEE
Confidence 47999999 678875 468889999886432 335688999999999999999999987543 3689999
Q ss_pred cCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|+.+|+|.+++.... .+++..+..++.||+.||.|||++| ++||||||+||+++ .++.+||+|||++...... .
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~-~ 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG-V 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecccc-C
Confidence 999999999998654 4899999999999999999999999 99999999999997 4579999999998654322 1
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
.....+..|+|||.+. ..++.++|+||||+++|+|++ |..||... +.......+..+..+. .+...++.+++||.+
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 232 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPADVYVLMTS 232 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHHHHHHHH
Confidence 2234467899999876 468899999999999999997 89999874 4555566666654333 344567899999999
Q ss_pred hcC-CCCCCCCHHHHhc
Q 006593 237 CLV-PASERLSAKDLLK 252 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~ 252 (639)
||. +|.+||++.+|+.
T Consensus 233 ~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 233 CWETEPKKRPSFHKLRE 249 (254)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.72 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=208.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||-|+|| .|.++....|...+|.|.+++.++.. ..+...++.|-.||...+.+-||++|.+|.+.++ +||||+|
T Consensus 637 iGvGAFG---eV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn--LYFVMdY 710 (1034)
T KOG0608|consen 637 IGVGAFG---EVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN--LYFVMDY 710 (1034)
T ss_pred ecccccc---eeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc--eEEEEec
Confidence 5556666 66666666788999999999888754 4667789999999999999999999999987755 9999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc---CCC-
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ---QPT- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~---~~~- 157 (639)
++||++-.+|-+.+.|.|..++.|+.++.+|+++.|..| +|||||||+||||| .+|.|||.||||++-++ ...
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceecccccc
Confidence 999999999999999999999999999999999999999 99999999999998 66999999999996432 100
Q ss_pred ----------------------------------------CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhc
Q 006593 158 ----------------------------------------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTF 196 (639)
Q Consensus 158 ----------------------------------------~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG 196 (639)
++..+||+.|+|||++. .+|+..+|+||.|+|||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 11346999999999886 5799999999999999999999
Q ss_pred cCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHHHHHHhcCCCCCCCC---HHHHhcCcccccccCCC
Q 006593 197 EYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVPASERLS---AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 197 ~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~LI~kcL~dP~~RpS---a~ELL~Hpff~~~~~~~ 263 (639)
+.||... .+.+...+|..... ........++++.++|.+++..+..|+. ++++..||||+...+..
T Consensus 868 ~~pf~~~-tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 868 QPPFLAD-TPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred CCCccCC-CCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHh
Confidence 9999873 34333333333222 2223445689999999999998888875 78899999999877654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=287.80 Aligned_cols=235 Identities=22% Similarity=0.374 Sum_probs=190.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus 13 ~lg~g~~~---~vy~~~~~-~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e 80 (260)
T cd05073 13 KLGAGQFG---EVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITE 80 (260)
T ss_pred EecCccce---EEEEEEec-CCccEEEEecCCCh-----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEE
Confidence 37888888 89999865 45669999876432 335678899999999999999999998755 45789999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|+.+|+|.+++.+. ..+++..+..|+.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceeeccCCCc
Confidence 99999999999764 35788899999999999999999999 99999999999997 557999999999875543211
Q ss_pred ---ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 159 ---RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 159 ---~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....++..|+|||++.. .++.++|+||||+++|+|+| |..||... +...+...+..+... ......+.++.++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM-PRPENCPEELYNI 235 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCC-CCcccCCHHHHHH
Confidence 12235677999998864 58889999999999999999 89999864 444555555555333 2334567889999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+||+ +|.+||++.+++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 999999 8999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=320.65 Aligned_cols=234 Identities=21% Similarity=0.347 Sum_probs=197.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+|.|+|+ .|..+.+..+++..++|++..... ...+|+.++... +||||+++++.+.+. ..+|+|||
T Consensus 330 ~~~gs~s---~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~~~--~~~~~v~e 396 (612)
T KOG0603|consen 330 LGEGSFS---AVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYEDG--KEIYLVME 396 (612)
T ss_pred cCCCCcc---ceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceecCC--ceeeeeeh
Confidence 4666666 788899999999999999986632 135688666666 899999999977554 67999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
++.||-|.+-+...+.+. ..+..|++||+.|+.|||++| |+||||||+|||++++.|+++|+|||.++..... ..+
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~t 472 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDT 472 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-hcc
Confidence 999999998887766665 788899999999999999999 9999999999999656789999999999877654 334
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
.+-|..|.|||++.. .|++++||||||++||+|++|..||....+..+++..+..+. +....+..+++||..||+
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~----~s~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK----FSECVSDEAKDLLQQLLQ 548 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc----cccccCHHHHHHHHHhcc
Confidence 466888999998874 699999999999999999999999986555556666665543 336778999999999999
Q ss_pred -CCCCCCCHHHHhcCccc
Q 006593 240 -PASERLSAKDLLKDPFL 256 (639)
Q Consensus 240 -dP~~RpSa~ELL~Hpff 256 (639)
+|.+||++.+++.||||
T Consensus 549 ~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 549 VDPALRLGADEIGAHPWF 566 (612)
T ss_pred CChhhCcChhhhccCcch
Confidence 99999999999999999
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=328.47 Aligned_cols=237 Identities=22% Similarity=0.324 Sum_probs=199.7
Q ss_pred cccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|.|| .||+|... .....||||.++... ..+..+.|++|+++|..|+|||||+|+|++..+ +.+|
T Consensus 494 LGegaFG---kVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~P~~ 565 (774)
T KOG1026|consen 494 LGEGAFG---KVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG--DPLC 565 (774)
T ss_pred hcCchhh---hhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--CeeE
Confidence 6888888 78888752 345779999998654 445778899999999999999999999987655 5699
Q ss_pred EEEecCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcE
Q 006593 77 MITELFTSGNLRQYRKKHK--------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 142 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~--------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~V 142 (639)
+|+|||..|+|.+||..+. .++......++.||+.|+.||-++. ++||||...|+||. .+-.|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-ENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cceEE
Confidence 9999999999999997532 2788899999999999999999999 99999999999996 44589
Q ss_pred EEeecchhhhccCCCCcccc----CCCCcCCcc-cccccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcC
Q 006593 143 KIGDLGLAIAMQQPTARSVI----GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSG 216 (639)
Q Consensus 143 KL~DFGlA~~l~~~~~~~~~----GTp~ymAPE-~l~~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g 216 (639)
||+|||+++..-....+... -..+||||| ++.++|++++|||||||+|||+++ |..||.+.. ..+.++.|..|
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-n~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-NQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-hHHHHHHHHcC
Confidence 99999999865433222222 256899999 456889999999999999999997 899999855 46677888888
Q ss_pred CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 006593 217 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 251 (639)
Q Consensus 217 ~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL 251 (639)
.. -.-+..++.++..|+..||+ .|.+||+.+||-
T Consensus 722 ~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 77 56678889999999999999 899999999983
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=298.07 Aligned_cols=254 Identities=30% Similarity=0.421 Sum_probs=199.4
Q ss_pred CcccccccCcEEEEEEEecCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
++|..|.|+.|.||+|..+.+.. ++|||.++-++-. ...-...-+|+.+++.|+||||+.+..+|... ...+|
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~--tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~v~ 104 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG--TGISMSACREIALLRELKHPNVISLVKVFLSH-DKKVW 104 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC--CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-CceEE
Confidence 36777778888999997655533 7999998866421 13345578999999999999999999998875 46799
Q ss_pred EEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC---CCcEEEeecc
Q 006593 77 MITELFTSGNLRQYRKKH-----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---HGEVKIGDLG 148 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~---~g~VKL~DFG 148 (639)
+++||.+. +|.+.|+-+ +.++...++.++.||+.|+.|||++- |+||||||.|||+.++ .|.|||+|||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeeccc
Confidence 99999986 999988744 45899999999999999999999999 9999999999999864 3899999999
Q ss_pred hhhhccCCC-----CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCC------CHHH--HHHHH
Q 006593 149 LAIAMQQPT-----ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECK------NPAQ--IFKKV 213 (639)
Q Consensus 149 lA~~l~~~~-----~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~------~~~~--i~~~i 213 (639)
+|+.+..+. ...++-|.+|+|||++-+ .|+.++|||+.|||+.||+|.++.|.+.. +|.+ ...+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999887653 234567999999997754 59999999999999999999998885421 1211 11111
Q ss_pred Hc--CCC-----------C----------------C------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 214 TS--GIK-----------P----------------A------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 214 ~~--g~~-----------p----------------~------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
.. |.+ | . ...+..++...+|+.++|. ||-+|.|+++.|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 10 100 0 0 0012346678899999999 999999999999999998
Q ss_pred ccc
Q 006593 258 VEN 260 (639)
Q Consensus 258 ~~~ 260 (639)
...
T Consensus 342 ~d~ 344 (438)
T KOG0666|consen 342 EDP 344 (438)
T ss_pred cCC
Confidence 654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=324.73 Aligned_cols=198 Identities=26% Similarity=0.428 Sum_probs=171.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~ 76 (639)
.||+|||| .||+++++++|+.||||.++... .....++.-+|+++|++|+|||||+++++-.... .+.-.
T Consensus 20 ~LG~Ga~g---~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 20 RLGKGAFG---NVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred hhcCCccc---eeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 48999999 89999999999999999998765 3456778899999999999999999999643333 34457
Q ss_pred EEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe-CCCC--cEEEeecchh
Q 006593 77 MITELFTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHG--EVKIGDLGLA 150 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk---~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~-~~~g--~VKL~DFGlA 150 (639)
+|||||.||+|+.++++ +..+++.++..++..+..||.|||.+| |+||||||+||++. +.+| ..||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999975 457999999999999999999999999 99999999999984 2323 3699999999
Q ss_pred hhccCC-CCccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCH
Q 006593 151 IAMQQP-TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNP 206 (639)
Q Consensus 151 ~~l~~~-~~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~ 206 (639)
+.+.+. ...+++||+.|.+||+++ ..|+..+|.|||||++|+++||..||-....+
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 988654 566789999999999998 45899999999999999999999999644334
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=277.60 Aligned_cols=238 Identities=33% Similarity=0.553 Sum_probs=203.1
Q ss_pred EEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCHHHH
Q 006593 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY 90 (639)
Q Consensus 11 ~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~ 90 (639)
+.||+|.+..+|..||+|++...... ...+.+.+|++.+++++|+||+++++++... ...++++||+.+++|..+
T Consensus 3 g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 3 GKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred eEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 48999999999999999998765431 1167899999999999999999999988765 468999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCccccCCCCcCC
Q 006593 91 RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMA 169 (639)
Q Consensus 91 lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~~~GTp~ymA 169 (639)
+.....++...++.++.|++.+|.|||+.+ ++|+||+|.||+++. .+.++|+|||.+...... ......+++.|++
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCCcCCCC
Confidence 988777999999999999999999999999 999999999999984 479999999999766543 3445678999999
Q ss_pred ccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCC-CChHHHHHHHHhcC-CCCCCCC
Q 006593 170 PELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV-NDPQIKGFIEKCLV-PASERLS 246 (639)
Q Consensus 170 PE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~-~s~~l~~LI~kcL~-dP~~RpS 246 (639)
||.+. ..++.++||||||+++++|++|..||........+...+..+......... .+..+.+++.+||. +|.+||+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99876 568889999999999999999999997755666776666665444332222 56789999999998 8999999
Q ss_pred HHHHhcCccc
Q 006593 247 AKDLLKDPFL 256 (639)
Q Consensus 247 a~ELL~Hpff 256 (639)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=272.93 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=196.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|.|| +||+|++..+++.||+|+++.++- .+.......+||-+|+.|+|+|||++++....+. .+-+|+||
T Consensus 10 igegtyg---tvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsdk--kltlvfe~ 82 (292)
T KOG0662|consen 10 IGEGTYG---TVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--KLTLVFEF 82 (292)
T ss_pred hcCCcce---eeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc--eeEEeHHH
Confidence 5666666 899999999999999999998874 3455667899999999999999999999765554 48899999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC--
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-- 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~-- 158 (639)
|. .+|..|... ++.++.+.++.++.|++.||.|+|+++ +.||||||+|.||+ .+|.+||+|||+|+.+.-+..
T Consensus 83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEee
Confidence 96 589998876 577999999999999999999999999 99999999999998 558999999999987765431
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHc--CCC-CCccc---------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS--GIK-PASLA--------- 223 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~--g~~-p~~l~--------- 223 (639)
...+-|.+|++|.++-+ -|+...|+||.||++.|+.. |.+.|.+..-..++ ++|-. |.+ ...++
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql-krif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH-HHHHHHhCCCccccCCccccCCCCc
Confidence 23356999999998764 39999999999999999997 56567664433343 33311 111 00011
Q ss_pred ---------------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 224 ---------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 224 ---------------~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
...+..-+++++++|. +|..|.+|++.|+||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 0112357899999998 8999999999999999964
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.10 Aligned_cols=242 Identities=19% Similarity=0.221 Sum_probs=180.2
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhh-------HHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGD-------LQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~-------~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~ 70 (639)
+||+|||| +||+|.+..+ +..+|+|...........+. ......+...+..++|+||+++++.+...
T Consensus 19 ~LG~G~fG---~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 19 LIGCGGFG---CVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EEecCCCc---eEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 47899998 7999998777 67788876544331100000 01122334456677999999999876554
Q ss_pred CCc--eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 71 KKK--TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 71 ~~~--~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
... +.+++++++. .++.++++.....++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.++|+|||
T Consensus 96 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~~~~~l~DFG 171 (294)
T PHA02882 96 RCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GNNRGYIIDYG 171 (294)
T ss_pred cCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCcEEEEEcC
Confidence 322 4567888885 478888877666789999999999999999999999 99999999999997 45799999999
Q ss_pred hhhhccCC---------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHH--------H
Q 006593 149 LAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--------F 210 (639)
Q Consensus 149 lA~~l~~~---------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i--------~ 210 (639)
+|+..... ......||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+......+ .
T Consensus 172 la~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~ 251 (294)
T PHA02882 172 IASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFI 251 (294)
T ss_pred CceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHH
Confidence 99765311 1223469999999998764 5899999999999999999999999875332222 2
Q ss_pred HHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 211 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 211 ~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+..+.. .....++.+.+++..|+. +|.+||+..+|++
T Consensus 252 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 252 KRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22222211 123346889999999998 9999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=327.78 Aligned_cols=239 Identities=20% Similarity=0.347 Sum_probs=196.9
Q ss_pred CcccccccCcEEEEEEEecCC-C----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA-G----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t-G----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
+||+|.|| .||.|.-... | ..||+|.++.. .+.++...|.+|..+|+.++|||||++++++.+.. ..
T Consensus 699 ~lG~G~FG---~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~--~~ 770 (1025)
T KOG1095|consen 699 VLGKGAFG---EVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG--PP 770 (1025)
T ss_pred eecccccc---ceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC--Cc
Confidence 48999999 7898886443 2 34888887654 35678889999999999999999999999988754 47
Q ss_pred EEEEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 76 NMITELFTSGNLRQYRKKH-------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~-------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
+|++|||.||+|..||++. ..+....+..++.||++|..||+++. +|||||.+.|+|++.. ..|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEEEcccc
Confidence 8999999999999999875 35889999999999999999999999 9999999999999865 799999999
Q ss_pred hhhhccCCCCccc----cCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 149 LAIAMQQPTARSV----IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 149 lA~~l~~~~~~~~----~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
+|+.+.....+.. .-...|||||.+. +.|+.++|||||||++||++| |..||.+.. ..+++..+..+- ....
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~-n~~v~~~~~~gg-RL~~ 925 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-NFEVLLDVLEGG-RLDP 925 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-hHHHHHHHHhCC-ccCC
Confidence 9996543322211 1234799999876 679999999999999999998 689998854 455555444443 4445
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+..++..+.++|..||. +|.+||+...|++
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 66777788899999999 8999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=319.33 Aligned_cols=247 Identities=22% Similarity=0.284 Sum_probs=172.0
Q ss_pred CcccccccCcEEEEEEEecCC----CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCC
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV----DDKK 72 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t----G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~----~~~~ 72 (639)
+||+|||| .||+|.+..+ +..||+|++.... ..+....+ .++...+.++..++..|. ....
T Consensus 139 ~LG~G~FG---~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 139 KLGEGAFG---VVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred EEeeCCCe---EEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 37888888 8999999998 9999999876332 11111111 122223333333332221 1334
Q ss_pred ceEEEEEecCCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCc
Q 006593 73 KTVNMITELFTSGNLRQYRKKHKN--------------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132 (639)
Q Consensus 73 ~~l~lV~Ey~~gGsL~d~lkk~~~--------------------l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~N 132 (639)
..+++|+||+.+++|.+++..... .....++.++.||+.||.|||+++ |+||||||+|
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP~N 285 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKPQN 285 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCHHH
Confidence 578999999999999999875421 123457789999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeecchhhhccCC---CCccccCCCCcCCcccccc-----------------------cCCccccccch
Q 006593 133 IFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPELYEE-----------------------EYNELVDIYSF 186 (639)
Q Consensus 133 ILl~~~~g~VKL~DFGlA~~l~~~---~~~~~~GTp~ymAPE~l~~-----------------------~ys~ksDIwSl 186 (639)
||++.+.+.+||+|||+|+.+... ....++||+.|||||.+.. .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 999866679999999999765432 2345789999999996521 24456799999
Q ss_pred hhhhhhhhhccCCCCCCCCHHHHHHHHHcCC----------CCC---------cccCCCChHHHHHHHHhcC-CCCCCCC
Q 006593 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGI----------KPA---------SLAKVNDPQIKGFIEKCLV-PASERLS 246 (639)
Q Consensus 187 Giil~ELltG~~Pf~~~~~~~~i~~~i~~g~----------~p~---------~l~~~~s~~l~~LI~kcL~-dP~~RpS 246 (639)
||++|||+++..|+.. ...+....+.... .+. ......+...++||.+||+ ||.+|||
T Consensus 366 GviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 366 GLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 9999999998776542 2222222221110 000 0111123346689999999 9999999
Q ss_pred HHHHhcCcccccccCC
Q 006593 247 AKDLLKDPFLQVENQK 262 (639)
Q Consensus 247 a~ELL~Hpff~~~~~~ 262 (639)
+.++|+||||+.....
T Consensus 444 a~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 444 AKAALAHPYFDREGLL 459 (566)
T ss_pred HHHHhCCcCcCCCCcc
Confidence 9999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=313.14 Aligned_cols=246 Identities=29% Similarity=0.503 Sum_probs=215.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
+|.|.|| .||||+|+.+++..|+|+|+.+. .++..-+++|+-+++.++|||||.||+++.-.++ +|+.|||
T Consensus 23 vgsgTyg---dvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk--lwicMEy 93 (829)
T KOG0576|consen 23 VGSGTYG---DVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK--LWICMEY 93 (829)
T ss_pred ecCCccc---chhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhhcC--cEEEEEe
Confidence 5666666 89999999999999999999875 3667778999999999999999999999977655 8899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
|.||+|.+...--+.+++..+..+++..++||.|||+.| -+|||||-.||+++ +.|.||++|||.+..+... ..+
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCchhhhhhhhhhhh
Confidence 999999998887889999999999999999999999999 99999999999998 6689999999999776533 456
Q ss_pred cccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--CCCChHHHHH
Q 006593 160 SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGF 233 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~l~~L 233 (639)
.++|||.|||||+-. +.|+.++|||++|+.+.|+.-.++|..+......++-...++..|+.+. ...++.+.+|
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence 899999999999653 5799999999999999999999999877555555666666777776554 3457889999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
++.||- +|.+||+++-+|.|||....
T Consensus 251 vK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHhcCCCccCCChhhheeceeeccc
Confidence 999998 79999999999999999654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=311.71 Aligned_cols=238 Identities=26% Similarity=0.351 Sum_probs=187.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
|+|.|..|+ .||+|.- .|++||||++-.+ ....+++|+..|+.- +|||||+||+ .+.+...+||..
T Consensus 516 ilG~Gs~Gt--~Vf~G~y--e~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIal 582 (903)
T KOG1027|consen 516 ILGYGSNGT--VVFRGVY--EGREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIAL 582 (903)
T ss_pred HcccCCCCc--EEEEEee--CCceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEe
Confidence 578888886 6899985 5889999987643 335678999999999 7999999998 556667899999
Q ss_pred ecCCCCCHHHHHHhCC-CCCH---HHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC----CCcEEEeecchhh
Q 006593 80 ELFTSGNLRQYRKKHK-NVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN----HGEVKIGDLGLAI 151 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~-~l~e---~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~----~g~VKL~DFGlA~ 151 (639)
|+|. -+|.++++... .+.. -..+.++.|++.||++||+.+ ||||||||+||||+.. ...++|.|||+++
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9997 49999998751 1111 335788999999999999999 9999999999999752 2468999999998
Q ss_pred hccCCC-----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhc-cCCCCCCCCHHHHHHHHHcCCC-CCccc
Q 006593 152 AMQQPT-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK-PASLA 223 (639)
Q Consensus 152 ~l~~~~-----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG-~~Pf~~~~~~~~i~~~i~~g~~-p~~l~ 223 (639)
.+.... ..+..||-+|+|||++.. .-+.++||+||||++|+.++| ..||.+. .++-. .|..+.. ...+.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~-NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQA-NILTGNYTLVHLE 736 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhh-hhhcCccceeeec
Confidence 875432 335679999999999875 456789999999999999987 8999752 22222 2333333 22333
Q ss_pred CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 224 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 224 ~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
...+.++++||.+||. +|..||+|.++|.||||=
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 3333489999999999 899999999999999993
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=299.17 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=201.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC------CCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK------DDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~------HpNIVkl~~~~~~~~~~~ 74 (639)
|.|.-|.|.|++|-+|.|...|..||||+|+-.+ .....=+.|+++|++|+ .-|+++||..|... .+
T Consensus 436 V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk--nH 508 (752)
T KOG0670|consen 436 VQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK--NH 508 (752)
T ss_pred EEeccccceeeeeeeccccCCCCeeEEEEeecch-----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--ce
Confidence 3566788888899999999999999999998544 33455678999999995 35899999988655 56
Q ss_pred EEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 75 VNMITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~---~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+|||+|-+ ..+|++.|++.+ .+..++++.|+.|++.||..|-.+| |+|.||||+|||++.....+||||||.|.
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCcccc
Confidence 99999999 579999999875 4899999999999999999999999 99999999999999777789999999998
Q ss_pred hccCCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHH-----------HHHcC---
Q 006593 152 AMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK-----------KVTSG--- 216 (639)
Q Consensus 152 ~l~~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~-----------~i~~g--- 216 (639)
.........+.-+..|.|||++-+ .|+...|+||+||+||||.||+..|.+..|...+-- .+..|
T Consensus 586 ~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 586 FASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred ccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence 777666666677888999997754 699999999999999999999999998666544311 11110
Q ss_pred -----------------------------CCC-Ccc----cC---CC------ChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 217 -----------------------------IKP-ASL----AK---VN------DPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 217 -----------------------------~~p-~~l----~~---~~------s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..| ..+ .. .. -..+++|+.+||. ||.+|.|..+.|+
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 111 000 00 00 1268899999999 9999999999999
Q ss_pred Cccccc
Q 006593 253 DPFLQV 258 (639)
Q Consensus 253 Hpff~~ 258 (639)
||||+.
T Consensus 746 HpFi~~ 751 (752)
T KOG0670|consen 746 HPFITE 751 (752)
T ss_pred CCcccC
Confidence 999974
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.70 Aligned_cols=238 Identities=24% Similarity=0.432 Sum_probs=196.4
Q ss_pred CcccccccCcEEEEEEEe----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFD----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||.|-|| .||+|.. +.....||||..+... .++..++|..|..+|+.++|||||+++|++.+. ..|
T Consensus 396 ~iG~GqFG---dVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~W 466 (974)
T KOG4257|consen 396 LIGEGQFG---DVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMW 466 (974)
T ss_pred hhcCCccc---ceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---cee
Confidence 47888888 6777764 3345568889877543 567799999999999999999999999988664 489
Q ss_pred EEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
||||+++-|.|+.|++.++ .++...+..++.||+.||.|||+.. ++||||...|||+... ..|||+|||+++.+..
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP-QCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-ceeeecccchhhhccc
Confidence 9999999999999999875 5899999999999999999999999 9999999999999855 4899999999998875
Q ss_pred CCCcc---ccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 156 PTARS---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 156 ~~~~~---~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
...+. ..-..-|||||.+. .+++.++|||-||+|+||++. |..||.+..|...+ -.+.+|..+ ..+..++|.+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iEnGeRl-P~P~nCPp~L 621 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIENGERL-PCPPNCPPAL 621 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEecCCCCC-CCCCCCChHH
Confidence 53221 12245699999887 569999999999999999875 88999986654433 344555443 3566778999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..++.+||. +|.+||...+|..
T Consensus 622 YslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHHH
Confidence 999999999 9999999877743
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=284.31 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=195.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEe------CCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD------DKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~------~~~~~l 75 (639)
||+|.|| .||+|..+.+|+.||+|.+-.++- .........+|+.+|..|+|+|++.++..+.. ..+..+
T Consensus 25 igqGtfg---eVFkAr~~n~~kkvalkkvlmene--KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 25 IGQGTFG---EVFKARSKNTGKKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred cCCchHH---HHHHHhhcCccchhHHHHHHHhcc--ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 4555555 899999999999999998766442 12334557899999999999999888765422 233469
Q ss_pred EEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 76 NMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
|+|+.+|+. +|.-++... .+++...|++++.+++.||.|+|+.. |+|||+||.|+||++ +|.+||+|||+++.+.
T Consensus 100 ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~-dgilklADFGlar~fs 175 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITK-DGILKLADFGLARAFS 175 (376)
T ss_pred eeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcC-CceEEeecccccccee
Confidence 999999986 888888765 57999999999999999999999999 999999999999984 4899999999997664
Q ss_pred CCCCc------cccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHH--HHHcC----CCC-
Q 006593 155 QPTAR------SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK--KVTSG----IKP- 219 (639)
Q Consensus 155 ~~~~~------~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~--~i~~g----~~p- 219 (639)
..... ..+-|.+|++||.+- ..|+++.|||..||++.||+|+.+.+.+..+..++.- .+-.. ..|
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 33211 224599999999765 4699999999999999999999999988655544321 11000 000
Q ss_pred -------------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 -------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 -------------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
..-+.+.++++.+|++++|. ||.+|+.++++|+|-||..+.
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 01122346789999999999 999999999999999997543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=284.70 Aligned_cols=255 Identities=21% Similarity=0.320 Sum_probs=211.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|. +|-++.++.|.+.+|+|+++++-+. ..+++.-++.|-.+..+. +||.+|-++..|..+. ++++|.
T Consensus 257 vigrgsya---kvl~~~~~~t~qiyamkvvkkel~n-ddedidwvqtek~vfe~asn~pflvglhscfqtes--rlffvi 330 (593)
T KOG0695|consen 257 VIGRGSYA---KVLLVRLKKTDQIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES--RLFFVI 330 (593)
T ss_pred eecCcchh---hhhheehcccceeeehhhHHHHhcC-CcccchhHHhhHHHHHhccCCCeEEehhhhhcccc--eEEEEE
Confidence 57888887 7888999999999999999977653 446677788999998888 8999999999887664 599999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||++||+|--.+++..+++++.++.+...|..||.|||++| ||+||||.+|+|++ ..|.+||.|+|.++.-- ...
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCCCCCcc
Confidence 99999999998999999999999999999999999999999 99999999999998 55899999999997543 335
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCC--CCCCH-----HHHHHHHHcCCCCCcccCCCChH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYS--ECKNP-----AQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~--~~~~~-----~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
..++||||.|.|||++++ .|+..+|+|+||++++||+.|+.||. +..|+ .-+++.|..... .++...+-.
T Consensus 408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprslsvk 485 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSLSVK 485 (593)
T ss_pred cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccceeehh
Confidence 668999999999999986 59999999999999999999999994 22222 335555554322 233333445
Q ss_pred HHHHHHHhcC-CCCCCCC------HHHHhcCcccccccCCCCcC
Q 006593 230 IKGFIEKCLV-PASERLS------AKDLLKDPFLQVENQKEPIC 266 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpS------a~ELL~Hpff~~~~~~~~~~ 266 (639)
+..+++.-|+ ||.+|.. ..++..|+||+...|.-..+
T Consensus 486 as~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq 529 (593)
T KOG0695|consen 486 ASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ 529 (593)
T ss_pred hHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh
Confidence 6677788887 8999874 68999999999888765433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=268.58 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=201.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+|+|.|+ .|+-|.+..+.+.++||+++.- ..+++.+|+.+|..|. ||||+++++...+...+...+|+|
T Consensus 46 ~GRGKYS---EVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 46 VGRGKYS---EVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred HcCccHh---hHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 4555555 7999999999999999998743 3467999999999995 999999999988888888899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+.+.+.+.+. +.++...++.++.|+++||.|||+.| |+|||+||.|++|+.....++|+|+|+|..........
T Consensus 116 ~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 116 YVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 99998887765 45888899999999999999999999 99999999999999777789999999998877554443
Q ss_pred c-cCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCC-CCCCCHHHHHHHHHc---------------------
Q 006593 161 V-IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPY-SECKNPAQIFKKVTS--------------------- 215 (639)
Q Consensus 161 ~-~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf-~~~~~~~~i~~~i~~--------------------- 215 (639)
+ +.+..|--||++- +.|+..-|+|||||++..|+..+-|| .+.+|..|+.+...-
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 3 4577888999875 46999999999999999999998886 566777776542210
Q ss_pred -----C--------CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 216 -----G--------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 216 -----g--------~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. ..+.......+|++.+|+.++|. |-.+|+||+|.+.||||....
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0 01111223346899999999999 999999999999999997543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=262.46 Aligned_cols=209 Identities=27% Similarity=0.431 Sum_probs=178.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| .|-+-++..+|...|+|.++..- ......++..|+.+..+. .+|.+|.||+.+..+.. +|+.||
T Consensus 54 lGrGayG---~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd--vwIcME 125 (282)
T KOG0984|consen 54 LGRGAYG---VVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD--VWICME 125 (282)
T ss_pred hcCCccc---hhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--EEEeHH
Confidence 7999999 45567788999999999998653 245567788899887766 89999999998876654 899999
Q ss_pred cCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYR----KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~l----kk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
.|. .+|..|. ++.+.++|..+-+++..|+.||.|||++- .+||||+||.|||++ ..|.|||||||++..+.+.
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhh
Confidence 995 5887764 45678999999999999999999999984 399999999999998 5689999999999988877
Q ss_pred CCcc-ccCCCCcCCcccccc-----cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006593 157 TARS-VIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS 221 (639)
Q Consensus 157 ~~~~-~~GTp~ymAPE~l~~-----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~ 221 (639)
.+.+ -.|...|||||.+.. .|+-++||||||+.++||+++++||....++.+..+.+.....|..
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~L 273 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQL 273 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCC
Confidence 7666 568889999998752 5999999999999999999999999988899998888887655543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=282.10 Aligned_cols=244 Identities=19% Similarity=0.318 Sum_probs=189.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CC----cceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DN----VVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pN----IVkl~~~~~~~~~~~l 75 (639)
||+|.|| .|-.+.|..++..||+|+++-- ....+...-|+++|.++.+ |+ +|++.++|- -++.+
T Consensus 97 lGeGtFG---kV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd--yrghi 166 (415)
T KOG0671|consen 97 LGEGTFG---KVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD--YRGHI 166 (415)
T ss_pred hcCCccc---ceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh--ccCce
Confidence 4555555 7888999999999999998743 2445667889999999943 22 567766553 34569
Q ss_pred EEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC----------C-----
Q 006593 76 NMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----------N----- 138 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~----------~----- 138 (639)
|||+|.+ |-++.++++.++ +++...++.+++||+.+++|||+.+ ++|-||||+|||+.. .
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCcccee
Confidence 9999999 569999998764 6899999999999999999999999 999999999999831 1
Q ss_pred ----CCcEEEeecchhhhccCCCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHH--HHH
Q 006593 139 ----HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--IFK 211 (639)
Q Consensus 139 ----~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~--i~~ 211 (639)
.-.|+|+|||.|+.-.+.. .+.+.|..|+|||++- -+++.++||||+||||+|++||...|..-.+.+. +++
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME 322 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence 1248999999997655443 5678899999999765 4799999999999999999999999976555442 334
Q ss_pred HHHcCCCCC----------------ccc----------------------CCCC---hHHHHHHHHhcC-CCCCCCCHHH
Q 006593 212 KVTSGIKPA----------------SLA----------------------KVND---PQIKGFIEKCLV-PASERLSAKD 249 (639)
Q Consensus 212 ~i~~g~~p~----------------~l~----------------------~~~s---~~l~~LI~kcL~-dP~~RpSa~E 249 (639)
.|....+.. .++ ...| .++.+||++||. ||.+|+|+.|
T Consensus 323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 333211100 000 0011 257899999999 9999999999
Q ss_pred HhcCcccccc
Q 006593 250 LLKDPFLQVE 259 (639)
Q Consensus 250 LL~Hpff~~~ 259 (639)
+|.||||+..
T Consensus 403 AL~HpFF~~~ 412 (415)
T KOG0671|consen 403 ALSHPFFARL 412 (415)
T ss_pred HhcCHHhhcC
Confidence 9999999753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=293.95 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=178.6
Q ss_pred CcccccccCcEEEEEEEe----------------cCCCeEEEEEEEecccccCCh----------hhHHHHHHHHHHHHh
Q 006593 1 MVLTGLYMTPFSSYKAFD----------------EFAGIEVAWSRVKIDDVLQLP----------GDLQKLYSEVHLLKS 54 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d----------------~~tG~~VAIK~v~~~~~~~~~----------~~~~~l~~Ei~iLk~ 54 (639)
+||+|||| +||+|.+ ...+..||+|++......... ...+....|+.++.+
T Consensus 152 ~LG~GgFG---~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 152 KLGGGNFG---ITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeecCCCe---EEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 48999999 7898865 234578999998754321000 111233457777888
Q ss_pred CCCCCc-----ceEEEEEEeC------CCceEEEEEecCCCCCHHHHHHhC------------------------CCCCH
Q 006593 55 LKDDNV-----VKFYKSWVDD------KKKTVNMITELFTSGNLRQYRKKH------------------------KNVDI 99 (639)
Q Consensus 55 L~HpNI-----Vkl~~~~~~~------~~~~l~lV~Ey~~gGsL~d~lkk~------------------------~~l~e 99 (639)
++|.++ ++++++|... .....|+||||+.+|+|.+++... ..+++
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 876654 6777776432 124578999999999999988642 12356
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-Cc--cccCCCCcCCccccccc
Q 006593 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-AR--SVIGTPEFMAPELYEEE 176 (639)
Q Consensus 100 ~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-~~--~~~GTp~ymAPE~l~~~ 176 (639)
..++.++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||++..+.... .. ...+||.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 778999999999999999999 999999999999984 4799999999997654321 11 23458999999976421
Q ss_pred ---------------------CC--ccccccchhhhhhhhhhccC-CCCCCCCHH----------HHHHHHHcCCCCCcc
Q 006593 177 ---------------------YN--ELVDIYSFGMCILEMVTFEY-PYSECKNPA----------QIFKKVTSGIKPASL 222 (639)
Q Consensus 177 ---------------------ys--~ksDIwSlGiil~ELltG~~-Pf~~~~~~~----------~i~~~i~~g~~p~~l 222 (639)
|+ .+.||||+||++|+|+++.+ ||....... ..+..+.........
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~ 465 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL 465 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCccc
Confidence 22 34799999999999999975 775321111 111222222223333
Q ss_pred cCCCChHHHHHHHHhcC-CC---CCCCCHHHHhcCccccc
Q 006593 223 AKVNDPQIKGFIEKCLV-PA---SERLSAKDLLKDPFLQV 258 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP---~~RpSa~ELL~Hpff~~ 258 (639)
....++..++|+.+||. +| .+|+|+.|+|+||||..
T Consensus 466 ~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 466 LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 44567899999999997 44 68999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=276.74 Aligned_cols=243 Identities=28% Similarity=0.382 Sum_probs=196.0
Q ss_pred cccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEEEEEec
Q 006593 6 LYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNMITEL 81 (639)
Q Consensus 6 GfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~lV~Ey 81 (639)
++|.- .|-.|.|..++++||+|.+... + .......+.++|+.++..++|+||++++.+|.-... ..+|+||||
T Consensus 26 ~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 26 GSGAQ-IVVAAFDQVLGRPVAIKKLSRP-F-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred CCCCc-eEEecchhhccCceehhhhcCc-c-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 45555 6788999999999999998776 3 335667889999999999999999999998854322 358899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
+. ++|.+.+. -.++-+.++.++.|++.|+.|||+.| |+||||||+||+++ ..+.+||.|||+|+..... ....
T Consensus 103 m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar~e~~~~~mtp 176 (369)
T KOG0665|consen 103 MD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLARTEDTDFMMTP 176 (369)
T ss_pred hh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhhcccCcccccCc
Confidence 95 69998887 45788899999999999999999999 99999999999997 5579999999999776544 4456
Q ss_pred ccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc---------------------C--
Q 006593 161 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---------------------G-- 216 (639)
Q Consensus 161 ~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~---------------------g-- 216 (639)
++.|..|.|||++- .+|.+.+||||+||++.||++|..-|.+.....+..+.+.. .
T Consensus 177 yVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~ 256 (369)
T KOG0665|consen 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRP 256 (369)
T ss_pred hhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcCh
Confidence 78899999999765 46999999999999999999999988875544444333211 0
Q ss_pred ---------CCCC-cc------cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 217 ---------IKPA-SL------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 217 ---------~~p~-~l------~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
..|. .+ .......+++++.+||. +|.+|.+++++|+|||++
T Consensus 257 ~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 257 QYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0010 01 11223468999999998 999999999999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=316.48 Aligned_cols=233 Identities=21% Similarity=0.312 Sum_probs=175.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|.++.... ....|++++++++|||||++++++.+.. ..++|||
T Consensus 697 ~ig~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~~--~~~lv~E 763 (968)
T PLN00113 697 VISRGKKG---ASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSEK--GAYLIHE 763 (968)
T ss_pred EEccCCCe---eEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcCC--CCEEEEe
Confidence 47888888 899999999999999998864321 1134688999999999999999987654 5889999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|+++|+|.++++. +++..+..++.||+.||+|||.+ .++|+||||||+||+++++ +..++. ||.+..... ..
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~--~~ 836 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT--DT 836 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc--CC
Confidence 9999999999963 78999999999999999999954 3349999999999999844 566665 665433222 22
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCC----HHHHHHHHHcC------CCCCc-----cc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN----PAQIFKKVTSG------IKPAS-----LA 223 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~----~~~i~~~i~~g------~~p~~-----l~ 223 (639)
...||+.|||||++.. .|+.++|||||||++|||+||+.||..... .....+..... ..+.. ..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 3468999999998864 599999999999999999999999853211 11111111110 00100 00
Q ss_pred CCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 224 KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 224 ~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.....++.+++.+||+ +|.+||++.|+++.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0111256788999998 89999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=287.16 Aligned_cols=238 Identities=24% Similarity=0.339 Sum_probs=190.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|-|| .|.++.-.. +..||+|.++-... ......|.+|+++|.+|+|||||.++++++.++ .+++||||
T Consensus 546 iGeGqFG---EVhLCeveg-~lkVAVK~Lr~~a~---~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~EY 616 (807)
T KOG1094|consen 546 IGEGQFG---EVHLCEVEG-PLKVAVKILRPDAT---KNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMITEY 616 (807)
T ss_pred hcCcccc---eeEEEEecC-ceEEEEeecCcccc---hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHHHH
Confidence 6777777 677777533 69999999987763 345688999999999999999999999987664 49999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
++.|+|.+|+.++. ....+...+++.||+.|++||.+.+ ++||||.+.|+|++++ +++||+|||.++.+-....+
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc-ccEEecCcccccccccCCce
Confidence 99999999999883 3344556679999999999999999 9999999999999865 69999999999866543333
Q ss_pred cc----cCCCCcCCccc-ccccCCccccccchhhhhhhhhh--ccCCCCCCCCHHHHHHHHH---cCCC---CCcccCCC
Q 006593 160 SV----IGTPEFMAPEL-YEEEYNELVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVT---SGIK---PASLAKVN 226 (639)
Q Consensus 160 ~~----~GTp~ymAPE~-l~~~ys~ksDIwSlGiil~ELlt--G~~Pf~~~~~~~~i~~~i~---~g~~---p~~l~~~~ 226 (639)
.. +-..+|||||. +.++++.++|+|+||+++||+++ .+.||.... .+++....- .... -...+..+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-DEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-HHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 22 33578999994 56889999999999999999876 589998744 344433321 1111 12345667
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+..+.++|.+||. +-.+||+.++|-.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 7889999999999 8999999999854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=284.92 Aligned_cols=236 Identities=25% Similarity=0.393 Sum_probs=200.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||-|-|| .||.|.++...-.||||.++.+. ...+.|..|..+|+.++|||+|+++++|..+ ..+|||+||
T Consensus 275 LGGGQYG---eVYeGvWKkyslTvAVKtLKEDt-----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E--pPFYIiTEf 344 (1157)
T KOG4278|consen 275 LGGGQYG---EVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--PPFYIITEF 344 (1157)
T ss_pred cCCCccc---ceeeeeeeccceeeehhhhhhcc-----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC--CCeEEEEec
Confidence 5666677 79999999999999999988553 4678899999999999999999999977544 569999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|..|+|.+||+... .++.-.+..++.||..|++||..++ +|||||...|.|+.. +..||++||||++.+...+..
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccc-cceEEeeccchhhhhcCCcee
Confidence 99999999998753 4777788899999999999999999 999999999999964 458999999999998766544
Q ss_pred cccC---CCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 160 SVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 160 ~~~G---Tp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
...| ..-|.|||-+. ..++.++|||+||++|||++| |-.||.+ -+..++|..+..|.. ..-+..+.+.+.+|+
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyR-M~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYR-MDGPEGCPPKVYELM 499 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccc-ccCCCCCCHHHHHHH
Confidence 3334 44699999775 569999999999999999998 6789987 467788888777754 345677889999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
..||+ .|++||+..|+-+
T Consensus 500 raCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHhcCCcccCccHHHHHH
Confidence 99999 9999999988743
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=289.65 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=202.4
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|.|| .|++|.++.. -..||||.++...... ....|.+|+.+|.+|+|||+|++|++..+. .+.|
T Consensus 117 ~LG~GsFg---vV~rg~Wt~psgk~V~VAVKclr~d~l~~---~mddflrEas~M~~L~H~hliRLyGvVl~q---p~mM 187 (1039)
T KOG0199|consen 117 LLGEGSFG---VVKRGTWTQPSGKHVNVAVKCLRDDSLNA---IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAMM 187 (1039)
T ss_pred HhcCccee---eEeeccccCCCCcEEeEEEEeccCCccch---hHHHHHHHHHHHHhccCcceeEEeeeeccc---hhhH
Confidence 47888888 7888987553 4679999998776532 567799999999999999999999987662 3789
Q ss_pred EEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 78 ITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
|||+++.|+|.+.|.+ ...|....+..|+.||+.|+.||.+++ +|||||...|+|+-. -..|||+||||.+-+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllas-prtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLAS-PRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecc-cceeeeecccceeccCC
Confidence 9999999999999987 345888999999999999999999999 999999999999974 45899999999988765
Q ss_pred CCCcccc-----CCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 156 PTARSVI-----GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 156 ~~~~~~~-----GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
....... -...|.|||.++ ..++.++|||+||+++|||+| |+.||.++ +..++++.|..+.. ..-++.++.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~er-LpRPk~cse 342 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGER-LPRPKYCSE 342 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhcccccc-CCCCCCChH
Confidence 4322222 234699999887 579999999999999999998 68999995 67889898885543 334677888
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
.+.+++..||. +|.+||+...|...-+++
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999 899999999987655553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=292.95 Aligned_cols=240 Identities=22% Similarity=0.385 Sum_probs=202.8
Q ss_pred CcccccccCcEEEEEEEecCCC---eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG---~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
|||.|.|| .|++|..+..| ..||||.++..- .+.+...|..|..||-+.+||||+++-++. ...+.+.|
T Consensus 636 VIGaGEFG---EVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tks~PvMI 707 (996)
T KOG0196|consen 636 VIGAGEFG---EVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TKSKPVMI 707 (996)
T ss_pred EEeccccc---ceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ecCceeEE
Confidence 68999998 68888887666 569999998664 567788899999999999999999999954 55567999
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|+|||++|+|..||+++ +.|..-++..+++-|+.|+.||-..+ ++||||.+.|||+|.+ -.+|++|||+++.+...
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEeccccceeecccC
Confidence 99999999999999876 66888889999999999999999999 9999999999999855 58999999999987543
Q ss_pred C--CccccC---CCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 157 T--ARSVIG---TPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 157 ~--~~~~~G---Tp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
. .++..| ..+|.|||.+. .+++.++|||||||+|||.++ |+.||=+.. ..+.++.|..|...+. |..++..
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-NQdVIkaIe~gyRLPp-PmDCP~a 862 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVIKAIEQGYRLPP-PMDCPAA 862 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-hHHHHHHHHhccCCCC-CCCCcHH
Confidence 3 222222 45899999886 679999999999999999775 899998754 4566788888765432 4456788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.+|+..||+ |..+||...+|+.+
T Consensus 863 L~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999 89999999999874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=291.30 Aligned_cols=239 Identities=24% Similarity=0.372 Sum_probs=197.9
Q ss_pred cccccccCcEEEEEEEec----C---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCc
Q 006593 2 VLTGLYMTPFSSYKAFDE----F---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 73 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~----~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~ 73 (639)
||.|.|| .|++|.-. . ....||+|.++... ...+.+.+..|+.+|+.+ +|+||+.+.+.+.. ..
T Consensus 304 lg~g~fG---~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--~~ 375 (609)
T KOG0200|consen 304 LGEGAFG---QVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--DG 375 (609)
T ss_pred eeccccc---ceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--CC
Confidence 6788888 66666532 1 25789999887554 236778899999999999 69999999998765 46
Q ss_pred eEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC
Q 006593 74 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~ 137 (639)
.+++|+||+..|+|..|++..+ .++...+..++.||+.|++||++.. +|||||.+.|||+..
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITK 453 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecC
Confidence 7999999999999999998766 3888999999999999999999998 999999999999985
Q ss_pred CCCcEEEeecchhhhccCCCCcc---ccCC--CCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHH
Q 006593 138 NHGEVKIGDLGLAIAMQQPTARS---VIGT--PEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 210 (639)
Q Consensus 138 ~~g~VKL~DFGlA~~l~~~~~~~---~~GT--p~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~ 210 (639)
+ ..+||+|||+|+.......+. ..|+ ..|||||.+.. .|+.++||||||+++||++| |..||.+......++
T Consensus 454 ~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 N-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred C-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 4 589999999998654433222 2222 24999998875 69999999999999999998 689998866577778
Q ss_pred HHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 211 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 211 ~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+..|.... .|..+++++.+++..||+ +|.+||+..++..
T Consensus 533 ~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 8888886654 456668999999999999 8999999998865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=236.94 Aligned_cols=209 Identities=35% Similarity=0.583 Sum_probs=183.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|++| .||++.+..+|..+++|++...... ...+.+.+|++.++.+.|++|+++++++... ...++++|+
T Consensus 1 l~~g~~~---~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~ 72 (215)
T cd00180 1 LGEGGFG---TVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEY 72 (215)
T ss_pred CCcCCce---EEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEec
Confidence 6788887 8999999888999999998866431 1457799999999999999999999988655 568899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--C
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--A 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~ 158 (639)
+.+++|.+++... ..++...++.++.+++.+|.|||+.+ ++|+||+|.||+++...+.++|+|||.+....... .
T Consensus 73 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 73 CEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchh
Confidence 9999999999876 57899999999999999999999999 99999999999998525799999999997665543 3
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+...|++||.+.. .++.+.|+|+||+++++| ..+.+++.+
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~ 196 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRK 196 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHH
Confidence 44668899999998875 678899999999999999 689999999
Q ss_pred hcC-CCCCCCCHHHHhcCc
Q 006593 237 CLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hp 254 (639)
|+. +|.+||++.++++|+
T Consensus 197 ~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 197 MLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HhhCCcccCcCHHHHhhCC
Confidence 998 899999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=266.65 Aligned_cols=128 Identities=27% Similarity=0.340 Sum_probs=109.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-----C---CCcceEEEEEEeC--C
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----D---DNVVKFYKSWVDD--K 71 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-----H---pNIVkl~~~~~~~--~ 71 (639)
+.+.|-|-|+|||+|.|....+.||+|+++-.. ...+....||.+|+++. | ..||+|++.|... +
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhh-----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 456788999999999999999999999988543 45677889999999993 3 4699999999754 3
Q ss_pred CceEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe
Q 006593 72 KKTVNMITELFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136 (639)
Q Consensus 72 ~~~l~lV~Ey~~gGsL~d~lkk--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~ 136 (639)
..++|||+|++ |.+|..+|++ ++.++...++.|++|||.||.|||..- +|||-||||+|||+.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeee
Confidence 56899999999 5688888876 467999999999999999999999872 499999999999973
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-31 Score=262.69 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=197.8
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC---ceEEEEEec
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNMITEL 81 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~---~~l~lV~Ey 81 (639)
.|||.+|.||...|...|+.||.|.+. .+.++-...+++.+|+.+|...+|.||+...+...-.+- ..+|+|+|+
T Consensus 61 IGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred ccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 467777799999999999999999764 444555667899999999999999999998886543332 247889999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---C
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT---A 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~---~ 158 (639)
+.+ +|...+..-..++.+.++-+++||+.||.|||+.+ |+||||||.|+|++.+ -.+||||||+|+...... .
T Consensus 139 mQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 139 MQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEecccccccccchhhhhhh
Confidence 965 89998888888999999999999999999999999 9999999999999854 689999999998654332 2
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH----------------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---------------------- 214 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~---------------------- 214 (639)
...+-|.+|+|||++-+ .|+.++||||.||++.||+..+..|... +|.+....|+
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq-~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA-GPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc-ChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 23456889999997754 5999999999999999999999999763 4444333332
Q ss_pred --cCCCCCcccCC---C-----ChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 215 --SGIKPASLAKV---N-----DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 215 --~g~~p~~l~~~---~-----s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.+.+++.++.. . ..+...++.++|. +|.+|.+..+.+.|+++.....
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 12333333222 1 2356677788888 8999999999999999865443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=268.38 Aligned_cols=234 Identities=25% Similarity=0.394 Sum_probs=177.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC--CCCCcceEEEEEEeCC--CceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL--KDDNVVKFYKSWVDDK--KKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVkl~~~~~~~~--~~~l~ 76 (639)
+||+|.|| .||+|... ++.||||++... +.+.++.|-.|.+.. +|+||++|+++=.... ...++
T Consensus 217 li~~Grfg---~V~KaqL~--~~~VAVKifp~~-------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 217 LIGRGRFG---CVWKAQLD--NRLVAVKIFPEQ-------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred HhhcCccc---eeehhhcc--CceeEEEecCHH-------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 47888888 89999864 589999998754 345577777776654 8999999998532222 33799
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~-------gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
+||+|.+.|+|.+||+.+ .++.....+++..++.||+|||+- .|+|+|||||..||||. ++++.-|+||||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccce
Confidence 999999999999999875 489999999999999999999973 46899999999999997 668999999999
Q ss_pred hhhccCC----CCccccCCCCcCCcccccccCC-------ccccccchhhhhhhhhhccC------------CCC----C
Q 006593 150 AIAMQQP----TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTFEY------------PYS----E 202 (639)
Q Consensus 150 A~~l~~~----~~~~~~GTp~ymAPE~l~~~ys-------~ksDIwSlGiil~ELltG~~------------Pf~----~ 202 (639)
|..+... ....-+||.+|||||++++..+ .+.||||+|.++|||++... ||. .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9776522 2334689999999999986432 35899999999999998532 221 0
Q ss_pred CCCHHHHHHHHHcCCCCCcccC----CC-ChHHHHHHHHhcC-CCCCCCCHH
Q 006593 203 CKNPAQIFKKVTSGIKPASLAK----VN-DPQIKGFIEKCLV-PASERLSAK 248 (639)
Q Consensus 203 ~~~~~~i~~~i~~g~~p~~l~~----~~-s~~l~~LI~kcL~-dP~~RpSa~ 248 (639)
-...+++...+.+....+.++. .. -..+++.++.||. ||..|.||.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 1122334444444333333332 22 2458899999998 999999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=261.24 Aligned_cols=241 Identities=27% Similarity=0.451 Sum_probs=189.9
Q ss_pred cccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||.|.|+ +||+|.+.. ....||+|.+.... ...++..|+++|..+ .+.||+++.+.+..++ .+.+
T Consensus 44 igeGsFs---sv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd--~v~i 112 (418)
T KOG1167|consen 44 IGEGSFS---SVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFRNND--QVAI 112 (418)
T ss_pred ccccchh---hhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhccCC--eeEE
Confidence 5555555 899999988 88999999987654 345699999999999 6999999999886554 5899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc---
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--- 154 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--- 154 (639)
|+||++....+++... ++...++.+++.++.||.++|.+| ||||||||.|+|++...+.-.|.|||+|....
T Consensus 113 vlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9999999999998865 678999999999999999999999 99999999999999888899999999996210
Q ss_pred ------C-------C-C----------------C-------------ccccCCCCcCCccccc--ccCCccccccchhhh
Q 006593 155 ------Q-------P-T----------------A-------------RSVIGTPEFMAPELYE--EEYNELVDIYSFGMC 189 (639)
Q Consensus 155 ------~-------~-~----------------~-------------~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGii 189 (639)
. + . . ....|||+|+|||++- +.-++++||||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 0 0 0 0124999999999875 457889999999999
Q ss_pred hhhhhhccCCCCCCCCH----HHHHH--------HH--HcCC-----------------------------------CCC
Q 006593 190 ILEMVTFEYPYSECKNP----AQIFK--------KV--TSGI-----------------------------------KPA 220 (639)
Q Consensus 190 l~ELltG~~Pf~~~~~~----~~i~~--------~i--~~g~-----------------------------------~p~ 220 (639)
++-++++.+||....+. .++.- +. ..|. .+.
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999999543322 22210 00 0011 011
Q ss_pred cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 221 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 221 ~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
......+..+.+|+.+||. +|.+|.||++.|+||||..
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 1122334578999999998 9999999999999999983
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=274.19 Aligned_cols=238 Identities=26% Similarity=0.392 Sum_probs=196.3
Q ss_pred CcccccccCcEEEEEEEecCCC----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||.|+|| +||+|.+-..| .+||||++.... .+.....+..|.-+|.+|+|||++++++++.... +-
T Consensus 703 vLGsgAfG---tV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~q 773 (1177)
T KOG1025|consen 703 VLGSGAFG---TVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLST---LQ 773 (1177)
T ss_pred eeccccce---eEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---HH
Confidence 47777777 89999986665 468888766443 4455677999999999999999999999876543 77
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
||++|+++|+|.+|++.+ .++-.+....|+.||++|+.|||.+. ++||||-..|+|+... ..|||.|||+|+.+..
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP-~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSP-NHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCC-CeEEEEecchhhccCc
Confidence 999999999999999876 46889999999999999999999998 9999999999999754 5899999999987753
Q ss_pred CC-C---ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PT-A---RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~-~---~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. . ....-.+-|||-|.+. ..|+.++|||||||++||++| |..||.+ ...+++-+.+..|.. ...+...+.+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiD 928 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTID 928 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHH
Confidence 32 1 1222356789999776 569999999999999999998 7899987 456667666666655 5567778889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.-++.+||. |+..||++++|-.
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHH
Confidence 9999999998 9999999988854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=257.54 Aligned_cols=237 Identities=26% Similarity=0.453 Sum_probs=177.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC--CCCCcceEEEEEEeCC--CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL--KDDNVVKFYKSWVDDK--KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVkl~~~~~~~~--~~~l~l 77 (639)
||+|-|| .||+|.+ .|+.||||++.-.+ .....+|.++.... +|+||+.|+++=.... -..+|+
T Consensus 219 IGkGRyG---EVwrG~w--rGe~VAVKiF~srd-------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 219 IGKGRFG---EVWRGRW--RGEDVAVKIFSSRD-------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred ecCcccc---ceeeccc--cCCceEEEEecccc-------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 6677666 7999986 48899999987443 35577888887665 9999999998533222 135899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~------gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
|++|.+.|||.|||++ ..++.....+++..++.||++||.. .|.|.|||||..|||+. ++|..-|+|+|||.
T Consensus 287 vTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEeeceeeE
Confidence 9999999999999998 6689999999999999999999963 47899999999999997 56899999999996
Q ss_pred hccCC------CCccccCCCCcCCcccccccCC-------ccccccchhhhhhhhhhc----------cCCCCCC----C
Q 006593 152 AMQQP------TARSVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEMVTF----------EYPYSEC----K 204 (639)
Q Consensus 152 ~l~~~------~~~~~~GTp~ymAPE~l~~~ys-------~ksDIwSlGiil~ELltG----------~~Pf~~~----~ 204 (639)
..... .....+||.+|||||++.+..+ ..+||||||.++||++.. .+||.+. .
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 55433 2345689999999999975422 358999999999999752 4788542 2
Q ss_pred CHHHHHHHHHcCCCCCcccCC--CChH---HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 205 NPAQIFKKVTSGIKPASLAKV--NDPQ---IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 205 ~~~~i~~~i~~g~~p~~l~~~--~s~~---l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+++.+.+=-....+.++.. .++. +-++++.||. +|.-|.||--+.+
T Consensus 445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 334444333222222222222 2343 5567899998 8999999866543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=268.10 Aligned_cols=193 Identities=27% Similarity=0.399 Sum_probs=171.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh----hhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCCce
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP----GDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~----~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~~~ 74 (639)
||.|+|| .|++|.+++...+|+||.+.++++.... ..+-.+-.||+||..|+ |+||+|++++|.++ ++
T Consensus 569 lG~GAyG---kV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd--d~ 643 (772)
T KOG1152|consen 569 LGEGAYG---KVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD--DY 643 (772)
T ss_pred ccccccc---eEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC--Ce
Confidence 6888888 8999999999999999999987764211 22345778999999997 99999999999665 57
Q ss_pred EEEEEecC-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 75 VNMITELF-TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 75 l~lV~Ey~-~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
+|++||-. +|-+|++|+..++.++|..++.|++||+.|+++||++| |||||||-+|+.++++ |.+||+|||.|...
T Consensus 644 yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSAAYT 720 (772)
T ss_pred eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccchhhh
Confidence 99999976 56799999999999999999999999999999999999 9999999999999855 89999999999988
Q ss_pred cCCCCccccCCCCcCCccccccc-C-CccccccchhhhhhhhhhccCCCCC
Q 006593 154 QQPTARSVIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSE 202 (639)
Q Consensus 154 ~~~~~~~~~GTp~ymAPE~l~~~-y-s~ksDIwSlGiil~ELltG~~Pf~~ 202 (639)
.......+.||..|.|||++.+. | +..-|||++|+++|.++..+-||..
T Consensus 721 ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 88777889999999999999864 5 6778999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=231.81 Aligned_cols=206 Identities=32% Similarity=0.488 Sum_probs=175.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||.|++| +||+|.+..++..+|+|.+...... ...+.+.+|++.++.++|+|++++++++... ...++++|+
T Consensus 7 i~~g~~~---~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (225)
T smart00221 7 LGEGAFG---KVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVMEY 78 (225)
T ss_pred eecCCCe---EEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEEec
Confidence 6778877 8999999988999999998865421 3567899999999999999999999987655 458899999
Q ss_pred CCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---C
Q 006593 82 FTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~-l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~ 157 (639)
+.+++|.+++..... +++..++.++.|++.+|.|||+++ ++|+||+|.||+++.+ +.++|+|||++...... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCccccc
Confidence 999999999988776 899999999999999999999998 9999999999999844 79999999998766543 2
Q ss_pred CccccCCCCcCCcccc-c-ccCCccccccchhhhhhhhhhccCCCCC-CCCHHHHHHHHHcCCC
Q 006593 158 ARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTFEYPYSE-CKNPAQIFKKVTSGIK 218 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l-~-~~ys~ksDIwSlGiil~ELltG~~Pf~~-~~~~~~i~~~i~~g~~ 218 (639)
.....++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. ..+...+.+.+..+..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 3446788999999987 3 3477899999999999999999999976 4555577777777653
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=287.10 Aligned_cols=200 Identities=20% Similarity=0.228 Sum_probs=148.2
Q ss_pred HhCCC-CCcceEEEEEEeC-----CCceEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeee
Q 006593 53 KSLKD-DNVVKFYKSWVDD-----KKKTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 125 (639)
Q Consensus 53 k~L~H-pNIVkl~~~~~~~-----~~~~l~lV~Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIH 125 (639)
+.+.| +||++++++|... ....+++++|++ +++|.+++.. ...+++..++.+++||+.||.|||++| |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvH 103 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVV 103 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eee
Confidence 34455 5888888876211 123577888987 6699999975 356999999999999999999999999 999
Q ss_pred eccCCCcEEEeC------------------CCCcEEEeecchhhhccCC------------------CCccccCCCCcCC
Q 006593 126 RDLKCDNIFVNG------------------NHGEVKIGDLGLAIAMQQP------------------TARSVIGTPEFMA 169 (639)
Q Consensus 126 RDLKp~NILl~~------------------~~g~VKL~DFGlA~~l~~~------------------~~~~~~GTp~ymA 169 (639)
|||||+||||+. ..+.+||+|||+++..... .....+||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999952 2346777788877532110 0012468999999
Q ss_pred ccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCH
Q 006593 170 PELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSA 247 (639)
Q Consensus 170 PE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa 247 (639)
||++. ..|+.++|||||||++|||++|.+|+.. ....+..+.....+.... ...+....++.+||. +|.+||++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE---KSRTMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh---HHHHHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 99875 5699999999999999999999888753 222223333222222211 124567899999999 89999999
Q ss_pred HHHhcCcccccc
Q 006593 248 KDLLKDPFLQVE 259 (639)
Q Consensus 248 ~ELL~Hpff~~~ 259 (639)
.|+|+||||...
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 999999999753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=225.48 Aligned_cols=160 Identities=24% Similarity=0.339 Sum_probs=128.3
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccccC
Q 006593 85 GNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 163 (639)
Q Consensus 85 GsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~G 163 (639)
|+|.+++..+ +.+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeeccc---cCCC
Confidence 7999999874 56999999999999999999999987 99999997 5578998 9998765432 2368
Q ss_pred CCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-----ccCCCCh--HHHHHHH
Q 006593 164 TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-----LAKVNDP--QIKGFIE 235 (639)
Q Consensus 164 Tp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-----l~~~~s~--~l~~LI~ 235 (639)
|+.|||||++.+ .|+.++|||||||++|||+||+.||.........+..+..+..+.. .....+. .+++||.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999998864 5899999999999999999999999765444444544444333221 1111222 6999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
+||. +|.+||++.|++.|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 9999 8999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-23 Score=207.65 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=197.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD-NVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp-NIVkl~~~~~~~~~~~l~lV~E 80 (639)
||.|+|| .||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +|+++++.+... ...+++++
T Consensus 8 l~~g~~~---~v~~~~~~---~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~ 78 (384)
T COG0515 8 LGEGSFG---EVYLARDR---KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYLVME 78 (384)
T ss_pred ecCCCCe---EEEEEEec---cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEEEEe
Confidence 5666665 89999987 779999988765422 13577899999999999988 799999998444 34789999
Q ss_pred cCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 81 LFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~---~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
++.++++.+++.... .+.+..+..++.|++.++.|+|+.+ ++|||+||+||+++.....++++|||++..+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999998888765 7999999999999999999999999 9999999999999854337999999999755432
Q ss_pred -------CCccccCCCCcCCcccccc----cCCccccccchhhhhhhhhhccCCCCCCCC---HHHHHHHHHcCCCC-Cc
Q 006593 157 -------TARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKP-AS 221 (639)
Q Consensus 157 -------~~~~~~GTp~ymAPE~l~~----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~p-~~ 221 (639)
......||+.|+|||.+.. .+....|+||+|++++++++|..||..... ..+....+.....+ ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 2356789999999998864 578899999999999999999999876543 45555555544433 11
Q ss_pred ccCCC------ChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 222 LAKVN------DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 222 l~~~~------s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
..... ...+.+++.+|+. +|..|.+..+...++|.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 11111 1478999999998 899999999999987665433
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=221.90 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=180.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|-|| .+-+|.|+.++.++|+|-+.... .-...|++|.+.=-.| .|.||+.-|+.-... .++++|++|
T Consensus 32 lgeG~Fg---kIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF~qE 102 (378)
T KOG1345|consen 32 LGEGRFG---KILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVFVQE 102 (378)
T ss_pred hccccee---eEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEEeec
Confidence 5555555 89999999999999999988654 3456789999877667 699999888754333 357889999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe-CCCCcEEEeecchhhhccCCCCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~-~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|++-|+|+.-+.. ..+-|..-+.++.|+++||.|+|+.+ ++|||||.+||||- .+...|||||||+.+..... ..
T Consensus 103 ~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-V~ 178 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-VK 178 (378)
T ss_pred cCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce-eh
Confidence 9999999987665 45888999999999999999999999 99999999999994 45568999999987543322 12
Q ss_pred cccCCCCcCCccccc----cc--CCccccccchhhhhhhhhhccCCCCCCCCHHH---HHHHHHcCCCC--CcccCCCCh
Q 006593 160 SVIGTPEFMAPELYE----EE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGIKP--ASLAKVNDP 228 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~----~~--ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~---i~~~i~~g~~p--~~l~~~~s~ 228 (639)
...-+..|.|||+.. +. .++..|||.||+++|.++||.+||........ -+.+...+.-+ +......++
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~ 258 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSE 258 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCH
Confidence 223466789999664 22 57889999999999999999999974322211 12222333222 222234467
Q ss_pred HHHHHHHHhcC-CCCCC---CCHHHHhcCccc
Q 006593 229 QIKGFIEKCLV-PASER---LSAKDLLKDPFL 256 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~R---pSa~ELL~Hpff 256 (639)
.+..+.++-|. ++.+| .+++...+.-|.
T Consensus 259 ~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 259 KALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 78888888888 68877 566666666665
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=222.16 Aligned_cols=237 Identities=21% Similarity=0.287 Sum_probs=191.9
Q ss_pred ccccccCcEEEEEEEecCCC-----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 3 LTGLYMTPFSSYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 3 G~GGfG~v~tVykA~d~~tG-----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
-+|-|| .||+|.+.++. +.|-+|.++... ++-+...+..|--+|..+.|||+..+.++.+.+. ...+.
T Consensus 293 qEGtFG---ri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-~~P~V 365 (563)
T KOG1024|consen 293 QEGTFG---RIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-ATPFV 365 (563)
T ss_pred hcCchh---heeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-CcceE
Confidence 345555 89999765443 345666665432 5677888999999999999999999999877644 45678
Q ss_pred EEecCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 78 ITELFTSGNLRQYRKKH--------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~--------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
++.+..-|+|+.|+... ..+....+..++.||..|++|||+++ |||.||...|.+|+ +.-.|||+|=.+
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltDsaL 442 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTDSAL 442 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEeccchh
Confidence 89999999999999832 23666677889999999999999999 99999999999998 456999999999
Q ss_pred hhhccCCCCcccc-----CCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 150 AIAMQQPTARSVI-----GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 150 A~~l~~~~~~~~~-----GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
++.+.... +.+. ....||+||.+. ..|+.++|+||||+++|||+| |+.||.+ -+|.++...+..|.... .
T Consensus 443 SRDLFP~D-YhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRla-Q 519 (563)
T KOG1024|consen 443 SRDLFPGD-YHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRLA-Q 519 (563)
T ss_pred ccccCccc-ccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhccceec-C
Confidence 88765432 2222 345799999776 569999999999999999998 7999988 57889988888886543 4
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
|..++.++..++.-||. .|.+||+..||..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 55677899999999999 9999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=245.70 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=188.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecc--cccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKID--DVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~--~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
++|.|.+| .|+.+.........++|.++.. ...........+..|+-+=..|.|||++.....+.+.. .++-+
T Consensus 325 ~~g~ga~g---~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~~ 399 (601)
T KOG0590|consen 325 VLGSGAYG---SVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQS 399 (601)
T ss_pred eeeecccC---ceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchhh
Confidence 46888888 4555555555555666665432 11111222333778888889999999877666544332 24445
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
||||++ +|..++...+.+....+..+++||+.|+.|||++| |.|||||++|++++ ..|.+||+|||.+.....+.
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceeeccCcc
Confidence 999999 99999998888999999999999999999999999 99999999999998 55799999999997665432
Q ss_pred -----CccccCCCCcCCcccccc-cCCc-cccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc------CCCCCcccC
Q 006593 158 -----ARSVIGTPEFMAPELYEE-EYNE-LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------GIKPASLAK 224 (639)
Q Consensus 158 -----~~~~~GTp~ymAPE~l~~-~ys~-ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~------g~~p~~l~~ 224 (639)
....+|+..|+|||++.+ .|++ .+||||.|+++..|++|++||.-.....+.+..... ...+..+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 345789999999998875 4764 599999999999999999999643322222111110 111223334
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 225 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 225 ~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
......+.+|.+||+ +|.+|.|+++|++++||+....
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 445678999999999 9999999999999999986554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-25 Score=226.12 Aligned_cols=241 Identities=34% Similarity=0.559 Sum_probs=187.0
Q ss_pred EEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---CceEEEEEecCCCCCHH
Q 006593 12 SSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVNMITELFTSGNLR 88 (639)
Q Consensus 12 tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~---~~~l~lV~Ey~~gGsL~ 88 (639)
.||+|.|..+|.+|+|+.++....+....+.++...-+..|-++.|.|||+|+.||-+.. ..++.|++||++.|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 489999999999999999998887777777788888888999999999999999996643 34788999999999999
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh------ccCCCC
Q 006593 89 QYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA------MQQPTA 158 (639)
Q Consensus 89 d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~------l~~~~~ 158 (639)
++|++ ++.+..+.+++|+.||+.||.|||++.|||+|+++.|+.||+. .+|.|||+.--.... .+....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhh
Confidence 99986 3568999999999999999999999999999999999999998 678999875322110 011111
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
....+-++|.|||.-. .+.+.++|||+||+|+++|..|+..-.........-..+.+ ......++.-+++|.+|
T Consensus 240 ~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~-----~i~~len~lqr~~i~kc 314 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN-----VIIGLENGLQRGSITKC 314 (458)
T ss_pred hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh-----heeeccCccccCcCccc
Confidence 1234678899999655 34677899999999999999998654332221111111111 11222345568899999
Q ss_pred cC-CCCCCCCHHHHhcCccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~ 258 (639)
|. .|..||+++++|.||.+-.
T Consensus 315 l~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 315 LEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccCCCCCCcchhhhhcCceeee
Confidence 99 7999999999999998743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=238.37 Aligned_cols=245 Identities=21% Similarity=0.267 Sum_probs=208.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
++|+|.||.+..|-++.-...|..+|.|+.+.......... .-..|..++..++ ||.+|+++..|..+.+ +++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~k--l~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGK--LYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccc--hhHhh
Confidence 58999999998888888888999999999887665443222 5677888999996 9999999999877665 78899
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
++..||.|...+.+...+.+...+.+...++.|++.+|+.+ |+|||+|++||+++. .|.+++.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~-~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecc-cCccccCCchhhhHhHhhhhc
Confidence 99999999999998889999999999999999999999999 999999999999984 589999999999876544333
Q ss_pred cccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 160 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
|||..|||||+.. .+...+|+||||++++||+||..||.. ++...|.... ...+...++.+++++..++.
T Consensus 154 --cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHh
Confidence 9999999999998 678899999999999999999999976 4455554422 22455567889999999998
Q ss_pred -CCCCCCC-----HHHHhcCcccccccCC
Q 006593 240 -PASERLS-----AKDLLKDPFLQVENQK 262 (639)
Q Consensus 240 -dP~~RpS-----a~ELL~Hpff~~~~~~ 262 (639)
+|..|.. +.|+++|+||+...|.
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeHh
Confidence 8988875 5899999999988776
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=212.42 Aligned_cols=165 Identities=18% Similarity=0.204 Sum_probs=124.6
Q ss_pred CcccccccCcEEEEEEEecC-CCeEEEEEEEecccc-cCChhhHHHHHHHHHHHHhCCCCCcce-EEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-AGIEVAWSRVKIDDV-LQLPGDLQKLYSEVHLLKSLKDDNVVK-FYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-tG~~VAIK~v~~~~~-~~~~~~~~~l~~Ei~iLk~L~HpNIVk-l~~~~~~~~~~~l~l 77 (639)
+||+|+|| +||+|.+.. +|..||+|++..... .......+.+.+|+++|++|+|+||+. +++. ...|+
T Consensus 25 ~IG~G~fg---~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------~~~~L 95 (365)
T PRK09188 25 VLKRDVFS---TVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------GKDGL 95 (365)
T ss_pred EEeecCcE---EEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------CCcEE
Confidence 37888888 899999876 688889998652210 012334667999999999999999985 5431 23789
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeecc-CCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL-KCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDL-Kp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.|++|... .. .. ...|+.|++.||.|||++| |+|||| ||+|||++ ..+.+||+|||+|+.+...
T Consensus 96 VmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 96 VRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccceecccC
Confidence 9999999999732 11 11 1468899999999999999 999999 99999997 4579999999999865432
Q ss_pred C----------CccccCCCCcCCccccccc-------CCcccccc
Q 006593 157 T----------ARSVIGTPEFMAPELYEEE-------YNELVDIY 184 (639)
Q Consensus 157 ~----------~~~~~GTp~ymAPE~l~~~-------ys~ksDIw 184 (639)
. ....++++.|+|||.+... .+...|-|
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 2 1345789999999998632 33446766
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-20 Score=200.15 Aligned_cols=242 Identities=19% Similarity=0.187 Sum_probs=178.6
Q ss_pred CcccccccCcEEEEEEEecCCC-eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC----CCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD----DNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG-~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H----pNIVkl~~~~~~~~~~~l 75 (639)
.||+|||| .||++.+..++ ..+|+|......... ...+..|+.+|+.+.. +++.++++... ....+-
T Consensus 25 ~iG~G~fG---~V~~v~~~~~~~~~~a~K~e~~~~~~~----~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~ 96 (322)
T KOG1164|consen 25 KIGEGGFG---AVYLVSDKSEKNKEYAKKLEKKELGSK----PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFN 96 (322)
T ss_pred eccccCCc---eEEEEEecCCCCeeEEEEEEEecccCC----CccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCcee
Confidence 37888888 89999998775 789999877653211 1157889999999973 68899988664 344578
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC----CcEEEeecch
Q 006593 76 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH----GEVKIGDLGL 149 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~----g~VKL~DFGl 149 (639)
|+||+++ |-+|.++.+.. +.++..++..++.|++.+|++||+.| ++||||||+|+++.... ..+.|.|||+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 8999999 67999998765 47999999999999999999999999 99999999999995332 3699999999
Q ss_pred hh--hcc-CC------C---CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHH--HHHHHH
Q 006593 150 AI--AMQ-QP------T---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ--IFKKVT 214 (639)
Q Consensus 150 A~--~l~-~~------~---~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~--i~~~i~ 214 (639)
++ ... .. . ...+.||..|+++.+..+ ..+++.|+||++.++.+|..|.+||........ .++...
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 321 11 1 123569999999998765 588999999999999999999999976543322 222222
Q ss_pred cCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 215 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 215 ~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..............++..+...+-. +...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2211111223334556666665555 67778887666554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=182.30 Aligned_cols=142 Identities=17% Similarity=0.141 Sum_probs=108.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChh----------------------hHHHHHHHHHHHHhCCCCC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPG----------------------DLQKLYSEVHLLKSLKDDN 59 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~----------------------~~~~l~~Ei~iLk~L~HpN 59 (639)
||+|++| .||+|.+. +|+.||+|+++......... .......|+++|.+|.+++
T Consensus 5 ig~G~~~---~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 5 ISTGKEA---NVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred cccccce---EEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 5666666 89999997 89999999998653211000 0123346999999998887
Q ss_pred cceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeeccCCCcEEEeCC
Q 006593 60 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGN 138 (639)
Q Consensus 60 IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yL-Hs~gppIIHRDLKp~NILl~~~ 138 (639)
+...+.... . . .+|||||++|+++...+.+.+.+++..+..++.||+.+|.|| |+.| |+||||||+|||++ +
T Consensus 81 v~~p~~~~~-~-~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL-K-S--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe-c-C--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence 754433221 1 1 379999999988876655567899999999999999999999 7999 99999999999997 3
Q ss_pred CCcEEEeecchhhhccC
Q 006593 139 HGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~~ 155 (639)
+.++|+|||+|.....
T Consensus 154 -~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 154 -GKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CcEEEEEccccccCCC
Confidence 6899999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=216.65 Aligned_cols=210 Identities=26% Similarity=0.430 Sum_probs=162.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
|-.|+|| .||..+|+.+.+++|+| +++.++ +.+- +|.....|.+|
T Consensus 91 isngAyg---avylvrh~~trqrfa~k-iNkq~l---------ilRn--ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 91 ISNGAYG---AVYLVRHKETRQRFAMK-INKQNL---------ILRN--ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred eccCCCC---ceeeeeccccccchhhc-ccccch---------hhhc--cccccCCccee--------------------
Confidence 3456666 79999999999999984 443322 1111 33333333333
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC------
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ------ 155 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~------ 155 (639)
|+-...++.-+.++... +.+++|||+.| |+|||+||+|.+|+ ..|.+|+.|||+++..-.
T Consensus 136 ---gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ---chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhccchh
Confidence 67777788777777665 78899999999 99999999999998 679999999999853210
Q ss_pred -----------CCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC--CCCc
Q 006593 156 -----------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPAS 221 (639)
Q Consensus 156 -----------~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~--~p~~ 221 (639)
-..+.+||||.|.|||++. ++|+..+|+|++|+|+||.+.|..||.+ +.+++++..+.... .+..
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcccccc
Confidence 0123579999999999765 6799999999999999999999999988 67888888876532 3333
Q ss_pred ccCCCChHHHHHHHHhcC-CCCCCC---CHHHHhcCcccccccCC
Q 006593 222 LAKVNDPQIKGFIEKCLV-PASERL---SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 222 l~~~~s~~l~~LI~kcL~-dP~~Rp---Sa~ELL~Hpff~~~~~~ 262 (639)
.....++++++|..+|+ +|..|. .+-++.+|+||+.-.|+
T Consensus 281 -dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 -DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred -CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 44456899999999998 788885 58899999999988887
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=176.62 Aligned_cols=142 Identities=19% Similarity=0.150 Sum_probs=109.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC----------------------hhhHHHHHHHHHHHHhCCCCC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL----------------------PGDLQKLYSEVHLLKSLKDDN 59 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~----------------------~~~~~~l~~Ei~iLk~L~HpN 59 (639)
||+|++| .||+|.+. +|+.||+|+++....... ......+..|+..+.++.|++
T Consensus 5 ig~G~~~---~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 5 ISTGKEA---NVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred eecCCCc---EEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 5666666 89999987 899999999986531100 001233568999999999998
Q ss_pred cceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCC
Q 006593 60 VVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGN 138 (639)
Q Consensus 60 IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~ 138 (639)
|.....++... .+|||||++|+++.........++...+..++.|++.+|.+||. .| |+||||||+||+++
T Consensus 81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 85544433322 37999999988655443344668889999999999999999999 89 99999999999997
Q ss_pred CCcEEEeecchhhhccC
Q 006593 139 HGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~~ 155 (639)
.+.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 47899999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-20 Score=212.67 Aligned_cols=235 Identities=20% Similarity=0.251 Sum_probs=172.7
Q ss_pred cccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCC
Q 006593 6 LYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSG 85 (639)
Q Consensus 6 GfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gG 85 (639)
|-+.|-+|.+|+|. +|. |+||++-+.+-.-+-....+...|++ .+.++|||++.|...-+ ..+..|||-+|+..
T Consensus 32 GstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~--t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 32 GSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV--TDKAAYLVRQYVKH- 105 (1431)
T ss_pred CchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH--hhHHHHHHHHHHhh-
Confidence 44555588999984 466 88999876653333334444455555 66679999999987533 33567889999976
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh--cc--CCCCc--
Q 006593 86 NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA--MQ--QPTAR-- 159 (639)
Q Consensus 86 sL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~--l~--~~~~~-- 159 (639)
+|.|-+..++-+..-+.+.|+.||+.||..+|..| |+|+|||.+||||+ ....+.|+||...+- +. ++...
T Consensus 106 nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeDNPadf~f 182 (1431)
T KOG1240|consen 106 NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPEDNPADFTF 182 (1431)
T ss_pred hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCCCCcccceE
Confidence 99999988888888889999999999999999999 99999999999998 556899999975532 11 11111
Q ss_pred ---cccCCCCcCCcccccc-----------c-CCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCC-C-CCc
Q 006593 160 ---SVIGTPEFMAPELYEE-----------E-YNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI-K-PAS 221 (639)
Q Consensus 160 ---~~~GTp~ymAPE~l~~-----------~-ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~-~-p~~ 221 (639)
+-..--+|.|||.+.. . .+++.||||+||+++||++ |.+||. ..|++..-..+. . ...
T Consensus 183 FFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 183 FFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred EEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCccCHHHH
Confidence 1123458999997632 1 4678999999999999988 577773 344443322211 1 122
Q ss_pred ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 222 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 222 l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+....+..++.+|..|++ ||++|.+|++.|+-
T Consensus 259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 345567789999999999 99999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=174.49 Aligned_cols=135 Identities=18% Similarity=0.157 Sum_probs=106.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCCC-ce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-----KDDNVVKFYKSWVDDKK-KT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-----~HpNIVkl~~~~~~~~~-~~ 74 (639)
+||+|+|| .||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++|+++..+.. ..
T Consensus 9 ~LG~G~~~---~Vy~--hp~~~~k-~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 9 PLGTGRHR---KCYA--HPEDAQR-CIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred eecCCCce---EEEE--CCCCcCe-EEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 48888888 7885 7777766 6998876532 2446789999999999 67999999999877542 34
Q ss_pred -EEEEEec--CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeeeeccCCCcEEEeC---CCCcEEEeec
Q 006593 75 -VNMITEL--FTSGNLRQYRKKHKNVDIKVIKNWARQILHGL-VYLHSHNPPIIHRDLKCDNIFVNG---NHGEVKIGDL 147 (639)
Q Consensus 75 -l~lV~Ey--~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL-~yLHs~gppIIHRDLKp~NILl~~---~~g~VKL~DF 147 (639)
+.+|+|| +.+|+|.+++++. .+++. ..+++|++.++ +|||+++ |+||||||+|||++. ..+.++|+||
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 3478999 5589999999764 46666 46788999888 9999999 999999999999973 2247999995
Q ss_pred chh
Q 006593 148 GLA 150 (639)
Q Consensus 148 GlA 150 (639)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.7e-19 Score=179.59 Aligned_cols=167 Identities=14% Similarity=0.094 Sum_probs=125.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHH------HHHHHHHHHhCCCCCcceEEEEEEeCCC--
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK------LYSEVHLLKSLKDDNVVKFYKSWVDDKK-- 72 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~------l~~Ei~iLk~L~HpNIVkl~~~~~~~~~-- 72 (639)
+||.|||| .||++.+ ++..+|+|+++... ...+...++ +.+|++.+.+|.||+|..+.+++.+...
T Consensus 38 ~l~~~~f~---~v~l~~~--~~~~~iiKvf~~~~-~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 38 VFRNIDDT---KVSLIDT--DYGKYILKVFAPKV-KRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred EecCCCce---EEEEEec--CCCcEEEEEechhc-CchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 47888888 7888655 46689999987443 233344444 5799999999999999999998776532
Q ss_pred ----ceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 73 ----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 73 ----~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
...++||||++|.+|.++.. +++ ....+|+.+|..||..| ++|||+||+||+++ ++| ++|+|||
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g-i~liDfg 179 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG-LRIIDLS 179 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-EEEEECC
Confidence 24789999999999988732 333 24669999999999999 99999999999998 456 9999999
Q ss_pred hhhhccCCCCccccCCCCcCCcccccccCCccccccchhhhhhhhh
Q 006593 149 LAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMV 194 (639)
Q Consensus 149 lA~~l~~~~~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELl 194 (639)
............. =++...|+.++|||+||+.+....
T Consensus 180 ~~~~~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 8754432211100 022345788999999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=173.61 Aligned_cols=231 Identities=19% Similarity=0.254 Sum_probs=173.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||.|+|| .+|.|.....|.+||||.-..... --.+..|..+.+.|++ ..|..++.+. ..+.+-.+||+
T Consensus 23 iGsGSFG---dIy~~~~i~~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvlVMd 91 (341)
T KOG1163|consen 23 IGSGSFG---DIYLGISITSGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVLVMD 91 (341)
T ss_pred ecCCchh---heeeeeeccCCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhc--cccccceeeee
Confidence 5666666 899999999999999997553321 1237789999999965 5665555543 33456779999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe--CCCCcEEEeecchhhhccCCC
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~--~~~g~VKL~DFGlA~~l~~~~ 157 (639)
++ |-+|.+++.- ...++.+++.-++-|++.-++|+|.++ +|||||||+|+|.- .....+.|+|||+|+......
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 99 6799998874 467999999999999999999999999 99999999999982 233469999999998764321
Q ss_pred ---------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC--CHHHHHHHHHcC---CCCCcc
Q 006593 158 ---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSG---IKPASL 222 (639)
Q Consensus 158 ---------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~--~~~~i~~~i~~g---~~p~~l 222 (639)
.+...||..|.+--..-+ .-+.+.|+-|+|.++..+.-|.+||.+.. +..|.+.+|... ..+..+
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~L 248 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVL 248 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHH
Confidence 234568999987654433 35778999999999999999999998743 345666666543 334456
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLS 246 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpS 246 (639)
....+.++.-.+.-|-. --.+-|.
T Consensus 249 C~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 249 CKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred hCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 66677888888888865 3334444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=178.31 Aligned_cols=201 Identities=18% Similarity=0.292 Sum_probs=161.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||.|.|| ..+.|.+..+++.||||.-... .+.-.+..|.+..+.| ..++|..+|.+- ....+-.+|+|
T Consensus 36 IGeGsFG---~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVid 104 (449)
T KOG1165|consen 36 IGEGSFG---VLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVID 104 (449)
T ss_pred cccCcce---eeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhh
Confidence 6777777 7999999999999999964432 2334578899999999 579999988643 33456679999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe----CCCCcEEEeecchhhhccC
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN----GNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~----~~~g~VKL~DFGlA~~l~~ 155 (639)
++ |-+|.|+..-. ..|+.+++.-++.|++.-++|+|++. +|.|||||+|+||- .+...|.|+|||+|+....
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 99 67999998854 57999999999999999999999999 99999999999993 2334699999999998765
Q ss_pred CCC---------ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCC--CCHHHHHHHHHcC
Q 006593 156 PTA---------RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSG 216 (639)
Q Consensus 156 ~~~---------~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~--~~~~~i~~~i~~g 216 (639)
+.. ++.-||.+||+--..- ..-+++-|+-|||-++++.+-|.+||.+. .+..+.+++|-..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 532 3456999999977443 34788899999999999999999999874 3445667777543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=171.96 Aligned_cols=181 Identities=13% Similarity=0.050 Sum_probs=134.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||.|+|| +||.+.. .+..++.+.+.........-....+.+|+++|++|. |++|++++++ ...+++|
T Consensus 9 ~l~~~~f~---~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 9 PLKSDTFG---RILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred eecCCCcc---eEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 47889999 6776655 577788777665543222223346889999999995 5889999884 2368999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeecc-CCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL-KCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDL-Kp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
||+.|.+|.+.+.. . ...++.|++.+|.++|++| |+|||| ||.|||++ .+|.++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999999764321 1 1357899999999999999 999999 79999997 557999999999974432220
Q ss_pred ---------------ccccCCCCcCCccccc--ccCC-ccccccchhhhhhhhhhccCCCCC
Q 006593 159 ---------------RSVIGTPEFMAPELYE--EEYN-ELVDIYSFGMCILEMVTFEYPYSE 202 (639)
Q Consensus 159 ---------------~~~~GTp~ymAPE~l~--~~ys-~ksDIwSlGiil~ELltG~~Pf~~ 202 (639)
.....+|.|+.|+.-. ...+ ...++++.|+-+|.++|+..|+-+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0123688888887432 2233 567889999999999999988643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=182.15 Aligned_cols=228 Identities=15% Similarity=0.164 Sum_probs=144.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC----------CCcceEEEEEEeC
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD----------DNVVKFYKSWVDD 70 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H----------pNIVkl~~~~~~~ 70 (639)
+||.|+++ .||.+.|..||+++|+|++.... .......+.+.+|.-....+.+ -.++.-++.....
T Consensus 19 ~i~~g~~~---~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 19 IIGKGGFS---IVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEETTE---EEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred ccccCCce---EEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 36777777 89999999999999999998877 4445677888888766655432 1222222221111
Q ss_pred ----------CCc-----eEEEEEecCCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCeeeecc
Q 006593 71 ----------KKK-----TVNMITELFTSGNLRQYRKK---HKN----VDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128 (639)
Q Consensus 71 ----------~~~-----~l~lV~Ey~~gGsL~d~lkk---~~~----l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDL 128 (639)
+.. ..+++|+-+ .++|.+++.- ... +...+...+..|+++.+++||++| ++|+||
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi 171 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDI 171 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEeccc
Confidence 111 136788888 4699888652 222 222333455689999999999999 999999
Q ss_pred CCCcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCcCCcccccc---------cCCccccccchhhhhhhhhhccCC
Q 006593 129 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE---------EYNELVDIYSFGMCILEMVTFEYP 199 (639)
Q Consensus 129 Kp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~---------~ys~ksDIwSlGiil~ELltG~~P 199 (639)
+|+|+|++ .+|.++|+||+........... ...+..|.+||+... .++.+.|.|+||+++|.|+++..|
T Consensus 172 ~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 172 KPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred ceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 99999998 5589999999876443322111 344678999997643 378899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCC
Q 006593 200 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASER 244 (639)
Q Consensus 200 f~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~R 244 (639)
|.... +...... ........+..++.||..+|+ +|.+|
T Consensus 250 f~~~~-~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 250 FGLSS-PEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TCCCG-GGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCC-ccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 97521 1110000 111122445679999999999 88877
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.8e-18 Score=177.82 Aligned_cols=197 Identities=22% Similarity=0.359 Sum_probs=144.5
Q ss_pred CCCCcceEEEEEEeC-------------------------CCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 006593 56 KDDNVVKFYKSWVDD-------------------------KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQIL 110 (639)
Q Consensus 56 ~HpNIVkl~~~~~~~-------------------------~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl 110 (639)
+|||||+++++|.+. ..+.+|+||.-+.. +|++|+-.+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 699999999988652 23579999999965 999999753 466778888999999
Q ss_pred HHHHHHHhCCCCeeeeccCCCcEEEeC-CC--CcEEEeecchhhhccC-----CC---CccccCCCCcCCccccccc---
Q 006593 111 HGLVYLHSHNPPIIHRDLKCDNIFVNG-NH--GEVKIGDLGLAIAMQQ-----PT---ARSVIGTPEFMAPELYEEE--- 176 (639)
Q Consensus 111 ~aL~yLHs~gppIIHRDLKp~NILl~~-~~--g~VKL~DFGlA~~l~~-----~~---~~~~~GTp~ymAPE~l~~~--- 176 (639)
+|..|||.|| |.|||||.+|||+.- ++ -.+.|+|||.+-.-.. +. .-..-|.-..||||+....
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999932 22 2578999997632111 11 1123477889999987632
Q ss_pred ----CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCC---HH
Q 006593 177 ----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS---AK 248 (639)
Q Consensus 177 ----ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpS---a~ 248 (639)
--.++|.|+.|.+.||+++..-||.+.... .+-...-+.-..+.++...+|.+++++..+|+ +|++|++ |.
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 125799999999999999999999762111 11111111223345677778999999999999 8999998 45
Q ss_pred HHhcCcccc
Q 006593 249 DLLKDPFLQ 257 (639)
Q Consensus 249 ELL~Hpff~ 257 (639)
.+|+-..+.
T Consensus 509 Nvl~LsLw~ 517 (598)
T KOG4158|consen 509 NVLNLSLWR 517 (598)
T ss_pred hHHHHHHhc
Confidence 555544333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6e-19 Score=192.11 Aligned_cols=174 Identities=26% Similarity=0.498 Sum_probs=139.5
Q ss_pred ceEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 73 KTVNMITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 73 ~~l~lV~Ey~~gGsL~d~lkk~~---~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
.++||.|++|..++|.+|+.+.. ..+....+.|+.|+..|+.| ++ .+|||+||.||++. ++..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhh
Confidence 36899999999999999998554 35677889999999999999 77 99999999999996 456899999999
Q ss_pred hhhccCCC--------CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCC
Q 006593 150 AIAMQQPT--------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKP 219 (639)
Q Consensus 150 A~~l~~~~--------~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p 219 (639)
........ .....||+.||+||.+. ..|+.++||||||++|+|++. -..++. ....+..+..|..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCC
Confidence 87665332 23457999999999887 569999999999999999998 333332 23344556677776
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
+.+... .|+-..|+..+|. .|.+||++.+.-.|+|++
T Consensus 479 ~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 479 PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 544333 4677899999999 799999988888888764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-18 Score=170.93 Aligned_cols=232 Identities=16% Similarity=0.259 Sum_probs=175.7
Q ss_pred ccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCC
Q 006593 7 YMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGN 86 (639)
Q Consensus 7 fG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGs 86 (639)
-...+..|+|++. |..++.|+++..++ .....+.|..|.-.|+-..||||+.+++.+... ..+.+|..|++-|+
T Consensus 200 e~hsgelwrgrwq--gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~isq~mp~gs 273 (448)
T KOG0195|consen 200 ESHSGELWRGRWQ--GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIISQYMPFGS 273 (448)
T ss_pred cCCCccccccccc--Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEeeeeccchH
Confidence 3445678888764 55678888887765 334456688999999999999999999987554 45889999999999
Q ss_pred HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC-CcEEEeecchhhhccCCCCccccC
Q 006593 87 LRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQPTARSVIG 163 (639)
Q Consensus 87 L~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~-g~VKL~DFGlA~~l~~~~~~~~~G 163 (639)
|...+.... .++..++.+++..|+.|++|||+..|-|.---|....++++.+. ..+-.+|--++. +. ....-
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---qe--~gr~y 348 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QE--VGRAY 348 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---ec--ccccc
Confidence 999997654 36777888999999999999999985444456888899997442 223344432221 11 11234
Q ss_pred CCCcCCccccccc----CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 164 TPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 164 Tp~ymAPE~l~~~----ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
.|.||+||.+... .-+++|+|||.+++|||.|.+.||.+..+.+--++.-..|..+ .++...++.+..|+.-|+.
T Consensus 349 ~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~klm~icmn 427 (448)
T KOG0195|consen 349 SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMNKLMNICMN 427 (448)
T ss_pred CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHHHHHHHHhc
Confidence 7899999988643 3367999999999999999999999876666556666666554 4556667899999999999
Q ss_pred -CCCCCCCHHHH
Q 006593 240 -PASERLSAKDL 250 (639)
Q Consensus 240 -dP~~RpSa~EL 250 (639)
||.+||..+.+
T Consensus 428 edpgkrpkfdmi 439 (448)
T KOG0195|consen 428 EDPGKRPKFDMI 439 (448)
T ss_pred CCCCcCCCccee
Confidence 89999986654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=163.69 Aligned_cols=142 Identities=21% Similarity=0.162 Sum_probs=110.0
Q ss_pred cccccccCcEEEEEEE-ecCCCeEEEEEEEecccccC------------------Ch--hhHHHHHHHHHHHHhCCCC--
Q 006593 2 VLTGLYMTPFSSYKAF-DEFAGIEVAWSRVKIDDVLQ------------------LP--GDLQKLYSEVHLLKSLKDD-- 58 (639)
Q Consensus 2 LG~GGfG~v~tVykA~-d~~tG~~VAIK~v~~~~~~~------------------~~--~~~~~l~~Ei~iLk~L~Hp-- 58 (639)
||+|+|| .||+|. +..+|..||+|+++...... .. .....+..|+++++++.+.
T Consensus 36 Lg~G~~g---~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 36 ISTGKEA---NVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred eccCcce---eEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 6777777 899999 77899999999998653210 00 0123467899999999753
Q ss_pred CcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC
Q 006593 59 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 138 (639)
Q Consensus 59 NIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~ 138 (639)
.+.+++.. . ..++||||+.|++|..+......+....+..++.||+.+|.+||.+| +|+||||||+||+++
T Consensus 113 ~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~-- 183 (237)
T smart00090 113 PVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH-- 183 (237)
T ss_pred CCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE--
Confidence 34555542 1 24799999999998876645556777778899999999999999997 599999999999998
Q ss_pred CCcEEEeecchhhhccC
Q 006593 139 HGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~~ 155 (639)
.+.++|+|||.+.....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 46899999999875443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=176.67 Aligned_cols=196 Identities=27% Similarity=0.433 Sum_probs=152.7
Q ss_pred HHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCe-eeeccC
Q 006593 52 LKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPI-IHRDLK 129 (639)
Q Consensus 52 Lk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppI-IHRDLK 129 (639)
|+.+.|.|+.+|++..++. ..+++|.+||+-|+|.|.+... -.++......+++.|+.||.|||... | .|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999998887 4588999999999999999873 46888888999999999999999875 5 999999
Q ss_pred CCcEEEeCCCCcEEEeecchhhhccC----CCCccccCCCCcCCccccccc--------CCccccccchhhhhhhhhhcc
Q 006593 130 CDNIFVNGNHGEVKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYEEE--------YNELVDIYSFGMCILEMVTFE 197 (639)
Q Consensus 130 p~NILl~~~~g~VKL~DFGlA~~l~~----~~~~~~~GTp~ymAPE~l~~~--------ys~ksDIwSlGiil~ELltG~ 197 (639)
..|.+++.. -.+||.|||+...... .......-..-|.|||++... .+.+.||||||++++|+++..
T Consensus 77 s~nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 77 SSNCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred cccceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999865 4899999999865532 111112234569999988742 467799999999999999999
Q ss_pred CCCCCC---CCHHHHHHHHHc-CCCC--Cccc-C-CCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 198 YPYSEC---KNPAQIFKKVTS-GIKP--ASLA-K-VNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 198 ~Pf~~~---~~~~~i~~~i~~-g~~p--~~l~-~-~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
-||... ..+.++...+.. +..+ +.+. . ...+++..++..||. +|.+||+++++-.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 999642 234566666666 3221 1111 1 234478999999998 8999999988744
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.5e-16 Score=154.79 Aligned_cols=137 Identities=19% Similarity=0.178 Sum_probs=109.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|++| .||+|.+ .|..|++|+......... .....++.+|+.++..+.|++|+....++.+.. ..+
T Consensus 3 ~l~~G~~~---~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 75 (211)
T PRK14879 3 LIKRGAEA---EIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFI 75 (211)
T ss_pred ccccCceE---EEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCE
Confidence 47888888 7999987 677899997653322111 112346889999999999999876666655554 467
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
++|||++|++|.+++..... ....++.+|+.+|.+||+.+ ++|||++|.|||++ .+.++|+|||.+..
T Consensus 76 lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 99999999999999876432 77899999999999999999 99999999999998 46899999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.6e-16 Score=152.71 Aligned_cols=134 Identities=19% Similarity=0.182 Sum_probs=104.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| .||+|.. .|..|++|+......... .....++.+|+++++.+.|+++.....++.... ..+
T Consensus 1 ~ig~G~~~---~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 73 (199)
T TIGR03724 1 LIAKGAEA---IIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKT 73 (199)
T ss_pred CCCCCceE---EEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCE
Confidence 58899998 7999984 578899998654332111 122467889999999999887644443444443 367
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+||||++|++|.+++..... .++.||+.+|.+||+.| ++|||++|.||+++ .+.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999999998865321 78999999999999999 99999999999998 47899999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.2e-18 Score=193.29 Aligned_cols=248 Identities=22% Similarity=0.290 Sum_probs=192.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|+.+.......+ ....+|.|.+.... .......++..|..+-+.+. |+|++.+++.+... .+.+++++
T Consensus 28 ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~~~~~~ 101 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRD--PESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSYLLSLS 101 (601)
T ss_pred ccccccchhhhhhhcCC--CcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCC--cccccccC
Confidence 57788886555444333 34456766666554 34566677888999999996 99999999976444 56889999
Q ss_pred cCCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeeccCCCcEEEeCCCC-cEEEeecchhhhccC-
Q 006593 81 LFTSGNLRQYR-KKHK-NVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCDNIFVNGNHG-EVKIGDLGLAIAMQQ- 155 (639)
Q Consensus 81 y~~gGsL~d~l-kk~~-~l~e~~i~~i~~QIl~aL~yLH-s~gppIIHRDLKp~NILl~~~~g-~VKL~DFGlA~~l~~- 155 (639)
|..||++...+ .... ..+......++.|+..++.|+| ..+ +.|||+||+|.+++.. + .++++|||+|.....
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCchhhcccccc
Confidence 99999999988 5554 6778888999999999999999 888 9999999999999844 6 899999999987765
Q ss_pred CC----CccccC-CCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC--CCCcccCCC
Q 006593 156 PT----ARSVIG-TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVN 226 (639)
Q Consensus 156 ~~----~~~~~G-Tp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~--~p~~l~~~~ 226 (639)
.. ....+| ++.|+|||.+.+ ...+..|+||.|+++.-|++|..|+.........+....... .........
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 22 234578 999999998876 357889999999999999999999965333222222222221 123344555
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
+....+++.++|. +|..|.+.+++-.+||+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 6789999999997 8999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-16 Score=188.00 Aligned_cols=183 Identities=22% Similarity=0.280 Sum_probs=147.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|||| +||+|.+.. |+.||+|+-+..... .++--.+++.+|+ -+-|+.++..++..+. -++
T Consensus 705 e~G~g~y~---~vy~a~~~~-~~~~alK~e~P~~~W-------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~--S~l 771 (974)
T KOG1166|consen 705 EIGEGSYG---SVYVATHSN-GKLVALKVEKPPNPW-------EFYICLQVMERLKPQMLPSIMHISSAHVFQNA--SVL 771 (974)
T ss_pred eeccccce---EEEEeecCC-CcEEEEEeecCCCce-------eeeehHHHHHhhchhhhcchHHHHHHHccCCc--cee
Confidence 47999999 899999987 999999987655431 1344445555555 2455566655554443 668
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe------CCCCcEEEeecchhh
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN------GNHGEVKIGDLGLAI 151 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~------~~~g~VKL~DFGlA~ 151 (639)
|+||.+-|+|.++++..+.+++..+..+..|+|.-++.||.++ |||+||||+|.+|. .+.--++|+|||.+.
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999999999998899999999999999999999999999 99999999999994 122359999999997
Q ss_pred hcc---CC-CCccccCCCCcCCccccccc-CCccccccchhhhhhhhhhccC
Q 006593 152 AMQ---QP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEY 198 (639)
Q Consensus 152 ~l~---~~-~~~~~~GTp~ymAPE~l~~~-ys~ksDIwSlGiil~ELltG~~ 198 (639)
.+. .. .....++|-.|-.+|+..+. +++.+|.|.|.-+++.|+.|++
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 664 22 23456789999999999864 8999999999999999999974
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-15 Score=168.62 Aligned_cols=133 Identities=17% Similarity=0.118 Sum_probs=103.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccC----ChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ----LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~----~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+|..... .+++|+........ .....+++.+|+++++.++|++|+..+.++.+.. ..+
T Consensus 340 ~iG~G~~g---~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~ 412 (535)
T PRK09605 340 LIGKGAEA---DIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--EKT 412 (535)
T ss_pred eeccCCcE---EEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--CCE
Confidence 47888887 7999886443 45555432221111 1123467889999999999999988776666543 367
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+||||+.|++|.+++. ....++.||+.+|.|||+.+ ++||||||+||+++ .+.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCccccc
Confidence 9999999999999886 35678999999999999999 99999999999994 36899999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.5e-15 Score=147.30 Aligned_cols=137 Identities=23% Similarity=0.209 Sum_probs=103.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEeccccc--CCh----------------hhHHHHHHHHHHHHhCCCC--Cc
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL--QLP----------------GDLQKLYSEVHLLKSLKDD--NV 60 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~--~~~----------------~~~~~l~~Ei~iLk~L~Hp--NI 60 (639)
.||+|+|| .||+|.+. +|..||+|+++..... ... ........|+.++..+.|+ .+
T Consensus 22 ~i~~G~~g---~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 22 QIGVGKES---DVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred ccccCcce---EEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 36777777 79999874 7999999998754310 000 0112367899999999887 44
Q ss_pred ceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC
Q 006593 61 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 140 (639)
Q Consensus 61 Vkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g 140 (639)
++.++ . ...++||||+.|++|..+... .....++.+|+.++.++|..| |+||||||+||+++. ++
T Consensus 98 ~~~~~----~--~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~-~~ 162 (198)
T cd05144 98 PKPID----W--NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD-DE 162 (198)
T ss_pred Cceee----c--CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC-CC
Confidence 55554 1 235899999999999875431 345678999999999999999 999999999999984 57
Q ss_pred cEEEeecchhhhccCC
Q 006593 141 EVKIGDLGLAIAMQQP 156 (639)
Q Consensus 141 ~VKL~DFGlA~~l~~~ 156 (639)
.++|+|||.+......
T Consensus 163 ~~~liDfg~~~~~~~~ 178 (198)
T cd05144 163 KIYIIDWPQMVSTDHP 178 (198)
T ss_pred cEEEEECCccccCCCc
Confidence 9999999999665543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-14 Score=147.75 Aligned_cols=139 Identities=14% Similarity=0.161 Sum_probs=103.9
Q ss_pred Ccc-cccccCcEEEEEEEecCCCeEEEEEEEeccccc----C-----ChhhHHHHHHHHHHHHhCCCCCc--ceEEEEEE
Q 006593 1 MVL-TGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL----Q-----LPGDLQKLYSEVHLLKSLKDDNV--VKFYKSWV 68 (639)
Q Consensus 1 iLG-~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~----~-----~~~~~~~l~~Ei~iLk~L~HpNI--Vkl~~~~~ 68 (639)
+|| .||.|+++.|+.+ +..+++|.+....+. . ......++.+|+.++..|.|++| ++.+++..
T Consensus 38 ~lg~~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred eeecCCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 467 7888865555543 778999988653320 0 11334678899999999998875 67777644
Q ss_pred eCCCc--eEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEe
Q 006593 69 DDKKK--TVNMITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 145 (639)
Q Consensus 69 ~~~~~--~l~lV~Ey~~g-GsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~ 145 (639)
..... ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||.+| |+||||||.|||++. .+.++|+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~-~~~v~LI 184 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDP-DGKFWLI 184 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcC-CCCEEEE
Confidence 43222 23599999997 699999875 3456543 578999999999999 999999999999974 4689999
Q ss_pred ecchhhh
Q 006593 146 DLGLAIA 152 (639)
Q Consensus 146 DFGlA~~ 152 (639)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.9e-14 Score=139.67 Aligned_cols=138 Identities=22% Similarity=0.169 Sum_probs=97.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHH---------------------HHHHHHHHHHhCCCC-
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQ---------------------KLYSEVHLLKSLKDD- 58 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~---------------------~l~~Ei~iLk~L~Hp- 58 (639)
+||+|+|| +||+|.+. +|..||+|+++...... ..... ....|...+..+.+.
T Consensus 4 ~lg~G~~g---~Vy~a~~~-~~~~vavKv~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (187)
T cd05119 4 PIGTGKEA---DVYLALDG-DGEPVAVKIYRTGRTSF-KKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG 78 (187)
T ss_pred ccccccce---eEEEEECC-CCCEEEEEEEecCccch-hhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence 47778887 89999986 89999999987543211 11111 114677777777544
Q ss_pred -CcceEEEEEEeCCCceEEEEEecCCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEE
Q 006593 59 -NVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFV 135 (639)
Q Consensus 59 -NIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~-lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl 135 (639)
.+.+.+... ..++||||++++.+... +.... .. ..++.++.|++.++.++|. ++ |+||||||+||++
T Consensus 79 ~~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili 148 (187)
T cd05119 79 VPVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILV 148 (187)
T ss_pred CCCCceEecC------CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEE
Confidence 355665531 25899999999543211 11111 11 6678999999999999999 88 9999999999999
Q ss_pred eCCCCcEEEeecchhhhccC
Q 006593 136 NGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 136 ~~~~g~VKL~DFGlA~~l~~ 155 (639)
+ .+.++|+|||.+.....
T Consensus 149 ~--~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D--DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E--CCcEEEEECcccccccC
Confidence 8 57899999999966544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.2e-13 Score=122.10 Aligned_cols=130 Identities=21% Similarity=0.087 Sum_probs=103.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||.|+++ .||++.+.. ..+++|.+..... ...+..|+.+++.+.| .++++++.+.... ...+++|
T Consensus 6 i~~g~~~---~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~ 72 (155)
T cd05120 6 LKGGLTN---RVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLM 72 (155)
T ss_pred ccccccc---ceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEE
Confidence 4556655 889888754 6799998764431 4568899999999976 5889998866433 4688999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN-PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~g-ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
||+.|+.+..+ +......++.+++.+|.+||... .+++|+|++|.||+++. .+.+++.|||.+..
T Consensus 73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 99999888754 55677788999999999999852 23999999999999985 57899999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.1e-14 Score=155.00 Aligned_cols=246 Identities=24% Similarity=0.256 Sum_probs=189.8
Q ss_pred ccc--ccccCcEEEEEEEe--cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEE
Q 006593 2 VLT--GLYMTPFSSYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~--GGfG~v~tVykA~d--~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+|. |++| .||.+.. ..++..+|+|.-++.- ..+....+=++|+...+.+ .|+|.++.+..|... ...+
T Consensus 122 ~g~~~g~~~---s~~~~~~~~~~s~~~~a~k~s~~p~--s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~--~~lf 194 (524)
T KOG0601|consen 122 TGSLPGSKG---SVFKSRCTNSESPHKFAVKKSKIPF--SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS--GILF 194 (524)
T ss_pred cccCCCCCc---eeecccCCcccCCcccccccccCCC--CCccccccccchhhcccccCccccccccCcccccC--Ccce
Confidence 455 6666 7888888 8899999998744332 1223334446777777777 599999999988665 4588
Q ss_pred EEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 77 MITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILH----GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~-l~e~~i~~i~~QIl~----aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+-+|+|. .+|..|...... ++...++..+.+... ||..+|+.+ ++|-|+||+||+...+....+++|||+..
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeE
Confidence 8899995 788888876544 899999999999999 999999999 99999999999998665789999999987
Q ss_pred hccCCCC-------ccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccC
Q 006593 152 AMQQPTA-------RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 224 (639)
Q Consensus 152 ~l~~~~~-------~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~ 224 (639)
.+..... ....|...|++||+..+-++...|||++|.+.++..++..+.....+ ..+..+..+..+..+..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN--SSWSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC--CCccccccccCchhhhc
Confidence 7754431 11246778999999999999999999999999999998655543211 11223344445555555
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 225 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 225 ~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
..+..+...+..++. +|..|+++..++.|+++...
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 556677778888888 79999999999999999743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=5.3e-14 Score=163.05 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=195.3
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCH
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL 87 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL 87 (639)
|..+.++.+.-..+|...++|.......... .+.+.+..+-.++-...+|-++.++..+.... ..+++++|+.+++|
T Consensus 815 ~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs--P~~L~~~~~~~~~~ 891 (1205)
T KOG0606|consen 815 GSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCRS--PLPLVGHYLNGGDL 891 (1205)
T ss_pred CCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCCC--CcchhhHHhccCCc
Confidence 3444666666666676677776665554322 33455666766766677888888877654443 48899999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc-------C-----
Q 006593 88 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ-------Q----- 155 (639)
Q Consensus 88 ~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~-------~----- 155 (639)
...+.+.+..++...+.++..+..+++|||+.. +.|||++|.|+++. ..|..++.|||...... .
T Consensus 892 ~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~ 968 (1205)
T KOG0606|consen 892 PSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTTDLSGPSS 968 (1205)
T ss_pred hhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcCCcccccc
Confidence 999998888999999999999999999999998 99999999999996 55899999998432100 0
Q ss_pred ---------------------CCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHH
Q 006593 156 ---------------------PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 156 ---------------------~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i 213 (639)
.......||+.|.|||... ......+|+|++|++++|.++|.+||.. ..+.+++..+
T Consensus 969 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tpq~~f~ni 1047 (1205)
T KOG0606|consen 969 SGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETPQQIFENI 1047 (1205)
T ss_pred cCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cchhhhhhcc
Confidence 0012356899999999765 4578899999999999999999999987 6788888888
Q ss_pred HcCCCC-CcccCCCChHHHHHHHHhcC-CCCCCCCHH---HHhcCcccccccCCCC
Q 006593 214 TSGIKP-ASLAKVNDPQIKGFIEKCLV-PASERLSAK---DLLKDPFLQVENQKEP 264 (639)
Q Consensus 214 ~~g~~p-~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~---ELL~Hpff~~~~~~~~ 264 (639)
..+..+ ..-+...++++++++.+.|. +|.+|..+. ++-.||||+...|...
T Consensus 1048 ~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1048 LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 776554 33445567899999999998 899999987 9999999999888653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.1e-10 Score=114.17 Aligned_cols=146 Identities=16% Similarity=0.084 Sum_probs=104.7
Q ss_pred CcccccccCcEEEEEEEecC------CCeEEEEEEEecccc--cC-------C---------hhhHHHHH----HHHHHH
Q 006593 1 MVLTGLYMTPFSSYKAFDEF------AGIEVAWSRVKIDDV--LQ-------L---------PGDLQKLY----SEVHLL 52 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~------tG~~VAIK~v~~~~~--~~-------~---------~~~~~~l~----~Ei~iL 52 (639)
+.|..|-|.-+.||.|.... .+..+|+|+.+.... .. . ..-...+. +|++.|
T Consensus 1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 35677778888999998754 368999999875321 10 0 01122333 899999
Q ss_pred HhCCC--CCcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeeccC
Q 006593 53 KSLKD--DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLK 129 (639)
Q Consensus 53 k~L~H--pNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yL-Hs~gppIIHRDLK 129 (639)
++|.. -++.+.+++ . .-+|||||+.++.+..-.-+...++++.+..+..|++.+|..| |..| ++|+||+
T Consensus 81 ~rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs 152 (197)
T cd05146 81 KRMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLS 152 (197)
T ss_pred HHHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence 99953 567777763 1 2568999998754432222233456667788899999999998 8999 9999999
Q ss_pred CCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 130 CDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 130 p~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+.||++. + |.+.|+|||.+.....+
T Consensus 153 ~~NIL~~-~-~~v~iIDF~qav~~~hp 177 (197)
T cd05146 153 EYNMLWH-D-GKVWFIDVSQSVEPTHP 177 (197)
T ss_pred HHHEEEE-C-CcEEEEECCCceeCCCC
Confidence 9999996 3 68999999988665543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-10 Score=131.56 Aligned_cols=169 Identities=23% Similarity=0.264 Sum_probs=129.6
Q ss_pred EE-EEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCHHHHH
Q 006593 13 SY-KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYR 91 (639)
Q Consensus 13 Vy-kA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~l 91 (639)
+| .|..+.++.+|.+...+... ....+.+.+-++.|+.|+||||++|++.+.... .+|+|||-+. .|..++
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ylvTErV~--Pl~~~l 98 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TLYLVTERVR--PLETVL 98 (690)
T ss_pred cccccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ceEEEeeccc--cHHHHH
Confidence 45 57778899999999888664 245667889999999999999999999987664 6999999994 788888
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--CccccCCCCcC
Q 006593 92 KKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFM 168 (639)
Q Consensus 92 kk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~~~~~GTp~ym 168 (639)
++.+ ...+..-++||+.||.|||. ++ ++|++|.-+.||++ ..|..||++|-++....... .+...--..|.
T Consensus 99 k~l~---~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~ 172 (690)
T KOG1243|consen 99 KELG---KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFD 172 (690)
T ss_pred HHhH---HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhccc
Confidence 8755 66677789999999999984 55 99999999999998 56899999998875443222 11112222344
Q ss_pred CcccccccCCccccccchhhhhhhhhhc
Q 006593 169 APELYEEEYNELVDIYSFGMCILEMVTF 196 (639)
Q Consensus 169 APE~l~~~ys~ksDIwSlGiil~ELltG 196 (639)
.|+.+... .-..|.|-|||++++++.|
T Consensus 173 ~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 173 DPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 55433211 1346999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.6e-11 Score=136.43 Aligned_cols=241 Identities=20% Similarity=0.173 Sum_probs=168.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||.|.|+.+..|- +....+..+++|.+...-. .. .....-..|+.+...| .|.+++.++..|....+ .|+=.|
T Consensus 273 i~~~~~~~~~~~~--~r~~~~~~Y~~ke~~~~l~-~~-~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--~~ip~e 346 (524)
T KOG0601|consen 273 ISDGNFSSVFKVS--KRPEGDCIYAAKELLNGLA-TF-ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--GYIPLE 346 (524)
T ss_pred ccCCccccceeee--ecCCCCceEeChhhhcccc-ch-HhhhcchhhhhHhhHhhcccccCCCCCCcccccc--ccCchh
Confidence 4566666444332 3446788899998765432 22 2223345677777777 69999999999977655 557889
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
||.++++...+.-...+++..+++...|++.++.++|+.. ++|+|+||.||++..+++..+++|||.++.+..... .
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-~ 423 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-V 423 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccceecc-c
Confidence 9999999887765567889999999999999999999998 999999999999974447889999998865332211 1
Q ss_pred ccCCCCcC--Ccccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 161 VIGTPEFM--APELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 161 ~~GTp~ym--APE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
..++-+++ +|...+. .+..++|++|||.-+.+.+++. |+... ......+..+..+. .+... .++..+.+.+
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~-~ls~~---~~~~~~i~~~~~p~-~~~~~-~~~q~~~kv~ 497 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS-PLSES---GVQSLTIRSGDTPN-LPGLK-LQLQVLLKVM 497 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCc-ccCcc---cccceeeecccccC-CCchH-Hhhhhhhhhh
Confidence 22333444 4444443 4788999999999999999986 33221 11122233443332 22222 5677788888
Q ss_pred cC-CCCCCCCHHHHhcCcccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~ 257 (639)
+. ++..||.+.++..|.-|.
T Consensus 498 ~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cCCccccchhhhhhcccchhh
Confidence 87 788999999999887653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.3e-10 Score=129.14 Aligned_cols=139 Identities=20% Similarity=0.179 Sum_probs=90.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhH------------------------------------HHH
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDL------------------------------------QKL 45 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~------------------------------------~~l 45 (639)
||.|++| .||+|.. .+|+.||||+.+..-......+. -.+
T Consensus 125 lasaSig---QVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 125 LAAASIA---QVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred eeeeehh---heEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 5667777 8999986 47999999987543111000000 023
Q ss_pred HHHHHHHHhCC-----CCCc--ceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHH
Q 006593 46 YSEVHLLKSLK-----DDNV--VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILH-GLVYL 116 (639)
Q Consensus 46 ~~Ei~iLk~L~-----HpNI--Vkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~-aL~yL 116 (639)
..|...+.++. +++| .++|..+ . ..-++||||+.|++|.++.... ...+ ...++.+++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~--~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDR--T--SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhh--c--CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 44555555552 3332 3333221 1 2357999999999999886532 1222 2345556655 46788
Q ss_pred HhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 117 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 117 Hs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
|..| ++|+|+||.||+++ .+|.++|+|||++..+.
T Consensus 274 ~~~g--~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LRDG--FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred HhCC--ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 9999 99999999999997 55899999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=9e-11 Score=132.70 Aligned_cols=141 Identities=15% Similarity=0.109 Sum_probs=89.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEeccccc--------------------------CCh----hhHHHH------
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL--------------------------QLP----GDLQKL------ 45 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~--------------------------~~~----~~~~~l------ 45 (639)
||.|++| .||+|....+|+.||||+++..-.. ... +..+.+
T Consensus 127 lasaSia---QVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 127 LASASIA---QVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hcCCCcc---EEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 5666666 8999999888999999998743100 000 112223
Q ss_pred HHHHHHHHhCC----CCCcceEEEEEEeCCCceEEEEEecCCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHH
Q 006593 46 YSEVHLLKSLK----DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY--RKKHK----NVDIKVIKNWARQILHGLVY 115 (639)
Q Consensus 46 ~~Ei~iLk~L~----HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~--lkk~~----~l~e~~i~~i~~QIl~aL~y 115 (639)
.+|...+.++. +.+.+.+-.++.+- ...-++||||+.|+.+.++ +...+ .+.+..+..++.||+
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif----- 277 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF----- 277 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence 33444444442 33333322222221 1235699999999999875 33333 255555666667765
Q ss_pred HHhCCCCeeeeccCCCcEEEeCCC---CcEEEeecchhhhccC
Q 006593 116 LHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 116 LHs~gppIIHRDLKp~NILl~~~~---g~VKL~DFGlA~~l~~ 155 (639)
..| ++|+|+||.||+++.+. +.++++|||++..+..
T Consensus 278 --~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 --RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 477 99999999999997432 3899999999876543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.1e-10 Score=107.11 Aligned_cols=123 Identities=19% Similarity=0.060 Sum_probs=88.2
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCCceEEEEEecCCCCC
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELFTSGN 86 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~~~~~~~~~l~lV~Ey~~gGs 86 (639)
|..+.||++... |..|++|+...... ....+..|+.+++.+.+.++ .+++.. +... -++||||++|.+
T Consensus 9 G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~--~~lv~e~i~G~~ 77 (170)
T cd05151 9 GMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYF--DPET--GVLITEFIEGSE 77 (170)
T ss_pred cccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEE--eCCC--CeEEEEecCCCc
Confidence 444578888764 78899998653321 12235789999999865554 456553 2322 468999999988
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 87 LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP---PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 87 L~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gp---pIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+... ......++.+++.+|..||+.+. .++|+|++|.||+++ + +.++++|||.+.
T Consensus 78 l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred cccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 8653 11123567899999999999871 259999999999998 3 579999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=5e-09 Score=115.02 Aligned_cols=212 Identities=19% Similarity=0.260 Sum_probs=153.8
Q ss_pred EEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--CceEEEEEecCCC-CCH
Q 006593 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--KKTVNMITELFTS-GNL 87 (639)
Q Consensus 11 ~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~--~~~l~lV~Ey~~g-GsL 87 (639)
.+.|+|+...+|..|+.|+++...... ..+...-++.++++.|+|||+|..+|.... ...++||++|.++ ++|
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~----~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQS----TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccC----cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 488999999999999999995544322 223456789999999999999999987322 2468999999875 677
Q ss_pred HHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 88 RQYRK---------------KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 88 ~d~lk---------------k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
.++.- .+...+|..+|.++.||..||.++|+.| +..+-|.|.+|+++|+. +|+|.-.|+.-.
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccceee
Confidence 76542 1235789999999999999999999999 99999999999999765 788887776654
Q ss_pred ccCCCCccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHH-HHHHHcCCCCCcccCCCChHHH
Q 006593 153 MQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 153 l~~~~~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i-~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
+.... + +.+++ -.+-|.--||.+++.|+||..--......... ...| ...++.+++
T Consensus 443 l~~d~-----~-------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I---------~~~yS~D~r 499 (655)
T KOG3741|consen 443 LQEDP-----T-------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI---------TTTYSTDLR 499 (655)
T ss_pred ecCCC-----C-------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh---------hhhhhHHHH
Confidence 44322 1 11221 23457888999999999996432211222222 2222 334567889
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
++|.-... .+.+ .+..+||.+
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHH
Confidence 99988877 4655 788888876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.2e-08 Score=100.77 Aligned_cols=139 Identities=20% Similarity=0.184 Sum_probs=98.7
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC-CceEEEEEecCCC
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDK-KKTVNMITELFTS 84 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~~~~~~-~~~l~lV~Ey~~g 84 (639)
|..+.||++.... |..+++|........ .....+..|+++++.+.+ .++.+++.+..... ....++||||++|
T Consensus 9 G~~n~~~~v~~~~-g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 9 GQSNLTYLLTAGG-GRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred CccceEEEEEecC-CcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 3444788887643 678999987644321 134568899999999975 44577776543221 1246899999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 006593 85 GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH--------------------------------------------- 119 (639)
Q Consensus 85 GsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~--------------------------------------------- 119 (639)
.++.+.+.. ..+++.....++.+++.+|.+||+.
T Consensus 85 ~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (223)
T cd05154 85 RVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRW 163 (223)
T ss_pred EecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHH
Confidence 988775432 3567777778888888888888852
Q ss_pred ---------CCCeeeeccCCCcEEEeCC-CCcEEEeecchhh
Q 006593 120 ---------NPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAI 151 (639)
Q Consensus 120 ---------gppIIHRDLKp~NILl~~~-~g~VKL~DFGlA~ 151 (639)
...++|+|++|.||+++.+ .+.+.|+||+.+.
T Consensus 164 ~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 164 LEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 1247999999999999853 4568999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.7e-08 Score=95.73 Aligned_cols=127 Identities=20% Similarity=0.261 Sum_probs=91.3
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhh-----HHHHHHHHHHHHhCCCCCc--ceEEEEEEeCCCceEEEEEe
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGD-----LQKLYSEVHLLKSLKDDNV--VKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~-----~~~l~~Ei~iLk~L~HpNI--Vkl~~~~~~~~~~~l~lV~E 80 (639)
|.-+.+|.+.. -|..+++|. ++.+....+.. .++-.+|..+|.++.--.| ..+|+ ++... ..|+||
T Consensus 7 GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~~--~~I~me 79 (204)
T COG3642 7 GAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPDN--GLIVME 79 (204)
T ss_pred CcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCCC--CEEEEE
Confidence 44446777743 455666664 44544444443 3456689999999965444 45554 55554 558999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
|++|-.|++++... . ..+++.|-.-+.-||..| |+|+||.+.||++.+ +.+.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC--CcEEEEECCcccc
Confidence 99999999999875 2 455666666777899999 999999999999974 3599999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.5e-07 Score=90.53 Aligned_cols=140 Identities=16% Similarity=0.164 Sum_probs=99.7
Q ss_pred ccCcEEEEEEEecCCCeEEEEEEEecccccCCh-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 7 YMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP-----GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 7 fG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~-----~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
+|.-+.|+++.. .|+...||.- ..+..+-+ -...+..+|+++|.+|.--.|.----+|+|..+ -.|+|||
T Consensus 17 QGAEArv~~~~~--~Ge~~iIK~R-f~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--~~i~ME~ 91 (229)
T KOG3087|consen 17 QGAEARVPRGSF--SGEAAIIKER-FSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG--GQIYMEF 91 (229)
T ss_pred ccceeeEeeecc--CCceeEEeec-ccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC--CeEEEEe
Confidence 455558888875 5777778753 22222222 235678899999999976566433334566655 4477899
Q ss_pred CCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc--EEEeecchhhhc
Q 006593 82 FTS-GNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLAIAM 153 (639)
Q Consensus 82 ~~g-GsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~--VKL~DFGlA~~l 153 (639)
+.| -++++|+.... .........++++|-..+.-||..+ |||+||..+||++..+++. +.|+|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 976 48899987643 2333344788999999999999999 9999999999999755444 489999998543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=9.8e-08 Score=94.48 Aligned_cols=131 Identities=26% Similarity=0.274 Sum_probs=85.8
Q ss_pred EEEEEEecCCCeEEEEEEEeccccc------------C---------C-hhhHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 006593 12 SSYKAFDEFAGIEVAWSRVKIDDVL------------Q---------L-PGDLQKLYSEVHLLKSLKDD--NVVKFYKSW 67 (639)
Q Consensus 12 tVykA~d~~tG~~VAIK~v~~~~~~------------~---------~-~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~~ 67 (639)
.||.|.. ..|..||+|..+..... . . ........+|.+.|.+|..- ++.+.+++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 3899987 56889999998764211 0 0 11245678999999999766 56777763
Q ss_pred EeCCCceEEEEEecCC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeeeeccCCCcEEEeCCCCcEEE
Q 006593 68 VDDKKKTVNMITELFT--SGNLRQYRKKHKNVDIKVIKNWARQILHGLVY-LHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144 (639)
Q Consensus 68 ~~~~~~~l~lV~Ey~~--gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~y-LHs~gppIIHRDLKp~NILl~~~~g~VKL 144 (639)
.. -.|||||+. |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.||+++. +.+.|
T Consensus 79 -~~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~--~~~~i 147 (188)
T PF01163_consen 79 -NR----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD--GKVYI 147 (188)
T ss_dssp -ET----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET--TCEEE
T ss_pred -eC----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec--ceEEE
Confidence 22 358999998 66665543321 1244567788888886655 57999 999999999999974 38999
Q ss_pred eecchhhhccC
Q 006593 145 GDLGLAIAMQQ 155 (639)
Q Consensus 145 ~DFGlA~~l~~ 155 (639)
+|||.+.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99998865543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.4e-07 Score=95.52 Aligned_cols=135 Identities=16% Similarity=0.085 Sum_probs=93.8
Q ss_pred EEEEEecCCCeEEEEEEEecccccC-------ChhhHHHHHHHHHHHHhCCCCCc--ceEEEEEEeCC---CceEEEEEe
Q 006593 13 SYKAFDEFAGIEVAWSRVKIDDVLQ-------LPGDLQKLYSEVHLLKSLKDDNV--VKFYKSWVDDK---KKTVNMITE 80 (639)
Q Consensus 13 VykA~d~~tG~~VAIK~v~~~~~~~-------~~~~~~~l~~Ei~iLk~L~HpNI--Vkl~~~~~~~~---~~~l~lV~E 80 (639)
|.+.. ..|+.|.+|+........ ...-...+.+|...+..|...+| ++...+..... ...-++|||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44543 457889999764332100 00001137799999988844333 33333333221 234679999
Q ss_pred cCCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC------CCCcEEEeecchhh
Q 006593 81 LFTSG-NLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------NHGEVKIGDLGLAI 151 (639)
Q Consensus 81 y~~gG-sL~d~lkk--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~------~~g~VKL~DFGlA~ 151 (639)
++++- +|.+++.. ....+......++.+|+..+.-||..| |+|+||++.|||++. ..+.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99876 89999864 244567778899999999999999999 999999999999974 24689999999774
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.7e-09 Score=116.36 Aligned_cols=233 Identities=19% Similarity=0.227 Sum_probs=159.2
Q ss_pred ccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCCceEEEEEec
Q 006593 3 LTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 3 G~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~~~~~~~~~l~lV~Ey 81 (639)
++|+++ ++||++...+...+ .+.+... ....-++++|.+++||| .+.+++.+ +...+.++.+++
T Consensus 251 vK~alt---knpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i 315 (829)
T KOG0576|consen 251 VKGALT---KNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRI 315 (829)
T ss_pred HHHHhc---CCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhhhh
Confidence 445555 78888887776655 5655433 33567999999999999 66666644 334678999999
Q ss_pred CCCC-CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSG-NLRQYR-KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gG-sL~d~l-kk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.+| +-...+ ...-.+.+-.....++.-+++|+|||+.. -+||| ||+.. .+.+|.+||+.+..+... ..
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcccCccccc
Confidence 9887 222111 01112333445566777788999999985 68998 77765 368999999998766543 45
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC-CCCccc-CCCChHHH-HHH
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KPASLA-KVNDPQIK-GFI 234 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~-~p~~l~-~~~s~~l~-~LI 234 (639)
++..+|+.++|||+.. ..+....|.|++|.-..+|.-|.+|-.. |......+..+. .+.... ....+... ++.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~ 464 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP 464 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC---CccccCCCCCCCCccccchhhhcCcccccCCc
Confidence 6788999999999665 5699999999999999999998888643 221111122221 111111 11122233 488
Q ss_pred HHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
..|+. -|..|+.....+.|.+|..-..
T Consensus 465 ~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 465 APCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 88998 6999999999999999975543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.1e-07 Score=88.87 Aligned_cols=109 Identities=20% Similarity=0.198 Sum_probs=85.0
Q ss_pred HHHHHHHHHHHHhCCCCCc--ceEEEEEEeCC--CceEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 006593 42 LQKLYSEVHLLKSLKDDNV--VKFYKSWVDDK--KKTVNMITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYL 116 (639)
Q Consensus 42 ~~~l~~Ei~iLk~L~HpNI--Vkl~~~~~~~~--~~~l~lV~Ey~~g-GsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yL 116 (639)
..+..+|...+..|..-+| ++.+.+..... ....++|||++++ -+|.+++......+......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4568899998888854333 45554443322 1345799999987 48999998866677888899999999999999
Q ss_pred HhCCCCeeeeccCCCcEEEeCCC--CcEEEeecchhhh
Q 006593 117 HSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIA 152 (639)
Q Consensus 117 Hs~gppIIHRDLKp~NILl~~~~--g~VKL~DFGlA~~ 152 (639)
|..| |+|+|+++.|||++.+. ..+.|+||+.+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999998442 2689999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.1e-07 Score=107.88 Aligned_cols=152 Identities=18% Similarity=0.305 Sum_probs=107.4
Q ss_pred HHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc-----------ccCCCCcCCcccccc
Q 006593 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-----------VIGTPEFMAPELYEE 175 (639)
Q Consensus 107 ~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~-----------~~GTp~ymAPE~l~~ 175 (639)
.++..||.|+|.+- .+||++|.|++|++++ .|.+||+.|+++.....+.... ......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34459999999984 5999999999999984 5899999999886544422211 124567999998765
Q ss_pred c-CCccccccchhhhhhhhhh-ccCCCCCCCCHHHH-HHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 006593 176 E-YNELVDIYSFGMCILEMVT-FEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLL 251 (639)
Q Consensus 176 ~-ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i-~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL 251 (639)
. -+.++|+||+|+++|-+.. |+.-+......... ......+..........+.++++=+.++|. ++.-||++.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 4 6788999999999999984 44444332111111 111111222223334557899999999998 899999999999
Q ss_pred cCccccccc
Q 006593 252 KDPFLQVEN 260 (639)
Q Consensus 252 ~Hpff~~~~ 260 (639)
.-|||+...
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999997554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.1e-06 Score=92.88 Aligned_cols=231 Identities=17% Similarity=0.227 Sum_probs=145.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEE-----E-eCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSW-----V-DDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~-----~-~~~~~~l 75 (639)
||+||-+.+.++=-+.| .| -|+...... .... ++-..+.+.-.||-+-. --.| . .+....+
T Consensus 19 LgqGgea~ly~l~e~~d-----~V-AKIYh~Ppp----a~~a--qk~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 19 LGQGGEADLYTLGEVRD-----QV-AKIYHAPPP----AAQA--QKVAELAATPDAPLLNY-RVAWPQATLHGGRRGKVI 85 (637)
T ss_pred ccCCccceeeecchhhc-----hh-heeecCCCc----hHHH--HHHHHhccCCCCcchhh-hhcccHHHhhCCCcccee
Confidence 78899886655443333 23 366665432 1111 12222223336665432 1112 1 1223457
Q ss_pred EEEEecCCCC-CHHHHH------HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 76 NMITELFTSG-NLRQYR------KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 76 ~lV~Ey~~gG-sL~d~l------kk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
-|+|..+.|. -+..++ +..+.++...+.+.++.|+.+.+.||.+| .+-+|+.++|+|+. +.+.|.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEEccc
Confidence 8899998774 223322 22356788999999999999999999999 99999999999997 66899998854
Q ss_pred hhhhccCC-CCccccCCCCcCCccccc-c-----cCCccccccchhhhhhhhhhc-cCCCCCCC------CHHH--HH--
Q 006593 149 LAIAMQQP-TARSVIGTPEFMAPELYE-E-----EYNELVDIYSFGMCILEMVTF-EYPYSECK------NPAQ--IF-- 210 (639)
Q Consensus 149 lA~~l~~~-~~~~~~GTp~ymAPE~l~-~-----~ys~ksDIwSlGiil~ELltG-~~Pf~~~~------~~~~--i~-- 210 (639)
......+. .....+|.++|.+||+-. . .-+...|-|.||+++++++.| +.||++.. ++-+ |.
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 32222222 223457999999999765 1 246679999999999999987 89997531 1211 11
Q ss_pred -----HHHHcCCCC--Ccc-cCCCChHHHHHHHHhcCC---CCCCCCHH
Q 006593 211 -----KKVTSGIKP--ASL-AKVNDPQIKGFIEKCLVP---ASERLSAK 248 (639)
Q Consensus 211 -----~~i~~g~~p--~~l-~~~~s~~l~~LI~kcL~d---P~~RpSa~ 248 (639)
++-..|.+| ..+ .....+.+..|..+|+.+ +.-||+++
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 111112222 222 233468899999999974 45899964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.2e-06 Score=104.19 Aligned_cols=208 Identities=22% Similarity=0.343 Sum_probs=147.2
Q ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCc--eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 006593 40 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK--TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH 117 (639)
Q Consensus 40 ~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~--~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLH 117 (639)
.++.....|+..+..+.|+|++.++.+-...... .+.+..++|+.-++...+..-+.++...++.|..++++||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 4455666777888888999999999876544322 23356689999999999999999999999999999999999999
Q ss_pred hCCCCeeeeccCCC---cEEEeCCCCcEEEe--ecchhhhccCC-CCccccCCCCcCCccccccc---CCccccccchhh
Q 006593 118 SHNPPIIHRDLKCD---NIFVNGNHGEVKIG--DLGLAIAMQQP-TARSVIGTPEFMAPELYEEE---YNELVDIYSFGM 188 (639)
Q Consensus 118 s~gppIIHRDLKp~---NILl~~~~g~VKL~--DFGlA~~l~~~-~~~~~~GTp~ymAPE~l~~~---ys~ksDIwSlGi 188 (639)
+.. ..|.-|... +...++. +.+.++ ||+....+... ......-+..+.|||..... .....|+|++|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 986 666655555 3333322 456666 88777655432 22233445667788877643 334579999999
Q ss_pred hhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 189 il~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
.+..+..|..+-.... .... .++........+++.+|+. ++++|+++.++|.|||+......
T Consensus 381 l~~~~~~~~~i~~~~~----~~~~--------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA----VPVS--------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDN 443 (1351)
T ss_pred HHhhhhhcCccccccc----chhh--------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccc
Confidence 9999998865432111 1111 1111222267889999998 79999999999999999765443
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.1e-07 Score=65.13 Aligned_cols=32 Identities=41% Similarity=0.534 Sum_probs=27.5
Q ss_pred eEEEEEecCCCC------CcceeeecccCCCCCHHHHH
Q 006593 339 VSLTLRIADSSG------RVRNIHFLFYLDSDTALSVA 370 (639)
Q Consensus 339 i~L~Lri~d~~~------~~~~i~F~f~~~~DTa~~vA 370 (639)
|.|+||++|+++ ++++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 689999999998 89999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.1e-05 Score=83.59 Aligned_cols=133 Identities=20% Similarity=0.161 Sum_probs=93.5
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccc-----cC-----------C--hhhHHHHHHHHHHHHhCCCC--CcceEE
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDV-----LQ-----------L--PGDLQKLYSEVHLLKSLKDD--NVVKFY 64 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~-----~~-----------~--~~~~~~l~~Ei~iLk~L~Hp--NIVkl~ 64 (639)
.|-|.-+.||.|.+. .|.++|+|.-+...- .. + -......++|.++|.+|.-. .|.+.+
T Consensus 99 IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~ 177 (304)
T COG0478 99 IGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPI 177 (304)
T ss_pred cccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcc
Confidence 344555689999985 799999997554211 00 1 01235578999999999655 788887
Q ss_pred EEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEE
Q 006593 65 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144 (639)
Q Consensus 65 ~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL 144 (639)
++ ++..+||||+.|-.|.... ++.+.+..++..|+.-+.-+-..| |||+|+.+=||+++ ++|.+.+
T Consensus 178 ~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~-~dg~~~v 243 (304)
T COG0478 178 AW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT-EDGDIVV 243 (304)
T ss_pred cc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-cCCCEEE
Confidence 62 3467999999997776532 133444555566666555555777 99999999999998 5589999
Q ss_pred eecchhhh
Q 006593 145 GDLGLAIA 152 (639)
Q Consensus 145 ~DFGlA~~ 152 (639)
+||-.+..
T Consensus 244 IDwPQ~v~ 251 (304)
T COG0478 244 IDWPQAVP 251 (304)
T ss_pred EeCccccc
Confidence 99976543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00013 Score=73.68 Aligned_cols=134 Identities=16% Similarity=0.154 Sum_probs=91.4
Q ss_pred EEEEEEecCCCeEEEEEEEe--cccccCChhhHHHHHHHHHHHHhCCCCC--cceEE--EEEEeCCCceEEEEEecCC-C
Q 006593 12 SSYKAFDEFAGIEVAWSRVK--IDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFY--KSWVDDKKKTVNMITELFT-S 84 (639)
Q Consensus 12 tVykA~d~~tG~~VAIK~v~--~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~--~~~~~~~~~~l~lV~Ey~~-g 84 (639)
.|++-.. .|..+-+|+-. ......-+--...+.+|+..|.+|..-+ +.+.. +.-.....-.-+||||-+. -
T Consensus 33 gV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~ 110 (216)
T PRK09902 33 GVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGF 110 (216)
T ss_pred eEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCC
Confidence 3555432 34467788754 1111111334567999999999995322 33333 2222222335679999664 3
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc--EEEeecchh
Q 006593 85 GNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLA 150 (639)
Q Consensus 85 GsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~--VKL~DFGlA 150 (639)
-+|.+++... .+.+......++.+|...|.-||..| +.|+|+-+.|||++.. |. |+++||--+
T Consensus 111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~ 177 (216)
T PRK09902 111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKS 177 (216)
T ss_pred ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhcc
Confidence 6899988764 34577878899999999999999999 9999999999999733 45 999999654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=9e-05 Score=76.10 Aligned_cols=145 Identities=18% Similarity=0.107 Sum_probs=99.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccC------------------Chhh--HHHHHHHHHHHHhCC--CC
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ------------------LPGD--LQKLYSEVHLLKSLK--DD 58 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~------------------~~~~--~~~l~~Ei~iLk~L~--Hp 58 (639)
+.|.++.|.-+.||+|.. ..+..||+|+++.....- .... ..=..+|+..|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 357888899999999986 568899999987643210 0001 112347888888884 45
Q ss_pred CcceEEEEEEeCCCceEEEEEecCCCCCHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEe
Q 006593 59 NVVKFYKSWVDDKKKTVNMITELFTSGNLR-QYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVN 136 (639)
Q Consensus 59 NIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~-d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~ 136 (639)
.+.+-+.+. . -.+||||+....+. =.|+. -.+....+..+..++++.+.-|-. .+ ++|+||..=|||+.
T Consensus 131 rvP~Pi~~~--~----nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~ 201 (268)
T COG1718 131 RVPEPIAFR--N----NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH 201 (268)
T ss_pred CCCCceeec--C----CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE
Confidence 566766643 1 35899999654110 00111 123333677888899999888766 67 99999999999997
Q ss_pred CCCCcEEEeecchhhhccCCC
Q 006593 137 GNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 137 ~~~g~VKL~DFGlA~~l~~~~ 157 (639)
.|.+.|+|||.|.....+.
T Consensus 202 --~~~p~iID~~QaV~~~hp~ 220 (268)
T COG1718 202 --DGEPYIIDVSQAVTIDHPN 220 (268)
T ss_pred --CCeEEEEECccccccCCCc
Confidence 4689999999987666543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00043 Score=68.34 Aligned_cols=135 Identities=19% Similarity=0.228 Sum_probs=75.5
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC--CcceEEEEEEeCC-CceEEEEEecCCC
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSWVDDK-KKTVNMITELFTS 84 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~~~~~~-~~~l~lV~Ey~~g 84 (639)
|..+.||+..... | .+++|..... .....+..|..+++.|... .+.+++....... ....+++|+++.|
T Consensus 8 G~~n~~~~v~~~~-~-~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 8 GFSNRVYRVTTDD-G-RYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp SSSSEEEEEEETT-S-EEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CCeeeEEEEEECC-c-EEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4445899998765 4 7888975422 3456788999999888533 3567776433322 2357899999999
Q ss_pred CCHHH----------------HHH---hC--C--CCCH------HHHHH---H------------HHHHHH-HHHHHHh-
Q 006593 85 GNLRQ----------------YRK---KH--K--NVDI------KVIKN---W------------ARQILH-GLVYLHS- 118 (639)
Q Consensus 85 GsL~d----------------~lk---k~--~--~l~e------~~i~~---i------------~~QIl~-aL~yLHs- 118 (639)
..+.. ++. .. . .+.. ..... + ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 98887 111 11 0 0000 00000 0 011222 2333332
Q ss_pred ----CCCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 119 ----HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 119 ----~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
....++|+|+.|.||+++..++.|-|+||+.+
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 22359999999999999844567789999866
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00027 Score=71.72 Aligned_cols=126 Identities=16% Similarity=0.183 Sum_probs=78.6
Q ss_pred EEEEEecCCCeEEEEEEEecccccCChhhHHH------HHHHHHHHHhCC---CCCcceEEEEEEeCCC---ceEEEEEe
Q 006593 13 SYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQK------LYSEVHLLKSLK---DDNVVKFYKSWVDDKK---KTVNMITE 80 (639)
Q Consensus 13 VykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~------l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~---~~l~lV~E 80 (639)
-|.|.-...|..+++|..+-.... .+..... ..+++..+..+. -.....+|-+..-... ...+++||
T Consensus 45 ~~ValIei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~E 123 (229)
T PF06176_consen 45 NYVALIEIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLME 123 (229)
T ss_pred cEEEEEEECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEE
Confidence 455666667888888876644321 1111111 223444444442 3333444433222111 24568999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
|++|..|.++.. +++ .+...|..++.-||..| +.|+|..|.|++++ + +.++++||+..+
T Consensus 124 YIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~-~-~~i~iID~~~k~ 182 (229)
T PF06176_consen 124 YIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS-N-NGIRIIDTQGKR 182 (229)
T ss_pred EecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE-C-CcEEEEECcccc
Confidence 999998877542 333 24456778899999999 99999999999997 3 359999997543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00047 Score=70.18 Aligned_cols=133 Identities=14% Similarity=0.107 Sum_probs=75.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|..+ .||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++..+ .....+||
T Consensus 9 i~~G~t~---~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~ 73 (226)
T TIGR02172 9 TGEGGNG---ESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIY 73 (226)
T ss_pred ecCCCCc---ceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeee
Confidence 4556555 67873 25567788765321 2345789999999996443 4667765433 34477899
Q ss_pred ecCCCCC-HHH-----------H---H----H-hCC----CCCHHH-HHHHHHH----------HHHH-HHHHH--hCCC
Q 006593 80 ELFTSGN-LRQ-----------Y---R----K-KHK----NVDIKV-IKNWARQ----------ILHG-LVYLH--SHNP 121 (639)
Q Consensus 80 Ey~~gGs-L~d-----------~---l----k-k~~----~l~e~~-i~~i~~Q----------Il~a-L~yLH--s~gp 121 (639)
|++.|.+ +.. + + . -|. ...... ...+..+ +... ..+|. ...+
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 9999864 111 1 1 0 011 111111 1111111 1111 12222 2334
Q ss_pred CeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
.++|+|+.|.||++++ .| +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~-~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSG-KG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcC-CC-cEEEechhcC
Confidence 5799999999999974 45 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.60 E-value=5.3e-06 Score=100.54 Aligned_cols=215 Identities=13% Similarity=0.018 Sum_probs=150.0
Q ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHH
Q 006593 40 GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVY 115 (639)
Q Consensus 40 ~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~y 115 (639)
...+.+..|...++...|+++...+.-.........|..++|+.+|.+++.+-+. +.++...+.....+.+.+..-
T Consensus 1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence 3455666777778888999999888866555566788999999999999998653 345555555555665777777
Q ss_pred HHhC---CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCCccccCCCCcCCcccccc-cCCccccccchhhh
Q 006593 116 LHSH---NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMC 189 (639)
Q Consensus 116 LHs~---gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGii 189 (639)
+|+. |--.+|++||+-|.+|..+. .||++++|+.+.... ...+...++|.|++|++... .++.++|+|..|+.
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 7765 23579999999999998764 899999999983322 23455678999999998875 58888999999999
Q ss_pred hhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 190 l~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
+|+..-|..+|... ..-..+.+........++...+.+.-.....+|- +-..||.-...+.-+.|.
T Consensus 1430 ly~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999988777431 1122233333333344455533333333333333 556688888888776664
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00054 Score=77.75 Aligned_cols=137 Identities=19% Similarity=0.132 Sum_probs=83.3
Q ss_pred cEEEEEEEecCCCeEEEEEEEecccccCC-h---------------------------hhHHHHHHHHHHH---------
Q 006593 10 PFSSYKAFDEFAGIEVAWSRVKIDDVLQL-P---------------------------GDLQKLYSEVHLL--------- 52 (639)
Q Consensus 10 v~tVykA~d~~tG~~VAIK~v~~~~~~~~-~---------------------------~~~~~l~~Ei~iL--------- 52 (639)
.+-||+|..+. |+.||||+-+ ..+... . +..+.+..|+..+
T Consensus 174 laQVhrA~L~~-G~~VaVKVQ~-P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~ 251 (538)
T KOG1235|consen 174 LAQVHRARLKN-GEDVAVKVQH-PGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERF 251 (538)
T ss_pred hhheEEEEecC-CCEEEEEecC-cChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHH
Confidence 44799999866 9999999644 333210 0 1122333333322
Q ss_pred -HhCCCCC------cceEEEEEEeCCCceEEEEEecCCCCCHHH--HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006593 53 -KSLKDDN------VVKFYKSWVDDKKKTVNMITELFTSGNLRQ--YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 123 (639)
Q Consensus 53 -k~L~HpN------IVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d--~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppI 123 (639)
+.+.|-+ |.++|-.+. ..-.++||||.|..+.| ++++++ ++...+..-+.+...-. +=..| +
T Consensus 252 ~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~q--If~~G--f 322 (538)
T KOG1235|consen 252 RENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQ--IFKTG--F 322 (538)
T ss_pred HHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHH--HHhcC--C
Confidence 2223444 556654321 12458999999987755 455544 55554444444433222 33346 9
Q ss_pred eeeccCCCcEEEeC---CCCcEEEeecchhhhccCCC
Q 006593 124 IHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 124 IHRDLKp~NILl~~---~~g~VKL~DFGlA~~l~~~~ 157 (639)
+|+|-+|.||++.. .++.+.+.|||+...+....
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 99999999999983 35789999999987665543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00039 Score=78.87 Aligned_cols=75 Identities=17% Similarity=0.236 Sum_probs=53.5
Q ss_pred EEEEEecCCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 75 VNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~--lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
-.++|||+.|-.+.++ ++. ..++.+.+...+.++.- ..+-..| +.|.|.+|.||+++.+ |.+.+.|||+...
T Consensus 241 ~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~ 314 (517)
T COG0661 241 RVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIVGR 314 (517)
T ss_pred cEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhcC--ccccCCCccceEEecC-CcEEEEcCcceec
Confidence 4589999999999887 444 44665554444333322 2222356 9999999999999854 8999999999866
Q ss_pred ccC
Q 006593 153 MQQ 155 (639)
Q Consensus 153 l~~ 155 (639)
+..
T Consensus 315 l~~ 317 (517)
T COG0661 315 LDP 317 (517)
T ss_pred CCH
Confidence 543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00092 Score=67.97 Aligned_cols=69 Identities=13% Similarity=0.006 Sum_probs=47.4
Q ss_pred EEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEecCCCCCHHH
Q 006593 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 89 (639)
Q Consensus 11 ~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d 89 (639)
..||+.... +..+.+|...... ...+.+|+++++.+. +-.+.+++.+.... ...++|||+++|.+|..
T Consensus 13 ~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 13 ATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAAA 81 (244)
T ss_pred CeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHhH
Confidence 578988653 3567778754321 234678999998883 44567888765443 34678999999987764
Q ss_pred H
Q 006593 90 Y 90 (639)
Q Consensus 90 ~ 90 (639)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00085 Score=66.51 Aligned_cols=100 Identities=23% Similarity=0.156 Sum_probs=77.6
Q ss_pred HHHHHHHHhCCC-CCcceEEEEEEeCCCceEEEEEecCCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006593 46 YSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ---YRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 121 (639)
Q Consensus 46 ~~Ei~iLk~L~H-pNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d---~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gp 121 (639)
..|.-+|+.+++ +++++++|++ + -++|+||...+++.. .+...-..++....+++.|++..+.+|+..-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--G----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--G----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--C----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 458889999976 6999999977 2 246889998776542 11222346789999999999999999987421
Q ss_pred -CeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 122 -PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 122 -pIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
.+.-.|++++|+-++ ++|.+|++|...+..
T Consensus 81 ~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEe-CCCcEEEEechhcch
Confidence 388899999999998 558999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0012 Score=67.04 Aligned_cols=74 Identities=11% Similarity=-0.012 Sum_probs=42.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC---CcceEEEEEEeCC-CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDK-KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp---NIVkl~~~~~~~~-~~~l~l 77 (639)
|+.||.. ..||+. +..+++|..+.. .....+.+|.++|+.|... .+.+++......+ ....++
T Consensus 5 ~~~gG~~--n~vy~~-----~~~~VlR~~~~~------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 5 VDSGGTD--NATFRL-----GDDMSVRLPSAA------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ccCCCcc--cceEEc-----CCceEEEcCCcc------chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3445444 357765 234666753321 1234688999999988532 3455555322211 124578
Q ss_pred EEecCCCCCHH
Q 006593 78 ITELFTSGNLR 88 (639)
Q Consensus 78 V~Ey~~gGsL~ 88 (639)
+|+++.|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0066 Score=60.82 Aligned_cols=130 Identities=20% Similarity=0.254 Sum_probs=82.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEeccccc------------CChhhHHHHHHHHHHHHhCC------CCCcceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL------------QLPGDLQKLYSEVHLLKSLK------DDNVVKF 63 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~------------~~~~~~~~l~~Ei~iLk~L~------HpNIVkl 63 (639)
||+|+.- .||.--+ .....||++...... ..........+|+.....+. +.+|.++
T Consensus 9 i~~G~~R---~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 9 IAQGGER---DCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccCCCc---eEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 5666665 6775433 333668887765500 01122455667777666665 7889999
Q ss_pred EEEEEeCCCceEEEEEecCCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC
Q 006593 64 YKSWVDDKKKTVNMITELFTS------GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137 (639)
Q Consensus 64 ~~~~~~~~~~~l~lV~Ey~~g------GsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~ 137 (639)
||....+ ..+-+|+|.+.. -+|.++++. +.+++ .++..+. .-..||-.+. |+.+||+|.||++..
T Consensus 83 ~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETN--LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHH--IVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecC--CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcC--CeecCCCcccEEEEe
Confidence 9965443 446778887643 478888865 44665 4333333 3445667777 999999999999953
Q ss_pred CC-C--cEEEee
Q 006593 138 NH-G--EVKIGD 146 (639)
Q Consensus 138 ~~-g--~VKL~D 146 (639)
.. | .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 22 2 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0072 Score=72.77 Aligned_cols=143 Identities=19% Similarity=0.235 Sum_probs=84.3
Q ss_pred ccCcEEEEEEEecCCC--eEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeCC-CceEEEEEe
Q 006593 7 YMTPFSSYKAFDEFAG--IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNV--VKFYKSWVDDK-KKTVNMITE 80 (639)
Q Consensus 7 fG~v~tVykA~d~~tG--~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNI--Vkl~~~~~~~~-~~~l~lV~E 80 (639)
-|....+|+......+ ..+++|+....... .....+.+|+++|+.|. |++| .+++.++.+.. -...|+|||
T Consensus 48 gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME 124 (822)
T PLN02876 48 HGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIME 124 (822)
T ss_pred CCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEE
Confidence 3445577876654322 46777765433221 12346789999999995 6665 77777554421 134679999
Q ss_pred cCCCCCHHH--------------------HHHh-CC------------C---CCHHHHHHHHHHH---------------
Q 006593 81 LFTSGNLRQ--------------------YRKK-HK------------N---VDIKVIKNWARQI--------------- 109 (639)
Q Consensus 81 y~~gGsL~d--------------------~lkk-~~------------~---l~e~~i~~i~~QI--------------- 109 (639)
|+.|..+.+ .+.. |. . .....+..|..|.
T Consensus 125 ~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~ 204 (822)
T PLN02876 125 YLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKM 204 (822)
T ss_pred ecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhH
Confidence 999864321 1110 11 0 1123444444332
Q ss_pred HHHHHHHHhCCC---------CeeeeccCCCcEEEeCCCCc-EEEeecchhhh
Q 006593 110 LHGLVYLHSHNP---------PIIHRDLKCDNIFVNGNHGE-VKIGDLGLAIA 152 (639)
Q Consensus 110 l~aL~yLHs~gp---------pIIHRDLKp~NILl~~~~g~-VKL~DFGlA~~ 152 (639)
...+.+|..+-| .+||+|++++||+++...+. +-|.||.++..
T Consensus 205 ~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 205 LELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred HHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 223566755433 39999999999999753334 57999988753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0082 Score=59.07 Aligned_cols=125 Identities=23% Similarity=0.201 Sum_probs=84.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~~~~~~~~~l~lV~E 80 (639)
||+|.+| .||++.. .|.++|+|+-+.+. -...+..|.++|..++-.++ .++|.+ +. .++.||
T Consensus 30 L~KG~~s---~Vyl~~~--~~~~~a~Kvrr~ds------~r~~l~kEakiLeil~g~~~~p~vy~y--g~----~~i~me 92 (201)
T COG2112 30 LAKGTTS---VVYLGEW--RGGEVALKVRRRDS------PRRNLEKEAKILEILAGEGVTPEVYFY--GE----DFIRME 92 (201)
T ss_pred hhccccc---EEEEeec--cCceEEEEEecCCc------chhhHHHHHHHHHHhhhcCCCceEEEe--ch----hhhhhh
Confidence 5666666 7898875 57789999755433 34668999999999988777 566653 22 346699
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCC--cEEEeCCCCcEEEeecchhhhcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD--NIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~--NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
|+.|-.|.+.-... +.+. +..++.+---|-..| |-|..|.-. ||++. + +.+.|+||.-|+...
T Consensus 93 ~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~-~-~~~~iIDFd~At~k~ 157 (201)
T COG2112 93 YIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN-D-RDVYIIDFDSATFKK 157 (201)
T ss_pred hhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEec-C-CcEEEEEccchhhcc
Confidence 99998887754421 2222 334445444456667 888888643 66664 3 489999999887433
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.01 Score=59.80 Aligned_cols=70 Identities=14% Similarity=0.037 Sum_probs=42.4
Q ss_pred ccCcEEEEEEEecC-CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCCceEEEEEecCCC
Q 006593 7 YMTPFSSYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTS 84 (639)
Q Consensus 7 fG~v~tVykA~d~~-tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~~~~~~~~~l~lV~Ey~~g 84 (639)
-|....+|+..... .+..|++|....... ..-...+|+.+++.+.. .-.++++..+ .+ .+||||++|
T Consensus 8 gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-----~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e~i~G 76 (235)
T cd05157 8 GGITNKLVKVSNKEDNQDAVLVRVYGNKTE-----LIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYEFIPG 76 (235)
T ss_pred CcccceEEEEEcCCCCCCeEEEEEccCCcc-----ceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEEeeCC
Confidence 34456888886543 356788886653211 11123579999999843 3345665532 22 279999998
Q ss_pred CCH
Q 006593 85 GNL 87 (639)
Q Consensus 85 GsL 87 (639)
-++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0022 Score=71.80 Aligned_cols=162 Identities=19% Similarity=0.217 Sum_probs=102.5
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006593 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 122 (639)
Q Consensus 43 ~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gpp 122 (639)
.++..-.++++.+.|+|...+.++-. +...+..+|+|++ +.+|.++++.+. +-.... + .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r-~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~-------~-------~~~-- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSR-GKHERVIVVMEHY-TMSLEDILKTGN-LKDESL-------L-------AHG-- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeec-CccceEEEEehhh-ccchHHHHHhcc-cchhhh-------c-------ccc--
Confidence 34677889999999999999987643 3345688999999 469999988765 211111 1 222
Q ss_pred eeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCC
Q 006593 123 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSE 202 (639)
Q Consensus 123 IIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~ 202 (639)
+.|- +.++++| .++ ... .+. ..+++||||+|.++.++..|...+..
T Consensus 88 ~~~~-------------~~~~~td-~~~---t~~--~~~---------------~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 88 VLHL-------------NIIYITD-HFL---TKY--PSP---------------IGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ccee-------------hhhhccc-ccc---ccC--CCC---------------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 3321 2334444 111 100 111 12489999999999999999877755
Q ss_pred CCCHHHHHHHHHcCCCCC---------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 203 CKNPAQIFKKVTSGIKPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 203 ~~~~~~i~~~i~~g~~p~---------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
..+.........-...+. .+....|..+..+..+|+- .|..||...++.+++-|.
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ 198 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT 198 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence 443333222211111111 1122345667888899998 899999999999998885
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.034 Score=61.46 Aligned_cols=78 Identities=18% Similarity=0.039 Sum_probs=52.9
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccc---cCChhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCCceEEEE
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDV---LQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~---~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.|-|....||+..+...++.|++|+-..... ...+...++...|.+.|+.+. -.+++++|.+ +.. ..++|
T Consensus 34 lggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~--~~~lV 109 (401)
T PRK09550 34 IGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE--LAVTV 109 (401)
T ss_pred cCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC--CCEEE
Confidence 3557778999999865446899998542111 012345678888999998872 2467888874 443 36799
Q ss_pred EecCCCCC
Q 006593 79 TELFTSGN 86 (639)
Q Consensus 79 ~Ey~~gGs 86 (639)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.02 Score=60.72 Aligned_cols=75 Identities=9% Similarity=-0.019 Sum_probs=48.1
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC---CCcceEEEEEEeCC-CceEEEEEe
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYKSWVDDK-KKTVNMITE 80 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H---pNIVkl~~~~~~~~-~~~l~lV~E 80 (639)
.|-|..+.||+..+. .| .+.+|..+.. .....+..|...|+.|.- -.|.++++++.+.. ...-++|||
T Consensus 22 i~~G~~~~vy~~~~~-~~-~~~~k~~~~~------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 22 ISEQPYAALWALYDS-QG-NPMPLMARSF------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred cCCccceeEEEEEcC-CC-CEEEEEeccc------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 344555688887542 23 4666764321 012457899999999843 46788888664432 244789999
Q ss_pred cCCCCCH
Q 006593 81 LFTSGNL 87 (639)
Q Consensus 81 y~~gGsL 87 (639)
++.|+++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.017 Score=62.73 Aligned_cols=145 Identities=16% Similarity=0.143 Sum_probs=95.7
Q ss_pred ccccccCcEEEEEEEecCCCeEEEEEEEeccccc--------------------CCh-hhHH-HHHHHHHHHHhCCCCCc
Q 006593 3 LTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL--------------------QLP-GDLQ-KLYSEVHLLKSLKDDNV 60 (639)
Q Consensus 3 G~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~--------------------~~~-~~~~-~l~~Ei~iLk~L~HpNI 60 (639)
|..+.|.-+.||.|.. ..|..+|||+++-+-+. ..+ .... =..+|++.|++|+...|
T Consensus 150 GCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 5566777789999986 56888999987643210 111 1111 13468888999876665
Q ss_pred ceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeeccCCCcEEEeCCC
Q 006593 61 VKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNH 139 (639)
Q Consensus 61 Vkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yL-Hs~gppIIHRDLKp~NILl~~~~ 139 (639)
.----..+. ...|||+|+.....---.-+.-.++...+..+-.|++.-+.-| |.++ +||.||.-=|+|+. .
T Consensus 229 P~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh--d 300 (520)
T KOG2270|consen 229 PCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH--D 300 (520)
T ss_pred CCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE--C
Confidence 322222221 2458999996433221112234577778888888888887776 5556 99999999999995 4
Q ss_pred CcEEEeecchhhhccCC
Q 006593 140 GEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 140 g~VKL~DFGlA~~l~~~ 156 (639)
|.+.|+|.+.+.....+
T Consensus 301 G~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDHP 317 (520)
T ss_pred CEEEEEEccccccCCCh
Confidence 79999999877654443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.033 Score=56.06 Aligned_cols=124 Identities=18% Similarity=0.119 Sum_probs=81.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC----------h-------hhHHHHHHHHHHHHhC---CCCCc-
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL----------P-------GDLQKLYSEVHLLKSL---KDDNV- 60 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~----------~-------~~~~~l~~Ei~iLk~L---~HpNI- 60 (639)
||.|.-- +.||++.. .|..+|+|.++.-..... . .....|..|.+..-+| .+.++
T Consensus 45 Lg~g~~~--~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~ 120 (207)
T PF13095_consen 45 LGHGSHD--GYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLW 120 (207)
T ss_pred cCCCCce--eEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCce
Confidence 5566551 47888875 478999999443222111 0 1234577888776666 45666
Q ss_pred -ceEEEEEEeCC----------------CceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006593 61 -VKFYKSWVDDK----------------KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 123 (639)
Q Consensus 61 -Vkl~~~~~~~~----------------~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppI 123 (639)
|+.|++..-.. .....||-||..... .+..+ -+.+|++-|..+|..| |
T Consensus 121 Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~k~g--I 185 (207)
T PF13095_consen 121 AVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILHKLG--I 185 (207)
T ss_pred EEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHHHCC--e
Confidence 99999874321 112357888776644 22333 3567888889999999 9
Q ss_pred eeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 124 IHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 124 IHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
+-+|+++.|.. + -||+|||.+
T Consensus 186 ~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 186 VPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred eeccCcccccc-C-----CEEEecccC
Confidence 99999999965 2 389999854
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.047 Score=59.57 Aligned_cols=84 Identities=11% Similarity=-0.062 Sum_probs=55.9
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccc---cCChhhHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCCceEEEE
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDV---LQLPGDLQKLYSEVHLLKSLK--DD-NVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~---~~~~~~~~~l~~Ei~iLk~L~--Hp-NIVkl~~~~~~~~~~~l~lV 78 (639)
.|-|....||++.+...+..|+||+-...-. ...+-..++..-|...|+... -| .++++|. .++. ...+|
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e--~~~~v 78 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE--MAVTV 78 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc--cceeh
Confidence 3557778999999864447899998542221 134666788889999998873 24 5677776 3443 35689
Q ss_pred EecCCC-CCHHHHHH
Q 006593 79 TELFTS-GNLRQYRK 92 (639)
Q Consensus 79 ~Ey~~g-GsL~d~lk 92 (639)
||+++. ..|++.+-
T Consensus 79 MEdL~~~~ilR~~Li 93 (370)
T TIGR01767 79 MEDLSHHKIARKGLI 93 (370)
T ss_pred HhhCccchHHHHHHH
Confidence 999955 33555553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.023 Score=59.68 Aligned_cols=70 Identities=19% Similarity=0.072 Sum_probs=43.7
Q ss_pred cCcEEEEEEEecC------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCCceEEEEEe
Q 006593 8 MTPFSSYKAFDEF------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 8 G~v~tVykA~d~~------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~~~~~~~~~l~lV~E 80 (639)
|....+|+..... .+..+++|+..... .......+|.++++.+...+ ..+++.++ .+ .+|++
T Consensus 9 GltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~----~~v~e 77 (302)
T cd05156 9 GLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-----ELLIDRERELVVFARLSERNLGPKLYGIF--PN----GRIEE 77 (302)
T ss_pred cccceeEEEEcCCcccccCCCCeEEEEEecCCC-----cceechHHHHHHHHHHHhCCCCCceEEEe--CC----Cchhh
Confidence 4456788886533 25789988855331 12234578999998885333 35666544 22 25889
Q ss_pred cCCCCCHH
Q 006593 81 LFTSGNLR 88 (639)
Q Consensus 81 y~~gGsL~ 88 (639)
|++|..+.
T Consensus 78 ~i~G~~l~ 85 (302)
T cd05156 78 FIPSRTLT 85 (302)
T ss_pred eeCCCcCC
Confidence 99887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.022 Score=58.48 Aligned_cols=130 Identities=18% Similarity=0.153 Sum_probs=72.0
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCCceEEEEEecCCCCC
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELFTSGN 86 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~~~~~~~~~l~lV~Ey~~gGs 86 (639)
|....+|+.. ..|..+++|....... ...-....|..+++.+....+ .+++.. +. -++||||++|..
T Consensus 7 G~tn~~y~~~--~~~~~~vlR~~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 7 GLTNRSWRIE--HPGISFVWRPQSPVCK----ALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEWLEGEV 74 (256)
T ss_pred cCcCCeEEEE--eCCccEEEeeCCcccc----cccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEeccCcc
Confidence 4455788776 4466788886443211 100124779999999954333 455543 22 258999999876
Q ss_pred HHH-----------H---HHh-C------CCCCH-HHHHHHHHHH---------HHHHHHHHhC------CCCeeeeccC
Q 006593 87 LRQ-----------Y---RKK-H------KNVDI-KVIKNWARQI---------LHGLVYLHSH------NPPIIHRDLK 129 (639)
Q Consensus 87 L~d-----------~---lkk-~------~~l~e-~~i~~i~~QI---------l~aL~yLHs~------gppIIHRDLK 129 (639)
+.. + +.+ | .+++. ..+..+..++ ...+..+-.. .+.++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 532 1 111 1 11121 1222332222 1112222221 1248999999
Q ss_pred CCcEEEeCCCCcEEEeecchhh
Q 006593 130 CDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 130 p~NILl~~~~g~VKL~DFGlA~ 151 (639)
|.||+++++ + +.|+||..|.
T Consensus 155 ~~Nil~~~~-~-~~lIDwE~a~ 174 (256)
T TIGR02721 155 AYNLVVTPQ-G-LKLIDWEYAS 174 (256)
T ss_pred cCcEEEeCC-C-CEEEeccccC
Confidence 999999853 4 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.068 Score=57.89 Aligned_cols=133 Identities=13% Similarity=0.166 Sum_probs=76.4
Q ss_pred cCcEEEEEEEecC----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCCceEEEEEecC
Q 006593 8 MTPFSSYKAFDEF----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELF 82 (639)
Q Consensus 8 G~v~tVykA~d~~----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~~~~~~~~~l~lV~Ey~ 82 (639)
|....+|+..... .+..|++|+..... .....+ ..|+.+++.+..-++ .++++.+ .+. .|++|+
T Consensus 47 GlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~g----~v~efi 115 (344)
T PLN02236 47 AMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PNG----RVEEFI 115 (344)
T ss_pred cccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CCc----eEEEee
Confidence 4455788876422 34678888765321 222233 779999999955444 5666654 221 478898
Q ss_pred CCCCHHHH--------------HHh-CC--------CCCHHHHHHHHHHHHH-----------------HHHH----HHh
Q 006593 83 TSGNLRQY--------------RKK-HK--------NVDIKVIKNWARQILH-----------------GLVY----LHS 118 (639)
Q Consensus 83 ~gGsL~d~--------------lkk-~~--------~l~e~~i~~i~~QIl~-----------------aL~y----LHs 118 (639)
.|-+|..- +++ |. ....+.+..|..++.. .+.. +..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87665311 111 10 1112344455433311 1111 221
Q ss_pred --CCCCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 119 --HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 119 --~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
....++|+|+++.||+++...+.+.|+||..|.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 112489999999999998545689999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.076 Score=55.73 Aligned_cols=30 Identities=20% Similarity=0.259 Sum_probs=23.9
Q ss_pred CeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
.++|+|++|.|||++++....-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 589999999999998432235699999774
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.0056 Score=69.50 Aligned_cols=67 Identities=27% Similarity=0.390 Sum_probs=56.9
Q ss_pred CCceEEEEEecCCCC----CcceeeecccCCCCCHHHHHHHHHhcccCCCccHHHHHHHHHHHHHHhCCCC
Q 006593 336 DTSVSLTLRIADSSG----RVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGW 402 (639)
Q Consensus 336 ~~~i~L~Lri~d~~~----~~~~i~F~f~~~~DTa~~vA~EmV~~~~i~~~d~~~iA~~i~~~i~~l~~~~ 402 (639)
+..++|.+|..|.++ ..+.|+|.|++..|+++.||+|||+++++++.|...+|..+...+.++--..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr 386 (632)
T KOG0584|consen 316 DPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKR 386 (632)
T ss_pred cccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhh
Confidence 345667788888763 3568999999999999999999999999999999999999998887776554
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.086 Score=58.22 Aligned_cols=84 Identities=15% Similarity=0.042 Sum_probs=56.9
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEeccc-c-cCChhhHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCCceEEEEE
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDD-V-LQLPGDLQKLYSEVHLLKSLK--DD-NVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~-~-~~~~~~~~~l~~Ei~iLk~L~--Hp-NIVkl~~~~~~~~~~~l~lV~ 79 (639)
.|-|....||++.+...+..|+||+-...- + ..++-..++..-|.+.|+.+. -| .++++|. .++. ...+||
T Consensus 37 igdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e--~~~~vM 112 (409)
T PRK12396 37 IGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV--MNCCVM 112 (409)
T ss_pred cCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH--HhhHHH
Confidence 456888899999985445679999853211 1 234667889999999999873 34 5677876 3443 356899
Q ss_pred ecCCCC-CHHHHHH
Q 006593 80 ELFTSG-NLRQYRK 92 (639)
Q Consensus 80 Ey~~gG-sL~d~lk 92 (639)
|+++.. .|++.+-
T Consensus 113 EdL~~~~ilR~~Li 126 (409)
T PRK12396 113 EDLSDHTILRTALI 126 (409)
T ss_pred HhCcccHHHHHHHH
Confidence 999553 3555543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.11 Score=55.93 Aligned_cols=139 Identities=14% Similarity=0.148 Sum_probs=81.7
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCCceEEEEEecCCCC
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMITELFTSG 85 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~~~~~~~~~l~lV~Ey~~gG 85 (639)
|....+|...+. ++.+++. .. ..........+..+|+.+|+.+.- -.+.+.++.+.++.....|+||+|+.|.
T Consensus 36 G~sn~t~~~~~~--~~~~vlR-~P--~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 36 GWSNDTFRLGDT--GQKYVLR-KP--PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred CcccceEEEecC--CceEEEe-cC--CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 334455656554 6777766 22 111233566778899999998853 3345555555444324678999999983
Q ss_pred CH---------H-HH--------HHh-C-------------CCCCHHHHHHHHHHH--------------HHHHHHHHhC
Q 006593 86 NL---------R-QY--------RKK-H-------------KNVDIKVIKNWARQI--------------LHGLVYLHSH 119 (639)
Q Consensus 86 sL---------~-d~--------lkk-~-------------~~l~e~~i~~i~~QI--------------l~aL~yLHs~ 119 (639)
.+ . .+ |.. | .......+..|..+. ..-..+|+.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 22 1 12 210 0 011222333333333 2224566655
Q ss_pred CC------CeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 120 NP------PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 120 gp------pIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
-| .++|+|+.+.||++++. +.+-+.||+++..
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~l 228 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATL 228 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCC-CeeEEEecccccc
Confidence 43 69999999999999844 5699999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.27 Score=54.66 Aligned_cols=81 Identities=12% Similarity=-0.068 Sum_probs=53.2
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEeccccc---CChhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCCceEEEE
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL---QLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~---~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.|-|....||+..+. +..|+||+-...-.. .++....+...|...|+.+. ..+++++|.+. ++ .-+++
T Consensus 40 iggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~~vlv 113 (418)
T PLN02756 40 VGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RT--MALIG 113 (418)
T ss_pred cCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--CCEEE
Confidence 466888899998873 456999986522221 12235667777888887774 24788898854 33 25688
Q ss_pred EecCCC--CCHHHHH
Q 006593 79 TELFTS--GNLRQYR 91 (639)
Q Consensus 79 ~Ey~~g--GsL~d~l 91 (639)
||++++ ..+++.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999977 3455544
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.67 Score=49.00 Aligned_cols=28 Identities=32% Similarity=0.420 Sum_probs=23.2
Q ss_pred CeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
.+||+|+.|.||+++++ ...-|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~ 215 (319)
T PRK05231 188 GVIHADLFRDNVLFEGD-RLSGFIDFYFA 215 (319)
T ss_pred ccCCCCCCCCcEEEECC-ceEEEEecccc
Confidence 49999999999999843 34579999876
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.027 Score=60.29 Aligned_cols=132 Identities=19% Similarity=0.126 Sum_probs=90.5
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccc-----cCC-----------hhhH--HHHHHHHHHHHhCCC--CCcceEE
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDV-----LQL-----------PGDL--QKLYSEVHLLKSLKD--DNVVKFY 64 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~-----~~~-----------~~~~--~~l~~Ei~iLk~L~H--pNIVkl~ 64 (639)
.|-|.-+-||.+-+ ..|.+.++|.-++... ... ...+ -...+|+..|+.|.- --|.+.+
T Consensus 100 IGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpi 178 (465)
T KOG2268|consen 100 IGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPI 178 (465)
T ss_pred cccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 45566668999988 5688888886543221 111 1111 235689999999943 4466666
Q ss_pred EEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEE
Q 006593 65 KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144 (639)
Q Consensus 65 ~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL 144 (639)
++ .+.++|||++.|-.|.+..+- ..+..+...++.-+.-|-.+| +||+|..-=||++. +++.+++
T Consensus 179 D~------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~-dd~~i~v 243 (465)
T KOG2268|consen 179 DH------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK-DDDKIVV 243 (465)
T ss_pred cc------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcC--ceecccchheeEEe-cCCCEEE
Confidence 52 347899999999888764321 223345556666677788999 99999999999998 4578999
Q ss_pred eecchhhh
Q 006593 145 GDLGLAIA 152 (639)
Q Consensus 145 ~DFGlA~~ 152 (639)
+||-....
T Consensus 244 IDFPQmvS 251 (465)
T KOG2268|consen 244 IDFPQMVS 251 (465)
T ss_pred eechHhhc
Confidence 99976543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.31 Score=51.53 Aligned_cols=135 Identities=19% Similarity=0.142 Sum_probs=72.4
Q ss_pred ccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC--CcceEEEEE----EeCCCceEEEEEe
Q 006593 7 YMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSW----VDDKKKTVNMITE 80 (639)
Q Consensus 7 fG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~~----~~~~~~~l~lV~E 80 (639)
.|....+|+... ..| .+++|+..... . ...+..|++++..|... .+.+++..- .....+..+++++
T Consensus 32 ~G~~n~~y~v~t-~~~-~~vLK~~~~~~---~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 32 EGVENSNYLLTT-DVG-RYILTLYEKRV---K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred CccccceEEEEe-CCC-cEEEEEecCCC---C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 444567888754 334 57788765321 1 23356677888777422 244554421 1111245789999
Q ss_pred cCCCCCH-----HHHH------Hh-C---CCC--------CHHHHH---------------HHHHHHHHHHHHHHh----
Q 006593 81 LFTSGNL-----RQYR------KK-H---KNV--------DIKVIK---------------NWARQILHGLVYLHS---- 118 (639)
Q Consensus 81 y~~gGsL-----~d~l------kk-~---~~l--------~e~~i~---------------~i~~QIl~aL~yLHs---- 118 (639)
|++|..+ .++. .+ | ..+ ...... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988543 1111 00 0 000 011100 001123334555543
Q ss_pred -CCCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 119 -HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 119 -~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
....++|+|+.+.||+++++ +.+.|+||+.+
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~ 215 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFA 215 (307)
T ss_pred cCCCccCCCCCCcCcEEEECC-ceEEEeecccc
Confidence 12359999999999999854 55689999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.39 Score=50.08 Aligned_cols=134 Identities=15% Similarity=0.156 Sum_probs=73.0
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC--CcceEEEE----EEeCCCceEEEEEec
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKS----WVDDKKKTVNMITEL 81 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~----~~~~~~~~l~lV~Ey 81 (639)
|....+|+... .+..+++|+.... ....+..|+.++..|.+. .+.+++.. +........++|+++
T Consensus 25 G~~n~~y~v~~--~~~~~vLr~~~~~-------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 25 GIENTNYFVTT--DSGRYVLTLFEKV-------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ccccceEEEEe--CCCcEEEEEcCCC-------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 44457887653 2346888876531 124567788888888433 24555442 011112346789999
Q ss_pred CCCCCHHH-----H------HHh-C---CCCC--------HHHHH------------HHHHHHHHHHHHHHhC-----CC
Q 006593 82 FTSGNLRQ-----Y------RKK-H---KNVD--------IKVIK------------NWARQILHGLVYLHSH-----NP 121 (639)
Q Consensus 82 ~~gGsL~d-----~------lkk-~---~~l~--------e~~i~------------~i~~QIl~aL~yLHs~-----gp 121 (639)
++|..+.. + +.+ | ..+. ..... .....+..++.++... ..
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876421 1 100 0 0000 00000 0111223344454431 12
Q ss_pred CeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
.++|+|+.|.||++++ ++.+.|.||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 4999999999999984 4456899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.2 Score=53.90 Aligned_cols=133 Identities=15% Similarity=0.130 Sum_probs=73.8
Q ss_pred cCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCCceEEEEEecCC
Q 006593 8 MTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELFT 83 (639)
Q Consensus 8 G~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~~~~~~~~~l~lV~Ey~~ 83 (639)
|....+|+...... +..|++++..... ...+. -.+|..+++.+..-++ .++++++ .+. +|.+|+.
T Consensus 25 GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~~Id-R~~E~~il~~l~~~gl~P~~l~~~--~~G----~i~~fi~ 93 (330)
T PLN02421 25 GITNLLLKVSVKEENGNEVSVTVRLFGPNT----DYVID-RERELQAIKYLSAAGFGAKLLGVF--GNG----MIQSFIN 93 (330)
T ss_pred cccceEEEEEecCCCCCCceEEEEEecCCc----CeEec-hHHHHHHHHHHHhcCCCCceeEEe--CCc----Eeehhhc
Confidence 44456787764322 3478888764321 11111 3679999999965555 5666654 222 4789998
Q ss_pred CCCHHH-------HH-------Hh-CC-C------C-CHHHHHHHHHHH-------------------------HHHHHH
Q 006593 84 SGNLRQ-------YR-------KK-HK-N------V-DIKVIKNWARQI-------------------------LHGLVY 115 (639)
Q Consensus 84 gGsL~d-------~l-------kk-~~-~------l-~e~~i~~i~~QI-------------------------l~aL~y 115 (639)
|-+|.. .+ ++ |. . . -...+..|..++ +..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 765521 11 11 11 0 1 122333333332 111221
Q ss_pred -HHhCC--CCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 116 -LHSHN--PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 116 -LHs~g--ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+...+ .-++|.||.+.||+++.+.+.++++||..|.
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21212 1379999999999997555689999998763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.14 Score=55.81 Aligned_cols=89 Identities=17% Similarity=0.131 Sum_probs=62.7
Q ss_pred hCCCCCcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcE
Q 006593 54 SLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133 (639)
Q Consensus 54 ~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NI 133 (639)
.+.-++..+.+-+-. ....+.|++|++- |++|.- .+.-..+++..++.+.+.-|.-+...- +.-|||+.-+||
T Consensus 281 ~~g~~~~e~~~vv~~-de~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~ni 353 (488)
T COG5072 281 ECGSVFLETLKVVSL-DETLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNI 353 (488)
T ss_pred hccchhhhcceEEec-CCceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccce
Confidence 333444444443222 3456888999987 455542 223456777788888888777777664 699999999999
Q ss_pred EEeCCCCcEEEeecchhh
Q 006593 134 FVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 134 Ll~~~~g~VKL~DFGlA~ 151 (639)
||+ .|.|.|+||-+++
T Consensus 354 LId--~GnvtLIDfklsR 369 (488)
T COG5072 354 LID--EGNVTLIDFKLSR 369 (488)
T ss_pred eee--cCceEEEEeeeee
Confidence 997 4899999999987
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.78 E-value=0.75 Score=48.72 Aligned_cols=29 Identities=10% Similarity=0.104 Sum_probs=24.6
Q ss_pred CeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
.++|+|+.++|++++++ +.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhcc
Confidence 49999999999999744 689999997663
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.82 E-value=1.1 Score=46.06 Aligned_cols=102 Identities=16% Similarity=0.244 Sum_probs=66.0
Q ss_pred EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHH
Q 006593 25 VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKN 104 (639)
Q Consensus 25 VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~ 104 (639)
..+|.++-..+.- ...-++.+..++.++. .|+++.. ++.-.+-+|.|+|..-..- ...
T Consensus 88 L~lKKi~slp~~~---~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i~-------------~~N 145 (308)
T PF07387_consen 88 LFLKKIRSLPCCI---NDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKIN-------------FSN 145 (308)
T ss_pred hhhhhccCCCccc---chhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcccc-------------hhH
Confidence 4455555444421 1233567788887764 5777763 2333466889999642111 112
Q ss_pred HHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 105 i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
++.-=+.+|.-.|+..+..+|+|-.|+||+-+ ..|.+||.|-+.
T Consensus 146 ~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D-~~G~lKlVDP~~ 189 (308)
T PF07387_consen 146 FITAGIKDLMDFHSENQHCLHGDCNPDNIMCD-KFGYLKLVDPVC 189 (308)
T ss_pred HHHHhHHHHHHhhccCCCeecCCCChhheeec-CCCCEEecChhh
Confidence 22223567888997777899999999999998 568999999763
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.39 E-value=1.2 Score=49.15 Aligned_cols=37 Identities=19% Similarity=0.189 Sum_probs=27.3
Q ss_pred HHHHHHHHhCCCCCc-ceEEEEEEeCCCceEEEEEecCCCCCHH
Q 006593 46 YSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELFTSGNLR 88 (639)
Q Consensus 46 ~~Ei~iLk~L~HpNI-Vkl~~~~~~~~~~~l~lV~Ey~~gGsL~ 88 (639)
.+|+++++.|...++ .++++.+ . -++|.||++|-+|.
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f--~----~g~l~efIeGr~l~ 137 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRF--G----DFTIQEWVEGNTMG 137 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEec--C----CEEEEEEeccccCC
Confidence 679999999966555 6777765 2 24889999987653
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=88.83 E-value=3.2 Score=42.93 Aligned_cols=70 Identities=16% Similarity=0.119 Sum_probs=45.7
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC---CcceEEEEEEeCCCceEEEEEecCCC
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDKKKTVNMITELFTS 84 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp---NIVkl~~~~~~~~~~~l~lV~Ey~~g 84 (639)
|.+...|+..+- ..++-+|+=. ......+..|+.-|+.|... .|.+++. ....+.+.|+|+||++-
T Consensus 27 G~inea~~v~dg--~~~~FvK~n~-------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylVle~L~~ 95 (286)
T COG3001 27 GDINEAWRLRDG--TDPFFVKCNQ-------REQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLVLEYLPT 95 (286)
T ss_pred ccccceeEeecC--CcceEEEecc-------hhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEEEeeccC
Confidence 545555655442 3456666522 34456788898888887544 4667766 44556789999999988
Q ss_pred CCHH
Q 006593 85 GNLR 88 (639)
Q Consensus 85 GsL~ 88 (639)
|.+.
T Consensus 96 ~~~d 99 (286)
T COG3001 96 GPLD 99 (286)
T ss_pred CCCC
Confidence 7664
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=88.66 E-value=2.4 Score=45.01 Aligned_cols=68 Identities=16% Similarity=-0.015 Sum_probs=39.7
Q ss_pred ccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCCceEEEEEecCC
Q 006593 7 YMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNMITELFT 83 (639)
Q Consensus 7 fG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~~~l~lV~Ey~~ 83 (639)
-|....+|+.. ..+..+.+|.-... ....+..|..-|+.|. --.+++.+.+....+. -+|||||+.
T Consensus 27 GG~i~~a~~~~--~~~~~~FvK~~~~~-------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLlle~l~ 95 (288)
T PF03881_consen 27 GGDINEAYRLD--TDGGSYFVKVNSES-------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLLLEFLE 95 (288)
T ss_dssp -SSSSEEEEEE--TTS-EEEEEEEEGG-------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEEEE---
T ss_pred CCChhheEEEE--CCCccEEEEecChh-------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEEEEeec
Confidence 36667888776 56778999976622 2234788888888883 3446788876554433 479999998
Q ss_pred CC
Q 006593 84 SG 85 (639)
Q Consensus 84 gG 85 (639)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.39 E-value=9.4 Score=40.90 Aligned_cols=72 Identities=11% Similarity=-0.041 Sum_probs=39.6
Q ss_pred CcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--cceEE---EEEEeCCCceEEEEEecCC
Q 006593 9 TPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFY---KSWVDDKKKTVNMITELFT 83 (639)
Q Consensus 9 ~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~---~~~~~~~~~~l~lV~Ey~~ 83 (639)
....||+... ..|..+++|+.+... -....+..|++++..|.... |+... +-.+..-....+.++++++
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~-----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPER-----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCccc-----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 3457888865 446678888765322 12344677888887773211 22211 1000011235677899988
Q ss_pred CCC
Q 006593 84 SGN 86 (639)
Q Consensus 84 gGs 86 (639)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 754
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.35 E-value=13 Score=46.43 Aligned_cols=30 Identities=30% Similarity=0.511 Sum_probs=24.0
Q ss_pred CeeeeccCCCcEEEeCCC-CcEE-Eeecchhh
Q 006593 122 PIIHRDLKCDNIFVNGNH-GEVK-IGDLGLAI 151 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~-g~VK-L~DFGlA~ 151 (639)
.+||.|+.+.|||++++. +.+. |+|||-+.
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 499999999999998542 1455 99999774
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=86.90 E-value=1.3 Score=46.45 Aligned_cols=27 Identities=26% Similarity=0.417 Sum_probs=23.4
Q ss_pred CeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
.++|+|+.+.||++++ +.+.|+||+.+
T Consensus 188 ~liHgD~~~~Nil~~~--~~i~lIDfd~~ 214 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD--NEVYVIDFDYC 214 (313)
T ss_pred ceEcCCCCcccEEEeC--CcEEEEECccc
Confidence 4999999999999984 46899999855
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=82.03 E-value=0.34 Score=54.55 Aligned_cols=64 Identities=13% Similarity=0.296 Sum_probs=54.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~ 70 (639)
.+|.|||| +|+.+..+..+..+|||++...+. .....+..+|..-+..+.|+++++++..|...
T Consensus 56 ~~~~~g~~---~~~~~~n~~d~~~~avkritlkn~---e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 56 CLGRGGFG---VVFSAQNKADENKYAVKRITLKNR---EESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred cccccCcc---ccCCccccccchhhHHHHhcccch---hhhhhhhhccccchhhhcccchhhheeceecC
Confidence 47889999 688898888888999999988764 45567788999999999999999999988654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 639 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-69 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-18 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 9e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-132
Identities = 130/247 (52%), Positives = 168/247 (68%), Gaps = 5/247 (2%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD--DK 71
YK D +EVAW ++ + Q+ E +LK L+ N+V+FY SW
Sbjct: 43 YKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
KK + ++TEL TSG L+ Y K+ K + IKV+++W RQIL GL +LH+ PPIIHRDLKCD
Sbjct: 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 191
NIF+ G G VKIGDLGLA + A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+L
Sbjct: 161 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 220
Query: 192 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 250
EM T EYPYSEC+N AQI+++VTSG+KPAS KV P++K IE C+ ER S KDL
Sbjct: 221 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280
Query: 251 LKDPFLQ 257
L F Q
Sbjct: 281 LNHAFFQ 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-56
Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 18/262 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
K + G + W + + Q L SEV+LL+ LK N+V++Y +D
Sbjct: 23 QKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80
Query: 74 TVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP---IIHR 126
T+ ++ E G+L + K+ + +D + + Q+ L H + ++HR
Sbjct: 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 140
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDI 183
DLK N+F++G VK+GD GLA + T A++ +GTP +M+PE YNE DI
Sbjct: 141 DLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDI 199
Query: 184 YSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-A 241
+S G C+L E+ P+ + ++ K+ G K + ++ I + L
Sbjct: 200 WSLG-CLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKD 256
Query: 242 SERLSAKDLLKDPFLQVENQKE 263
R S +++L++P + +
Sbjct: 257 YHRPSVEEILENPLILEHHHHH 278
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-56
Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 16/248 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
+K + G A R + P D + +EV + + V+ ++W +
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 73 KTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ + TE +L+Q+ + ++ + + R L L +LHS ++H D+K
Sbjct: 132 --LYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPA 186
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCI 190
NIF+ G K+GD GL + + G P +MAPEL + Y D++S G+ I
Sbjct: 187 NIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTI 245
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 249
LE+ + Q+ + A L +++ + L P R +A+
Sbjct: 246 LEVACNMELPHGGEGWQQLRQGYLPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEA 301
Query: 250 LLKDPFLQ 257
LL P L+
Sbjct: 302 LLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-55
Identities = 57/250 (22%), Positives = 115/250 (46%), Gaps = 15/250 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
G + + I + ++ EV +L ++K N+V++ +S+ ++
Sbjct: 41 ILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKHPNIVQYRESFEENGS- 97
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ ++ + G+L + K V I +W QI L ++H I+HRD+K
Sbjct: 98 -LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQ 154
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSFGM 188
NIF+ + G V++GD G+A + AR+ IGTP +++PE+ E + YN DI++ G
Sbjct: 155 NIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGC 213
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 247
+ E+ T ++ + E + + K+ SG ++ ++ + + +R S
Sbjct: 214 VLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSV 271
Query: 248 KDLLKDPFLQ 257
+L+ F+
Sbjct: 272 NSILEKGFIA 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-54
Identities = 79/259 (30%), Positives = 120/259 (46%), Gaps = 17/259 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y D + +A + D Q L+ E+ L K LK N+V++ S+ ++
Sbjct: 39 YAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF- 93
Query: 74 TVNMITELFTSGNLRQ-YRKKHKNVDIK--VIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ + E G+L R K + I + +QIL GL YLH + I+HRD+K
Sbjct: 94 -IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKG 150
Query: 131 DNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE---LYEEEYNELVDIYS 185
DN+ +N G +KI D G + +A P + GT ++MAPE Y + DI+S
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWS 210
Query: 186 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 244
G I+EM T + P+ E P KV + + + K FI KC P +R
Sbjct: 211 LGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270
Query: 245 LSAKDLLKDPFLQVENQKE 263
A DLL D FL+V ++K+
Sbjct: 271 ACANDLLVDEFLKVSSKKK 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-54
Identities = 65/269 (24%), Positives = 108/269 (40%), Gaps = 38/269 (14%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--- 70
+KA G RVK ++ +K EV L L N+V + W
Sbjct: 28 FKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79
Query: 71 -----------KKKTVNMITELFTSGNLRQYRKKHKNVDI--KVIKNWARQILHGLVYLH 117
K K + + E G L Q+ +K + + + QI G+ Y+H
Sbjct: 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH 139
Query: 118 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPELYEEE 176
S +I+RDLK NIF+ +VKIGD GL +++ R GT +M+PE +
Sbjct: 140 SKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ 196
Query: 177 -YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235
Y + VD+Y+ G+ + E++ E F + GI D + K ++
Sbjct: 197 DYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIISDIF----DKKEKTLLQ 249
Query: 236 KCLVP-ASERLSAKDLLKDPFLQVENQKE 263
K L +R + ++L+ + + E
Sbjct: 250 KLLSKKPEDRPNTSEILRTLTVW-KKSPE 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-53
Identities = 70/253 (27%), Positives = 122/253 (48%), Gaps = 15/253 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+A G+ VA +V+I D L E+ LLK L NV+K+Y S+++D
Sbjct: 49 YRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-- 105
Query: 74 TVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+N++ EL +G+L + ++K+ + + + + + Q+ L ++HS ++HRD+K
Sbjct: 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIK 163
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE-YNELVDIYSF 186
N+F+ G VK+GDLGL T A S++GTP +M+PE E YN DI+S
Sbjct: 164 PANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL 222
Query: 187 GMCILEMVTFEYPY-SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 244
G + EM + P+ + N + KK+ P + +++ + C+ P +R
Sbjct: 223 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282
Query: 245 LSAKDLLKDPFLQ 257
+
Sbjct: 283 PDVTYVYDVAKRM 295
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 9e-52
Identities = 61/273 (22%), Positives = 114/273 (41%), Gaps = 39/273 (14%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--- 70
++A ++ A R+++ + +K+ EV L L+ +V+++ +W++
Sbjct: 22 FEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78
Query: 71 -------KKKTVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHN 120
K + + +L NL+ + R + + V + QI + +LHS
Sbjct: 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG 138
Query: 121 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--------------SVIGTPE 166
++HRDLK NIF + VK+GD GL AM Q +GT
Sbjct: 139 --LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL 195
Query: 167 FMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 225
+M+PE Y+ VDI+S G+ + E++ YP+S + V + P +
Sbjct: 196 YMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRNLKFPPLFTQK 252
Query: 226 NDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
P ++ L P ER A +++++ +
Sbjct: 253 Y-PCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-51
Identities = 84/290 (28%), Positives = 124/290 (42%), Gaps = 44/290 (15%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--- 70
KA + A +++ + L + SEV LL SL VV++Y +W++
Sbjct: 23 VKARNALDSRYYAIKKIRHTE-----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77
Query: 71 --------KKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNP 121
KK T+ + E +G L ++ N RQIL L Y+HS
Sbjct: 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG- 136
Query: 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR----------------SVIGTP 165
IIHRDLK NIF++ + VKIGD GLA + + S IGT
Sbjct: 137 -IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTA 194
Query: 166 EFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PAS 221
++A E+ + YNE +D+YS G+ EM+ YP+S I KK+ S P
Sbjct: 195 MYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKLRSVSIEFPPD 251
Query: 222 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 270
K I + ++R A+ LL +L V++Q E I + LK
Sbjct: 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 56/273 (20%), Positives = 105/273 (38%), Gaps = 23/273 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ D+ G + A +V+++ E+ L +V Y + +
Sbjct: 75 HRMKDKQTGFQCAVKKVRLEVFRV---------EELVACAGLSSPRIVPLYGAVREGPW- 124
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
VN+ EL G+L Q K+ + + Q L GL YLH+ I+H D+K DN+
Sbjct: 125 -VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNV 181
Query: 134 FVNGNHGEVKIGDLGLA-------IAMQQPTARSVIGTPEFMAPELYEEE-YNELVDIYS 185
++ + + D G A + T + GT MAPE+ + + VDI+S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 186 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 244
+L M+ +P+++ K + + P I++ L R
Sbjct: 242 SCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
Query: 245 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 277
SA +L + ++ + + P K + +
Sbjct: 302 ASAMELRRKVGKALQ-EVGGLKSPWKGEYKEPR 333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 57/279 (20%), Positives = 105/279 (37%), Gaps = 40/279 (14%)
Query: 11 FSS-YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWV 68
F S +K G A R K D Q EV+ L +VV+++ +W
Sbjct: 24 FGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 81
Query: 69 DDKKKTVNMITELFTSGNLRQYRKKHKNVDI----KVIKNWARQILHGLVYLHSHNPPII 124
+D + + E G+L ++ + +K+ Q+ GL Y+HS + ++
Sbjct: 82 EDDH--MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LV 137
Query: 125 HRDLKCDNIFVNGN------------------HGEVKIGDLGLAIAMQQPTARSVIGTPE 166
H D+K NIF++ KIGDLG + + + G
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH--VTRISSPQVEEGDSR 195
Query: 167 FMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 224
F+A E+ +E + DI++ + ++ E + ++ G P + +
Sbjct: 196 FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGRLP-RIPQ 250
Query: 225 VNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 262
V + ++ + P R SA L+K L ++K
Sbjct: 251 VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 20/230 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
KA ++ +VA +K ++ + + E+ L + N+VK Y +
Sbjct: 25 CKA--KWRAKDVA---IK---QIESESERKAFIVELRQLSRVNHPNIVKLYGAC----LN 72
Query: 74 TVNMITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLK 129
V ++ E G+L + +W Q G+ YLHS P +IHRDLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGM 188
N+ + +KI D G A +Q + G+ +MAPE++E Y+E D++S+G+
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQT-HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 189 CILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKC 237
+ E++T P+ E PA I V +G +P L K I+ + +C
Sbjct: 192 ILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLMTRC 240
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-49
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 25/240 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKI------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSW 67
+K VA +K + ++ Q+ EV ++ +L N+VK Y
Sbjct: 36 HKGRLVKDKSVVA---IKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92
Query: 68 VDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
M+ E G+L K + V I G+ Y+ + NPPI+HR
Sbjct: 93 ----HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHR 148
Query: 127 DLKCDNIFVNGNHGE----VKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE---YNE 179
DL+ NIF+ K+ D GL+ + ++G ++MAPE E Y E
Sbjct: 149 DLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 180 LVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237
D YSF M + ++T E P+ E I G++P ++ + P+++ IE C
Sbjct: 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPEDCPPRLRNVIELC 266
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-48
Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 14/223 (6%)
Query: 22 GIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80
G +VA VKI + + + EV ++K L+ N+V F + + ++++TE
Sbjct: 60 GSDVA---VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT--QPPNLSIVTE 114
Query: 81 LFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137
+ G+L + + +D + + A + G+ YLH+ NPPI+HR+LK N+ V+
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD- 173
Query: 138 NHGEVKIGDLGLAIAMQQ--PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 194
VK+ D GL+ +++S GTPE+MAPE+ E NE D+YSFG+ + E+
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 195 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237
T + P+ + + + + +PQ+ IE C
Sbjct: 234 TLQQPWGNLNPAQVVAAVGFKCKRL-EIPRNLNPQVAAIIEGC 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-47
Identities = 58/320 (18%), Positives = 130/320 (40%), Gaps = 38/320 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKD--DNVVKFYKSWVDD 70
++ +E A +K ++ + L +E+ L L+ D +++ Y + D
Sbjct: 26 FQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ + M+ E + +L + KK K++D K++ + +L + +H H I+H DLK
Sbjct: 82 QY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP 136
Query: 131 DNI-FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPEL------------Y 173
N V+G +K+ D G+A MQ T S +GT +M PE
Sbjct: 137 ANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 193
Query: 174 EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233
+ + + D++S G + M + P+ + N + + + ++
Sbjct: 194 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 253
Query: 234 IEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDID 292
++ CL +R+S +LL P++Q++ ++ + + ++ + ++
Sbjct: 254 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVN-----QMAKGTTEEMKYVLGQLVGLNSP 308
Query: 293 SDYKQLSLSTCTESNNGSPH 312
+ + + + + G H
Sbjct: 309 NSILKAAKTLYEHYSGGESH 328
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 59/273 (21%), Positives = 116/273 (42%), Gaps = 35/273 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDD 70
++ +E A +K ++ + L +E+ L L+ D +++ Y + D
Sbjct: 45 FQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ + M+ E + +L + KK K++D K++ + +L + +H H I+H DLK
Sbjct: 101 QY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP 155
Query: 131 DNI-FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEE--------- 176
N V+G +K+ D G+A MQ T S +GT +M PE ++
Sbjct: 156 ANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKS 212
Query: 177 ---YNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232
+ D++S G CIL M + P+ + N + + + ++
Sbjct: 213 KSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 233 FIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 264
++ CL +R+S +LL P++Q++
Sbjct: 272 VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 2e-46
Identities = 62/288 (21%), Positives = 121/288 (42%), Gaps = 37/288 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDD 70
++ +E A +K ++ + L +E+ L L+ D +++ Y + D
Sbjct: 73 FQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ + M+ E + +L + KK K++D K++ + +L + +H H I+H DLK
Sbjct: 129 QY--IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKP 183
Query: 131 DNI-FVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEE--------- 176
N V+G +K+ D G+A MQ T S +G +M PE ++
Sbjct: 184 ANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 177 ---YNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232
+ D++S G CIL M + P+ + N + + + ++
Sbjct: 241 KSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 299
Query: 233 FIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKML 279
++ CL +R+S +LL P++Q Q P+ K + +K +
Sbjct: 300 VLKCCLKRDPKQRISIPELLAHPYVQ--IQTHPVNQMAKGTTEEMKYV 345
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-45
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 13/225 (5%)
Query: 22 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81
G EVA + D + ++ + E L LK N++ + K+ + ++ E
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL--KEPNLCLVMEF 87
Query: 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLKCDNIFVN---- 136
G L + + + ++ NWA QI G+ YLH PIIHRDLK NI +
Sbjct: 88 ARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 137 ---GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILE 192
++ +KI D GLA + T S G +MAPE+ +++ D++S+G+ + E
Sbjct: 147 NGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237
++T E P+ A + + + + +E C
Sbjct: 207 LLTGEVPFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKLMEDC 250
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-45
Identities = 42/223 (18%), Positives = 86/223 (38%), Gaps = 15/223 (6%)
Query: 22 GIEVAWSRVKIDDVLQLPGDLQKLY-SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80
G ++ VK+ V + + E L+ NV+ + +IT
Sbjct: 33 GNDIV---VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89
Query: 81 LFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 138
G+L + VD +A + G+ +LH+ P I L ++ ++
Sbjct: 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-E 148
Query: 139 HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMV 194
+I + + Q P + P ++APE +++ D++SF + + E+V
Sbjct: 149 DMTARISMADVKFSFQSPG---RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 195 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237
T E P+++ N K G++P ++ P + ++ C
Sbjct: 206 TREVPFADLSNMEIGMKVALEGLRP-TIPPGISPHVSKLMKIC 247
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-44
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 28/234 (11%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---RKKHKNVDI 99
++ + N V + K + + +L NL+ + R ++ +
Sbjct: 106 DAPSVKIRRMDPFSTKNTVGQLQPS--SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
V + QI + +LHS ++HRDLK NIF + VK+GD GL AM Q
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEE 220
Query: 160 --------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECK 204
+GT +M+PE Y+ VDI+S G+ + E++ Y +S
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQM 277
Query: 205 NPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
+I V + P + PQ ++ L P +ER A D++++ +
Sbjct: 278 ERVRIITDVRNLKFPLLFTQKY-PQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 53/233 (22%), Positives = 101/233 (43%), Gaps = 29/233 (12%)
Query: 24 EVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 82
EVA +++ D+ + D L+ EV + + +NVV F + + + +IT L
Sbjct: 57 EVA---IRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM--SPPHLAIITSLC 111
Query: 83 TSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141
L R +D+ + A++I+ G+ YLH+ I+H+DLK N+F ++G+
Sbjct: 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFY--DNGK 167
Query: 142 VKIGDLGLA-------IAMQQPTARSVIGTPEFMAPEL----------YEEEYNELVDIY 184
V I D GL ++ R G +APE+ + +++ D++
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 185 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237
+ G E+ E+P+ + I ++ +G+KP +I + C
Sbjct: 228 ALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 22/227 (9%)
Query: 24 EVAWSRVKIDDVLQLPGDLQKLY-SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 82
+VA VK+ +V + + +EV +L+ + N++ F + ++T+
Sbjct: 48 DVA---VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS---TAPQLAIVTQWC 101
Query: 83 TSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141
+L + ++K + + ARQ G+ YLH+ + IIHRDLK +NIF+
Sbjct: 102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL-HEDNT 158
Query: 142 VKIGDLGLAIAMQQ----PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEM 193
VKIGD GLA + + G+ +MAPE+ + Y+ D+Y+FG+ + E+
Sbjct: 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
Query: 194 VTFEYPYSECKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKC 237
+T + PYS N QI + V G L+KV ++K + +C
Sbjct: 219 MTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 78/258 (30%), Positives = 132/258 (51%), Gaps = 34/258 (13%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
A ++ +G +VA VK+ D+ + + L++EV +++ + NVV+ YKS++ ++
Sbjct: 62 CLAREKHSGRQVA---VKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 74 TVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
V M +T++ + L + I + +L L YLH+ +IHR
Sbjct: 118 WVLMEFLQGGALTDIVSQVRLNEE-------QIATV---CEAVLQALAYLHAQG--VIHR 165
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPEL-YEEEYNELVDI 183
D+K D+I + + G VK+ D G I+ P +S++GTP +MAPE+ Y VDI
Sbjct: 166 DIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDI 224
Query: 184 YSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP 240
+S G+ ++EMV E PY +P Q + + S P L + P ++ F+E+ LV
Sbjct: 225 WSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSP--PPKLKNSHKVSPVLRDFLERMLVR 281
Query: 241 -ASERLSAKDLLKDPFLQ 257
ER +A++LL PFL
Sbjct: 282 DPQERATAQELLDHPFLL 299
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 80/268 (29%), Positives = 128/268 (47%), Gaps = 31/268 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+K D VA +KI D+ + +++ + E+ +L V K+Y S++ D K
Sbjct: 39 FKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95
Query: 74 TVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
+ M +L G L + I I R+IL GL YLHS IHR
Sbjct: 96 WIIMEYLGGGSALDLLEPGPLDE-------TQIATI---LREILKGLDYLHSEK--KIHR 143
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEE-EYNELVDI 183
D+K N+ ++ HGEVK+ D G+A + + + +GTP +MAPE+ ++ Y+ DI
Sbjct: 144 DIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 184 YSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-A 241
+S G+ +E+ E P+SE +P + +F + P +L +K F+E CL
Sbjct: 203 WSLGITAIELARGEPPHSE-LHPMKVLFLIPKN--NPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 242 SERLSAKDLLKDPFLQVENQKEPICDPL 269
S R +AK+LLK F+ +K L
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTEL 287
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 74/258 (28%), Positives = 129/258 (50%), Gaps = 34/258 (13%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y A D G EVA ++ ++ Q P + + +E+ +++ K+ N+V + S++ +
Sbjct: 37 YTAMDVATGQEVA---IRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92
Query: 74 TVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
V M +T++ T + + I + R+ L L +LHS+ +IHR
Sbjct: 93 WVVMEYLAGGSLTDVVTETCMDE-------GQIAAV---CRECLQALEFLHSNQ--VIHR 140
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPEL-YEEEYNELVDI 183
D+K DNI + + G VK+ D G I +Q +++GTP +MAPE+ + Y VDI
Sbjct: 141 DIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 184 YSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCL-V 239
+S G+ +EM+ E PY +NP + ++ T+G L + F+ +CL +
Sbjct: 200 WSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNG--TPELQNPEKLSAIFRDFLNRCLEM 256
Query: 240 PASERLSAKDLLKDPFLQ 257
+R SAK+LL+ FL+
Sbjct: 257 DVEKRGSAKELLQHQFLK 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 35/270 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
A+ +VA +K ++ + + +L E+ + N+V +Y S+V +
Sbjct: 32 QAAYCAPKKEKVA---IKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88
Query: 74 TVNM-------ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
+ M + ++ + + K +D I R++L GL YLH + IHR
Sbjct: 89 WLVMKLLSGGSVLDIIKHI-VAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHR 145
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLA-------IAMQQPTARSVIGTPEFMAPELYEE--EY 177
D+K NI + + G V+I D G++ + ++ +GTP +MAPE+ E+ Y
Sbjct: 146 DVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY 204
Query: 178 NELVDIYSFGMCILEMVTFEYPYSECKNPAQ----IFKKVTSGIKPASLAKVND----PQ 229
+ DI+SFG+ +E+ T PY + P + + ++ K
Sbjct: 205 DFKADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 230 IKGFIEKCLV--PASERLSAKDLLKDPFLQ 257
+ I CL P +R +A +LL+ F Q
Sbjct: 264 FRKMISLCLQKDP-EKRPTAAELLRHKFFQ 292
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA ++ G A K+ + +L+ E+ +L + +VK ++ D K
Sbjct: 36 YKAKNKETGALAA---AKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91
Query: 74 TVNMITELFTSGNLRQYRKKHKNV----DIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+ + E G + + I+V+ RQ+L L +LHS IIHRDLK
Sbjct: 92 WIMI--EFCPGGAVDAIMLELDRGLTEPQIQVV---CRQMLEALNFLHSKR--IIHRDLK 144
Query: 130 CDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE------LYEEEYNELV 181
N+ + G++++ D G++ S IGTP +MAPE + + Y+
Sbjct: 145 AGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 182 DIYSFGMCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCL 238
DI+S G+ ++EM E P+ E NP + + K S P +L + + + F++ L
Sbjct: 204 DIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSD--PPTLLTPSKWSVEFRDFLKIAL 260
Query: 239 VP-ASERLSAKDLLKDPFLQVENQKEPICD 267
R SA LL+ PF+ + + +
Sbjct: 261 DKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 76/252 (30%), Positives = 123/252 (48%), Gaps = 22/252 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA + G VA +K V ++ K E+ +++ +VVK+Y S+ +
Sbjct: 46 YKAIHKETGQIVA---IKQVPVESDLQEIIK---EISIMQQCDSPHVVKYYGSYFKNTDL 99
Query: 74 TVNMITELFTSGNLRQ-YRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ M E +G++ R ++K + I + L GL YLH IHRD+K N
Sbjct: 100 WIVM--EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGN 155
Query: 133 IFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMC 189
I +N G K+ D G+A + +VIGTP +MAPE + E YN + DI+S G+
Sbjct: 156 ILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGIT 214
Query: 190 ILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERL 245
+EM + PY++ +P + IF T+ P + K F+++CLV +R
Sbjct: 215 AIEMAEGKPPYAD-IHPMRAIFMIPTNP--PPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271
Query: 246 SAKDLLKDPFLQ 257
+A LL+ PF++
Sbjct: 272 TATQLLQHPFVR 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 22/253 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
Y A D VA +K Q + EV L+ L+ N +++ ++ +
Sbjct: 71 YFARDVRNSEVVA---IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ M E K + I L GL YLHSHN +IHRD+K
Sbjct: 128 TAWLVM--EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAG 183
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE----LYEEEYNELVDIYSFG 187
NI ++ G VK+GD G A M A S +GTP +MAPE + E +Y+ VD++S G
Sbjct: 184 NILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240
Query: 188 MCILEMVTFEYPYSECKNPAQ-IFKKVTSGIKPASLAKVN-DPQIKGFIEKCL-VPASER 244
+ +E+ + P N ++ + +L + + F++ CL +R
Sbjct: 241 ITCIELAERKPPLFNM-NAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDR 297
Query: 245 LSAKDLLKDPFLQ 257
+++ LLK F+
Sbjct: 298 PTSEVLLKHRFVL 310
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 55/246 (22%), Positives = 98/246 (39%), Gaps = 43/246 (17%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNW 105
E++ ++ +N++ F + + + IT+ +G+L Y K +D K +
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKL 139
Query: 106 ARQILHGLVYLHS------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
A + GL +LH+ P I HRDLK NI V N G I DLGLA+ T
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNE 198
Query: 160 ------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVT----------F 196
+ +GT +M PE+ +E + + D+YSFG+ + E+ +
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 197 EYPYSECKNPAQIFKKVTSG---------IKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ PY + ++ + + Q+ + +C + RL+
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 247 AKDLLK 252
A + K
Sbjct: 319 ALRVKK 324
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 54/275 (19%), Positives = 106/275 (38%), Gaps = 33/275 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ + G A +K+ + + + E +LK L N+VK + + +
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+I E G+L ++ N R ++ G+ +L + I+HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 131 DNIFVNGN---HGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE---------EEY 177
NI K+ D G A ++ S+ GT E++ P++YE ++Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 178 NELVDIYSFGMCIL-EMVT----FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232
VD++S G T F P+ + ++ K+ +G +++ V +
Sbjct: 201 GATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 233 FIEKCLVPASERLS--AKDLLKDPF---LQVENQK 262
+P S LS + LL L+ + +K
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 51/281 (18%), Positives = 91/281 (32%), Gaps = 35/281 (12%)
Query: 11 FSS-YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 69
FS G A R+ + D ++ E + + N+++ +
Sbjct: 42 FSYVDLVEGLHDGHFYALKRILCHE----QQDREEAQREADMHRLFNHPNILRLVAYCLR 97
Query: 70 DK--KKTVNMITELFTSGNLRQY----RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPI 123
++ K ++ F G L + K + I I GL +H+
Sbjct: 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGY 155
Query: 124 IHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVI----------GTPEFMAPEL 172
HRDLK NI + G+ + DLG A T + APEL
Sbjct: 156 AHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 173 YEEE----YNELVDIYSFGMCIL-EMVTFEYPY-SECKNPAQIFKKVTSGIKPASLAKVN 226
+ + +E D++S G C+L M+ E PY + + V + + + +
Sbjct: 215 FSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHS 273
Query: 227 DPQIKGFIEKCLVP-ASERLSAKDLLKDP-FLQVENQKEPI 265
+ + + +R LL LQ +
Sbjct: 274 -SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 50/280 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ + G VA VKI ++ E++ L+ +N++ F S + +
Sbjct: 25 WRG--SWQGENVA---VKIFSSRDEKSWFRET--ELYNTVMLRHENILGFIASDMTSRHS 77
Query: 74 TVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIH 125
+ + IT G+L Y + +D I GL +LH P I H
Sbjct: 78 STQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH 136
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR------SVIGTPEFMAPELYEE---- 175
RDLK NI V N G+ I DLGLA+ Q T + +GT +MAPE+ +E
Sbjct: 137 RDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 176 ---EYNELVDIYSFGMCILEMVT----------FEYPYSECKNPAQIFKKVTSG------ 216
+ + VDI++FG+ + E+ ++ P+ + F+ +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255
Query: 217 ---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 252
I + + +++C S RL+A + K
Sbjct: 256 RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 33/287 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
YK G A +K+ DV + +++ E+++LK N+ +Y +++
Sbjct: 41 YKGRHVKTGQLAA---IKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95
Query: 73 KTVN----MITELFTSGNLRQYRKKHKNVDIK--VIKNWARQILHGLVYLHSHNPPIIHR 126
++ ++ E +G++ K K +K I R+IL GL +LH H +IHR
Sbjct: 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHR 153
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE------LYEEEYN 178
D+K N+ + + EVK+ D G++ + + R + IGTP +MAPE + Y+
Sbjct: 154 DIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 212
Query: 179 ELVDIYSFGMCILEMVTFEYPYSECKNPA----QIFKKVTSGIKPASLAKVNDPQIKGFI 234
D++S G+ +EM P + +P I + +K +K + + FI
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSKKWSK----KFQSFI 267
Query: 235 EKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 280
E CLV S+R + + L+K PF++ + + + LK I K R
Sbjct: 268 ESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKR 314
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 29/274 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
++ D A KI +L P +K+ E+ + +SL +VV F+ + D+
Sbjct: 32 FEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
V ++ EL +L + K+ K + + + RQI+ G YLH + +IHRDLK
Sbjct: 89 F--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 144
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 188
N+F+N + EVKIGD GLA ++ R + GTP ++APE L ++ ++ VD++S G
Sbjct: 145 NLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG- 202
Query: 189 CIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 244
CI+ ++ P E + + ++ P + P I+K L + R
Sbjct: 203 CIMYTLLV-GKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTAR 257
Query: 245 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKM 278
+ +LL D F P +LPI L +
Sbjct: 258 PTINELLNDEFFTSG------YIPARLPITCLTI 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 53/261 (20%), Positives = 114/261 (43%), Gaps = 19/261 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
+K G +A VK + +++ ++ ++ D +V+ + +++ +
Sbjct: 42 WKMRFRKTGHVIA---VKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
V + EL + + ++ + +++ I+ L YL + +IHRD+K N
Sbjct: 99 --VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSN 155
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE------LYEEEYNELVDIYS 185
I ++ G++K+ D G++ + A+ G +MAPE + +Y+ D++S
Sbjct: 156 ILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 186 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLV-PAS 242
G+ ++E+ T ++PY CK ++ KV +P L + F++ CL
Sbjct: 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHR 273
Query: 243 ERLSAKDLLKDPFLQVENQKE 263
+R LL+ F++ E
Sbjct: 274 KRPKYNKLLEHSFIKRYETLE 294
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 54/274 (19%), Positives = 105/274 (38%), Gaps = 31/274 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ + G A +K+ + + + E +LK L N+VK + + +
Sbjct: 26 FRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+I E G+L ++ N R ++ G+ +L + I+HR++K
Sbjct: 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKP 140
Query: 131 DNIFVNGN---HGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE---------EEY 177
NI K+ D G A ++ S+ GT E++ P++YE ++Y
Sbjct: 141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 178 NELVDIYSFGMCIL-EMVT----FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232
VD++S G T F P+ + ++ K+ +G +++ V +
Sbjct: 201 GATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 233 FIEKCLVPASERLS--AKDLLKDPFLQVENQKEP 264
+P S LS + LL P L + +
Sbjct: 259 IDWSGDMPVSCSLSRGLQVLLT-PVLANILEADQ 291
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 50/280 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ ++ G EVA VKI + ++ +E++ L+ +N++ F + D
Sbjct: 59 WRG--KWRGEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGT 111
Query: 74 TVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIH 125
+ +++ G+L Y ++ V ++ + A GL +LH P I H
Sbjct: 112 WTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEE---- 175
RDLK NI V N G I DLGLA+ T +GT +MAPE+ ++
Sbjct: 171 RDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
Query: 176 ---EYNELVDIYSFGMCILEMVT----------FEYPYSECKNPAQIFKKVTSG------ 216
E + DIY+ G+ E+ ++ PY + +++
Sbjct: 230 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 289
Query: 217 ---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 252
I + + + +C + RL+A + K
Sbjct: 290 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 30/295 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
++ D A KI +L P +K+ E+ + +SL +VV F+ + D+
Sbjct: 58 FEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
V ++ EL +L + K+ K + + + RQI+ G YLH + +IHRDLK
Sbjct: 115 F--VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 170
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 188
N+F+N + EVKIGD GLA ++ R + GTP ++APE L ++ ++ VD++S G
Sbjct: 171 NLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG- 228
Query: 189 CIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 244
CI+ ++ P E + + ++ P + P I+K L + R
Sbjct: 229 CIMYTLLV-GKPPFETSCLKETYLRIKKNEYSIPKHIN----PVAASLIQKMLQTDPTAR 283
Query: 245 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLS 299
+ +LL D F P +LPI L + PSS+D + K L+
Sbjct: 284 PTINELLNDEFFTSG------YIPARLPITCLTIPPRFSIAPSSLDPSNR-KPLT 331
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 62/262 (23%), Positives = 114/262 (43%), Gaps = 20/262 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKK 72
K +G +A VK + ++L ++ ++++ V FY + +
Sbjct: 24 EKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80
Query: 73 KTVNMITELFTSGN---LRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDL 128
V + EL + +Q K + + ++ A I+ L +LHS + +IHRD+
Sbjct: 81 --VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDV 136
Query: 129 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-SVIGTPEFMAPE-----LYEEEYNELVD 182
K N+ +N G+VK+ D G++ + A+ G +MAPE L ++ Y+ D
Sbjct: 137 KPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSD 195
Query: 183 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PA 241
I+S G+ ++E+ +PY P Q K+V P A + F +CL +
Sbjct: 196 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNS 255
Query: 242 SERLSAKDLLKDPFLQVENQKE 263
ER + +L++ PF + K
Sbjct: 256 KERPTYPELMQHPFFTLHESKG 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 57/267 (21%), Positives = 113/267 (42%), Gaps = 26/267 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
K + +G +A VK + ++L ++ ++ D +V+FY + +
Sbjct: 39 NKMVHKPSGQIMA---VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95
Query: 73 KTVNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRD 127
+ EL ++ + Y+ + +++ + L +L IIHRD
Sbjct: 96 --CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRD 151
Query: 128 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV-IGTPEFMAPE-----LYEEEYNELV 181
+K NI ++ G +K+ D G++ + A++ G +MAPE + Y+
Sbjct: 152 IKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS 210
Query: 182 DIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND----PQIKGFIEKC 237
D++S G+ + E+ T +PY + + +V G P L+ + P F+ C
Sbjct: 211 DVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLC 269
Query: 238 LV-PASERLSAKDLLKDPFLQVENQKE 263
L S+R K+LLK PF+ + ++
Sbjct: 270 LTKDESKRPKYKELLKHPFILMYEERA 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 24/227 (10%)
Query: 30 VKIDDVLQLPGDLQKLY-SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLR 88
+ + ++++ + Q+ + EV +++ L+ NV+KF K K +N ITE G LR
Sbjct: 38 MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY--KDKRLNFITEYIKGGTLR 95
Query: 89 QY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147
+ ++A+ I G+ YLHS N IIHRDL N V N V + D
Sbjct: 96 GIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENK-NVVVADF 152
Query: 148 GLA----------------IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 190
GLA + +V+G P +MAPE + Y+E VD++SFG+ +
Sbjct: 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237
E++ + F G P +C
Sbjct: 213 CEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRC 259
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 52/334 (15%), Positives = 108/334 (32%), Gaps = 69/334 (20%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGD-LQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
A + G V V+ ++ + + L E+H+ K N+V + +++ D +
Sbjct: 44 NLARYKPTGEYVT---VRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIK--VIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ ++T G+ + H + I + +L L Y+H +HR +K
Sbjct: 101 --LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKA 156
Query: 131 DNIFVNGNHGEVKIGDLGLAIAMQQPTAR---------SVIGTPEFMAPELYEEE---YN 178
+I ++ + G+V + L ++M R + +++PE+ ++ Y+
Sbjct: 157 SHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215
Query: 179 ELVDIYSFGMCILEMVTFEYPYSEC----------KNPAQIFKKVTSGIKPASLAKVND- 227
DIYS G+ E+ P+ + ++ +
Sbjct: 216 AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS 275
Query: 228 --------------------------------PQIKGFIEKCLVP-ASERLSAKDLLKDP 254
P F+E+CL R SA LL
Sbjct: 276 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335
Query: 255 FLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSS 288
F + K + L ++ + + S
Sbjct: 336 FFK--QIKRRASEALPELLRPVTPITNFEGSQSQ 367
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 66/294 (22%), Positives = 120/294 (40%), Gaps = 52/294 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+K + +G+ +A K+ + P ++ E+ +L +V FY ++ D +
Sbjct: 50 FKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 105
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDN 132
+++ E G+L Q KK + +++ + ++ GL YL H I+HRD+K N
Sbjct: 106 -ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSN 162
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 191
I VN + GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++
Sbjct: 163 ILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 192 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK--------------------------- 224
EM YP A+
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 225 ---VND-----------PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQKE 263
VN+ + + F+ KCL+ +ER K L+ F++ + +E
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 54/293 (18%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
Y+A D +G E A R+ ++ + + EV +K L N+V+F + K+
Sbjct: 45 YEAQDVGSGREYALKRLLSNE----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100
Query: 73 KTVN-----MITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPII 124
++ ++ G L ++ KK ++ + Q + ++H PPII
Sbjct: 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160
Query: 125 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV--------------IGTPEFMAP 170
HRDLK +N+ ++ G +K+ D G A + S TP + P
Sbjct: 161 HRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219
Query: 171 ELYE----EEYNELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKV 225
E+ + E DI++ G CIL + ++P+ E +I K
Sbjct: 220 EIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPF-EDGAKLRIVN-----------GKY 266
Query: 226 NDPQ-------IKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 270
+ P I L ERLS +++ + P+
Sbjct: 267 SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 4e-34
Identities = 70/280 (25%), Positives = 110/280 (39%), Gaps = 20/280 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ + G +VA +K P + ++ E+ ++K L NVV + +K
Sbjct: 31 LRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87
Query: 74 TVN----MITELFTSGNLRQYRKKHKNVDI---KVIKNWARQILHGLVYLHSHNPPIIHR 126
N + E G+LR+Y + +N I+ I L YLH + IIHR
Sbjct: 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHR 145
Query: 127 DLKCDNI--FVNGNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYE-EEYNELVD 182
DLK +NI KI DLG A + Q +GT +++APEL E ++Y VD
Sbjct: 146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVD 205
Query: 183 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPAS 242
+SFG E +T P+ P Q KV + + F P
Sbjct: 206 YWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265
Query: 243 ERLSAKDLLKDPFLQ---VENQKEPICDPLKLPIQSLKML 279
L+ +LQ + +Q++ DP + + L
Sbjct: 266 LSGILAGKLE-RWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 53/234 (22%), Positives = 109/234 (46%), Gaps = 14/234 (5%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 102
+L EV + L+ N+++ Y + D + V +I E G + + +K D +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 103 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 162
+ ++ + L Y HS +IHRD+K +N+ + G+ GE+KI D G ++ +
Sbjct: 112 ATYITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLC 168
Query: 163 GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-P 219
GT +++ PE+ E ++E VD++S G+ E + + P+ E + +K+++ P
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFP 227
Query: 220 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLP 272
+ + I + L S+R +++L+ P++ + K C +
Sbjct: 228 DFV----TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-32
Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 17/275 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
D+ +E A +KI + KL EV +LK L N++K Y + D +
Sbjct: 54 LLCRDKVTHVERA---IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++ E + G L + +Q+L G+ YLH HN I+HRDLK +N
Sbjct: 111 --YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPEN 166
Query: 133 I-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 189
+ + +KI D GL+ + + +GT ++APE+ ++Y+E D++S G+
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVI 226
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERL 245
+ ++ P+ + +I +KV G V K I++ L + R+
Sbjct: 227 LFILLAGYPPFG-GQTDQEILRKVEKGKYTFDSPEWKNV-SEGAKDLIKQMLQFDSQRRI 284
Query: 246 SAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 280
SA+ L+ P+++ K+ L +++ +R
Sbjct: 285 SAQQALEHPWIKEMCSKKESGIELPSLANAIENMR 319
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 66/254 (25%), Positives = 123/254 (48%), Gaps = 24/254 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
Y+A G+EVA +K+ D + G +Q++ +EV + LK ++++ Y + D
Sbjct: 28 YRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84
Query: 72 KKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
V ++ E+ +G + +Y + + K +++ QI+ G++YLHSH I+HRDL
Sbjct: 85 Y--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTL 140
Query: 131 DNIFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFG 187
N+ + N +KI D GLA ++ P + ++ GTP +++PE + D++S G
Sbjct: 141 SNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG 199
Query: 188 MCIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASE 243
C+ ++ P+ + KV P+ L+ + K I + L ++
Sbjct: 200 -CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFLS----IEAKDLIHQLLRRNPAD 253
Query: 244 RLSAKDLLKDPFLQ 257
RLS +L PF+
Sbjct: 254 RLSLSSVLDHPFMS 267
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-32
Identities = 33/251 (13%), Positives = 77/251 (30%), Gaps = 34/251 (13%)
Query: 29 RVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTS---- 84
R+++ ++ + + +KD K + +D++ V L+
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 85 -----GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
L + HK++ Q++ L LH + ++H L+ +I ++
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR- 242
Query: 140 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE------------YNELVDIYSFG 187
G V + + + F PEL D ++ G
Sbjct: 243 GGVFLTGFEHLVRDGARV--VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ I + + P ++ + + K ++ +E L +RL
Sbjct: 301 LVIYWIWCADLPITK-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLL 353
Query: 247 AKDLLKDPFLQ 257
++ P +
Sbjct: 354 PLQAMETPEYE 364
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-32
Identities = 67/275 (24%), Positives = 106/275 (38%), Gaps = 30/275 (10%)
Query: 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVD 69
+ F +VA VK LP EV LL+ + NV++++ + D
Sbjct: 37 EGTIVYRGMFDNRDVA---VKR----ILPECFSFADREVQLLRESDEHPNVIRYFCTEKD 89
Query: 70 DKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128
+ + EL + L++Y +K +Q GL +LHS N I+HRDL
Sbjct: 90 RQF--QYIAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDL 144
Query: 129 KCDNIFVNGNHGE----VKIGDLGLAIAMQQP-----TARSVIGTPEFMAPELYEEE--- 176
K NI ++ + I D GL + V GT ++APE+ E+
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 177 -YNELVDIYSFGMCILEMVTFEY-PYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234
VDI+S G +++ P+ + + K D + I
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELI 264
Query: 235 EKCLVP-ASERLSAKDLLKDPFLQ-VENQKEPICD 267
EK + +R SAK +LK PF +E Q + D
Sbjct: 265 EKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQD 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 17/275 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
K D E A VK+ + D + EV LLK L N++K ++ D
Sbjct: 39 LKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++ EL+T G L K K +Q+ G+ Y+H HN I+HRDLK +N
Sbjct: 96 --FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPEN 151
Query: 133 I-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMC 189
I + ++KI D GL+ QQ + IGT ++APE+ Y+E D++S G+
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVI 211
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERL 245
+ +++ P+ KN I K+V +G ++D K I K L S R+
Sbjct: 212 LYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSLRI 269
Query: 246 SAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 280
+A L+ P++Q + + P L ++ +R
Sbjct: 270 TATQCLEHPWIQKYSSETPTISDLPSLESAMTNIR 304
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 56/237 (23%), Positives = 114/237 (48%), Gaps = 16/237 (6%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVI 102
+L E+ + L+ N+++ Y + D K+ + ++ E G L + +KH D +
Sbjct: 59 HQLRREIEIQSHLRHPNILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 103 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 162
+ ++ L Y H +IHRD+K +N+ + G GE+KI D G ++ R++
Sbjct: 117 ATFMEELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMC 173
Query: 163 GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-P 219
GT +++ PE+ E + ++E VD++ G+ E + P+ + + + +++ + +K P
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFP 232
Query: 220 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 275
L K I K L +RL K +++ P+++ N + + P+ QS
Sbjct: 233 PFL----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK-ANSR-RVLPPVYQSTQS 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-31
Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 19/276 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
D+ G E A VK+ Q+ D + L EV LLK L N++K Y+ + D
Sbjct: 43 ILCKDKITGQECA---VKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
++ E++T G L K RQ+L G+ Y+H + I+HRDLK +
Sbjct: 100 Y--FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPE 155
Query: 132 NI-FVN-GNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGM 188
N+ + ++I D GL+ + + IGT ++APE+ Y+E D++S G+
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGV 215
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASER 244
+ +++ P++ N I KKV G + KV++ K I K L S R
Sbjct: 216 ILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSE-SAKDLIRKMLTYVPSMR 273
Query: 245 LSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 280
+SA+D L ++Q +++ D ++ +R
Sbjct: 274 ISARDALDHEWIQTYTKEQISVDV-PSLDNAILNIR 308
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 72/293 (24%), Positives = 130/293 (44%), Gaps = 41/293 (13%)
Query: 14 YKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKS 66
AF+ +VA +KI + + +E+ +LK L ++K +
Sbjct: 27 KLAFERKTCKKVA---IKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK-N 82
Query: 67 WVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
+ D + ++ EL G L +K + K + Q+L + YLH + IIHR
Sbjct: 83 FFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHR 138
Query: 127 DLKCDNIFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE----LYEEEYNE 179
DLK +N+ ++ + +KI D G + + + + R++ GTP ++APE + YN
Sbjct: 139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 198
Query: 180 LVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQ 229
VD +S G IL + P+SE + + ++TSG P A+V++
Sbjct: 199 AVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK- 250
Query: 230 IKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 281
++K LV R + ++ L+ P+LQ E+ K D L +S + ++
Sbjct: 251 ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-31
Identities = 71/261 (27%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 28 SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL 87
DD + +++Y+E+ LLKSL N++K + + D K ++TE + G L
Sbjct: 76 KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEFYEGGEL 133
Query: 88 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIG 145
+ D N +QIL G+ YLH HN I+HRD+K +NI N + +KI
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIV 191
Query: 146 DLGLAIAMQQ-PTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL-EMVTFEYPYSEC 203
D GL+ + R +GT ++APE+ +++YNE D++S G I+ ++ P+
Sbjct: 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG- 249
Query: 204 KNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE 259
+N I KKV G + + K I+ L ++R +A++ L +++
Sbjct: 250 QNDQDIIKKVEKGKYYFDFNDWKNI-SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308
Query: 260 NQKEPICDPLKLPIQSLKMLR 280
D K +L +R
Sbjct: 309 ANNINKSD-QKTLCGALSNMR 328
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 56/267 (20%), Positives = 111/267 (41%), Gaps = 34/267 (12%)
Query: 33 DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRK 92
+D + + +E+ ++ +K++ + + + V +I E + ++ ++ +
Sbjct: 78 NDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDE 135
Query: 93 KHKNVD--------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144
+D I+VIK + +L+ Y+H+ I HRD+K NI + +G VK+
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKL 193
Query: 145 GDLGLAIAMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTFEYPYS 201
D G + M + GT EFM PE + E VDI+S G+C+ M P+S
Sbjct: 194 SDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 202 ECKNPAQIFKKVTSG-----------------IKPASLAKVNDPQIKGFIEKCLVP-ASE 243
+ ++F + + K + F++ L +E
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 244 RLSAKDLLKDPFLQVENQKEPICDPLK 270
R++++D LK +L + E + + K
Sbjct: 314 RITSEDALKHEWLA-DTNIEDLREFSK 339
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 41/277 (14%)
Query: 14 YKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKS 66
AF+ +VA ++I + + +E+ +LK L ++K +
Sbjct: 152 KLAFERKTCKKVA---IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK-N 207
Query: 67 WVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
+ D + ++ EL G L +K + K + Q+L + YLH + IIHR
Sbjct: 208 FFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHR 263
Query: 127 DLKCDNIFV--NGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE----LYEEEYNE 179
DLK +N+ + +KI D G + + + + R++ GTP ++APE + YN
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNR 323
Query: 180 LVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQ 229
VD +S G IL + P+SE + + ++TSG P A+V++
Sbjct: 324 AVDCWSLG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK- 375
Query: 230 IKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPI 265
++K LV R + ++ L+ P+LQ E+ K
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 54/261 (20%), Positives = 114/261 (43%), Gaps = 33/261 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ + +G+E +K + + ++++ +E+ +LKSL N++K ++ + D
Sbjct: 39 HLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN- 94
Query: 74 TVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+ ++ E G L + + K + + +Q+++ L Y HS + ++H+DLK
Sbjct: 95 -MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLK 151
Query: 130 CDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSF 186
+NI F + H +KI D GLA + + GT +MAPE+++ + DI+S
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSA 211
Query: 187 GMCILEMVTFEYP--YSECKNPAQIFKKVTSGI-------KPASLAKVNDPQIKGFIEKC 237
G ++ + + ++ +K T +P + PQ +++
Sbjct: 212 G-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVECRPLT------PQAVDLLKQM 262
Query: 238 LVP-ASERLSAKDLLKDPFLQ 257
L R SA +L + +
Sbjct: 263 LTKDPERRPSAAQVLHHEWFK 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 77/260 (29%), Positives = 118/260 (45%), Gaps = 21/260 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
K D E A VK+ + D + EV LLK L N++K ++ D
Sbjct: 39 LKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++ EL+T G L K K +Q+ G+ Y+H HN I+HRDLK +N
Sbjct: 96 --FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPEN 151
Query: 133 IFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSFGMC 189
I + + +KI D GL+ QQ T + IGT ++APE+ Y+E D++S G
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG-V 210
Query: 190 ILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASE 243
IL ++ P Y + N I K+V +G ++D K I K L S
Sbjct: 211 ILYILLSGTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISD-DAKDLIRKMLTFHPSL 267
Query: 244 RLSAKDLLKDPFLQVENQKE 263
R++A L+ P++Q + +E
Sbjct: 268 RITATQCLEHPWIQKYSSEE 287
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 43/246 (17%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNW 105
EV+ L +K +N+++F + V++ IT G+L + K + V + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHI 126
Query: 106 ARQILHGLVYLHS--------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI----AM 153
A + GL YLH H P I HRD+K N+ + N I D GLA+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGK 185
Query: 154 QQPTARSVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVT----FEYPYSEC 203
+GT +MAPE+ ++ + +D+Y+ G+ + E+ + + P E
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 204 KNPAQ----------------IFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
P + + KK ++ + IE+C A RLS
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 247 AKDLLK 252
A + +
Sbjct: 306 AGCVGE 311
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 53/264 (20%), Positives = 111/264 (42%), Gaps = 27/264 (10%)
Query: 14 YKAFDEFAGIEVAW---SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
A + I A + ++DV + E+ ++KSL N+++ Y+++ D+
Sbjct: 26 KIAVQKGTRIRRAAKKIPKYFVEDV-------DRFKQEIEIMKSLDHPNIIRLYETFEDN 78
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ ++ EL T G L + + + +L + Y H N + HRDLK
Sbjct: 79 TD--IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKP 134
Query: 131 DNIFVNGNHGE--VKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYEEEYNELVDIYSFG 187
+N + + +K+ D GLA + R+ +GTP +++P++ E Y D +S G
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAG 194
Query: 188 MCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-A 241
++ ++ YP + +++ K+ G V+ Q + I + L
Sbjct: 195 -VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSP-QAESLIRRLLTKSP 250
Query: 242 SERLSAKDLLKDPFLQVENQKEPI 265
+R+++ L+ + + + P
Sbjct: 251 KQRITSLQALEHEWFEKQLSSSPR 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 40/287 (13%), Positives = 85/287 (29%), Gaps = 56/287 (19%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG--DLQKLYSEVHLLKSL---------------- 55
+A D+ G V + + P ++++ EV L+ L
Sbjct: 95 LEATDQETGESFE---VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151
Query: 56 ------KDDNVVKFYKSWVDDKKKTVNMITELFTS---------GNLRQYRKKHKNVDIK 100
KD K + +D++ V L+ L + HK++
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 211
Query: 101 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157
Q++ L LH + ++H L+ +I ++ G V + +
Sbjct: 212 ARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGASAVSP 268
Query: 158 ARSVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFK 211
PE A + D ++ G+ I + + P ++ +
Sbjct: 269 IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSE 327
Query: 212 KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
+ K ++ +E L +RL ++ P +
Sbjct: 328 WIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 61/310 (19%), Positives = 110/310 (35%), Gaps = 69/310 (22%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 69
A + A +KI + ++ P D++++ +EV L+K L N+ + Y+ + D
Sbjct: 43 RVAIENQTRAIRA---IKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA----------------------- 106
++ + ++ EL G+L +
Sbjct: 100 EQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGF 157
Query: 107 -----------------RQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLG 148
RQI L YLH+ I HRD+K +N F E+K+ D G
Sbjct: 158 RESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFG 215
Query: 149 LAIAMQQPTA------RSVIGTPEFMAPEL---YEEEYNELVDIYSFGMCIL-EMVTFEY 198
L+ + + GTP F+APE+ E Y D +S G +L ++
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAV 274
Query: 199 PYSECKNPAQIFKKVTSG---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDP 254
P+ N A +V + + + ++ + + L ER A L+ P
Sbjct: 275 PF-PGVNDADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDAMRALQHP 332
Query: 255 FLQVENQKEP 264
++ + K
Sbjct: 333 WISQFSDKIY 342
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 74/287 (25%), Positives = 143/287 (49%), Gaps = 22/287 (7%)
Query: 22 GIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80
G EVA +KI D QL P LQKL+ EV ++K L N+VK ++ V + +KT+ +I E
Sbjct: 40 GREVA---IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE--VIETEKTLYLIME 94
Query: 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 140
+ G + Y H + K ++ RQI+ + Y H I+HRDLK +N+ ++ +
Sbjct: 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-M 151
Query: 141 EVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTFE 197
+KI D G + + G P + APEL++ ++Y+ VD++S G+ + +V+
Sbjct: 152 NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
Query: 198 YPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDP 254
P+ +N ++ ++V G P ++ + +++ LV +R + + ++KD
Sbjct: 212 LPFDG-QNLKELRERVLRGKYRIPFYMS----TDCENLLKRFLVLNPIKRGTLEQIMKDR 266
Query: 255 FLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLS 301
++ ++++ + ++ + R+ + M + Q SLS
Sbjct: 267 WINAGHEEDELKPFVEPELDISDQKRIDIM--VGMGYSQEEIQESLS 311
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 44/238 (18%), Positives = 83/238 (34%), Gaps = 32/238 (13%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 98
P + + LK +KFY + + ++ EL++ G L +KN
Sbjct: 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNTP 165
Query: 99 IKVIKN-----WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----------NHGEVK 143
KV+ +A ++L+ + +H IIH D+K DN + +
Sbjct: 166 EKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223
Query: 144 IGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY 198
+ DLG +I M+ + T F E L + +N +D + + M+ Y
Sbjct: 224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
Query: 199 PYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL-VPASERLSAKDLLKDPF 255
+ + + + + + F L +P L + DLL+
Sbjct: 284 MKVKNEGGECKPEGLFRRLP-------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 47/215 (21%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSE--VHLLKSLKDDNVVKFYKSWVDDK 71
YK VA VK+ + Q +E ++ + ++ DN+ +F D+
Sbjct: 30 YKG--SLDERPVA---VKVFS----FANRQNFINEKNIYRVPLMEHDNIARFIVG---DE 77
Query: 72 KKTVN------MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------- 118
+ T + ++ E + +G+L +Y H D A + GL YLH+
Sbjct: 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDH 136
Query: 119 HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM----------QQPTARSVIGTPEFM 168
+ P I HRDL N+ V + G I D GL++ + + A S +GT +M
Sbjct: 137 YKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM 195
Query: 169 APELYE--------EEYNELVDIYSFGMCILEMVT 195
APE+ E E + VD+Y+ G+ E+
Sbjct: 196 APEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 32/275 (11%)
Query: 10 PFSS-YKAFDEFAGIEVAWSRVKIDDVLQLPG----DLQKLYSEVHLLKSLKDDNVVKFY 64
PFS + + G + A VKI DV + + L E + LK ++V+
Sbjct: 36 PFSVVRRCINRETGQQFA---VKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 65 KSWVDDKKKTVNMITELFTSGNL--RQYRKKHKNVDI--KVIKNWARQILHGLVYLHSHN 120
+++ D + M+ E +L ++ V ++ RQIL L Y H +N
Sbjct: 93 ETYSSDGM--LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 121 PPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPE-LYEE 175
IIHRD+K + + N VK+G G+AI + + A +GTP FMAPE + E
Sbjct: 151 --IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE 208
Query: 176 EYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQI 230
Y + VD++ G IL ++ Y ++F+ + G P + +++
Sbjct: 209 PYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQWSHISE-SA 263
Query: 231 KGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 264
K + + L+ +ER++ + L P+L+ ++
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 63/260 (24%), Positives = 118/260 (45%), Gaps = 32/260 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
+ + G+E A KI + +L D QKL E + + L+ N+V+ + S ++
Sbjct: 23 RRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++ +L T G L + + + +QIL + Y HS+ I+HR+LK +N
Sbjct: 80 --HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPEN 135
Query: 133 I-FVN-GNHGEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 188
+ + VK+ D GLAI + GTP +++PE L ++ Y++ VDI++ G
Sbjct: 136 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG- 194
Query: 189 CILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCL 238
IL Y P+ + ++ +++ ++ +G V + K I+ L
Sbjct: 195 VIL------YILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLIDSML 246
Query: 239 VP-ASERLSAKDLLKDPFLQ 257
+R++A LK P++
Sbjct: 247 TVNPKKRITADQALKVPWIC 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 58/271 (21%), Positives = 107/271 (39%), Gaps = 52/271 (19%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 106
E+ +LK LK N+V + V +K+ ++++ E + + +++ V ++K+
Sbjct: 52 EIRMLKQLKHPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSIT 108
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
Q L + + H HN IHRD+K +NI + H +K+ D G A + P+ E
Sbjct: 109 WQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY---DDE 162
Query: 167 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE------------ 202
+PEL + +Y VD+++ G C+ E+++ P S+
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLSGV-PLWPGKSDVDQLYLIRKTLG 220
Query: 203 ----------CKNPAQIFKKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSA 247
N K+ L G ++ CL P ERL+
Sbjct: 221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPT-ERLTC 279
Query: 248 KDLLKDPFLQVENQKEPICDPLKLPIQSLKM 278
+ LL P+ + + E + P ++L
Sbjct: 280 EQLLHHPYFENIREIEDLAKEHDKPAENLYF 310
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-28
Identities = 61/290 (21%), Positives = 104/290 (35%), Gaps = 50/290 (17%)
Query: 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVD 69
+ F G VA VK L E+ LL D NV+++Y S
Sbjct: 28 SGTVVFQGSFQGRPVA---VKR----MLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT 80
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA-------RQILHGLVYLHSHNPP 122
D+ + + EL + NL+ + D + RQI G+ +LHS
Sbjct: 81 DRF--LYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK-- 135
Query: 123 IIHRDLKCDNIFVN------------GNHGEVKIGDLGLAIAMQ------QPTARSVIGT 164
IIHRDLK NI V+ + + I D GL + + + GT
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 165 PEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKVT 214
+ APEL + +DI+S G +++ + + I + +
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 255
Query: 215 SGIKPASLAKVN-DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 262
S + L + + I + + +R +A +L+ P +++K
Sbjct: 256 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 70/267 (26%), Positives = 112/267 (41%), Gaps = 52/267 (19%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNWA 106
E+ LLK L+ +N+V + V KKK ++ E F + + N +D +V++ +
Sbjct: 74 EIKLLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYL 130
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
QI++G+ + HSHN IIHRD+K +NI V+ G VK+ D G A + P E
Sbjct: 131 FQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY---DDE 184
Query: 167 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE------------ 202
APEL + +Y + VD+++ G C++ EM E P S+
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHIMMCLG 242
Query: 203 ----------CKNP---AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSA 247
KNP ++ + +KCL P +R
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD-KRPFC 301
Query: 248 KDLLKDPFLQVENQKEPICDPLKLPIQ 274
+LL F Q++ E L+L +Q
Sbjct: 302 AELLHHDFFQMDGFAERFSQELQLKVQ 328
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 35/287 (12%), Positives = 76/287 (26%), Gaps = 51/287 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDN------------ 59
+ D + A +K+ +L++L+ L ++
Sbjct: 79 FLVRDVERLEDFA---LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 60 ------------VVKFYKSWVDDKKKTVNMITELFTS------GNLRQYRKKHKNVDIKV 101
+ D ++ + L + I
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161
+ Q++ L S ++H DN+F+ G + +GD+ + T
Sbjct: 196 LHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPDGRLMLGDVSALWKV--GTRGPA 250
Query: 162 IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTS 215
P AP + + ++ + G+ I + P+ +
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLR 310
Query: 216 GIKPASLAKVNDPQI----KGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
SLA + + K I + L RL + ++ P
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 58/253 (22%), Positives = 116/253 (45%), Gaps = 21/253 (8%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 98
+++ EV +L+ + NV+ + + + V +I EL + G L + + +++
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLS 113
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQQ 155
+ ++ +QIL G+ YLH+ I H DLK +NI + N +K+ D GLA ++
Sbjct: 114 EEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 156 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFK 211
+++ GTPEF+APE + E D++S G I ++ + +
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLA 228
Query: 212 KVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICD 267
+TS + ++ K FI K LV +RL+ ++ L+ P++ + ++
Sbjct: 229 NITSVSYDFDEEFFSHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQA--M 285
Query: 268 PLKLPIQSLKMLR 280
+ + +L+ R
Sbjct: 286 VRRESVVNLENFR 298
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 68/284 (23%), Positives = 127/284 (44%), Gaps = 34/284 (11%)
Query: 11 FSS-YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWV 68
FS + + G+E A KI + +L D QKL E + + L+ N+V+ + S
Sbjct: 42 FSVVRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98
Query: 69 DDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128
++ ++ +L T G L + + + +QIL + Y HS+ I+HR+L
Sbjct: 99 EESF--HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNL 154
Query: 129 KCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIY 184
K +N+ + VK+ D GLAI + A GTP +++PE L ++ Y++ VDI+
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 214
Query: 185 SFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI 234
+ G IL Y P+ + ++ +++ ++ +G V + K I
Sbjct: 215 ACG-VIL------YILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP-EAKSLI 265
Query: 235 EKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 277
+ L +R++A LK P++ ++ + + LK
Sbjct: 266 DSMLTVNPKKRITADQALKVPWIC-NRERVASAIHRQDTVDCLK 308
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
Y + G VA VK D Q+ E+ +LK+L D +VK+
Sbjct: 44 YDPLGDNTGALVA---VKQLQHSGPDQQRDFQR---EIQILKALHSDFIVKYRGVSYGPG 97
Query: 72 KKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
++++ ++ E SG LR + ++H+ +D + ++ QI G+ YL S +HRDL
Sbjct: 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAA 155
Query: 131 DNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIY 184
NI V + VKI D GLA + R +P F APE L + ++ D++
Sbjct: 156 RNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVW 214
Query: 185 SFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGI 217
SFG+ + E+ T+ + S ++
Sbjct: 215 SFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 58/241 (24%), Positives = 111/241 (46%), Gaps = 20/241 (8%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKNVD 98
D +++ +E+ ++ L N+++ Y ++ + ++ E G L R + + +
Sbjct: 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPT 157
+ I + +QI G+ ++H I+H DLK +NI VN + ++KI D GLA +
Sbjct: 187 LDTI-LFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 158 A-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKV 213
+ GTPEF+APE + + + D++S G+ I M+ + N A+ +
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNI 300
Query: 214 TSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPL 269
+ + +++ + K FI K L+ S R+SA + LK P+L +
Sbjct: 301 LACRWDLEDEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQK 359
Query: 270 K 270
K
Sbjct: 360 K 360
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 61/265 (23%), Positives = 109/265 (41%), Gaps = 45/265 (16%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ G A +K L +E+ +LK +K +N+V +
Sbjct: 26 FLVKQRLTGKLFA---LKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLED-IYESTTH 80
Query: 74 TVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
++ +L + G L R + D ++ +Q+L + YLH + I+HRDLK
Sbjct: 81 -YYLVMQLVSGGELFDRILERGVYTEKDASLV---IQQVLSAVKYLHENG--IVHRDLKP 134
Query: 131 DNIFV--NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFG 187
+N+ + ++ I D GL+ Q + GTP ++APE L ++ Y++ VD +S G
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIG 194
Query: 188 MCILEMVTFEYP--YSECKNPAQIFKKVTSGI------------KPASLAKVNDPQIKGF 233
I ++ YP Y E +++F+K+ G + A K F
Sbjct: 195 -VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFESPFWDDISESA----------KDF 241
Query: 234 IEKCLVP-ASERLSAKDLLKDPFLQ 257
I L +ER + + L P++
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWID 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 55/235 (23%), Positives = 104/235 (44%), Gaps = 20/235 (8%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN 96
P D + +E+ ++ L ++ + ++ D + + +I E + G L R + +K
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKM 146
Query: 97 VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQ 155
+ +VI N+ RQ GL ++H H+ I+H D+K +NI VKI D GLA +
Sbjct: 147 SEAEVI-NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 156 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFK 211
+ T EF APE + E D+++ G + ++ E + + +
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQ 260
Query: 212 KVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 262
V + + V+ + K FI+ L +RL+ D L+ P+L+ ++
Sbjct: 261 NVKRCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 49/248 (19%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 106
E+ LLK LK N+V+ + DKK + ++ E F +L++Y D +++K++
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKK--LTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
Q+L GL + HS N ++HRDLK N+ +N +GE+K+ + GLA A P R + E
Sbjct: 108 FQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY--SAE 161
Query: 167 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVTFEYPY----SE------------ 202
+ P++ + Y+ +D++S G CI E+ P
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 203 ----------CKNP-AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKD 249
K P + + + ++ + + ++ L P +R+SA++
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPV-QRISAEE 279
Query: 250 LLKDPFLQ 257
L+ P+
Sbjct: 280 ALQHPYFS 287
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 66/281 (23%), Positives = 123/281 (43%), Gaps = 34/281 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPG-DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
+ AG E A I + +L D QKL E + + LK N+V+ + S ++
Sbjct: 28 RRCVKVLAGQEYA---AMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+I +L T G L + + + +QIL +++ H ++HR+LK +N
Sbjct: 85 --HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPEN 140
Query: 133 I-FVN-GNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPE-LYEEEYNELVDIYSFG 187
+ + VK+ D GLAI ++ GTP +++PE L ++ Y + VD+++ G
Sbjct: 141 LLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG 200
Query: 188 MCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKC 237
IL Y P+ + ++ ++++++ +G V + K I K
Sbjct: 201 -VIL------YILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTP-EAKDLINKM 251
Query: 238 LVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 277
L S+R++A + LK P++ C + + LK
Sbjct: 252 LTINPSKRITAAEALKHPWIS-HRSTVASCMHRQETVDCLK 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 18/192 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
Y + G VA VK LQ L+ E+ +LKSL+ DN+VK+
Sbjct: 62 YDPLQDNTGEVVA---VK---KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115
Query: 72 KKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
++ + +I E G+LR Y +KHK +D + + QI G+ YL + IHRDL
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLAT 173
Query: 131 DNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--PEF-MAPE-LYEEEYNELVDIY 184
NI V N VKIGD GL + + + P F APE L E +++ D++
Sbjct: 174 RNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232
Query: 185 SFGMCILEMVTF 196
SFG+ + E+ T+
Sbjct: 233 SFGVVLYELFTY 244
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 18/192 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
Y + G VA VK LQ L+ E+ +LKSL+ DN+VK+
Sbjct: 31 YDPLQDNTGEVVA---VK---KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84
Query: 72 KKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
++ + +I E G+LR Y +KHK +D + + QI G+ YL + IHRDL
Sbjct: 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLAT 142
Query: 131 DNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGT--PEF-MAPE-LYEEEYNELVDIY 184
NI V N VKIGD GL + + + P F APE L E +++ D++
Sbjct: 143 RNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVW 201
Query: 185 SFGMCILEMVTF 196
SFG+ + E+ T+
Sbjct: 202 SFGVVLYELFTY 213
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 48/160 (30%), Positives = 83/160 (51%), Gaps = 21/160 (13%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWAR 107
EV LLK L+ N+++ + + +++I E + +L++Y K+ +V ++VIK++
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHR--LHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLY 139
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVN----GNHGEVKIGDLGLAIAMQQPTARSVIG 163
Q+++G+ + HS +HRDLK N+ ++ +KIGD GLA A P +
Sbjct: 140 QLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--- 194
Query: 164 TPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 195
T E + PE+ Y+ VDI+S CI EM+
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 14 YKA--FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
YKA D + A +++ + E+ LL+ LK NV+ K ++
Sbjct: 38 YKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRELKHPNVISLQKVFLSHA 91
Query: 72 KKTVNMITELFTSGNLRQYRKKHKN---------VDIKVIKNWARQILHGLVYLHSHNPP 122
+ V ++ + + +L K H+ + ++K+ QIL G+ YLH++
Sbjct: 92 DRKVWLLFD-YAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148
Query: 123 IIHRDLKCDNIFVNG---NHGEVKIGDLGLAIAMQQPTARSVIGTPEFM-----APELY- 173
++HRDLK NI V G G VKI D+G A P P + APEL
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 174 -EEEYNELVDIYSFGMCIL-EMVT 195
Y + +DI++ G CI E++T
Sbjct: 209 GARHYTKAIDIWAIG-CIFAELLT 231
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 63/294 (21%), Positives = 120/294 (40%), Gaps = 25/294 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKI---DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
+ D A VKI + ++P + E+ LL+ L+ NV++ ++
Sbjct: 22 KEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78
Query: 71 KKKTVNMITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+K+ + M+ E G K + + Q++ GL YLHS I+H+D+K
Sbjct: 79 EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIK 136
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPELY--EEEYN-ELVD 182
N+ + G +KI LG+A A+ A G+P F PE+ + ++ VD
Sbjct: 137 PGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVD 195
Query: 183 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP 240
I+S G+ + + T YP+ E N ++F+ + G P P + ++ L
Sbjct: 196 IWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDC----GPPLSDLLKGMLEY 250
Query: 241 -ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDS 293
++R S + + + + + ++ P+ + R P D+
Sbjct: 251 EPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDLHG 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 29/224 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y ++ G VA VK P E+ +L++L ++++K+ D
Sbjct: 52 YDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
++ ++ E G+LR Y +H + + + +A+QI G+ YLH+ + IHRDL N+
Sbjct: 109 SLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNV 165
Query: 134 FVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFG 187
+ N VKIGD GLA A+ + R +P F APE L E ++ D++SFG
Sbjct: 166 LL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFG 224
Query: 188 MCILEMVTF---------------EYPYSECKNPAQIFKKVTSG 216
+ + E++T + ++ + + G
Sbjct: 225 VTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV-LRLTELLERG 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 59/254 (23%), Positives = 117/254 (46%), Gaps = 23/254 (9%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 98
+ + EV +LK ++ NV+ ++ + + V +I EL G L + + +++
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLT 112
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNH--GEVKIGDLGLAIAMQQ 155
+ + +QIL+G+ YLHS I H DLK +NI ++ N +KI D GLA +
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 156 PTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFK 211
+++ GTPEF+APE + E D++S G I ++ + +
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLA 227
Query: 212 KVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICD 267
V++ + + + K FI + LV +R++ +D L+ P+++ ++ ++
Sbjct: 228 NVSAVNYEFEDEYFSNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ---- 282
Query: 268 PLKLPIQSLKMLRL 281
L ++ M +
Sbjct: 283 ALSRKASAVNMEKF 296
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 56/252 (22%), Positives = 106/252 (42%), Gaps = 21/252 (8%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL-RQYRKKHKNV 97
D + + E+ + L+ +V + ++ DD + + MI E + G L + +H +
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKM 252
Query: 98 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQP 156
+ RQ+ GL ++H +N +H DLK +NI F E+K+ D GL +
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310
Query: 157 TA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKK 212
+ + GT EF APE + D++S G + ++ E N + +
Sbjct: 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRN 367
Query: 213 VTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDP 268
V S ++ + +++ K FI K L+ + R++ L+ P+L N
Sbjct: 368 VKSCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD--- 423
Query: 269 LKLPIQSLKMLR 280
++P +R
Sbjct: 424 SQIPSSRYTKIR 435
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 57/237 (24%), Positives = 109/237 (45%), Gaps = 17/237 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
D + + +E+ +L L N++K + + + ++++ EL T G L + +
Sbjct: 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISLVLELVTGGELFDRIVEKGYYSER 148
Query: 101 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTA 158
+ +QIL + YLH + I+HRDLK +N+ + +KI D GL+ ++
Sbjct: 149 DAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206
Query: 159 -RSVIGTPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTFEYPYSECKNPAQIFKKVT 214
++V GTP + APE L Y VD++S G IL + FE P+ + + +F+++
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL-LCGFE-PFYDERGDQFMFRRIL 264
Query: 215 SGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICD 267
+ +V+ K + K +V +RL+ L+ P++ + D
Sbjct: 265 NCEYYFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMD 320
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/250 (21%), Positives = 108/250 (43%), Gaps = 12/250 (4%)
Query: 15 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 74
+ +R +Q G ++++Y E+ +LK L NVVK + D +
Sbjct: 53 RQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH 112
Query: 75 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIF 134
+ M+ EL G + + + + + + ++ G+ YLH IIHRD+K N+
Sbjct: 113 LYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLL 169
Query: 135 VNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPEL---YEEEYN-ELVDIYSFGM 188
V + G +KI D G++ + A + +GTP FMAPE + ++ + +D+++ G+
Sbjct: 170 VGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 247
+ V + P+ + + + K+ S +K I + L R+
Sbjct: 229 TLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV 287
Query: 248 KDLLKDPFLQ 257
++ P++
Sbjct: 288 PEIKLHPWVT 297
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 55/244 (22%), Positives = 109/244 (44%), Gaps = 25/244 (10%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN 96
+++ EV +L+ + N++ + + + V +I EL + G L +K+ +
Sbjct: 56 GVCREEIEREVSILRQVLHPNIITLHDVYENRTD--VVLILELVSGGELFDFLAQKESLS 113
Query: 97 -VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIA 152
+ +QIL G+ YLH+ I H DLK +NI + N +K+ D GLA
Sbjct: 114 EEEATSF---IKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 153 MQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQ 208
++ +++ GTPEF+APE + E D++S G I ++ + +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQE 225
Query: 209 IFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 264
+T+ ++ ++ K FI K LV +RL+ ++ L+ P++ + ++
Sbjct: 226 TLANITAVSYDFDEEFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQA 284
Query: 265 ICDP 268
+
Sbjct: 285 MVRR 288
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 52/238 (21%), Positives = 104/238 (43%), Gaps = 25/238 (10%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN 96
+++ EV++L+ ++ N++ + + + V +I EL + G L K+
Sbjct: 49 GVSREEIEREVNILREIRHPNIITLHDIFENKTD--VVLILELVSGGELFDFLAEKESLT 106
Query: 97 -VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIA 152
+ +QIL G+ YLHS I H DLK +NI + N + +K+ D G+A
Sbjct: 107 EDEATQF---LKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 153 MQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQ 208
++ +++ GTPEF+APE + E D++S G I ++ E +
Sbjct: 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQE 218
Query: 209 IFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQK 262
+++ + ++ K FI + LV R++ L+ +++ ++
Sbjct: 219 TLTNISAVNYDFDEEYFSNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 19/157 (12%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 106
E+ LLK L N+V ++ + ++ E F +L++ ++K IK +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERC--LTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
Q+L G+ + H H I+HRDLK N+ +N + G +K+ D GLA A P T E
Sbjct: 126 YQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY---THE 179
Query: 167 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 195
+ AP++ ++Y+ VDI+S G CI EM+T
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 32/226 (14%)
Query: 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 61
V GL++ K I VA +K P +++ E +++ S+ + +V
Sbjct: 31 VYKGLWIPEGEKVK-------IPVA---IKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 62 KFY----KSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYL 116
+ S TV +IT+L G L Y ++HK N+ + + NW QI G+ YL
Sbjct: 81 RLLGICLTS-------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 117 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE- 171
++HRDL N+ V VKI D GLA + ++ + G P ++MA E
Sbjct: 134 EDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 172 LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
+ Y D++S+G+ + E++TF PY ++I + G
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 13/190 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y + G +VA VK + L E+ +L++L +N+VK+ +D
Sbjct: 42 YDPEGDNTGEQVA---VKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98
Query: 74 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ +I E SG+L++Y K+K +++K +A QI G+ YL S +HRDL N
Sbjct: 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARN 156
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEF-MAPE-LYEEEYNELVDIYSF 186
+ V H +VKIGD GL A++ T + +P F APE L + ++ D++SF
Sbjct: 157 VLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215
Query: 187 GMCILEMVTF 196
G+ + E++T+
Sbjct: 216 GVTLHELLTY 225
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 68/266 (25%), Positives = 110/266 (41%), Gaps = 50/266 (18%)
Query: 48 EVHLLKSLKDDNVVK----FYKSWVDDKKKTVNMITELFTSGNL----RQYRKKHKNVDI 99
E+ +++ +K NVV FY + + +N++ E + R Y K + + +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTA 158
+IK + Q+L L Y+HS I HRD+K N+ ++ G +K+ D G A I +
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 159 RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT-----------------FEY 198
S I + + APEL Y +DI+S G C++ E++ +
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPGESGIDQLVEIIKV 257
Query: 199 ---PYSE---CKNPAQIFKKVTSGIKPASLAKV----NDPQIKGFIEKCLV--PASERLS 246
P E NP + K I+P +KV P I + L P S RL+
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTP-SARLT 315
Query: 247 AKDLLKDPF---LQVENQKEPICDPL 269
A + L PF L+ + P L
Sbjct: 316 AIEALCHPFFDELRTGEARMPNGREL 341
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 106
E+ +LK LK N+VK Y K+ + ++ E +L++ + + K++
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKR--LVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
Q+L+G+ Y H ++HRDLK N+ +N GE+KI D GLA A P R T E
Sbjct: 107 LQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY--THE 160
Query: 167 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 195
+ AP++ ++Y+ +DI+S G CI EMV
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 47/252 (18%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI- 99
D + E+ +L + N++ ++S+ ++ + MI E + ++ + R ++
Sbjct: 44 DQVLVKKEISILNIARHRNILHLHESFESMEE--LVMIFEFISGLDIFE-RINTSAFELN 100
Query: 100 -KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPT 157
+ I ++ Q+ L +LHSHN I H D++ +NI + +KI + G A ++
Sbjct: 101 EREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
Query: 158 A-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECKNPAQIFKKV 213
R + PE+ APE + + D++S G ++ ++ +E QI + +
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENI 215
Query: 214 TSGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPL 269
+ + +++ + F+++ LV R++A + L+ P+L+ + + +
Sbjct: 216 MNAEYTFDEEAFKEISI-EAMDFVDRLLVKERKSRMTASEALQHPWLK-QKIERVSTKVI 273
Query: 270 KLPIQSLKMLRL 281
+ L
Sbjct: 274 RTLKHRRYYHTL 285
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 51/273 (18%), Positives = 112/273 (41%), Gaps = 27/273 (9%)
Query: 14 YKAFDEFAGIEVA---WSRVKIDDVLQLPGDLQKLYSEVHLLKSLK--DDNVVKFYKSWV 68
Y + VA + +I D +LP + ++ EV LLK + V++ W
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELP-NGTRVPMEVVLLKKVSSGFSGVIRLLD-WF 117
Query: 69 DDKKKTVNMITELFT-SGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 127
+ V +I E +L + + + ++ +++ Q+L + + H+ ++HRD
Sbjct: 118 ERPDSFV-LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRD 174
Query: 128 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYN-ELVDIYS 185
+K +NI ++ N GE+K+ D G ++ GT + PE Y+ ++S
Sbjct: 175 IKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 186 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVPA-S 242
G+ + +MV + P+ +++ G ++ + + I CL S
Sbjct: 235 LGILLYDMVCGDIPFEH-------DEEIIRGQVFFRQRVS----SECQHLIRWCLALRPS 283
Query: 243 ERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 275
+R + +++ P++Q + + +
Sbjct: 284 DRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 57/260 (21%), Positives = 106/260 (40%), Gaps = 29/260 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDD-- 70
+ F G + A +K+ D K EV ++V + +
Sbjct: 46 LECFHRRTGQKCA---LKLLY------DSPKARQEVDHHWQASGGPHIVCILDVYENMHH 96
Query: 71 KKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128
K+ + +I E G L R + + + R I + +LHSHN I HRD+
Sbjct: 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDV 154
Query: 129 KCDNI-FVNGNHG-EVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYS 185
K +N+ + + +K+ D G A Q ++ TP ++APE L E+Y++ D++S
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 186 FGMCILEMVTFEYP--YSECKN--PAQIFKKVTSG---IKPASLAKVNDPQIKGFIEKCL 238
G I+ ++ +P YS + +++ G ++V++ K I L
Sbjct: 215 LG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE-DAKQLIRLLL 272
Query: 239 VP-ASERLSAKDLLKDPFLQ 257
+ERL+ + P++
Sbjct: 273 KTDPTERLTITQFMNHPWIN 292
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/276 (21%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDD-NVVKFYKSWVDDK 71
+ + G E A K + ++ E+ +L+ K V+ ++ + +
Sbjct: 46 RQCISKSTGQEYA---AKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102
Query: 72 KKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+ + +I E G + + + V + +QIL G+ YLH +N I+H DLK
Sbjct: 103 E--IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLK 158
Query: 130 CDNI-FVNGN-HGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-LYEEEYNELVDIYS 185
NI + G++KI D G++ + R ++GTPE++APE L + D+++
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 186 FGMCILEMVTFEYP--YSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFIEKCLVP 240
G+ I M+ E + + + ++ + + V+ FI+ LV
Sbjct: 219 IGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDYSEETFSSVSQ-LATDFIQSLLVK 274
Query: 241 -ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 275
+R +A+ L +LQ + E + P + S
Sbjct: 275 NPEKRPTAEICLSHSWLQ-QWDFENLFHPEETSSSS 309
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 20/306 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
A + VA VKI D+ + + + E+ + K L +NVVKFY +
Sbjct: 24 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG--HRREGN 78
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ E + G L + + + + Q++ G+VYLH I HRD+K +N+
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPELYE-EEYN-ELVDIYSFG 187
++ +KI D GLA + ++ GT ++APEL + E++ E VD++S G
Sbjct: 137 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 188 MCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL 245
+ + M+ E P+ + + Q K+ D + K LV S R+
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPLALLHKILVENPSARI 254
Query: 246 SAKDLLKDPFLQV---ENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLST 302
+ D+ KD + + K P + + S ++S +
Sbjct: 255 TIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGW 314
Query: 303 CTESNN 308
E ++
Sbjct: 315 SKEHHH 320
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 61/252 (24%), Positives = 108/252 (42%), Gaps = 22/252 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
Y A D I+VA +K + L++ EVH L N+V +D
Sbjct: 28 YLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
++ E L +Y + H + + N+ QIL G+ + H I+HRD+K
Sbjct: 85 --CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQ 140
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFG 187
NI + ++ +KI D G+A A+ + + V+GT ++ +PE + E +E DIYS G
Sbjct: 141 NILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIG 199
Query: 188 MCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVND---PQIKGFIEKCLV--PA 241
+ + EM+ E P++ + I K + + P V + I + A
Sbjct: 200 IVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVILRATEKDKA 257
Query: 242 SERLSAKDLLKD 253
+ + +++ D
Sbjct: 258 NRYKTIQEMKDD 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 59/284 (20%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 14 YKAFDEFAGIEVA---WSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD----NVVKFYKS 66
+ ++VA R ++ L D EV LL + V++
Sbjct: 48 FAGHRLTDRLQVAIKVIPRNRVLGWSPLS-DSVTCPLEVALLWKVGAGGGHPGVIRLLD- 105
Query: 67 WVDDKKKTVNMITELFTSGN-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 125
W + ++ + ++ E L Y + + + + Q++ + + HS ++H
Sbjct: 106 WFETQEGFM-LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVH 162
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI-GTPEFMAPELYE-EEYN-ELVD 182
RD+K +NI ++ G K+ D G A+ + GT + PE +Y+
Sbjct: 163 RDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPAT 221
Query: 183 IYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLV 239
++S G+ +L +MV + P+ +++ PA ++ P I +CL
Sbjct: 222 VWSLGI-LLYDMVCGDIPFER-------DQEILEAELHFPAHVS----PDCCALIRRCLA 269
Query: 240 PA-SERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLP 282
P S R S +++L DP++Q + P+ +P K L LP
Sbjct: 270 PKPSSRPSLEEILLDPWMQTPAEDVPL-NPSKGGPAPLAWSLLP 312
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 63/251 (25%), Positives = 109/251 (43%), Gaps = 15/251 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
A + VA VKI D+ + + + E+ + K L +NVVKFY +
Sbjct: 24 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG--HRREGN 78
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ E + G L + + + + Q++ G+VYLH I HRD+K +N+
Sbjct: 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 136
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVI----GTPEFMAPE-LYEEEYN-ELVDIYSFG 187
++ +KI D GLA + ++ GT ++APE L E++ E VD++S G
Sbjct: 137 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ + M+ E P+ + + Q + + K D + K LV S R++
Sbjct: 196 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 255
Query: 247 AKDLLKDPFLQ 257
D+ KD +
Sbjct: 256 IPDIKKDRWYN 266
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 106
EV LLK LK N+V + +K + ++ E + +L+QY N+ ++ +K +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKS--LTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFL 106
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
Q+L GL Y H ++HRDLK N+ +N GE+K+ D GLA A PT E
Sbjct: 107 FQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY---DNE 160
Query: 167 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 195
+ P++ +Y+ +D++ G CI EM T
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 56/275 (20%), Positives = 107/275 (38%), Gaps = 39/275 (14%)
Query: 14 YKAFDEFAGIEVA-----WSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSW 67
+ + E A + ++ + EV +L+ + N+++ ++
Sbjct: 34 RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93
Query: 68 VDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 127
+ ++ +L G L Y + + K + R +L + LH N I+HRD
Sbjct: 94 ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRD 149
Query: 128 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-------LYEEEYNE 179
LK +NI ++ + +K+ D G + + R V GTP ++APE Y +
Sbjct: 150 LKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 208
Query: 180 LVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVNDPQ 229
VD++S G I+ Y P+ + + + + SG +D
Sbjct: 209 EVDMWSTG-VIM------YTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260
Query: 230 IKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 263
K + + LV +R +A++ L PF Q +E
Sbjct: 261 -KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 24/162 (14%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY------RKKHKNVDIKV 101
E+ L+K LK +N+V+ Y + K + ++ E F +L++Y + +++ +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENK--LTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNL 109
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161
+K + Q+L GL + H + I+HRDLK N+ +N G++K+GD GLA A P
Sbjct: 110 VKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF- 165
Query: 162 IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 195
+ E + AP++ Y+ +DI+S G CIL EM+T
Sbjct: 166 --SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 63/301 (20%), Positives = 121/301 (40%), Gaps = 52/301 (17%)
Query: 11 FSS-YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWV 68
+ + E A VKI + +++ EV +L + NV++ + +
Sbjct: 26 HARVQTCINLITSQEYA---VKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 69 DDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIH 125
++ + ++ E G++ ++++H N ++ V+ + + L +LH+ I H
Sbjct: 82 EEDR--FYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDVASALDFLHNKG--IAH 134
Query: 126 RDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ---------QPTARSVIGTPEFMAPE--- 171
RDLK +NI + N VKI D L ++ P + G+ E+MAPE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 172 ---LYEEEYNELVDIYSFG--MCIL------------EMVTFEYPYSECKNPAQIFKKVT 214
Y++ D++S G + IL ++ + +F+ +
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254
Query: 215 SGI---KPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLK 270
G A ++ K I K LV A +RLSA +L+ P++Q + + P+
Sbjct: 255 EGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMV 313
Query: 271 L 271
L
Sbjct: 314 L 314
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 59/308 (19%), Positives = 112/308 (36%), Gaps = 74/308 (24%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 69
Y+A +G VA +V D + E+ +++ L N+V+ FY S
Sbjct: 71 YQAKLCDSGELVAIKKVLQDK--------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEK 122
Query: 70 DKKKTVNMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 125
+ +N++ + + R Y + + + + +K + Q+ L Y+HS I H
Sbjct: 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICH 179
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APELY-- 173
RD+K N+ ++ + +K+ D G A+ ++ E APEL
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRG-EPNVSYICSRYYRAPELIFG 230
Query: 174 EEEYNELVDIYSFGMCIL-EMVTFE--YPYSECKN------------PAQIFKKVTSG-- 216
+Y +D++S G C+L E++ + +P + + +++
Sbjct: 231 ATDYTSSIDVWSAG-CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289
Query: 217 ------IKPASLAKV----NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV---ENQ 261
IK KV P+ + L P + RL+ + F N
Sbjct: 290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTPLEACAHSFFDELRDPNV 348
Query: 262 KEPICDPL 269
K P
Sbjct: 349 KLPNGRDT 356
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 62/276 (22%), Positives = 100/276 (36%), Gaps = 64/276 (23%)
Query: 48 EVHLLKSLKDDNVVKFY------KSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIK 100
E+ +L+ LK +NVV S + K ++ ++ + F +L +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLS 124
Query: 101 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160
IK + +L+GL Y+H + I+HRD+K N+ + G +K+ D GLA A
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQ 181
Query: 161 VIG-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT---------------- 195
T + PEL E +Y +D++ G CI+ EM T
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWTRSPIMQGNTEQHQLAL 240
Query: 196 ----------------FEYP-YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238
Y Y + + +KV +K DP I+K L
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR----DPYALDLIDKLL 296
Query: 239 V--PASERLSAKDLLKDPFLQVENQKEPICDPLKLP 272
V PA +R+ + D L F D +
Sbjct: 297 VLDPA-QRIDSDDALNHDFF---WSDPMPSDLKGML 328
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 57/289 (19%), Positives = 121/289 (41%), Gaps = 37/289 (12%)
Query: 11 FSS-YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWV 68
+ F++ + A +K+ D K EV L ++V+ +
Sbjct: 75 NGKVLQIFNKRTQEKFA---LKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYE 125
Query: 69 D--DKKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 124
+ +K + ++ E G L R + + + + I + YLHS N I
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IA 183
Query: 125 HRDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPE-LYEEEYNEL 180
HRD+K +N+ + + +K+ D G A + + TP ++APE L E+Y++
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 243
Query: 181 VDIYSFGMCILEMVTFEYP--YSECKNPAQ--IFKKVTSGI---KPASLAKVNDPQIKGF 233
D++S G I+ ++ YP YS + ++ G ++V++ ++K
Sbjct: 244 CDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-EVKML 301
Query: 234 IEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRL 281
I L ++R++ + + P++ ++ K P + P+ + ++L+
Sbjct: 302 IRNLLKTEPTQRMTITEFMNHPWIM-QSTKVP-----QTPLHTSRVLKE 344
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 51/163 (31%), Positives = 76/163 (46%), Gaps = 24/163 (14%)
Query: 48 EVHLLKSLKD---DNVVKFYK---SWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DI 99
EV +L+ L+ NVV+ + D++ + ++ E +L Y K
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPT 119
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
+ IK+ Q+L GL +LHSH ++HRDLK NI V + G++K+ D GLA A
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 160 SVIGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 195
T + APE L + Y VD++S G CI EM
Sbjct: 177 ----TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 57/271 (21%), Positives = 109/271 (40%), Gaps = 44/271 (16%)
Query: 14 YKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYK 65
+ G E A VKI QL + E H+L+ + +++
Sbjct: 111 RRCVHRATGHEFA---VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 66 SWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 125
S+ + ++ +L G L Y + + K ++ R +L + +LH++N I+H
Sbjct: 168 SYESSSF--MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVH 223
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPE-------LYEEEY 177
RDLK +NI ++ N ++++ D G + ++ R + GTP ++APE Y
Sbjct: 224 RDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 178 NELVDIYSFGMCILEMVTFEY-------PYSECKNPAQIFKKVTSGI---KPASLAKVND 227
+ VD+++ G IL + P+ + + + + G +
Sbjct: 283 GKEVDLWACG-VIL------FTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDRSS 334
Query: 228 PQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
K I + L RL+A+ L+ PF +
Sbjct: 335 TV-KDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 7e-23
Identities = 62/305 (20%), Positives = 121/305 (39%), Gaps = 38/305 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKI-------DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKS 66
+ A D+ EV VK +D L K+ E+ +L ++ N++K
Sbjct: 41 WTAVDKEKNKEVV---VKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD- 96
Query: 67 WVDDKKKTVNMITELFTSGN-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 125
+ + + ++ E SG L + +H +D + RQ++ + YL + IIH
Sbjct: 97 -IFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIH 153
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYE-EEYN-ELVD 182
RD+K +NI + + +K+ D G A +++ + GT E+ APE+ Y ++
Sbjct: 154 RDIKDENIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE 212
Query: 183 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP 240
++S G+ + +V E P+ E ++ P ++ ++ + L P
Sbjct: 213 MWSLGVTLYTLVFEENPFCE-------LEETVEAAIHPPYLVS----KELMSLVSGLLQP 261
Query: 241 -ASERLSAKDLLKDPFLQ-----VENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSD 294
R + + L+ DP++ + E + K L L M S D+
Sbjct: 262 VPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQA 321
Query: 295 YKQLS 299
+
Sbjct: 322 QELCG 326
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 13/177 (7%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 105
E +LK N+V+ V +K+ + ++ EL G+ + R + + +K +
Sbjct: 161 QEARILKQYSHPNIVRLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM 218
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTP 165
G+ YL S IHRDL N V + +KI D G++ + G
Sbjct: 219 VGDAAAGMEYLESKC--CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLR 275
Query: 166 EF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
+ APE L Y+ D++SFG+ + E + PY N Q + V G
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVV 61
V GL++ K I VA +K P +++ E +++ S+ + +V
Sbjct: 31 VYKGLWIPEGEKVK-------IPVA---IKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 62 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHN 120
+ + TV +IT+L G L Y ++HK N+ + + NW QI G+ YL
Sbjct: 81 RLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 121 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG-TP-EFMAPE-LYEE 175
++HRDL N+ V VKI D GLA + ++ + G P ++MA E +
Sbjct: 138 --LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 176 EYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
Y D++S+G+ + E++TF PY ++I + G
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKG 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 39/205 (19%)
Query: 14 YKAFDEFAGIEVAWSRVKIDD----VLQLPGDLQKLYS----EVHLLKSLKD---DNVVK 62
YKA D +G VA V++ + LP EV LL+ L+ NVV+
Sbjct: 26 YKARDPHSGHFVALKSVRVPNGGGGGGGLP-------ISTVREVALLRRLEAFEHPNVVR 78
Query: 63 FYK---SWVDDKKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLH 117
+ D++ V ++ E +LR Y + + + IK+ RQ L GL +LH
Sbjct: 79 LMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 137
Query: 118 SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM-----APE- 171
++ I+HRDLK +NI V + G VK+ D GLA A TP + APE
Sbjct: 138 ANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL----TPVVVTLWYRAPEV 190
Query: 172 LYEEEYNELVDIYSFGMCIL-EMVT 195
L + Y VD++S G CI EM
Sbjct: 191 LLQSTYATPVDMWSVG-CIFAEMFR 214
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 48 EVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV-DIKVIKNWA 106
E+ LL+ L N++ ++ ++++ + F +L K + V IK +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSN--ISLVFD-FMETDLEVIIKDNSLVLTPSHIKAYM 118
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
L GL YLH H I+HRDLK +N+ ++ +G +K+ D GLA + P R+ T +
Sbjct: 119 LMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY--THQ 172
Query: 167 FM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 195
+ APEL Y VD+++ G CIL E++
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 62/255 (24%), Positives = 114/255 (44%), Gaps = 23/255 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
+ G +VA VKI + ++ + K+ E+ LK + +++K Y+ V
Sbjct: 28 KIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ--VIST 82
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
M+ E + G L Y KH V+ + +QIL + Y H H ++HRDLK +
Sbjct: 83 PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPE 140
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFG 187
N+ ++ + KI D GL+ M R+ G+P + APE+ Y VDI+S G
Sbjct: 141 NVLLDAH-MNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 244
+ + ++ P+ + ++ +FKK+ G+ P L + + L +R
Sbjct: 199 VILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPEYLN----RSVATLLMHMLQVDPLKR 253
Query: 245 LSAKDLLKDPFLQVE 259
+ KD+ + + + +
Sbjct: 254 ATIKDIREHEWFKQD 268
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 25/258 (9%)
Query: 41 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
E+ LK + N+VK ++ + D ++ EL G L + KK K+
Sbjct: 48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH--TFLVMELLNGGELFERIKKKKHFSE 105
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHG-EVKIGDLGLAIAMQ--Q 155
R+++ + ++H ++HRDLK +N+ F + N E+KI D G A
Sbjct: 106 TEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 156 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSE-----CKNPA 207
++ T + APE L + Y+E D++S G IL + S C +
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAV 222
Query: 208 QIFKKVTSG---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ-- 261
+I KK+ G + + V+ + K I+ L ++RL L + +LQ +Q
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
Query: 262 KEPICDPLKLPIQSLKML 279
P+ P L +
Sbjct: 282 SNPLMTPDILGSSGAAVH 299
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 86/323 (26%), Positives = 127/323 (39%), Gaps = 78/323 (24%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 69
AFD G+ VA K+ Q ++ Y E+ LLK +K +NV+ F +
Sbjct: 46 CAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
++ V ++T L + +L K K D ++ QIL GL Y+HS + IIHRDLK
Sbjct: 104 EEFNDVYLVTHLMGA-DLNNIVKCQKLTDDH-VQFLIYQILRGLKYIHSAD--IIHRDLK 159
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE--LYEEEY 177
N+ VN + E+KI D GL AR T + M APE L Y
Sbjct: 160 PSNLAVNED-CELKILDFGL--------ARH---TADEMTGYVATRWYRAPEIMLNWMHY 207
Query: 178 NELVDIYSFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGF 233
N+ VDI+S G CI+ E++T + K + + L K++ + +
Sbjct: 208 NQTVDIWSVG-CIMAELLTGR-TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 234 I--------------------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKE 263
I EK LV +R++A L + + E
Sbjct: 266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS-DKRITAAQALAHAYFAQYHDPDDE 324
Query: 264 PICDPL-------KLPIQSLKML 279
P+ DP L I K L
Sbjct: 325 PVADPYDQSLESRDLLIDEWKSL 347
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 99
+ + E + L +VKFY V K+ + ++TE ++G L Y R K ++
Sbjct: 46 SEDEFFQEAQTMMKLSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP 103
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
+ + G+ +L SH IHRDL N V VK+ D G+ +
Sbjct: 104 SQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLV-DRDLCVKVSDFGMTRYVLDDQYV 160
Query: 160 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
S +GT +F APE + +Y+ D+++FG+ + E+ + + PY N +++ KV
Sbjct: 161 SSVGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKV 218
Query: 214 TSG 216
+ G
Sbjct: 219 SQG 221
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 40/183 (21%), Positives = 79/183 (43%), Gaps = 14/183 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDI 99
+ E ++ L +V+ Y V ++ + ++TE G L Y + +
Sbjct: 46 SEEDFIEEAEVMMKLSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA 103
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
+ + + G+ YL +IHRDL N V G + +K+ D G+ +
Sbjct: 104 ETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYT 160
Query: 160 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
S GT +F +PE Y+ D++SFG+ + E+ + + PY N +++ + +
Sbjct: 161 SSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDI 218
Query: 214 TSG 216
++G
Sbjct: 219 STG 221
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 13/183 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
++++ E ++K +K N+V+ V ++ +ITE T GNL Y ++ ++
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 316
Query: 101 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156
+ A QI + YL N IHR+L N V G + VK+ D GL+ M
Sbjct: 317 AVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTY 373
Query: 157 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
TA + P ++ APE L +++ D+++FG+ + E+ T+ PY +Q+++ +
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELL 432
Query: 214 TSG 216
Sbjct: 433 EKD 435
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 46/194 (23%), Positives = 92/194 (47%), Gaps = 22/194 (11%)
Query: 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
M+ +L G+LR + +++ + + +K + +++ L YL + IIHRD+K DNI ++
Sbjct: 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD 149
Query: 137 GNHGEVKIGDLGLAIAMQQPT-ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCIL 191
HG V I D +A + + T ++ GT +MAPE++ Y+ VD +S G+
Sbjct: 150 -EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208
Query: 192 EMVT----FEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIEKCLVP-ASER 244
E++ + S + +I + + P++ ++ ++K L P +R
Sbjct: 209 ELLRGRRPYHIRSST--SSKEIVHTFETTVVTYPSAW----SQEMVSLLKKLLEPNPDQR 262
Query: 245 L-SAKDLLKDPFLQ 257
D+ P++
Sbjct: 263 FSQLSDVQNFPYMN 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 41/185 (22%), Positives = 89/185 (48%), Gaps = 14/185 (7%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVD 98
P +L +E ++++ L + +V+ + + + + ++ E+ G L +Y +++++V
Sbjct: 59 PALKDELLAEANVMQQLDNPYIVRMIG--ICEAE-SWMLVMEMAELGPLNKYLQQNRHVK 115
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQP 156
K I Q+ G+ YL N +HRDL N+ + H KI D GL+ + +
Sbjct: 116 DKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQH-YAKISDFGLSKALRADEN 172
Query: 157 TARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 211
++ P ++ APE + +++ D++SFG+ + E ++ + PY K ++
Sbjct: 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTA 231
Query: 212 KVTSG 216
+ G
Sbjct: 232 MLEKG 236
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 23 IEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80
+ VA VK DVL P + EV+ + SL N+++ Y V + M+TE
Sbjct: 47 VSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG--VV-LTPPMKMVTE 100
Query: 81 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
L G+L +KH+ + + + +A Q+ G+ YL S IHRDL N+ +
Sbjct: 101 LAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD 158
Query: 140 GEVKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEM 193
VKIGD GL + P + APE L ++ D + FG+ + EM
Sbjct: 159 -LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 217
Query: 194 VTF-EYPYSECKNPAQIFKKV 213
T+ + P+ +QI K+
Sbjct: 218 FTYGQEPWIGLNG-SQILHKI 237
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 76/314 (24%), Positives = 124/314 (39%), Gaps = 60/314 (19%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 69
A D+ +G +VA K+ Q ++ Y E+ LLK ++ +NV+ F +
Sbjct: 41 CSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
++ + +L++ + I+ Q+L GL Y+HS ++HRDLK
Sbjct: 99 RNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLK 153
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 187
N+ VN + E+KI D GLA V+ T + APE L YN+ VDI+S G
Sbjct: 154 PGNLAVNED-CELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 188 MCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI--------- 234
CI+ EM+T + + K+ ++ + K+ND K +I
Sbjct: 212 -CIMAEMLTGK-TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK 269
Query: 235 -----------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDP----- 268
EK L +RL+A L PF + + ++E
Sbjct: 270 DFTQLFPRASPQAADLLEKMLELDV-DKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDS 328
Query: 269 ---LKLPIQSLKML 279
KL + K
Sbjct: 329 LEHEKLTVDEWKQH 342
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 36/191 (18%), Positives = 73/191 (38%), Gaps = 30/191 (15%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKV 101
+ + ++ L ++V Y V ++ E G+L Y KK+KN ++I
Sbjct: 57 ESFFEAASMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 102 IKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-------GNHGEVKIGDLGLAIAMQ 154
A+Q+ + +L + +IH ++ NI + GN +K+ D G+
Sbjct: 115 KLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI----- 167
Query: 155 QPTARSVIGTPEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 205
+ +V+ + PE + N D +SFG + E+ + + P S +
Sbjct: 168 ---SITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224
Query: 206 PAQIFKKVTSG 216
+ +
Sbjct: 225 -QRKLQFYEDR 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 45/210 (21%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ E I V +K+ + Q + + + SL ++V+
Sbjct: 34 WIPEGESIKIPVC---IKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS--- 87
Query: 74 TVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++ ++T+ G+L + ++H+ + +++ NW QI G+ YL H ++HR+L N
Sbjct: 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARN 145
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFG 187
+ + +V++ D G+A + S TP ++MA E ++ +Y D++S+G
Sbjct: 146 VLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYG 204
Query: 188 MCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
+ + E++TF PY+ + A++ + G
Sbjct: 205 VTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 73/313 (23%), Positives = 123/313 (39%), Gaps = 58/313 (18%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 69
A D G +VA K+ Q ++ Y E+ LLK ++ +NV+ F
Sbjct: 42 CSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
D ++ + +L + K K + + I+ Q+L GL Y+H+ IIHRDLK
Sbjct: 100 DDFTDFYLVMPFMGT-DLGKLMKHEKLGEDR-IQFLVYQMLKGLRYIHAAG--IIHRDLK 155
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFG 187
N+ VN + E+KI D GLA V+ T + APE L Y + VDI+S G
Sbjct: 156 PGNLAVNED-CELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 188 MCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI--------- 234
CI+ EM+T + + + K++ + ++ + K ++
Sbjct: 214 -CIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271
Query: 235 -----------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPL---- 269
EK LV +R++A + L P+ + + + EP
Sbjct: 272 DFASILTNASPLAVNLLEKMLVLDA-EQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSF 330
Query: 270 ---KLPIQSLKML 279
+ K +
Sbjct: 331 DDVDRTLDEWKRV 343
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 43/183 (23%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 99
+ E ++ +L + +V+ Y V K++ + +ITE +G L Y R+
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
+ + + + + YL S +HRDL N V + G VK+ D GL+ +
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLV-NDQGVVKVSDFGLSRYVLDDEYT 176
Query: 160 SVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
S +G+ +F PE L +++ DI++FG+ + E+ + + PY N ++ + +
Sbjct: 177 SSVGS-KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHI 234
Query: 214 TSG 216
G
Sbjct: 235 AQG 237
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 77/330 (23%), Positives = 125/330 (37%), Gaps = 79/330 (23%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 69
A+D VA K+ Q ++ Y E+ L+K + N++ F
Sbjct: 42 CAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
++ + V ++ EL + NL Q + +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 100 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 154
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE-LYEEEYNELVDI 183
NI V + +KI D GLA + S + TP + APE + Y E VDI
Sbjct: 155 PSNIVVKSD-CTLKILDFGLA----RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 184 YSFGMCIL-EMVT----F------------------------------------EYPYSE 202
+S G CI+ EM+ F P
Sbjct: 210 WSVG-CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA 268
Query: 203 CKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV-- 258
+ ++F V + K+ Q + + K LV S+R+S + L+ P++ V
Sbjct: 269 GYSFEKLFPDVLF-PADSEHNKLKASQARDLLSKMLVIDA-SKRISVDEALQHPYINVWY 326
Query: 259 ENQKEPICDPL---------KLPIQSLKML 279
+ + P + I+ K L
Sbjct: 327 DPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 79/328 (24%), Positives = 133/328 (40%), Gaps = 73/328 (22%)
Query: 15 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDDK 71
A + G VA +K + P + E+ +LK K +N++ + + +
Sbjct: 29 SATHKPTGEIVA---IKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
V +I EL + +L + D I+ + Q L + LH N +IHRDLK
Sbjct: 86 FNEVYIIQELMQT-DLHRVISTQMLSDDH-IQYFIYQTLRAVKVLHGSN--VIHRDLKPS 141
Query: 132 NIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFM----------APE--LYEEEY 177
N+ +N N ++K+ D GLA I G M APE L +Y
Sbjct: 142 NLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200
Query: 178 NELVDIYSFGMCIL-EMVT-----------------FEY---PYSE-----CKNP-AQIF 210
+ +D++S G CIL E+ F P+S+ ++P A+ +
Sbjct: 201 SRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREY 259
Query: 211 KKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKE 263
K A L K+ +P+ +++ LV P ++R++AK+ L+ P+LQ + E
Sbjct: 260 IKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP-AKRITAKEALEHPYLQTYHDPNDE 318
Query: 264 PICDPL------------KLPIQSLKML 279
P +P+ L + LK L
Sbjct: 319 PEGEPIPPSFFEFDHYKEALTTKDLKKL 346
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 106
E ++ L VK Y ++ DD+K + +G L +Y +K + D + +
Sbjct: 79 RERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 136
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA----IAMQQPTARSVI 162
+I+ L YLH IIHRDLK +NI +N ++I D G A +Q A S +
Sbjct: 137 AEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 163 GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-P 219
GT ++++PE L E+ + D+++ G I ++V P+ N IF+K+ P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEYDFP 252
Query: 220 ASLAKVNDPQIKGFIEKCLVP-ASERL------SAKDLLKDPF 255
P+ + +EK LV A++RL L PF
Sbjct: 253 EKF----FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 63/255 (24%), Positives = 118/255 (46%), Gaps = 24/255 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
A +VA +K +L+ ++ E+ LK L+ +++K Y V
Sbjct: 26 KLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD--VITT 80
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ M+ E + G L Y + K + + + +QI+ + Y H H I+HRDLK +
Sbjct: 81 PTDIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPE 137
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFG 187
N+ ++ N VKI D GL+ + ++ G+P + APE+ + Y VD++S G
Sbjct: 138 NLLLDDN-LNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 244
+ + M+ P+ + + +FKKV S + P L P + I + +V +R
Sbjct: 196 IVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDFL----SPGAQSLIRRMIVADPMQR 250
Query: 245 LSAKDLLKDPFLQVE 259
++ +++ +DP+ V
Sbjct: 251 ITIQEIRRDPWFNVN 265
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 26/231 (11%)
Query: 48 EVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNL--RQYRKKHKN-VDIKVIK 103
E+ +L N++ + D K V ++TEL G L + R+K + + +
Sbjct: 65 EIEILLRYGQHPNIITLKDVYDDGKY--VYVVTELMKGGELLDKILRQKFFSEREASAV- 121
Query: 104 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFV---NGNHGEVKIGDLGLAIAMQ--QPTA 158
I + YLH+ ++HRDLK NI +GN ++I D G A ++
Sbjct: 122 --LFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 159 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYP--YSECK-NPAQIFKKVT 214
+ T F+APE L + Y+ DI+S G +L + Y + P +I ++
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIG 236
Query: 215 SG---IKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQ 261
SG + V+D K + K L +RL+A +L+ P++ +Q
Sbjct: 237 SGKFSLSGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 52/263 (19%), Positives = 105/263 (39%), Gaps = 53/263 (20%)
Query: 39 PGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV 97
P +K+ E+ +L++L+ N++ D +T ++ E + + +Q + +
Sbjct: 71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY 130
Query: 98 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQ 154
DI+ +IL L Y HS I+HRD+K N+ ++ H ++++ D GLA Q
Sbjct: 131 DIRFY---MYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 155 QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT---------------- 195
+ R + + F PE + + Y+ +D++S G C+L M+
Sbjct: 186 EYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLV 242
Query: 196 -----------FEYPYSECKNPAQIF--------KKVTSGIKPASLAKVNDPQIKGFIEK 236
++Y F +K + + P+ F++K
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302
Query: 237 CLV--PASERLSAKDLLKDPFLQ 257
L RL+A++ ++ P+
Sbjct: 303 LLRYDHQ-SRLTAREAMEHPYFY 324
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 55/255 (21%), Positives = 96/255 (37%), Gaps = 23/255 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
+ A D +VA VK+ L D + E +L +V Y + +
Sbjct: 29 HLARDLRDHRDVA---VKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84
Query: 71 --KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128
++ E LR + K L + H + IIHRD+
Sbjct: 85 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDV 142
Query: 129 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR-----SVIGTPEFMAPELYE-EEYNELVD 182
K NI + VK+ D G+A A+ +VIGT ++++PE + + D
Sbjct: 143 KPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 183 IYSFGMCILEMVTFEYPYSECKNPAQI-FKKVTSGIKPASLAKVNDPQ-IKGFIEKCLV- 239
+YS G + E++T E P++ +P + ++ V P S + + K L
Sbjct: 202 VYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAK 260
Query: 240 -PASERLSAKDLLKD 253
P + +A ++ D
Sbjct: 261 NPENRYQTAAEMRAD 275
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVD 98
+ E ++K L+ + +V+ Y ++ + ++TE + G+L + K K +
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLR 278
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156
+ + + A QI G+ Y+ N +HRDL+ NI V G + K+ D GLA ++
Sbjct: 279 LPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEY 335
Query: 157 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
TAR P ++ APE + D++SFG+ + E+ T PY N ++ +V
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV 394
Query: 214 TSG 216
G
Sbjct: 395 ERG 397
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 64/300 (21%), Positives = 125/300 (41%), Gaps = 24/300 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
D+ VA VK + + + E+ +SL+ N+V+F + V
Sbjct: 37 RLMRDKLTKELVA---VKYIERGAA--IDENVQREIINHRSLRHPNIVRFKE--VILTPT 89
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ +I E + G L + + + +Q+L G+ Y HS I HRDLK +N
Sbjct: 90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENT 147
Query: 134 FVNGNH-GEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMC 189
++G+ +KI D G + + + +S +GTP ++APE+ +EY+ ++ D++S G+
Sbjct: 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVT 207
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIK------PASLAKVNDPQIKGFIEKCLVP-AS 242
+ M+ YP+ E + ++K I P + P+ I + V +
Sbjct: 208 LYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSIPDDIRI--SPECCHLISRIFVADPA 264
Query: 243 ERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPSSMDIDSDYKQLSLST 302
R+S ++ + N + + Q + + S + M I S+ ++
Sbjct: 265 TRISIPEIKTHSWFLK-NLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRN 323
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-21
Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 15/189 (7%)
Query: 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
I +L G+L + +H ++ +A +I+ GL ++H+ +++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 137 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 194
HG V+I DLGLA + + +GT +MAPE Y+ D +S G + +++
Sbjct: 327 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 195 TFEYPY--SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL-----S 246
P+ + K+ +I + + L P+++ +E L + RL
Sbjct: 386 RGHSPFRQHKTKDKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 247 AKDLLKDPF 255
A+++ + PF
Sbjct: 444 AQEVKESPF 452
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 43/176 (24%), Positives = 85/176 (48%), Gaps = 13/176 (7%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNW 105
SE ++K+L ++VK + +++ +I EL+ G L Y + ++ + + +
Sbjct: 62 SEAVIMKNLDHPHIVKLIG--IIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT- 164
+ QI + YL S N +HRD+ NI V VK+GD GL+ ++ T
Sbjct: 119 SLQICKAMAYLESIN--CVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 165 -P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
P ++M+PE + + D++ F +C+ E+++F + P+ +N + + G
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 4e-21
Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 42/224 (18%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDD 70
+A+D+ VA KI V + D +++ E+ +L L D+VVK +
Sbjct: 70 CEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
K + ++ E+ S + ++ + + IK +L G+ Y+HS I+HRDLK
Sbjct: 128 KFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKP 184
Query: 131 DNIFVNGNHGEVKIGDLGLA-------------------IAMQQPTARSVIGTPEFM--- 168
N VN + VK+ D GLA M T +
Sbjct: 185 ANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243
Query: 169 -------APE--LYEEEYNELVDIYSFGMCIL-EMVTFEYPYSE 202
APE L +E Y E +D++S G CI E++
Sbjct: 244 VVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKENVA 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 4e-21
Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 25/197 (12%)
Query: 14 YKAFDEF-AGIEVAWSRVKIDDVLQLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWVD 69
Y A D G V +K L GD +E L + ++V+ + ++V+
Sbjct: 97 YLALDRNVNGRPVV---LK---GLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF-NFVE 149
Query: 70 DKKKTVNMIT----ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 125
+ + + E +L++ + + V + I + +IL L YLHS +++
Sbjct: 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAI-AYLLEILPALSYLHSIG--LVY 205
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYS 185
DLK +NI + ++K+ DLG + + GTP F APE+ DIY+
Sbjct: 206 NDLKPENIML--TEEQLKLIDLGAVSRINSFGY--LYGTPGFQAPEIVRTGPTVATDIYT 261
Query: 186 FGMCIL-EMVTFEYPYS 201
G L + +
Sbjct: 262 VG-RTLAALTLDLPTRN 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 4e-21
Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 14/183 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
+ E ++K L+ + +V+ Y ++ + ++TE + G+L + K ++
Sbjct: 305 SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLR 361
Query: 101 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156
+ + + A QI G+ Y+ N +HRDL+ NI V G + K+ D GLA ++
Sbjct: 362 LPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEY 418
Query: 157 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
TAR P ++ APE + D++SFG+ + E+ T PY N ++ +V
Sbjct: 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQV 477
Query: 214 TSG 216
G
Sbjct: 478 ERG 480
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 15/184 (8%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVD 98
++++ E ++K +K N+V+ V ++ +ITE T GNL Y ++ + V
Sbjct: 52 EVEEFLKEAAVMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVS 109
Query: 99 IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158
V+ A QI + YL N IHRDL N V NH VK+ D GL+ M T
Sbjct: 110 AVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTY 166
Query: 159 RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 212
+ G +F APE L +++ D+++FG+ + E+ T+ PY +Q+++
Sbjct: 167 TAHAGA-KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYEL 224
Query: 213 VTSG 216
+
Sbjct: 225 LEKD 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-21
Identities = 66/255 (25%), Positives = 119/255 (46%), Gaps = 23/255 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDD--VLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
E G +VA VKI + ++ + K+ E+ LK + +++K Y+ V
Sbjct: 33 KVGKHELTGHKVA---VKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ--VIST 87
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ M+ E + G L Y K+ +D K + +QIL G+ Y H H ++HRDLK +
Sbjct: 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPE 145
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTA--RSVIGTPEFMAPELYE-EEYN-ELVDIYSFG 187
N+ ++ + KI D GL+ M R+ G+P + APE+ Y VDI+S G
Sbjct: 146 NVLLDAH-MNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG 203
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKGFIEKCLVP-ASER 244
+ + ++ P+ + + +FKK+ GI P L +P + ++ L +R
Sbjct: 204 VILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQYL----NPSVISLLKHMLQVDPMKR 258
Query: 245 LSAKDLLKDPFLQVE 259
+ KD+ + + + +
Sbjct: 259 ATIKDIREHEWFKQD 273
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 41/202 (20%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 23 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 82
I+VA +K+ D +++ E ++ L + +V+ V + + + ++ E+
Sbjct: 38 IDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG--VC-QAEALMLVMEMA 91
Query: 83 TSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141
G L ++ K + + + + Q+ G+ YL N +HRDL N+ + H
Sbjct: 92 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH-Y 148
Query: 142 VKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 195
KI D GL+ + + P ++ APE + +++ D++S+G+ + E ++
Sbjct: 149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
Query: 196 F-EYPYSECKNPAQIFKKVTSG 216
+ + PY + K ++ + G
Sbjct: 209 YGQKPYKKMKG-PEVMAFIEQG 229
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-21
Identities = 47/178 (26%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 47 SEVHLLKSLKDDNVVKFYK--SWVDDKKKTVNMITELFTSGNLRQYRKKHK-NVDIKVIK 103
E ++ ++VK + + V +I EL T G LR + + K ++D+ +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVIT-----ENPVWIIMELCTLGELRSFLQVRKYSLDLASLI 119
Query: 104 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 163
+A Q+ L YL S +HRD+ N+ V+ N VK+GD GL+ M+ T
Sbjct: 120 LYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASK 176
Query: 164 T--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
P ++MAPE + + D++ FG+C+ E++ P+ KN + ++ +G
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 69/317 (21%), Positives = 125/317 (39%), Gaps = 61/317 (19%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDD 70
A+D + VA +K + Q+ E+ +L + +N++ ++ +
Sbjct: 44 CSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ K V ++ +L + +L + K + I + QIL GL Y+HS N ++HRDLK
Sbjct: 101 QMKDVYIVQDLMET-DLYKLLKTQHLSNDH-ICYFLYQILRGLKYIHSAN--VLHRDLKP 156
Query: 131 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE--LYEEEYNELVDI 183
N+ +N ++KI D GLA + T + APE L + Y + +DI
Sbjct: 157 SNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215
Query: 184 YSFGMCIL-EMVTFE--YPYSECKN------------PAQIFKKVTS-----------GI 217
+S G CIL EM++ +P + + + +
Sbjct: 216 WSVG-CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274
Query: 218 KPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPL- 269
++ D + ++K L P +R+ + L P+L+ + EPI +
Sbjct: 275 NKVPWNRLFPNADSKALDLLDKMLTFNP-HKRIEVEQALAHPYLEQYYDPSDEPIAEAPF 333
Query: 270 -------KLPIQSLKML 279
LP + LK L
Sbjct: 334 KFDMELDDLPKEKLKEL 350
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 42/184 (22%), Positives = 78/184 (42%), Gaps = 14/184 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDI 99
+ SE ++ N+++ V + + ++TE +G+L + + H I
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI 150
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPT 157
+ R + G+ YL +HRDL N+ V+ N K+ D GL+ +
Sbjct: 151 MQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDA 207
Query: 158 ARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 212
A + G P + APE + ++ D++SFG+ + E++ + E PY N +
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISS 266
Query: 213 VTSG 216
V G
Sbjct: 267 VEEG 270
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 64/302 (21%), Positives = 120/302 (39%), Gaps = 61/302 (20%)
Query: 15 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---------- 64
A D VA ++ + D ++ E+ +++ L DN+VK +
Sbjct: 29 SAVDNDCDKRVAIKKIVLTDPQ----SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 65 --KSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPP 122
+ +V ++ E + +L ++ ++ + + Q+L GL Y+HS N
Sbjct: 85 TDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEH-ARLFMYQLLRGLKYIHSAN-- 140
Query: 123 IIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE-----FMAPE--LYEE 175
++HRDLK N+F+N +KIGD GLA M + + + +P L
Sbjct: 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN 200
Query: 176 EYNELVDIYSFGMCIL-EMVT----F--------------------EYPYSECKNPAQIF 210
Y + +D+++ G CI EM+T F E E + ++
Sbjct: 201 NYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY 259
Query: 211 KKVTSGIKPASLAKV---NDPQIKGFIEKCLV--PASERLSAKDLLKDPFLQV--ENQKE 263
+ L ++ + F+E+ L P +RL+A++ L P++ + E
Sbjct: 260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP-MDRLTAEEALSHPYMSIYSFPMDE 318
Query: 264 PI 265
PI
Sbjct: 319 PI 320
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-20
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 13/184 (7%)
Query: 39 PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-V 97
+K E ++ ++VK + V +I EL T G LR + + K +
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKFSL 488
Query: 98 DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157
D+ + +A Q+ L YL S +HRD+ N+ V+ N VK+GD GL+ M+ T
Sbjct: 489 DLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDST 545
Query: 158 ARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 212
P ++MAPE + + D++ FG+C+ E++ P+ KN + +
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGR 604
Query: 213 VTSG 216
+ +G
Sbjct: 605 IENG 608
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 60/321 (18%), Positives = 106/321 (33%), Gaps = 91/321 (28%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK---FYKSWVDD 70
++ G+ VA I V+Q P + + L L N+V+ ++ + +
Sbjct: 40 QLGKEKSTGMSVA-----IKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94
Query: 71 KKKTV--NMITELFTSGNL----RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPII 124
++ + N++ E L R Y ++ +IK + Q++ + LH + +
Sbjct: 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVC 153
Query: 125 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APELY- 173
HRD+K N+ VN G +K+ D G A+ + + E APEL
Sbjct: 154 HRDIKPHNVLVNEADGTLKLCDFGS--------AKKLSPS-EPNVAYICSRYYRAPELIF 204
Query: 174 -EEEYNELVDIYSFGMCIL-EMVT------------------------------------ 195
+ Y VDI+S G CI EM+
Sbjct: 205 GNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH 263
Query: 196 --FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLL 251
+ S+ + +F + + D + L P ER+ + L
Sbjct: 264 TDVDLYNSKGIPWSNVFSDHSLKDAKEAY----D-----LLSALLQYLP-EERMKPYEAL 313
Query: 252 KDPFLQV---ENQKEPICDPL 269
P+ K P L
Sbjct: 314 CHPYFDELHDPATKLPNNKDL 334
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 39/185 (21%), Positives = 75/185 (40%), Gaps = 14/185 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 99
++ E L++ L NV+ + + +++ G+L Q+ R +N +
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPT 157
K + ++ Q+ G+ YL +HRDL N ++ + VK+ D GLA I ++
Sbjct: 124 KDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREYY 180
Query: 158 ARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 211
+ A E L + D++SFG+ + E++T PY +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTH 239
Query: 212 KVTSG 216
+ G
Sbjct: 240 FLAQG 244
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 14/185 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 99
++ + +E ++K NV+ + + ++ G+LR + R + N +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
K + + Q+ G+ YL S +HRDL N ++ VK+ D GLA M
Sbjct: 128 KDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYY 184
Query: 160 SVIGTPEF------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 211
SV MA E L +++ D++SFG+ + E++T PY + I
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV 243
Query: 212 KVTSG 216
+ G
Sbjct: 244 YLLQG 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 2e-20
Identities = 80/335 (23%), Positives = 123/335 (36%), Gaps = 89/335 (26%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 69
A+D VA K+ Q ++ Y E+ L+K + N++ F
Sbjct: 79 CAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
++ + V ++ EL + NL Q + +D + + Q+L G+ +LHS IIHRDLK
Sbjct: 137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 191
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE-LYEEEYN 178
NI V + +KI D GL AR+ GT M APE + Y
Sbjct: 192 PSNIVVKSD-CTLKILDFGL--------ART-AGTSFMMTPYVVTRYYRAPEVILGMGYK 241
Query: 179 ELVDIYSFGMCIL-EMVT----F------------------------------------E 197
E VDI+S G CI+ EMV F
Sbjct: 242 ENVDIWSVG-CIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 300
Query: 198 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV--PASERLSAKDLLKDPF 255
P ++F + K+ Q + + K LV PA +R+S D L+ P+
Sbjct: 301 RPKYAGLTFPKLFPDSLFP-ADSEHNKLKASQARDLLSKMLVIDPA-KRISVDDALQHPY 358
Query: 256 LQV---ENQKEPICDPL--------KLPIQSLKML 279
+ V + E + + I+ K L
Sbjct: 359 INVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 393
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 3e-20
Identities = 39/202 (19%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 23 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELF 82
I+VA +K+ D +++ E ++ L + +V+ + + + ++ E+
Sbjct: 364 IDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMA 417
Query: 83 TSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141
G L ++ + + + + Q+ G+ YL N +HR+L N+ + H
Sbjct: 418 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRH-Y 474
Query: 142 VKIGDLGLA--IAMQQPTARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 195
KI D GL+ + + P ++ APE + +++ D++S+G+ + E ++
Sbjct: 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 196 F-EYPYSECKNPAQIFKKVTSG 216
+ + PY + K P ++ + G
Sbjct: 535 YGQKPYKKMKGP-EVMAFIEQG 555
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 14/178 (7%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNW 105
E ++ N+++ V K K V ++TE +G+L + +KH + +
Sbjct: 95 GEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 163
R I G+ YL +HRDL NI +N N K+ D GL + A + G
Sbjct: 153 LRGIASGMKYLSDMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRG 209
Query: 164 T--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
P + +PE + ++ D++S+G+ + E++++ E PY E N + K V G
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG 266
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 53/203 (26%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWA 106
+E +L+++ +VK S+ D+ + M+ E G + + ++ + +A
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 107 RQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPE 166
QI+ YLHS + +I+RDLK +N+ ++ G +++ D G A ++ T ++ GTPE
Sbjct: 148 AQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTPE 203
Query: 167 FMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PASLA 223
+APE + + YN+ VD ++ G+ I EM P+ P QI++K+ SG ++ P+
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHF- 261
Query: 224 KVNDPQIKGFIEKCLVP-ASERL 245
+K + L ++R
Sbjct: 262 ---SSDLKDLLRNLLQVDLTKRF 281
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 51/315 (16%), Positives = 103/315 (32%), Gaps = 74/315 (23%)
Query: 23 IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDDKKKTVNMIT 79
+ S + ++L +++ E+ LL N++ + + + ++T
Sbjct: 54 VFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 80 ELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 138
EL + +L Q + + + I+ + IL GL LH ++HRDL NI + N
Sbjct: 114 ELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN 170
Query: 139 HGEVKIGDLGLAIAMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSF 186
++ I D L AR APE + + + +LVD++S
Sbjct: 171 -NDITICDFNL--------ARE-DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220
Query: 187 GMCIL-EMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVNDPQIKGFI-------- 234
G C++ EM + K+ + K + + P + ++
Sbjct: 221 G-CVMAEMFNRK-ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278
Query: 235 -------------------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPL-- 269
K L P R+S + L+ P+ + +
Sbjct: 279 ARAWTAVVPTADPVALDLIAKMLEFNP-QRRISTEQALRHPYFESLFDPLDLTEGLSERF 337
Query: 270 -----KLPIQSLKML 279
+ + +
Sbjct: 338 HFDESVTDVYDMHKI 352
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 6e-20
Identities = 56/348 (16%), Positives = 116/348 (33%), Gaps = 103/348 (29%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 69
+ FD +G A +V D + E+ ++K L N++K FY + +
Sbjct: 24 CEVFDIESGKRFALKKVLQDP--------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75
Query: 70 DKKKT--------------------------------VNMITELFTS---GNLRQYRKKH 94
+ K +N+I E L+ + +
Sbjct: 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG 135
Query: 95 KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154
+++ + +I + Q+ + ++HS I HRD+K N+ VN +K+ D G
Sbjct: 136 RSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGS----- 188
Query: 155 QPTARSVIGTPEFM----------APELY--EEEYNELVDIYSFGMCIL-EMVTFE--YP 199
A+ +I + E APEL EY +D++S G C+ E++ + +
Sbjct: 189 ---AKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVFGELILGKPLFS 243
Query: 200 YSECKN------------PAQIFKKVTSG--------IKPASLAKV----NDPQIKGFIE 235
+ + ++ +K K+ +E
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303
Query: 236 KCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDPLKLPIQSLKML 279
+ L P R++ + + PF + + + + P + +
Sbjct: 304 QILRYEP-DLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-20
Identities = 51/183 (27%), Positives = 94/183 (51%), Gaps = 14/183 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
++ +E +++K+L+ D +VK + K+ + +ITE G+L + K +
Sbjct: 226 SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQP 282
Query: 101 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156
+ K +++ QI G+ ++ N IHRDL+ NI V+ + KI D GLA ++
Sbjct: 283 LPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEY 339
Query: 157 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
TAR P ++ APE + + D++SFG+ ++E+VT+ PY NP ++ + +
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRAL 398
Query: 214 TSG 216
G
Sbjct: 399 ERG 401
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 47 SEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN-VDIKVIKNW 105
E ++ N+++ V K K + +ITE +G L ++ ++ + +
Sbjct: 95 GEAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 152
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 163
R I G+ YL + N +HRDL NI V ++ K+ D GL+ + + G
Sbjct: 153 LRGIAAGMKYLANMN--YVHRDLAARNILV-NSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 164 T--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
P + APE + ++ D++SFG+ + E++T+ E PY E N ++ K + G
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 68/364 (18%), Positives = 123/364 (33%), Gaps = 107/364 (29%)
Query: 15 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFY---KSWVDDK 71
A+D+ VA K++ + + D +++ E+ +L LK D +++ Y K
Sbjct: 44 LAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ ++ E+ S +L++ K + + IK +L G ++H IIHRDLK
Sbjct: 102 FDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPA 158
Query: 132 NIFVNGNHGEVKIGDLGLA--------------IAMQQPTARSVIGTPEFM--------- 168
N +N + VK+ D GLA + + + +
Sbjct: 159 NCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217
Query: 169 -APE--LYEEEYNELVDIYSFGMCIL-EMVTFEY-------------PYSECKNPAQIFK 211
APE L +E Y + +DI+S G CI E++ P S C +
Sbjct: 218 RAPELILLQENYTKSIDIWSTG-CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRN 276
Query: 212 KVTSGIK-----------------PASLAKVNDPQIKGFI-------------------- 234
K L +N P++ +I
Sbjct: 277 SKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336
Query: 235 ------EKCLV--PASERLSAKDLLKDPFLQV--ENQKEPICDP---------LKLPIQS 275
E L P ++R++ L P+L+ + + E + L
Sbjct: 337 DGINLLESMLKFNP-NKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQ 395
Query: 276 LKML 279
L+ +
Sbjct: 396 LRYI 399
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)
Query: 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
++ ++ + + + QI+ GL +LH N II+RDLK +N+ ++ +
Sbjct: 271 DIRY--HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DD 325
Query: 140 GEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF 196
G V+I DLGLA + Q + GTP FMAPE L EEY+ VD ++ G+ + EM+
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 197 EYPY---SECKNPAQIFKKVTSG 216
P+ E ++ ++V
Sbjct: 386 RGPFRARGEKVENKELKQRVLEQ 408
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 41/184 (22%), Positives = 82/184 (44%), Gaps = 22/184 (11%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIK 100
Q +E ++ L+ N+V+ + ++K + ++TE G+L Y + +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 101 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTA 158
+ ++ + + YL +N +HRDL N+ V+ ++ K+ D GL + Q T
Sbjct: 118 CLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTG 174
Query: 159 RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 212
+ APE L E++++ D++SFG+ + E+ +F PY + +
Sbjct: 175 K-------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPR 226
Query: 213 VTSG 216
V G
Sbjct: 227 VEKG 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 36/164 (21%), Positives = 73/164 (44%), Gaps = 24/164 (14%)
Query: 104 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQP 156
AR +++ + +H + +HRD+K DNI ++ +G +++ D G +
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTV 231
Query: 157 TARSVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMVTFEYP-YSECKNPAQI 209
+ +GTP++++PE+ + Y D +S G+C+ EM+ E P Y+E + +
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVET 289
Query: 210 FKKVTSGIK----PASLAKVNDPQIKGFIEKCLVPASERLSAKD 249
+ K+ + + P + V K I + + RL
Sbjct: 290 YGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNG 332
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
+E +L+K L+ +V+ Y + + +ITE +G+L + K + +
Sbjct: 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 101 VIK--NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQP 156
+ K + A QI G+ ++ N IHRDL+ NI V+ KI D GLA I +
Sbjct: 108 INKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEY 164
Query: 157 TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKV 213
TAR P ++ APE + + D++SFG+ + E+VT PY NP ++ + +
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL 223
Query: 214 TSG 216
G
Sbjct: 224 ERG 226
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 42/200 (21%), Positives = 80/200 (40%), Gaps = 36/200 (18%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFY----KSWVDDKKKTVNMITELFTSGNLRQYRKKHK- 95
D+++ E +K +V K +S + +I G+L + +
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI 127
Query: 96 -----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150
N+ ++ + + I G+ YL S N IHRDL N + + V + D GL+
Sbjct: 128 GENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLS 184
Query: 151 IAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF- 196
R + + +A E L + Y D+++FG+ + E++T
Sbjct: 185 --------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRG 236
Query: 197 EYPYSECKNPAQIFKKVTSG 216
+ PY+ +N A+I+ + G
Sbjct: 237 QTPYAGIEN-AEIYNYLIGG 255
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 40/170 (23%), Positives = 77/170 (45%), Gaps = 23/170 (13%)
Query: 104 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156
WAR +++ L +HS IHRD+K DN+ ++ G +K+ D G + M +
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224
Query: 157 TARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPAQIF 210
+ +GTP++++PE+ + Y D +S G+ + EM+ + P Y++ + +
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTY 282
Query: 211 KKVTSGIKPASLAKVND--PQIKGFIEKCLVPASERL---SAKDLLKDPF 255
K+ + + ND + K I L RL +++ + F
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 42/185 (22%), Positives = 78/185 (42%), Gaps = 14/185 (7%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVDI 99
++ + +E ++K NV+ + + ++ G+LR + R + N +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159
K + + Q+ G+ +L S +HRDL N ++ VK+ D GLA M
Sbjct: 192 KDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFD 248
Query: 160 SVIGTPE------FMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 211
SV +MA E L +++ D++SFG+ + E++T PY + I
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV 307
Query: 212 KVTSG 216
+ G
Sbjct: 308 YLLQG 312
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 44/206 (21%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------ 94
+ E LL +L+ +++VKFY V + M+ E G+L ++ + H
Sbjct: 60 ARKDFQREAELLTNLQHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117
Query: 95 ----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144
+ + + + A QI G+VYL S + +HRDL N V N VKI
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKI 174
Query: 145 GDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCIL 191
GD G+ +R V T + M PE + ++ D++SFG+ +
Sbjct: 175 GDFGM--------SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 226
Query: 192 EMVTF-EYPYSECKNPAQIFKKVTSG 216
E+ T+ + P+ + N ++ + +T G
Sbjct: 227 EIFTYGKQPWFQLSN-TEVIECITQG 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 71/352 (20%), Positives = 123/352 (34%), Gaps = 99/352 (28%)
Query: 15 KAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKK 73
K+ D G VA KI D Q D Q+ + E+ +L L +N+V D +
Sbjct: 27 KSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
V ++ + + +L + + + + Q++ + YLHS ++HRD+K NI
Sbjct: 85 DVYLVFDYMET-DLHAVIRANILEPVH-KQYVVYQLIKVIKYLHSGG--LLHRDMKPSNI 140
Query: 134 FVNGNHGEVKIGDLGLA-------------IAMQQPTARSVIGTPEFM----------AP 170
+N VK+ D GL+ + + AP
Sbjct: 141 LLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199
Query: 171 E--LYEEEYNELVDIYSFGMCIL-EMVT----F--------------------------- 196
E L +Y + +D++S G CIL E++ F
Sbjct: 200 EILLGSTKYTKGIDMWSLG-CILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESI 258
Query: 197 ------EY----------PYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 239
S ++ +K + I P + + + ++K L
Sbjct: 259 QSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC---NEEALDLLDKLLQF 315
Query: 240 -PASERLSAKDLLKDPFLQV--ENQKEPICDP---------LKLPIQSLKML 279
P ++R+SA D LK PF+ + +EP CD +K I + L
Sbjct: 316 NP-NKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNL 366
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 56/251 (22%), Positives = 94/251 (37%), Gaps = 34/251 (13%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVL--QLPGD---LQKLYSEVHLLKSLKDDNVVKFYKSWV 68
Y+A D VA +K ++ L D ++ E L++ +VV +
Sbjct: 51 YEAEDTVRERIVA---LK---LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE 104
Query: 69 DDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128
D + V+M L +L ++ + RQI L H+ HRD+
Sbjct: 105 IDGQLYVDM--RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDV 160
Query: 129 KCDNIFVNGNHGEVKIGDLGLAIAMQQPT---ARSVIGTPEFMAPELYE-EEYNELVDIY 184
K +NI V+ + + D G+A A + +GT +MAPE + DIY
Sbjct: 161 KPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIY 219
Query: 185 SFGMCIL-EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASE 243
+ C+L E +T PY + + + I S P I A +
Sbjct: 220 ALT-CVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTV---RPGIP--------VAFD 266
Query: 244 RLSAKDLLKDP 254
+ A+ + K+P
Sbjct: 267 AVIARGMAKNP 277
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 38/200 (19%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY---------- 90
+ + +E ++K +VV+ V + + +I EL T G+L+ Y
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 91 RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150
+ + A +I G+ YL+++ +HRDL N V + VKIGD G+
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGM- 184
Query: 151 IAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF- 196
R + T + M+PE L + + D++SFG+ + E+ T
Sbjct: 185 -------TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 197 EYPYSECKNPAQIFKKVTSG 216
E PY N Q+ + V G
Sbjct: 238 EQPYQGLSN-EQVLRFVMEG 256
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 24/185 (12%)
Query: 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139
ELF+ LR+ ++ V K +A ++ L YLHS + II+RDLK +NI ++ N
Sbjct: 92 ELFS--LLRKSQR----FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN- 142
Query: 140 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEY 198
G +KI D G A + T ++ GTP+++APE + + YN+ +D +SFG+ I EM+
Sbjct: 143 GHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
Query: 199 PYSECKNPAQIFKKVTSG-IK-PASLAKVNDPQIKGFIEKCLVP-ASERL-----SAKDL 250
P+ N + ++K+ + ++ P + +K + + + S+RL +D+
Sbjct: 202 PF-YDSNTMKTYEKILNAELRFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256
Query: 251 LKDPF 255
P+
Sbjct: 257 KNHPW 261
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 41/174 (23%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 104 NWAR----QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156
AR +I+ + +H +HRD+K DNI ++ G +++ D G + ++
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTV 218
Query: 157 TARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTFEYP-YSECKNPA 207
+ +GTP++++PE+ Y D ++ G+ EM + P Y++ + A
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STA 276
Query: 208 QIFKKVTSGIKPASLAKVND---PQIKGFIEKCLVPASERL---SAKDLLKDPF 255
+ + K+ + SL V++ + + FI++ L P RL A D PF
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARSVIG 163
A +I L YLHS N I++RDLK +NI ++ G + + D GL T + G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCG 201
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 222
TPE++APE L+++ Y+ VD + G + EM+ P+ +N A+++ + + KP L
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILN--KPLQL 258
Query: 223 AKVNDPQIKGFIEKCLV--PASERLSAKD 249
+ +E L +RL AKD
Sbjct: 259 KPNITNSARHLLEGLLQKDRT-KRLGAKD 286
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 40/185 (21%), Positives = 82/185 (44%), Gaps = 24/185 (12%)
Query: 43 QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIK 100
Q +E ++ L+ N+V+ + ++K + ++TE G+L Y + +
Sbjct: 231 QAFLAEASVMTQLRHSNLVQLLGV-IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 289
Query: 101 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160
+ ++ + + YL +N +HRDL N+ V+ ++ K+ D GL +
Sbjct: 290 CLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGL--------TKE 338
Query: 161 VIGTPE-------FMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFK 211
T + + APE L E++++ D++SFG+ + E+ +F PY +
Sbjct: 339 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVP 397
Query: 212 KVTSG 216
+V G
Sbjct: 398 RVEKG 402
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 20/191 (10%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------ 94
D E ++ N+V+ V + ++ EL G+L+ + ++
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 133
Query: 95 -KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAI 151
++ + + + AR I G YL ++ IHRD+ N + G KIGD G+A
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 152 AMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 205
+ + + G M PE E + D +SFG+ + E+ + PY N
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251
Query: 206 PAQIFKKVTSG 216
++ + VTSG
Sbjct: 252 -QEVLEFVTSG 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 45/206 (21%), Positives = 80/206 (38%), Gaps = 44/206 (21%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------ 94
++ E L L+ NVV V K + ++MI + G+L ++
Sbjct: 55 LREEFRHEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV 112
Query: 95 ----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144
++ + QI G+ YL SH+ ++H+DL N+ V VKI
Sbjct: 113 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKI 169
Query: 145 GDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCIL 191
DLGL R V + MAPE + +++ DI+S+G+ +
Sbjct: 170 SDLGLF--------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 221
Query: 192 EMVTF-EYPYSECKNPAQIFKKVTSG 216
E+ ++ PY N + + + +
Sbjct: 222 EVFSYGLQPYCGYSN-QDVVEMIRNR 246
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIG 163
+A +I GL LH I++RDLK +NI ++ +HG ++I DLGLA+ + + T + +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPA 220
T +MAPE + E Y D ++ G + EM+ + P+ + + ++V + P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPE 406
Query: 221 SLAKVNDPQIKGFIEKCLV--PASERL-----SAKDLLKDPF 255
++ PQ + + L PA ERL SA+++ + P
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPA-ERLGCRGGSAREVKEHPL 447
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 165
+I L +LH II+RDLK +NI +N G VK+ D GL ++ + GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 166 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 216
E+MAPE L +N VD +S G + +M+T P+ +N + K+
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKC 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 7/109 (6%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 165
++ L +LHS II+RDLK +NI ++ G +K+ D GL+ ++ A S GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 166 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213
E+MAPE + + + D +SFG+ + EM+T P+ + K+ + +
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMI 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 165
+I+ GL +LHS I++RDLK DNI ++ + G +KI D G+ M + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 166 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAK 224
+++APE L ++YN VD +SFG+ + EM+ + P+ ++ ++F + +
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRM--DNPFYPR 239
Query: 225 VNDPQIKGFIEKCLV--PASERL-SAKDLLKDPF 255
+ + K + K V P +RL D+ + P
Sbjct: 240 WLEKEAKDLLVKLFVREPE-KRLGVRGDIRQHPL 272
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 34/119 (28%), Positives = 64/119 (53%), Gaps = 14/119 (11%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGT 164
+I+ L +LH II+RD+K +NI ++ ++G V + D GL+ +A + A GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 165 PEFMAPELYEEE---YNELVDIYSFGMCILEMVT----FEYPYSECKNPAQIFKKVTSG 216
E+MAP++ +++ VD +S G+ + E++T F E + A+I +++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKS 281
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 36/199 (18%), Positives = 79/199 (39%), Gaps = 35/199 (17%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN---MITELFTSGNLRQYRKKHK-- 95
++++ SE +K NV++ ++ + + +I G+L Y +
Sbjct: 79 EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 96 ----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151
++ ++ + + I G+ YL + N +HRDL N + + V + D GL
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGL-- 193
Query: 152 AMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-E 197
++ + + +A E L + Y D+++FG+ + E+ T
Sbjct: 194 ------SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM 247
Query: 198 YPYSECKNPAQIFKKVTSG 216
PY +N +++ + G
Sbjct: 248 TPYPGVQN-HEMYDYLLHG 265
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 8e-18
Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 163
A +I GL +L S II+RDLK DN+ ++ G +KI D G+ T ++ G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCG 504
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPA 220
TP+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563
Query: 221 SLAKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 255
S++K KG + K +RL +D+ + F
Sbjct: 564 SMSKEAVAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 600
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 46/197 (23%), Positives = 83/197 (42%), Gaps = 27/197 (13%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKH------ 94
Q E LL L+ ++V+F+ V + + + M+ E G+L ++ + H
Sbjct: 86 ARQDFQREAELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 95 ---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 145
+ + + A Q+ G+VYL + +HRDL N V VKIG
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIG 200
Query: 146 DLGLAIAMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYP 199
D G++ + V G M PE + ++ D++SFG+ + E+ T+ + P
Sbjct: 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 200 YSECKNPAQIFKKVTSG 216
+ + N + +T G
Sbjct: 261 WYQLSN-TEAIDCITQG 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 20/191 (10%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHK----- 95
D E ++ N+V+ V + ++ EL G+L+ + ++ +
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 96 --NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAI 151
++ + + + AR I G YL ++ IHRD+ N + G KIGD G+A
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 152 AMQQPTARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKN 205
+ + G M PE E + D +SFG+ + E+ + PY N
Sbjct: 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292
Query: 206 PAQIFKKVTSG 216
++ + VTSG
Sbjct: 293 -QEVLEFVTSG 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 41 DLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
+ + L SE+ +L + NVV + + +I E GNL Y + +N +
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 100 KVIKN----------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
++ Q+ G+ +L S IHRDL NI ++ + VK
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVK 188
Query: 144 IGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCI 190
I D GL AR + P++ MAPE +++ Y D++SFG+ +
Sbjct: 189 ICDFGL--------ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 191 LEMVTF-EYPYSECKNPAQIFKKVTSG 216
E+ + PY K + +++ G
Sbjct: 241 WEIFSLGASPYPGVKIDEEFCRRLKEG 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 71/316 (22%), Positives = 115/316 (36%), Gaps = 78/316 (24%)
Query: 11 FSS-YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-----------D 58
FS+ + A D VA +KI V + E+ LL+ + D +
Sbjct: 32 FSTVWLAKDMVNNTHVA---MKI--VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86
Query: 59 NVVKFYKS--WVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLV 114
+++K V M+ E+ NL KK+++ + +K ++Q+L GL
Sbjct: 87 HILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145
Query: 115 YLHSHNPPIIHRDLKCDNIFV-----NGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMA 169
Y+H IIH D+K +N+ + N ++KI DLG A + + I T E+ +
Sbjct: 146 YMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRS 203
Query: 170 PE-LYEEEYNELVDIYSFGMCILEMVT----FE--------------------------Y 198
PE L + DI+S I E++T FE Y
Sbjct: 204 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 263
Query: 199 PYSECKNPAQIFK-----KVTSGIKPASLAKV----------NDPQIKGFIEKCLV--PA 241
K F + S +K L V +I F+ L P
Sbjct: 264 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP- 322
Query: 242 SERLSAKDLLKDPFLQ 257
+R A L+ P+L+
Sbjct: 323 RKRADAGGLVNHPWLK 338
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 46/209 (22%)
Query: 41 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
+ + L SE+ +L L + N+V + V ITE G+L + ++ ++ I
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV--ITEYCCYGDLLNFLRRKRDSFI 126
Query: 100 KVIKN------------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141
+ ++ Q+ G+ +L S N IHRDL NI + +
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRI 183
Query: 142 VKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGM 188
KI D GL AR + + MAPE ++ Y D++S+G+
Sbjct: 184 TKICDFGL--------ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 189 CILEMVTF-EYPYSECKNPAQIFKKVTSG 216
+ E+ + PY ++ +K + G
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEG 264
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 43/160 (26%), Positives = 85/160 (53%), Gaps = 17/160 (10%)
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIG 163
+I+ L YLHS + +++RD+K +N+ ++ + G +KI D GL + T ++ G
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCG 167
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG-IK-PA 220
TPE++APE L + +Y VD + G+ + EM+ P+ ++ ++F+ + I+ P
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPR 226
Query: 221 SLAKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 255
+L+ + G ++K +RL AK++++ F
Sbjct: 227 TLSPEAKSLLAGLLKKD---PKQRLGGGPSDAKEVMEHRF 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 42/205 (20%)
Query: 41 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQY-RKKHKNVD 98
+ + L SE+ ++ L +N+V V +ITE G+L + R+K + ++
Sbjct: 92 EKEALMSELKIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 99 IKVIKN-------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIG 145
++ Q+ G+ +L S N IHRD+ N+ + N KIG
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIG 206
Query: 146 DLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCILE 192
D GL AR ++ + MAPE +++ Y D++S+G+ + E
Sbjct: 207 DFGL--------ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 193 MVTF-EYPYSECKNPAQIFKKVTSG 216
+ + PY ++ +K V G
Sbjct: 259 IFSLGLNPYPGILVNSKFYKLVKDG 283
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 52/283 (18%), Positives = 113/283 (39%), Gaps = 55/283 (19%)
Query: 14 YKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVD-- 69
+ F++ + A +K + D K EV L ++V+ + +
Sbjct: 35 LQIFNKRTQEKFA---LKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY 84
Query: 70 DKKKTVNMITELFTSGNL--RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 127
+K + ++ E G L R + + + + I + YLHS N I HRD
Sbjct: 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRD 142
Query: 128 LKCDNI-FVN-GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYS 185
+K +N+ + + + +K+ D G A E E+Y++ D++S
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGF-------------------AKETTGEKYDKSCDMWS 183
Query: 186 FGMCILEMVTFEYP--YSECKNPAQ--IFKKVTSGI---KPASLAKVNDPQIKGFIEKCL 238
G I+ ++ YP YS + ++ G ++V++ ++K I L
Sbjct: 184 LG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE-EVKMLIRNLL 241
Query: 239 VP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 280
++R++ + + P++ ++ K P + P+ + ++L+
Sbjct: 242 KTEPTQRMTITEFMNHPWIM-QSTKVP-----QTPLHTSRVLK 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 165
+I GL +L S II+RDLK DN+ ++ G +KI D G+ + T ++ GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 166 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASL 222
+++APE + + Y + VD ++FG+ + EM+ + P+ E ++ ++F+ + P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244
Query: 223 AKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 255
+K KG + K +RL +D+ + F
Sbjct: 245 SKEAVAICKGLMTKH---PGKRLGCGPEGERDIKEHAF 279
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 7/108 (6%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 165
+I+ L++LH II+RDLK DN+ ++ G K+ D G+ + T + GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 166 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 212
+++APE L E Y VD ++ G+ + EM+ P+ E +N +F+
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEA 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 52/214 (24%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
+L+ L SE ++LK + +V+K Y + + +I E G+LR + ++ + V
Sbjct: 69 ELRDLLSEFNVLKQVNHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 101 VIKN------------------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
+ + +A QI G+ YL ++HRDL NI V
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVA 184
Query: 137 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDI 183
++KI D GL +R V + MA E L++ Y D+
Sbjct: 185 EGR-KMKISDFGL--------SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 184 YSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
+SFG+ + E+VT PY ++F + +G
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTG 268
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 163
+ +I L YLH II+RDLK DN+ ++ G +K+ D G+ +P T + G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 208
TP ++APE L E+Y VD ++ G+ + EM+ P+ +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 41/214 (19%), Positives = 75/214 (35%), Gaps = 52/214 (24%)
Query: 41 DLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIK 100
E L+ + N+VK V K + ++ E G+L ++ + +
Sbjct: 93 MQADFQREAALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 150
Query: 101 VIKNW------------------------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
+ + ARQ+ G+ YL +HRDL N V
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG 208
Query: 137 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDI 183
N VKI D GL+ R++ + M PE ++ Y D+
Sbjct: 209 ENM-VVKIADFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 259
Query: 184 YSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
+++G+ + E+ ++ PY + ++ V G
Sbjct: 260 WAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDG 292
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 45/214 (21%), Positives = 78/214 (36%), Gaps = 51/214 (23%)
Query: 41 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
+ + L SE+ ++ L +N+V +I E G+L Y + +
Sbjct: 91 EREALMSELKMMTQLGSHENIVNLL-GACTLSGPIY-LIFEYCCYGDLLNYLRSKREKFS 148
Query: 100 KVIKN-----------------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136
+ +A Q+ G+ +L + +HRDL N+ V
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT 206
Query: 137 GNHGEVKIGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDI 183
VKI D GL AR ++ + MAPE L+E Y D+
Sbjct: 207 HGK-VVKICDFGL--------ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 257
Query: 184 YSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSG 216
+S+G+ + E+ + PY A +K + +G
Sbjct: 258 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 291
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 68/320 (21%), Positives = 113/320 (35%), Gaps = 80/320 (25%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD------NVVKFYKSW 67
KA+D VA +K+ V ++ E+ +L+ L+ NV+
Sbjct: 114 VKAYDHKVHQHVA---LKM--VRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML-EN 167
Query: 68 VDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIH 125
+ M EL S NL + KK+K + +++ +A IL L LH + IIH
Sbjct: 168 FTFRNHIC-MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIH 223
Query: 126 RDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 183
DLK +NI +K+ D G + Q + I + + APE + Y +D+
Sbjct: 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-TYIQSRFYRAPEVILGARYGMPIDM 282
Query: 184 YSFGMCIL-EMVT--------------------------------------FE---YPYS 201
+S G CIL E++T YP
Sbjct: 283 WSLG-CILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 341
Query: 202 ECKNPAQIFKKVTSGIKP---------------ASLAKVNDPQIKGFIEKCLVP-ASERL 245
V +G + +L +DP F+++CL + R+
Sbjct: 342 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401
Query: 246 SAKDLLKDPFLQVENQKEPI 265
+ L+ P+L+ K P
Sbjct: 402 TPGQALRHPWLRRRLPKPPT 421
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 45/207 (21%)
Query: 41 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
DL L SE+ ++K + N++ + + +I E + GNLR+Y + + +
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 100 KVIKN----------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
+ + Q+ G+ YL S IHRDL N+ V N+ +K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMK 243
Query: 144 IGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCI 190
I D GLA R + + MAPE L++ Y D++SFG+ +
Sbjct: 244 IADFGLA--------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295
Query: 191 LEMVTF-EYPYSECKNPAQIFKKVTSG 216
E+ T PY ++FK + G
Sbjct: 296 WEIFTLGGSPYPGIPV-EELFKLLKEG 321
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 45/207 (21%)
Query: 41 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
DL L SE+ ++K + N++ + + +I E + GNLR+Y + + +
Sbjct: 83 DLSDLVSEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 100 KVIKN----------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
+ + Q+ G+ YL S IHRDL N+ V N+ +K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMK 197
Query: 144 IGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCI 190
I D GL AR + + MAPE L++ Y D++SFG+ +
Sbjct: 198 IADFGL--------ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 191 LEMVTF-EYPYSECKNPAQIFKKVTSG 216
E+ T PY ++FK + G
Sbjct: 250 WEIFTLGGSPYPGIPV-EELFKLLKEG 275
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TARSVIG 163
+ +I L YLH II+RDLK DN+ ++ G +K+ D G+ +P T + G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 164 TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ 208
TP ++APE L E+Y VD ++ G+ + EM+ P+ +
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 45/207 (21%)
Query: 41 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
DL L SE+ ++K + N++ + + +I E + GNLR+Y + + +
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 100 KVIKN----------------WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
+ N A Q+ G+ YL S IHRDL N+ V ++ +K
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMK 231
Query: 144 IGDLGLAIAMQQPTARSVIGTPEF------------MAPE-LYEEEYNELVDIYSFGMCI 190
I D GLA R + + MAPE L++ Y D++SFG+ +
Sbjct: 232 IADFGLA--------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
Query: 191 LEMVTF-EYPYSECKNPAQIFKKVTSG 216
E+ T PY ++FK + G
Sbjct: 284 WEIFTLGGSPYPGVPV-EELFKLLKEG 309
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 16/158 (10%)
Query: 108 QILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQP-TARSVIGTP 165
+I+ L YLHS +++RDLK +N+ ++ + G +KI D GL ++ T ++ GTP
Sbjct: 256 EIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 166 EFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASL 222
E++APE L + +Y VD + G+ + EM+ P+ ++ ++F+ + P +L
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTL 372
Query: 223 AKVNDPQIKGFIEKCLVPASERL-----SAKDLLKDPF 255
+ G ++K +RL AK++++ F
Sbjct: 373 GPEAKSLLSGLLKKD---PKQRLGGGSEDAKEIMQHRF 407
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 44/196 (22%), Positives = 79/196 (40%), Gaps = 26/196 (13%)
Query: 41 DLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDI 99
D + E+ +L L N++ + + + + E GNL + +K + ++
Sbjct: 68 DHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 100 KVIKNW----------------ARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143
A + G+ YL IHRDL NI V N+ K
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAK 182
Query: 144 IGDLGLAIAMQQPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPY 200
I D GL+ + +++ P +MA E L Y D++S+G+ + E+V+ PY
Sbjct: 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 201 SECKNPAQIFKKVTSG 216
A++++K+ G
Sbjct: 243 CGMTC-AELYEKLPQG 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 48 EVHLLKSLKDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKN--VDI 99
EV LL+ + +V + + + + ++ E+ S NL + V +
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHF--MFRNHLCLVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI-FVNGNHGEVKIGDLGLAIAMQQPTA 158
+ + +A+Q+ L++L + IIH DLK +NI N +KI D G + + Q
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216
Query: 159 RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 195
I + + +PE L Y+ +D++S G CIL EM T
Sbjct: 217 -QYIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-15
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 20/96 (20%)
Query: 112 GLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-----VIGTP 165
GL YLH H +P IIHRD+K NI ++ E +GD GLA M + V GT
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGTI 199
Query: 166 EFMAPELYEEEY------NELVDIYSFGMCILEMVT 195
+AP EY +E D++ +G+ +LE++T
Sbjct: 200 GHIAP-----EYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 25/127 (19%)
Query: 104 NWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIG 163
++ Q+ G+ +L S IHRDL NI ++ + VKI D GL AR +
Sbjct: 197 CYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL--------ARDIYK 245
Query: 164 TPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQI 209
P++ MAPE +++ Y D++SFG+ + E+ + PY K +
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 210 FKKVTSG 216
+++ G
Sbjct: 306 CRRLKEG 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 33/88 (37%), Positives = 46/88 (52%), Gaps = 7/88 (7%)
Query: 112 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA--IAMQQPTARS--VIGTPEF 167
G+ +LH IHRD+K NI ++ KI D GLA T + ++GT +
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 168 MAPELYEEEYNELVDIYSFGMCILEMVT 195
MAPE E DIYSFG+ +LE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 12/91 (13%)
Query: 112 GLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP------TARSVIGTP 165
GL YLH IIHRD+K NI ++ N KI D G++ + T V GT
Sbjct: 151 GLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGTL 205
Query: 166 EFMAPELYEEEY-NELVDIYSFGMCILEMVT 195
++ PE + + E D+YSFG+ + E++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 55/289 (19%), Positives = 98/289 (33%), Gaps = 88/289 (30%)
Query: 48 EVHLLKSLKDD-----NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DIK 100
E +LK +++D N+VK++ + + +I E +L + ++ I+
Sbjct: 81 EADILKKIQNDDINNNNIVKYHGKF--MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 101 VIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG-------------------- 140
IK + +IL L YL + + H DLK +NI ++ +
Sbjct: 138 DIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 141 ----EVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMV 194
+K+ D G A S+I T ++ APE + ++ D++SFG C+L E+
Sbjct: 196 TKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAELY 253
Query: 195 T---------------------------------------------FEYPYSECKNPAQI 209
T + + E +
Sbjct: 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313
Query: 210 FKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
K V P + F+ L + R S +LLK FL+
Sbjct: 314 IKHVKKC-LPLYK-IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 51/288 (17%), Positives = 101/288 (35%), Gaps = 79/288 (27%)
Query: 48 EVHLLKSLKDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DI 99
E+ +L+ L V+ W + ++ EL + + K++ + +
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQML-EWFEHHGHIC-IVFELL-GLSTYDFIKENGFLPFRL 117
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG------------------E 141
I+ A QI + +LHS+ + H DLK +NI + +
Sbjct: 118 DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 142 VKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT---- 195
+K+ D G A + +++ T + APE + +++ D++S G CIL E
Sbjct: 176 IKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFTV 233
Query: 196 ---------------------------------FEYPYSECKNPAQIFKKVTSGIKP--- 219
F + + + + V+ KP
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 220 -ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPI 265
V ++ I+K L ++R++ ++ LK PF + K+ I
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL--LKKSI 339
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 48/297 (16%), Positives = 101/297 (34%), Gaps = 77/297 (25%)
Query: 48 EVHLLKSLKDD------NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNV--DI 99
E+++LK +K+ V + + + + EL N ++ K++ +
Sbjct: 66 EINVLKKIKEKDKENKFLCVLMSDWF--NFHGHMCIAFELL-GKNTFEFLKENNFQPYPL 122
Query: 100 KVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN------------------HGE 141
+++ A Q+ H L +LH + + H DLK +NI + +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 142 VKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT---- 195
+++ D G A +++ T + PE + E + + D++S G CIL E
Sbjct: 181 IRVADFGSAT-FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYRGFTL 238
Query: 196 F------------------------------------EYPYSECKNPAQIFKKVTSGIKP 219
F + E + + K+ +K
Sbjct: 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298
Query: 220 ASLAK-VNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQ 274
L + Q+ + + L ++R++ + L PF +E + P +
Sbjct: 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 52/269 (19%), Positives = 84/269 (31%), Gaps = 101/269 (37%)
Query: 86 NLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV-------- 135
+L ++ K + + +K +Q+L GL YLH+ IIH D+K +NI +
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIR 188
Query: 136 ----------------------------------------NGNHGEVKIGDLGLAIAMQQ 155
N +VKI DLG A + +
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248
Query: 156 PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPY-------------- 200
I T ++ + E L YN DI+S E+ T +Y +
Sbjct: 249 HF-TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
Query: 201 ----------------SECKNPAQIFK-----KVTSGIKPASLAKV----------NDPQ 229
K + F K + +KP L +V
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 230 IKGFIEKCLV--PASERLSAKDLLKDPFL 256
F+ L P +R +A + L+ P+L
Sbjct: 368 FTDFLLPMLELIP-EKRATAAECLRHPWL 395
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 34/184 (18%), Positives = 67/184 (36%), Gaps = 39/184 (21%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y AF + A VK++ + L+SE+ + + + +K W++ K+
Sbjct: 54 YLAFPTNKPEKDARHVVKVE-----YQENGPLFSELKFYQRVAKKDCIK---KWIERKQL 105
Query: 74 TVNMITELFTSG-------------------NLRQYRKKHKNVDIKVIKNWARQILHGLV 114
I + SG +L++ ++ + ++L L
Sbjct: 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLE 165
Query: 115 YLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQPTARSVIGT 164
Y+H + +H D+K N+ + N +V + D GL+ Q+ + GT
Sbjct: 166 YIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGT 223
Query: 165 PEFM 168
EF
Sbjct: 224 IEFT 227
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 23/198 (11%), Positives = 51/198 (25%), Gaps = 36/198 (18%)
Query: 14 YKAFDEFAGIEVAWSRVKI--DDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
++A D +VA + + LQ+ S L + V +
Sbjct: 48 WQALDTALDRQVA---LTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
V E G+L++ + + + + H +
Sbjct: 105 GGLVVA--EWIRGGSLQEVADTSPSPVGAI--RAMQSLAAAADAAHRAG--VALSIDHPS 158
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 191
+ V+ + G+V + M + DI G +
Sbjct: 159 RVRVSID-GDVVLAYPA---TMPDANPQD---------------------DIRGIGASLY 193
Query: 192 EMVTFEYPYSECKNPAQI 209
++ +P E + +
Sbjct: 194 ALLVNRWPLPEAGVRSGL 211
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 4e-09
Identities = 77/536 (14%), Positives = 145/536 (27%), Gaps = 190/536 (35%)
Query: 28 SRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKF--------YKSWVDDKKKTVN--- 76
S+ +ID ++ + L S +++ V KF YK ++ KT
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK-FLMSPIKTEQRQP 105
Query: 77 -MITELFTSGNLRQYR-----KKHKNV----DIKVIKNWARQ-------ILHG------- 112
M+T ++ R Y K+ NV ++ + ++ G
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKY-NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT 164
Query: 113 -LVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLAI-------AMQQPTARS 160
+ + K N + L + T+RS
Sbjct: 165 WVALD-------VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 161 VIGTPEFMAPELYEEEYNELVDIYSFGMC--ILEMV-------TFEYPYSECKNPAQI-- 209
+ + + E L+ + C +L V F CK I
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL---SCK----ILL 270
Query: 210 ---FKKVTSGIKPASLAKVN-DPQIKGFIEKCLVPASERLSAK-------DL-------- 250
FK+VT + A+ ++ D + L K DL
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTP----DEVKSLLLKYLDCRPQDLPREVLTTN 326
Query: 251 ----------LKDPFLQVENQKEPICDPL------------------------------K 270
++D +N K CD L
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 271 LPIQSLKMLRLPMSGPSSMDIDSDYKQLSLSTCTESNNGSP----------HCPVLEFQR 320
+P L ++ + M + + + SL + S +
Sbjct: 387 IPTILLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKESTISIPSIYLELKVKLENEYA 444
Query: 321 MHKN--NEFRL-RGTKNDDTSVSLT-----------LRIADSSGRVRNIHFLF---YLD- 362
+H++ + + + + +DD L+ + R+ LF +LD
Sbjct: 445 LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMT----LFRMVFLDF 500
Query: 363 ---------SDTALSVAGEMVEQL-DL-------ADHDVAFIAEFIDYLIMKLLPG 401
TA + +G ++ L L D+D + E + I+ LP
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY--ERLVNAILDFLPK 554
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 5e-06
Identities = 80/618 (12%), Positives = 174/618 (28%), Gaps = 184/618 (29%)
Query: 89 QYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI--FVNG--NHGEVKI 144
+ H + + + + IL + C ++ + E+
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS-------VFEDAFVDNFDCKDVQDMPKSILSKEEID- 52
Query: 145 GDLGLAIAMQQPT----ARSVIGTPEFMAPELYEEEYNELVDI-YSFGMCILEMVTFEYP 199
+ + + T E+ ++ E++ I Y F ++ +
Sbjct: 53 -HI-----IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF---LMSPIK---- 99
Query: 200 YSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFLQVE 259
+E + P+ + + ND Q+ K V RL L+ L++
Sbjct: 100 -TEQRQPSMMTRMYIEQRDRLY----NDNQV---FAKYNVS---RLQPYLKLRQALLELR 148
Query: 260 NQKEPICDPLKLPIQSLKMLRLPM--SGPSSMDID--SDYKQ----------LSLSTCTE 305
K + I + SG + + +D YK L+L C
Sbjct: 149 PAK-------NVLIDG-------VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 306 SNNGSPHCPVLE-FQRMHKNNEFRLRGTKNDDTSVSLTLRIADSSGRVRNIHFLFYLDSD 364
VLE Q++ + T D S ++ LRI +R L +
Sbjct: 195 PET------VLEMLQKLL--YQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKSKPYE 244
Query: 365 TALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKLLPGWKP----SYDYSSSGAL---SFY 417
L V L +V +++ S L F
Sbjct: 245 NCLLV-------LL----NV-----------------QNAKAWNAFNLSCK-ILLTTRFK 275
Query: 418 SVSPILGNGKTSTPSPWDAMGAGVPSEFVVKQDVVSGPTRNPSQDLAPAQ---------- 467
V+ L T+ S P E + ++ QDL P +
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLDCRPQDL-PREVLTTNPRRLS 331
Query: 468 --GENLHDNAGGGGISSPSLAKLEDQESQSSVASDIFVDDTSTKNDKASEFSDYSTDRSY 525
E++ D + + + + I ++S + +E+ +
Sbjct: 332 IIAESIRDG--------LATWDNWKHVNCDKLTTII---ESSLNVLEPAEYRKM-----F 375
Query: 526 KDL-----NGYVSELELGDLCYDECKLQGNYSEDGEDILLYQFVKNSKLTFPNLSTVLSL 580
L + ++ + L + + + +++ + K S + + +S+
Sbjct: 376 DRLSVFPPSAHIPTILL-------SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428
Query: 581 TSSYSSLSLTGKDVDEL-KMEIDA--IEAQYEH-----------WFQELS------KMKE 620
S Y L + ++ L + +D I ++ ++ + + E
Sbjct: 429 PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE 488
Query: 621 EALEASRK----RWMAKK 634
R++ +K
Sbjct: 489 RMTLFRMVFLDFRFLEQK 506
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 38/340 (11%), Positives = 95/340 (27%), Gaps = 91/340 (26%)
Query: 18 DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL------KSLKDD-NVVKFYKSWVDD 70
DE + + + + D LP ++ + +S++D +K D
Sbjct: 301 DEVKSLLLKYLDCRPQD---LPREVLT----TNPRRLSIIAESIRDGLATWDNWKHVNCD 353
Query: 71 K-KKTVNMITELFTSGNLRQYRKK----HKNVDI--KVIKN-WA-------RQILHGLVY 115
K + + R+ + + I ++ W +++ L
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL-- 411
Query: 116 LHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE 175
H ++ + K I + + L + ++ ++
Sbjct: 412 ---HKYSLVEKQPKESTISI---P------SIYLELKVKLENEYAL-------------- 445
Query: 176 EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGIKPASLAKVND--PQI 230
+ +VD Y+ + + P + + +K + +
Sbjct: 446 -HRSIVDHYNIPKT--------FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV 496
Query: 231 K---GFIEKCLVPASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMSGPS 287
F+E+ + S +A + + Q++ K ICD + P
Sbjct: 497 FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD----------------NDPK 540
Query: 288 SMDIDSDYKQLSLSTCTESNNGSPHCPVLEFQRMHKNNEF 327
+ + L E+ S + +L M ++
Sbjct: 541 YERLVNAILDF-LPKIEENLICSKYTDLLRIALMAEDEAI 579
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 36/168 (21%), Positives = 60/168 (35%), Gaps = 24/168 (14%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
Y D AG EVA + +L+ E + K ++ + +
Sbjct: 26 YLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79
Query: 73 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
M+ EL +L + +K + A Q++ + Y+HS N IHRD+K D
Sbjct: 80 NV--MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPD 134
Query: 132 NIFV--NGNHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFM 168
N + V I D GLA + +++ GT +
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 17/73 (23%), Positives = 33/73 (45%), Gaps = 12/73 (16%)
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQ 155
A ++L L +LH + +H ++ +NIFV+ + +V + G A +A +
Sbjct: 165 ACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 156 PTARSVIGTPEFM 168
+ G EF+
Sbjct: 223 GSRSPHEGDLEFI 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 27/141 (19%), Positives = 54/141 (38%), Gaps = 15/141 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
Y + EVA + +L E + + L+ + V+
Sbjct: 24 YLGTNIQTNEEVAIKLENVKT------KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77
Query: 73 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
++ +L +L + + +K + A Q+++ + ++HS + +HRD+K D
Sbjct: 78 NV--LVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPD 132
Query: 132 NIFV--NGNHGEVKIGDLGLA 150
N + +V I D GLA
Sbjct: 133 NFLMGLGRRANQVYIIDFGLA 153
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 3e-06
Identities = 50/280 (17%), Positives = 81/280 (28%), Gaps = 51/280 (18%)
Query: 3 LTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK 62
L+ L + + F + P L K + + K +D
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSY--------PPLLLKAWDHYNSTKGSANDRPDF 131
Query: 63 FYKSWVDDKKKTVNMITELFTSGN-LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP 121
F K + ++ E G L Q R K ++ K+ Q+ L +
Sbjct: 132 F-------KDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAE-ASL 181
Query: 122 PIIHRDLKCDNIFVN------------------GNHG-EVKIGDLGLAIAMQQPTARSVI 162
HRDL N+ + + G +V I D L+ + V+
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI---VV 238
Query: 163 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEY-PYSECK-----NPAQIFKKVTSG 216
M +L+ + + DIY EY PYS + +
Sbjct: 239 FCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT 298
Query: 217 IKPASLAKVNDPQIKGFIEKCLVPASERLSAKDLLKDPFL 256
K +I+ F L + SA DLL L
Sbjct: 299 KCNTPAMKQIKRKIQEFHRTMLNFS----SATDLLCQHSL 334
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 23/73 (31%), Positives = 32/73 (43%), Gaps = 12/73 (16%)
Query: 106 ARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLA---------IAMQQ 155
+ +IL L Y+H H +H D+K N+ +N N +V + D GLA A
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 156 PTARSVIGTPEFM 168
R GT EF
Sbjct: 216 DPKRCHDGTIEFT 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 22/143 (15%), Positives = 51/143 (35%), Gaps = 17/143 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
++ + +VA D +L E K L + Y +
Sbjct: 27 FEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80
Query: 73 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
++ +L +L + +K + A+Q+L + +H + +++RD+K D
Sbjct: 81 NV--LVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPD 135
Query: 132 NIFVNGNHGE----VKIGDLGLA 150
N + + + + + D G+
Sbjct: 136 NFLIGRPNSKNANMIYVVDFGMV 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 31/143 (21%), Positives = 56/143 (39%), Gaps = 17/143 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
+ + VA +K++ + +L+ E K L D + + Y K
Sbjct: 26 RLGKNLYTNEYVA---IKLEPM---KSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79
Query: 73 KTVNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
M+ EL +L + +K + A Q++ + Y+HS N +I+RD+K +
Sbjct: 80 NA--MVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPE 134
Query: 132 NIFV----NGNHGEVKIGDLGLA 150
N + N + I D LA
Sbjct: 135 NFLIGRPGNKTQQVIHIIDFALA 157
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 3e-05
Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 9/83 (10%)
Query: 327 FRLRGTKNDD---TSVSLTLRIADS---SGRVRN---IHFLFYLDSDTALSVAGEMVEQL 377
R+ + DD ++ L LRI D G+ ++ I F F L+ D VA EMVE
Sbjct: 11 VRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESG 70
Query: 378 DLADHDVAFIAEFIDYLIMKLLP 400
+ + D +A+ I + +
Sbjct: 71 YVCEGDHKTMAKAIKDRVSLIKR 93
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.08 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.82 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.77 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.63 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.23 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.16 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.12 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.72 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.6 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.54 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.83 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.24 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.95 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 94.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.45 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 82.05 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-60 Score=495.96 Aligned_cols=253 Identities=52% Similarity=0.934 Sum_probs=232.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~--~~~~l~lV~ 79 (639)
||+|||| +||+|.+..+|..||+|++..... .....+++.+|+.+|++|+|||||++|++|.+. ....+||||
T Consensus 34 iG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 34 IGRGSFK---TVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EecCcCc---EEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 7888888 899999999999999999986653 456678899999999999999999999998753 345789999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|||.||+|.+++++.+.+++..++.|++||+.||.|||+++++||||||||+|||+++.+|.+||+|||+|+........
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~ 188 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBE
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccC
Confidence 99999999999999999999999999999999999999999889999999999999866789999999999877666677
Q ss_pred cccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 160 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
+.+|||.|||||++.+.|+.++|||||||++|||+||++||.+..+..+++..+..+..|..++...++++++||.+||.
T Consensus 189 ~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~ 268 (290)
T 3fpq_A 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred CcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHcc
Confidence 88999999999999989999999999999999999999999988888999999999988888888889999999999999
Q ss_pred -CCCCCCCHHHHhcCcccccc
Q 006593 240 -PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 240 -dP~~RpSa~ELL~Hpff~~~ 259 (639)
||.+|||+.|+|+||||+..
T Consensus 269 ~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 269 QNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp SSGGGSCCHHHHHTSGGGC--
T ss_pred CChhHCcCHHHHhcCccccCC
Confidence 89999999999999999853
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=471.53 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=222.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|+.||+|++.+..... ....+.+.+|+++|++|+|||||++|++|.++ ..+|||||
T Consensus 39 ~lG~G~fg---~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~yivmE 112 (311)
T 4aw0_A 39 ILGEGSFS---TVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLS 112 (311)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEecccCe---EEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEEEe
Confidence 37888888 89999999999999999998765322 34567899999999999999999999999765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
||.||+|.+++++.+.+++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999999999999999999999999999999 99999999999997 5589999999999876422
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
...+.+|||.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+..+++.++..+.. .++...++++++||.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~ 266 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDLVE 266 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHHHH
Confidence 3457899999999998875 599999999999999999999999987 578888888887654 355677899999999
Q ss_pred HhcC-CCCCCCCHHH------HhcCcccccccCCCC
Q 006593 236 KCLV-PASERLSAKD------LLKDPFLQVENQKEP 264 (639)
Q Consensus 236 kcL~-dP~~RpSa~E------LL~Hpff~~~~~~~~ 264 (639)
+||+ ||.+|||++| |++||||+..+|...
T Consensus 267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 267 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 9999 9999999887 689999998887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=471.28 Aligned_cols=244 Identities=29% Similarity=0.518 Sum_probs=214.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.++.+|+.||||++...+. ...+.+.+|+.+|++|+|||||++|++|.+.+ .+||||||
T Consensus 82 iG~G~fG---~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~ivmEy 152 (346)
T 4fih_A 82 IGEGSTG---IVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEF 152 (346)
T ss_dssp EEECSSC---EEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEECC
T ss_pred eecCcCe---EEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEeC
Confidence 7888888 899999999999999999987653 23456889999999999999999999998764 59999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
|.||+|.+++.+ +.+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.+... ...
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCceecCCCCCccc
Confidence 999999999986 56999999999999999999999999 99999999999998 5589999999999876533 356
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l~~LI~kc 237 (639)
+.+|||.|||||++.. .|+.++|||||||++|||++|.+||.+ .+..+++..+..+..+ ...+...++++++||.+|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 307 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 307 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence 7899999999998874 699999999999999999999999987 5677777777766443 233455689999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|. ||.+|||+.|+|+||||+..
T Consensus 308 L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 308 LVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCCChhHCcCHHHHhcCHhhcCC
Confidence 99 99999999999999999854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=471.41 Aligned_cols=246 Identities=23% Similarity=0.436 Sum_probs=212.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|||| +||+|.+..+|+.||||+++.... .....+++.+|+.+|++|+|||||++|++|.+. ..+||||||
T Consensus 32 lG~G~fg---~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~--~~~yiVmEy 104 (350)
T 4b9d_A 32 IGEGSFG---KAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN--GSLYIVMDY 104 (350)
T ss_dssp C---------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEEEeC
Confidence 7888888 799999999999999999987654 456678899999999999999999999999876 469999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
|.||+|.+++... ..+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.|||+|||+|+.+... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCCHHHHH
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeecCCccc
Confidence 9999999999764 35799999999999999999999999 99999999999998 5589999999999876532 2
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
..+.+|||.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++.++..+..+. .+...++++++||.+
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~~-~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPP-VSLHYSYDLRSLVSQ 259 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHH
Confidence 346789999999998875 599999999999999999999999987 56778888888776543 445678999999999
Q ss_pred hcC-CCCCCCCHHHHhcCcccccc
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
||. ||.+|||+.|+|+||||+..
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HccCChhHCcCHHHHhcCHHhhcC
Confidence 999 99999999999999999754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=454.84 Aligned_cols=245 Identities=24% Similarity=0.473 Sum_probs=202.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||+|+++..... .....+++.+|+++|++|+|||||++|++|.++ ..+|+||||
T Consensus 21 lG~G~fg---~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ivmEy 94 (275)
T 3hyh_A 21 LGEGSFG---KVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK--DEIIMVIEY 94 (275)
T ss_dssp EEC---C---CEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCcCe---EEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEEEEeC
Confidence 7888888 7999999999999999999876543 234567899999999999999999999998765 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
| +|+|.+++.+++.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|+..... ...+
T Consensus 95 ~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 95 A-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp C-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC-----------
T ss_pred C-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeecCCCCccCC
Confidence 9 6899999999999999999999999999999999999 99999999999998 5589999999999876533 3456
Q ss_pred ccCCCCcCCccccccc-C-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~~-y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
.+|||.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+..++++.+..+..+ ++...++++++||.+||
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L 247 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVYT--LPKFLSPGAAGLIKRML 247 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC--CCTTSCHHHHHHHHHHS
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHHHc
Confidence 8999999999998753 4 6899999999999999999999987 5778888888877543 45667899999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+ ||.+|||++|+|+||||+..
T Consensus 248 ~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 248 IVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp CSSGGGSCCHHHHHHCHHHHTT
T ss_pred cCChhHCcCHHHHHcCcccccC
Confidence 9 99999999999999999743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=473.49 Aligned_cols=244 Identities=29% Similarity=0.518 Sum_probs=214.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||||++..... ...+.+.+|+.+|++|+|||||++|++|.+.+ .+||||||
T Consensus 159 iG~G~fG---~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~--~~~iVmEy 229 (423)
T 4fie_A 159 IGEGSTG---IVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEF 229 (423)
T ss_dssp EEECSSC---EEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eccCcCc---EEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC--EEEEEEeC
Confidence 7888888 899999999999999999987653 23456889999999999999999999998764 69999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
|.||+|.++++. +.+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.|||+|||+|+.+... ...
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCEECCSSCCCBC
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccceECCCCCcccc
Confidence 999999999976 56999999999999999999999999 99999999999998 5589999999999876533 456
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l~~LI~kc 237 (639)
+.+|||.|||||++.+ .|+.++|||||||++|||++|++||.+ .+..+++..+..+..+ ...+...++++++||.+|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~ 384 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL 384 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence 7899999999998874 599999999999999999999999987 5677777777766443 233456789999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|. ||.+|||+.|||+||||+..
T Consensus 385 L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 385 LVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCCChhHCcCHHHHhcCHHhcCC
Confidence 99 99999999999999999854
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=463.37 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=211.2
Q ss_pred CcccccccCcEEEEEEEe---cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d---~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|||| +||+|.+ ..+++.||+|+++..... .....++.+|+++|++|+|||||++|++|.++ ..+||
T Consensus 31 ~lG~G~fg---~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~i 103 (304)
T 3ubd_A 31 VLGQGSFG---KVFLVKKISGSDARQLYAMKVLKKATLK--VRDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKLYL 103 (304)
T ss_dssp EEECGGGC---EEEEEEECSSTTTTCEEEEEEEESEEEE--EEECC------CCCCCCCCTTEECEEEEEEET--TEEEE
T ss_pred EEecCCCe---EEEEEEEccCCCCCEEEEEEEEehHHcC--hHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEE
Confidence 37889888 7999987 457899999999865432 12334688999999999999999999999876 46999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~-- 155 (639)
|||||.||+|.+++++.+.+++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceeccCCC
Confidence 9999999999999999999999999999999999999999999 99999999999998 558999999999976532
Q ss_pred CCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 156 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....+.+|||.|||||++. ..|+.++|||||||++|||+||++||.+ .+..+++..+..+.. .++...++++++||
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 257 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLL 257 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHHHHHH
Confidence 3445789999999999886 4599999999999999999999999987 567788888877654 34567789999999
Q ss_pred HHhcC-CCCCCCC-----HHHHhcCcccccccCCC
Q 006593 235 EKCLV-PASERLS-----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 235 ~kcL~-dP~~RpS-----a~ELL~Hpff~~~~~~~ 263 (639)
.+||+ ||.+||| ++|+|+||||+..+|..
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 99999 9999998 58999999999877654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=459.09 Aligned_cols=240 Identities=26% Similarity=0.359 Sum_probs=205.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.++.+|+.||||+++.... ..+|+.+|++|+|||||++|++|.+. ..+||||||
T Consensus 66 lG~G~fG---~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~--~~~~ivmEy 131 (336)
T 4g3f_A 66 VGRGSFG---EVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREG--PWVNIFMEL 131 (336)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEET--TEEEEEECC
T ss_pred eccCCCe---EEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEec
Confidence 7888888 899999999999999999987643 24699999999999999999999776 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-----
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~----- 156 (639)
|+||+|.+++++.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.+...+||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 999999999999999999999999999999999999999 9999999999999854336999999999866432
Q ss_pred --CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHHHH
Q 006593 157 --TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKG 232 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l~~ 232 (639)
....++|||.|||||++.+ .|+.++|||||||++|||+||.+||.+. +..+++..+..+..+ ..++...++++++
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~~ 288 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY-FRGPLCLKIASEPPPIREIPPSCAPLTAQ 288 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT-CCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence 1234689999999998875 5999999999999999999999999874 344455556555443 3466678899999
Q ss_pred HHHHhcC-CCCCCCCHHHH-------------hcCccccc
Q 006593 233 FIEKCLV-PASERLSAKDL-------------LKDPFLQV 258 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~EL-------------L~Hpff~~ 258 (639)
||.+||. ||.+|||+.|| |+|||+..
T Consensus 289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 9999999 99999999998 46788754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=439.57 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=197.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC--------
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK-------- 72 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~-------- 72 (639)
.||+|||| +||+|.++.+|+.||+|+++... .....+++.+|+.+|++|+|||||++|++|.+.+.
T Consensus 12 ~lG~G~fg---~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 12 CLGRGGFG---VVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp EEEECC-----EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred EEecCCCe---EEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 37888888 89999999999999999998664 34566789999999999999999999999986543
Q ss_pred --ceEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeec
Q 006593 73 --KTVNMITELFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147 (639)
Q Consensus 73 --~~l~lV~Ey~~gGsL~d~lkk~~~---l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DF 147 (639)
.++|+|||||.||+|.++++..+. .++..++.|+.||+.||+|||++| ||||||||+|||++ .+|.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEEccC
Confidence 358999999999999999997755 455678999999999999999999 99999999999998 4579999999
Q ss_pred chhhhccCCC--------------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHH
Q 006593 148 GLAIAMQQPT--------------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 212 (639)
Q Consensus 148 GlA~~l~~~~--------------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~ 212 (639)
|+|+.+.... ..+.+|||.|||||++.+ .|+.++|||||||++|||++ ||....+.......
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~ 239 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHH
Confidence 9998764321 234689999999998875 59999999999999999996 88653333344555
Q ss_pred HHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 213 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 213 i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+.....|..+ ...++.+++||.+||+ ||.+|||+.|+|+||||+..++
T Consensus 240 ~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 240 VRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 5555444332 3345788999999999 8999999999999999986543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=446.64 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=207.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----CCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----KKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~----~~~~l~l 77 (639)
||+|+|| +||+|.+..+|+.||||+++... ......+++.+|+++|++|+|||||++++++... +...+||
T Consensus 62 lG~G~fG---~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 62 IGNGAYG---VVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEECSSC---EEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EecccCe---EEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 7888888 89999999999999999997553 2445677899999999999999999999987643 2357999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~-- 155 (639)
|||||. |+|.+++.+.+.+++..++.|++||+.||.|||++| ||||||||+|||++ ..|.+||+|||+|+.+..
T Consensus 137 vmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 137 VLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCC----
T ss_pred EEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceeeecccCc
Confidence 999996 689999999999999999999999999999999999 99999999999998 558999999999976532
Q ss_pred ----CCCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCCCCc------
Q 006593 156 ----PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPAS------ 221 (639)
Q Consensus 156 ----~~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p~~------ 221 (639)
....+.+||+.|||||++.+ .|+.++||||+||++|||++|.+||.+. +....+..|.. +..+..
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~-~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK-NYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS-SHHHHHHHHHHHHCCCCGGGTC---
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhcCCCChHHhhhhh
Confidence 23456799999999998754 4799999999999999999999999874 44444444432 111110
Q ss_pred ---------------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 222 ---------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 222 ---------------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.....++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 112357899999999999 99999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=424.82 Aligned_cols=238 Identities=29% Similarity=0.435 Sum_probs=200.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|||| +||+|.+.. .||||+++... ......+.+.+|+.+|++|+|||||++++++.. ..+||||||
T Consensus 44 iG~G~fG---~Vy~~~~~~---~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVmEy 112 (307)
T 3omv_A 44 IGSGSFG---TVYKGKWHG---DVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVTQW 112 (307)
T ss_dssp CCCCSSS---EEEEEESSS---EEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEEC
T ss_pred EeeCCCc---EEEEEEECC---cEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEEEc
Confidence 7899998 899998643 59999987654 356677889999999999999999999997643 347899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
|+||+|.+++... +.+++..+..|+.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccCceecccCCcce
Confidence 9999999999765 57999999999999999999999999 99999999999998 5579999999999765422
Q ss_pred CCccccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC---cccCCCChH
Q 006593 157 TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLAKVNDPQ 229 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~---~l~~~~s~~ 229 (639)
.....+||+.|||||++. +.|+.++|||||||++|||+||+.||.+..+...+...+..+..++ ..+...+++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 234578999999999885 2489999999999999999999999998777777777777765443 344556889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+++||.+||+ +|.+|||+.||+.+
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999 89999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=465.20 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=217.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
+||+|||| +||+|.++.+|+.||+|++++..+... .........++.+++.++|||||++|++|.+. ..+|||
T Consensus 196 ~LG~G~fG---~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--~~lylV 270 (689)
T 3v5w_A 196 IIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFI 270 (689)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SEEEEE
T ss_pred EEecccCe---EEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--CEEEEE
Confidence 48889888 899999999999999999987654221 12223334456777888999999999999776 469999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
||||.||+|.+++.+.+.+++..++.|++||+.||.|||++| ||||||||+|||++ .+|.|||+|||+|+.+.....
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~~~ 347 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP 347 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSCCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeecCCCCC
Confidence 999999999999999999999999999999999999999999 99999999999998 568999999999988877777
Q ss_pred ccccCCCCcCCccccc-c-cCCccccccchhhhhhhhhhccCCCCCC--CCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 RSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~-~ys~ksDIwSlGiil~ELltG~~Pf~~~--~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.+.+|||.|||||++. + .|+.++|||||||++|||++|.+||.+. .+...+...+..... .++...++++++||
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~--~~p~~~S~~a~dLI 425 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDSFSPELRSLL 425 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC--CCCccCCHHHHHHH
Confidence 7899999999999885 3 5999999999999999999999999753 344556666665433 35566789999999
Q ss_pred HHhcC-CCCCCCC-----HHHHhcCcccccccCCCC
Q 006593 235 EKCLV-PASERLS-----AKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 235 ~kcL~-dP~~RpS-----a~ELL~Hpff~~~~~~~~ 264 (639)
.+||+ ||.+|++ ++|+++||||+..+|...
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred HHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 99999 9999998 899999999999887654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=422.42 Aligned_cols=241 Identities=23% Similarity=0.363 Sum_probs=204.9
Q ss_pred cccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| +||+|.+. .+|..||||+++.. .....+.+.+|+++|++|+|||||++|+++.+. ..+|
T Consensus 21 lG~G~fG---~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~~~ 91 (299)
T 4asz_A 21 LGEGAFG---KVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DPLI 91 (299)
T ss_dssp EEC--CC---CEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSEE
T ss_pred EeeCCCc---EEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CEEE
Confidence 7899999 79999864 46899999998743 345678899999999999999999999998765 4589
Q ss_pred EEEecCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEE
Q 006593 77 MITELFTSGNLRQYRKKHK-------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVK 143 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~-------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VK 143 (639)
||||||++|+|.+++.+++ .+++..+..|+.||+.||.|||+++ ||||||||+|||++ .++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~-~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEEC-CCCcEE
Confidence 9999999999999998653 6999999999999999999999999 99999999999998 457999
Q ss_pred EeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCC
Q 006593 144 IGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGI 217 (639)
Q Consensus 144 L~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~ 217 (639)
|+|||+|+...... ....+||+.|||||++. ..|+.++|||||||++|||+| |+.||.+ .+..+++..+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999998664321 23457999999999886 569999999999999999999 8999987 46778888888876
Q ss_pred CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 218 KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 218 ~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
.+ ..+...++++.+||.+||+ +|.+|||+.|| |+||+.
T Consensus 248 ~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 248 VL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CC-CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 54 3456678999999999999 89999999999 457754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=423.72 Aligned_cols=238 Identities=22% Similarity=0.365 Sum_probs=198.4
Q ss_pred cccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| +||+|.+. .+|..||||+++.. .....+.+.+|+++|++|+|||||++|+++.+. ..+|
T Consensus 49 LG~G~fG---~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~--~~~~ 119 (329)
T 4aoj_A 49 LGEGAFG---KVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEG--RPLL 119 (329)
T ss_dssp EEECSSE---EEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSEE
T ss_pred EccCCCc---EEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEE
Confidence 7888888 89999864 47899999998743 356678899999999999999999999988655 4599
Q ss_pred EEEecCCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc
Q 006593 77 MITELFTSGNLRQYRKKH---------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~---------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~ 141 (639)
||||||++|+|.++++++ +++++..+..|+.||+.||.|||+++ ||||||||+|||++ .++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~-~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG-QGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC-CCCc
Confidence 999999999999999764 35899999999999999999999999 99999999999998 5579
Q ss_pred EEEeecchhhhccCC----CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHc
Q 006593 142 VKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 215 (639)
Q Consensus 142 VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~ 215 (639)
+||+|||+|+.+... .....+||+.|||||++.. .|+.++|||||||++|||+| |+.||.+ .+..+++..+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ-LSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-SCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC-CCHHHHHHHHHc
Confidence 999999999866432 2234689999999998864 69999999999999999999 8999987 456777788887
Q ss_pred CCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 216 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 216 g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+..+ ..+..+++++.+||.+||. +|.+|||+.||+.+
T Consensus 276 g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7544 3566778999999999999 89999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=427.93 Aligned_cols=242 Identities=19% Similarity=0.320 Sum_probs=196.6
Q ss_pred cccccccCcEEEEEEEec---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||+|+|| +||+|.++ .+++.||+|++.... ...++.+|+++|+.+ +|||||+++++|.+. .++|+
T Consensus 29 lG~G~fg---~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--~~~~l 97 (361)
T 4f9c_A 29 IGEGTFS---SVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--DHVVI 97 (361)
T ss_dssp EEECSSE---EEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--TEEEE
T ss_pred EecccCc---EEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--CEEEE
Confidence 7888888 89999875 468999999886442 345688999999999 699999999999775 46999
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
|||||.||+|.++++ .+++..++.|++||+.||.|||++| |+||||||+|||++.+.|.+||+|||+|+.....
T Consensus 98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 999999999999984 5999999999999999999999999 9999999999999877689999999999644321
Q ss_pred -----------------------------CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCC
Q 006593 157 -----------------------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN 205 (639)
Q Consensus 157 -----------------------------~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~ 205 (639)
...+.+|||.|||||++.+ .|+.++||||+||++|||+||+.||....+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1234589999999998854 489999999999999999999999976555
Q ss_pred HHHHHHHHHc--C--------------------------------------------------CCCCcccCCCChHHHHH
Q 006593 206 PAQIFKKVTS--G--------------------------------------------------IKPASLAKVNDPQIKGF 233 (639)
Q Consensus 206 ~~~i~~~i~~--g--------------------------------------------------~~p~~l~~~~s~~l~~L 233 (639)
..+.+..+.. | ..........++++++|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 4433332211 0 00001123457899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|.+||+ ||.+||||+|+|+||||+..
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999 99999999999999999753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=419.63 Aligned_cols=239 Identities=21% Similarity=0.264 Sum_probs=202.6
Q ss_pred cccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| +||+|.. ..+++.||||+++... .....+.|.+|+.+|++|+|||||++|+++... ..++
T Consensus 34 lG~G~fG---~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~~~~ 105 (308)
T 4gt4_A 34 LGEDRFG---KVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--QPLS 105 (308)
T ss_dssp EEECSSC---EEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCE
T ss_pred eccCCCc---EEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--CEEE
Confidence 7889988 8999985 4578999999987443 334567899999999999999999999988655 4589
Q ss_pred EEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC
Q 006593 77 MITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 140 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g 140 (639)
||||||++|+|.++|..+ ..+++..+..|+.||+.||.|||+++ ||||||||+|||++ +++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY-DKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC-CCC
Confidence 999999999999999753 35899999999999999999999999 99999999999998 457
Q ss_pred cEEEeecchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHH
Q 006593 141 EVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVT 214 (639)
Q Consensus 141 ~VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~ 214 (639)
.+||+|||+|+.+... .....+||+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHH
Confidence 9999999999765432 234568999999999876 569999999999999999998 8999987 46778888888
Q ss_pred cCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 215 SGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 215 ~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+..++ .+..+++++.+||.+||. +|.+|||+.||+++
T Consensus 262 ~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 775543 456678899999999999 89999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=448.43 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=216.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.++.+|+.||+|++.... ....+.+.+|+.+|+.|+|||||+++++|.+. ..+||||||
T Consensus 165 lG~G~fg---~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~iv~E~ 235 (573)
T 3uto_A 165 LGTGAFG---VVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYEF 235 (573)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EeeccCe---EEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEee
Confidence 6778777 89999999999999999998653 35567899999999999999999999999765 569999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC-CCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~-~g~VKL~DFGlA~~l~~~-~~ 158 (639)
|.||+|.+++.+ ++.+++..++.|++||+.||.|||+++ |+||||||+|||++.+ .|.+||+|||+|+.+... ..
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999999964 467999999999999999999999999 9999999999999743 479999999999877543 34
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~LI~ 235 (639)
...+||+.|||||++.+ .|+.++|||||||++|||++|.+||.+ .+..+++..+..+.. +.......++++++||.
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~ 392 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 56799999999998875 599999999999999999999999987 567777778876543 33445567899999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||+ ||.+|||+.|+|+||||+...+
T Consensus 393 ~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 393 KLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp TTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999 9999999999999999987654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=418.94 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=205.8
Q ss_pred cccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~~~~~~~~~l 75 (639)
||+|+|| +||+|.+.. +++.||+|+++... .....+.+.+|+.+|+++.| ||||+++++|...+ ..+
T Consensus 72 LG~G~fG---~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-~~~ 144 (353)
T 4ase_A 72 LGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPL 144 (353)
T ss_dssp EEECSSE---EEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-SCC
T ss_pred EecCCCe---EEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC-CEE
Confidence 7888888 899998754 35789999987543 34566789999999999965 99999999876543 458
Q ss_pred EEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC
Q 006593 76 NMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~ 139 (639)
++|||||++|+|.++|++. ..+++..+..|+.||+.||.|||+++ ||||||||+|||++ ++
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~ 221 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EK 221 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GG
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeC-CC
Confidence 8999999999999999863 34899999999999999999999999 99999999999998 45
Q ss_pred CcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHH
Q 006593 140 GEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 140 g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i 213 (639)
+.+||+|||+|+.+.... ....+||+.|||||++. ..|+.++|||||||++|||+| |..||.+......+.+.+
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999998664332 23467999999999886 569999999999999999998 899999876677777888
Q ss_pred HcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 214 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 214 ~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+..+ ..+...++++.+||.+||. ||.+|||+.||++|
T Consensus 302 ~~g~~~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 KEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCC-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 777654 3456678999999999999 89999999999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=390.07 Aligned_cols=253 Identities=52% Similarity=0.934 Sum_probs=229.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~--~~~~l~lV~ 79 (639)
||+|+|| +||+|.+..++..||+|.+..... .....+.+.+|+.+|++++||||++++++|... ....+++||
T Consensus 34 lg~G~~g---~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 34 IGRGSFK---TVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred ccCCCCe---EEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 6777777 899999999999999999986653 456778899999999999999999999998653 346789999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
||+.+|+|.+++...+.+++..++.|+.||+.||.|||+++++|+||||||+|||+++..+.+||+|||++.........
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 188 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 188 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBE
T ss_pred EecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccc
Confidence 99999999999998889999999999999999999999998889999999999999766789999999999876666666
Q ss_pred cccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 160 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
...||+.|+|||++.+.++.++||||||+++|+|++|..||....+...+...+..+..+..++...++++++||.+||.
T Consensus 189 ~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 268 (290)
T 1t4h_A 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268 (290)
T ss_dssp ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred cccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHcc
Confidence 77899999999999888999999999999999999999999988888899999998888888888888999999999999
Q ss_pred -CCCCCCCHHHHhcCcccccc
Q 006593 240 -PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 240 -dP~~RpSa~ELL~Hpff~~~ 259 (639)
+|.+|||+.|+|+||||+..
T Consensus 269 ~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 269 QNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp SSGGGSCCHHHHHTSGGGC--
T ss_pred CChhhCCCHHHHhhCcccccC
Confidence 89999999999999999854
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=393.55 Aligned_cols=246 Identities=26% Similarity=0.457 Sum_probs=216.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++..... .....+++.+|+.+|+.++||||+++++++... ..+|+||||
T Consensus 23 lG~G~~g---~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e~ 95 (328)
T 3fe3_A 23 IGKGNFA---KVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE--KTLYLIMEY 95 (328)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred EeeCCCE---EEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CEEEEEEEC
Confidence 6777777 899999999999999999987653 456778899999999999999999999988654 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ....
T Consensus 96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSSCGGGT
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecCCCCcccc
Confidence 999999999998899999999999999999999999999 99999999999998 4579999999999766533 3456
Q ss_pred ccCCCCcCCcccccc-cC-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
.+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+ .+...+...+..+... ++...++++.+||.+||
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L 249 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENLLKRFL 249 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHC
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHC
Confidence 789999999998865 34 5789999999999999999999987 5677777788776543 34557899999999999
Q ss_pred C-CCCCCCCHHHHhcCccccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. +|.+|||++|+|+||||+...
T Consensus 250 ~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 250 VLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp CSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCChhHCcCHHHHhcCHhhcCCC
Confidence 9 999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=395.34 Aligned_cols=240 Identities=23% Similarity=0.316 Sum_probs=185.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC--ceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--KTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~--~~l~lV~ 79 (639)
||+|||| +||+|.+ +|+.||||+++... ........|+..+.+|+|||||++++++...+. ..+||||
T Consensus 11 iG~G~fG---~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 11 IGKGRFG---EVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp EEECSSS---EEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EeeCCCe---EEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 7999999 8999987 58999999986442 222233456667788999999999999886543 3689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~------gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
|||++|+|.+++++. .+++..+..++.||+.||.|||++ .++||||||||+|||++ .+|.+||+|||+|+..
T Consensus 81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCTTCEEE
T ss_pred cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCCCCccc
Confidence 999999999999874 589999999999999999999987 23499999999999998 5589999999999766
Q ss_pred cCCC------CccccCCCCcCCcccccc-------cCCccccccchhhhhhhhhhccCCCCC----------C----CCH
Q 006593 154 QQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSE----------C----KNP 206 (639)
Q Consensus 154 ~~~~------~~~~~GTp~ymAPE~l~~-------~ys~ksDIwSlGiil~ELltG~~Pf~~----------~----~~~ 206 (639)
.... ....+||+.|||||++.+ .|+.++|||||||++|||+||..||.. . ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 4332 234589999999998864 378899999999999999999766531 1 123
Q ss_pred HHHHHHHHcCCCCCcccCCC-----ChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 207 AQIFKKVTSGIKPASLAKVN-----DPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 207 ~~i~~~i~~g~~p~~l~~~~-----s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+.+.+......+.++... ...+.+||.+||. ||.+|||+.||++.
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 44555554443333333221 2367899999999 89999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=383.63 Aligned_cols=246 Identities=28% Similarity=0.487 Sum_probs=211.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|++..... ...+.+.+|+.++++++||||++++++|...+ .+++||||
T Consensus 28 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~ 98 (297)
T 3fxz_A 28 IGQGASG---TVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEY 98 (297)
T ss_dssp EEEETTE---EEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred eccCCCe---EEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC--EEEEEEEC
Confidence 6777777 899999999999999999986643 33567899999999999999999999988764 58999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+|+|.+++.+. .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ...
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBC
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCceecCCcccccC
Confidence 9999999999875 6999999999999999999999999 99999999999997 5579999999998765433 234
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.............+......+...++.+++||.+||
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 254 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence 5689999999998864 589999999999999999999999987544444444445555555556677889999999999
Q ss_pred C-CCCCCCCHHHHhcCccccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. ||.+|||+.|+|+||||+...
T Consensus 255 ~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 255 EMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCChhHCcCHHHHhhChhhcccC
Confidence 9 999999999999999998543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=395.13 Aligned_cols=251 Identities=20% Similarity=0.390 Sum_probs=217.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|+.||+|+++..... .....+.+.+|+.+|+.++||||++++++|.+. ..+|+|||
T Consensus 12 ~lG~G~fg---~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--~~~~lv~E 85 (337)
T 1o6l_A 12 LLGKGTFG---KVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVME 85 (337)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred EEecCCCe---EEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC--CEEEEEEe
Confidence 37888888 8999999999999999999865421 124567789999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~~ 158 (639)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++... ....
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCB
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhcccCCCcc
Confidence 9999999999998889999999999999999999999999 99999999999997 55899999999997543 2234
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+...++..+..+.. .++...++++++||.+|
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 56789999999998864 599999999999999999999999986 466777777766533 34566789999999999
Q ss_pred cC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 238 LV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 238 L~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
|. +|.+|| ++.|+++||||+..+|..
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~ 271 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99 899999 899999999999877654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=399.03 Aligned_cols=251 Identities=22% Similarity=0.379 Sum_probs=213.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|..||+|+++..... .....+.+..|..+|+.+ +||||++++++|.+. ..+|+||
T Consensus 30 ~lG~G~fg---~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~~lv~ 103 (353)
T 3txo_A 30 VLGKGSFG---KVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DRLFFVM 103 (353)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEeeCCCE---EEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CEEEEEE
Confidence 37788877 8999999999999999999865322 234567789999999998 799999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++... ...
T Consensus 104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC----
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecccCCcc
Confidence 99999999999999899999999999999999999999999 99999999999997 55899999999997543 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..+..+... ++...++.+++||.+
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~~~~~~~li~~ 257 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVV--YPTWLHEDATGILKS 257 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHH
T ss_pred ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCC--CCCCCCHHHHHHHHH
Confidence 456789999999998864 599999999999999999999999987 5677788888776442 455678999999999
Q ss_pred hcC-CCCCCCCH------HHHhcCcccccccCCC
Q 006593 237 CLV-PASERLSA------KDLLKDPFLQVENQKE 263 (639)
Q Consensus 237 cL~-dP~~RpSa------~ELL~Hpff~~~~~~~ 263 (639)
||. +|.+||++ .|+++||||+..+|..
T Consensus 258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 258 FMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp HTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred HhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 999 89999998 9999999999877654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=395.19 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=216.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|.+..+|..||+|+++....... ....+.+.+|+.+|++++||||++++++|.+. ..+++||
T Consensus 20 LG~G~fg---~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv~ 94 (361)
T 2yab_A 20 LGSGQFA---IVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR--TDVVLIL 94 (361)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EeeCcCE---EEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC--CEEEEEE
Confidence 6778777 899999999999999999987654322 12457799999999999999999999998665 5699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC---cEEEeecchhhhccCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG---EVKIGDLGLAIAMQQP 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g---~VKL~DFGlA~~l~~~ 156 (639)
||+.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.+ .+||+|||++......
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~ 172 (361)
T 2yab_A 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172 (361)
T ss_dssp ECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC
Confidence 99999999999998889999999999999999999999999 999999999999974432 7999999999776543
Q ss_pred -CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHH
Q 006593 157 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKG 232 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~ 232 (639)
.....+||+.|+|||++.. .|+.++|||||||++|+|++|..||.+ .+..+++..+..+... .......++++++
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 251 (361)
T 2yab_A 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKD 251 (361)
T ss_dssp CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhccCCCHHHHH
Confidence 3456789999999998875 699999999999999999999999987 4667777777766443 2334566889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||.+||. +|.+|||+.|+|+||||+...
T Consensus 252 li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 252 FIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred HHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 9999999 999999999999999998543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=387.59 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=217.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|+.||+|+++...... ....+.+.+|+.+|+.++||||++++++|.+. ..+|+|||
T Consensus 13 ~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--~~~~lv~e 86 (318)
T 1fot_A 13 TLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMIMD 86 (318)
T ss_dssp EEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC--CEEEEEEe
Confidence 37888888 89999999999999999998654321 23456788999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.... ....
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~-~~~~ 162 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD-VTYT 162 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSS-CBCC
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCC-cccc
Confidence 9999999999999899999999999999999999999999 99999999999997 558999999999976543 3356
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
.+||+.|+|||++.. .|+.++|||||||++|||++|..||.+ .+....+..+..+.. .++...++++++||.+||.
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTC
T ss_pred ccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhc
Confidence 789999999998864 589999999999999999999999987 456677777776543 3455678999999999999
Q ss_pred -CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 240 -PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 240 -dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
+|.+|| +++++++||||+...|..
T Consensus 240 ~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~ 269 (318)
T 1fot_A 240 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 269 (318)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred cCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence 899999 999999999999776654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=388.04 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=215.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|+.||+|+++.... ......+.+.+|+.+|+++ +||||++++++|.+. ..+|+||
T Consensus 16 ~lG~G~fg---~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~~lv~ 89 (345)
T 3a8x_A 16 VIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVI 89 (345)
T ss_dssp EEEECSSE---EEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEEecCCe---EEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CEEEEEE
Confidence 37888887 899999999999999999987654 3345677899999999998 899999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++... ...
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSCCTTCC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEeccccccccCCCCc
Confidence 99999999999998889999999999999999999999999 99999999999997 55899999999997542 223
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC--------CCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
....+||+.|+|||++.+ .|+.++|||||||++|||++|..||... .....++..+..+.. .++...++
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~ 244 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSV 244 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTTSCH
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCCCCH
Confidence 456789999999998864 5899999999999999999999999642 233445566665433 34566789
Q ss_pred HHHHHHHHhcC-CCCCCCCH------HHHhcCcccccccCCC
Q 006593 229 QIKGFIEKCLV-PASERLSA------KDLLKDPFLQVENQKE 263 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa------~ELL~Hpff~~~~~~~ 263 (639)
++++||.+||. +|.+||++ .|+++||||+...|..
T Consensus 245 ~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~ 286 (345)
T 3a8x_A 245 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 286 (345)
T ss_dssp HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence 99999999999 89999995 8999999998776643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=391.65 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=218.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|+++...... ....+.+.+|+.+|+.++||||+++++++.+. ..+|+|||
T Consensus 48 ~lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e 121 (350)
T 1rdq_E 48 TLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYMVME 121 (350)
T ss_dssp EEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred EeecCcCc---EEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--CEEEEEEc
Confidence 37888888 89999999999999999998654321 23467789999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++..... ...
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~~-~~~ 197 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-TWT 197 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-BCC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceeccCC-ccc
Confidence 9999999999998889999999999999999999999999 99999999999997 5589999999999766443 346
Q ss_pred ccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
.+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+..+++..+..+.. .++...++++++||.+||.
T Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSC
T ss_pred ccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhh
Confidence 78999999999876 4689999999999999999999999987 567788888877643 3456678999999999999
Q ss_pred -CCCCCCC-----HHHHhcCcccccccCCC
Q 006593 240 -PASERLS-----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 240 -dP~~RpS-----a~ELL~Hpff~~~~~~~ 263 (639)
+|.+||+ ++++++||||+..+|..
T Consensus 275 ~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~ 304 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred cCHHhccCCccCCHHHHHhCcCcCCCCHHH
Confidence 9999998 99999999999877643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=399.28 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=213.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|+.||+|+++..... .....+.+..|..+|+++ +|||||+++++|.+. ..+|+||
T Consensus 59 ~LG~G~fG---~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~~lV~ 132 (396)
T 4dc2_A 59 VIGRGSYA---KVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVI 132 (396)
T ss_dssp EEEECSSE---EEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CEEEEEE
Confidence 47888888 8999999999999999999876542 234456688999999887 899999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++... ...
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCC
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecccCCCc
Confidence 99999999999999889999999999999999999999999 99999999999998 55899999999997532 234
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC--------CCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--------KNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~--------~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
....+||+.|+|||++.+ .|+.++|||||||++|||++|..||... .....+++.+..... .++...++
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~ 287 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSLSV 287 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CCCTTSCH
T ss_pred cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CCCCcCCH
Confidence 556799999999998864 5999999999999999999999999632 123345566665433 34566789
Q ss_pred HHHHHHHHhcC-CCCCCCCH------HHHhcCcccccccCCC
Q 006593 229 QIKGFIEKCLV-PASERLSA------KDLLKDPFLQVENQKE 263 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa------~ELL~Hpff~~~~~~~ 263 (639)
++++||.+||+ +|.+||++ .|+++||||+..+|..
T Consensus 288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~ 329 (396)
T 4dc2_A 288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329 (396)
T ss_dssp HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence 99999999999 99999985 8999999999877654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.30 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=218.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.++.+|+.||+|+++...... ....+.+..|..+|+.+ +||||+++++++.+. ..+|+||
T Consensus 24 ~lG~G~fg---~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~~~lv~ 97 (345)
T 1xjd_A 24 MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLFFVM 97 (345)
T ss_dssp EEEECSSS---EEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CEEEEEE
Confidence 47888888 89999999999999999998654211 23456788999999987 999999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++... ...
T Consensus 98 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhcccCCCc
Confidence 99999999999998889999999999999999999999999 99999999999997 55899999999997543 233
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+...++..+..+.. .++...++++++||.+
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 251 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVK 251 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHH
T ss_pred ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHHHHHHHH
Confidence 456789999999998864 589999999999999999999999987 567777777776543 3455678999999999
Q ss_pred hcC-CCCCCCCHH-HHhcCcccccccCCCC
Q 006593 237 CLV-PASERLSAK-DLLKDPFLQVENQKEP 264 (639)
Q Consensus 237 cL~-dP~~RpSa~-ELL~Hpff~~~~~~~~ 264 (639)
||. +|.+||++. ++++||||+..+|...
T Consensus 252 lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l 281 (345)
T 1xjd_A 252 LFVREPEKRLGVRGDIRQHPLFREINWEEL 281 (345)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred HhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence 999 899999998 9999999998776543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=387.43 Aligned_cols=248 Identities=23% Similarity=0.417 Sum_probs=214.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++..... .....+.+.+|+.+|++|+||||+++++++.+. ..+|+||||
T Consensus 37 lG~G~~g---~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv~e~ 109 (362)
T 2bdw_A 37 LGKGAFS---VVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLVFDL 109 (362)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEEEec
Confidence 6777777 899999999999999999987653 446678899999999999999999999988765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++...... ..
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 999999999998888999999999999999999999999 9999999999999743 356999999999766533 33
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~LI~ 235 (639)
...+||+.|+|||++.. .|+.++|||||||++|+|++|..||.+ .+...++..+..+... .......++++++||.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 266 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 45789999999998875 599999999999999999999999987 4566777777766443 2233456889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+||. +|.+||++.|+|+||||+..
T Consensus 267 ~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 267 SMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHcCCChhhCcCHHHHhcCcccCCC
Confidence 9999 99999999999999999754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=374.86 Aligned_cols=249 Identities=23% Similarity=0.407 Sum_probs=205.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC----------------------hhhHHHHHHHHHHHHhCCCC
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL----------------------PGDLQKLYSEVHLLKSLKDD 58 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~----------------------~~~~~~l~~Ei~iLk~L~Hp 58 (639)
.||+|+|| .||+|.+..+|..||+|++........ ....+.+.+|+.+|++++||
T Consensus 20 ~lG~G~~g---~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 96 (298)
T 2zv2_A 20 EIGKGSYG---VVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96 (298)
T ss_dssp EEEC--CC---EEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred EEeecCCE---EEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence 37888888 899999999999999999986643211 12346789999999999999
Q ss_pred CcceEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC
Q 006593 59 NVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 138 (639)
Q Consensus 59 NIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~ 138 (639)
||+++++++.+.....+++||||+.+|+|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~ 172 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVG-E 172 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-T
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-C
Confidence 9999999998766678999999999999988654 457999999999999999999999999 99999999999997 4
Q ss_pred CCcEEEeecchhhhccCCC--CccccCCCCcCCccccccc----CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHH
Q 006593 139 HGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 212 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~~~~--~~~~~GTp~ymAPE~l~~~----ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~ 212 (639)
+|.+||+|||++....... .....||+.|+|||++... ++.++|||||||++|+|++|..||.+ .+...+...
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~ 251 (298)
T 2zv2_A 173 DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSK 251 (298)
T ss_dssp TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHH
T ss_pred CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHHHHH
Confidence 5799999999997665332 3456899999999988643 47889999999999999999999987 455566666
Q ss_pred HHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 213 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 213 i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
+.............++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 666544433345567899999999999 899999999999999995
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=398.02 Aligned_cols=249 Identities=23% Similarity=0.388 Sum_probs=215.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|++..... .....+.+.+|+.+|++|+||||++++++|.+. ..+|+|||
T Consensus 18 ~LG~G~fg---~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lv~E 90 (444)
T 3soa_A 18 ELGKGAFS---VVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEE--GHHYLIFD 90 (444)
T ss_dssp EEEEC--C---EEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS--SEEEEEEC
T ss_pred EeccCCCe---EEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC--CEEEEEEE
Confidence 37888888 899999999999999999987653 345667899999999999999999999988655 56899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhccCC--
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~~~-- 156 (639)
||.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. +.+.+||+|||++......
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999999999999999999999999999999999 999999999999974 3478999999999766533
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC--cccCCCChHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIKGF 233 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s~~l~~L 233 (639)
.....+||+.|+|||++.. .|+.++|||||||++|+|++|..||.+ .+...++..+..+.... ......++++++|
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 2345689999999998875 599999999999999999999999987 56777777777765432 2334568999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|.+||. ||.+|||+.|+|+||||+..
T Consensus 248 i~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999 99999999999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=370.51 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=203.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||+|+++.... .....+.+.+|+.+|++++||||+++++++.+. ..+++||||
T Consensus 10 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 82 (292)
T 3o0g_A 10 IGEGTYG---TVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVFEF 82 (292)
T ss_dssp EEECSSS---EEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred ecCCCCe---EEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEEEEEec
Confidence 7888888 899999999999999999987653 345567789999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.++.+..+....+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ...
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSCCSCCC
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCCcccccc
Confidence 986444444445678999999999999999999999999 99999999999998 4579999999999766432 234
Q ss_pred cccCCCCcCCcccccc-c-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CCC----------------
Q 006593 160 SVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP---------------- 219 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~p---------------- 219 (639)
...||+.|+|||++.+ . |+.++|||||||++|+|++|..||....+.......+... ..+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 5688999999998754 3 8999999999999999999988865556666555554321 000
Q ss_pred ---------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 220 ---------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 220 ---------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
.......++++++||.+||. ||.+|||++|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 01112357889999999999 9999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=390.75 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=217.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|+.||+|+++...... ....+.+..|..+|..+ +||||++++++|.+. ..+|+||
T Consensus 27 ~lG~G~fg---~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~~lv~ 100 (353)
T 2i0e_A 27 VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFVM 100 (353)
T ss_dssp EEEEETTE---EEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEeeCCCE---EEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CEEEEEE
Confidence 37888888 89999999999999999998654321 24467789999999998 899999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++... ...
T Consensus 101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCcccccccCCcc
Confidence 99999999999998889999999999999999999999999 99999999999997 55899999999997543 234
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+..+++..+..+.. .++...++++++||.+
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 254 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKG 254 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHH
T ss_pred cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHH
Confidence 45678999999999886 4699999999999999999999999987 567778888877543 3455678999999999
Q ss_pred hcC-CCCCCCC-----HHHHhcCcccccccCCC
Q 006593 237 CLV-PASERLS-----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 237 cL~-dP~~RpS-----a~ELL~Hpff~~~~~~~ 263 (639)
||. +|.+||+ ++++++||||+..+|..
T Consensus 255 lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~ 287 (353)
T 2i0e_A 255 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287 (353)
T ss_dssp HTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence 999 8999994 79999999999877654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=378.97 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=212.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| .||+|.+..+|..||+|+++....... ....+.+.+|+.+|++++||||++++++|.+. ..+++||
T Consensus 19 lG~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~ 93 (326)
T 2y0a_A 19 LGSGQFA---VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--TDVILIL 93 (326)
T ss_dssp EECCSSE---EEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EeeCCCe---EEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEEEE
Confidence 7888887 899999999999999999987654322 12467799999999999999999999998764 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC----cEEEeecchhhhccC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG----EVKIGDLGLAIAMQQ 155 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g----~VKL~DFGlA~~l~~ 155 (639)
||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ + .+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 94 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDR-NVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp ECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCS-SSSSCCEEECCCTTCEECCT
T ss_pred EcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecC-CCCCCCEEEEECCCCeECCC
Confidence 99999999999998889999999999999999999999999 9999999999999743 4 799999999977643
Q ss_pred C-CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHH
Q 006593 156 P-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIK 231 (639)
Q Consensus 156 ~-~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~ 231 (639)
. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+ .+.......+..... +.......++.++
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (326)
T 2y0a_A 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAK 249 (326)
T ss_dssp TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence 2 334568999999999887 4689999999999999999999999987 345555555554432 2223355678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||.+||. +|.+|||+.|+|+||||+...
T Consensus 250 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 99999999 899999999999999997543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=382.05 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=202.8
Q ss_pred CcccccccCcEEEEEEEec---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+. .+|..||+|+++.............+.+|+.+|+.++||||+++++++... ..+|+
T Consensus 24 ~lG~G~~g---~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~l 98 (327)
T 3a62_A 24 VLGKGGYG---KVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG--GKLYL 98 (327)
T ss_dssp EEEEETTE---EEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--SCEEE
T ss_pred EEEeCCCE---EEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--CEEEE
Confidence 37888887 78888875 689999999998765433445566788999999999999999999998765 45899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-- 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~-- 155 (639)
||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCcccccccCC
Confidence 9999999999999998889999999999999999999999999 99999999999998 558999999999875432
Q ss_pred CCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 156 PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+ .+....+..+..+.. .++...++++++||
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 252 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLTQEARDLL 252 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHH
T ss_pred ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHH
Confidence 2344568999999999876 4589999999999999999999999987 456666666666533 24456688999999
Q ss_pred HHhcC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 235 EKCLV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 235 ~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
.+||. +|.+|| ++.|+|+||||+...+..
T Consensus 253 ~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~ 287 (327)
T 3a62_A 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287 (327)
T ss_dssp HHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred HHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence 99999 899999 899999999998766543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=400.68 Aligned_cols=253 Identities=19% Similarity=0.331 Sum_probs=212.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|+++...... ....+.+.+|+.+|+.++|||||+++++|.+. ..+|+|||
T Consensus 76 ~LG~G~fG---~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lV~E 149 (410)
T 3v8s_A 76 VIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMVME 149 (410)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEEcCCCE---EEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEe
Confidence 37888888 89999999999999999998643211 12234578999999999999999999998765 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
||.||+|.+++++ ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+|+......
T Consensus 150 ~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 150 YMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp CCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSEEE
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeeccCCccc
Confidence 9999999999986 46999999999999999999999999 99999999999997 55899999999997665432
Q ss_pred CccccCCCCcCCccccccc-----CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHH
Q 006593 158 ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQI 230 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~~-----ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l 230 (639)
..+.+||+.|+|||++... |+.++|||||||++|||++|..||.+ .+...++..+..+.. ........++++
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccccHHH
Confidence 3467899999999988632 78999999999999999999999987 567777777765422 111223568999
Q ss_pred HHHHHHhcC-CCCC--CCCHHHHhcCcccccccCCCC
Q 006593 231 KGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 231 ~~LI~kcL~-dP~~--RpSa~ELL~Hpff~~~~~~~~ 264 (639)
++||.+||. +|.+ ||+++|+++||||+...|...
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 999999999 6777 999999999999998877643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=393.78 Aligned_cols=253 Identities=21% Similarity=0.395 Sum_probs=216.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|++....... ....+.+.+|+.+|+.++|||||+++++|.+. ..+|+|||
T Consensus 22 ~LG~G~fG---~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~lv~e 95 (384)
T 4fr4_A 22 AIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--EDMFMVVD 95 (384)
T ss_dssp EEECCTTC---CEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEEEEe
Confidence 47888888 79999999999999999998654322 24567789999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-CCCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~-~~~~ 159 (639)
|+.||+|.+++++.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..+.. ....
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeeeccCCCcee
Confidence 9999999999999889999999999999999999999999 99999999999997 558999999999987643 3445
Q ss_pred cccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCC--CCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 160 SVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~--~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
..+||+.|+|||++. ..|+.++|||||||++|+|++|..||... .....++..+..... .++...++.+++|
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~p~~~s~~~~~l 250 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--TYPSAWSQEMVSL 250 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--CCCTTSCHHHHHH
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--CCCCcCCHHHHHH
Confidence 678999999999885 24899999999999999999999999742 334555555555432 3455678999999
Q ss_pred HHHhcC-CCCCCCC-HHHHhcCcccccccCCCC
Q 006593 234 IEKCLV-PASERLS-AKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 234 I~kcL~-dP~~RpS-a~ELL~Hpff~~~~~~~~ 264 (639)
|.+||. +|.+||+ +.++++||||+..+|...
T Consensus 251 i~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp HHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred HHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence 999999 8999998 999999999998877543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=382.26 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=207.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ..+|+||||
T Consensus 15 lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~ 86 (323)
T 3tki_A 15 LGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFLEY 86 (323)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCCCE---EEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeEEEEEEc
Confidence 6777777 899999999999999999976543 23346688999999999999999999988654 568999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----C
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~----~ 157 (639)
|.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++..+... .
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECC
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceeccCCcccc
Confidence 999999999988888999999999999999999999999 99999999999998 5579999999999765322 2
Q ss_pred CccccCCCCcCCcccccc-c-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
....+||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........+................++.+++||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence 345689999999998864 3 47889999999999999999999987555545555555544443444567889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||. +|.+|||+.|+|+||||+...
T Consensus 244 ~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 244 KILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHccCChhhCcCHHHHhhChhhcccc
Confidence 9999 899999999999999998543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=380.92 Aligned_cols=245 Identities=20% Similarity=0.325 Sum_probs=210.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|.+.... .....+.+|+.+|+.++||||+++++++.+. ..+++||||
T Consensus 13 lG~G~~g---~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e~ 82 (321)
T 1tki_A 13 LGRGEFG---IVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--EELVMIFEF 82 (321)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEEECC
T ss_pred EecCCCe---EEEEEEECCCCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC--CEEEEEEEe
Confidence 6777777 89999999999999999987442 4556789999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC-CCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~-~g~VKL~DFGlA~~l~~~-~~ 158 (639)
|.||+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++...... ..
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 99999999997654 7999999999999999999999999 9999999999999742 579999999999776533 23
Q ss_pred ccccCCCCcCCccccccc-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC--cccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s~~l~~LI~ 235 (639)
....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+ .+..+++..+..+.... ......++++++||.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence 456799999999988754 79999999999999999999999987 45666777776654432 223456789999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+||. +|.+|||+.|+|+||||+..
T Consensus 240 ~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 240 RLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHcCCChhHCcCHHHHhcChhhccC
Confidence 9999 89999999999999999854
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=398.90 Aligned_cols=251 Identities=29% Similarity=0.454 Sum_probs=216.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|++...... ......+.+|+.+|++|+||||+++++++.+. ..+|+|||
T Consensus 29 ~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 101 (486)
T 3mwu_A 29 MLGKGSFG---EVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGE 101 (486)
T ss_dssp EEECCSSS---EEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeecCCE---EEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC--CEEEEEEE
Confidence 37888888 8999999999999999999765432 23457789999999999999999999988654 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~~~-~ 157 (639)
||.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++...... .
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 9999999999988889999999999999999999999999 999999999999953 3468999999999866533 3
Q ss_pred CccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--cCCCChHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKGFIE 235 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~s~~l~~LI~ 235 (639)
....+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+ .+..++...+..+..+... ....++++++||.
T Consensus 180 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 258 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258 (486)
T ss_dssp --CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHH
T ss_pred cCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHH
Confidence 345689999999999998999999999999999999999999987 5667777777776554332 3456889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||. +|.+|||+.|+|+||||+....
T Consensus 259 ~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 259 KMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 9999 8999999999999999986544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=372.16 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=202.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|..||+|++.... ....+.+.+|+.+|+++ +||||+++++++.+. ..+++||
T Consensus 20 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~lv~ 90 (316)
T 2ac3_A 20 VLGEGAHA---RVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFYLVF 90 (316)
T ss_dssp CCCCCSSE---EEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred eecCCceE---EEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEEEE
Confidence 36777777 89999999999999999997653 24457789999999995 799999999998775 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC--CcEEEeecchhhhccCC-
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~--g~VKL~DFGlA~~l~~~- 156 (639)
||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+. +.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 99999999999998889999999999999999999999999 99999999999997432 23999999998654321
Q ss_pred --------CCccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCC--------------HHH
Q 006593 157 --------TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKN--------------PAQ 208 (639)
Q Consensus 157 --------~~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--------------~~~ 208 (639)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+... ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 123456999999999885 3489999999999999999999999976432 234
Q ss_pred HHHHHHcCCCCCc--ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 209 IFKKVTSGIKPAS--LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 209 i~~~i~~g~~p~~--l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
++..+..+..... .....++.+++||.+||. ||.+|||+.|+|+||||+...+
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 5566665543221 223467899999999999 9999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=367.34 Aligned_cols=246 Identities=23% Similarity=0.384 Sum_probs=204.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|.+..... ....+.+.+|+++|++++||||+++++++.+. ..+++||||
T Consensus 30 lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 101 (285)
T 3is5_A 30 LGSGAFG---DVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY--HNMYIVMET 101 (285)
T ss_dssp EEECSSC---EEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred eccCCCe---EEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecC--CeEEEEEEe
Confidence 7888888 899999999999999999987642 33467789999999999999999999998654 468999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhccC
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~~ 155 (639)
+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++.....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999854 367999999999999999999999999 999999999999953 347899999999976543
Q ss_pred C-CCccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHHHHH
Q 006593 156 P-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIKGF 233 (639)
Q Consensus 156 ~-~~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l~~L 233 (639)
. ......||+.|+|||++...++.++||||||+++|+|++|..||.+ .+.......+...... .......++++++|
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258 (285)
T ss_dssp -------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred cccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence 2 3345679999999999988899999999999999999999999987 4455555555443332 22223467899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
|.+||. +|.+|||+.|+|+||||+.
T Consensus 259 i~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 259 LKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999 8999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=399.17 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=219.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|++....... ....+.+.+|+.+|++|+||||++++++|.+. ..+++|||
T Consensus 33 ~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 106 (484)
T 3nyv_A 33 VLGKGSFG---EVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--GYFYLVGE 106 (484)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEecCCCE---EEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEEEEe
Confidence 37888887 89999999999999999998765432 34567899999999999999999999998664 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe--CCCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~--~~~g~VKL~DFGlA~~l~~~-~ 157 (639)
||.+|+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++ ...+.+||+|||++...... .
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999999999999999999999999999999999999 99999999999995 24578999999999876543 3
Q ss_pred CccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--cCCCChHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVNDPQIKGFIE 235 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~s~~l~~LI~ 235 (639)
....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+..++...+..+...... ....++++++||.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 263 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263 (484)
T ss_dssp HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHH
T ss_pred cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHH
Confidence 345689999999999988999999999999999999999999987 5677777888777554332 3456889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||. +|.+|||+.|+|+||||+....
T Consensus 264 ~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 264 KMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHCCCChhHCcCHHHHhhChhhccccc
Confidence 9999 8999999999999999986543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=398.40 Aligned_cols=251 Identities=21% Similarity=0.377 Sum_probs=206.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|+++.... ........+.+|+.+|+.++||||++++++|...+ .+++|||
T Consensus 155 ~lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~lv~e 228 (446)
T 4ejn_A 155 LLGKGTFG---KVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD--RLCFVME 228 (446)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEETT--EEEEEEC
T ss_pred EEeeCcCE---EEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC--EEEEEEe
Confidence 37788887 899999999999999999986532 22345567889999999999999999999987764 5999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~ 157 (639)
|+.+|+|.+++.+.+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+|.+||+|||+|+.... ..
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceeccCCCcc
Confidence 99999999999988899999999999999999999998 88 99999999999998 457999999999975432 23
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+...++..+..... .++...++++++||.+
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 382 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEAKSLLSG 382 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHH
T ss_pred cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHH
Confidence 45678999999999886 4699999999999999999999999987 456666666665433 2455678999999999
Q ss_pred hcC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 237 CLV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 237 cL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
||. ||.+|| +++|+|+||||+...+..
T Consensus 383 ~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 383 LLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 999 899999 999999999999776644
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=395.72 Aligned_cols=254 Identities=19% Similarity=0.335 Sum_probs=212.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.++.+|+.||+|+++..... .....+.+..|..+|..++||||++++++|.+. ..+|+|||
T Consensus 68 ~lG~G~fG---~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~lVmE 141 (412)
T 2vd5_A 68 VIGRGAFS---EVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE--NYLYLVME 141 (412)
T ss_dssp EEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEEEEEc
Confidence 37888888 8999999999999999999864321 123345588999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|+.||+|.+++.+. ..+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++......
T Consensus 142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheeccCCCcc
Confidence 99999999999875 47999999999999999999999999 99999999999998 55899999999997665332
Q ss_pred -CccccCCCCcCCccccc--------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC---CCCcccCC
Q 006593 158 -ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKV 225 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~--------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~---~p~~l~~~ 225 (639)
....+||+.|+|||++. ..|+.++|||||||++|||++|..||.+ .+..+++..+.... ........
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 297 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEG 297 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC----C
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCCccccC
Confidence 23468999999999886 3589999999999999999999999987 55666776665432 22223356
Q ss_pred CChHHHHHHHHhcCCCCCC---CCHHHHhcCcccccccCCCC
Q 006593 226 NDPQIKGFIEKCLVPASER---LSAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 226 ~s~~l~~LI~kcL~dP~~R---pSa~ELL~Hpff~~~~~~~~ 264 (639)
.++++++||.+||.+|.+| |+++|+++||||+..+|...
T Consensus 298 ~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 298 VPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp CCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred CCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 7899999999999988877 69999999999998888754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=363.31 Aligned_cols=248 Identities=21% Similarity=0.354 Sum_probs=213.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..++..||+|.+..... ...+.+.+|+++|++++||||+++++++.+. ..+++||||
T Consensus 17 lg~G~~g---~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 87 (277)
T 3f3z_A 17 IGRGSWG---EVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN--TDIYLVMEL 87 (277)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EeecCCE---EEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeEEEEEec
Confidence 6777777 899999999999999999986542 3457789999999999999999999998654 568999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe--CCCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~--~~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||++. ...+.+||+|||++...... ..
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 999999999998889999999999999999999999999 99999999999992 25579999999999765433 34
Q ss_pred ccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--ccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~~~~s~~l~~LI~k 236 (639)
....||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+..+....+..+..... .....++.+++||.+
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244 (277)
T ss_dssp CCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred hccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence 45689999999999988899999999999999999999999987 455666666666543322 223567899999999
Q ss_pred hcC-CCCCCCCHHHHhcCcccccccC
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
||. +|.+|||+.++|+||||+....
T Consensus 245 ~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 245 LLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HccCChhhCcCHHHHhcCHHHhcccc
Confidence 999 8999999999999999976443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=389.57 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=209.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL-LKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.++.+|+.||+|+++...... ......+..|..+ ++.++||||++++++|.+. ..+|+||
T Consensus 45 ~lG~G~fg---~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--~~~~lv~ 118 (373)
T 2r5t_A 45 VIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA--DKLYFVL 118 (373)
T ss_dssp EEECCTTC---EEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEeeCCCe---EEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--CEEEEEE
Confidence 47888888 89999999999999999998776533 3445567778776 5778999999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++... ...
T Consensus 119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCCCCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCccccccccCCCc
Confidence 99999999999999889999999999999999999999999 99999999999998 55899999999998643 234
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..+..+.. .++...++.+++||.+
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~ 272 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPL--QLKPNITNSARHLLEG 272 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSCC--CCCSSSCHHHHHHHHH
T ss_pred cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhccc--CCCCCCCHHHHHHHHH
Confidence 456799999999998864 589999999999999999999999987 567777877776533 3455678999999999
Q ss_pred hcC-CCCCCCCH----HHHhcCcccccccCCCC
Q 006593 237 CLV-PASERLSA----KDLLKDPFLQVENQKEP 264 (639)
Q Consensus 237 cL~-dP~~RpSa----~ELL~Hpff~~~~~~~~ 264 (639)
||. +|.+||++ .++++||||+..+|...
T Consensus 273 lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l 305 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305 (373)
T ss_dssp HTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred HcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence 999 89999986 79999999998777543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=398.76 Aligned_cols=254 Identities=17% Similarity=0.328 Sum_probs=212.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|+.||+|+++...... ......+..|+.+|+.++||||++++++|.+. ..+|+|||
T Consensus 81 ~LG~G~fG---~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--~~~~lV~E 154 (437)
T 4aw2_A 81 VIGRGAFG---EVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQDD--NNLYLVMD 154 (437)
T ss_dssp EEEECSSE---EEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEEeCCCE---EEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--CEEEEEEe
Confidence 37888888 89999999999999999998643211 12234478999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
||.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|+......
T Consensus 155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhcccCCCc
Confidence 9999999999987 478999999999999999999999999 99999999999998 55899999999997654332
Q ss_pred -CccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC---CCCcccCCCC
Q 006593 158 -ARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI---KPASLAKVND 227 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~---~p~~l~~~~s 227 (639)
....+||+.|||||++. ..|+.++|||||||++|||++|..||.+ .+..+.+..+.... ..+......+
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s 310 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVS 310 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCcccccCC
Confidence 23468999999999875 3589999999999999999999999987 56667777765432 1122223468
Q ss_pred hHHHHHHHHhcC-CCCC--CCCHHHHhcCcccccccCCCC
Q 006593 228 PQIKGFIEKCLV-PASE--RLSAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~--RpSa~ELL~Hpff~~~~~~~~ 264 (639)
+++++||.+||. +|.+ |++++|+++||||+..+|...
T Consensus 311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred HHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 899999999998 6666 999999999999998888754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=397.13 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=211.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|+++..... ......+.+|+.+|+.++||||++++++|.+. ..+|+||||
T Consensus 45 lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~ 117 (494)
T 3lij_A 45 LGSGAYG---EVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--RNYYLVMEC 117 (494)
T ss_dssp EECC------EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCCCE---EEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEEEec
Confidence 7888888 8999999999999999999876532 23356789999999999999999999998665 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~~~-~~ 158 (639)
|.+|+|.+++.....+++..++.|++||+.||.|||++| |+||||||+|||++.. .+.+||+|||++...... ..
T Consensus 118 ~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 999999999998889999999999999999999999999 9999999999999642 456999999999766543 33
Q ss_pred ccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC--cccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s~~l~~LI~k 236 (639)
...+||+.|+|||++...|+.++|||||||++|+|++|..||.+ .+..++...+..+.... ......++.+++||.+
T Consensus 196 ~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 274 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274 (494)
T ss_dssp CCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred cccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence 45689999999999988899999999999999999999999987 56677777777765433 2334568899999999
Q ss_pred hcC-CCCCCCCHHHHhcCcccccc
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
||. +|.+|||+.|+|+||||+..
T Consensus 275 ~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 275 MLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HCCCChhhCccHHHHhcCcccccC
Confidence 999 89999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=376.33 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=198.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|+++.... .....+.+.+|+.+|++++||||+++++++.+. ..+++||||
T Consensus 42 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 114 (329)
T 3gbz_A 42 LGEGTYG---EVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--HRLHLIFEY 114 (329)
T ss_dssp EEECSSS---EEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred EEecCCe---EEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC--CEEEEEEec
Confidence 7888887 899999999999999999976542 234456778999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC----CCCcEEEeecchhhhccCC-
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~----~~g~VKL~DFGlA~~l~~~- 156 (639)
+. |+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++......
T Consensus 115 ~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 115 AE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp CS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred CC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 97 599999999999999999999999999999999999 999999999999952 3356999999999876533
Q ss_pred -CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCCC-c----------
Q 006593 157 -TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPA-S---------- 221 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~-~---------- 221 (639)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+...+.. +..+. .
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 2344578999999998864 4899999999999999999999999875444443333221 11110 0
Q ss_pred ---------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 222 ---------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 222 ---------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+....++++++||.+||. ||.+|||+.|+|+||||+...+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 111256889999999999 99999999999999999876654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=381.96 Aligned_cols=251 Identities=20% Similarity=0.377 Sum_probs=204.3
Q ss_pred Ccccc--cccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTG--LYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~G--GfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
+||+| ||| +||+|.+..+|..||+|+++.... .....+.+.+|+.+|+.++|||||+++++|.+.+ .+|+|
T Consensus 32 ~lG~G~~~~g---~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv 104 (389)
T 3gni_B 32 VIGKGFEDLM---TVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVV 104 (389)
T ss_dssp EEEEETTTTE---EEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEE
T ss_pred cccCCcCCce---EEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC--EEEEE
Confidence 36777 555 899999999999999999987653 4566788999999999999999999999998764 69999
Q ss_pred EecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-
Q 006593 79 TELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 155 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~- 155 (639)
||||.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccccceeeccc
Confidence 9999999999999876 67999999999999999999999999 99999999999997 557999999998854321
Q ss_pred --------CCCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC-------
Q 006593 156 --------PTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI------- 217 (639)
Q Consensus 156 --------~~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~------- 217 (639)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+...+....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 12233579999999998865 589999999999999999999999987544443332221110
Q ss_pred ------------------------------------CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 218 ------------------------------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 218 ------------------------------------~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.....+...++++++||.+||+ ||.+|||+.|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 0111334567889999999999 999999999999999998654
Q ss_pred C
Q 006593 261 Q 261 (639)
Q Consensus 261 ~ 261 (639)
.
T Consensus 342 ~ 342 (389)
T 3gni_B 342 R 342 (389)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=380.60 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=209.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~-~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.+..+|..||+|++........ ....+.+.+|+.+|+.++||||++++++|.+. ..+|+|||
T Consensus 32 lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~e 106 (351)
T 3c0i_A 32 IGKGPFS---VVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD--GMLYMVFE 106 (351)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred EeeCCCE---EEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CEEEEEEe
Confidence 7788877 899999999999999999986543221 12457799999999999999999999998775 46999999
Q ss_pred cCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhcc
Q 006593 81 LFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 81 y~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~ 154 (639)
||.||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++....
T Consensus 107 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp CCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 99999999887643 35899999999999999999999999 9999999999999743 3459999999997665
Q ss_pred CCC--CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC--cccCCCChH
Q 006593 155 QPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQ 229 (639)
Q Consensus 155 ~~~--~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s~~ 229 (639)
... ....+||+.|+|||++.. .|+.++|||||||++|+|++|..||.+ ....++..+..+.... ......+++
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~ 262 (351)
T 3c0i_A 185 ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSHISES 262 (351)
T ss_dssp TTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred CCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCccccccCCHH
Confidence 432 345689999999998864 589999999999999999999999986 3556666666654332 222456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 263 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 263 AKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 9999999999 999999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=365.71 Aligned_cols=249 Identities=22% Similarity=0.387 Sum_probs=209.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..++..||+|++...... .......+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 17 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 90 (279)
T 3fdn_A 17 LGKGKFG---NVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYLILEY 90 (279)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred EecCCCe---EEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEecC--CEEEEEEec
Confidence 6777777 8999999999999999998764421 123356789999999999999999999998665 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 161 (639)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...........
T Consensus 91 ~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~ 167 (279)
T 3fdn_A 91 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTDL 167 (279)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC--------
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCCccccccc
Confidence 999999999998889999999999999999999999999 99999999999997 557999999999866555555567
Q ss_pred cCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-
Q 006593 162 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 239 (639)
Q Consensus 162 ~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~- 239 (639)
.||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..... .++...++.+++||.+||.
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~ 244 (279)
T 3fdn_A 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKH 244 (279)
T ss_dssp CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHCCS
T ss_pred CCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHhcc
Confidence 89999999998865 578999999999999999999999986 456666666665433 2455678899999999999
Q ss_pred CCCCCCCHHHHhcCcccccccCC
Q 006593 240 PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 240 dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+|.+|||+.|+|+||||+.....
T Consensus 245 ~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 245 NPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp SGGGSCCHHHHHHCHHHHHHCSS
T ss_pred ChhhCCCHHHHhhCccccCCccC
Confidence 89999999999999999876544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=360.55 Aligned_cols=250 Identities=23% Similarity=0.417 Sum_probs=213.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|++..... .....+.+.+|+.++++++||||+++++++... ...++||||
T Consensus 14 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~ 86 (284)
T 3kk8_A 14 LGKGAFS---VVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEE--SFHYLVFDL 86 (284)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred hcCcCCe---EEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC--CEEEEEEec
Confidence 6777777 899999999999999999987653 456678899999999999999999999988654 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++.+ .+.+||+|||++...... ..
T Consensus 87 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 87 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 999999999998889999999999999999999999999 9999999999999633 345999999999766533 23
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~LI~ 235 (639)
....||+.|+|||++.. .++.++||||||+++|+|++|..||.+ .+.......+..+... .......++++++||.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence 45689999999998865 589999999999999999999999987 4566666666665432 2233456889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||. +|.+|||+.|+|+||||+....
T Consensus 244 ~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 244 SMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHcccChhhCCCHHHHhcCccccCChh
Confidence 9999 8999999999999999976543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.58 Aligned_cols=244 Identities=30% Similarity=0.524 Sum_probs=209.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|+.||+|++.... ....+.+.+|+.+|++++||||++++++|.... .+++||||
T Consensus 53 lg~G~~g---~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 123 (321)
T 2c30_A 53 IGEGSTG---IVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE--ELWVLMEF 123 (321)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEECC
T ss_pred eccCCCe---EEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEEec
Confidence 6888887 89999999999999999998654 234567899999999999999999999988764 58999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+|+|.+++.+ ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ...
T Consensus 124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBC
T ss_pred CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCccccc
Confidence 999999999875 56999999999999999999999999 99999999999997 4579999999998766432 334
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC-cccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~~~s~~l~~LI~kc 237 (639)
...||+.|+|||++.. .++.++||||||+++|+|++|..||.. .+..+....+.....+. ......++.+++||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 5689999999998864 589999999999999999999999986 45666666666554432 23345678999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|. +|.+|||+.|+|+||||...
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ccCChhhCcCHHHHhcChhhccC
Confidence 99 89999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=382.83 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=197.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|+|| +||+|.+..+|..||+|++.... ......+++.+|+.+|+.+. ||||+++++++...+...+|+||
T Consensus 16 ~lG~G~~g---~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 16 KLGKGAYG---IVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp C----------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred EeeeCCCe---EEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 47888888 79999999999999999986442 34567788999999999997 99999999999877767899999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC----
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---- 155 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~---- 155 (639)
|||. |+|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+....
T Consensus 91 e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 91 DYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp ECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESSSCCCC
T ss_pred cccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCcccccccccccc
Confidence 9997 699999986 57999999999999999999999999 99999999999998 457999999999975432
Q ss_pred -------------------CCCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH
Q 006593 156 -------------------PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT 214 (639)
Q Consensus 156 -------------------~~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~ 214 (639)
......+||+.|+|||++.+ .|+.++|||||||++|||++|.+||.+.....++ ..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~ 244 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL-ERII 244 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence 11234689999999998854 5899999999999999999999999875443333 3332
Q ss_pred c--CCCCC-------------------------------------------cccCCCChHHHHHHHHhcC-CCCCCCCHH
Q 006593 215 S--GIKPA-------------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAK 248 (639)
Q Consensus 215 ~--g~~p~-------------------------------------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ 248 (639)
. +.++. ......++++++||.+||. ||.+|||++
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 1 10000 0011457899999999999 999999999
Q ss_pred HHhcCcccccc
Q 006593 249 DLLKDPFLQVE 259 (639)
Q Consensus 249 ELL~Hpff~~~ 259 (639)
|+|+||||+..
T Consensus 325 e~l~Hp~~~~~ 335 (388)
T 3oz6_A 325 DALKHPFVSIF 335 (388)
T ss_dssp HHTTSTTTTTT
T ss_pred HHhCCHHHHHh
Confidence 99999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.85 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=208.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.++.+|+.||+|++..... ...+|+++|.++ +||||++++++|.+. ..+|+|||
T Consensus 30 lG~G~~g---~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E 96 (342)
T 2qr7_A 30 IGVGSYS---VCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDG--KYVYVVTE 96 (342)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEEC
T ss_pred EeeCCCE---EEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcC--CEEEEEEe
Confidence 7888887 899999999999999999986542 135688888888 799999999998654 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC---CcEEEeecchhhhccCC-
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~---g~VKL~DFGlA~~l~~~- 156 (639)
||.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||+.... +.+||+|||++......
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999999999899999999999999999999999999 99999999999995433 35999999999766432
Q ss_pred -CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC--CCHHHHHHHHHcCCCCC--cccCCCChHH
Q 006593 157 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIKPA--SLAKVNDPQI 230 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~--~~~~~i~~~i~~g~~p~--~l~~~~s~~l 230 (639)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||... ....+++..+..+.... ..+...++++
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHH
Confidence 3456789999999998875 4899999999999999999999999753 45677888887765432 2335568899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
++||.+||. ||.+||++.++|+||||...
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 999999999 99999999999999999653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=371.06 Aligned_cols=245 Identities=25% Similarity=0.402 Sum_probs=201.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC--------
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK-------- 72 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~-------- 72 (639)
.||+|+|| .||+|.+..+|..||+|+++... .....+.+.+|+.+|++|+||||++++++|.+...
T Consensus 13 ~lG~G~~g---~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 13 CMGRGGFG---VVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp EEECC-CS---EEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred EecCCCCe---EEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 37888888 89999999999999999998654 34566789999999999999999999999876542
Q ss_pred -----------------------------------------------ceEEEEEecCCCCCHHHHHHhCCC---CCHHHH
Q 006593 73 -----------------------------------------------KTVNMITELFTSGNLRQYRKKHKN---VDIKVI 102 (639)
Q Consensus 73 -----------------------------------------------~~l~lV~Ey~~gGsL~d~lkk~~~---l~e~~i 102 (639)
.++++|||||.+|+|.+++++... .++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 248999999999999999987653 566678
Q ss_pred HHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--------------CCccccCCCCcC
Q 006593 103 KNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--------------TARSVIGTPEFM 168 (639)
Q Consensus 103 ~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--------------~~~~~~GTp~ym 168 (639)
+.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... .....+||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 999999999999999999 99999999999997 5579999999999766432 123457999999
Q ss_pred Ccccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCC
Q 006593 169 APELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLS 246 (639)
Q Consensus 169 APE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpS 246 (639)
|||++.+ .|+.++|||||||++|+|++|..|+.. .......+.....+.. ....++.+++||.+||. +|.+|||
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLL-FTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcc-cccCChhHHHHHHHHccCCCCcCCC
Confidence 9998864 689999999999999999998766532 3344445555444332 23345788999999999 8999999
Q ss_pred HHHHhcCccccc
Q 006593 247 AKDLLKDPFLQV 258 (639)
Q Consensus 247 a~ELL~Hpff~~ 258 (639)
+.|+|+||||+.
T Consensus 320 ~~~~l~~~~f~~ 331 (332)
T 3qd2_B 320 ATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHSTTCCC
T ss_pred HHHHhhchhhhc
Confidence 999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=373.62 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=193.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|+.||+|++... ....+.+|+.+|+.+. ||||+++++++.+. ..+|+||
T Consensus 18 ~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~ 85 (325)
T 3kn6_A 18 PLGEGSFS---ICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVM 85 (325)
T ss_dssp CSEEETTE---EEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred ccccCCCe---EEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEE
Confidence 47888888 8999999999999999998743 3456789999999996 99999999998755 5689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC--CcEEEeecchhhhccCC-
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~--g~VKL~DFGlA~~l~~~- 156 (639)
||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.++ ..+||+|||++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 99999999999999999999999999999999999999999 99999999999997432 27999999999755432
Q ss_pred -CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC------CCHHHHHHHHHcCCCCCc--ccCCC
Q 006593 157 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC------KNPAQIFKKVTSGIKPAS--LAKVN 226 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~------~~~~~i~~~i~~g~~p~~--l~~~~ 226 (639)
.....+||+.|+|||++.. .|+.++|||||||++|+|++|..||... ....++...+..+..+.. .....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 2345688999999998864 5899999999999999999999999753 234566777776654322 22356
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 8899999999999 899999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=365.24 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=197.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+ .+|..||+|++..... .....+.+.+|+.+|++++||||+++++++... ..+++||||
T Consensus 10 lg~G~~g---~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 81 (288)
T 1ob3_A 10 IGEGTYG---VVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLVLVFEH 81 (288)
T ss_dssp EEEETTE---EEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEEEEEEC
T ss_pred cccCCCE---EEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEEEEEEe
Confidence 6777777 8999999 6799999999976542 223346788999999999999999999998765 458999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+ +|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccCcccccc
Confidence 975 999999864 67999999999999999999999999 99999999999997 5579999999999876532 23
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCC-C---------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK-P--------------- 219 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~-p--------------- 219 (639)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.. +.. .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 34578999999998853 4899999999999999999999999875443333322211 100 0
Q ss_pred ---------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 220 ---------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 220 ---------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.......++++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01123457889999999999 99999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=378.62 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=197.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+++.||+|+++... ..+.+.+|+.+|++|+||||+++++++... ..+++||||
T Consensus 61 lG~G~~g---~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 129 (349)
T 2w4o_A 61 LGRGATS---IVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP--TEISLVLEL 129 (349)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred EeeCCCE---EEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecC--CeEEEEEEe
Confidence 6777777 89999999999999999988542 335678999999999999999999998665 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++...... ..
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 207 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence 999999999998888999999999999999999999999 999999999999963 3579999999999766433 23
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~LI~ 235 (639)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......++..+..+... .......++++++||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence 45689999999998875 58999999999999999999999998766666677777665432 2233456789999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||. ||.+|||+.|+|+||||+....
T Consensus 288 ~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 288 KLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp TTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHccCChhhCcCHHHHhcCcccCCCcc
Confidence 9999 9999999999999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=379.43 Aligned_cols=247 Identities=21% Similarity=0.334 Sum_probs=196.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++... ..+++|||
T Consensus 27 ~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 96 (361)
T 3uc3_A 27 DIGSGNFG---VARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIIME 96 (361)
T ss_dssp EESSSTTS---SEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred EeccCCCE---EEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--CEEEEEEE
Confidence 37888888 799999999999999999976532 225688999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC-CcEEEeecchhhhccC-CCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQ-PTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~-g~VKL~DFGlA~~l~~-~~~ 158 (639)
|+.+|+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+. +.+||+|||+++.... ...
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 9999999999998889999999999999999999999999 99999999999997432 3599999999874432 233
Q ss_pred ccccCCCCcCCcccccc-cCCcc-ccccchhhhhhhhhhccCCCCCCCC---HHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNEL-VDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~k-sDIwSlGiil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
...+||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+... ...+...+.............++++++|
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHH
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHH
Confidence 45689999999998754 45544 8999999999999999999976432 3444555555443333334568899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|.+||. +|.+|||+.|+|+||||...
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999 89999999999999999654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=394.84 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=213.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC---------hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL---------PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~---------~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~ 72 (639)
||+|+|| +||+|.+..+|..||+|++........ ....+.+.+|+.+|++|+||||++++++|.+.
T Consensus 44 lG~G~~g---~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 118 (504)
T 3q5i_A 44 LGSGAYG---EVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK-- 118 (504)
T ss_dssp EEC--CE---EEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred ecccCCe---EEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--
Confidence 6777777 899999999999999999987653211 13457799999999999999999999998654
Q ss_pred ceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC--CcEEEeecchh
Q 006593 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH--GEVKIGDLGLA 150 (639)
Q Consensus 73 ~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~--g~VKL~DFGlA 150 (639)
..+|+|||||.||+|.+++...+.+++..++.+++||+.||.|||++| |+||||||+|||++.+. ..+||+|||++
T Consensus 119 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 196 (504)
T 3q5i_A 119 KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLS 196 (504)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEECCCC
Confidence 569999999999999999998889999999999999999999999999 99999999999997443 26999999999
Q ss_pred hhccCC-CCccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--ccCCCC
Q 006593 151 IAMQQP-TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKVND 227 (639)
Q Consensus 151 ~~l~~~-~~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~~~~s 227 (639)
...... .....+||+.|+|||++...|+.++|||||||++|+|++|..||.+ .+..++...+..+..... .....+
T Consensus 197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (504)
T 3q5i_A 197 SFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNIS 275 (504)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred EEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCccccCCCC
Confidence 766543 3456689999999999988899999999999999999999999987 567778888877755432 234568
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 228 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 276 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 899999999999 999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=373.96 Aligned_cols=245 Identities=22% Similarity=0.401 Sum_probs=207.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|.+ .++..||+|++..... .....+.+.+|+.+|++++| |||+++++++... ..+++||
T Consensus 17 lG~G~~g---~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~~lv~ 88 (343)
T 3dbq_A 17 IGSGGSS---KVFQVLN-EKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVM 88 (343)
T ss_dssp ESCCSSE---EEEEEEC-TTSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred EecCCCe---EEEEEEe-CCCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC--CEEEEEE
Confidence 7778877 8999998 4689999999987653 45567889999999999976 9999999988765 5699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
| +.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ +|.+||+|||++.......
T Consensus 89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccccccCccccc
Confidence 9 568899999999999999999999999999999999999 99999999999997 3689999999997664322
Q ss_pred --CccccCCCCcCCccccc------------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 006593 158 --ARSVIGTPEFMAPELYE------------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 223 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~------------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 223 (639)
....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+..+.......+........++
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 23568999999999874 4588999999999999999999999987666666666666665666677
Q ss_pred CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 224 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 224 ~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
...++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 7778899999999999 89999999999999999854
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=370.69 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=196.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. +|..||+|+++.... .....+.+.+|+.+|++++||||+++++++.+. ..+++||||
T Consensus 29 lG~G~~g---~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 100 (311)
T 3niz_A 29 VGEGTYG---VVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--RCLTLVFEF 100 (311)
T ss_dssp EEECSSC---EEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS--SCEEEEEEC
T ss_pred ccCCCCe---EEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC--CEEEEEEcC
Confidence 6777777 89999995 599999999976542 334557789999999999999999999988654 469999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... ..
T Consensus 101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEETTSCCC--
T ss_pred CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCceecCCCcccc
Confidence 985 888887765 45999999999999999999999999 99999999999998 4579999999999766432 23
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHH--HcCCCCCc-------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV--TSGIKPAS------------- 221 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i--~~g~~p~~------------- 221 (639)
....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+.... .....+..
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 34578999999998754 58999999999999999999999998754443332221 11111111
Q ss_pred ------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 222 ------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 222 ------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.....++++++||.+||. ||.+|||+.|+|+||||+..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 112346789999999999 999999999999999998644
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=371.46 Aligned_cols=248 Identities=28% Similarity=0.503 Sum_probs=198.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|+++.... ....+.+.+|+.+|++++||||+++++++... ..+++|||
T Consensus 12 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e 83 (317)
T 2pmi_A 12 KLGNGTYA---TVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIHTE--NKLTLVFE 83 (317)
T ss_dssp -------C---EEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT--TEEEEEEE
T ss_pred EECCCCCE---EEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC--CeEEEEEE
Confidence 37778777 899999999999999999986542 23346688999999999999999999988654 56999999
Q ss_pred cCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 81 LFTSGNLRQYRKKH------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 81 y~~gGsL~d~lkk~------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
|+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCccceecC
Confidence 998 5999998754 35899999999999999999999999 99999999999998 45799999999997654
Q ss_pred CC--CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCCC---------
Q 006593 155 QP--TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP--------- 219 (639)
Q Consensus 155 ~~--~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p--------- 219 (639)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. .......+.. +..+
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-DEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhHhhhhhh
Confidence 32 2345689999999998864 58999999999999999999999998743 4443333321 1110
Q ss_pred ---------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 220 ---------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 220 ---------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.......++++++||.+||. ||.+|||+.|+|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 01112457789999999999 9999999999999999986543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=382.81 Aligned_cols=246 Identities=22% Similarity=0.404 Sum_probs=210.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~--HpNIVkl~~~~~~~~~~~l~lV 78 (639)
.||+|+|| +||+|.+.. |..||+|++..... .....+.+.+|+.+|++|+ ||||+++++++... ..+|+|
T Consensus 63 ~LG~G~fg---~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~~lv 134 (390)
T 2zmd_A 63 QIGSGGSS---KVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYMV 134 (390)
T ss_dssp EEECCSSE---EEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEE
T ss_pred EEccCCCe---EEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEEEEE
Confidence 37888887 899999865 99999999987653 4566788999999999996 59999999988765 459999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|| +.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ + +.+||+|||++..+...
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-S-SCEEECCCSSSCCC-----
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-C-CeEEEEecCccccccCCCc
Confidence 99 568899999999889999999999999999999999999 99999999999995 3 78999999999766432
Q ss_pred --CCccccCCCCcCCcccccc------------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 157 --TARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~~------------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
.....+||+.|+|||++.. .|+.++|||||||++|+|++|..||....+....+..+..+.....+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 1345689999999998753 58999999999999999999999998766666666677766555566
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+...++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 67778899999999999 99999999999999999854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=377.75 Aligned_cols=249 Identities=25% Similarity=0.462 Sum_probs=209.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|++.... .....+.+.+|+.+|++++||||+++++++... ..+++||||
T Consensus 41 lg~G~~g---~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 112 (360)
T 3eqc_A 41 LGAGNGG---VVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEH 112 (360)
T ss_dssp EEECSSC---EEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--TEEEEEECC
T ss_pred ecCCCCe---EEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--CEEEEEEEC
Confidence 6777777 89999999999999999998653 456678899999999999999999999998775 459999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||+. | |+||||||+|||++ ..|.+||+|||++..........
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 189 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 189 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCcccccccccC
Confidence 99999999999988999999999999999999999995 8 99999999999998 45799999999997665444556
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHH-------------------------------
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ------------------------------- 208 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~------------------------------- 208 (639)
..||+.|+|||++.+ .|+.++|||||||++|+|++|..||... +...
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC-CHHHHHHHHC-------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 789999999998864 5899999999999999999999999753 2222
Q ss_pred -----------HHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 209 -----------IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 209 -----------i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
....+.....+.......++++++||.+||. +|.+|||+.|+|+||||+.....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 2223333333433444567899999999999 99999999999999999876544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=384.74 Aligned_cols=245 Identities=24% Similarity=0.410 Sum_probs=204.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|++...... ......++.+|+.+|+.++||||+++++++... ..+++||||
T Consensus 17 lG~G~~g---~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~E~ 90 (336)
T 3h4j_B 17 LGEGSFG---KVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTP--TDIVMVIEY 90 (336)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--CEEEEEEEC
Confidence 6777777 8999999999999999999754321 122345789999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
+ +|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++...... ....
T Consensus 91 ~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 91 A-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp C-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTTSBTTCC
T ss_pred C-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceeccCCccccc
Confidence 9 7899999988889999999999999999999999999 99999999999998 5579999999999766533 3456
Q ss_pred ccCCCCcCCccccccc-C-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~~-y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
.+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.. ...+++.+..+ ...++...++++++||.+||
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSC--VYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS-STTCBCCCCSS--CCCCCTTSCHHHHHHHHTTS
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHcC--CCCCcccCCHHHHHHHHHHc
Confidence 7899999999998754 4 789999999999999999999997632 22222222222 12345567899999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
. ||.+|||+.|+++||||+..
T Consensus 244 ~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 244 VADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CSSGGGSCCHHHHTTCHHHHTT
T ss_pred CCChhHCcCHHHHHhChhhccC
Confidence 9 99999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=365.98 Aligned_cols=250 Identities=23% Similarity=0.384 Sum_probs=200.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++... ..+++||||
T Consensus 11 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 83 (311)
T 4agu_A 11 IGEGSYG---VVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRLHLVFEY 83 (311)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred EeecCCe---EEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeEEEEEEe
Confidence 6777777 89999999999999999987654 2345567788999999999999999999998765 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++...... ...
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC-------
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccCcccccC
Confidence 999999999998889999999999999999999999999 99999999999997 5579999999999765432 234
Q ss_pred cccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc---CC-----------------
Q 006593 160 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GI----------------- 217 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~---g~----------------- 217 (639)
...||+.|+|||++.+ .++.++||||||+++|+|++|..||.+........ .+.. ..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhcccccccccccccccccccC
Confidence 5679999999998853 58999999999999999999999998754333322 2211 00
Q ss_pred C---CCc------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 218 K---PAS------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 218 ~---p~~------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
. +.. .....++.+.+||.+||. +|.+|||++|+|+||||+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 0 000 012356789999999999 99999999999999999876544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=367.35 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=212.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh--hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP--GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~--~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| .||+|.+..+|..||+|+++........ ...+.+.+|+.+|++++||||+++++++.+. ..+++||
T Consensus 20 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 94 (321)
T 2a2a_A 20 LGSGQFA---IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR--TDVVLIL 94 (321)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred eeecCCE---EEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC--CEEEEEE
Confidence 6777777 8999999999999999999876543221 2467799999999999999999999988655 5699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC---cEEEeecchhhhccCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG---EVKIGDLGLAIAMQQP 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g---~VKL~DFGlA~~l~~~ 156 (639)
||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.. .+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~ 172 (321)
T 2a2a_A 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172 (321)
T ss_dssp CCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccceecCcc
Confidence 99999999999998888999999999999999999999999 999999999999974432 7999999999766543
Q ss_pred -CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHH
Q 006593 157 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKG 232 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~ 232 (639)
......||+.|+|||++. ..++.++||||||+++|+|++|..||.+ .+.......+...... .......++.+++
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (321)
T 2a2a_A 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFDEEFFSHTSELAKD 251 (321)
T ss_dssp CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccccChhhhcccCHHHHH
Confidence 234567999999999886 4589999999999999999999999987 4556666666655332 2233566789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||.+||. +|.+|||+.|+|+||||+...
T Consensus 252 li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 252 FIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 9999999 899999999999999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=358.57 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=210.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..+|..||+|++..... ....+.+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus 14 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 85 (276)
T 2yex_A 14 TLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFLE 85 (276)
T ss_dssp EEEECSSS---EEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred EeecCCCc---EEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC--CEEEEEEE
Confidence 37888888 899999999999999999986542 34567899999999999999999999988765 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
|+.+|+|.+++.....+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCCCcchh
Confidence 9999999999988888999999999999999999999999 99999999999998 5579999999999755322
Q ss_pred CCccccCCCCcCCcccccc-c-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
......||+.|+|||++.. . ++.++||||||+++|+|++|..||.........+..+.............++.+++||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 2345679999999998864 3 4788999999999999999999998755544455555544333333445688999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.+||. +|.+|||+.|+++||||+...
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChh
Confidence 99999 899999999999999997543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=364.71 Aligned_cols=251 Identities=29% Similarity=0.400 Sum_probs=199.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccC-ChhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCCc---e
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDDKKK---T 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~-~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~~~~~~~~---~ 74 (639)
||+|+|| +||+|.+..+|+.||+|+++...... .......+.+|+.+++.+ +||||+++++++...... .
T Consensus 17 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 17 IGVGAYG---TVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp ECCSSSC---CEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EecCCCe---EEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 7888888 79999999999999999998654221 112234566788777776 499999999998775432 5
Q ss_pred EEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 75 VNMITELFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~~--l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+++||||+. |+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~ 169 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARI 169 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEECSCSCTTT
T ss_pred EEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEEeeCccccc
Confidence 889999997 599999988654 999999999999999999999999 99999999999997 557999999999986
Q ss_pred ccCC-CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCCC-Cc------
Q 006593 153 MQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP-AS------ 221 (639)
Q Consensus 153 l~~~-~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p-~~------ 221 (639)
.... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.. .......+.. +..+ ..
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (308)
T 3g33_A 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGKIFDLIGLPPEDDWPRDVS 248 (308)
T ss_dssp STTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSCSSCS
T ss_pred cCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhccchhh
Confidence 6533 334568999999999875 569999999999999999999999998743 4444433322 1111 00
Q ss_pred ----------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 222 ----------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 222 ----------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.....++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 249 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp SCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 112456889999999999 999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=367.51 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=200.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.+..+|..||+|++..... ..........|+..+..+ +||||++++++|.+. ..+++|||
T Consensus 65 LG~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--~~~~lv~e 137 (311)
T 3p1a_A 65 LGHGSYG---EVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTE 137 (311)
T ss_dssp EEEETTE---EEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred eccCCCe---EEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC--CEEEEEEe
Confidence 6777777 899999999999999998765432 334445556666666555 999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CC
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
|+ +|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++...... ..
T Consensus 138 ~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 138 LC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp CC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC-----
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeecccCCCC
Confidence 99 67998888764 46999999999999999999999999 99999999999997 4579999999998766433 23
Q ss_pred ccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 159 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
....||+.|+|||++.+.++.++|||||||++|||++|..|+.. ......+..+..+..++...++++++||.+||
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 289 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYLPPEFTAGLSSELRSVLVMML 289 (311)
T ss_dssp -CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHS
T ss_pred cccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCCCcccccCCCHHHHHHHHHHc
Confidence 44579999999999988999999999999999999999766643 23345566666666667778899999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~ 258 (639)
. +|.+|||+.|+|+||||+.
T Consensus 290 ~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 290 EPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CSSTTTSCCHHHHHTSGGGSC
T ss_pred CCChhhCcCHHHHHhCccccC
Confidence 9 8999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=360.91 Aligned_cols=250 Identities=30% Similarity=0.474 Sum_probs=206.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..+++|||
T Consensus 29 ~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 99 (295)
T 2clq_A 29 VLGKGTYG---IVYAGRDLSNQVRIAIKEIPERD----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFME 99 (295)
T ss_dssp EEEECSSS---EEEEEEETTTCCEEEEEEEECCC----C---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred EEeecCcE---EEEEEEECCCCeEEEEEEccCCc----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEE
Confidence 47888888 89999999999999999998653 24457789999999999999999999998765 46899999
Q ss_pred cCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 81 LFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~---~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++...+.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999998752 4679999999999999999999999 9999999999999865789999999999765432
Q ss_pred -CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 157 -TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
......||+.|+|||++.. .++.++||||||+++|+|++|..||.....................++...++++++
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 2345679999999998864 388999999999999999999999976545444333332222333455667899999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
||.+||. +|.+||++.++|+||||+....
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 9999999 8999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=389.00 Aligned_cols=252 Identities=24% Similarity=0.350 Sum_probs=191.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---CceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~---~~~l~l 77 (639)
+||+|+|| +||+|.+..+|..||+|++.... ......+++.+|+.+|+.|+|||||++++++.... ...+|+
T Consensus 60 ~lG~G~~g---~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 60 LIGTGSYG---HVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp C----------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EeeecCCe---EEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 47888888 79999999999999999986542 34566788999999999999999999999886543 256899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||||+ +|+|.++++..+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 135 v~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCTTSCT
T ss_pred EEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchhccCcc
Confidence 99998 5799999998889999999999999999999999999 99999999999998 4579999999999765321
Q ss_pred ----------------------------CCccccCCCCcCCcccc-c-ccCCccccccchhhhhhhhhh-----------
Q 006593 157 ----------------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVT----------- 195 (639)
Q Consensus 157 ----------------------------~~~~~~GTp~ymAPE~l-~-~~ys~ksDIwSlGiil~ELlt----------- 195 (639)
.....+||+.|+|||++ . ..|+.++|||||||++|||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 12345789999999975 3 459999999999999999999
Q ss_pred ccCCCCCCCC--------------------HHHHHHHHHc--CCC---------------------------CCcccCCC
Q 006593 196 FEYPYSECKN--------------------PAQIFKKVTS--GIK---------------------------PASLAKVN 226 (639)
Q Consensus 196 G~~Pf~~~~~--------------------~~~i~~~i~~--g~~---------------------------p~~l~~~~ 226 (639)
|.++|.+... ..++ ..+.. |.. ........
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL-NVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp CCCSCC--------------------CHHHHHHH-HHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred ccccCCCCccccccccccccccccccccCCHHHH-HHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 6666754321 0111 11100 000 01112334
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
++++++||.+||. ||.+|||++|+|+||||+...+.
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 7899999999999 99999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=374.04 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=208.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|++..... ......+.+.+|+.+|++++||||+++++++... ..+++||||
T Consensus 62 lG~G~~g---~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~ 135 (348)
T 1u5q_A 62 IGHGSFG---AVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEY 135 (348)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred EccCCCE---EEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEEEEEec
Confidence 6777777 899999999999999999986543 2344567899999999999999999999998776 468999999
Q ss_pred CCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lk-k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
+. |+|.+++. ..+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..... ...
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~--~~~ 209 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANS 209 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--BCC
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCceecCC--CCc
Confidence 97 68888775 4567999999999999999999999999 99999999999998 557999999999976543 345
Q ss_pred ccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 161 VIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 161 ~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
..||+.|+|||++. ..|+.++|||||||++|||++|..||.+.. .......+..+..+.......++.+++||.+
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 68999999999873 468999999999999999999999998744 4444445555555555556678899999999
Q ss_pred hcC-CCCCCCCHHHHhcCccccccc
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||. +|.+|||+.++|+||||....
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HcccChhhCcCHHHHhhChhhhccC
Confidence 999 899999999999999997543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=360.67 Aligned_cols=247 Identities=21% Similarity=0.391 Sum_probs=212.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..++..||+|++....... ....+.+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 22 lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 95 (284)
T 2vgo_A 22 LGKGKFG---NVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDR--KRIYLMLEF 95 (284)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred ecCCCCe---EEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC--CEEEEEEEe
Confidence 6777777 89999999999999999997654211 22356789999999999999999999998764 568999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 161 (639)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++...........
T Consensus 96 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (284)
T 2vgo_A 96 APRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM 172 (284)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECSSSCBCCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCcccccccc
Confidence 999999999998889999999999999999999999999 99999999999997 557999999999876655555667
Q ss_pred cCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-
Q 006593 162 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 239 (639)
Q Consensus 162 ~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~- 239 (639)
.||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..... .++...++.+++||.+||.
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDL--KFPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp CSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHSCS
T ss_pred cCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhcccc--CCCCcCCHHHHHHHHHHhhc
Confidence 89999999998875 589999999999999999999999986 345555556655432 2445668899999999999
Q ss_pred CCCCCCCHHHHhcCccccccc
Q 006593 240 PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 240 dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+|.+||++.++|+||||+...
T Consensus 250 ~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 250 HPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp SGGGSCCHHHHHTCHHHHHHC
T ss_pred CHhhCCCHHHHhhCHHHHhhc
Confidence 899999999999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=364.01 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=209.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|+.||+|+++.... ...+.+.+|+.+|++++||||+++++++.+. ..+++|||
T Consensus 16 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 86 (304)
T 2jam_A 16 VLGSGAFS---EVFLVKQRLTGKLFALKCIKKSPA----FRDSSLENEIAVLKKIKHENIVTLEDIYEST--THYYLVMQ 86 (304)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred eccCCCCc---eEEEEEECCCCCEEEEEEEecccc----cchHHHHHHHHHHHhCCCCCeeehhhhcccC--CEEEEEEE
Confidence 36778777 899999999999999999986532 2345688999999999999999999988655 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe--CCCCcEEEeecchhhhccCCCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~--~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
|+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||++. +..+.+||+|||++........
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 9999999999988888999999999999999999999999 99999999999993 2457999999999876554444
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~LI~ 235 (639)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+... .......++.+++||.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 243 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDFIC 243 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence 55679999999998864 589999999999999999999999987 4566677777766433 2334556889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 244 HLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHcCCChhHCcCHHHHhcCccccCC
Confidence 9999 89999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=379.79 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=205.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|+++... ....+.+.+|+.+|++|+||||+++++++... ..+++||||
T Consensus 97 lG~G~~g---~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~E~ 167 (373)
T 2x4f_A 97 LGGGRFG---QVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESK--NDIVLVMEY 167 (373)
T ss_dssp CC--------CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCcCE---EEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEeC
Confidence 7888888 79999999999999999998653 34567899999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe-CCCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN-GNHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~-~~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+|||++...... ..
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999999988764 46999999999999999999999999 99999999999984 34578999999999766533 23
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~LI~ 235 (639)
...+||+.|+|||++.. .++.++|||||||++|+|++|..||.+. +....+..+..... +.......++++++||.
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 45679999999998864 5899999999999999999999999874 45555555555433 22233456889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||. +|.+|||+.|+|+||||+...
T Consensus 325 ~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 9999 899999999999999998543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=373.63 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=203.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ-LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.+..++..||+|++....... .....+.+.+|+.+|++++||||++++++|.+. ..+++|||
T Consensus 34 lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 108 (345)
T 3hko_A 34 IGQGSYG---VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE--QYICLVME 108 (345)
T ss_dssp EEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred eeecCCe---EEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC--CeEEEEEe
Confidence 7888888 89999999999999999998654321 345677899999999999999999999998664 56999999
Q ss_pred cCCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 006593 81 LFTSGNLRQYRKK----------------------------------------HKNVDIKVIKNWARQILHGLVYLHSHN 120 (639)
Q Consensus 81 y~~gGsL~d~lkk----------------------------------------~~~l~e~~i~~i~~QIl~aL~yLHs~g 120 (639)
||.+|+|.+++.. ...+++..++.++.||+.||.|||+++
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 188 (345)
T 3hko_A 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188 (345)
T ss_dssp CCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999852 112467889999999999999999999
Q ss_pred CCeeeeccCCCcEEEeCCC-CcEEEeecchhhhccCC------CCccccCCCCcCCccccc---ccCCccccccchhhhh
Q 006593 121 PPIIHRDLKCDNIFVNGNH-GEVKIGDLGLAIAMQQP------TARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCI 190 (639)
Q Consensus 121 ppIIHRDLKp~NILl~~~~-g~VKL~DFGlA~~l~~~------~~~~~~GTp~ymAPE~l~---~~ys~ksDIwSlGiil 190 (639)
|+||||||+|||++.+. +.+||+|||++..+... ......||+.|+|||++. ..|+.++|||||||++
T Consensus 189 --ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp --EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred --ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 99999999999997332 38999999999755321 123567999999999885 4589999999999999
Q ss_pred hhhhhccCCCCCCCCHHHHHHHHHcCCCCC--cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 191 ~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
|+|++|..||.+.. ..+....+..+.... ......++.+++||.+||. +|.+||++.++|+||||+...+
T Consensus 267 ~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 267 HLLLMGAVPFPGVN-DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHSSCSSCCSS-HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHCCCCCCCCC-hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 99999999998754 444555554443322 2233468899999999999 8999999999999999986543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=380.43 Aligned_cols=248 Identities=21% Similarity=0.349 Sum_probs=210.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|++.... ......+.+|+.+|+.|+||||+++++++.+. ..+++||||
T Consensus 59 LG~G~~g---~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~lv~E~ 129 (387)
T 1kob_A 59 LGSGAFG---VVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLILEF 129 (387)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCCCE---EEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC--CEEEEEEEc
Confidence 6777777 89999999999999999987543 34556789999999999999999999998765 569999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC-CCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~-~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++...... ..
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 99999999997654 7999999999999999999999999 999999999999974 3468999999999876533 23
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~LI~ 235 (639)
...+||+.|+|||++.. .++.++|||||||++|+|++|..||.+ .+.......+..... +.......++++++||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 44689999999998864 589999999999999999999999987 455566666655433 22333456889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||. +|.+|||+.|+|+||||+....
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 287 NLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999 8999999999999999986543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=361.85 Aligned_cols=251 Identities=23% Similarity=0.422 Sum_probs=210.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|+++...........+.+.+|+.++++++||||+++++++.......+++|||
T Consensus 12 ~lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (305)
T 2wtk_C 12 LLGEGSYG---KVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88 (305)
T ss_dssp EEEECSSC---EEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred EEecCCCe---EEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence 37788888 899999999999999999987654333456678999999999999999999999987766677999999
Q ss_pred cCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 81 LFTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|+.+| |.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 89 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~ 164 (305)
T 2wtk_C 89 YCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAA 164 (305)
T ss_dssp CCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCS
T ss_pred hccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeeccccccccCcccc
Confidence 99876 8888776 356999999999999999999999999 99999999999997 5579999999999765422
Q ss_pred --CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 --TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+ .+...+...+..+.. .++...++.+.
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~~~l~ 241 (305)
T 2wtk_C 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCGPPLS 241 (305)
T ss_dssp SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSCHHHH
T ss_pred ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccCHHHH
Confidence 2235579999999998864 247899999999999999999999986 456677777766543 34556788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||.+||. +|.+|||+.|+++||||+....
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999 8999999999999999986544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=393.26 Aligned_cols=246 Identities=25% Similarity=0.434 Sum_probs=214.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++...... .....+.+.+|+.+|+.++||||+++++++... ..+|+||||
T Consensus 24 LG~G~fg---~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--~~~~lv~E~ 97 (476)
T 2y94_A 24 LGVGTFG---KVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP--SDIFMVMEY 97 (476)
T ss_dssp EECCSSS---CEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EeeCCCe---EEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEeC
Confidence 7888888 7999999999999999999865431 123467899999999999999999999988665 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
+.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ....
T Consensus 98 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~ 174 (476)
T 2y94_A 98 VSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRT 174 (476)
T ss_dssp CSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECCTTCCBCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhccccccccc
Confidence 999999999998889999999999999999999999999 99999999999998 4579999999999766532 3456
Q ss_pred ccCCCCcCCccccccc-C-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~~-y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
.+||+.|+|||++.+. | +.++|||||||++|+|++|..||.+ .+...++..+..+... .+...++++++||.+||
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~~L 251 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFY--TPQYLNPSVISLLKHML 251 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTCCC--CCTTCCHHHHHHHHHHT
T ss_pred cCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCcC--CCccCCHHHHHHHHHHc
Confidence 7899999999988754 4 7899999999999999999999987 4556677777776543 34567889999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
. +|.+|||+.|+++||||+..
T Consensus 252 ~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 252 QVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCchhCcCHHHHHhCHHhhhc
Confidence 9 99999999999999999854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=372.50 Aligned_cols=247 Identities=21% Similarity=0.420 Sum_probs=210.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP----GDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~----~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| .||+|.+..+|..||+|+++........ ...+.+.+|+.+++++ +||||++++++|... ..++
T Consensus 102 lg~G~~g---~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 176 (365)
T 2y7j_A 102 IGRGVSS---VVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS--SFMF 176 (365)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS--SEEE
T ss_pred EecCCCE---EEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC--CEEE
Confidence 6777777 8999999999999999999865422222 2356788999999999 899999999998664 5699
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 177 lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCcccccCCC
Confidence 99999999999999998888999999999999999999999999 99999999999998 5589999999999766533
Q ss_pred -CCccccCCCCcCCcccccc-------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc--cCCC
Q 006593 157 -TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL--AKVN 226 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l--~~~~ 226 (639)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+.......+..+...... ....
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 332 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSPEWDDR 332 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHHHHSSS
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccC
Confidence 3445789999999998752 488999999999999999999999986 4556666666665443322 2456
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
++.+++||.+||. +|.+|||+.++|+||||+
T Consensus 333 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 7889999999999 999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=356.95 Aligned_cols=252 Identities=27% Similarity=0.461 Sum_probs=213.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.+.....+++|||
T Consensus 13 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 13 TIGTGSYG---RCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEECSSS---EEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred hccCCCCc---EEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 37888888 899999999999999999987653 4566788999999999999999999999988776678999999
Q ss_pred cCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 81 LFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHN---PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 81 y~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~yLHs~g---ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
|+.+|+|.+++... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ ..+.+||+|||++...
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARIL 166 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCHHHHC
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCchheee
Confidence 99999999999754 34999999999999999999999987 3499999999999998 4579999999999876
Q ss_pred cCCC--CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 154 QQPT--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 154 ~~~~--~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
.... .....||+.|+|||++.. .++.++||||||+++|+|++|..||.. .+...+...+..+..+ .++...++++
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l 244 (279)
T 2w5a_A 167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDEL 244 (279)
T ss_dssp ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC-CCCTTSCHHH
T ss_pred ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhcccc-cCCcccCHHH
Confidence 5432 234579999999998864 589999999999999999999999987 4566677777766543 3455678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
++||.+||. +|.+||++.|||+|+|+....
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 999999999 899999999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=387.16 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=203.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccC----ChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ----LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~----~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||+|+|| +||+|.+..+|..||+|++....... .......+.+|+.+|++++||||+++++++.. ..+++
T Consensus 143 LG~G~~g---~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~l 216 (419)
T 3i6u_A 143 LGSGACG---EVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---EDYYI 216 (419)
T ss_dssp EEECSSS---EEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES---SEEEE
T ss_pred EeeCCCe---EEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec---CceEE
Confidence 7888888 89999999999999999998764321 11223457899999999999999999998743 34789
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhccC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~~ 155 (639)
||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||+++....
T Consensus 217 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~ 294 (419)
T 3i6u_A 217 VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294 (419)
T ss_dssp EEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence 9999999999999988889999999999999999999999999 9999999999999632 34699999999987654
Q ss_pred C-CCccccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC--cccCCCCh
Q 006593 156 P-TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDP 228 (639)
Q Consensus 156 ~-~~~~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s~ 228 (639)
. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+......+...+..+.... ......++
T Consensus 295 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 374 (419)
T 3i6u_A 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374 (419)
T ss_dssp ----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCH
T ss_pred CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCH
Confidence 3 334678999999999874 4588999999999999999999999987555555556666654432 22345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 375 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 99999999999 9999999999999999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=380.66 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=199.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC---ceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~---~~l~l 77 (639)
+||+|+|| +||+|.+..+|..||+|+++... ......+++.+|+.+|++++||||+++++++..... ..+|+
T Consensus 33 ~lG~G~~g---~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 33 LIGRGSYG---YVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEETTE---EEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEeecCCE---EEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 37788887 89999999999999999997542 345667889999999999999999999998866532 46899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||||+. |+|.++++....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 108 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEEC----
T ss_pred EEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccCCCcccccccc
Confidence 999996 599999998888999999999999999999999999 99999999999998 5589999999999765422
Q ss_pred -----------------------CCccccCCCCcCCcccc-c-ccCCccccccchhhhhhhhhhccCC-----------C
Q 006593 157 -----------------------TARSVIGTPEFMAPELY-E-EEYNELVDIYSFGMCILEMVTFEYP-----------Y 200 (639)
Q Consensus 157 -----------------------~~~~~~GTp~ymAPE~l-~-~~ys~ksDIwSlGiil~ELltG~~P-----------f 200 (639)
.....+||+.|+|||++ . ..|+.++|||||||++|||++|..| |
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 12457899999999975 3 4599999999999999999984333 3
Q ss_pred CCCCC-----------------HHHH-----------------------HHHHHcCCC--CC---cccCCCChHHHHHHH
Q 006593 201 SECKN-----------------PAQI-----------------------FKKVTSGIK--PA---SLAKVNDPQIKGFIE 235 (639)
Q Consensus 201 ~~~~~-----------------~~~i-----------------------~~~i~~g~~--p~---~l~~~~s~~l~~LI~ 235 (639)
.+... ..++ ...+..... +. ......++++++||.
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 33110 0111 111111000 00 011346789999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+||. ||.+|||++|+|+||||+...+.
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999 99999999999999999876554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=357.84 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=195.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||+|+++.... .....+.+..+...++.++||||+++++++.+.+ .+++||||
T Consensus 15 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~--~~~lv~e~ 87 (290)
T 3fme_A 15 LGRGAYG---VVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG--DVWICMEL 87 (290)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--SEEEEEEC
T ss_pred cCCCCCe---EEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC--CEEEEEeh
Confidence 6777777 899999999999999999875532 2233444555666688889999999999987654 58999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+. |+|.+++.. .+.+++..++.++.||+.||.|||++ | |+||||||+|||++ ..+.+||+|||++......
T Consensus 88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC---------
T ss_pred hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecCCccccccc
Confidence 97 588777653 56899999999999999999999998 8 99999999999998 4579999999999766543
Q ss_pred C-CccccCCCCcCCccccc-----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 157 T-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 157 ~-~~~~~GTp~ymAPE~l~-----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
. .....||+.|+|||++. ..++.++||||||+++|+|++|..||..................+.......++++
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (290)
T 3fme_A 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHH
T ss_pred ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHH
Confidence 2 33457999999999862 35889999999999999999999999876666666666665555555555678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
++||.+||. +|.+|||+.|+|+||||+....
T Consensus 244 ~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 244 VDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 999999999 8999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=354.37 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=201.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.+..+|..||+|+++.... .......+.+|+..+..+ +||||+++++++.+. ..+++|||
T Consensus 19 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~lv~e 91 (289)
T 1x8b_A 19 IGSGEFG---SVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHMLIQNE 91 (289)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEEEEEE
T ss_pred hcCCCce---EEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEEEEEE
Confidence 6777777 899999999999999999986542 334567889999999999 999999999998765 46899999
Q ss_pred cCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC------------------C
Q 006593 81 LFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG------------------N 138 (639)
Q Consensus 81 y~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~------------------~ 138 (639)
|+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++. .
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------------
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999999865 67999999999999999999999999 999999999999972 2
Q ss_pred CCcEEEeecchhhhccCCCCccccCCCCcCCccccccc--CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC
Q 006593 139 HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 216 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~~--ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g 216 (639)
.+.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+|+... .....+..+
T Consensus 170 ~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~ 243 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQG 243 (289)
T ss_dssp CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHHHTT
T ss_pred ceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHHHcC
Confidence 347999999998766543 335699999999988653 568999999999999999999776542 233445554
Q ss_pred CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 217 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 217 ~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
..+ .++...++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 244 RLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp CCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 443 3456678999999999999 89999999999999999854
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=374.75 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=199.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----------
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD---------- 70 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~---------- 70 (639)
.||+|+|| +||+|.+..+|..||+|++...... ..+|+.+|+.++||||++++++|...
T Consensus 14 ~lG~G~fg---~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 14 TLGTGSFG---IVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp EEECC-CE---EEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred EEEeccCE---EEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 37888888 8999999999999999998755321 24799999999999999999998653
Q ss_pred --------------------------CCceEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 006593 71 --------------------------KKKTVNMITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHN 120 (639)
Q Consensus 71 --------------------------~~~~l~lV~Ey~~gGsL~d~lk----k~~~l~e~~i~~i~~QIl~aL~yLHs~g 120 (639)
...++++||||+. |+|.+++. ..+.+++..++.++.||+.||.|||++|
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 2346899999998 47766654 4578999999999999999999999999
Q ss_pred CCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhcc
Q 006593 121 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFE 197 (639)
Q Consensus 121 ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~ 197 (639)
|+||||||+|||++...+.+||+|||+|..+... ......||+.|+|||++.+ .|+.++|||||||++|+|++|.
T Consensus 162 --i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 162 --ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp --EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred --CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 9999999999999866789999999999865433 3445688999999998754 4899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHc-CCC-----------------C--------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 006593 198 YPYSECKNPAQIFKKVTS-GIK-----------------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDL 250 (639)
Q Consensus 198 ~Pf~~~~~~~~i~~~i~~-g~~-----------------p--------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~EL 250 (639)
.||.+.....++...+.. +.. + ..++...++++++||.+||. +|.+|||+.|+
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999875444444333221 100 0 01234467889999999999 99999999999
Q ss_pred hcCccccccc
Q 006593 251 LKDPFLQVEN 260 (639)
Q Consensus 251 L~Hpff~~~~ 260 (639)
|+||||+...
T Consensus 320 l~hp~f~~~~ 329 (383)
T 3eb0_A 320 MAHPFFDHLR 329 (383)
T ss_dssp HTSGGGHHHH
T ss_pred hcCHHHHHHH
Confidence 9999997543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=399.13 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=215.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|++....... ......+.+|+.+|+.++|||||+++++|.+. ..+|+|||
T Consensus 191 ~LG~G~fG---~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lVmE 264 (576)
T 2acx_A 191 VLGKGGFG---EVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETK--DALCLVLT 264 (576)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeeCCCE---EEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC--CEEEEEEE
Confidence 47888888 89999999999999999998654321 23456788999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~--l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~ 157 (639)
|+.||+|.+++...+. +++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... .
T Consensus 265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTTCC
T ss_pred cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccceecccCcc
Confidence 9999999999987644 999999999999999999999999 99999999999997 5589999999999776533 3
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC---CHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.... ....+...+... +..++...++++++|
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQARSL 419 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHHHHHH
Confidence 345689999999998865 59999999999999999999999997642 345666666654 334556678999999
Q ss_pred HHHhcC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 234 IEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 234 I~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
|.+||. +|.+|| +++|+++||||+..+|..
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~ 455 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR 455 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence 999999 999999 899999999999877653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=374.44 Aligned_cols=247 Identities=29% Similarity=0.430 Sum_probs=199.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~l 77 (639)
||+|+|| .||+|.+..+|..||+|++.... ......+++.+|+.+|+.++||||+++++++..... ..+|+
T Consensus 33 lG~G~~g---~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 33 VGSGAYG---AVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp C---------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred eeecCCe---EEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 7888888 79999999999999999986543 245567789999999999999999999999865432 35789
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+ +++|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.....
T Consensus 108 v~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~- 181 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSE- 181 (367)
T ss_dssp EEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSS-
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeecccccccc-
Confidence 99999 8899999987 56999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCCC--------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP-------------- 219 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p-------------- 219 (639)
....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.....++ ..+.. +..+
T Consensus 182 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~~~~~~~~~~~~~~~~~ 260 (367)
T 1cm8_A 182 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKVTGTPPAEFVQRLQSDEAKN 260 (367)
T ss_dssp CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCHHHHHHhhhHHHHH
Confidence 345689999999998764 5999999999999999999999999874433333 22221 1111
Q ss_pred -------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 -------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
..+....++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11223457899999999999 999999999999999998543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=406.25 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=219.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|+.||+|+++...... ....+.+..|..+|..+ +||||++++++|.+. ..+||||
T Consensus 348 ~LG~G~fG---~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--~~~~lV~ 421 (674)
T 3pfq_A 348 VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYFVM 421 (674)
T ss_dssp ESSBTTTB---CEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--SEEEEEE
T ss_pred EEccCCCE---EEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--CEEEEEE
Confidence 47888888 79999999999999999998654322 24456788999999988 799999999988554 5699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc--CCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ--QPT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~--~~~ 157 (639)
||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+... ...
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECCCTTCC
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccccCCcc
Confidence 99999999999999889999999999999999999999999 99999999999998 55899999999997543 234
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|||||++. ..|+.++|||||||++|||++|..||.+ .+..+++..+..+.. .++...++++++||.+
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~ 575 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKG 575 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHHHHHH
T ss_pred cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHH
Confidence 55679999999999886 4699999999999999999999999987 567788888887643 3456678999999999
Q ss_pred hcC-CCCCCCCH-----HHHhcCcccccccCCCC
Q 006593 237 CLV-PASERLSA-----KDLLKDPFLQVENQKEP 264 (639)
Q Consensus 237 cL~-dP~~RpSa-----~ELL~Hpff~~~~~~~~ 264 (639)
||. +|.+||++ +||++||||+..+|...
T Consensus 576 lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 576 LMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp HSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred HccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 999 89999997 99999999998877543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=369.49 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=198.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-----CCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----DDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-----HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| +||+|.+..+|..||+|+++.. ......+..|+.+|+.+. ||||++++++|... ..++
T Consensus 43 lG~G~~g---~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~~~~ 112 (360)
T 3llt_A 43 MGDGTFG---RVLLCQHIDNKKYYAVKVVRNI-----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--DHMC 112 (360)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEECSC-----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--TEEE
T ss_pred EcccCCe---EEEEEEECCCCeEEEEEEeccc-----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--CeeE
Confidence 6777777 8999999999999999998732 355667888999999996 99999999999876 4699
Q ss_pred EEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC-----------------
Q 006593 77 MITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----------------- 137 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~----------------- 137 (639)
+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccc
Confidence 999999 899999998764 5999999999999999999999999 999999999999963
Q ss_pred -------CCCcEEEeecchhhhccCCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHH
Q 006593 138 -------NHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI 209 (639)
Q Consensus 138 -------~~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i 209 (639)
..+.+||+|||++..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||... +..+.
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~ 267 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH-EHMEH 267 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS-SHHHH
T ss_pred cccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC-cHHHH
Confidence 257899999999975443 3346789999999998764 6999999999999999999999999874 33333
Q ss_pred HHHHHcCCC--CC------------------------------------------cccCCCChHHHHHHHHhcC-CCCCC
Q 006593 210 FKKVTSGIK--PA------------------------------------------SLAKVNDPQIKGFIEKCLV-PASER 244 (639)
Q Consensus 210 ~~~i~~g~~--p~------------------------------------------~l~~~~s~~l~~LI~kcL~-dP~~R 244 (639)
...+..... +. ......++.+.+||.+||+ ||.+|
T Consensus 268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 347 (360)
T 3llt_A 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347 (360)
T ss_dssp HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence 333322111 10 0111224678899999999 99999
Q ss_pred CCHHHHhcCcccc
Q 006593 245 LSAKDLLKDPFLQ 257 (639)
Q Consensus 245 pSa~ELL~Hpff~ 257 (639)
||+.|+|+||||+
T Consensus 348 pta~elL~hp~f~ 360 (360)
T 3llt_A 348 PSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHTTSGGGC
T ss_pred CCHHHHhcCcccC
Confidence 9999999999996
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=358.00 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=214.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||+|++..... .....+.+.+|+.++++++||||+++++++... ..+++||||
T Consensus 30 lg~G~~g---~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 102 (287)
T 2wei_A 30 LGKGSFG---EVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDS--SSFYIVGEL 102 (287)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEECC
T ss_pred EcCCCCE---EEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--CeEEEEEEc
Confidence 6777777 899999999999999999986543 234567899999999999999999999988654 568999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+.+++|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+||+++.+ .+.+||+|||++...... ..
T Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 999999999988888999999999999999999999999 9999999999999643 347999999999876543 23
Q ss_pred ccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc--CCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA--KVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~--~~~s~~l~~LI~k 236 (639)
....||+.|+|||++.+.++.++||||||+++|+|++|..||.+ .+..++...+..+..+...+ ...++++++||.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 259 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (287)
T ss_dssp SCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHH
T ss_pred ccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHH
Confidence 34568999999999988899999999999999999999999987 45666777777665443322 4567899999999
Q ss_pred hcC-CCCCCCCHHHHhcCccccccc
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
||. +|.+|||+.|+|+||||+...
T Consensus 260 ~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 260 MLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HcccChhhCcCHHHHhcCHHHhccc
Confidence 999 899999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=362.55 Aligned_cols=246 Identities=26% Similarity=0.493 Sum_probs=203.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC----CceEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDK----KKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~----~~~l~ 76 (639)
||+|+|| .||+|.+..+|..||+|++.... ...+.+.+|+.+++++ +||||+++++++.... ...++
T Consensus 32 lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 32 VGNGTYG---QVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred eccCCCE---EEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 6777777 89999999999999999997553 2346688999999999 8999999999998753 45799
Q ss_pred EEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 77 MITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++....
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEEEeeCcCceecC
Confidence 999999999999999875 56999999999999999999999999 99999999999997 55799999999987654
Q ss_pred CC--CCccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCC
Q 006593 155 QP--TARSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN 226 (639)
Q Consensus 155 ~~--~~~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~ 226 (639)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+. +.......+.....+.......
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKW 259 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCSCS
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCccccCCcccc
Confidence 32 234567999999999874 35889999999999999999999999874 4444555555555555555667
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 260 ~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 8999999999999 89999999999999999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=366.73 Aligned_cols=255 Identities=20% Similarity=0.276 Sum_probs=206.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC--ceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--KTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~--~~l~lV 78 (639)
+||+|+|| .||+|.+..+|..||+|+++.... .......++.+|+.++++++||||+++++++..... ..+|+|
T Consensus 19 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv 94 (311)
T 3ork_A 19 ILGFGGMS---EVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 94 (311)
T ss_dssp EEEECSSE---EEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEccCCCE---EEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence 36777777 899999999999999999986543 345667789999999999999999999999876543 256899
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|||+.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 95 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~ 171 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGN 171 (311)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC--------
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCccccccccc
Confidence 999999999999998889999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred ---CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC-cccCCCChHHH
Q 006593 157 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA-SLAKVNDPQIK 231 (639)
Q Consensus 157 ---~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~-~l~~~~s~~l~ 231 (639)
.....+||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+..........+.....+. ......++++.
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (311)
T 3ork_A 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 251 (311)
T ss_dssp ----------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHH
T ss_pred ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHH
Confidence 1234579999999998864 589999999999999999999999987443333344444433332 23345688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
+||.+||. +|.+||++.++|.|+|++.....
T Consensus 252 ~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 252 AVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred HHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 99999999 89999999999999999865543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=387.91 Aligned_cols=245 Identities=28% Similarity=0.398 Sum_probs=194.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~l 77 (639)
||+|+|| +||+|.+..+|+.||+|++.... ......+++.+|+.+|+.++||||++++++|.... ...+|+
T Consensus 70 lG~G~~g---~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 70 IGSGAQG---IVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEECSSC---EEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred eecCCCe---EEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 7888888 89999999999999999998653 24566788999999999999999999999986543 246899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||||+.+ +|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.....
T Consensus 145 v~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 145 VMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC-----CC
T ss_pred EEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeeeecCCCc
Confidence 9999976 5666664 35999999999999999999999999 99999999999998 4579999999999876543
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCCCC-------------
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPA------------- 220 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p~------------- 220 (639)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....+ +..+.. |.++.
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~~~~~~~~ 297 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNY 297 (464)
T ss_dssp CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTSCHHHHHH
T ss_pred ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHcchhhhhH
Confidence 3455789999999998764 699999999999999999999999987543333 333321 11100
Q ss_pred ----------cc----cC-----------CCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 221 ----------SL----AK-----------VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 221 ----------~l----~~-----------~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
.+ +. ..++++++||.+||. ||.+|||++|+|+||||+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00 00 004578999999999 9999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=357.77 Aligned_cols=247 Identities=26% Similarity=0.444 Sum_probs=203.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|++.... ....+.+.+|+.+|+.++||||+++++++.... .+++||||
T Consensus 27 lg~G~~g---~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~ 97 (302)
T 2j7t_A 27 LGDGAFG---KVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--KLWIMIEF 97 (302)
T ss_dssp EECSTTC---CEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eccCCCe---EEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC--eEEEEEEe
Confidence 6788887 79999999999999999987543 345678899999999999999999999987654 58999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~ 158 (639)
+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| ++||||||+|||++ ..|.+||+|||++..... ...
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHHHHHHHHHHHC-
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCCCcccccccccc
Confidence 999999999876 567999999999999999999999999 99999999999997 457999999999864321 123
Q ss_pred ccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC-CcccCCCChHHH
Q 006593 159 RSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP-ASLAKVNDPQIK 231 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p-~~l~~~~s~~l~ 231 (639)
....||+.|+|||++. ..++.++||||||+++|+|++|..||... +.......+..+..+ ...+...++.++
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDPPTLLTPSKWSVEFR 253 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHhccCCcccCCccccCHHHH
Confidence 4567999999999873 45889999999999999999999999874 444444555444333 334556688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||.+||. +|.+|||+.++|+||||+...+
T Consensus 254 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 254 DFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp HHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred HHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 99999999 8999999999999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.38 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=210.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC-----hhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL-----PGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~-----~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l 75 (639)
||+|+|| .||+|.+..+|+.||+|+++....... ....+.+.+|+.+|+++. ||||+++++++... ..+
T Consensus 25 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--~~~ 99 (298)
T 1phk_A 25 LGRGVSS---VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN--TFF 99 (298)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEE
T ss_pred ecCCCce---EEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC--CeE
Confidence 6777777 899999999999999999986542111 234567889999999995 99999999988654 569
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 76 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++.....
T Consensus 100 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~ 176 (298)
T 1phk_A 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDP 176 (298)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecccchhhcCC
Confidence 999999999999999998889999999999999999999999999 99999999999997 557999999999976543
Q ss_pred C-CCccccCCCCcCCccccc-------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--ccCC
Q 006593 156 P-TARSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS--LAKV 225 (639)
Q Consensus 156 ~-~~~~~~GTp~ymAPE~l~-------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~--l~~~ 225 (639)
. ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+..+..... ....
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 1phk_A 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDD 255 (298)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcccCcccccc
Confidence 2 334567999999999874 3478899999999999999999999986 455566666665543322 2234
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 226 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 226 ~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.++.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 67899999999999 8999999999999999986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=377.75 Aligned_cols=244 Identities=19% Similarity=0.300 Sum_probs=194.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHH-hCCCCCcceEEEEEEe--CCCceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK-SLKDDNVVKFYKSWVD--DKKKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk-~L~HpNIVkl~~~~~~--~~~~~l~lV 78 (639)
||+|+|| +||+|.+..+|..||+|+++.. ..+.+|+.++. .++||||++++++|.. .+...+|+|
T Consensus 70 LG~G~~g---~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv 137 (400)
T 1nxk_A 70 LGLGING---KVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137 (400)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeeccCe---EEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence 6777777 8999999999999999998632 34678998874 4589999999998864 334679999
Q ss_pred EecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhcc
Q 006593 79 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~ 154 (639)
||||.||+|.+++...+ .+++..++.|+.||+.||.|||++| |+||||||+|||++.. .+.+||+|||+++...
T Consensus 138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 99999999999998754 5999999999999999999999999 9999999999999752 5789999999997654
Q ss_pred CC-CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCH---HHHHHHHHcCCC--CCcccCCCC
Q 006593 155 QP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP---AQIFKKVTSGIK--PASLAKVND 227 (639)
Q Consensus 155 ~~-~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~---~~i~~~i~~g~~--p~~l~~~~s 227 (639)
.. .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.... ..+...+..+.. +.......+
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 295 (400)
T 1nxk_A 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295 (400)
T ss_dssp -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence 32 335678999999999886 46999999999999999999999999753321 123344444432 222234568
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 228 PQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+++++||.+||. +|.+|||+.|+|+||||...
T Consensus 296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 899999999999 99999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.92 Aligned_cols=244 Identities=20% Similarity=0.335 Sum_probs=201.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.+..+|..||+|+++.. ..+.+.+|+.+|++++ ||||+++++++.+.....+++|||
T Consensus 44 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 44 LGRGKYS---EVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ecccCCe---EEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 6777777 8999999999999999998733 2366899999999997 999999999998766678999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~ 159 (639)
|+.+++|.++++. +++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|||++...... ...
T Consensus 114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 9999999998854 899999999999999999999999 9999999999999866558999999999765432 334
Q ss_pred cccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH-------------cCC-------
Q 006593 160 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-------------SGI------- 217 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~-------------~g~------- 217 (639)
...||+.|+|||++.. .++.++|||||||++|+|++|..||............+. ...
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 5689999999998764 589999999999999999999999965444333222211 110
Q ss_pred ---------------CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 218 ---------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 218 ---------------~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.+.......++++++||.+||. ||.+|||++|+|+||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0111122357899999999999 999999999999999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=366.83 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=208.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.+..+|..||+|+++.... .......+.+|+.+++.+ .||||++++++|.+. ..+++|||
T Consensus 37 lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--~~~~lv~e 109 (327)
T 3lm5_A 37 LGRGKFA---VVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENT--SEIILILE 109 (327)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEE
T ss_pred eCCCCCe---EEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC--CeEEEEEE
Confidence 6777777 899999999999999999986543 334567799999999999 569999999998654 56999999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~~~ 156 (639)
|+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++. ..|.+||+|||++......
T Consensus 110 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 110 YAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp CCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999999998653 67999999999999999999999999 999999999999974 2579999999999766433
Q ss_pred -CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC--CCCcccCCCChHHHH
Q 006593 157 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI--KPASLAKVNDPQIKG 232 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~--~p~~l~~~~s~~l~~ 232 (639)
.....+||+.|+|||++. ..++.++||||||+++|+|++|..||... +....+..+.... .+.......++.+++
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 266 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQETYLNISQVNVDYSEETFSSVSQLATD 266 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHhcccccCchhhcccCHHHHH
Confidence 234568999999999886 45899999999999999999999999874 4455555444432 233334556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcccccccCCCC
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVENQKEP 264 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~~~ 264 (639)
||.+||. +|.+|||++++|+||||+...+...
T Consensus 267 li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 267 FIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred HHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 9999999 8999999999999999998776543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=353.25 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=209.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|.+..+|..||+|+++....... ....+.+.+|+.+|++++||||+++++++.+. ..+++||
T Consensus 13 lg~G~~g---~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 87 (283)
T 3bhy_A 13 LGSGQFA---IVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK--TDVVLIL 87 (283)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred hcccCce---EEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--CeEEEEE
Confidence 6777777 899999999999999999987654322 12467799999999999999999999988764 4689999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC---CcEEEeecchhhhccCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~---g~VKL~DFGlA~~l~~~ 156 (639)
||+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++.+. +.+||+|||++......
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~ 165 (283)
T 3bhy_A 88 ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165 (283)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--
T ss_pred eecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccceeccCC
Confidence 99999999999998888999999999999999999999999 99999999999997432 27999999999765432
Q ss_pred -CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHH
Q 006593 157 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKG 232 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~ 232 (639)
......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+...... .......++.+++
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T 3bhy_A 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFDEEYFSNTSELAKD 244 (283)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence 234457999999999886 4589999999999999999999999987 4455566666554332 2233556789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
||.+||. +|.+||++.++|+||||+....
T Consensus 245 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 245 FIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 9999999 8999999999999999986543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=353.73 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=202.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++...... .....+.+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 19 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 92 (276)
T 2h6d_A 19 LGVGTFG---KVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP--TDFFMVMEY 92 (276)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred ecCCCCe---EEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC--CeEEEEEec
Confidence 6777777 8999999999999999999765321 123456789999999999999999999988665 568999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~~ 160 (639)
+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++...... ....
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 169 (276)
T 2h6d_A 93 VSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRT 169 (276)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC------
T ss_pred cCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccCCCcceec
Confidence 999999999998888999999999999999999999999 99999999999998 4579999999999766433 2345
Q ss_pred ccCCCCcCCccccccc-C-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 161 VIGTPEFMAPELYEEE-Y-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~~-y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
..||+.|+|||++.+. + +.++||||||+++|+|++|..||.. .....+...+..+... ++...++.+++||.+||
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l 246 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVATLLMHML 246 (276)
T ss_dssp -------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHT
T ss_pred ccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHHHHHHHc
Confidence 6799999999988754 3 6899999999999999999999987 4566677777665432 34556789999999999
Q ss_pred C-CCCCCCCHHHHhcCcccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
. +|.+|||+.++|+||||+..
T Consensus 247 ~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 247 QVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCChhhCCCHHHHHhChhhccC
Confidence 9 89999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=367.26 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=203.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|++.... ......+.+.+|+.++++++||||+++++++.+. ..+++|||
T Consensus 32 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 104 (331)
T 4aaa_A 32 LVGEGSYG---MVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK--KRWYLVFE 104 (331)
T ss_dssp EGGGGTTS---SEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred EEeecCCE---EEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC--CEEEEEEe
Confidence 37888888 79999999999999999987654 2445567788999999999999999999998765 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+.+++|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... ..
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceeecCCcccc
Confidence 9999999999888888999999999999999999999999 99999999999997 4579999999999765432 23
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-C------------------C
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------------I 217 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g------------------~ 217 (639)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......+...+.. + .
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 45679999999998865 5899999999999999999999999875444433332211 0 0
Q ss_pred CCC---------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 218 KPA---------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 218 ~p~---------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
... ......++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 000 0112347889999999999 999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=366.18 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=201.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------Cce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK------KKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~------~~~ 74 (639)
.||+|+|| +||+|.+..+|..||+|++..... .......+.+|+.+|+.++||||+++++++.... ...
T Consensus 24 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 24 KIGQGTFG---EVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp ECSSCSTT---SEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred EEecCCCc---EEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 37888888 799999999999999999876643 2233456789999999999999999999987753 356
Q ss_pred EEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 75 VNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...
T Consensus 99 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAF 174 (351)
T ss_dssp EEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEEccchhcccc
Confidence 8999999985 777776654 67999999999999999999999999 99999999999997 5579999999999765
Q ss_pred cCC------CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH---cCCCCCcc
Q 006593 154 QQP------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT---SGIKPASL 222 (639)
Q Consensus 154 ~~~------~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~---~g~~p~~l 222 (639)
... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. .......+. ....+..+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhc
Confidence 421 2234578999999998754 48999999999999999999999998743 433333332 22222222
Q ss_pred cCC---------------------------CChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 223 AKV---------------------------NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 223 ~~~---------------------------~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+.. .++.+++||.+||. ||.+|||+.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 111 26789999999999 999999999999999997543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=360.99 Aligned_cols=245 Identities=29% Similarity=0.501 Sum_probs=200.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+ +|..||+|++..... .....+.+.+|+.+|++++||||+++++++... ..+++||||
T Consensus 45 lG~G~~g---~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 115 (309)
T 3p86_A 45 IGAGSFG---TVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP--PNLSIVTEY 115 (309)
T ss_dssp EEECSSE---EEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--TCCEEEEEC
T ss_pred eecCCCe---EEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CceEEEEec
Confidence 6777777 8999987 588999999876543 445667899999999999999999999988655 458899999
Q ss_pred CCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 82 FTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~---l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
+.+|+|.+++.+.+. +++..++.++.||+.||.|||++|++|+||||||+|||++ ..+.+||+|||++......
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCcccccccc
Confidence 999999999987654 9999999999999999999999998899999999999997 5579999999999755433
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+..+....+........++...++++.+||.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 273 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHH
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence 2345689999999998864 589999999999999999999999987 45666666665555555667778899999999
Q ss_pred HhcC-CCCCCCCHHHHhc--Ccccc
Q 006593 236 KCLV-PASERLSAKDLLK--DPFLQ 257 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~--Hpff~ 257 (639)
+||. +|.+|||+.++++ .++++
T Consensus 274 ~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999 8999999999988 45554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=365.50 Aligned_cols=246 Identities=19% Similarity=0.307 Sum_probs=202.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|+.||+|+++.... ....+.+.+|+++|++++||||+++++++.......+++|||
T Consensus 16 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 16 ILGQGATA---NVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EecCCCCe---EEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 37788877 899999999999999999986543 234567789999999999999999999998877668999999
Q ss_pred cCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEE----eCCCCcEEEeecchhhhc
Q 006593 81 LFTSGNLRQYRKKHKN---VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV----NGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~---l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl----~~~~g~VKL~DFGlA~~l 153 (639)
|+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||+ + ..+.+||+|||++...
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEccCCCceec
Confidence 9999999999986543 999999999999999999999999 9999999999998 4 3467999999999766
Q ss_pred cCC-CCccccCCCCcCCccccc---------ccCCccccccchhhhhhhhhhccCCCCCCCC---HHHHHHHHHcCCCCC
Q 006593 154 QQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTFEYPYSECKN---PAQIFKKVTSGIKPA 220 (639)
Q Consensus 154 ~~~-~~~~~~GTp~ymAPE~l~---------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~---~~~i~~~i~~g~~p~ 220 (639)
... ......||+.|+|||++. ..|+.++|||||||++|+|+||..||..... ...+...+..+.++.
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 543 334567999999999874 4689999999999999999999999964333 234444444433221
Q ss_pred -----------------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcc
Q 006593 221 -----------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 221 -----------------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
.+....++.+.+||.+||. ||.+|||++|+|+||-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 1112224578999999999 9999999999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=365.41 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=204.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEeccccc----CChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL----QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~----~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||+|+|| .||+|.+..+|..||+|++...... ........+.+|+.+|++++||||+++++++.... +++
T Consensus 18 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~l 91 (322)
T 2ycf_A 18 LGSGACG---EVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED---YYI 91 (322)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS---EEE
T ss_pred EecCCCE---EEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc---eEE
Confidence 6777777 8999999999999999999765431 11233456889999999999999999999875432 789
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhccC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~~ 155 (639)
||||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+ .+.+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 92 VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp EEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred EEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence 9999999999999998889999999999999999999999999 9999999999999743 23599999999976543
Q ss_pred CC-CccccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCCh
Q 006593 156 PT-ARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDP 228 (639)
Q Consensus 156 ~~-~~~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~ 228 (639)
.. .....||+.|+|||++. ..++.++|||||||++|+|++|..||........+...+..+... .......++
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (322)
T 2ycf_A 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249 (322)
T ss_dssp CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCH
Confidence 32 23457999999999873 458999999999999999999999998755444455555554332 223345678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.+++||.+||. +|.+||++.++|+||||+....
T Consensus 250 ~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 99999999999 9999999999999999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=356.24 Aligned_cols=247 Identities=25% Similarity=0.470 Sum_probs=184.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++...... .....+++.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 19 lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 92 (278)
T 3cok_A 19 LGKGSFA---GVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS--NYVYLVLEM 92 (278)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred ecCCCce---EEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC--CeEEEEEec
Confidence 6777777 8999999999999999999755321 123357799999999999999999999998664 568999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+++|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...... ..
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEECC------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeeccCCCCcc
Confidence 9999999999875 67999999999999999999999999 99999999999997 5579999999999765432 23
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
....||+.|+|||++.. .++.++||||||+++|+|++|..||...... .....+... ....+...++++++||.+|
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVVLA--DYEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHHHHHHHHHH
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHhhc--ccCCccccCHHHHHHHHHH
Confidence 35679999999998864 5889999999999999999999999764332 222222211 1234455688999999999
Q ss_pred cC-CCCCCCCHHHHhcCccccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
|. +|.+|||+.++|+||||....
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC---
T ss_pred cccCHhhCCCHHHHhcCccccCCC
Confidence 99 899999999999999997543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=393.05 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=215.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|+.||+|++....... ....+.+..|+.+|++++||||++++++|.+. ..+|+|||
T Consensus 192 ~LG~G~fG---~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~l~lVmE 265 (543)
T 3c4z_A 192 VLGRGGFG---EVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETK--TDLCLVMT 265 (543)
T ss_dssp EEEECSSS---EEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeeCCCe---EEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC--CEEEEEEE
Confidence 38888888 89999999999999999998654321 23456789999999999999999999998765 46999999
Q ss_pred cCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYRKKH----KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~----~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|+.||+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.+...
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecceeeeccCC
Confidence 99999999999864 36999999999999999999999999 99999999999998 5589999999999876543
Q ss_pred C--CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC---CHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 157 T--ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 157 ~--~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
. ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.... ....+...+..+.. .++...++++
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 420 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKFSPAS 420 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTSCHHH
T ss_pred CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCcccCHHH
Confidence 2 345689999999998865 59999999999999999999999997642 45667777766533 3456678999
Q ss_pred HHHHHHhcC-CCCCCCC-----HHHHhcCcccccccCCC
Q 006593 231 KGFIEKCLV-PASERLS-----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpS-----a~ELL~Hpff~~~~~~~ 263 (639)
++||.+||. +|.+||+ ++++++||||+...|..
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~ 459 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ 459 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHH
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHH
Confidence 999999999 8999995 59999999999876643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=354.79 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=212.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|++..... ......+.+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus 22 ~lg~G~~g---~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 95 (294)
T 2rku_A 22 FLGKGGFA---KCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFVFVVLE 95 (294)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred EEeecCCE---EEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC--CEEEEEEe
Confidence 37888888 899999999999999999986643 2345677899999999999999999999988654 56899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~ 158 (639)
|+.+++|.++++..+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..... ...
T Consensus 96 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCB
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCceecccCcccc
Confidence 9999999999998889999999999999999999999999 99999999999998 557999999999976542 233
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
....||+.|+|||++.. .++.++||||||+++|+|++|..||.. ....+.+..+..+.. .++...++.+.+||.+|
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAASLIQKM 249 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHH
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhccC--CCccccCHHHHHHHHHH
Confidence 45679999999998864 588999999999999999999999986 445555555555432 34556788999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|. +|.+|||+.|+|+||||...
T Consensus 250 l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 250 LQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTS
T ss_pred cccChhhCcCHHHHhhChheecC
Confidence 99 89999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=366.29 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=194.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|+++.... ......+.+|+.+|++++||||+++++++... ..+++||||
T Consensus 10 lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~ 81 (324)
T 3mtl_A 10 LGEGTYA---TVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE--KSLTLVFEY 81 (324)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECS--SCEEEEEEC
T ss_pred EcCCCCE---EEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeC--CEEEEEecc
Confidence 6777777 899999999999999999875542 12222356799999999999999999998765 458999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+. |+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++...... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccCCcccc
Confidence 97 5999988875 45999999999999999999999999 99999999999998 4579999999999755432 23
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc---CCCCCcc-----------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPASL----------- 222 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~---g~~p~~l----------- 222 (639)
....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. +..+....+.. ...+..+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS-TVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 34578999999998754 5899999999999999999999999874 34443333322 1111111
Q ss_pred --------------cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 223 --------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 223 --------------~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
....++++++||.+||. ||.+|||++|+|+||||......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 12346789999999999 99999999999999999876543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=356.98 Aligned_cols=245 Identities=30% Similarity=0.538 Sum_probs=203.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++.... ..+.+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 37 lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 105 (314)
T 3com_A 37 LGEGSYG---SVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKN--TDLWIVMEY 105 (314)
T ss_dssp CC----C---EEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred eccCCCe---EEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeC--CEEEEEeec
Confidence 6778887 89999999999999999998543 235688999999999999999999998765 458999999
Q ss_pred CCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lk-k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
+.+|+|.+++. ....+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++...... ..
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECBTTBSCB
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecccchhhhhhcccc
Confidence 99999999997 4578999999999999999999999999 99999999999997 4579999999999765433 23
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCC-CCCcccCCCChHHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGI-KPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~-~p~~l~~~~s~~l~~LI~k 236 (639)
....||+.|+|||++.. .++.++||||||+++|+|++|..||.... .......+.... .....+...++.+.+||.+
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-PMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence 45679999999998864 58999999999999999999999998744 333333333332 2233445568899999999
Q ss_pred hcC-CCCCCCCHHHHhcCcccccccC
Q 006593 237 CLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
||. +|.+|||+.++|+||||+....
T Consensus 262 ~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 262 CLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HccCChhhCcCHHHHHhCHHHhcCCc
Confidence 999 8999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=375.57 Aligned_cols=246 Identities=19% Similarity=0.301 Sum_probs=198.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----CCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----KKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~----~~~~l~ 76 (639)
+||+|+|| +||+|.+..+|+.||||++..... ...+|+++|+.|+|||||+++++|... +..+++
T Consensus 61 ~lG~G~fg---~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 61 VIGNGSFG---VVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred EEeeCCCE---EEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 37888888 899999999999999999875432 124799999999999999999988653 234678
Q ss_pred EEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 77 MITELFTSGNLRQYRK----KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lk----k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+||||+.+ +|.+++. ....+++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|||+++.
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 99999986 6665554 3567999999999999999999999999 999999999999986667899999999986
Q ss_pred ccCC-CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CC-----------
Q 006593 153 MQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI----------- 217 (639)
Q Consensus 153 l~~~-~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~----------- 217 (639)
+... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++.+.+.. +.
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 5432 3345789999999998753 5899999999999999999999999875544444333321 00
Q ss_pred --CCCc------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 218 --KPAS------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 218 --~p~~------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.... +....++++++||.+||. +|.+||++.|+|+||||+...
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000 123457899999999999 999999999999999997644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=369.02 Aligned_cols=242 Identities=22% Similarity=0.359 Sum_probs=203.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|+|| +||+|.+..+|..||+|+++....... ....+.+.+|+.+|++++||||++++++|.+. ..++
T Consensus 31 ~lG~G~~g---~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--~~~~ 105 (335)
T 3dls_A 31 PLGSGAFG---FVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ--GFFQ 105 (335)
T ss_dssp ECSSSSSC---SEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS--SEEE
T ss_pred EEEecCCE---EEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC--CEEE
Confidence 37888888 799999999999999999987653221 11334577899999999999999999998654 5689
Q ss_pred EEEecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSG-NLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gG-sL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.....
T Consensus 106 lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCT
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeecccceECCC
Confidence 999999777 99999999989999999999999999999999999 99999999999998 458999999999976654
Q ss_pred C-CCccccCCCCcCCcccccc-cC-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 156 P-TARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 156 ~-~~~~~~GTp~ymAPE~l~~-~y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
. .....+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ... .....+...++++++
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~--~~~~~~~~~~~~l~~ 253 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVE--AAIHPPYLVSKELMS 253 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTT--TCCCCSSCCCHHHHH
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHh--hccCCCcccCHHHHH
Confidence 3 3345689999999998864 34 7899999999999999999999975211 111 112234456889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
||.+||. +|.+|||+.++|+||||+..
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHccCChhhCcCHHHHhcCccccCC
Confidence 9999999 89999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=358.48 Aligned_cols=251 Identities=26% Similarity=0.467 Sum_probs=183.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|++..... ....+.+.+|+.++++++||||+++++++...+ .+++|||
T Consensus 22 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e 93 (303)
T 2vwi_A 22 VIGSGATA---VVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD--ELWLVMK 93 (303)
T ss_dssp ECC---CC---CEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSS--CEEEEEE
T ss_pred eeccccce---EEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--CcEEEeh
Confidence 37888888 799999999999999999876542 344567889999999999999999999987664 4899999
Q ss_pred cCCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 81 LFTSGNLRQYRKK--------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 81 y~~gGsL~d~lkk--------~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
|+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||+++ .+|.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEEeccchhe
Confidence 9999999999974 456999999999999999999999999 99999999999997 457999999999976
Q ss_pred ccCC-------CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC----
Q 006593 153 MQQP-------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP---- 219 (639)
Q Consensus 153 l~~~-------~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p---- 219 (639)
.... ......||+.|+|||++.. .++.++||||||+++|+|++|..||............+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 5422 1234579999999998864 58999999999999999999999998754444333333222111
Q ss_pred ---CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 220 ---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 220 ---~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
.......++++++||.+||. +|.+||++.++|+||||+.....
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 12234557899999999999 89999999999999999865543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=363.16 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=212.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..++..||+|++..... ......+.+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus 48 ~lg~G~~g---~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 121 (335)
T 2owb_A 48 FLGKGGFA---KCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN--DFVFVVLE 121 (335)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CeEEEEEe
Confidence 37888887 899999999999999999986543 2346678899999999999999999999998764 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ..
T Consensus 122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCB
T ss_pred cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCceecccCcccc
Confidence 9999999999998889999999999999999999999999 99999999999998 5579999999999765422 23
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
....||+.|+|||++.. .++.++||||||+++|+|++|..||.. ......+..+..+.. .++...++.+++||.+|
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNEY--SIPKHINPVAASLIQKM 275 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHH
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHH
Confidence 45679999999998864 588999999999999999999999986 345555555555432 24556788999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|. +|.+||++.|+|+||||...
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccCChhHCcCHHHHhcCccccCC
Confidence 99 89999999999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=373.83 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=207.3
Q ss_pred cccccccCcEEEEEEEec---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||+|+|| +||+|.+. .+|..||+|+++...........+.+.+|+++|+++ +||||+++++++... ..+++
T Consensus 62 lG~G~~g---~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~l 136 (355)
T 1vzo_A 62 LGTGAYG---KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE--TKLHL 136 (355)
T ss_dssp EEETTTE---EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--TEEEE
T ss_pred eccCCCE---EEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--ceEEE
Confidence 7888887 89999884 589999999987654322223345577899999999 799999999998765 45899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+++.....
T Consensus 137 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 137 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGG
T ss_pred EeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCeecccCC
Confidence 9999999999999998889999999999999999999999999 99999999999997 4579999999999754321
Q ss_pred --CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCC---CCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 157 --TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 157 --~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~---~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|..||... .....+...+..... .++...++
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 291 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSA 291 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCH
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCCcccCH
Confidence 2335689999999998863 4789999999999999999999999642 234555555554432 23455678
Q ss_pred HHHHHHHHhcC-CCCCCC-----CHHHHhcCcccccccCC
Q 006593 229 QIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQK 262 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~ 262 (639)
.+++||.+||. +|.+|| ++.|+++||||+..++.
T Consensus 292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 99999999999 899999 99999999999876654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=353.13 Aligned_cols=245 Identities=29% Similarity=0.508 Sum_probs=210.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++..... ....+.+.+|+.++++++||||+++++++... ..+++||||
T Consensus 30 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 101 (303)
T 3a7i_A 30 IGKGSFG---EVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIMEY 101 (303)
T ss_dssp EEECSSS---EEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred hcccCCe---EEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEEe
Confidence 7888888 899999999999999999986653 34567899999999999999999999998775 468999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++...... ...
T Consensus 102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECBTTBCCBC
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeecccceecCccccccC
Confidence 999999999875 57999999999999999999999999 99999999999997 5579999999999765433 234
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
...||+.|+|||++.. .++.++||||||+++|+|++|..||... ........+..+.. ..+....++.+++||.+||
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 255 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACL 255 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHC
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-CHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHc
Confidence 5679999999998864 5899999999999999999999999873 45555555555443 3455667889999999999
Q ss_pred C-CCCCCCCHHHHhcCccccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. +|.+|||+.++|+||||....
T Consensus 256 ~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 256 NKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CSSGGGSCCHHHHTTCHHHHHHC
T ss_pred CCChhhCcCHHHHhhChhhhcCC
Confidence 9 899999999999999997543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=352.04 Aligned_cols=245 Identities=32% Similarity=0.489 Sum_probs=199.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---------
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--------- 71 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~--------- 71 (639)
+||+|+|| +||+|.+..+|..||+|++... ....+.+.+|+.++++++||||++++++|.+..
T Consensus 13 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 13 VLGQGAFG---QVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred eeccCCcE---EEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 36777777 8999999999999999998643 355678999999999999999999999987642
Q ss_pred --CceEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 72 --KKTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 72 --~~~l~lV~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
...+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg 161 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFG 161 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEEEeeCc
Confidence 457899999999999999998654 5889999999999999999999999 99999999999997 55799999999
Q ss_pred hhhhccCC----------------CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHH
Q 006593 149 LAIAMQQP----------------TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIF 210 (639)
Q Consensus 149 lA~~l~~~----------------~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~ 210 (639)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ ||....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 98755321 1234579999999998864 58999999999999999998 665433444555
Q ss_pred HHHHcCC--CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 211 KKVTSGI--KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 211 ~~i~~g~--~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
..+.... .+..+....++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 5555432 2344555567789999999999 89999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.82 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=198.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~-~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|..||+|+++....... ....+.+.+|+.+|++++||||++++++|.+. ..+++||
T Consensus 17 ~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 91 (346)
T 1ua2_A 17 FLGEGQFA---TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--SNISLVF 91 (346)
T ss_dssp EEEEETTE---EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--TCCEEEE
T ss_pred EEeecCCE---EEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--CceEEEE
Confidence 36777777 899999999999999999876543211 11234688999999999999999999988654 4588999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 80 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
||+.+ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 92 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp ECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCC
T ss_pred EcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccceeccCCcc
Confidence 99986 899888765 46899999999999999999999999 99999999999998 4579999999999876433
Q ss_pred CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCC-CCcc---------
Q 006593 157 TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK-PASL--------- 222 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~-p~~l--------- 222 (639)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.. ....+..+.. +.. ...+
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLPDY 246 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence 2345689999999998853 48999999999999999999999998744 4443333322 111 1111
Q ss_pred --------------cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 223 --------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 223 --------------~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
....++++++||.+||. +|.+|||+.|+|+||||+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 13346789999999999 9999999999999999986543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=372.89 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=187.3
Q ss_pred CcccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
+||+|+|| +||+|.+. .++..||+|++..... ...+.+|+.+|++|+||||++++++|.......+++|
T Consensus 28 ~lG~G~~g---~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 28 KVGRGTYG---HVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp CCC--------EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred EeeecCCe---EEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 36777777 89999965 6789999999875432 2457899999999999999999999988777889999
Q ss_pred EecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe---CCCCcEEEee
Q 006593 79 TELFTSGNLRQYRKKH---------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---GNHGEVKIGD 146 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~---------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~---~~~g~VKL~D 146 (639)
|||+. |+|.+++..+ ..+++..++.|+.||+.||.|||++| |+||||||+|||+. ...+.+||+|
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99996 5888887632 24999999999999999999999999 99999999999993 2457999999
Q ss_pred cchhhhccCC-----CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCC---------HHHHH
Q 006593 147 LGLAIAMQQP-----TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKN---------PAQIF 210 (639)
Q Consensus 147 FGlA~~l~~~-----~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~---------~~~i~ 210 (639)
||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... ..++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999765432 2345689999999998864 489999999999999999999999965322 12221
Q ss_pred HHHH-cCCCCCc-cc---------------------------------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 211 KKVT-SGIKPAS-LA---------------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 211 ~~i~-~g~~p~~-l~---------------------------------~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
..+. -+..+.. +. ...++.+.+||.+||. ||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 1111 0111110 00 1126789999999999 999999999999999
Q ss_pred ccccccC
Q 006593 255 FLQVENQ 261 (639)
Q Consensus 255 ff~~~~~ 261 (639)
||+....
T Consensus 336 ~f~~~~~ 342 (405)
T 3rgf_A 336 YFLEDPL 342 (405)
T ss_dssp GGTSSSC
T ss_pred hhccCCC
Confidence 9986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=371.09 Aligned_cols=246 Identities=30% Similarity=0.415 Sum_probs=185.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~l 77 (639)
||+|+|| .||+|.+..+|..||+|++.... ......+++.+|+.+|+.++||||+++++++.... ...+|+
T Consensus 37 lG~G~~g---~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 37 VGSGAYG---SVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp CC----C---CEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EeecCCe---EEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 7888888 79999999999999999987543 24556778999999999999999999999886532 245789
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+ +++|.++++. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 112 v~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~- 185 (367)
T 2fst_X 112 VTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTADE- 185 (367)
T ss_dssp EEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC-----------
T ss_pred Eeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeecccccccccc-
Confidence 99999 7899999876 67999999999999999999999999 99999999999998 5579999999999765433
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCC---------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK--------------- 218 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~--------------- 218 (639)
.....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....+ +..+.. +.+
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 345689999999998764 589999999999999999999999987543333 322221 110
Q ss_pred ---------CC---cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 219 ---------PA---SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 219 ---------p~---~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.. ......++.+++||.+||. ||.+|||+.|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 00 0112347889999999999 99999999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=353.21 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=200.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|.+..... ......+++.+|+.++++++||||+++++++... ..+|+||||
T Consensus 19 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 92 (294)
T 4eqm_A 19 LGGGGMS---TVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--DCYYLVMEY 92 (294)
T ss_dssp EEEETTE---EEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EccCCCE---EEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC--CeEEEEEeC
Confidence 6777777 899999999999999999976543 3456678899999999999999999999987654 569999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---CC
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~~ 158 (639)
+.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++...... ..
T Consensus 93 ~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 93 IEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTTC--------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCcccccccccccc
Confidence 999999999999889999999999999999999999999 99999999999997 4579999999999766432 22
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~LI~ 235 (639)
...+||+.|+|||++.+ .++.++||||||+++|+|+||..||.+........+.+...... .......++.+.++|.
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 249 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVIL 249 (294)
T ss_dssp -----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHH
T ss_pred CccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHH
Confidence 34679999999998864 58899999999999999999999998744333334444333222 1234556789999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
+||. +|.+||+..+.+.+.|..
T Consensus 250 ~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 250 RATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHhcCCHhHccccHHHHHHHHHH
Confidence 9999 899999766666666654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=364.54 Aligned_cols=247 Identities=24% Similarity=0.369 Sum_probs=201.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---CceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~---~~~l~lV 78 (639)
||+|+|| .||+|.+..+|..||+|++.... .....+++.+|+.+|++++||||+++++++.... ...+++|
T Consensus 35 lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 35 IGEGAYG---MVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eecCCCe---EEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 6778777 89999999999999999987533 3456678999999999999999999999886543 2468999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|||+. |+|.++++. +.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 109 ~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 109 QDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGC
T ss_pred EcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEecCCCCC
Confidence 99997 599999976 46999999999999999999999999 99999999999997 5579999999999765422
Q ss_pred ---CCccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCC-----------
Q 006593 157 ---TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP----------- 219 (639)
Q Consensus 157 ---~~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p----------- 219 (639)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+...+.. +..+
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 124568999999999764 34899999999999999999999999875433332222110 0000
Q ss_pred ----------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 220 ----------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 220 ----------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01123457899999999999 99999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=352.75 Aligned_cols=247 Identities=24% Similarity=0.393 Sum_probs=198.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----------
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----------- 70 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~----------- 70 (639)
||+|+|| +||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 19 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 19 LGCGGNG---LVFSAVDNDCDKRVAIKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp CC--------CEEEEEETTTTEEEEEEEEECCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred eccCCCe---EEEEEEECCCCeEEEEEEEecCC----hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 6777777 89999999999999999987553 46678899999999999999999999987432
Q ss_pred -CCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 71 -KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 71 -~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
....+++||||+. |+|.+++++ +.+++..++.++.||+.||.|||++| |+||||||+|||++.+++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 2357899999997 699999865 56999999999999999999999999 999999999999986667999999999
Q ss_pred hhhccCC-----CCccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC---
Q 006593 150 AIAMQQP-----TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--- 219 (639)
Q Consensus 150 A~~l~~~-----~~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--- 219 (639)
+...... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.. .......+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH-ELEQMQLILESIPVVHE 246 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHSCCCCH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCch
Confidence 9765321 223456899999999775 468999999999999999999999998744 33333333322110
Q ss_pred -------------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 -------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 -------------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.......++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 11223467899999999999 999999999999999998543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=368.00 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=196.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~ 76 (639)
+||+|+|| +||+|.+..++. ||+|++...... ..+|+++|+.++||||++++++|.... ..+++
T Consensus 47 ~lG~G~~g---~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 47 VIGNGSFG---VVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEETTE---EEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred EEeeCCCe---EEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 37888887 899999987766 888888654321 236999999999999999999987643 23588
Q ss_pred EEEecCCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 77 MITELFTSGNLRQYR---KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 77 lV~Ey~~gGsL~d~l---kk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
+||||+.++.+..+. +....+++..++.|+.||+.||.|||++| |+||||||+|||++...|.+||+|||+|+..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999999875444332 33578999999999999999999999999 9999999999999856689999999999765
Q ss_pred cC-CCCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCC-----------
Q 006593 154 QQ-PTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIK----------- 218 (639)
Q Consensus 154 ~~-~~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~----------- 218 (639)
.. .......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....++...+.. +..
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 43 33446789999999998753 5899999999999999999999999875544444332221 000
Q ss_pred ------C--------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 219 ------P--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 219 ------p--------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+ ..++...++++++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 0 01223467899999999999 9999999999999999986554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.24 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=200.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---CceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~---~~~l~lV 78 (639)
||+|+|| +||+|.+..+|..||+|++.... .......+.+|+.+|++++||||+++++++.... ...+++|
T Consensus 19 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 19 LGEGAYG---VVCSATHKPTGEIVAIKKIEPFD---KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECCCS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred EcCCCCe---EEEEEEECCCCcEEEEEeecccc---cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 6788887 89999999999999999986432 3556678899999999999999999999875432 2568999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.......
T Consensus 93 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp ECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECC----
T ss_pred EeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEecccccccccccc
Confidence 99997 699999887 56999999999999999999999999 99999999999997 45799999999997654221
Q ss_pred -----------CccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCC----
Q 006593 158 -----------ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKP---- 219 (639)
Q Consensus 158 -----------~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p---- 219 (639)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+......+...... +..+
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 22357899999999764 45899999999999999999999999874433322211110 1000
Q ss_pred ------------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 220 ------------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 220 ------------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.......++++++||.+||. ||.+|||+.|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 01123457889999999999 9999999999999999986543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.58 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=209.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh-------------hhHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP-------------GDLQKLYSEVHLLKSLKDDNVVKFYKSWV 68 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~-------------~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~ 68 (639)
||+|+|| .||+|.+ +|..||+|++......... ...+.+.+|+.++++++||||+++++++.
T Consensus 39 lg~G~~g---~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 113 (348)
T 2pml_X 39 LNQGKFN---KIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113 (348)
T ss_dssp EECCSSC---CEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred EcCCCCe---EEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 7888888 7999998 8999999999865432211 11277999999999999999999999987
Q ss_pred eCCCceEEEEEecCCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCC
Q 006593 69 DDKKKTVNMITELFTSGNLRQY------RKK--HKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNH 139 (639)
Q Consensus 69 ~~~~~~l~lV~Ey~~gGsL~d~------lkk--~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~ 139 (639)
+. ..+++||||+.+|+|.++ +.+ ...+++..++.++.||+.||.|||+ +| |+||||||+|||++ .+
T Consensus 114 ~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~-~~ 188 (348)
T 2pml_X 114 NY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMD-KN 188 (348)
T ss_dssp SS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEEC-TT
T ss_pred eC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEc-CC
Confidence 65 469999999999999998 665 5779999999999999999999999 88 99999999999997 55
Q ss_pred CcEEEeecchhhhccCCCCccccCCCCcCCccccccc--CCc-cccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC
Q 006593 140 GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNE-LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG 216 (639)
Q Consensus 140 g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~~--ys~-ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g 216 (639)
+.+||+|||++............||+.|+|||++.+. ++. ++||||||+++|+|++|..||........+...+..+
T Consensus 189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 7999999999987655555567899999999988753 555 9999999999999999999998766657777777765
Q ss_pred CCCCcc-----------------cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 217 IKPASL-----------------AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 217 ~~p~~l-----------------~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
...... ....++++++||.+||. +|.+|||+.|+|+||||+..+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 433221 14567899999999999 899999999999999998654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.29 Aligned_cols=245 Identities=23% Similarity=0.416 Sum_probs=205.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~--HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| .||+|.+. +|..||+|++..... .....+.+.+|+.+|++++ ||||+++++++... ..+++||
T Consensus 36 lg~G~~g---~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~~~lv~ 107 (313)
T 3cek_A 36 IGSGGSS---KVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYIYMVM 107 (313)
T ss_dssp EECCSSE---EEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--SEEEEEE
T ss_pred ecCCCCE---EEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecC--CEEEEEE
Confidence 6777777 89999985 589999999987653 4566788999999999997 59999999988765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
| +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ + |.+||+|||++.......
T Consensus 108 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-T-TEEEECCCSSSCC-------
T ss_pred e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-C-CeEEEeeccccccccCcccc
Confidence 9 568899999999899999999999999999999999999 99999999999997 3 799999999997654322
Q ss_pred --CccccCCCCcCCcccccc------------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 006593 158 --ARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 223 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~~------------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 223 (639)
.....||+.|+|||++.. .++.++||||||+++|+|++|..||............+........++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 234579999999998753 588899999999999999999999987666655666666655555566
Q ss_pred CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 224 KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 224 ~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
...++.+++||.+||. +|.+||++.|+|+||||+..
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 6678899999999999 89999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=377.09 Aligned_cols=241 Identities=16% Similarity=0.171 Sum_probs=190.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHH---HHHHhCCCCCcceEE-------EEEEeCC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEV---HLLKSLKDDNVVKFY-------KSWVDDK 71 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei---~iLk~L~HpNIVkl~-------~~~~~~~ 71 (639)
||+|+|| +||+|.+..+|+.||+|++...... .....+.+.+|+ ++|++++|||||+++ +++.+.+
T Consensus 81 lG~G~~g---~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 81 LGQEDPY---AYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEETTE---EEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred eecCCCE---EEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 6777777 8999999999999999999865432 345678899999 555666899999998 6654432
Q ss_pred C----------c-----eEEEEEecCCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCeeeeccC
Q 006593 72 K----------K-----TVNMITELFTSGNLRQYRKKHKNVDI-------KVIKNWARQILHGLVYLHSHNPPIIHRDLK 129 (639)
Q Consensus 72 ~----------~-----~l~lV~Ey~~gGsL~d~lkk~~~l~e-------~~i~~i~~QIl~aL~yLHs~gppIIHRDLK 129 (639)
. . ..|+||||+ +|+|.+++.+.+.+++ ..++.|+.||+.||.|||++| |+|||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDik 233 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLR 233 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence 1 1 378999999 6899999987665655 888899999999999999999 9999999
Q ss_pred CCcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCcCCcccccc------------cCCccccccchhhhhhhhhhcc
Q 006593 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE------------EYNELVDIYSFGMCILEMVTFE 197 (639)
Q Consensus 130 p~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~------------~ys~ksDIwSlGiil~ELltG~ 197 (639)
|+|||++ .+|.+||+|||+++.... .....+| +.|+|||++.. .|+.++|||||||++|||++|.
T Consensus 234 p~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 234 PVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp GGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred HHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 9999998 457999999999975433 3345678 99999998864 5999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 198 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 198 ~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.||.+.. .......+.. .....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 311 ~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 311 LPITKDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp CCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred CCCcccc-cccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9997532 1111111111 123557899999999999 89999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.33 Aligned_cols=249 Identities=21% Similarity=0.270 Sum_probs=190.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----CceE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK-----KKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~-----~~~l 75 (639)
+||+|+|| +||+|.+..+|..||+|++..... ...+...+++.++.++||||++++++|.... ..++
T Consensus 30 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 30 MAGQGTFG---TVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp ------------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred EEecCCCe---EEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 47888888 799999999999999999865432 2234677888899999999999999987632 2358
Q ss_pred EEEEecCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 76 NMITELFTSGNLRQYR----KKHKNVDIKVIKNWARQILHGLVYLH--SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~l----kk~~~l~e~~i~~i~~QIl~aL~yLH--s~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
++||||+.++ |...+ .....+++..++.++.||+.||.||| ++| |+||||||+|||++..++.+||+|||+
T Consensus 102 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 102 NVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 8999999874 44333 35677999999999999999999999 888 999999999999986568999999999
Q ss_pred hhhccCC-CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CCC-----
Q 006593 150 AIAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP----- 219 (639)
Q Consensus 150 A~~l~~~-~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~p----- 219 (639)
+...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....+..+... ..+
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-SAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-hHHHHHHHHHHcCCCCHHHHH
Confidence 9766533 3345679999999998753 48999999999999999999999998744 43333333221 000
Q ss_pred -----------------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 220 -----------------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 220 -----------------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.......++++++||.+||+ +|.+|||+.|+|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00111135689999999999 9999999999999999986544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=364.56 Aligned_cols=245 Identities=28% Similarity=0.392 Sum_probs=191.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~l 77 (639)
||+|+|| +||+|.+..+|..||+|++.... ......+.+.+|+.+++.++||||+++++++..... ..+|+
T Consensus 33 lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 33 IGSGAQG---IVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEecCCE---EEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 6777777 89999999999999999998643 245667789999999999999999999999865432 37899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 108 v~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 108 VMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC--------
T ss_pred EEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeeccccccccc
Confidence 999997 47888886 45899999999999999999999999 99999999999998 4579999999999766533
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc--------------
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-------------- 221 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-------------- 221 (639)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.. ....+..+........
T Consensus 182 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 260 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260 (371)
T ss_dssp --------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHC-CCCCCHHHHTTSCHHHHHH
T ss_pred ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 2345689999999998764 58999999999999999999999998743 4444444433211100
Q ss_pred --------------------cc------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 222 --------------------LA------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 222 --------------------l~------~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
++ ...++++++||.+||. ||.+|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00 0014578999999999 9999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.81 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=197.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC------CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL------KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L------~HpNIVkl~~~~~~~~~~~ 74 (639)
+||+|+|| +||+|.+..+|..||+|+++.. ....+.+..|+.+++.+ +|+||+++++++... ..
T Consensus 104 ~LG~G~fg---~V~~a~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~ 173 (429)
T 3kvw_A 104 VIGKGSFG---QVVKAYDHKVHQHVALKMVRNE-----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--NH 173 (429)
T ss_dssp EEEESSSE---EEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--TE
T ss_pred EcccCccE---EEEEEEECCCCcEEEEEEECCc-----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--Ce
Confidence 36777777 8999999999999999998743 34456778899988887 577999999998765 46
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc--EEEeecchh
Q 006593 75 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--VKIGDLGLA 150 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~--VKL~DFGlA 150 (639)
+++||||+. |+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceEEeecccc
Confidence 999999996 69999998764 4999999999999999999999999 9999999999999744 55 999999999
Q ss_pred hhccCCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCCC--------
Q 006593 151 IAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPA-------- 220 (639)
Q Consensus 151 ~~l~~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~-------- 220 (639)
..... .....+||+.|+|||++.+ .|+.++|||||||++|||+||..||.+......+...+.. +..+.
T Consensus 250 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 250 CYEHQ-RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp EETTC-CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred eecCC-cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 65443 3446789999999998764 6999999999999999999999999875433333222211 11100
Q ss_pred -----------------------------------------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 221 -----------------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 221 -----------------------------------------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.+....++.+++||.+||. ||.+|||+.|+|+
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 0112336789999999999 9999999999999
Q ss_pred CcccccccC
Q 006593 253 DPFLQVENQ 261 (639)
Q Consensus 253 Hpff~~~~~ 261 (639)
||||+....
T Consensus 409 Hpw~~~~~~ 417 (429)
T 3kvw_A 409 HPWLRRRLP 417 (429)
T ss_dssp STTTC----
T ss_pred ChhhccCCC
Confidence 999986543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=345.08 Aligned_cols=244 Identities=26% Similarity=0.415 Sum_probs=191.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+. |..||+|+++...........+.+.+|+.+++.++||||+++++++... ..+++|||
T Consensus 14 ~lg~G~~g---~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e 86 (271)
T 3dtc_A 14 IIGIGGFG---KVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--PNLCLVME 86 (271)
T ss_dssp EEEEETTE---EEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----CEEEEE
T ss_pred eeccCCCe---EEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC--CceEEEEE
Confidence 37788887 89999974 8999999988665433345567899999999999999999999988654 45889999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeeeeccCCCcEEEeC-------CCCcEEEeecchhhh
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNP-PIIHRDLKCDNIFVNG-------NHGEVKIGDLGLAIA 152 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gp-pIIHRDLKp~NILl~~-------~~g~VKL~DFGlA~~ 152 (639)
|+.+|+|.+++. .+.+++..++.++.||+.||.|||+++. +|+||||||+|||++. ..+.+||+|||++..
T Consensus 87 ~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 999999999986 4679999999999999999999999983 4889999999999974 257899999999987
Q ss_pred ccCCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 153 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 153 l~~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
..........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+. +.......+.........+...++.++
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (271)
T 3dtc_A 166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAMNKLALPIPSTCPEPFA 244 (271)
T ss_dssp ----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHhhhcCCCCCCCCcccCHHHH
Confidence 66555556789999999998864 5899999999999999999999999874 444455555555555556677789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+||.+||. +|.+|||+.|+++|
T Consensus 245 ~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 245 KLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999 89999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.38 Aligned_cols=239 Identities=17% Similarity=0.268 Sum_probs=201.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. |..||+|+++.... .....+.+.+|+.+|++++||||+++++++.+.....+++||||
T Consensus 18 lg~G~~g---~V~~~~~~--~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 18 LNENHSG---ELWKGRWQ--GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp EEEETTE---EEEEEEET--TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hcCCCcc---eEEEEEEC--CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 6777777 89999985 88999999987643 45666789999999999999999999999877655678999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++++|+||||||+|||++ .+|.++|+|||++..... .
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~~~---~ 166 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQS---P 166 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTTSC---T
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceeeecc---c
Confidence 99999999998765 48999999999999999999999988899999999999997 557999999888754322 3
Q ss_pred cccCCCCcCCccccccc----CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 160 SVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~~----ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
...||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.. .......+.........+...++.+.+||.
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISPHVSKLMK 245 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCCHHHHHHHH
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 45789999999988643 3447999999999999999999998744 444444454444444566777899999999
Q ss_pred HhcC-CCCCCCCHHHHhc
Q 006593 236 KCLV-PASERLSAKDLLK 252 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~ 252 (639)
+||. +|.+|||+.++++
T Consensus 246 ~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 246 ICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9999 8999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.54 Aligned_cols=236 Identities=26% Similarity=0.379 Sum_probs=195.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|.+... .....+.+.+|+.+|++++||||+++++++.+. ..+++|||
T Consensus 17 ~lG~G~~g---~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e 87 (310)
T 3s95_A 17 VLGKGCFG---QAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNFITE 87 (310)
T ss_dssp EEECCSSE---EEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred eecCCCCE---EEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEEEEE
Confidence 37888888 8999999999999999988543 356778899999999999999999999998776 45899999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
|+.+|+|.++++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceeccccccc
Confidence 9999999999987 567999999999999999999999999 99999999999998 557999999999976532211
Q ss_pred ---------------ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHH----HHHHHHcCCC
Q 006593 159 ---------------RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ----IFKKVTSGIK 218 (639)
Q Consensus 159 ---------------~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~----i~~~i~~g~~ 218 (639)
...+||+.|+|||++.+ .++.++||||||+++|+|++|..||........ ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence 15679999999998874 589999999999999999999999865322110 01111111
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+...++.+.+||.+||. +|.+|||+.++++
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 243 --YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp --TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1234556789999999999 8999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=359.72 Aligned_cols=241 Identities=23% Similarity=0.352 Sum_probs=203.5
Q ss_pred cccccccCcEEEEEEE-----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~-----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l 75 (639)
||+|+|| .||+|. +..+|+.||+|+++... .....+.+.+|+.+|+++ +||||+++++++...+ ..+
T Consensus 30 lG~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~-~~~ 102 (359)
T 3vhe_A 30 LGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPL 102 (359)
T ss_dssp EEECSSE---EEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-SCC
T ss_pred ecCCCCc---eEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-Cce
Confidence 6778777 899998 66788999999997543 345667899999999999 8999999999886643 458
Q ss_pred EEEEecCCCCCHHHHHHhCCC-----------------------------------------------------------
Q 006593 76 NMITELFTSGNLRQYRKKHKN----------------------------------------------------------- 96 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~----------------------------------------------------------- 96 (639)
++|||||.+|+|.+++.....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 899999999999999987543
Q ss_pred -------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC----CccccCCC
Q 006593 97 -------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTP 165 (639)
Q Consensus 97 -------l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp 165 (639)
+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++....... .....||+
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhccccCCCc
Confidence 899999999999999999999999 99999999999997 45799999999997653321 23456899
Q ss_pred CcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCC
Q 006593 166 EFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PAS 242 (639)
Q Consensus 166 ~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~ 242 (639)
.|+|||++. ..|+.++|||||||++|+|+| |..||.+......+...+..+..+ ..+...++++.++|.+||. +|.
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~ 338 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPS 338 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChh
Confidence 999999876 468999999999999999998 999998866666666666655433 3456678899999999999 899
Q ss_pred CCCCHHHHhcC
Q 006593 243 ERLSAKDLLKD 253 (639)
Q Consensus 243 ~RpSa~ELL~H 253 (639)
+|||+.|+++|
T Consensus 339 ~Rps~~ell~~ 349 (359)
T 3vhe_A 339 QRPTFSELVEH 349 (359)
T ss_dssp GSCCHHHHHHH
T ss_pred hCCCHHHHHHH
Confidence 99999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=361.44 Aligned_cols=245 Identities=28% Similarity=0.382 Sum_probs=197.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCc----eEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK----TVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~----~l~l 77 (639)
||+|+|| +||+|.+..+|..||+|++.... ......+.+.+|+.+|+.++||||+++++++...... .+++
T Consensus 50 lG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 50 VGSGAYG---SVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEE
Confidence 6778777 89999999999999999987543 2445678899999999999999999999998665432 2489
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 125 v~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~- 197 (371)
T 4exu_A 125 VMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE- 197 (371)
T ss_dssp EEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC-------
T ss_pred EEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccccccC-
Confidence 999997 68988774 45999999999999999999999999 99999999999997 5579999999999765433
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCCC--------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKP-------------- 219 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p-------------- 219 (639)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+....+.. +..+
T Consensus 198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp --CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 345689999999998764 68999999999999999999999998744 3333333221 1110
Q ss_pred -------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 220 -------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 220 -------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.......++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 01123457899999999999 99999999999999999854
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=343.16 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=200.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhH---HHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDL---QKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~---~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|+|| +||+|.+..++..||+|++............ +.+.+|+.++++++||||+++++++.+. .++
T Consensus 26 ~lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~l 98 (287)
T 4f0f_A 26 QIGKGGFG---LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP----PRM 98 (287)
T ss_dssp ECCCCSSS---CEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT----TEE
T ss_pred ccccCCce---eEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC----CeE
Confidence 37888888 7999999999999999998766543322222 6789999999999999999999987433 258
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc-----EEEeecchhh
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-----VKIGDLGLAI 151 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~-----VKL~DFGlA~ 151 (639)
||||+.+|+|.+++... ..+++..++.++.||+.||.|||++|++|+||||||+|||++.+ +. +||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKVADFGLSQ 177 (287)
T ss_dssp EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEECCCTTCB
T ss_pred EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEeCCCCccc
Confidence 99999999999988754 47999999999999999999999999889999999999999743 44 9999999997
Q ss_pred hccCCCCccccCCCCcCCccccc---ccCCccccccchhhhhhhhhhccCCCCCCCCHH-HHHHHHHcCCCCCcccCCCC
Q 006593 152 AMQQPTARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-QIFKKVTSGIKPASLAKVND 227 (639)
Q Consensus 152 ~l~~~~~~~~~GTp~ymAPE~l~---~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~-~i~~~i~~g~~p~~l~~~~s 227 (639)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... .....+........++...+
T Consensus 178 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T 4f0f_A 178 QSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256 (287)
T ss_dssp CCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred cccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccC
Confidence 5433 234568999999999883 347899999999999999999999998654333 33444444445555667778
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 228 PQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+++||.+||. +|.+|||+.++++
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 257 PRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999 8999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=349.52 Aligned_cols=251 Identities=29% Similarity=0.408 Sum_probs=199.6
Q ss_pred cccccccCcEEEEEEEec-CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceEEEEEEe---CCCce
Q 006593 2 VLTGLYMTPFSSYKAFDE-FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVD---DKKKT 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~~~~---~~~~~ 74 (639)
||+|+|| +||+|.+. .+|..||+|+++..... ......+.+|+.+++.+ +||||+++++++.. .....
T Consensus 19 lg~G~~g---~V~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 19 IGEGAYG---KVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEETTE---EEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred ecccccE---EEEEEEecCCCCEEEEEEEeccCccc--ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 6777777 89999995 67999999999865431 12223456777777766 89999999998863 23457
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 75 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
+++||||+. |+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++..
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCC
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEecCccccc
Confidence 899999998 69999998754 4999999999999999999999999 99999999999997 557999999999976
Q ss_pred ccCC-CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CC----------
Q 006593 153 MQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK---------- 218 (639)
Q Consensus 153 l~~~-~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~---------- 218 (639)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.. .......+... ..
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (326)
T 1blx_A 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKILDVIGLPGEEDWPRDVA 248 (326)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred ccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHHcCCCCcccCccccc
Confidence 5422 234567999999999876 458999999999999999999999998744 33333333211 00
Q ss_pred -------------CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccCC
Q 006593 219 -------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQK 262 (639)
Q Consensus 219 -------------p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~ 262 (639)
...+....++.+++||.+||. +|.+|||+.|+|+||||+.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 011224467889999999999 89999999999999999865443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.43 Aligned_cols=247 Identities=20% Similarity=0.294 Sum_probs=176.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~--~~~~l~lV 78 (639)
+||+|+|| +||+|.+..+|+.||+|++.... .. .......++.+.||||+++++++... ....+++|
T Consensus 36 ~lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~-----~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 36 VLGLGVNG---KVLECFHRRTGQKCALKLLYDSP-----KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEESSH-----HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred eeeeCCCe---EEEEEEECCCCCEEEEEEecCcH-----HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 36777777 89999999999999999986432 11 22333446777999999999998652 24568999
Q ss_pred EecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhcc
Q 006593 79 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~ 154 (639)
|||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. ..+.+||+|||++....
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 99999999999998764 6999999999999999999999999 999999999999973 24569999999998766
Q ss_pred CCCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHH---HHHHHHcCC--CCCcccCCCCh
Q 006593 155 QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ---IFKKVTSGI--KPASLAKVNDP 228 (639)
Q Consensus 155 ~~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~---i~~~i~~g~--~p~~l~~~~s~ 228 (639)
.......+||+.|+|||++. ..|+.++||||||+++|+|++|..||........ ....+..+. .+.......++
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T 3fhr_A 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence 55556678999999999885 4589999999999999999999999975322211 112222221 12223345688
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 99999999999 899999999999999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=361.30 Aligned_cols=239 Identities=26% Similarity=0.399 Sum_probs=201.8
Q ss_pred cccccccCcEEEEEEEec-------CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCc
Q 006593 2 VLTGLYMTPFSSYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 73 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-------~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~ 73 (639)
||+|+|| +||+|.+. .++..||+|+++... .....+.+.+|+.+|+.+ +||||+++++++... .
T Consensus 89 LG~G~fg---~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~ 160 (370)
T 2psq_A 89 LGEGCFG---QVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--G 160 (370)
T ss_dssp ESCCSSS---EEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS--S
T ss_pred EeeCCCe---eEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC--C
Confidence 7888888 89999874 456789999987543 345677899999999999 899999999988654 4
Q ss_pred eEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC
Q 006593 74 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~ 137 (639)
.+|+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~- 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT- 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC-
Confidence 5899999999999999998754 4789999999999999999999999 99999999999997
Q ss_pred CCCcEEEeecchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHH
Q 006593 138 NHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 211 (639)
Q Consensus 138 ~~g~VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~ 211 (639)
.+|.+||+|||+++..... ......||+.|+|||++. ..|+.++|||||||++|||+| |..||.+ ....+++.
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~-~~~~~~~~ 316 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFK 316 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 5589999999999765432 123346788999999876 459999999999999999999 9999987 45566667
Q ss_pred HHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 212 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 212 ~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+..+..+ ..+...++++.+||.+||. +|.+||++.|++++
T Consensus 317 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 317 LLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77666543 3455678899999999999 89999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=355.66 Aligned_cols=245 Identities=28% Similarity=0.380 Sum_probs=197.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC----ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK----KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~----~~l~l 77 (639)
||+|+|| +||+|.+..+|..||+|++.... ......+++.+|+.+|+.++||||+++++++..... ..+++
T Consensus 32 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 32 VGSGAYG---SVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEE
Confidence 6778877 89999999999999999987543 244567789999999999999999999999866543 23589
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+. |+|.+++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++......
T Consensus 107 v~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~- 179 (353)
T 3coi_A 107 VMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE- 179 (353)
T ss_dssp EEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTTC-----
T ss_pred Eecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeecccccCCCCC-
Confidence 999997 68888774 35999999999999999999999999 99999999999998 5579999999999765432
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CC----------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI---------------- 217 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~---------------- 217 (639)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....+..+.. +.
T Consensus 180 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp ----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC-HHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 345688999999998764 58999999999999999999999998743 3333322211 00
Q ss_pred -----------CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 218 -----------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 218 -----------~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.........++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0011223457899999999999 99999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.70 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=193.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC--------CCCcceEEEEEEeC--C
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK--------DDNVVKFYKSWVDD--K 71 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~--------HpNIVkl~~~~~~~--~ 71 (639)
||+|+|| +||+|.+..+|+.||+|+++.. ....+.+.+|+.+|+.++ |+||++++++|... .
T Consensus 45 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 45 LGWGHFS---TVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred eeecCCe---eEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 6777777 8999999999999999998743 355678899999999995 78899999998743 3
Q ss_pred CceEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCC---------
Q 006593 72 KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNH--------- 139 (639)
Q Consensus 72 ~~~l~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~--------- 139 (639)
...+++||||+ +|+|.+++.+. +.+++..++.++.||+.||.|||++ | |+||||||+|||++.+.
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhhhhh
Confidence 45799999999 56666666544 5699999999999999999999998 8 99999999999997432
Q ss_pred ---------------------------------------CcEEEeecchhhhccCCCCccccCCCCcCCcccccc-cCCc
Q 006593 140 ---------------------------------------GEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNE 179 (639)
Q Consensus 140 ---------------------------------------g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~-~ys~ 179 (639)
..+||+|||++...... ....+||+.|+|||++.+ .|+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSCCCT
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCCCCCc
Confidence 27999999999766543 345689999999998864 5999
Q ss_pred cccccchhhhhhhhhhccCCCCCCCC-----HHHHHHHHH--cCCCCC--------------------------------
Q 006593 180 LVDIYSFGMCILEMVTFEYPYSECKN-----PAQIFKKVT--SGIKPA-------------------------------- 220 (639)
Q Consensus 180 ksDIwSlGiil~ELltG~~Pf~~~~~-----~~~i~~~i~--~g~~p~-------------------------------- 220 (639)
++|||||||++|+|+||..||..... .......+. .+..+.
T Consensus 273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence 99999999999999999999975332 111111111 111110
Q ss_pred ------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccc
Q 006593 221 ------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 221 ------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~ 257 (639)
.++...++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0011123568899999999 999999999999999996
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=367.08 Aligned_cols=250 Identities=12% Similarity=0.121 Sum_probs=184.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC--CCCCcceEE-------EEEEeCCC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL--KDDNVVKFY-------KSWVDDKK 72 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVkl~-------~~~~~~~~ 72 (639)
||+|+|| +||+|.+..+|..||+|++..... ......+.+.+|+.+++.| +||||++++ +++.....
T Consensus 70 lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 70 LRVGDRS---VVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred ccCCCCE---EEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence 6777777 899999999999999999997653 2345567788886555555 699988766 44443332
Q ss_pred ---------------ceEEEEEecCCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCeeeeccCC
Q 006593 73 ---------------KTVNMITELFTSGNLRQYRKKH-KNVDIKVI------KNWARQILHGLVYLHSHNPPIIHRDLKC 130 (639)
Q Consensus 73 ---------------~~l~lV~Ey~~gGsL~d~lkk~-~~l~e~~i------~~i~~QIl~aL~yLHs~gppIIHRDLKp 130 (639)
..+|+||||+. |+|.+++... ..++...+ ..++.||+.||.|||++| |+||||||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp 222 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTP 222 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCH
Confidence 45899999998 8999999864 33444555 577799999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCCCCHH
Q 006593 131 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSECKNPA 207 (639)
Q Consensus 131 ~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~ 207 (639)
+|||++ .+|.+||+|||+++...... ....+|+.|+|||++.. .|+.++|||||||++|+|+||..||.+.....
T Consensus 223 ~NIll~-~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 223 DNLFIM-PDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp GGEEEC-TTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred HHEEEC-CCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 999998 55899999999997654322 24567799999998864 58999999999999999999999997642110
Q ss_pred -HHHHH---HHcC--CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 208 -QIFKK---VTSG--IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 208 -~i~~~---i~~g--~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
..+.. .... ..........++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 00000 0001 11111223567899999999999 999999999999999998543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=360.50 Aligned_cols=246 Identities=20% Similarity=0.315 Sum_probs=204.3
Q ss_pred cccccccCcEEEEEEE-----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~-----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| +||+|. +..++..||+|+++... .......+.+|+.+|++++||||+++++++.... ..+
T Consensus 79 LG~G~fg---~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~ 150 (367)
T 3l9p_A 79 LGHGAFG---EVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL--PRF 150 (367)
T ss_dssp CCCCSSS---CEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCE
T ss_pred eeeCCCE---EEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--CCE
Confidence 7888888 799998 56688999999986432 4556677899999999999999999999886554 478
Q ss_pred EEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeec
Q 006593 77 MITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDL 147 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~-------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DF 147 (639)
+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++. +...+||+||
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCC
Confidence 9999999999999998643 5899999999999999999999999 999999999999973 2336999999
Q ss_pred chhhhccC----CCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc
Q 006593 148 GLAIAMQQ----PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS 221 (639)
Q Consensus 148 GlA~~l~~----~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~ 221 (639)
|+++.... .......||+.|+|||++. ..|+.++|||||||++|||++ |..||.. .....+...+..+..+ .
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~~~~-~ 306 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-D 306 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-C
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-C
Confidence 99975532 2233467899999999875 569999999999999999998 9999987 4567777777776543 3
Q ss_pred ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 222 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 222 l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.+...++.+.+||.+||. +|.+||++.+|++|.++...
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 345667899999999999 89999999999999877543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=356.91 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=192.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEeccccc-------CChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL-------QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--- 71 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~-------~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~--- 71 (639)
||+|+|| .||+|.+.. |..||+|++...... ......+.+.+|+.+|++++||||+++++++....
T Consensus 30 lg~G~~g---~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 30 ISSGSYG---AVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEETTE---EEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred eccCCCE---EEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence 6777777 899999865 999999998654321 12334578999999999999999999999987633
Q ss_pred CceEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 72 KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 72 ~~~l~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
...+|+||||+. |+|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~ 181 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDITICDFNLA 181 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCTTC-
T ss_pred cceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEEEEecCcc
Confidence 347899999998 6888888754 47999999999999999999999999 99999999999997 4579999999999
Q ss_pred hhccCC-CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CC-------
Q 006593 151 IAMQQP-TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IK------- 218 (639)
Q Consensus 151 ~~l~~~-~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~------- 218 (639)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. .......+... ..
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 260 (362)
T 3pg1_A 182 REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST-FYNQLNKIVEVVGTPKIEDVVM 260 (362)
T ss_dssp --------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHHH
T ss_pred cccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHcCCCChHHhhh
Confidence 754432 3345679999999998764 58999999999999999999999998743 33333333210 00
Q ss_pred -----------------C----CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 219 -----------------P----ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 219 -----------------p----~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+ .......++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 0 01123447889999999999 99999999999999999854
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=349.76 Aligned_cols=244 Identities=21% Similarity=0.331 Sum_probs=196.5
Q ss_pred cccccccCcEEEEEEEe-cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC------cceEEEEEEeCCCce
Q 006593 2 VLTGLYMTPFSSYKAFD-EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN------VVKFYKSWVDDKKKT 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d-~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN------IVkl~~~~~~~~~~~ 74 (639)
||+|+|| +||+|.+ ..+|..||+|+++.. ....+.+.+|+.+++.++|++ |+++++++... ..
T Consensus 22 lg~G~~g---~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~--~~ 91 (339)
T 1z57_A 22 LGEGAFG---KVVECIDHKAGGRHVAVKIVKNV-----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH--GH 91 (339)
T ss_dssp EEEETTE---EEEEEEETTTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--TE
T ss_pred EecCCCe---EEEEEEecCCCCcEEEEEEEecC-----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--Cc
Confidence 6777777 8999999 568999999998743 345677899999999997654 99999988765 46
Q ss_pred EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--------------
Q 006593 75 VNMITELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN-------------- 138 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~-------------- 138 (639)
+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++..
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcccccc
Confidence 99999999 889999998765 6899999999999999999999999 9999999999999742
Q ss_pred ----CCcEEEeecchhhhccCCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHH
Q 006593 139 ----HGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 139 ----~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i 213 (639)
.+.+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... .+....+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~ 246 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS-KEHLAMM 246 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH-HHHHHHH
T ss_pred ccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Confidence 46799999999976443 2345689999999998864 689999999999999999999999987433 3322222
Q ss_pred Hc--CCCCCc----------------------------------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 006593 214 TS--GIKPAS----------------------------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDL 250 (639)
Q Consensus 214 ~~--g~~p~~----------------------------------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~EL 250 (639)
.. +..|.. .....++.+.+||.+||. ||.+|||+.|+
T Consensus 247 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 247 ERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 11 111100 011123578899999999 99999999999
Q ss_pred hcCccccccc
Q 006593 251 LKDPFLQVEN 260 (639)
Q Consensus 251 L~Hpff~~~~ 260 (639)
|+||||+...
T Consensus 327 l~hp~f~~~~ 336 (339)
T 1z57_A 327 LKHPFFDLLK 336 (339)
T ss_dssp TTSGGGGGGG
T ss_pred hcCHHHHHHh
Confidence 9999998543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=345.19 Aligned_cols=248 Identities=21% Similarity=0.389 Sum_probs=191.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|++..... .....+.+..+..+++.++||||+++++++... ..+++||||
T Consensus 33 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~--~~~~lv~e~ 105 (318)
T 2dyl_A 33 MGSGTCG---QVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN--TDVFIAMEL 105 (318)
T ss_dssp C---------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEECC
T ss_pred eeecCCe---eEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC--CcEEEEEec
Confidence 6777777 899999999999999999986542 223334455555678888999999999998765 469999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
+ ++.+..++.. .+.+++..++.++.||+.||.|||+. | |+||||||+|||++ ..+.+||+|||++...... ..
T Consensus 106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC---------
T ss_pred c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchhccCCccc
Confidence 9 5677766654 57799999999999999999999995 8 99999999999997 5579999999999765432 23
Q ss_pred ccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc-ccCCCChHHH
Q 006593 159 RSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS-LAKVNDPQIK 231 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~-l~~~~s~~l~ 231 (639)
....||+.|+|||++. ..++.++||||||+++|+|++|..||............+..+..+.. .....+++++
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHH
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHH
Confidence 3457999999999874 35889999999999999999999999887677777776666544322 2234678999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||.+||. +|.+||++.++|+||||+...
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 99999999 899999999999999998544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=345.94 Aligned_cols=239 Identities=26% Similarity=0.395 Sum_probs=202.0
Q ss_pred cccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| .||+|.+ ..++..||+|+++... .....+.+.+|+.+|++++||||+++++++.+. ..++
T Consensus 31 lg~G~~g---~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 102 (314)
T 2ivs_A 31 LGEGEFG---KVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD--GPLL 102 (314)
T ss_dssp EEECSSS---EEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSCE
T ss_pred ecccCCe---eEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC--CceE
Confidence 7888888 8999988 4566899999987543 456778899999999999999999999988654 4588
Q ss_pred EEEecCCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCc
Q 006593 77 MITELFTSGNLRQYRKKHKN------------------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~------------------------l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~N 132 (639)
+||||+.+|+|.+++...+. +++..++.++.||+.||.|||++| |+||||||+|
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~N 180 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARN 180 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccccchhe
Confidence 99999999999999987543 899999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCH
Q 006593 133 IFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNP 206 (639)
Q Consensus 133 ILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~ 206 (639)
||++ ..+.+||+|||++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ ...
T Consensus 181 Ili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~ 258 (314)
T 2ivs_A 181 ILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IPP 258 (314)
T ss_dssp EEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCG
T ss_pred EEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC-CCH
Confidence 9998 55799999999997654321 234467889999998764 58999999999999999999 9999987 445
Q ss_pred HHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 207 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 207 ~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+...+..+..+ ..+...++.+.+||.+||. +|.+||++.+++++
T Consensus 259 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 259 ERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5666666665433 3455678899999999999 89999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.15 Aligned_cols=251 Identities=20% Similarity=0.308 Sum_probs=187.0
Q ss_pred cccccccCcEEEEEEEecCCCe---EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCc----e
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK----T 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~---~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~----~ 74 (639)
||+|+|| +||+|.+..++. .||+|+++.... .....+.+.+|+.++++++||||+++++++...... .
T Consensus 31 lg~G~~g---~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 31 LGKGEFG---SVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEETTE---EEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred ecccCCe---EEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 6777777 899999887775 899999876542 335678899999999999999999999998765432 2
Q ss_pred EEEEEecCCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 75 VNMITELFTSGNLRQYRKKHK------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
.++||||+.+|+|.+++.... .+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~~~~kl~Dfg 182 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-EDMTVCVADFG 182 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CCCCEEEeecc
Confidence 489999999999999996543 5999999999999999999999999 99999999999998 45799999999
Q ss_pred hhhhccCCC----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 149 LAIAMQQPT----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 149 lA~~l~~~~----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
++....... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+. +...+...+..+..+ ..
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~ 260 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLIGGNRL-KQ 260 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CC
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHHHhcCCCC-CC
Confidence 997654321 223457889999998864 58999999999999999999 89999874 445566666655433 33
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCC-------HHHHhcCcccccccCC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLS-------AKDLLKDPFLQVENQK 262 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpS-------a~ELL~Hpff~~~~~~ 262 (639)
+...++++++||.+||. +|.+||| +++++.|||+......
T Consensus 261 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 261 PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 45567899999999999 8999999 7888999999765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=351.82 Aligned_cols=240 Identities=18% Similarity=0.303 Sum_probs=199.7
Q ss_pred CcccccccCcEEEEEEEecCCC---eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG---~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| +||+|.+..+| ..||+|+++... .....+.+.+|+.+|++++||||+++++++.+. ..+++
T Consensus 56 ~lG~G~~g---~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l 127 (325)
T 3kul_A 56 IIGSGDSG---EVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG--RLAMI 127 (325)
T ss_dssp EEEETTTE---EEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG--GCCEE
T ss_pred EEEeCCCc---EEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CccEE
Confidence 37888887 89999997555 459999987542 355677899999999999999999999988554 45889
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.++++.. +.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECCCCcccccccC
Confidence 99999999999999765 57999999999999999999999999 99999999999997 5579999999999766432
Q ss_pred C-----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 157 T-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 157 ~-----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
. .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+ .....+...+..+..+ ..+...++.
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 282 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL-PAPMGCPHA 282 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHH
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC-CCCCCcCHH
Confidence 1 12235678899999887 468999999999999999999 9999987 4566677777666443 244566889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.+||.+||. +|.+|||+.++++.
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999 89999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=351.84 Aligned_cols=248 Identities=23% Similarity=0.419 Sum_probs=182.0
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| .||+|.+..+|..||+|+++... .......+..|+. +++.++||||+++++++... ..+++|||
T Consensus 30 lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~~~~lv~e 101 (327)
T 3aln_A 30 IGRGAYG---SVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--GDCWICME 101 (327)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred eccCCCE---EEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--CceEEEEe
Confidence 6777777 89999999999999999998653 2344455666666 77788999999999998765 46899999
Q ss_pred cCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 81 LFTSGNLRQYRKK-----HKNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 81 y~~gGsL~d~lkk-----~~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
|+.+ +|.+++.. ...+++..++.++.||+.||.|||+. | |+||||||+|||++ ..|.+||+|||++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEccCCCceecc
Confidence 9985 88888764 56799999999999999999999998 8 99999999999998 55799999999997654
Q ss_pred CCC-CccccCCCCcCCccccc-----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC---cccCC
Q 006593 155 QPT-ARSVIGTPEFMAPELYE-----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLAKV 225 (639)
Q Consensus 155 ~~~-~~~~~GTp~ymAPE~l~-----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~---~l~~~ 225 (639)
... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+..........+..+..+. .....
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence 332 23347999999999873 3589999999999999999999999986443333333333332221 12234
Q ss_pred CChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 226 NDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 226 ~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.++.+++||.+||. +|.+||++.++|+||||.....
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 67899999999999 8999999999999999986544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.54 Aligned_cols=236 Identities=17% Similarity=0.375 Sum_probs=200.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. ++..||+|++..... ..+.+.+|+.+|++++||||+++++++.+. ..+++||||
T Consensus 18 lg~G~~g---~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 86 (269)
T 4hcu_A 18 IGSGQFG---LVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVFEF 86 (269)
T ss_dssp EEECSSC---EEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEEEEC
T ss_pred ecCCCcc---EEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CceEEEEEe
Confidence 6788888 89999986 578899999985542 235689999999999999999999988654 458999999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---C
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~ 157 (639)
+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++...... .
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEecccccccccccccccc
Confidence 9999999999764 46899999999999999999999999 99999999999997 4579999999999765432 2
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
.....||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...++.+.+||.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIMN 241 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHHHHHHHH
Confidence 23446788999999886 568999999999999999999 9999987 5566777777766443 345556889999999
Q ss_pred HhcC-CCCCCCCHHHHhcC
Q 006593 236 KCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~H 253 (639)
+||. +|.+||++.++++|
T Consensus 242 ~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 9999 89999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.58 Aligned_cols=243 Identities=20% Similarity=0.333 Sum_probs=204.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh--hhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP--GDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~--~~~~~l~~Ei~iLk~L~--HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+|.+..+|..||+|+++........ ...+++.+|+.+++++. ||||+++++++... ..++
T Consensus 50 ~lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~--~~~~ 124 (320)
T 3a99_A 50 LLGSGGFG---SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP--DSFV 124 (320)
T ss_dssp ECSSSSSC---EEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--SEEE
T ss_pred EEeeCCCe---EEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC--CcEE
Confidence 37888888 8999999999999999999876532210 12245678999999996 59999999988765 4689
Q ss_pred EEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~g-GsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+.+.+||+|||++.....
T Consensus 125 lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 125 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202 (320)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence 99999976 899999998889999999999999999999999999 999999999999986668999999999987766
Q ss_pred CCCccccCCCCcCCcccccc-c-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 156 PTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.......||+.|+|||++.. . ++.++||||||+++|+|++|..||.. ... +..+. ..++...++++++|
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~---~~~----~~~~~--~~~~~~~~~~~~~l 273 (320)
T 3a99_A 203 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQ--VFFRQRVSSECQHL 273 (320)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCC--CCCSSCCCHHHHHH
T ss_pred ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC---hhh----hhccc--ccccccCCHHHHHH
Confidence 55566789999999998864 3 47889999999999999999999965 222 22221 22345568899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|.+||. +|.+|||+.|+++||||+..
T Consensus 274 i~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 274 IRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 999999 89999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=351.30 Aligned_cols=239 Identities=25% Similarity=0.309 Sum_probs=192.4
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--CceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK--KKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~--~~~l~lV 78 (639)
+||+|+|| +||+|.+. |..||+|++.... ........|+.+|++++||||+++++++.... ...+++|
T Consensus 31 ~lg~G~~g---~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 31 VKARGRFG---CVWKAQLL--NEYVAVKIFPIQD-----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp EEECSTTC---EEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred eecccCce---EEEEEEEC--CCEEEEEEeecCc-----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 37888888 89999875 8999999987543 34455677999999999999999999998754 3468999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH----------NPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~----------gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
|||+.+|+|.++++.. .+++..++.++.||+.||.|||+. + |+||||||+|||++ ..+.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCCEEECCCT
T ss_pred EecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCeEEEccCC
Confidence 9999999999999874 599999999999999999999999 8 99999999999997 55799999999
Q ss_pred hhhhccCC----CCccccCCCCcCCcccccc------cCCccccccchhhhhhhhhhccCCCCCCC--------------
Q 006593 149 LAIAMQQP----TARSVIGTPEFMAPELYEE------EYNELVDIYSFGMCILEMVTFEYPYSECK-------------- 204 (639)
Q Consensus 149 lA~~l~~~----~~~~~~GTp~ymAPE~l~~------~ys~ksDIwSlGiil~ELltG~~Pf~~~~-------------- 204 (639)
+++..... .....+||+.|+|||++.+ .++.++|||||||++|||+||..||.+..
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99765432 2234679999999998864 46788999999999999999999996532
Q ss_pred -CHHHHHHHHHcCCCCCcccCCC-----ChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 205 -NPAQIFKKVTSGIKPASLAKVN-----DPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 205 -~~~~i~~~i~~g~~p~~l~~~~-----s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
....+...+........+.... ++++.+||.+||. +|.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2333344443333332222211 2459999999999 99999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=358.64 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=195.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CC-----CcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DD-----NVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-Hp-----NIVkl~~~~~~~~~~~l 75 (639)
||+|+|| +||+|.+..+|+.||+|+++.. ......+..|+.+++.++ |+ +|+++++++... ..+
T Consensus 62 lG~G~~g---~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~~ 131 (382)
T 2vx3_A 62 IGKGSFG---QVVKAYDRVEQEWVAIKIIKNK-----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--NHL 131 (382)
T ss_dssp EEEETTE---EEEEEEETTTTEEEEEEEECSS-----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--TEE
T ss_pred EeecCCE---EEEEEEEcCCCcEEEEEEEecc-----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--Cce
Confidence 6777777 8999999999999999998743 345667888999999885 55 499999998776 469
Q ss_pred EEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC-CCCcEEEeecchhhh
Q 006593 76 NMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIA 152 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~-~~g~VKL~DFGlA~~ 152 (639)
++||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. ..+.+||+|||++..
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 99999996 5999999875 4699999999999999999999964334999999999999953 357899999999976
Q ss_pred ccCCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCCCCccc------
Q 006593 153 MQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIKPASLA------ 223 (639)
Q Consensus 153 l~~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~p~~l~------ 223 (639)
.... ....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.. ..+.+..+.. +..+....
T Consensus 211 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 211 LGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN-EVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp TTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred cccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 6433 346789999999998864 59999999999999999999999998744 4443333322 11110000
Q ss_pred --------C----------------------------------------------CCChHHHHHHHHhcC-CCCCCCCHH
Q 006593 224 --------K----------------------------------------------VNDPQIKGFIEKCLV-PASERLSAK 248 (639)
Q Consensus 224 --------~----------------------------------------------~~s~~l~~LI~kcL~-dP~~RpSa~ 248 (639)
. ...+++++||.+||. ||.+|||+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 0 001378999999999 999999999
Q ss_pred HHhcCcccccc
Q 006593 249 DLLKDPFLQVE 259 (639)
Q Consensus 249 ELL~Hpff~~~ 259 (639)
|+|+||||+..
T Consensus 369 e~L~hp~f~~~ 379 (382)
T 2vx3_A 369 YALQHSFFKKT 379 (382)
T ss_dssp HHTTSGGGCC-
T ss_pred HHhcCcccccC
Confidence 99999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=350.69 Aligned_cols=244 Identities=20% Similarity=0.334 Sum_probs=198.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh--hhHHHHHHHHHHHHhC----CCCCcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP--GDLQKLYSEVHLLKSL----KDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~--~~~~~l~~Ei~iLk~L----~HpNIVkl~~~~~~~~~~~l 75 (639)
||+|+|| .||+|.+..+|..||+|++......... .....+.+|+.+++++ +||||+++++++... ..+
T Consensus 39 lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~--~~~ 113 (312)
T 2iwi_A 39 LGKGGFG---TVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ--EGF 113 (312)
T ss_dssp EEEETTE---EEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-------C
T ss_pred EEcCCCE---EEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC--CeE
Confidence 6777777 8999999999999999999765432111 2234466899999999 899999999988665 457
Q ss_pred EEEEec-CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 76 NMITEL-FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 76 ~lV~Ey-~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++...|.+||+|||++....
T Consensus 114 ~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~ 191 (312)
T 2iwi_A 114 MLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191 (312)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcc
Confidence 899999 789999999998888999999999999999999999999 99999999999998566899999999998776
Q ss_pred CCCCccccCCCCcCCcccccc-cC-CccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 155 QPTARSVIGTPEFMAPELYEE-EY-NELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 155 ~~~~~~~~GTp~ymAPE~l~~-~y-s~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
........||+.|+|||++.. .+ +.++||||||+++|+|++|..||.. ...+ ... ...++...++.+++
T Consensus 192 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~---~~~~----~~~--~~~~~~~~~~~~~~ 262 (312)
T 2iwi_A 192 DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER---DQEI----LEA--ELHFPAHVSPDCCA 262 (312)
T ss_dssp SSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHHH----HHT--CCCCCTTSCHHHHH
T ss_pred cCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC---hHHH----hhh--ccCCcccCCHHHHH
Confidence 665667789999999998864 34 5689999999999999999999975 2222 221 12244556889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
||.+||. +|.+|||+.|+|+||||+....
T Consensus 263 li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 263 LIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred HHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 9999999 8999999999999999986544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.54 Aligned_cols=239 Identities=19% Similarity=0.267 Sum_probs=202.2
Q ss_pred cccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| .||+|.+. .++..||+|+++... .....+.+.+|+.+|++++||||+++++++.+. ..++
T Consensus 55 lg~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~ 126 (343)
T 1luf_A 55 IGEGAFG---RVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--KPMC 126 (343)
T ss_dssp EEECSSC---EEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCE
T ss_pred eeecCCe---eEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--CceE
Confidence 7888888 89999987 456999999987543 355677899999999999999999999988654 4589
Q ss_pred EEEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCc
Q 006593 77 MITELFTSGNLRQYRKKH------------------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~------------------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~N 132 (639)
+||||+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~N 204 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRN 204 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcce
Confidence 999999999999999874 56999999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeecchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCH
Q 006593 133 IFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNP 206 (639)
Q Consensus 133 ILl~~~~g~VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~ 206 (639)
||++ .++.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|+| |..||.+ .+.
T Consensus 205 Il~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~ 282 (343)
T 1luf_A 205 CLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAH 282 (343)
T ss_dssp EEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCH
T ss_pred EEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC-CCh
Confidence 9997 4579999999999765422 223456899999999876 468999999999999999999 9999987 456
Q ss_pred HHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 207 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 207 ~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.++...+..+..+ ..+...++.+.+||.+||. +|.+||++.+++++
T Consensus 283 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 283 EEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 6677777666443 3455678899999999999 89999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.12 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=200.1
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
.||+|+|| +||+|.+ ..++..||+|+++... .....+.+.+|+.+|+++ +||||+++++++... ..
T Consensus 52 ~lG~G~~g---~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~ 123 (344)
T 1rjb_A 52 VLGSGAFG---KVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS--GP 123 (344)
T ss_dssp EEEECSSE---EEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SS
T ss_pred eecCCCCc---eeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--Cc
Confidence 37888887 8999997 4567899999997543 234557899999999999 999999999988665 45
Q ss_pred EEEEEecCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCC
Q 006593 75 VNMITELFTSGNLRQYRKKHK-----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~-----------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~ 131 (639)
+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~ 201 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAAR 201 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChh
Confidence 889999999999999998653 2799999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCC
Q 006593 132 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKN 205 (639)
Q Consensus 132 NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~ 205 (639)
|||++ .++.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+...
T Consensus 202 NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99998 45799999999997654332 22346788999999875 568999999999999999998 9999988665
Q ss_pred HHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcc
Q 006593 206 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 206 ~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
.......+..+..+ ..+...++++.+||.+||. +|.+|||+.++++|..
T Consensus 281 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 281 DANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp SHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 66666656555333 3455668899999999999 8999999999998753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=343.19 Aligned_cols=238 Identities=27% Similarity=0.408 Sum_probs=194.0
Q ss_pred cccccccCcEEEEEEE----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||+|+|| +||+|. +..+|..||+|++... .....+.+.+|+.+|++++||||+++++++...+...+++
T Consensus 18 lg~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 18 LGKGNFG---SVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp EEECSSE---EEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred eeccCCE---EEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 6777777 899998 6789999999998744 3466778999999999999999999999987655556899
Q ss_pred EEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++......
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCSCC-----
T ss_pred EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEccCcccccccCC
Confidence 999999999999998765 4999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred C-----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHH-----------------HHHHHH
Q 006593 157 T-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPA-----------------QIFKKV 213 (639)
Q Consensus 157 ~-----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~-----------------~i~~~i 213 (639)
. .....||+.|+|||++. ..++.++||||||+++|+|+||..||... +. .+...+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH--HHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC--hHHHHhhhcCccccchhHHHHHHHH
Confidence 1 22345778899999886 46899999999999999999999998541 11 122223
Q ss_pred HcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 214 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 214 ~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+. ....+...++++.+||.+||. +|.+|||+.|+++
T Consensus 246 ~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 246 KNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 3332 223455678899999999999 8999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=354.84 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=195.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-----------CCCcceEEEEEEeC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----------DDNVVKFYKSWVDD 70 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-----------HpNIVkl~~~~~~~ 70 (639)
||+|+|| +||+|.+..+|..||+|++... ....+.+.+|+.+++++. ||||+++++++...
T Consensus 27 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 27 LGWGHFS---TVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eeecCCe---EEEEEEecCCCcEEEEEEecCC-----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 6777777 8999999999999999998743 345567889999999886 89999999998764
Q ss_pred C--CceEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeccCCCcEEEeC-----CCC
Q 006593 71 K--KKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSH-NPPIIHRDLKCDNIFVNG-----NHG 140 (639)
Q Consensus 71 ~--~~~l~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~-gppIIHRDLKp~NILl~~-----~~g 140 (639)
. ...+++||||+ +++|.+++... +.+++..++.++.||+.||.|||++ | |+||||||+|||++. ..+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcc
Confidence 3 33789999999 89999999874 4599999999999999999999998 9 999999999999952 334
Q ss_pred cEEEeecchhhhccCCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCC-----HHHHHHHHH
Q 006593 141 EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN-----PAQIFKKVT 214 (639)
Q Consensus 141 ~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~-----~~~i~~~i~ 214 (639)
.+||+|||++...... .....||+.|+|||++.+ .|+.++|||||||++|+|+||..||..... .......+.
T Consensus 176 ~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp EEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 7999999999766543 345689999999998864 589999999999999999999999975321 111111111
Q ss_pred c--CCCCC--------------------------------------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 215 S--GIKPA--------------------------------------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 215 ~--g~~p~--------------------------------------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
. +..|. .++...++++++||.+||. ||.+|||+.|+|+|
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 1 11110 1112234678999999999 99999999999999
Q ss_pred ccccccc
Q 006593 254 PFLQVEN 260 (639)
Q Consensus 254 pff~~~~ 260 (639)
|||+...
T Consensus 335 p~f~~~~ 341 (373)
T 1q8y_A 335 PWLKDTL 341 (373)
T ss_dssp GGGTTCT
T ss_pred hhhhccc
Confidence 9998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=335.91 Aligned_cols=236 Identities=20% Similarity=0.366 Sum_probs=197.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. ++..||+|+++.... ..+.+.+|+.+|++++||||+++++++.+. ..+++||||
T Consensus 32 lg~G~~g---~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 100 (283)
T 3gen_A 32 LGTGQFG---VVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIITEY 100 (283)
T ss_dssp CC---CE---EEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEEEEECC
T ss_pred cCCCCCc---eEEEEEEc-CCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEecC--CCeEEEEec
Confidence 6777777 89999885 678899999985542 235688999999999999999999988554 458999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---C
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~ 157 (639)
+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++...... .
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEcccccccccccccccc
Confidence 999999999987 467999999999999999999999999 99999999999997 5579999999999765432 1
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
.....+|+.|+|||++. ..++.++||||||+++|+|+| |..||.. .+.......+..+... ..+...++.+.+||.
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIAQGLRL-YRPHLASEKVYTIMY 255 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHH
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHhcccCC-CCCCcCCHHHHHHHH
Confidence 23345788999999886 568999999999999999998 9999987 4566666677666433 334566789999999
Q ss_pred HhcC-CCCCCCCHHHHhcC
Q 006593 236 KCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~H 253 (639)
+||. +|.+|||+.++++|
T Consensus 256 ~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 256 SCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9999 89999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=341.77 Aligned_cols=240 Identities=22% Similarity=0.336 Sum_probs=202.0
Q ss_pred cccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l 75 (639)
||+|+|| +||+|.+ ..++..||+|+++... .....+.+.+|+.+|+++ +||||+++++++... ..+
T Consensus 31 lg~G~~g---~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~ 102 (313)
T 1t46_A 31 LGAGAFG---KVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--GPT 102 (313)
T ss_dssp EEECSSE---EEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred hCccCCc---ceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC--CCc
Confidence 7888887 8999984 5678999999997553 345668899999999999 999999999988655 458
Q ss_pred EEEEecCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC
Q 006593 76 NMITELFTSGNLRQYRKKHK------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~ 137 (639)
++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~- 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT- 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEc-
Confidence 89999999999999998754 4899999999999999999999999 99999999999998
Q ss_pred CCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHH
Q 006593 138 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 211 (639)
Q Consensus 138 ~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~ 211 (639)
.++.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+.........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 45799999999997665432 22345788999999775 468999999999999999999 9999987665566655
Q ss_pred HHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 212 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 212 ~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+..+..+ ..+...++.+++||.+||. +|.+|||+.|++++
T Consensus 260 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 260 MIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55555433 3345567899999999999 89999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.95 Aligned_cols=239 Identities=23% Similarity=0.388 Sum_probs=189.6
Q ss_pred CcccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|+|| +||+|.+.. .+..||+|.++... .....+.+.+|+.++++++||||+++++++.+ ..+++
T Consensus 22 ~lg~G~~g---~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~l 92 (281)
T 1mp8_A 22 CIGEGQFG---DVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWI 92 (281)
T ss_dssp EEEECSSS---EEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCEE
T ss_pred EeeecCCe---eEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---CccEE
Confidence 37888888 899999865 45679999876542 45667789999999999999999999998732 34789
Q ss_pred EEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECccccccccCcc
Confidence 999999999999998754 6999999999999999999999999 99999999999998 4579999999999766433
Q ss_pred C---CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 ~---~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
. .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+. ...++...+..+..+ ..+...++.+.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~ 247 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPPNCPPTLY 247 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC-CHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 2 22345788999999886 468999999999999999997 99999874 444555666655433 34556788999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+||.+||. +|.+|||+.+++++
T Consensus 248 ~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 248 SLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999 89999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=336.89 Aligned_cols=237 Identities=27% Similarity=0.463 Sum_probs=200.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----------
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD----------- 69 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~----------- 69 (639)
+||+|+|| .||+|.+..+|+.||+|+++... +.+.+|++++++++||||++++++|..
T Consensus 18 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 18 LIGSGGFG---QVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp EEECSSSC---CEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred eeccCCce---EEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 37888888 79999999999999999998543 236789999999999999999998854
Q ss_pred ---CCCceEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEE
Q 006593 70 ---DKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKI 144 (639)
Q Consensus 70 ---~~~~~l~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL 144 (639)
.....+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CCCCEEE
Confidence 2235689999999999999999764 57999999999999999999999999 99999999999998 4579999
Q ss_pred eecchhhhccCC-CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 145 GDLGLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 145 ~DFGlA~~l~~~-~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
+|||++...... ......||+.|+|||++.. .++.++||||||+++|+|++|..||.. .......+..+..
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~~---- 236 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGII---- 236 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTCC----
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhcccc----
Confidence 999999766543 3345679999999998864 589999999999999999999988753 3344444544433
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
+...++.+++||.+||. +|.+|||+.|+++|++.-.
T Consensus 237 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 34567899999999999 8999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=332.92 Aligned_cols=236 Identities=21% Similarity=0.361 Sum_probs=197.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. ++..||+|+++.... ..+.+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 16 lg~G~~g---~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 84 (268)
T 3sxs_A 16 LGSGQFG---VVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE--YPIYIVTEY 84 (268)
T ss_dssp EEEETTE---EEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEEEEEEC
T ss_pred eccCCCc---eEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CceEEEEEc
Confidence 6777777 89999875 577899999975542 235689999999999999999999988544 458999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC--
Q 006593 82 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-- 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~-- 158 (639)
+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCccceecchhhhhc
Confidence 99999999998754 5999999999999999999999999 99999999999997 557999999999976544322
Q ss_pred -ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 159 -RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 -~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
....+|+.|+|||++.. .++.++||||||+++|+|++ |..||... ........+..+... ..+...++.+.+||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQGHRL-YRPHLASDTIYQIMY 239 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHTTCCC-CCCTTSCHHHHHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc-ChHHHHHHHHcCCCC-CCCCcChHHHHHHHH
Confidence 23456778999998875 68999999999999999999 99999874 455555566555432 334556789999999
Q ss_pred HhcC-CCCCCCCHHHHhcC
Q 006593 236 KCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~H 253 (639)
+||. +|.+|||+.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999 89999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.35 Aligned_cols=239 Identities=24% Similarity=0.402 Sum_probs=191.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEE----EEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEV----AWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~V----AIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|||| +||+|.+..+|..| |+|.++... .....+.+.+|+.+|++++||||+++++++.... .+
T Consensus 22 ~lG~G~~g---~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~ 92 (327)
T 3poz_A 22 VLGSGAFG---TVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST---VQ 92 (327)
T ss_dssp EEEEETTE---EEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS---EE
T ss_pred EEeeCCCe---EEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---eE
Confidence 37788887 89999998887765 666655332 3355678999999999999999999999987643 77
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+|++|+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccCcceeEccC
Confidence 899999999999999874 57999999999999999999999999 99999999999998 457999999999987653
Q ss_pred CC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. .....||+.|+|||++. ..|+.++|||||||++|+|+| |..||.+ .+...+...+..+... ..+...++.
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 247 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTID 247 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHH
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHHHcCCCC-CCCccCCHH
Confidence 32 22345788999999876 458999999999999999999 9999986 3455565666655433 344556789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.+||.+||. +|.+||++.+++++
T Consensus 248 ~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 248 VYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999 89999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.09 Aligned_cols=244 Identities=18% Similarity=0.303 Sum_probs=194.0
Q ss_pred cccccccCcEEEEEEEecCCC-eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC------cceEEEEEEeCCCce
Q 006593 2 VLTGLYMTPFSSYKAFDEFAG-IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN------VVKFYKSWVDDKKKT 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG-~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN------IVkl~~~~~~~~~~~ 74 (639)
||+|+|| +||+|.+..++ ..||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++... ..
T Consensus 27 lg~G~~g---~V~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~--~~ 96 (355)
T 2eu9_A 27 LGEGTFG---KVVECLDHARGKSQVALKIIRNV-----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH--GH 96 (355)
T ss_dssp EEEETTE---EEEEEEETTTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET--TE
T ss_pred eeccCCe---EEEEEEecCCCceEEEEEEEccc-----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC--Ce
Confidence 6777777 89999998877 79999998743 345677889999999997766 89999988765 46
Q ss_pred EEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe----------------
Q 006593 75 VNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN---------------- 136 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~---------------- 136 (639)
+++||||+ +|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccc
Confidence 99999999 66777777665 36999999999999999999999999 99999999999993
Q ss_pred --CCCCcEEEeecchhhhccCCCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHH
Q 006593 137 --GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 137 --~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i 213 (639)
...+.+||+|||++..... ......||+.|+|||++. ..|+.++|||||||++|+|++|..||........ ...+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~ 251 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH-LVMM 251 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHH
T ss_pred cccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 1457899999999975443 234568999999999886 4689999999999999999999999987443322 2221
Q ss_pred Hc--CCCCCcc----------------------------------------cCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 006593 214 TS--GIKPASL----------------------------------------AKVNDPQIKGFIEKCLV-PASERLSAKDL 250 (639)
Q Consensus 214 ~~--g~~p~~l----------------------------------------~~~~s~~l~~LI~kcL~-dP~~RpSa~EL 250 (639)
.. +..|..+ ....++++.+||.+||. ||.+|||+.|+
T Consensus 252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 331 (355)
T 2eu9_A 252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA 331 (355)
T ss_dssp HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence 11 1111100 01113478899999999 99999999999
Q ss_pred hcCccccccc
Q 006593 251 LKDPFLQVEN 260 (639)
Q Consensus 251 L~Hpff~~~~ 260 (639)
|+||||+...
T Consensus 332 l~hp~f~~~~ 341 (355)
T 2eu9_A 332 LLHPFFAGLT 341 (355)
T ss_dssp TTSGGGGGCC
T ss_pred hcChhhcCCC
Confidence 9999998654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=338.66 Aligned_cols=241 Identities=24% Similarity=0.400 Sum_probs=195.0
Q ss_pred cccccccCcEEEEEEE----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||+|+|| .||+|. +..+|..||+|+++... .....+.+.+|+.+|+.++||||+++++++.......+++
T Consensus 29 lg~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 29 LGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEECSSE---EEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred cCCCCce---EEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 6777777 899998 67899999999987654 2345677999999999999999999999998876667999
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++.. ...+++..++.|+.||+.||.|||++| |+||||||+|||++. .|.+||+|||++......
T Consensus 103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVES-EHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEE-TTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcC-CCCEEECcccccccccCC
Confidence 9999999999999954 467999999999999999999999999 999999999999984 579999999999766433
Q ss_pred C-----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCC--------------CCHHHHHHHHHcC
Q 006593 157 T-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSEC--------------KNPAQIFKKVTSG 216 (639)
Q Consensus 157 ~-----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~--------------~~~~~i~~~i~~g 216 (639)
. .....||+.|+|||++. ..++.++||||||+++|+|+||..|+... .....+...+..+
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 2 23456888999999876 45889999999999999999998876321 1122333334443
Q ss_pred CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 217 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 217 ~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.. ...+...++.+.+||.+||. +|.+|||+.++++
T Consensus 260 ~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 260 KR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 33 33455678899999999999 8999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=352.82 Aligned_cols=239 Identities=27% Similarity=0.390 Sum_probs=202.8
Q ss_pred cccccccCcEEEEEEEecC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCc
Q 006593 2 VLTGLYMTPFSSYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 73 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~ 73 (639)
||+|+|| +||+|.+.. .+..||+|+++... .....+.+.+|+++++++ +||||+++++++... .
T Consensus 77 LG~G~~g---~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~ 148 (382)
T 3tt0_A 77 LGEGAFG---QVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD--G 148 (382)
T ss_dssp EEECSSE---EEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred EecCCCe---EEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC--C
Confidence 6777777 899999753 44689999987553 456678899999999999 999999999988654 4
Q ss_pred eEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC
Q 006593 74 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~ 137 (639)
.+++||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~- 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT- 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEc-
Confidence 5899999999999999998754 4999999999999999999999999 99999999999997
Q ss_pred CCCcEEEeecchhhhccCC----CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHH
Q 006593 138 NHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 211 (639)
Q Consensus 138 ~~g~VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~ 211 (639)
..+.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+ ....++..
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~-~~~~~~~~ 304 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFK 304 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHH
Confidence 4579999999999765432 2234467899999998764 58999999999999999999 9999987 45677777
Q ss_pred HHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 212 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 212 ~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+..+..+ ..+...++++.+||.+||. +|.+|||+.|++++
T Consensus 305 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 305 LLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77766543 3455678899999999999 89999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.28 Aligned_cols=243 Identities=28% Similarity=0.473 Sum_probs=195.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|+++.... ......+.+.+|+.++++++||||+++++++... ..+++||||
T Consensus 40 lg~G~~g---~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 113 (310)
T 2wqm_A 40 IGRGQFS---EVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNIVLEL 113 (310)
T ss_dssp EECC--C---EEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred ecCCCCc---eEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CcEEEEEec
Confidence 7888888 899999999999999999986543 2356677899999999999999999999998775 468999999
Q ss_pred CCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-
Q 006593 82 FTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~- 156 (639)
+.+|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++ ..|.+||+|||++......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccceeeecCCC
Confidence 999999999874 466999999999999999999999999 99999999999997 5579999999999765432
Q ss_pred -CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC-CCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 157 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~-~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
......||+.|+|||++.. .++.++||||||+++|+|++|..||.+. .+...+...+..+..+.......++++++|
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 270 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHH
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHH
Confidence 2334579999999998764 5899999999999999999999999753 244566666766655554456678899999
Q ss_pred HHHhcC-CCCCCCCHHHHhcC
Q 006593 234 IEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~H 253 (639)
|.+||. +|.+|||+.+++++
T Consensus 271 i~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 271 VNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999 89999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.13 Aligned_cols=235 Identities=19% Similarity=0.314 Sum_probs=193.2
Q ss_pred cccccccCcEEEEEEEecCCC-------eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCce
Q 006593 2 VLTGLYMTPFSSYKAFDEFAG-------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG-------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~ 74 (639)
||+|+|| +||+|.+..+| ..||+|++.... ....+.+.+|+.+|++++||||+++++++.+.+ .
T Consensus 16 lg~G~~g---~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 86 (289)
T 4fvq_A 16 LGQGTFT---KIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD--E 86 (289)
T ss_dssp EEEETTE---EEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT--C
T ss_pred eccCCCc---eEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC--C
Confidence 6777777 89999998877 579999987543 355678999999999999999999999886654 5
Q ss_pred EEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc--------EEEe
Q 006593 75 VNMITELFTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE--------VKIG 145 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~~-l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~--------VKL~ 145 (639)
.++||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||+++ |+||||||+|||++.+ +. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE-EDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-CBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-Ccccccccceeeec
Confidence 7899999999999999988765 999999999999999999999999 9999999999999744 44 9999
Q ss_pred ecchhhhccCCCCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCccc
Q 006593 146 DLGLAIAMQQPTARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLA 223 (639)
Q Consensus 146 DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~ 223 (639)
|||++..... .....||+.|+|||++.. .++.++|||||||++|+|++|..|+................ ..++
T Consensus 164 Dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~---~~~~ 238 (289)
T 4fvq_A 164 DPGISITVLP--KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR---HQLP 238 (289)
T ss_dssp CCCSCTTTSC--HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCC
T ss_pred cCcccccccC--ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc---CCCC
Confidence 9999865432 234568999999998864 58999999999999999999654444334454444444332 2233
Q ss_pred CCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 224 KVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 224 ~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
...++++++||.+||. +|.+|||+.++++|
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4446789999999999 89999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.62 Aligned_cols=236 Identities=20% Similarity=0.252 Sum_probs=194.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|+|| +||+|.+..+|+.||+|++..... .+.+..|+.++++| +||||+++++++.+. ..+++||
T Consensus 16 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~ 84 (330)
T 2izr_A 16 KIGCGNFG---ELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMVL 84 (330)
T ss_dssp ECCC-CTT---SEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEEE
T ss_pred EeeccCCc---eEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEEE
Confidence 37888888 799999999999999999876542 13478999999999 999999999988775 4689999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc-----EEEeecchhhhc
Q 006593 80 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-----VKIGDLGLAIAM 153 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~-----VKL~DFGlA~~l 153 (639)
||+ +|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++. .+. +||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~-~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGR-PGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECC-GGGTCTTSEEECCCTTCEES
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecc-CCCCCCceEEEEEcccceee
Confidence 999 99999999874 67999999999999999999999999 999999999999974 355 999999999765
Q ss_pred cCCC---------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC--CCHHHHHHHHHcCCC--C
Q 006593 154 QQPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC--KNPAQIFKKVTSGIK--P 219 (639)
Q Consensus 154 ~~~~---------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~--~~~~~i~~~i~~g~~--p 219 (639)
.... ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+. ....+.+..+..... +
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 4322 245689999999998875 5899999999999999999999999764 234444555433221 1
Q ss_pred -CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 220 -ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 220 -~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+... .|++++||.+||. +|.+||++.+|++
T Consensus 241 ~~~~~~~-~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCEN-FPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTT-CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhcc-ChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111222 3499999999998 9999999998876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.89 Aligned_cols=238 Identities=20% Similarity=0.304 Sum_probs=199.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|..||+|+++... .....+.+.+|+.+|++++||||+++++++... ..+++||||
T Consensus 122 lG~G~~g---~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e~ 193 (377)
T 3cbl_A 122 IGRGNFG---EVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--QPIYIVMEL 193 (377)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS--SSCEEEEEC
T ss_pred eccCCCC---eEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC--CCcEEEEEc
Confidence 6777777 89999999999999999987432 345566789999999999999999999988554 458999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC--
Q 006593 82 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-- 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~-- 158 (639)
+.+|+|.++++..+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+++.......
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecCCCceee
Confidence 99999999998654 6999999999999999999999999 99999999999997 557999999999975433211
Q ss_pred --ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 --~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....+++.|+|||++. ..|+.++|||||||++|||+| |..||.+. ...++...+..+... ..+...++++.+||
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 348 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRL-PCPELCPDAVFRLM 348 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 1223577899999886 568999999999999999998 99999874 455666666665433 34556788999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||. +|.+|||+.+|++
T Consensus 349 ~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 349 EQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 99999 8999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=360.44 Aligned_cols=244 Identities=18% Similarity=0.307 Sum_probs=199.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+..+|..||+|+++.... ....+.+.+|+++|++++||||+++++++.......+++|||
T Consensus 16 ~LG~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 16 ILGQGATA---NVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred EEEcCCCe---EEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 37888887 899999999999999999986543 234567789999999999999999999998877667899999
Q ss_pred cCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEE----eCCCCcEEEeecchhhhc
Q 006593 81 LFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFV----NGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 81 y~~gGsL~d~lkk~~---~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl----~~~~g~VKL~DFGlA~~l 153 (639)
||.+|+|.++++... .+++..++.|+.||+.||.|||++| |+||||||+|||+ + ..+.+||+|||++...
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEecCCCceEc
Confidence 999999999997643 3999999999999999999999999 9999999999998 4 3457999999999765
Q ss_pred cCC-CCccccCCCCcCCccccc---------ccCCccccccchhhhhhhhhhccCCCCCCC---CHHHHHHHHHcCCCCC
Q 006593 154 QQP-TARSVIGTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTFEYPYSECK---NPAQIFKKVTSGIKPA 220 (639)
Q Consensus 154 ~~~-~~~~~~GTp~ymAPE~l~---------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~---~~~~i~~~i~~g~~p~ 220 (639)
... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||.... ...+++..+..+.++.
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 433 234567999999999875 357889999999999999999999996432 2344555555544321
Q ss_pred c-----------------------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 221 S-----------------------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 221 ~-----------------------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
. +....++.+.+||.+||. ||.+||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1 112224578899999999 99999999998664
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.56 Aligned_cols=241 Identities=23% Similarity=0.351 Sum_probs=203.0
Q ss_pred cccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l 75 (639)
||+|+|| +||+|.+ ..++..||+|+++... .....+.+.+|+.+|+++ +||||+++++++...+ ..+
T Consensus 35 lg~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~ 107 (316)
T 2xir_A 35 LGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPL 107 (316)
T ss_dssp EEECSSE---EEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-SCC
T ss_pred EcCCCce---eEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC-Cce
Confidence 6777777 8999984 5678999999987543 345667899999999999 7999999999876543 468
Q ss_pred EEEEecCCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC
Q 006593 76 NMITELFTSGNLRQYRKKHKN----------------VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH 139 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~----------------l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~ 139 (639)
++||||+.+|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++ ..
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CC
Confidence 899999999999999987654 899999999999999999999999 99999999999997 45
Q ss_pred CcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHH
Q 006593 140 GEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 140 g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i 213 (639)
+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+..........+
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence 799999999997654322 22346789999999876 468999999999999999998 999998866666666666
Q ss_pred HcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 214 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 214 ~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+..+ ..+...++.++++|.+||. +|.+|||+.++++|
T Consensus 265 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 265 KEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665433 3455578899999999999 89999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.79 Aligned_cols=238 Identities=19% Similarity=0.301 Sum_probs=198.2
Q ss_pred cccccccCcEEEEEEE--ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~--d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|. +..++..||+|+++.... .....+.+.+|+.+++.++||||+++++++ .. ..+++||
T Consensus 25 lg~G~~g---~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~--~~~~lv~ 96 (291)
T 1xbb_A 25 LGSGNFG---TVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGIC-EA--ESWMLVM 96 (291)
T ss_dssp EEECSSE---EEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES--SSEEEEE
T ss_pred cccccCe---eeEeeeecCCCceeeEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC--CCcEEEE
Confidence 6777777 899994 467789999999876532 345577899999999999999999999988 33 3488999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
||+.+|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 97 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSE
T ss_pred EeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCcceeeccCCCc
Confidence 99999999999999888999999999999999999999999 99999999999998 45799999999997654332
Q ss_pred ---CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 158 ---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 158 ---~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
.....+|+.|+|||++.. .++.++||||||+++|+|++ |..||.+ .+..++...+..+..+ ..+...++.+.+
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 251 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYD 251 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 122356789999998864 58899999999999999999 9999987 4566666777666443 345567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006593 233 FIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~ 252 (639)
||.+||. +|.+||++.++++
T Consensus 252 li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 9999999 8999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=343.88 Aligned_cols=240 Identities=23% Similarity=0.334 Sum_probs=198.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEE--EEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEV--AWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~V--AIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+..+|..+ |+|.++... .....+.+.+|+.+|+++ +||||+++++++.+. ..+++
T Consensus 32 ~lg~G~~g---~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~l 103 (327)
T 1fvr_A 32 VIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYL 103 (327)
T ss_dssp EEECGGGC---EEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEEE
T ss_pred eeecCCCc---eEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--CceEE
Confidence 37888888 89999999999866 999887432 334566789999999999 999999999998765 46999
Q ss_pred EEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc
Q 006593 78 ITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~ 141 (639)
||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc-CCCe
Confidence 999999999999998764 6999999999999999999999999 99999999999997 4579
Q ss_pred EEEeecchhhhccCC-CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCC
Q 006593 142 VKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIK 218 (639)
Q Consensus 142 VKL~DFGlA~~l~~~-~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~ 218 (639)
+||+|||++...... ......+++.|+|||++.. .++.++|||||||++|+|++ |..||.+ .+...+...+..+..
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYR 259 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHhhcCCC
Confidence 999999998644322 2233467899999998864 58999999999999999998 9999987 456677777766643
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+ ..+...++.+++||.+||. +|.+|||+.+++++
T Consensus 260 ~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 L-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp C-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3 2344567899999999999 89999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=340.27 Aligned_cols=242 Identities=21% Similarity=0.211 Sum_probs=194.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| .||+|.+..+|..||+|++..... ......+.+.+|+.++++++||||+++++++... ..+++|||
T Consensus 41 ~lg~G~~g---~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e 114 (309)
T 2h34_A 41 LVGRGGMG---DVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID--GQLYVDMR 114 (309)
T ss_dssp EEEECSSS---EEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred EEcCCCCe---eEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC--CeEEEEEE
Confidence 37888888 899999999999999999875532 2345567899999999999999999999998775 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
|+.+++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999997 45799999999987654322
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCcccCCCChHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~s~~l~~LI~ 235 (639)
.....||+.|+|||++.+ .++.++||||||+++|+|++|..||... +...+...+..... +...+...++.+++||.
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 270 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA 270 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccCCCCccccCCCCCHHHHHHHH
Confidence 234579999999998864 5889999999999999999999999863 33444444444333 23445567889999999
Q ss_pred HhcC-CCCCCC-CHHHHhc
Q 006593 236 KCLV-PASERL-SAKDLLK 252 (639)
Q Consensus 236 kcL~-dP~~Rp-Sa~ELL~ 252 (639)
+||. +|.+|| ++++++.
T Consensus 271 ~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 271 RGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHTCSSGGGSCSSHHHHHH
T ss_pred HhccCCHHHHHHhHHHHHH
Confidence 9999 899999 7888876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=342.79 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=201.0
Q ss_pred CcccccccCcEEEEEEE-----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceE
Q 006593 1 MVLTGLYMTPFSSYKAF-----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~-----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l 75 (639)
.||+|+|| +||+|. +..+|..||+|++.... .......+.+|+.++++++||||+++++++... ..+
T Consensus 37 ~lg~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 108 (327)
T 2yfx_A 37 GLGHGAFG---EVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--LPR 108 (327)
T ss_dssp ECC--CSS---CEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred EEcCCCCe---eEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC--CCc
Confidence 37888888 789998 56788999999986432 345667899999999999999999999988655 347
Q ss_pred EEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEee
Q 006593 76 NMITELFTSGNLRQYRKKHK-------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGD 146 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~-------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~D 146 (639)
++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++. +.+.+||+|
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECc
Confidence 89999999999999998763 4899999999999999999999999 999999999999972 334699999
Q ss_pred cchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCC
Q 006593 147 LGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 220 (639)
Q Consensus 147 FGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 220 (639)
||++...... ......||+.|+|||++. ..++.++||||||+++|+|+| |..||.. .....+...+..+..+
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~- 264 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM- 264 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcCCCC-
Confidence 9999765432 223456899999999875 568999999999999999998 8999986 4566666777666443
Q ss_pred cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 221 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 221 ~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
..+...++.+++||.+||. +|.+||++.++++|.++..
T Consensus 265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 3445668899999999999 8999999999999988753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.84 Aligned_cols=240 Identities=18% Similarity=0.326 Sum_probs=201.3
Q ss_pred cccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|.+. .++..||+|+++... .....+.+.+|+.+|++++||||+++++++. . ..+++||
T Consensus 18 lg~G~~g---~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~--~~~~lv~ 88 (287)
T 1u59_A 18 LGCGNFG---SVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A--EALMLVM 88 (287)
T ss_dssp EECCTTE---EEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S--SSEEEEE
T ss_pred ccccCce---eEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C--CCcEEEE
Confidence 6777777 89999853 578899999998653 4567788999999999999999999999883 2 3489999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 80 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccceeeeccCcc
Confidence 999999999999754 56999999999999999999999999 99999999999998 45799999999997654321
Q ss_pred ----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 158 ----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 158 ----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
.....||+.|+|||++. ..++.++||||||+++|+|++ |..||... ...++...+..+..+ ..+...++.++
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~ 243 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPELY 243 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHhcCCcC-CCCCCcCHHHH
Confidence 22345789999999886 468999999999999999998 99999874 445566666665443 34556789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCcc
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
+||.+||. +|.+||++.++++|.+
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999 8999999999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.84 Aligned_cols=236 Identities=17% Similarity=0.381 Sum_probs=199.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 16 lg~G~~g---~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 84 (267)
T 3t9t_A 16 IGSGQFG---LVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVTEF 84 (267)
T ss_dssp EEEETTE---EEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCEEEECC
T ss_pred ecCCCce---eEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCeEEEEeC
Confidence 6777777 89999986 678999999986542 235689999999999999999999988655 458899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---C
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---T 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---~ 157 (639)
+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...... .
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccccccccccccc
Confidence 9999999999875 56899999999999999999999999 99999999999997 4579999999999765432 2
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
.....||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+..+..+ ..+...++.+.+||.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIMN 239 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHHHHHHHH
Confidence 23446788999999886 468999999999999999999 8999987 4566677777766433 334566889999999
Q ss_pred HhcC-CCCCCCCHHHHhcC
Q 006593 236 KCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~H 253 (639)
+||. +|.+||++.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999 89999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=341.40 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=200.7
Q ss_pred cccccccCcEEEEEEE----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||+|+|| .||+|. +..+|..||+|++... .....+.+.+|+++|++++||||+++++++...+...+++
T Consensus 31 lg~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 31 LGKGNFG---SVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp EEEETTE---EEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred ccCCCCe---EEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 6777777 899998 6789999999998754 3466678999999999999999999999998777788999
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEcccccceecccC
Confidence 9999999999999987 356999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred C-----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCC--------------HHHHHHHHHcC
Q 006593 157 T-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--------------PAQIFKKVTSG 216 (639)
Q Consensus 157 ~-----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--------------~~~i~~~i~~g 216 (639)
. .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+...+..+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 2 233468889999998864 589999999999999999999999854211 12233333443
Q ss_pred CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 217 IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 217 ~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
. ....+...++.+++||.+||. +|.+|||+.||+++
T Consensus 261 ~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 261 Q-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 333456678899999999999 89999999999765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.50 Aligned_cols=242 Identities=18% Similarity=0.287 Sum_probs=199.7
Q ss_pred CcccccccCcEEEEEEEecCCC---eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG---IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG---~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|||| +||+|.+..++ ..||+|.+.... .....+.+.+|+.+|++++||||+++++++.+.+ ...++
T Consensus 28 ~lg~G~~g---~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 100 (298)
T 3pls_A 28 VIGKGHFG---VVYHGEYIDQAQNRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPHV 100 (298)
T ss_dssp EEEEETTE---EEEEEEEECSSSCEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEE
T ss_pred eeccCCCc---eEEEEEEecCCCceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcEE
Confidence 37888888 89999865544 489999986432 4566788999999999999999999999886654 34479
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC-
Q 006593 78 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ- 155 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~- 155 (639)
||||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcccccCC
Confidence 9999999999999987 456899999999999999999999999 99999999999997 557999999999975432
Q ss_pred -----CCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 -----PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 -----~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.......+|+.|+|||.+.+ .++.++||||||+++|+|++|..|+....+...+...+..+..+ ..+...++.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 256 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPDS 256 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCHH
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchHH
Confidence 22334578999999998865 58999999999999999999666655446666666666665443 345556789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.+||.+||. +|.+|||+.++++.
T Consensus 257 l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 257 LYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999 89999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=336.55 Aligned_cols=237 Identities=29% Similarity=0.457 Sum_probs=191.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+.. .||+|+++.... .....+.+.+|+.+|++++||||++++++. .. ..+++||||
T Consensus 32 lG~G~~g---~Vy~~~~~~---~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~--~~~~lv~e~ 100 (289)
T 3og7_A 32 IGSGSFG---TVYKGKWHG---DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA--PQLAIVTQW 100 (289)
T ss_dssp EEECSSE---EEEEEESSS---EEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS--SSCEEEEEC
T ss_pred ecCCCCe---EEEEEEEcC---ceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC--CccEEEEEe
Confidence 6777777 899998754 499999876642 456778899999999999999999999954 22 347899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC----C
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ----P 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~----~ 156 (639)
+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++..... .
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEccceeccccccccccc
Confidence 9999999999643 56999999999999999999999999 99999999999998 457999999999975542 1
Q ss_pred CCccccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCc---ccCCCChH
Q 006593 157 TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---LAKVNDPQ 229 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~---l~~~~s~~ 229 (639)
......||+.|+|||++. ..++.++||||||+++|+|++|..||.+..+...+...+..+..+.. .....++.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 223457999999999874 35888999999999999999999999987777777777776654433 33456789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+++||.+||. +|.+|||+.++++
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999 8999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=343.49 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=196.9
Q ss_pred cccccccCcEEE-EEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSS-YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tV-ykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+||.|..+ |++.+..+|+.||+|+++... .....+.+.+|+.+|++++||||+++++++.+.+...+++|||
T Consensus 39 lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred ecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 788888844332 555567789999999998553 4566788999999999999999999999998877778999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
|+.+|+|.+++.+.+ +++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.......
T Consensus 116 ~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 116 YVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp CCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECCTTCSEE
T ss_pred cccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCcccccccccccccc
Confidence 999999999997654 999999999999999999999999 99999999999997 55799999999997665332
Q ss_pred --CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH--------------HHHHHHHHcCCCCC
Q 006593 158 --ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--------------AQIFKKVTSGIKPA 220 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~--------------~~i~~~i~~g~~p~ 220 (639)
.....||+.|+|||++.+ .++.++||||||+++|+|+||..||...... ..+...+..+ ...
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 270 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-ERL 270 (318)
T ss_dssp EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT-CCC
T ss_pred ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc-cCC
Confidence 234568889999998864 5889999999999999999999998642111 0122223333 333
Q ss_pred cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 221 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 221 ~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+...++++.+||.+||. +|.+|||+.|+++
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 271 PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4456678899999999999 8999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.87 Aligned_cols=237 Identities=14% Similarity=0.175 Sum_probs=195.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.+..+|..||+|++..... .+.+.+|+.+++.+ +|+||+++++++... ..+++|||
T Consensus 18 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~lv~e 86 (298)
T 1csn_A 18 IGEGSFG---VIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLVID 86 (298)
T ss_dssp EEECSSC---EEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEEEE
T ss_pred EeecCCE---EEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCC--ceeEEEEE
Confidence 7788888 899999999999999999875432 23478899999999 899999999988655 46899999
Q ss_pred cCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc-----EEEeecchhhhcc
Q 006593 81 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE-----VKIGDLGLAIAMQ 154 (639)
Q Consensus 81 y~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~-----VKL~DFGlA~~l~ 154 (639)
|+ +|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.+ |. +||+|||++....
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCS-SSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccC-CCCCCCeEEEEECccccccc
Confidence 99 999999998754 5999999999999999999999999 9999999999999733 34 9999999997654
Q ss_pred CCC---------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC--CHHHHHHHHHcCC---CC
Q 006593 155 QPT---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTSGI---KP 219 (639)
Q Consensus 155 ~~~---------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~--~~~~i~~~i~~g~---~p 219 (639)
... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.. ...+.+..+.... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 321 245679999999998864 58999999999999999999999997642 3444444443321 22
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.......++++++||.+||. +|.+||++.+|++.
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22334567899999999998 99999999999774
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=334.75 Aligned_cols=237 Identities=24% Similarity=0.366 Sum_probs=201.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 21 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e~ 90 (288)
T 3kfa_A 21 LGGGQYG---EVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIITEF 90 (288)
T ss_dssp SGGGTTC---SEEEEEEGGGTEEEEEEEECSCS-----THHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSEEEEEEC
T ss_pred cCCCCce---eEEEeEecCCCEEEEEEecCcCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--CCEEEEEEc
Confidence 7888888 79999999999999999987442 4567789999999999999999999988654 458999999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++ ..+.+||+|||++........
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGGTSCSSSSE
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccCccceeccCCccc
Confidence 9999999999874 45999999999999999999999999 99999999999997 457999999999987654322
Q ss_pred --ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 --~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+.....+ ..+...++.+.+||
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 245 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEKVYELM 245 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCCHHHHHHH
Confidence 2345688999999886 468999999999999999999 9999986 4455566666555333 34456688999999
Q ss_pred HHhcC-CCCCCCCHHHHhcC
Q 006593 235 EKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~H 253 (639)
.+||. +|.+|||+.++++.
T Consensus 246 ~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 246 RACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCChhhCcCHHHHHHH
Confidence 99999 89999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=340.34 Aligned_cols=241 Identities=23% Similarity=0.356 Sum_probs=181.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEe------CCCc
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVD------DKKK 73 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~------~~~~ 73 (639)
+||+|+|| .||+|.+..+|..||+|++... .....+.+.+|+.+|+++. ||||+++++++.. ....
T Consensus 35 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 35 VLAEGGFA---FVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEECCSSE---EEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred EEccCCce---EEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 37788877 8999999999999999998654 3456678999999999995 9999999999863 3345
Q ss_pred eEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 74 TVNMITELFTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk---~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
.+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+++++|+||||||+|||++ ..+.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEecCccc
Confidence 6899999996 799998875 5679999999999999999999999988899999999999998 5579999999999
Q ss_pred hhccCCCC--------------ccccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHH
Q 006593 151 IAMQQPTA--------------RSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK 212 (639)
Q Consensus 151 ~~l~~~~~--------------~~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~ 212 (639)
........ ....||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~---- 260 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-LR---- 260 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-HH----
Confidence 76543211 1456999999999873 3588999999999999999999999975322 22
Q ss_pred HHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcc
Q 006593 213 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 213 i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
+..+..........++.+++||.+||. +|.+||++.|+++|..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222222223344556789999999999 8999999999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.51 Aligned_cols=239 Identities=21% Similarity=0.340 Sum_probs=200.3
Q ss_pred cccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|+|| .||+|.+. .++..||+|.+.... .......+.+|+.+|+.++||||+++++++.+. ..++
T Consensus 33 lg~G~~g---~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~ 104 (322)
T 1p4o_A 33 LGQGSFG---MVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--QPTL 104 (322)
T ss_dssp EEECSSS---EEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--SSCE
T ss_pred eccCCce---EEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC--CccE
Confidence 7888888 79999876 468899999987443 345667799999999999999999999988554 4588
Q ss_pred EEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEee
Q 006593 77 MITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 146 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~----------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~D 146 (639)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-CCCeEEECc
Confidence 999999999999999753 45799999999999999999999999 99999999999998 557999999
Q ss_pred cchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCC
Q 006593 147 LGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPA 220 (639)
Q Consensus 147 FGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~ 220 (639)
||++....... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+ .+..++...+..+..+
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~- 259 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLL- 259 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCC-
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHHHcCCcC-
Confidence 99997654321 22346789999999886 458999999999999999999 8999987 4566666666665443
Q ss_pred cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 221 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 221 ~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
..+...++.+++||.+||. +|.+|||+.|+++|
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2345667899999999999 89999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=342.48 Aligned_cols=239 Identities=26% Similarity=0.399 Sum_probs=200.6
Q ss_pred cccccccCcEEEEEEEec-------CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCc
Q 006593 2 VLTGLYMTPFSSYKAFDE-------FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 73 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-------~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~ 73 (639)
||+|+|| +||+|.+. .++..||+|+++... .....+.+.+|+.+|+++ +||||+++++++... .
T Consensus 43 lG~G~~g---~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 114 (334)
T 2pvf_A 43 LGEGAFG---QVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--G 114 (334)
T ss_dssp EEECSSC---EEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred EeecCce---eEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC--C
Confidence 7888888 89999975 467899999987543 456678899999999999 999999999988654 4
Q ss_pred eEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC
Q 006593 74 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~ 137 (639)
.+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~- 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT- 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEc-
Confidence 5899999999999999998754 3899999999999999999999999 99999999999997
Q ss_pred CCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHH
Q 006593 138 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 211 (639)
Q Consensus 138 ~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~ 211 (639)
..|.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+ ....++..
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~ 270 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFK 270 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-CCHHHHHH
Confidence 55799999999997654321 23346788999999876 458999999999999999999 9999987 45667777
Q ss_pred HHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 212 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 212 ~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+..+..+ ..+...++.+++||.+||. +|.+||++.|++++
T Consensus 271 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 271 LLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77666443 3445678899999999999 89999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=339.72 Aligned_cols=243 Identities=19% Similarity=0.314 Sum_probs=191.5
Q ss_pred CcccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCc---e
Q 006593 1 MVLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK---T 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~---~ 74 (639)
+||+|+|| +||+|.+.. ++..||+|+++.... .....+.+.+|+.++++++||||+++++++...... .
T Consensus 41 ~lg~G~~g---~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 41 ILGEGEFG---SVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEC-CCC---CEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred ceeecCCe---EEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 37888888 677777654 677999999886542 456677899999999999999999999998775432 4
Q ss_pred EEEEEecCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecc
Q 006593 75 VNMITELFTSGNLRQYRKK------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLG 148 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk------~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFG 148 (639)
.++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR-DDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC-TTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEEeecC
Confidence 6899999999999999953 356999999999999999999999999 99999999999997 45799999999
Q ss_pred hhhhccCC----CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 149 LAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 149 lA~~l~~~----~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
++...... ......+++.|+|||++.. .++.++||||||+++|+|++ |..||... ....+...+..+..+ ..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~ 270 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYLLHGHRL-KQ 270 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CC
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHHcCCCC-CC
Confidence 99765432 1233467889999998864 58999999999999999999 88999874 455566666665443 34
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+...++.+.+||.+||. +|.+||++.+++.+
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55667899999999999 89999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=343.09 Aligned_cols=241 Identities=18% Similarity=0.201 Sum_probs=193.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~--~~~~l~lV~ 79 (639)
||+|+|| .||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++... ....+++||
T Consensus 37 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 37 LGEGGFS---YVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEC--CE---EEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred ecCCCCe---EEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 6777777 8999999999999999998754 346678899999999999999999999998743 345789999
Q ss_pred ecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 80 ELFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 80 Ey~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecCcchhccc
Confidence 99999999999986 467999999999999999999999999 99999999999997 557999999998765421
Q ss_pred CC-----------CccccCCCCcCCcccccc----cCCccccccchhhhhhhhhhccCCCCCCCC-HHHHHHHHHcCCCC
Q 006593 156 PT-----------ARSVIGTPEFMAPELYEE----EYNELVDIYSFGMCILEMVTFEYPYSECKN-PAQIFKKVTSGIKP 219 (639)
Q Consensus 156 ~~-----------~~~~~GTp~ymAPE~l~~----~ys~ksDIwSlGiil~ELltG~~Pf~~~~~-~~~i~~~i~~g~~p 219 (639)
.. .....||+.|+|||++.. .++.++||||||+++|+|++|..||..... ...+...+... ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~ 265 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ-LS 265 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-CC
Confidence 11 123457999999998853 378999999999999999999999953100 01122222222 22
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.......++.+++||.+||. +|.+||++.+++++
T Consensus 266 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 22234567899999999999 89999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.28 Aligned_cols=239 Identities=19% Similarity=0.346 Sum_probs=195.0
Q ss_pred CcccccccCcEEEEEEEecCCCeE----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIE----VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~----VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+|.+..+|.. ||+|.+.... .....+.+.+|+.++++++||||+++++++.. ..++
T Consensus 20 ~lG~G~~g---~Vy~~~~~~~~~~~~~kv~~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 90 (325)
T 3kex_A 20 VLGSGVFG---TVHKGVWIPEGESIKIPVCIKVIEDKS---GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SSLQ 90 (325)
T ss_dssp EEECCSSC---EEEEEEECCTTCSCCEEEEEEEECCTT---SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SSEE
T ss_pred eeeecCCc---eEEEEEEcCCCceEEEEEEEEeccccc---cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CccE
Confidence 37888888 8999999888876 6777664332 12333457889999999999999999998743 3488
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+||||+.+|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCCcccccCc
Confidence 999999999999999875 57999999999999999999999999 99999999999997 557999999999987643
Q ss_pred CC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. .....||+.|+|||++. ..|+.++|||||||++|+|+| |..||.+. ....+...+..+..+ ..+...+++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 245 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLLEKGERL-AQPQICTID 245 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHHHTTCBC-CCCTTBCTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCCC-CCCCcCcHH
Confidence 32 23456888999999886 569999999999999999999 99999874 445555566555332 334456778
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.+||.+||. +|.+||++.++++|
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999 89999999999997
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=343.35 Aligned_cols=240 Identities=22% Similarity=0.354 Sum_probs=200.2
Q ss_pred cccccccCcEEEEEEEecCCCe-----EEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGI-----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~-----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l 75 (639)
||+|+|| +||+|.+..+|. .||+|.++... .....+.+.+|+.+|+++ +||||+++++++... ..+
T Consensus 54 lG~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~ 125 (333)
T 2i1m_A 54 LGAGAFG---KVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGACTHG--GPV 125 (333)
T ss_dssp EEECSSE---EEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSC
T ss_pred eccCCCc---ceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC--Cce
Confidence 7888887 899999977664 79999987543 345677899999999999 899999999988654 458
Q ss_pred EEEEecCCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc
Q 006593 76 NMITELFTSGNLRQYRKKH--------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~--------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~ 141 (639)
++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT-NGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE-GGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEEC-CCCe
Confidence 8999999999999999753 35899999999999999999999999 99999999999998 4579
Q ss_pred EEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHc
Q 006593 142 VKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTS 215 (639)
Q Consensus 142 VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~ 215 (639)
+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+..........+..
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 9999999997654332 22345788999999876 468999999999999999998 89999876655555555555
Q ss_pred CCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 216 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 216 g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.. ...+...++.+.+||.+||. +|.+|||+.+++++
T Consensus 283 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 283 GYQ-MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 433 33455568899999999999 89999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=333.17 Aligned_cols=239 Identities=22% Similarity=0.388 Sum_probs=195.1
Q ss_pred CcccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| +||+|.+.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 19 ~lg~G~~g---~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 89 (281)
T 3cc6_A 19 ILGEGFFG---EVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---PTWI 89 (281)
T ss_dssp EEEECSSS---EEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS---SCEE
T ss_pred EEEecCCe---eEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CCEE
Confidence 37888888 799998643 45679999987553 345678899999999999999999999987432 3689
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCCCcccccc
Confidence 99999999999999765 45999999999999999999999999 99999999999998 4579999999999765433
Q ss_pred C---CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 T---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 ~---~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
. .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.... .......+..+..+ ..+...++.+.
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~ 244 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLEKGDRL-PKPDLCPPVLY 244 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-GGGHHHHHHHTCCC-CCCTTCCHHHH
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-hHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence 2 23346788999999886 468999999999999999998 999997643 33444555544332 23455688999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+||.+||. +|.+||++.|++++
T Consensus 245 ~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 245 TLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCchhCcCHHHHHHH
Confidence 99999999 89999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=350.98 Aligned_cols=239 Identities=20% Similarity=0.348 Sum_probs=189.8
Q ss_pred CcccccccCcEEEEEEEec---CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDE---FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~---~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| .||+|.+. .++..||+|+++... .....+.+.+|+.+|++++||||+++++++... ..+++
T Consensus 52 ~lG~G~fg---~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 123 (373)
T 2qol_A 52 VVGAGEFG---EVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS--KPVMI 123 (373)
T ss_dssp EEEECSSS---EEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSCEE
T ss_pred EEeeCCCe---EEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC--CceEE
Confidence 37888888 89999886 567889999987543 355677899999999999999999999988654 45889
Q ss_pred EEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcCccccccccC
Confidence 999999999999998764 6999999999999999999999999 99999999999997 4579999999999766432
Q ss_pred C-----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 157 T-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 157 ~-----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
. .....+|+.|+|||++. ..++.++|||||||++|||++ |+.||.+ .+...+...+..+.... .+...++.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~ 278 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGYRLP-PPMDCPAA 278 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTEECC-CCTTCBHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccccHH
Confidence 1 11234578899999886 468999999999999999998 9999987 45666666666653322 23456788
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+||.+||. +|.+||++.++++
T Consensus 279 l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 279 LYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhCcChhhCcCHHHHHH
Confidence 9999999999 8999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.20 Aligned_cols=235 Identities=27% Similarity=0.414 Sum_probs=185.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHh--CCCCCcceEEEEEEeC--CCceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS--LKDDNVVKFYKSWVDD--KKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~--L~HpNIVkl~~~~~~~--~~~~l~l 77 (639)
||+|+|| +||+|.+ +|..||+|++... ....+..|.+++.. ++||||+++++++... ....+++
T Consensus 16 lg~G~~g---~V~~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 16 VGKGRYG---EVWRGSW--QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp EEECSSE---EEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred eccCCCc---EEEEEEE--CCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 7788877 8999987 6899999998643 23456677777777 7999999999987653 3356899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH--------SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLH--------s~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
||||+.+|+|.++++. ..+++..++.++.||+.||.||| +++ |+||||||+|||++ ..+.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEEECCCTT
T ss_pred ehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCCEEEeeCCC
Confidence 9999999999999964 57999999999999999999999 888 99999999999998 557999999999
Q ss_pred hhhccCCC------CccccCCCCcCCcccccc-------cCCccccccchhhhhhhhhhc----------cCCCCCCC--
Q 006593 150 AIAMQQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTF----------EYPYSECK-- 204 (639)
Q Consensus 150 A~~l~~~~------~~~~~GTp~ymAPE~l~~-------~ys~ksDIwSlGiil~ELltG----------~~Pf~~~~-- 204 (639)
+....... .....||+.|+|||++.. .++.++|||||||++|||+|| ..||.+..
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 97554322 234589999999998864 355799999999999999999 88886432
Q ss_pred --CHHHHHHHHHcCCCCCccc-----CCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 205 --NPAQIFKKVTSGIKPASLA-----KVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 205 --~~~~i~~~i~~g~~p~~l~-----~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
....+...+........++ ...++.+.+||.+||. +|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2233333332222222222 1234679999999999 8999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.36 Aligned_cols=234 Identities=27% Similarity=0.452 Sum_probs=187.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+. +..||+|++.. ....+.+.+|+.+|++++||||+++++++. + .+++|||
T Consensus 15 ~lg~G~~g---~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~--~~~lv~e 79 (307)
T 2eva_A 15 VVGRGAFG---VVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACL--N--PVCLVME 79 (307)
T ss_dssp EEECCSSS---EEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--T--TTEEEEE
T ss_pred EeecCCCc---eEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C--CcEEEEE
Confidence 37888888 79999874 78999998753 245677899999999999999999999764 2 2789999
Q ss_pred cCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 81 LFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHS---HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 81 y~~gGsL~d~lkk~~---~l~e~~i~~i~~QIl~aL~yLHs---~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
|+.+|+|.+++.... .+++..+..|+.||+.||.|||+ +| |+||||||+|||++.+...+||+|||++....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999998765 37899999999999999999999 67 99999999999998553348999999997654
Q ss_pred CCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH-HHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 155 QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP-AQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 155 ~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~-~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
.. .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... ..+...+..+..+ ......++.+++
T Consensus 158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 235 (307)
T 2eva_A 158 TH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIES 235 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCHHHHH
T ss_pred cc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCHHHHH
Confidence 32 234579999999998865 5899999999999999999999999764433 3344444454443 344566789999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcC
Q 006593 233 FIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~H 253 (639)
||.+||. +|.+|||+.+++++
T Consensus 236 li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999999 89999999999884
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=336.95 Aligned_cols=242 Identities=22% Similarity=0.319 Sum_probs=195.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+ ++..||+|++............+.+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 39 lg~G~~g---~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~ 111 (307)
T 2nru_A 39 MGEGGFG---VVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG--DDLCLVYVY 111 (307)
T ss_dssp EEECSSE---EEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEEC
T ss_pred cccCCCe---EEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC--CceEEEEEe
Confidence 6778877 8999986 58899999987654334455678899999999999999999999988654 458899999
Q ss_pred CCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 82 FTSGNLRQYRKK---HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk---~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
+.+|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSCSS
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeecccccccccccc
Confidence 999999999974 356999999999999999999999999 99999999999997 55799999999987654321
Q ss_pred ---CccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHH---HHHHHHHcCCC---------CCcc
Q 006593 158 ---ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIK---------PASL 222 (639)
Q Consensus 158 ---~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~---~i~~~i~~g~~---------p~~l 222 (639)
.....||+.|+|||++.+.++.++||||||+++|+|++|..||....... .+...+..... ....
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred cccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 23457999999999998889999999999999999999999997643321 22222222111 0111
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+...+..+.++|.+||. +|.+|||+.+++++
T Consensus 269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12224578999999999 89999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.89 Aligned_cols=233 Identities=21% Similarity=0.368 Sum_probs=195.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+. |..||+|+++... ..+.+.+|+.+|++++||||+++++++.... ..+++||||
T Consensus 201 lG~G~fg---~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~iv~e~ 268 (450)
T 1k9a_A 201 IGKGEFG---DVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEY 268 (450)
T ss_dssp EEECSSE---EEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCEEEEEEC
T ss_pred ecCcCCe---eEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-CceEEEEEe
Confidence 7788887 89999875 7899999987542 3467899999999999999999999877653 368999999
Q ss_pred CCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 82 FTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~--l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
+.+|+|.+++++.+. +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..... ..
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~-~~ 344 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QD 344 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccccccc-cc
Confidence 999999999987643 799999999999999999999999 99999999999997 5579999999999754332 23
Q ss_pred cccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+++.|+|||++. ..|+.++|||||||++|||+| |..||.+. +..++...+..+..+ ..+...++.+.+||.+|
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~c 422 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAVYDVMKNC 422 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-CTTTHHHHHHTTCCC-CCCTTCCHHHHHHHHHH
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHH
Confidence 346789999999886 469999999999999999998 99999874 345566677766543 34566789999999999
Q ss_pred cC-CCCCCCCHHHHhc
Q 006593 238 LV-PASERLSAKDLLK 252 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~ 252 (639)
|. +|.+|||+.+|+.
T Consensus 423 l~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 423 WHLDAATRPTFLQLRE 438 (450)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCChhHCcCHHHHHH
Confidence 99 8999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=329.24 Aligned_cols=238 Identities=20% Similarity=0.253 Sum_probs=192.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|+.||+|++..... .+.+.+|+.+++.++|++++..+..+... ...+++||||
T Consensus 17 lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e~ 86 (296)
T 3uzp_A 17 IGSGSFG---DIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVMEL 86 (296)
T ss_dssp EEEETTE---EEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEEC
T ss_pred EccCCCe---EEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccCC-CCceEEEEEe
Confidence 6777777 899999999999999999876542 13478999999999998887777655443 3578999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe--CCCCcEEEeecchhhhccCCC-
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~--~~~g~VKL~DFGlA~~l~~~~- 157 (639)
+ +|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ ...+.+||+|||++.......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9 8999999984 457999999999999999999999999 99999999999994 355799999999997654332
Q ss_pred --------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCC--HHHHHHHHHcC---CCCCccc
Q 006593 158 --------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSG---IKPASLA 223 (639)
Q Consensus 158 --------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--~~~i~~~i~~g---~~p~~l~ 223 (639)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+... ..+.+..+... .....+.
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 243 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHT
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHH
Confidence 245679999999998865 589999999999999999999999976322 12222222221 1112233
Q ss_pred CCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 224 KVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 224 ~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
...++.+.+||.+||. +|.+||++.++++
T Consensus 244 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 244 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 5567899999999999 8999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=332.22 Aligned_cols=241 Identities=21% Similarity=0.318 Sum_probs=193.9
Q ss_pred CcccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| +||+|.+.. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++...+ ...++
T Consensus 32 ~lg~G~~g---~Vy~~~~~~~~~~~~~~avk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 104 (298)
T 3f66_A 32 VIGRGHFG---CVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLV 104 (298)
T ss_dssp EEEEETTE---EEEEEEEC-----CEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEE
T ss_pred eeeecCCc---eEEEEEEecCCCceeEEEEEecccCC---CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC-CceEE
Confidence 37888887 899998644 34568999887532 4566788999999999999999999999865543 46789
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.++++.. ..+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||++......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEECccccccccccc
Confidence 99999999999999864 56899999999999999999999999 99999999999997 5579999999999765322
Q ss_pred ------CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 157 ------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 157 ------~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
......||+.|+|||.+. ..++.++||||||+++|+|++ |.+||.. .+.......+..+..+ ..+...++
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~ 259 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL-LQPEYCPD 259 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-CCCTTCCH
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-CCCccCCH
Confidence 223456788999999886 468999999999999999999 5666655 4444455555555433 33455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+.++|.+||. +|.+|||+.|+++.
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 89999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.28 Aligned_cols=239 Identities=24% Similarity=0.405 Sum_probs=192.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEE----EEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEV----AWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~V----AIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+|.+..+|..| |+|.+.... .....+.+.+|+.+|++++||||+++++++.... .+
T Consensus 22 ~lG~G~~g---~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---~~ 92 (327)
T 3lzb_A 22 VLGSGAFG---TVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST---VQ 92 (327)
T ss_dssp EEEECSSE---EEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS---EE
T ss_pred EeeeCCCe---EEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC---ce
Confidence 36778777 89999998888765 555554322 3455678999999999999999999999987643 78
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+|++|+.+|+|.+++... +.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCcceeEccC
Confidence 899999999999999874 56999999999999999999999999 99999999999998 457999999999976543
Q ss_pred CC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. .....||+.|+|||++. ..|+.++|||||||++|+|++ |..||.+ .....+...+..+... ..+...+++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 247 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTID 247 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTBCHH
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccCCHH
Confidence 21 22345788999999876 458999999999999999999 9999987 3455565666555433 335556889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.+||.+||. +|.+||++.|+++.
T Consensus 248 l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 248 VYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999 89999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=338.13 Aligned_cols=240 Identities=21% Similarity=0.353 Sum_probs=195.0
Q ss_pred CcccccccCcEEEEEEEecCC----CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA----GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t----G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+|.+..+ +..||+|.++... .......+.+|+.++++++||||+++++++... ..++
T Consensus 51 ~lG~G~~g---~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~ 122 (333)
T 1mqb_A 51 VIGAGEFG---EVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPMM 122 (333)
T ss_dssp EEEECSSS---EEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEE
T ss_pred EEecCCCe---EEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC--CCcE
Confidence 37888888 8999987655 3569999987543 345667899999999999999999999987554 4689
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+||||+.+|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEECCCCcchhhcc
Confidence 999999999999999865 67999999999999999999999999 99999999999998 457999999999976643
Q ss_pred CC-----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 156 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 156 ~~-----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
.. .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+ .+...+...+..+..+. .+...++
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 277 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKAINDGFRLP-TPMDCPS 277 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCBH
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHCCCcCC-CcccCCH
Confidence 21 12234688999999886 468999999999999999999 9999987 45666777777664432 3445678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+.++|.+||. +|.+||++.+++++
T Consensus 278 ~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 278 AIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 89999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.45 Aligned_cols=237 Identities=24% Similarity=0.364 Sum_probs=201.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| .||+|.+..++..||+|+++... ...+.+.+|+.+|++|+|||||++++++... ..+++|||
T Consensus 227 ~lG~G~fg---~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~E 296 (495)
T 1opk_A 227 KLGGGQYG---EVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIITE 296 (495)
T ss_dssp ESGGGTTS---SEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEE
T ss_pred EecCCCCe---EEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC--CcEEEEEE
Confidence 37888888 79999999999999999987543 2356789999999999999999999988654 45899999
Q ss_pred cCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 81 LFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|+.+|+|.++++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceeccCCce
Confidence 99999999999874 45899999999999999999999999 99999999999997 45799999999997664332
Q ss_pred --CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 158 --ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 158 --~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
.....+++.|+|||++. ..|+.++|||||||++|||+| |..||.+. +..++...+..+... ..+...++.+.+|
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 451 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRM-ERPEGCPEKVYEL 451 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 22345678999999886 468999999999999999999 99999874 455666666665433 3455678899999
Q ss_pred HHHhcC-CCCCCCCHHHHhc
Q 006593 234 IEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~ 252 (639)
|.+||. +|.+|||+.+|++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 999999 8999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=353.22 Aligned_cols=234 Identities=22% Similarity=0.389 Sum_probs=197.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. .+..||+|+++... ...+.+.+|+.+|++|+||||+++++++. ...+++||||
T Consensus 196 lG~G~fg---~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv~e~ 263 (454)
T 1qcf_A 196 LGAGQFG---EVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEF 263 (454)
T ss_dssp EECCSSE---EEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEECC
T ss_pred cccCCce---EEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEEEee
Confidence 7888888 89999985 47889999998543 23577999999999999999999999874 2358899999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
+.+|+|.++++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+++.....
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCceEcCCCcee
Confidence 9999999999854 36899999999999999999999999 99999999999997 5579999999999866432
Q ss_pred CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
......+|+.|+|||++. ..|+.++|||||||++|||+| |..||.+. +..++...+..+.... .+...++++.+||
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li 418 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENCPEELYNIM 418 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHHTCCCC-CCTTSCHHHHHHH
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHH
Confidence 122345678999999886 569999999999999999999 99999874 5666667777664432 3456678999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||. +|.+|||+.+|+.
T Consensus 419 ~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 419 MRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHHH
Confidence 99999 8999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=330.75 Aligned_cols=226 Identities=19% Similarity=0.307 Sum_probs=181.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHH-HhCCCCCcceEEEEEEe--CCCceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLL-KSLKDDNVVKFYKSWVD--DKKKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iL-k~L~HpNIVkl~~~~~~--~~~~~l~lV 78 (639)
||+|+|| +||+|.+..+|+.||+|+++.. ..+.+|+.++ +.++||||+++++++.. .....+++|
T Consensus 26 lg~G~~g---~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 26 LGLGING---KVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cccCCCe---EEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 6777777 8999999999999999998632 3467899888 66699999999999865 334679999
Q ss_pred EecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--CCcEEEeecchhhhcc
Q 006593 79 TELFTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--HGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~g~VKL~DFGlA~~l~ 154 (639)
|||+.+|+|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++.. .+.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 99999999999998764 6999999999999999999999999 9999999999999752 5789999999875432
Q ss_pred CCCCccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC------CCcccCCCCh
Q 006593 155 QPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------PASLAKVNDP 228 (639)
Q Consensus 155 ~~~~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~------p~~l~~~~s~ 228 (639)
...|+.++|||||||++|+|++|..||..... ......+..... +.......++
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRMGQYEFPNPEWSEVSE 231 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHHHHHhhccccCCchhcccCCH
Confidence 23578899999999999999999999976322 111111111111 1111145678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
++++||.+||. +|.+|||+.|+|+||||+....
T Consensus 232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 99999999999 8999999999999999986543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=367.12 Aligned_cols=238 Identities=19% Similarity=0.297 Sum_probs=199.9
Q ss_pred cccccccCcEEEEEEEe--cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFD--EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d--~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|.+ ..++..||||+++.... .....+.+.+|+.+|++|+|||||++++++..+ .+++||
T Consensus 377 LG~G~fG---~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~ 448 (635)
T 4fl3_A 377 LGSGNFG---TVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVM 448 (635)
T ss_dssp EEECSSE---EEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEE
T ss_pred eccCCCE---EEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEE
Confidence 6788887 8999954 56789999999976532 345567899999999999999999999987532 378999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
||+.+|+|.++++..+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+++.+....
T Consensus 449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC----
T ss_pred EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccCccc
Confidence 99999999999999899999999999999999999999999 99999999999998 45799999999998764322
Q ss_pred ---CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 158 ---ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 158 ---~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
.....||+.|+|||++.. .|+.++|||||||++|||++ |..||.+ .+..++...+..+..+ ..+...++++.+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~ 603 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYD 603 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHH
Confidence 223456889999998864 69999999999999999998 9999987 4566777777776543 345567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhc
Q 006593 233 FIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~ 252 (639)
||.+||. +|.+||++.+|++
T Consensus 604 li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 9999999 8999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.51 Aligned_cols=243 Identities=22% Similarity=0.322 Sum_probs=188.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+ .+|..||+|++..... ......+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 37 ~lg~G~~g---~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 107 (326)
T 3uim_A 37 ILGRGGFG---KVYKGRL-ADGTLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYP 107 (326)
T ss_dssp EEECCSSS---EEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--CCEEEEE
T ss_pred eEecCCCc---EEEEEEe-cCCCEEEEEEeccccC---chHHHHHHHHHHHHHhccCCCccceEEEEecCC--ceEEEEE
Confidence 37888888 8999985 4689999999876542 222235899999999999999999999886554 4789999
Q ss_pred cCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 81 LFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSH---NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 81 y~~gGsL~d~lkk~~----~l~e~~i~~i~~QIl~aL~yLHs~---gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++ | |+||||||+|||++ ..+.+||+|||++...
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKLM 184 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECCCSSCEEC
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEeccCcccccc
Confidence 999999999998653 499999999999999999999999 8 99999999999998 5579999999999765
Q ss_pred cCCC---CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCC----CCCHHHHHHHHHcCCCCC-----
Q 006593 154 QQPT---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSE----CKNPAQIFKKVTSGIKPA----- 220 (639)
Q Consensus 154 ~~~~---~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~----~~~~~~i~~~i~~g~~p~----- 220 (639)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.. ..........+.......
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred CcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence 4322 23456999999999885 4689999999999999999999999951 011111111111111111
Q ss_pred -------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcc
Q 006593 221 -------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPF 255 (639)
Q Consensus 221 -------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpf 255 (639)
.......+.+.+||.+||. +|.+|||+.|+++|-.
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1111112578999999999 8999999999999854
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=351.11 Aligned_cols=240 Identities=25% Similarity=0.329 Sum_probs=182.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||.+ ...+|+.||||++.... .+.+.+|+.+|+++ +|||||++++++.+. ..+|+||
T Consensus 22 ~LG~G~~g---~V~~~-~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~lv~ 88 (434)
T 2rio_A 22 ILGYGSSG---TVVFQ-GSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTD--RFLYIAL 88 (434)
T ss_dssp EEEECSTT---CEEEE-EESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS--SEEEEEE
T ss_pred eEeeCCCe---EEEEE-EEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecC--CeEEEEE
Confidence 48999999 45544 44679999999987532 34578999999987 899999999987654 5699999
Q ss_pred ecCCCCCHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC------------CC
Q 006593 80 ELFTSGNLRQYRKKHKNVD-------IKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN------------HG 140 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~-------e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~------------~g 140 (639)
|||. |+|.+++...+... +..++.++.||+.||.|||++| |+||||||+|||++.+ .+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCce
Confidence 9996 69999998765432 2345789999999999999999 9999999999999732 34
Q ss_pred cEEEeecchhhhccCCC------CccccCCCCcCCccccc--------ccCCccccccchhhhhhhhhh-ccCCCCCCCC
Q 006593 141 EVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT-FEYPYSECKN 205 (639)
Q Consensus 141 ~VKL~DFGlA~~l~~~~------~~~~~GTp~ymAPE~l~--------~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~ 205 (639)
.+||+|||++....... ....+||+.|+|||++. ..++.++|||||||++|||+| |..||.+...
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 89999999997664321 23457999999999875 358899999999999999999 9999976433
Q ss_pred HHHHHHHHHcCCC-CCcccC----CCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 206 PAQIFKKVTSGIK-PASLAK----VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 206 ~~~i~~~i~~g~~-p~~l~~----~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.. ..+..+.. ...... ..++++++||.+||. +|.+|||+.++|+||||...
T Consensus 246 ~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 246 RE---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HH---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred hH---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 32 12222222 111111 124689999999999 89999999999999999643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=326.68 Aligned_cols=239 Identities=20% Similarity=0.251 Sum_probs=191.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|..||+|++...... ..+.+|+.+++.++|++++..+..+... ....++|||
T Consensus 16 ~lg~G~~g---~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~e 85 (296)
T 4hgt_A 16 KIGSGSFG---DIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVME 85 (296)
T ss_dssp EEEECSSS---EEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEEE
T ss_pred eecCCCCe---EEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEEEEE
Confidence 37888888 8999999999999999987755422 2478899999999998888777766443 357899999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe--CCCCcEEEeecchhhhccCCC
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~--~~~g~VKL~DFGlA~~l~~~~ 157 (639)
|+ +|+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++ ...+.+||+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99 9999999985 467999999999999999999999999 99999999999993 255799999999997654321
Q ss_pred ---------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH--HHHHHHHHcC---CCCCcc
Q 006593 158 ---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP--AQIFKKVTSG---IKPASL 222 (639)
Q Consensus 158 ---------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~--~~i~~~i~~g---~~p~~l 222 (639)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .+.+..+... ......
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 235679999999998864 5899999999999999999999999763321 1222222211 111222
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
....++++++||.+||. +|.+|||+.++++
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 34557899999999999 9999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.54 Aligned_cols=242 Identities=27% Similarity=0.328 Sum_probs=184.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+||.| ||++ ..+|+.||||++..... ..+.+|+++|+.+ +|||||++++++.+. ..+|+||
T Consensus 31 ~LG~G~~G~V--~~~~--~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~lv~ 97 (432)
T 3p23_A 31 VLGHGAEGTI--VYRG--MFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKDR--QFQYIAI 97 (432)
T ss_dssp EEEECGGGCE--EEEE--ESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred eeecCcCEEE--EEEE--EeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEEEE
Confidence 4899999964 4444 46789999999875432 1256899999999 899999999988765 4689999
Q ss_pred ecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC--C--CcEEEeecchhhhcc
Q 006593 80 ELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN--H--GEVKIGDLGLAIAMQ 154 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~--~--g~VKL~DFGlA~~l~ 154 (639)
|||. |+|.+++.... .+.+..++.|+.||+.||.|||++| |+||||||+|||++.+ . ..+||+|||+++...
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9996 69999998754 4556667899999999999999999 9999999999999521 2 358899999997654
Q ss_pred CC-----CCccccCCCCcCCccccc----ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCc--c
Q 006593 155 QP-----TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPAS--L 222 (639)
Q Consensus 155 ~~-----~~~~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~--l 222 (639)
.. .....+||+.|+|||++. ..++.++|||||||++|+|+| |..||.... ..+.. .+........ .
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-~~~~~-~~~~~~~~~~~~~ 252 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-QRQAN-ILLGACSLDCLHP 252 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-THHHH-HHTTCCCCTTSCT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-HHHHH-HHhccCCccccCc
Confidence 22 234567999999999886 347789999999999999999 899996532 22222 2222211111 1
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
....++.+++||.+||. +|.+|||+.++|+||||....
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 22234568999999999 899999999999999997543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.00 Aligned_cols=241 Identities=22% Similarity=0.311 Sum_probs=191.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+ .+|..||+|++.... ....+.+.+|+.+|+.++||||+++++++... ..+++|||
T Consensus 46 ~lg~G~~g---~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 115 (321)
T 2qkw_B 46 LIGHGVFG---KVYKGVL-RDGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFCDER--NEMILIYK 115 (321)
T ss_dssp CSCBCSSS---EEEEEEC-TTCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT--TCCEEEEE
T ss_pred eeecCCCe---eEEEEEE-CCCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC--CeEEEEEE
Confidence 47888888 8999997 468999999876543 34567899999999999999999999987554 45889999
Q ss_pred cCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 81 LFTSGNLRQYRKKHK----NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~----~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTTCEECSSS
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeecccccccccc
Confidence 999999999987543 5899999999999999999999999 99999999999997 5579999999999754322
Q ss_pred ----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCH-----HHHH-HHHHcCCCC------
Q 006593 157 ----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP-----AQIF-KKVTSGIKP------ 219 (639)
Q Consensus 157 ----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~-----~~i~-~~i~~g~~p------ 219 (639)
......||+.|+|||++. ..++.++|||||||++|+|++|..||...... .... .....+...
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence 123456899999999875 56899999999999999999999999653221 1111 111111111
Q ss_pred --CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 220 --ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 220 --~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
.......+..+.++|.+||. +|.+|||+.|+++|.
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11111223568899999999 899999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=325.92 Aligned_cols=234 Identities=22% Similarity=0.386 Sum_probs=196.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. .+..||+|.++... ...+.+.+|+++|++++||||+++++++.. ..+++||||
T Consensus 21 lg~G~~g---~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~ 88 (279)
T 1qpc_A 21 LGAGQFG---EVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEY 88 (279)
T ss_dssp EEEETTE---EEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEEC
T ss_pred ecCCCCe---EEEEEEEc-CCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEEEEec
Confidence 6777777 89999975 57889999987543 234678999999999999999999998743 247899999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
+.+|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCcccccccCcccc
Confidence 99999999997543 6999999999999999999999999 99999999999997 55799999999997664332
Q ss_pred -CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+ .+..++...+..+..+ ..+...++.+.+||
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 243 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNLERGYRM-VRPDNCPEELYQLM 243 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHHhcccCC-CCcccccHHHHHHH
Confidence 22345788999999886 468999999999999999999 8999987 4556666677665433 34456688999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||. +|.+|||+.++++
T Consensus 244 ~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 244 RLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccChhhCCCHHHHHH
Confidence 99999 8999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=346.12 Aligned_cols=246 Identities=17% Similarity=0.208 Sum_probs=188.4
Q ss_pred cccccccCcEEEEEEEecC---CCeEEEEEEEecccccCCh-------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeC-
Q 006593 2 VLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLP-------GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD- 70 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~-------~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~- 70 (639)
||+|+|| +||+|.+.. ++..||+|++......... .....+.+|+.+++.++||||+++++++...
T Consensus 45 lg~G~~g---~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 45 IGSGGFG---LIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp C---------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeecCCe---EEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 7888887 799999987 8899999998865321000 0113466888999999999999999998773
Q ss_pred -CCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC-CcEEEeecc
Q 006593 71 -KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH-GEVKIGDLG 148 (639)
Q Consensus 71 -~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~-g~VKL~DFG 148 (639)
+...+|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++.+. +.+||+|||
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kL~Dfg 198 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYG 198 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESSSTTSEEECCCT
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccCCCCcEEEEeCC
Confidence 246799999999 9999999988888999999999999999999999999 99999999999998431 389999999
Q ss_pred hhhhccCC---------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCC-CCHHHHHHHHH--c
Q 006593 149 LAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSEC-KNPAQIFKKVT--S 215 (639)
Q Consensus 149 lA~~l~~~---------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~-~~~~~i~~~i~--~ 215 (639)
+++.+... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. .+......... .
T Consensus 199 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 278 (345)
T 2v62_A 199 LSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL 278 (345)
T ss_dssp TCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH
T ss_pred CceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc
Confidence 99755321 1134579999999998875 4899999999999999999999999542 23322221111 1
Q ss_pred CCCCCcc-----cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 216 GIKPASL-----AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 216 g~~p~~l-----~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
...+..+ ....++++++||.+||. +|.+||++.+|++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 279 DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111111 11567899999999999 99999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.90 Aligned_cols=245 Identities=21% Similarity=0.229 Sum_probs=187.9
Q ss_pred CcccccccCcEEEEEEEecCC-----CeEEEEEEEecccccCChhh--------HHHHHHHHHHHHhCCCCCcceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA-----GIEVAWSRVKIDDVLQLPGD--------LQKLYSEVHLLKSLKDDNVVKFYKSW 67 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t-----G~~VAIK~v~~~~~~~~~~~--------~~~l~~Ei~iLk~L~HpNIVkl~~~~ 67 (639)
.||+|+|| +||+|.+..+ ++.||+|++...... ...+ ...+..|+..++.++||||+++++++
T Consensus 42 ~lG~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 117 (364)
T 3op5_A 42 PIGQGGFG---CIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSG 117 (364)
T ss_dssp ECCCC-CC---EEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEE
T ss_pred EEecCCCe---EEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeee
Confidence 37888888 8999998764 588999998755310 0000 11234456677788899999999998
Q ss_pred EeCC--CceEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC-CCCcEE
Q 006593 68 VDDK--KKTVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVK 143 (639)
Q Consensus 68 ~~~~--~~~l~lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~-~~g~VK 143 (639)
.... ..++++||||+ ||+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++. ..+.+|
T Consensus 118 ~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 118 LHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp EEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCTTCEE
T ss_pred eeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCCCeEE
Confidence 7653 35689999999 99999999876 67999999999999999999999999 999999999999972 347999
Q ss_pred EeecchhhhccCC---------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHH
Q 006593 144 IGDLGLAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 144 L~DFGlA~~l~~~---------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i 213 (639)
|+|||+++.+... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+...........
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~ 274 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS 274 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHH
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHH
Confidence 9999999654321 1234569999999998875 49999999999999999999999998533322222111
Q ss_pred HcC---CCCC----c-ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 214 TSG---IKPA----S-LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 214 ~~g---~~p~----~-l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
... ..+. . .....++++.+||..||. +|.+||++.+|++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 275 KIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 110 0000 0 113457899999999999 8999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.04 Aligned_cols=233 Identities=21% Similarity=0.369 Sum_probs=188.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. |..||+|+++.. ...+.+.+|+.++++++||||+++++++.... ..+++||||
T Consensus 29 lg~G~~g---~V~~~~~~--~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~ 96 (278)
T 1byg_A 29 IGKGEFG---DVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEY 96 (278)
T ss_dssp EEECSSC---EEEEEEET--TEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECC
T ss_pred EecCCCc---eEEEEEEc--CCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-CceEEEEec
Confidence 7888888 89999874 889999998643 24567899999999999999999999875543 468899999
Q ss_pred CCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 82 FTSGNLRQYRKKHKN--VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~--l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
+.+|+|.+++.+.+. +++..++.++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++...... ..
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~-~~ 172 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QD 172 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeecccccccccc-cc
Confidence 999999999987543 899999999999999999999999 99999999999997 5579999999998755432 23
Q ss_pred cccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+++.|+|||++. ..++.++||||||+++|+|+| |..||... +...+...+..+.. ...+...++.++++|.+|
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 250 (278)
T 1byg_A 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYK-MDAPDGCPPAVYEVMKNC 250 (278)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCC-CCCCTTCCHHHHHHHHHH
T ss_pred CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHH
Confidence 446789999999886 458999999999999999998 99999863 45556666666543 334556788999999999
Q ss_pred cC-CCCCCCCHHHHhc
Q 006593 238 LV-PASERLSAKDLLK 252 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~ 252 (639)
|. +|.+||++.++++
T Consensus 251 l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 251 WHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred hcCChhhCCCHHHHHH
Confidence 99 8999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=327.90 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=190.9
Q ss_pred cccccccCcEEEEEEEecC-C--CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEF-A--GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~-t--G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
||+|+|| +||+|.+.. + +..||+|+++.... ......+.+.+|+.++++++||||+++++++.... .++|
T Consensus 26 lg~G~~g---~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~v 98 (291)
T 1u46_A 26 LGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP---MKMV 98 (291)
T ss_dssp CC----C---CCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---CEEE
T ss_pred ecCCCce---eEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC---ceee
Confidence 7888888 788888533 3 34799999876543 23456788999999999999999999999886543 7899
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 79 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
|||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-C
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEccccccccccccc
Confidence 9999999999999864 56999999999999999999999999 99999999999998 45799999999997654322
Q ss_pred -----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 158 -----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 158 -----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
.....+|+.|+|||++.. .++.++||||||+++|+|++ |..||.. .+..++...+.........+...++.+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDI 254 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence 223467889999998864 58999999999999999999 9999987 456666677766554445556678899
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+++|.+||. +|.+|||+.+++++
T Consensus 255 ~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 255 YNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999 89999999999973
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.88 Aligned_cols=236 Identities=25% Similarity=0.419 Sum_probs=183.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC--CCCCcceEEEEEEeCCC--ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL--KDDNVVKFYKSWVDDKK--KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVkl~~~~~~~~~--~~l~l 77 (639)
||+|+|| .||+|.+. |..||+|++.... ......|.+++..+ +||||+++++++..... ..+++
T Consensus 45 lg~G~~g---~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 45 IGKGRYG---EVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp EEEETTE---EEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred eecCCCe---EEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 6777777 89999885 8999999986432 23455566666555 99999999999887643 57899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH--------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~--------gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
||||+.+|+|.++++.. .+++..++.++.||+.||.|||++ + |+||||||+|||++ ..+.+||+|||+
T Consensus 113 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGL 188 (337)
T ss_dssp EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSCEEECCCTT
T ss_pred EEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCCEEEEeCCC
Confidence 99999999999999764 699999999999999999999998 7 99999999999997 557999999999
Q ss_pred hhhccCCC------CccccCCCCcCCccccccc-CCc------cccccchhhhhhhhhhc----------cCCCCCCC--
Q 006593 150 AIAMQQPT------ARSVIGTPEFMAPELYEEE-YNE------LVDIYSFGMCILEMVTF----------EYPYSECK-- 204 (639)
Q Consensus 150 A~~l~~~~------~~~~~GTp~ymAPE~l~~~-ys~------ksDIwSlGiil~ELltG----------~~Pf~~~~-- 204 (639)
+....... ....+||+.|+|||++.+. +.. ++|||||||++|||+|| ..||....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 96554322 1256899999999988653 333 48999999999999999 77775432
Q ss_pred --CHHHHHHHHHcCCCCCcccC-----CCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 205 --NPAQIFKKVTSGIKPASLAK-----VNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 205 --~~~~i~~~i~~g~~p~~l~~-----~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
........+........++. ..++++.+||.+||. +|.+|||+.++++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 12233333322222222222 234569999999999 89999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.54 Aligned_cols=243 Identities=25% Similarity=0.347 Sum_probs=181.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHH--HHhCCCCCcceEEEEEEe---CCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHL--LKSLKDDNVVKFYKSWVD---DKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~i--Lk~L~HpNIVkl~~~~~~---~~~~~l~ 76 (639)
||+|+|| +||+|.+ +|..||+|++.... ...+..|.++ ++.++||||+++++.+.. .....++
T Consensus 21 lg~G~~g---~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 21 IGRGRYG---AVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp EEECSSE---EEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred cccCCCe---EEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 6778777 8999976 68999999997543 2233444444 556899999999986543 3344688
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeeeeccCCCcEEEeCCCCcEEEeec
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH---------NPPIIHRDLKCDNIFVNGNHGEVKIGDL 147 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~---------gppIIHRDLKp~NILl~~~~g~VKL~DF 147 (639)
+||||+.+|+|.++++..+ .++..++.++.||+.||.|||++ + |+||||||+|||++ ..|.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCCcEEEeec
Confidence 9999999999999998755 58999999999999999999999 7 99999999999998 4579999999
Q ss_pred chhhhccCC----------CCccccCCCCcCCcccccc--------cCCccccccchhhhhhhhhhccCCCCCCCC----
Q 006593 148 GLAIAMQQP----------TARSVIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTFEYPYSECKN---- 205 (639)
Q Consensus 148 GlA~~l~~~----------~~~~~~GTp~ymAPE~l~~--------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~---- 205 (639)
|++..+... .....+||+.|+|||++.+ .++.++|||||||++|||++|..||.....
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 999765421 1224579999999998864 467899999999999999999776532111
Q ss_pred -------------HHHHHHHHHcCCCCCcccCCC------ChHHHHHHHHhcC-CCCCCCCHHHHhc------Ccccccc
Q 006593 206 -------------PAQIFKKVTSGIKPASLAKVN------DPQIKGFIEKCLV-PASERLSAKDLLK------DPFLQVE 259 (639)
Q Consensus 206 -------------~~~i~~~i~~g~~p~~l~~~~------s~~l~~LI~kcL~-dP~~RpSa~ELL~------Hpff~~~ 259 (639)
...+...+........++... ++.+++||.+||. +|.+|||+.|+++ ++|-+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 112222222222222333322 3479999999999 8999999999954 5666544
Q ss_pred c
Q 006593 260 N 260 (639)
Q Consensus 260 ~ 260 (639)
.
T Consensus 325 ~ 325 (336)
T 3g2f_A 325 S 325 (336)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=334.72 Aligned_cols=240 Identities=26% Similarity=0.392 Sum_probs=194.4
Q ss_pred cccccccCcEEEEEEE----ecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 2 VLTGLYMTPFSSYKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~----d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
||+|+|| .||+|. +..+|..||+|++... .....+.+.+|+.+|++++||||+++++++.......+++
T Consensus 49 lg~G~~g---~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 49 LGKGNFG---SVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp EECCSSE---EEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred eccCCCe---EEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 6777777 899998 5778999999998754 3466778999999999999999999999887766557899
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||++......
T Consensus 122 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp EECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCSS
T ss_pred EEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEecCcchhhcccc
Confidence 99999999999999876 45999999999999999999999999 99999999999998 4579999999999766433
Q ss_pred C-----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCH---------------HHHHHHHHc
Q 006593 157 T-----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNP---------------AQIFKKVTS 215 (639)
Q Consensus 157 ~-----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~---------------~~i~~~i~~ 215 (639)
. .....+++.|+|||++.+ .++.++||||||+++|+|+||..||...... ..+...+..
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 2 223457888999998864 5899999999999999999999888531000 012223333
Q ss_pred CCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 216 GIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 216 g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.. ...+...++++.+||.+||. +|.+|||+.|+++
T Consensus 279 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 279 NGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 322 23455678899999999999 8999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=345.92 Aligned_cols=241 Identities=21% Similarity=0.316 Sum_probs=188.9
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| +||+|.+..+ +..||+|.++.. ......+.+.+|+.+|++++||||+++++++...+ ...++
T Consensus 96 ~LG~G~fg---~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~~l 168 (373)
T 3c1x_A 96 VIGRGHFG---CVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLV 168 (373)
T ss_dssp EEECCSSS---EEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS-SCCEE
T ss_pred EeeeCCCe---EEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-CCeEE
Confidence 37888888 7999987543 356899987643 24466788999999999999999999999875443 45789
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
||||+.+|+|.+++++. ..+++..++.++.||+.||.|||++| |+||||||+|||++ ..+.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeecccccccccc
Confidence 99999999999999865 45899999999999999999999999 99999999999997 5579999999999765332
Q ss_pred C------CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCCh
Q 006593 157 T------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDP 228 (639)
Q Consensus 157 ~------~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~ 228 (639)
. .....+|+.|+|||++. ..|+.++|||||||++|||+| |.+||.+. +..++...+..+..+ ..+...++
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-~~~~~~~~~~~~~~~-~~p~~~~~ 323 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRL-LQPEYCPD 323 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CSSCHHHHHHTTCCC-CCCTTCCH
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCH
Confidence 1 12345788999999886 468999999999999999999 67788763 334444555555433 33456678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
.+.++|.+||. +|.+||++.|++++
T Consensus 324 ~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 324 PLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 89999999999885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=335.36 Aligned_cols=238 Identities=24% Similarity=0.380 Sum_probs=196.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.+.. .||+|+++.... .....+.+.+|+.++++++||||+++++++.... .+++|||
T Consensus 40 ~lg~G~~g---~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~iv~e 109 (319)
T 2y4i_B 40 LIGKGRFG---QVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP--HLAIITS 109 (319)
T ss_dssp BCCCSSSS---EEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS--CEEEECB
T ss_pred EeccCCce---EEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC--ceEEEee
Confidence 47888888 899999864 399999876542 2233455788999999999999999999987654 5899999
Q ss_pred cCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC----
Q 006593 81 LFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ---- 155 (639)
Q Consensus 81 y~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~---- 155 (639)
|+.+++|.+++...+ .+++..++.++.||+.||.|||++| |+||||||+|||++ +|.+||+|||++.....
T Consensus 110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC--------
T ss_pred cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCcccccccccc
Confidence 999999999998755 6999999999999999999999999 99999999999997 36899999999765421
Q ss_pred ---CCCccccCCCCcCCcccccc----------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcc
Q 006593 156 ---PTARSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASL 222 (639)
Q Consensus 156 ---~~~~~~~GTp~ymAPE~l~~----------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l 222 (639)
.......||+.|+|||++.. .++.++||||||+++|+|++|..||.. .....+...+..+..+...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~ 264 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLS 264 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCCCCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCCCCCC
Confidence 12234568999999998753 378899999999999999999999987 4566677777777666555
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
....++++.+||.+||. +|.+|||+.++++.
T Consensus 265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 55677899999999999 89999999999873
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=361.54 Aligned_cols=242 Identities=17% Similarity=0.332 Sum_probs=198.7
Q ss_pred cccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| .||+|.+. .++..||||+++... .....+.+.+|+.+|++|+|||||++++++..+ .+++||
T Consensus 344 LG~G~fG---~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~ 414 (613)
T 2ozo_A 344 LGCGNFG---SVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVM 414 (613)
T ss_dssp EEECSSS---EEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---SEEEEE
T ss_pred EecCCCc---EEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---CeEEEE
Confidence 6888888 89999875 457789999987653 234567899999999999999999999988652 489999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC-
Q 006593 80 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~- 157 (639)
|||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||+++.+....
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCcccccCCCc
Confidence 999999999999754 45999999999999999999999999 99999999999998 45799999999998664321
Q ss_pred ----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 158 ----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 158 ----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
.....+|+.|+|||++. ..|+.++|||||||++|||++ |..||.+. +..++...+..+... ..+...++++.
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~ 569 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRM-ECPPECPPELY 569 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CSHHHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHH
Confidence 12234678999999886 569999999999999999998 99999874 445667777776543 34556789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhc---Ccccc
Q 006593 232 GFIEKCLV-PASERLSAKDLLK---DPFLQ 257 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~---Hpff~ 257 (639)
+||.+||. +|.+||++.+|++ +.|+.
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999 8999999999854 45544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=338.03 Aligned_cols=235 Identities=17% Similarity=0.230 Sum_probs=189.0
Q ss_pred cccccccCcEEEEEEEecCC--------CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcce-----------
Q 006593 2 VLTGLYMTPFSSYKAFDEFA--------GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----------- 62 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~t--------G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk----------- 62 (639)
||+|+|| +||+|.+..+ |..||+|++... +.+.+|+.++++++||||++
T Consensus 50 lg~G~~g---~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 50 QTRDNQG---ILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEETTE---EEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred ecCCCCe---EEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 6777777 8999999874 889999998754 24789999999999999988
Q ss_pred ----EEEEEEeCCCceEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe
Q 006593 63 ----FYKSWVDDKKKTVNMITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136 (639)
Q Consensus 63 ----l~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~ 136 (639)
+++++... ...+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++| |+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEE
T ss_pred CccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEc
Confidence 66666553 35789999999 99999999986 78999999999999999999999999 99999999999998
Q ss_pred CCCC--cEEEeecchhhhccCC---------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC
Q 006593 137 GNHG--EVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK 204 (639)
Q Consensus 137 ~~~g--~VKL~DFGlA~~l~~~---------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~ 204 (639)
. .+ .+||+|||++..+... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....
T Consensus 194 ~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 P-EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp T-TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred C-CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 4 45 8999999999755322 1234589999999998875 68999999999999999999999998654
Q ss_pred -CHHHHHHHHH---cCCCCC----cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 205 -NPAQIFKKVT---SGIKPA----SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 205 -~~~~i~~~i~---~g~~p~----~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+...+..... ...... ......++++++||.+||. +|.+||++.+|++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 3444333322 221111 0112357899999999999 89999999999873
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.81 Aligned_cols=236 Identities=24% Similarity=0.391 Sum_probs=191.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHh--CCCCCcceEEEEEEeCCC--ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKS--LKDDNVVKFYKSWVDDKK--KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~--L~HpNIVkl~~~~~~~~~--~~l~l 77 (639)
||+|+|| +||+|.+ +|..||+|++... ....+.+|+++++. ++||||+++++++..... ..+++
T Consensus 50 lg~G~~g---~Vy~~~~--~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 50 IGKGRFG---EVWRGKW--RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp EEEETTE---EEEEEEE--TTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ecCCCCc---EEEEEEE--cCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 6777777 8999988 5899999998633 34567889999988 799999999999877653 26899
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeeeeccCCCcEEEeCCCCcEEEeecch
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH--------SHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGL 149 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLH--------s~gppIIHRDLKp~NILl~~~~g~VKL~DFGl 149 (639)
||||+.+|+|.+++++. .+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.+||+|||+
T Consensus 118 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGL 193 (342)
T ss_dssp EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEEECCCTT
T ss_pred EEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEEEEECCC
Confidence 99999999999999874 6899999999999999999999 788 99999999999997 457999999999
Q ss_pred hhhccCCC------CccccCCCCcCCccccccc-------CCccccccchhhhhhhhhhc----------cCCCCCCC--
Q 006593 150 AIAMQQPT------ARSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTF----------EYPYSECK-- 204 (639)
Q Consensus 150 A~~l~~~~------~~~~~GTp~ymAPE~l~~~-------ys~ksDIwSlGiil~ELltG----------~~Pf~~~~-- 204 (639)
+....... .....||+.|+|||++... ++.++|||||||++|+|+|| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 97654332 2445799999999988653 34789999999999999999 78886532
Q ss_pred --CHHHHHHHHHcCCCCCcccC-----CCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 205 --NPAQIFKKVTSGIKPASLAK-----VNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 205 --~~~~i~~~i~~g~~p~~l~~-----~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
....+...+........++. .....+.+||.+||. +|.+|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23455555544433333332 123478999999998 99999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.19 Aligned_cols=240 Identities=18% Similarity=0.187 Sum_probs=187.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEeccccc----CChhhHHHHHHHHHHHHhCC---------CCCcceEEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL----QLPGDLQKLYSEVHLLKSLK---------DDNVVKFYKSWV 68 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~----~~~~~~~~l~~Ei~iLk~L~---------HpNIVkl~~~~~ 68 (639)
||+|+|| +||+|.+ +|..||+|+++..... ......+.+.+|+.+|+.|+ |||||++++.+.
T Consensus 28 lG~G~~g---~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~ 102 (336)
T 2vuw_A 28 IGEGVFG---EVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102 (336)
T ss_dssp EEEETTE---EEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred ecccCce---EEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence 6777777 8999998 6899999999876432 12344577899999999986 888888887764
Q ss_pred eC----------------------------CCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hC
Q 006593 69 DD----------------------------KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SH 119 (639)
Q Consensus 69 ~~----------------------------~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLH-s~ 119 (639)
.. ....+|+|||||.+|++.+.+.+ +.+++..++.|++||+.||.||| ++
T Consensus 103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ 181 (336)
T 2vuw_A 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASL 181 (336)
T ss_dssp EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 32 14579999999999976666644 67899999999999999999999 89
Q ss_pred CCCeeeeccCCCcEEEeCCCC--------------------cEEEeecchhhhccCCCCccccCCCCcCCcccccccCCc
Q 006593 120 NPPIIHRDLKCDNIFVNGNHG--------------------EVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNE 179 (639)
Q Consensus 120 gppIIHRDLKp~NILl~~~~g--------------------~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~~~ys~ 179 (639)
| |+||||||+|||++.+ | .+||+|||+|+..... ..+||+.|||||++.+..+.
T Consensus 182 ~--ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~~~ 255 (336)
T 2vuw_A 182 R--FEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDGDY 255 (336)
T ss_dssp C--CBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCCSSH
T ss_pred C--EeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCCCcc
Confidence 9 9999999999999844 4 8999999999876542 45899999999999877789
Q ss_pred cccccchhhh-hhhhhhccCCCCCCCCHHHHHHHHHcCCC-----CCcccCCCChHHHHHHHHhcCCCCCCCCHHHHh-c
Q 006593 180 LVDIYSFGMC-ILEMVTFEYPYSECKNPAQIFKKVTSGIK-----PASLAKVNDPQIKGFIEKCLVPASERLSAKDLL-K 252 (639)
Q Consensus 180 ksDIwSlGii-l~ELltG~~Pf~~~~~~~~i~~~i~~g~~-----p~~l~~~~s~~l~~LI~kcL~dP~~RpSa~ELL-~ 252 (639)
++||||||++ .+++++|..||.+......+...+..... +.......++++++||.+||..+ ||.|+| +
T Consensus 256 ~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----sa~e~l~~ 331 (336)
T 2vuw_A 256 QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SATDLLCQ 331 (336)
T ss_dssp HHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----SHHHHHHH
T ss_pred ceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----CHHHHHhc
Confidence 9999998776 88899999998542111223333332211 11222335688999999999832 999999 9
Q ss_pred Ccccc
Q 006593 253 DPFLQ 257 (639)
Q Consensus 253 Hpff~ 257 (639)
||||+
T Consensus 332 Hp~f~ 336 (336)
T 2vuw_A 332 HSLFK 336 (336)
T ss_dssp CGGGC
T ss_pred CCCcC
Confidence 99995
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.75 Aligned_cols=232 Identities=20% Similarity=0.274 Sum_probs=180.9
Q ss_pred cccccccCcEEEEEE-----EecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCCc
Q 006593 2 VLTGLYMTPFSSYKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKK 73 (639)
Q Consensus 2 LG~GGfG~v~tVykA-----~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~~ 73 (639)
||+|+|| +||+| .+..+++.||+|+++... ...+..|+++++.++ |+||+++++++...+
T Consensus 73 lG~G~~g---~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~-- 140 (365)
T 3e7e_A 73 LGEGAFA---QVYEATQGDLNDAKNKQKFVLKVQKPAN-------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN-- 140 (365)
T ss_dssp EEECSSE---EEEEEEC-------CCCCEEEEEESSCC-------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS--
T ss_pred eeccCCE---EEEEEEecCCcccccCcEEEEEEeCCCC-------hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC--
Confidence 7788887 89999 477889999999986432 345788888888886 999999999987664
Q ss_pred eEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC----------
Q 006593 74 TVNMITELFTSGNLRQYRKK-----HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN---------- 138 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk-----~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~---------- 138 (639)
..++|||||.+|+|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC------
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCccccccc
Confidence 48899999999999999974 467999999999999999999999999 9999999999999741
Q ss_pred CCcEEEeecchhhhcc----CCCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHH
Q 006593 139 HGEVKIGDLGLAIAMQ----QPTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKV 213 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~----~~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i 213 (639)
.+.+||+|||+|+.+. .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 5799999999996543 112345689999999998875 4899999999999999999999999542110000
Q ss_pred HcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 214 TSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 214 ~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
...... ....+..+.+++.+||. +|.+|++..+.|.+.
T Consensus 295 ~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 295 PEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred echhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000000 11235678999999999 888886655554443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.53 Aligned_cols=234 Identities=21% Similarity=0.356 Sum_probs=192.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+.. +..||+|+++.... ..+.+.+|+.+|++|+||||+++++++.. ..+++||||
T Consensus 192 lG~G~fg---~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~e~ 259 (452)
T 1fmk_A 192 LGQGCFG---EVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEY 259 (452)
T ss_dssp EEECSSC---EEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECC
T ss_pred ecCCCCe---EEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEehh
Confidence 7888888 899999865 56799999875432 24568999999999999999999998744 348899999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
+.+|+|.++++.. +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCccceecCCCcee
Confidence 9999999999743 56999999999999999999999999 99999999999997 45799999999997654321
Q ss_pred -CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.....+|+.|+|||++. ..|+.++||||||+++|||+| |..||.+ ....++...+..+... ..+...++.+.+||
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 414 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECPESLHDLM 414 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHH
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 22345678999999876 569999999999999999999 9999987 4566677777766443 23456678999999
Q ss_pred HHhcC-CCCCCCCHHHHhc
Q 006593 235 EKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~ 252 (639)
.+||. +|.+|||+.+|+.
T Consensus 415 ~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 415 CQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCChhhCcCHHHHHH
Confidence 99999 8999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=350.20 Aligned_cols=235 Identities=21% Similarity=0.349 Sum_probs=197.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+.. +..||+|+++.... ..+.+.+|+.+|++|+||||+++++++.+ ..+++||||
T Consensus 275 lG~G~fg---~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~e~ 342 (535)
T 2h8h_A 275 LGQGCFG---EVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEY 342 (535)
T ss_dssp EEECSSE---EEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECC
T ss_pred cccCCCe---EEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEeeeh
Confidence 7788877 899999865 56799999986542 24568999999999999999999998744 358899999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
+.+|+|.++++.. +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcccccceecCCCcee
Confidence 9999999999753 56999999999999999999999999 99999999999997 4579999999999765432
Q ss_pred CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
......+++.|+|||++. ..|+.++|||||||++|||++ |..||.+ ....++...+..+... ..+...+..+.+||
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 497 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGYRM-PCPPECPESLHDLM 497 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHH
Confidence 122345688999999876 569999999999999999999 8999987 4566677777766443 23456678999999
Q ss_pred HHhcC-CCCCCCCHHHHhcC
Q 006593 235 EKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~H 253 (639)
.+||. +|.+|||+.+|+..
T Consensus 498 ~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 498 CQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999 89999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=343.54 Aligned_cols=238 Identities=17% Similarity=0.263 Sum_probs=190.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN-VVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| .||+|.+..+|..||||++...... ..+..|+.+++.|+|++ |..++.++.. ....++||
T Consensus 14 ~LG~G~fG---~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvm 82 (483)
T 3sv0_A 14 KIGSGSFG---EIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVM 82 (483)
T ss_dssp CCEECSSC---EEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEE
T ss_pred EEeeCCCE---EEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEE
Confidence 47888888 8999999999999999988765432 23788999999998755 4455444443 35689999
Q ss_pred ecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe--CCCCcEEEeecchhhhccCC
Q 006593 80 ELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN--GNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~--~~~g~VKL~DFGlA~~l~~~ 156 (639)
||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ...+.+||+|||+++.....
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999 8999999986 567999999999999999999999999 99999999999994 25579999999999766433
Q ss_pred C---------CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCC--HHHHHHHHHcCC---CCCc
Q 006593 157 T---------ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGI---KPAS 221 (639)
Q Consensus 157 ~---------~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--~~~i~~~i~~g~---~p~~ 221 (639)
. ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.+... ..+.+..+.... ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 2 125689999999998864 589999999999999999999999976432 333443333221 1122
Q ss_pred ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 222 LAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 222 l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+....++++.+||.+||. +|.+||++.+|++
T Consensus 240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 335567899999999999 8999999988765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.09 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=200.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD----DKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~----~~~~~l~ 76 (639)
.||+|||| +||+|.+..+|..||+|+++... .....+.+.+|+.+|++++||||+++++++.. .....++
T Consensus 21 ~LG~G~fG---~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 21 RLGTGGFG---YVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp CCCBCSSS---BCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred EEeeCCCe---EEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 47888888 79999999999999999887542 45667889999999999999999999997643 1245688
Q ss_pred EEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC--cEEEeecchhh
Q 006593 77 MITELFTSGNLRQYRKKHK---NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG--EVKIGDLGLAI 151 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~---~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g--~VKL~DFGlA~ 151 (639)
+|||||.||+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.+.+ .+||+|||++.
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 9999999999999998754 5999999999999999999999999 999999999999984422 48999999997
Q ss_pred hccCC-CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHH-------------cC
Q 006593 152 AMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVT-------------SG 216 (639)
Q Consensus 152 ~l~~~-~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~-------------~g 216 (639)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....+......+. .+
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 76543 334568999999999886 4689999999999999999999999976433322111100 00
Q ss_pred --------CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 217 --------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 217 --------~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
..+..+....++.+.+||.+||. ||.+|||+.++|+||||+..
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 01112223345789999999999 99999999999999999753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.14 Aligned_cols=242 Identities=17% Similarity=0.197 Sum_probs=182.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCcc------------------
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVV------------------ 61 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIV------------------ 61 (639)
+||+|||| +||+|.+..+|+.||||+++..... .....+.+.+|+.+++.+.| +|+.
T Consensus 85 ~LG~G~fG---~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 85 VLGQEDPY---AYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred ccccCCCE---EEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 47888888 8999999999999999998854432 23446779999999999987 3211
Q ss_pred ---eEEEEEEeCC---CceEEEEEecCCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeecc
Q 006593 62 ---KFYKSWVDDK---KKTVNMITELFTSGNLRQYRKK-------HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128 (639)
Q Consensus 62 ---kl~~~~~~~~---~~~l~lV~Ey~~gGsL~d~lkk-------~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDL 128 (639)
.++.++.... ...++++|+++ +++|.++++. .+.+++..+..++.||+.||.|||++| |+||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDi 237 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYL 237 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCc
Confidence 1111111111 12366777776 5799999852 234778889999999999999999999 999999
Q ss_pred CCCcEEEeCCCCcEEEeecchhhhccCCCCccccCCCCcCCcccc----------cc-cCCccccccchhhhhhhhhhcc
Q 006593 129 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY----------EE-EYNELVDIYSFGMCILEMVTFE 197 (639)
Q Consensus 129 Kp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l----------~~-~ys~ksDIwSlGiil~ELltG~ 197 (639)
||+|||++ .+|.+||+|||+++..... ....+| +.|+|||++ .. .|+.++|||||||++|+|+||+
T Consensus 238 Kp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 99999998 4578999999998765433 345678 999999987 32 3788999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 198 YPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 198 ~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.||.... .......+... ....++.+++||.+||. +|.+||++.++|+||||+..
T Consensus 315 ~Pf~~~~-~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 315 LPNTDDA-ALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp CCCCTTG-GGSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCcc-hhhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9997632 22222222111 12456899999999999 89999999999999999754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=350.37 Aligned_cols=238 Identities=23% Similarity=0.388 Sum_probs=197.0
Q ss_pred cccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
||+|+|| +||+|.+.. .+..||+|.++... .....+.+.+|+.+|++++||||+++++++.+ ..+|+|
T Consensus 398 LG~G~fG---~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~lv 468 (656)
T 2j0j_A 398 IGEGQFG---DVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWII 468 (656)
T ss_dssp EECCSSC---CEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred EeeCCCE---EEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---CceEEE
Confidence 7888888 799998854 45789999876432 45566789999999999999999999998732 347899
Q ss_pred EecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 79 TELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
|||+.+|+|.++++..+ .+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++.......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCCeecCCCc
Confidence 99999999999998654 6999999999999999999999999 99999999999998 45799999999997664332
Q ss_pred ---CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 158 ---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 158 ---~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
.....||+.|+|||++. ..|+.++|||||||++|||++ |..||.+ ....++...+..+..+ ..+...++.+.+
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 623 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPTLYS 623 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHHTCCC-CCCTTCCHHHHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHcCCCC-CCCccccHHHHH
Confidence 22345788999999886 468999999999999999997 9999987 4566666677666443 345567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcC
Q 006593 233 FIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~H 253 (639)
||.+||. +|.+|||+.+|++.
T Consensus 624 li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 624 LMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999 89999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=357.02 Aligned_cols=234 Identities=18% Similarity=0.236 Sum_probs=191.4
Q ss_pred cccccccCcEEEEEEEecC-CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC---ceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEF-AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~-tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~---~~l~l 77 (639)
||+|||| +||+|.+.. +|+.||+|++.... .....+.+.+|+.+|++++||||+++++++...+. ..+|+
T Consensus 88 lg~G~~g---~Vy~a~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 88 IAHGGLG---WIYLALDRNVNGRPVVLKGLVHSG---DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEETTE---EEEEEEEGGGTTEEEEEEESCSSC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred EeeCCCe---EEEEEEEcCCCCcEEEEEEeCccC---CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 6777777 899999976 79999999886432 34566788999999999999999999999876543 13699
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||+.|++|.+++.. .+++..++.|+.||+.||.|||++| |+||||||+|||++. +.+||+|||+++.....
T Consensus 162 v~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS--SCEEECCCTTCEETTCC-
T ss_pred EEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC--CcEEEEecccchhcccC-
Confidence 9999999999998765 7999999999999999999999999 999999999999974 48999999999766543
Q ss_pred CccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 158 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+||+.|+|||++...++.++|||||||++|+|++|..||.+... .+..........++.+.+||.+|
T Consensus 235 -~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~ 304 (681)
T 2pzi_A 235 -GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYGRLLRRA 304 (681)
T ss_dssp -SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHHHHHHHH
T ss_pred -CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHHHHHhhh
Confidence 45689999999999988889999999999999999999988864210 11111111111246899999999
Q ss_pred cC-CCCCCCCHHHHhcCccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~ 258 (639)
|. +|.+||++.+.+.|+|+..
T Consensus 305 l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 305 IDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp TCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHHHHHH
Confidence 99 8999999999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.03 Aligned_cols=216 Identities=16% Similarity=0.103 Sum_probs=174.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+..+|+.||+|++..... ......+.+.+|+.++++++||||+++++++.+. ..+|+||||
T Consensus 39 lg~G~~g---~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~ 112 (286)
T 3uqc_A 39 HGGVPPL---QFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR--AGGLVVAEW 112 (286)
T ss_dssp EEBSTTC---EEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred EcccCCe---EEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC--CcEEEEEEe
Confidence 6778877 899999999999999999886543 2355678899999999999999999999998775 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 161 (639)
+.|++|.++++.. .....+..|+.||+.||.|||++| |+||||||+|||++ .+|.+||+++
T Consensus 113 ~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~~~-------------- 173 (286)
T 3uqc_A 113 IRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLAYP-------------- 173 (286)
T ss_dssp CCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEECSC--------------
T ss_pred cCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEEec--------------
Confidence 9999999999643 456678899999999999999999 99999999999998 5579999844
Q ss_pred cCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHH---HHHHHcCCC-CCcccCCCChHHHHHHHHh
Q 006593 162 IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI---FKKVTSGIK-PASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 162 ~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i---~~~i~~g~~-p~~l~~~~s~~l~~LI~kc 237 (639)
.|++| ++.++|||||||++|+|+||+.||.+......+ .+.+..... +.......++++++||.+|
T Consensus 174 ----~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 243 (286)
T 3uqc_A 174 ----ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243 (286)
T ss_dssp ----CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHH
T ss_pred ----cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHH
Confidence 34444 789999999999999999999999864322111 011111111 1123345678999999999
Q ss_pred cC-CCCCCCCHHHHhcC
Q 006593 238 LV-PASERLSAKDLLKD 253 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~H 253 (639)
|. ||.+| |+.|+++.
T Consensus 244 l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 244 VQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HCTTSSCC-CHHHHHHH
T ss_pred cccCCccC-CHHHHHHH
Confidence 99 89999 99999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=308.95 Aligned_cols=187 Identities=13% Similarity=0.088 Sum_probs=135.1
Q ss_pred ccccccCcEEEEEEEecCCCeEEEEEEEecccccC------ChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceE
Q 006593 3 LTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ------LPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTV 75 (639)
Q Consensus 3 G~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~------~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l 75 (639)
+.|+.| .++.++....|+.||+|++....... .....+.+.+|+++|+++ .|+||+++++++.++ ..+
T Consensus 243 ~~~~~~---~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~ 317 (569)
T 4azs_A 243 YAGAGL---AHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG 317 (569)
T ss_dssp C-----------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred ccCCcc---cccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence 344555 34455556678999999998653221 223456799999999999 799999999998765 469
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 76 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
||||||++||+|.++|++.+++++. .|++||+.||.|||++| ||||||||+|||++ .+|.|||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCC
Confidence 9999999999999999999989875 47899999999999999 99999999999997 568999999999987653
Q ss_pred C--CCccccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCC
Q 006593 156 P--TARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPY 200 (639)
Q Consensus 156 ~--~~~~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf 200 (639)
. ...+.+||+.|||||++.+.+...+|+||+|+++++|.++..|+
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred CCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 3 34567899999999999998889999999999999988765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-26 Score=260.23 Aligned_cols=181 Identities=17% Similarity=0.167 Sum_probs=143.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC----hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL----PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+| ...+..+|+|+......... ....+++.+|+++|++++||||+++..++...+. .|
T Consensus 343 ~LG~G~fg---~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~~ 415 (540)
T 3en9_A 343 LIGKGAEA---DIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--KR 415 (540)
T ss_dssp -----CCE---EEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--TE
T ss_pred EEeeCCCE---EEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--cE
Confidence 47888888 89999 45678899998765332211 1124568999999999999999955544455544 68
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+||||++||+|.++++. +..|+.||+.||.|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCCc
Confidence 99999999999999876 5689999999999999999 999999999999974 8999999999876542
Q ss_pred C---------CccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCC
Q 006593 157 T---------ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYS 201 (639)
Q Consensus 157 ~---------~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~ 201 (639)
. ....+||+.|||||++.. .|+..+|+||..+-.++.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 235789999999999874 58889999999999999988887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-22 Score=206.58 Aligned_cols=141 Identities=16% Similarity=0.132 Sum_probs=109.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccC-----Ch---------hhHHHHHHHHHHHHhCCCCCcceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ-----LP---------GDLQKLYSEVHLLKSLKDDNVVKFYKSW 67 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~-----~~---------~~~~~l~~Ei~iLk~L~HpNIVkl~~~~ 67 (639)
||+|+|| .||+|.+ .+|..||+|.++...... .. .....+.+|+.+|++++| +++++++
T Consensus 98 iG~G~~g---~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~ 170 (282)
T 1zar_A 98 MGEGKES---AVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY 170 (282)
T ss_dssp EEECSSE---EEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred eccCCCc---eEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence 6777777 8999999 889999999987543110 00 245678999999999994 4555543
Q ss_pred EeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeec
Q 006593 68 VDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDL 147 (639)
Q Consensus 68 ~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DF 147 (639)
.. ..+|+||||++||+|.+ +. ......++.||+.||.|||++| |+||||||+|||++ +|.+||+||
T Consensus 171 ~~---~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~vkl~DF 236 (282)
T 1zar_A 171 AW---EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEGIWIIDF 236 (282)
T ss_dssp EE---ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTEEEECCC
T ss_pred ec---cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCcEEEEEC
Confidence 22 23689999999999987 32 1335579999999999999999 99999999999998 589999999
Q ss_pred chhhhccCCCCccccCCCCcCCccccc
Q 006593 148 GLAIAMQQPTARSVIGTPEFMAPELYE 174 (639)
Q Consensus 148 GlA~~l~~~~~~~~~GTp~ymAPE~l~ 174 (639)
|+|+ .+..++|||++.
T Consensus 237 G~a~-----------~~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSV-----------EVGEEGWREILE 252 (282)
T ss_dssp TTCE-----------ETTSTTHHHHHH
T ss_pred CCCe-----------ECCCCCHHHHHH
Confidence 9985 355678999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=175.67 Aligned_cols=135 Identities=18% Similarity=0.186 Sum_probs=102.8
Q ss_pred cccccccCcEEEEEEEecCCCeE--EEEEEEeccccc--C------------------ChhhHHHHHHHHHHHHhCCCCC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIE--VAWSRVKIDDVL--Q------------------LPGDLQKLYSEVHLLKSLKDDN 59 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~--VAIK~v~~~~~~--~------------------~~~~~~~l~~Ei~iLk~L~HpN 59 (639)
||+|+|| .||+|.+..+|.. ||+|+++..... . .......+.+|+.+|+.|.|++
T Consensus 55 ig~G~~g---~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 55 ISTGKEA---NVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEECSSE---EEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EeecceE---EEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 6777777 8999999888999 999997654211 0 0012246889999999998886
Q ss_pred c--ceEEEEEEeCCCceEEEEEecCCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeeccCCC
Q 006593 60 V--VKFYKSWVDDKKKTVNMITELFTS-G----NLRQYRKKHKNVDIKVIKNWARQILHGLVYLH-SHNPPIIHRDLKCD 131 (639)
Q Consensus 60 I--Vkl~~~~~~~~~~~l~lV~Ey~~g-G----sL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLH-s~gppIIHRDLKp~ 131 (639)
| +.++.. . ..++||||+.+ | +|.++... .++..+..++.||+.||.||| ++| |+||||||+
T Consensus 132 i~~p~~~~~--~----~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~ 200 (258)
T 1zth_A 132 VSVPQPYTY--M----KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEY 200 (258)
T ss_dssp CCCCCEEEE--E----TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTT
T ss_pred CCCCeEEEc--C----CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHH
Confidence 4 455542 2 35799999942 3 78876533 235567899999999999999 999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhc
Q 006593 132 NIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 132 NILl~~~~g~VKL~DFGlA~~l 153 (639)
|||++. .++|+|||+|...
T Consensus 201 NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS---SEEECCCTTCEET
T ss_pred HEEEcC---cEEEEECcccccC
Confidence 999974 8999999999654
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.7e-15 Score=125.46 Aligned_cols=59 Identities=25% Similarity=0.395 Sum_probs=57.9
Q ss_pred ceEEEEEecCCCCCcceeeecccCCCCCHHHHHHHHHhcccCCCccHHHHHHHHHHHHH
Q 006593 338 SVSLTLRIADSSGRVRNIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIM 396 (639)
Q Consensus 338 ~i~L~Lri~d~~~~~~~i~F~f~~~~DTa~~vA~EmV~~~~i~~~d~~~iA~~i~~~i~ 396 (639)
+|+|+||++|+++++++|+|+|.++.|||++||+|||.+|+|+++|+.+||++|+++|.
T Consensus 2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 68999999999999999999999999999999999999999999999999999999997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=7.4e-15 Score=158.76 Aligned_cols=134 Identities=16% Similarity=0.187 Sum_probs=93.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEeccccc-----------CC--hhh---H--HHHHHHHHHHHhCCCCCc--c
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL-----------QL--PGD---L--QKLYSEVHLLKSLKDDNV--V 61 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~-----------~~--~~~---~--~~l~~Ei~iLk~L~HpNI--V 61 (639)
||+|++| .||+|.+. +|+.||+|+++..... .. ... . -...+|...|.+|.+.++ .
T Consensus 103 IG~Gk~a---~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 103 IGVGKES---DIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEECSSE---EEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred eeeCCce---EEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 5666666 89999984 6999999987643210 00 000 0 112467888888865554 3
Q ss_pred eEEEEEEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCC-
Q 006593 62 KFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG- 140 (639)
Q Consensus 62 kl~~~~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g- 140 (639)
..++ ... .++||||+.|++|.++. .......++.||+.+|.|||++| ||||||||.|||++.+ |
T Consensus 179 ~p~~--~~~----~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~d-gd 243 (397)
T 4gyi_A 179 EPIA--QSR----HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREE-KD 243 (397)
T ss_dssp CEEE--EET----TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEE-EC
T ss_pred eeee--ccC----ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCC-CC
Confidence 3333 222 36999999999986542 12335678899999999999999 9999999999999733 3
Q ss_pred ---------cEEEeecchhhhcc
Q 006593 141 ---------EVKIGDLGLAIAMQ 154 (639)
Q Consensus 141 ---------~VKL~DFGlA~~l~ 154 (639)
.+.|+||+.+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 38999999775433
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.8e-14 Score=121.31 Aligned_cols=63 Identities=32% Similarity=0.402 Sum_probs=58.6
Q ss_pred CCceEEEEEecCCC---CCcc---eeeecccCCCCCHHHHHHHHHhcccCCCccHHHHHHHHHHHHHHh
Q 006593 336 DTSVSLTLRIADSS---GRVR---NIHFLFYLDSDTALSVAGEMVEQLDLADHDVAFIAEFIDYLIMKL 398 (639)
Q Consensus 336 ~~~i~L~Lri~d~~---~~~~---~i~F~f~~~~DTa~~vA~EmV~~~~i~~~d~~~iA~~i~~~i~~l 398 (639)
..+|+|+|||.|++ |+.| +|+|+|++++|||.+||+|||++|+|+++|...||.+|+..|..+
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~ 91 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLI 91 (98)
Confidence 46899999999994 7888 999999999999999999999999999999999999999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=1.1e-09 Score=109.92 Aligned_cols=126 Identities=18% Similarity=0.084 Sum_probs=94.3
Q ss_pred EEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEecCCCCCHHH
Q 006593 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 89 (639)
Q Consensus 11 ~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d 89 (639)
+.||++... |..+++|....... .....+.+|+.+|+.|. +.++.+++++..+. ...|+||||++|.+|.+
T Consensus 28 ~~v~~~~~~--~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~ 99 (263)
T 3tm0_A 28 AKVYKLVGE--NENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMSEADGVLCSE 99 (263)
T ss_dssp SEEEEEECS--SCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCSSEEHHH
T ss_pred CeEEEEECC--CCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEEEEecCCeehhh
Confidence 478988753 67899998874321 11234889999999994 67788999877654 46889999999999987
Q ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 006593 90 YRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------------------- 120 (639)
Q Consensus 90 ~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~g------------------------------------------------- 120 (639)
.+. +......++.++..+|..||+..
T Consensus 100 ~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 174 (263)
T 3tm0_A 100 EYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp HCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHH
T ss_pred ccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHH
Confidence 531 12234578899999999999811
Q ss_pred --------CCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 121 --------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 121 --------ppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
+.++|+|++|.||++++ .+.+.|+||+.+
T Consensus 175 ~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a 211 (263)
T 3tm0_A 175 KTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRS 211 (263)
T ss_dssp HHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTC
T ss_pred HhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhc
Confidence 23899999999999973 345679999866
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.82 E-value=1.9e-08 Score=99.68 Aligned_cols=123 Identities=12% Similarity=0.020 Sum_probs=88.1
Q ss_pred cEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCCceEEEEEecCCCCCH
Q 006593 10 PFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFYKSWVDDKKKTVNMITELFTSGNL 87 (639)
Q Consensus 10 v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~~~~~~~~~~~l~lV~Ey~~gGsL 87 (639)
.+.||++.. .+|..+++|...... ...+..|+.+|+.|.+.+ +.+++.+.... ...++||||++|.+|
T Consensus 33 ~~~v~~~~~-~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 33 DAAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL 102 (264)
T ss_dssp SCEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred CceEEEEec-CCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEEEEecCCccc
Confidence 358998864 567789999865331 134788999999995444 56688866544 458899999999888
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q 006593 88 RQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN----------------------------------------------- 120 (639)
Q Consensus 88 ~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~g----------------------------------------------- 120 (639)
. . ...+ ...++.++...|..||+..
T Consensus 103 ~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 103 L--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp T--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred C--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 4 1 1122 2356778888888888753
Q ss_pred ---------CCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 121 ---------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 121 ---------ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+.++|+|++|.||++++ ++.+.|+|||.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 12999999999999974 3456799999763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.6e-08 Score=106.78 Aligned_cols=137 Identities=15% Similarity=0.171 Sum_probs=95.9
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEe--cccccCChhhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCC-ceEEEEEecC
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVK--IDDVLQLPGDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDDKK-KTVNMITELF 82 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~--~~~~~~~~~~~~~l~~Ei~iLk~L~--HpNIVkl~~~~~~~~~-~~l~lV~Ey~ 82 (639)
|..+.||+.... +..+++|+.. ..... .....+.+|+.+|+.|. +..+++++.++.+... ...|+||||+
T Consensus 49 G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 49 GQSNPTFKLVTP--GQTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp -CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred cccceEEEEEEC--CceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 444578888764 4578888665 32211 12346788999999996 4567888886544321 3478999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 006593 83 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------------------------------------------- 119 (639)
Q Consensus 83 ~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~------------------------------------------- 119 (639)
+|..+.+. ....++......++.+++.+|..||+.
T Consensus 124 ~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (359)
T 3dxp_A 124 SGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLM 201 (359)
T ss_dssp CCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHH
T ss_pred CCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHH
Confidence 99887531 123577888889999999999999983
Q ss_pred -------------CCCeeeeccCCCcEEEeCCCC-cEEEeecchhh
Q 006593 120 -------------NPPIIHRDLKCDNIFVNGNHG-EVKIGDLGLAI 151 (639)
Q Consensus 120 -------------gppIIHRDLKp~NILl~~~~g-~VKL~DFGlA~ 151 (639)
.+.++|+|+++.||+++.+.+ .+.|+||+.+.
T Consensus 202 ~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 202 DWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 135999999999999985432 36899999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.63 E-value=2.5e-08 Score=102.91 Aligned_cols=180 Identities=18% Similarity=0.131 Sum_probs=115.5
Q ss_pred cccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCC--cceEEEEEEeCCC-ceEEEEEec
Q 006593 6 LYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDN--VVKFYKSWVDDKK-KTVNMITEL 81 (639)
Q Consensus 6 GfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpN--IVkl~~~~~~~~~-~~l~lV~Ey 81 (639)
+.|....||+.. ..+++|.... ......+.+|+.+|+.| .+.. +.+++........ ...|+||++
T Consensus 29 ~~G~~n~v~~v~-----~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 29 GEGNDCIAYEIN-----RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp EECSSEEEEEST-----TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred CCCCcceEEEEC-----CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 345556788763 3588887432 23457789999999988 4433 3455543212111 134789999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN----------------------------------------- 120 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~g----------------------------------------- 120 (639)
++|.+|.+... ..++......++.|+...|..||+..
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988875332 34677778888888888888888621
Q ss_pred ---------------CCeeeeccCCCcEEEeCC-CCcEEEeecchhhhccCCCCccccCCCCc---CCccccc---ccC-
Q 006593 121 ---------------PPIIHRDLKCDNIFVNGN-HGEVKIGDLGLAIAMQQPTARSVIGTPEF---MAPELYE---EEY- 177 (639)
Q Consensus 121 ---------------ppIIHRDLKp~NILl~~~-~g~VKL~DFGlA~~l~~~~~~~~~GTp~y---mAPE~l~---~~y- 177 (639)
+.++|+|++|.||+++.+ .+.+.|+||+.+..-... ........+ ..|+... ..|
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHHHHHHHHcC
Confidence 247999999999999854 456789999987542211 000011111 2333221 112
Q ss_pred -----------CccccccchhhhhhhhhhccCCC
Q 006593 178 -----------NELVDIYSFGMCILEMVTFEYPY 200 (639)
Q Consensus 178 -----------s~ksDIwSlGiil~ELltG~~Pf 200 (639)
....+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12258899999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=2.5e-05 Score=78.33 Aligned_cols=127 Identities=15% Similarity=0.052 Sum_probs=90.4
Q ss_pred EEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEecCCCCCHHH
Q 006593 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 89 (639)
Q Consensus 11 ~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d 89 (639)
..||+......+..+++|+-.. .....+..|..+|+.|. +-.|.+++.++.+. ...++|||+++|.++.+
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHHH
T ss_pred CeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCccccc
Confidence 3689888877788899997552 33456889999999884 33467888876665 45789999999999887
Q ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 006593 90 YRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------------------- 120 (639)
Q Consensus 90 ~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~g------------------------------------------------- 120 (639)
...... .....++.++...|.-||+..
T Consensus 110 ~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 110 VLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred cccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 654321 223345566666666666421
Q ss_pred -------CCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 121 -------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 121 -------ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+.++|+|+.+.||+++ +.+.+-|+||+.+.
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred cccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECcccc
Confidence 1279999999999998 44556799998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.8e-05 Score=81.92 Aligned_cols=132 Identities=17% Similarity=0.042 Sum_probs=87.5
Q ss_pred cccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC---CcceEEEEEEeCCCceEEEEEecC
Q 006593 6 LYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD---NVVKFYKSWVDDKKKTVNMITELF 82 (639)
Q Consensus 6 GfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp---NIVkl~~~~~~~~~~~l~lV~Ey~ 82 (639)
+-|....||+. |..+++|.-. .......+.+|..+|+.|.+. .|.+++.+... .....++||+++
T Consensus 28 ~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i 95 (306)
T 3tdw_A 28 GEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKV 95 (306)
T ss_dssp EECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECC
T ss_pred CCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEecc
Confidence 34555678877 4568888632 234567899999999999652 35666665442 234567999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 006593 83 TSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------------ 120 (639)
Q Consensus 83 ~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~g------------------------------------------ 120 (639)
+|.+|....- ..++......++.|+...|..||+..
T Consensus 96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9988876321 22344555555555555555555432
Q ss_pred ----------------CCeeeeccCCCcEEEeCC--CCc-EEEeecchhh
Q 006593 121 ----------------PPIIHRDLKCDNIFVNGN--HGE-VKIGDLGLAI 151 (639)
Q Consensus 121 ----------------ppIIHRDLKp~NILl~~~--~g~-VKL~DFGlA~ 151 (639)
+.++|+|++|.||+++.+ .+. +.|+||+.+.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 236999999999999751 244 5899998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00011 Score=78.45 Aligned_cols=75 Identities=11% Similarity=0.024 Sum_probs=44.3
Q ss_pred ccCcEEEEEEEecCCCeEEEEEEEecccc-c--CChhhHHHHHHHHHHHHhCCC--C-CcceEEEEEEeCCCceEEEEEe
Q 006593 7 YMTPFSSYKAFDEFAGIEVAWSRVKIDDV-L--QLPGDLQKLYSEVHLLKSLKD--D-NVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 7 fG~v~tVykA~d~~tG~~VAIK~v~~~~~-~--~~~~~~~~l~~Ei~iLk~L~H--p-NIVkl~~~~~~~~~~~l~lV~E 80 (639)
-|..+.||++.+...+..|++|+...... . ..+...+++..|.++|+.+.. | .+.++|.+ +... .++|||
T Consensus 40 ~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~--~~lvmE 115 (397)
T 2olc_A 40 DGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM--AVTVME 115 (397)
T ss_dssp SSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT--TEEEEC
T ss_pred CCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc--cEEEEE
Confidence 34455899998766678899998653211 0 001223567889999988832 3 34566653 4433 468999
Q ss_pred cCCCC
Q 006593 81 LFTSG 85 (639)
Q Consensus 81 y~~gG 85 (639)
++.|.
T Consensus 116 ~l~g~ 120 (397)
T 2olc_A 116 DLSHL 120 (397)
T ss_dssp CCTTS
T ss_pred eCCCc
Confidence 99874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00035 Score=73.00 Aligned_cols=81 Identities=4% Similarity=-0.162 Sum_probs=47.5
Q ss_pred cccCcEEEEEEEec--C----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCC-CceE
Q 006593 6 LYMTPFSSYKAFDE--F----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-D--DNVVKFYKSWVDDK-KKTV 75 (639)
Q Consensus 6 GfG~v~tVykA~d~--~----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-H--pNIVkl~~~~~~~~-~~~l 75 (639)
+-|....+|+.... . .|..+++|.......... .....+.+|+.+|+.|. + -.+.+++.+..+.. ....
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~-~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~ 108 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV-FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTP 108 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS-SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSC
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc-CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCc
Confidence 34555678877543 0 256788887543220000 00134678999998884 3 35678887653321 0245
Q ss_pred EEEEecCCCCCH
Q 006593 76 NMITELFTSGNL 87 (639)
Q Consensus 76 ~lV~Ey~~gGsL 87 (639)
++|||+++|..+
T Consensus 109 ~~v~e~l~G~~l 120 (357)
T 3ats_A 109 FFLMDYVEGVVP 120 (357)
T ss_dssp EEEEECCCCBCC
T ss_pred eEEEEecCCCCh
Confidence 789999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.002 Score=66.08 Aligned_cols=41 Identities=22% Similarity=0.236 Sum_probs=30.8
Q ss_pred HHHHHHHHHh-----------CCCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 109 ILHGLVYLHS-----------HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 109 Il~aL~yLHs-----------~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
+..++.+|+. ..+.++|+|+++.||+++.+ +.+.|+||+.+
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a 250 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTC
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhc
Confidence 4446667763 23359999999999999633 68999999865
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0076 Score=64.75 Aligned_cols=29 Identities=21% Similarity=0.434 Sum_probs=24.3
Q ss_pred CCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 121 PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 121 ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+.++|+|++|.||+++.+ + ++|+||+.+.
T Consensus 232 ~~liHGDl~~~Nil~~~~-~-~~lID~e~a~ 260 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQD-S-TQVIDPEFSF 260 (420)
T ss_dssp CEEECSCCSGGGEEECSS-C-EEECCCTTCE
T ss_pred CeEEecCCCCCcEEEeCC-C-CEEEeCcccc
Confidence 349999999999999743 3 9999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.60 E-value=0.013 Score=58.18 Aligned_cols=121 Identities=17% Similarity=0.155 Sum_probs=79.2
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcccc
Q 006593 85 GNLRQYRKK-HKNVDIKVIKNWARQILHGLVYL-HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI 162 (639)
Q Consensus 85 GsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yL-Hs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~~ 162 (639)
.+|.+.|+. ..+++|+.+|.++.|.+.+|.-+ +...+ ..+=+.|..|++. .+|.|-+.+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVW-RDGAVTLAP-AADD----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEE-TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEe-cCCceeccc-cccc----------c
Confidence 479999886 46899999999999999998776 22221 1233456889997 457887664 2110 1
Q ss_pred CCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 163 GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 163 GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
....|.|||......+.+.=|||||+++|.-+--..|= ..+...++.+..||..|..
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e--------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE--------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT--------------------TEEECCCHHHHHHHHHHTT
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc--------------------ccchhhCHHHHHHHHHHHh
Confidence 23356788877555667788999999999988644332 2344557889999988875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.013 Score=61.05 Aligned_cols=70 Identities=13% Similarity=-0.078 Sum_probs=50.4
Q ss_pred ccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCCceEEEEEecCC
Q 006593 7 YMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSWVDDKKKTVNMITELFT 83 (639)
Q Consensus 7 fG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~~~~~~~~l~lV~Ey~~ 83 (639)
-|....+|+... .+..+++|+.... ....+..|...|+.|. ...+++++.+.... ...++|||+++
T Consensus 46 gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~ 114 (312)
T 3jr1_A 46 SGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALN 114 (312)
T ss_dssp CSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCC
T ss_pred CccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEecc
Confidence 355568898875 3667888876532 2456889999999883 35678888765443 56889999999
Q ss_pred CCCH
Q 006593 84 SGNL 87 (639)
Q Consensus 84 gGsL 87 (639)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.83 E-value=0.025 Score=57.56 Aligned_cols=28 Identities=21% Similarity=0.215 Sum_probs=23.2
Q ss_pred CeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
.++|+|+.+.||+.+ .+.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil~~--~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFLDT--GERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEEEC--SSCEEECCCTTCE
T ss_pred eeeccCCCcCCEEEC--CCCEEEEeccccc
Confidence 489999999999953 4578999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.029 Score=57.80 Aligned_cols=30 Identities=23% Similarity=0.289 Sum_probs=25.0
Q ss_pred CeeeeccCCCcEEEeCC---CCcEEEeecchhh
Q 006593 122 PIIHRDLKCDNIFVNGN---HGEVKIGDLGLAI 151 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~---~g~VKL~DFGlA~ 151 (639)
.++|+|+.+.||+++++ .+.+.|+||+.+.
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 59999999999999743 1579999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.56 E-value=0.041 Score=56.31 Aligned_cols=71 Identities=8% Similarity=-0.045 Sum_probs=42.5
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC--CcceEEEEEEeC-----CCceEEEEEe
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDD--NVVKFYKSWVDD-----KKKTVNMITE 80 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~~~~~-----~~~~l~lV~E 80 (639)
|....||+... ..|..+++|....... ....+..|..+++.|... .+++++.. ++ .....+++|+
T Consensus 36 g~~n~~y~v~~-~~g~~~vlK~~~~~~~-----~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 36 SYENRVYQFQD-EDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred CcccceEEEEc-CCCCEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence 44457887754 3466799998763221 234567788888887422 24444432 11 1235678999
Q ss_pred cCCCCC
Q 006593 81 LFTSGN 86 (639)
Q Consensus 81 y~~gGs 86 (639)
+++|..
T Consensus 108 ~i~G~~ 113 (328)
T 1zyl_A 108 SVGGRQ 113 (328)
T ss_dssp CCCCEE
T ss_pred ecCCCC
Confidence 998744
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.06 Score=54.39 Aligned_cols=71 Identities=15% Similarity=0.006 Sum_probs=46.7
Q ss_pred cccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCCceEEEEEecC
Q 006593 6 LYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-D--DNVVKFYKSWVDDKKKTVNMITELF 82 (639)
Q Consensus 6 GfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-H--pNIVkl~~~~~~~~~~~l~lV~Ey~ 82 (639)
|.|..+.||+... .+|+.|++|+-.... ......+..|...|+.|. . -.+++++.+ +. -++||||+
T Consensus 24 g~G~~~~vyrv~l-~DG~~~~vK~~~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~----~~lv~e~l 92 (288)
T 3f7w_A 24 GHSHRWHLYRVEL-ADGTPLFVKALPDDA----PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD----RTLAMEWV 92 (288)
T ss_dssp EEETTEEEEEEEE-TTSCEEEEEECCTTC----CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET----TEEEEECC
T ss_pred CCCCCeEEEEEEE-CCCCEEEEEEeCCCC----cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC----ceEEEEee
Confidence 4556678999875 568899999754332 112234778999999884 2 235666653 33 25789999
Q ss_pred CCCCH
Q 006593 83 TSGNL 87 (639)
Q Consensus 83 ~gGsL 87 (639)
.++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.24 E-value=0.06 Score=56.15 Aligned_cols=71 Identities=11% Similarity=-0.048 Sum_probs=42.6
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC---CCCcceEEEEE----EeCCCceEEE
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK---DDNVVKFYKSW----VDDKKKTVNM 77 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~~----~~~~~~~l~l 77 (639)
+|.|....||+.... .| .+++|+...... ..|+.+++.|. -|+|++.+... +.......++
T Consensus 31 ~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~----------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~ 98 (339)
T 3i1a_A 31 GGADTNAFAYQADSE-SK-SYFIKLKYGYHD----------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII 98 (339)
T ss_dssp TTSCSSCEEEEEECS-SC-EEEEEEEECSSC----------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred ccCccccceEEEEeC-CC-CEEEEEecCccc----------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence 556666789998753 45 899998765431 34666666552 23244544320 0011356789
Q ss_pred EEecCCCCCH
Q 006593 78 ITELFTSGNL 87 (639)
Q Consensus 78 V~Ey~~gGsL 87 (639)
+|+|++|..+
T Consensus 99 l~~~i~G~~~ 108 (339)
T 3i1a_A 99 AYPFIHAPNG 108 (339)
T ss_dssp EEECCCCCBT
T ss_pred EEeccCCCcC
Confidence 9999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.95 E-value=0.052 Score=58.05 Aligned_cols=133 Identities=14% Similarity=0.141 Sum_probs=78.7
Q ss_pred cCcEEEEEEEecC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 8 MTPFSSYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 8 G~v~tVykA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
|....+|+..... ++..|++++... . ......+.+|..+++.|. +.-..++++.+ .+ .+||
T Consensus 61 G~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~v~ 129 (379)
T 3feg_A 61 GLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--I---LQGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GRLE 129 (379)
T ss_dssp ---CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EEEE
T ss_pred cccccEEEEEeCCCccccCCCCCeEEEEECCC--c---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----ccEE
Confidence 4455788887632 357888887421 1 123445678999998884 33336777644 33 2899
Q ss_pred ecCCCCCHH-----------HH---HHh-C-------CCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 006593 80 ELFTSGNLR-----------QY---RKK-H-------KNVD--IKVIKNWARQILH-------------------GLVYL 116 (639)
Q Consensus 80 Ey~~gGsL~-----------d~---lkk-~-------~~l~--e~~i~~i~~QIl~-------------------aL~yL 116 (639)
||++|.+|. .+ +.+ | +... ...+.+|..|+.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 999985542 11 111 1 1111 4567777766532 12333
Q ss_pred ----HhCC--CCeeeeccCCCcEEEeCC---CCcEEEeecchhh
Q 006593 117 ----HSHN--PPIIHRDLKCDNIFVNGN---HGEVKIGDLGLAI 151 (639)
Q Consensus 117 ----Hs~g--ppIIHRDLKp~NILl~~~---~g~VKL~DFGlA~ 151 (639)
...+ ..++|+|+.+.||+++.+ .+.+.|+||..|.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 259999999999999854 3689999997663
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=94.68 E-value=0.068 Score=57.86 Aligned_cols=68 Identities=12% Similarity=0.005 Sum_probs=42.9
Q ss_pred ccCcEEEEEEEecC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCCceEEEE
Q 006593 7 YMTPFSSYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 7 fG~v~tVykA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~~~~~~~~~l~lV 78 (639)
-|....||+..... .+..|++|+..... . .+.+..|..+++.|...++ +++++.+ .+ .+|
T Consensus 83 gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g~v 150 (429)
T 1nw1_A 83 GGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---T---ESHLVAESVIFTLLSERHLGPKLYGIF--SG----GRL 150 (429)
T ss_dssp CCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---C---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEE
T ss_pred CCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---c---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----CEE
Confidence 35556899987642 35788888763211 1 1345579999998843333 6777654 32 278
Q ss_pred EecCCCCC
Q 006593 79 TELFTSGN 86 (639)
Q Consensus 79 ~Ey~~gGs 86 (639)
+||++|-+
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99998733
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.46 E-value=0.11 Score=56.81 Aligned_cols=70 Identities=14% Similarity=-0.018 Sum_probs=43.3
Q ss_pred ccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCCceEEEEEecCCCC
Q 006593 7 YMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV-VKFYKSWVDDKKKTVNMITELFTSG 85 (639)
Q Consensus 7 fG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~~~~~~~~~l~lV~Ey~~gG 85 (639)
-|....+|+......+..+++|+..... ..... -..|..+|+.|...++ .++++.+ .+ .+|+||++|-
T Consensus 118 gG~tN~~y~v~~~~~~~~~vLRi~g~~~----~~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I~G~ 186 (458)
T 2qg7_A 118 GGITNILIKVKDMSKQAKYLIRLYGPKT----DEIIN-REREKKISCILYNKNIAKKIYVFF--TN----GRIEEFMDGY 186 (458)
T ss_dssp C--CEEEEEEEETTTTEEEEEEEECC-C----CSCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECCCSE
T ss_pred CCeEeEEEEEEECCCCceEEEEECCCCh----hhhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEeeCCc
Confidence 3556789998875545788888764221 11111 2589999999965445 6777755 32 1489999874
Q ss_pred CH
Q 006593 86 NL 87 (639)
Q Consensus 86 sL 87 (639)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.42 E-value=0.094 Score=53.43 Aligned_cols=132 Identities=15% Similarity=0.094 Sum_probs=68.8
Q ss_pred cCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCCceEEEEE
Q 006593 8 MTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDN--VVKFYKS------WVDDKKKTVNMIT 79 (639)
Q Consensus 8 G~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~~~------~~~~~~~~l~lV~ 79 (639)
|....+|+.... .| .+++|+..... ..+.+..|+.+++.|...+ +.+++.. ... ....++++
T Consensus 33 G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~--~g~~~~l~ 102 (322)
T 2ppq_A 33 GVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL--SGRPAALI 102 (322)
T ss_dssp ---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE--TTEEEEEE
T ss_pred CcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE--CCEEEEEE
Confidence 445678887653 33 58888876421 1123567888887773212 3344321 011 13468899
Q ss_pred ecCCCCCH-----HHH------H----HhCCC--------CCHHHHHHHH---------------HHHHHHHHHHHhC--
Q 006593 80 ELFTSGNL-----RQY------R----KKHKN--------VDIKVIKNWA---------------RQILHGLVYLHSH-- 119 (639)
Q Consensus 80 Ey~~gGsL-----~d~------l----kk~~~--------l~e~~i~~i~---------------~QIl~aL~yLHs~-- 119 (639)
++++|..+ ..+ + ..... .........+ ..+...+.+|+..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 99998643 111 1 11011 1111111100 1133445555532
Q ss_pred ---CCCeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 120 ---NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 120 ---gppIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
.+.++|+|+.+.||+++++ +.+.|+||+.+
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a 215 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFA 215 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETT-EEEEECCCTTC
T ss_pred ccCCcccCCCCCCccCEEEeCC-ceEEEecchhc
Confidence 1249999999999999843 34579999865
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=82.05 E-value=2.3 Score=45.93 Aligned_cols=69 Identities=9% Similarity=0.015 Sum_probs=41.1
Q ss_pred cCcEEEEEEEecC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEE
Q 006593 8 MTPFSSYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 8 G~v~tVykA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
|....+|+..... ++..|++++..... +..-...+|..+++.|. +.-..++++.+ .+ ++|+
T Consensus 81 G~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-----~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~----~~I~ 149 (424)
T 3mes_A 81 GLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-----GKFYDSKVELDVFRYLSNINIAPNIIADF--PE----GRIE 149 (424)
T ss_dssp CSSSEEEEEEECCC-----CCCSEEEEEECCCCC------CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT----EEEE
T ss_pred CcccceEEEEeCCCcccccCCCCeEEEEECCCCc-----chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC----CEEE
Confidence 4455788887642 15778888743211 11111357888888884 33346676533 32 5789
Q ss_pred ecCCCCCH
Q 006593 80 ELFTSGNL 87 (639)
Q Consensus 80 Ey~~gGsL 87 (639)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 639 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-36 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 7e-71
Identities = 131/247 (53%), Positives = 169/247 (68%), Gaps = 5/247 (2%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD--DK 71
YK D +EVAW ++ D + Q+ E +LK L+ N+V+FY SW
Sbjct: 26 YKGLDTETTVEVAW--CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
KK + ++TEL TSG L+ Y K+ K + IKV+++W RQIL GL +LH+ PPIIHRDLKCD
Sbjct: 84 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 143
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCIL 191
NIF+ G G VKIGDLGLA + A++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+L
Sbjct: 144 NIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCML 203
Query: 192 EMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDL 250
EM T EYPYSEC+N AQI+++VTSG+KPAS KV P++K IE C+ ER S KDL
Sbjct: 204 EMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
Query: 251 LKDPFLQ 257
L F Q
Sbjct: 264 LNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-52
Identities = 66/254 (25%), Positives = 119/254 (46%), Gaps = 16/254 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
K + G + W + + + + Q L SEV+LL+ LK N+V++Y +D
Sbjct: 21 QKIRRKSDGKILVWKELDYGSMTE--AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78
Query: 74 TVNMITELFTSGNLRQY----RKKHKNVDIKVIKNWARQILHGLVYLHSHN---PPIIHR 126
T+ ++ E G+L K+ + +D + + Q+ L H + ++HR
Sbjct: 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHR 138
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--ARSVIGTPEFMAPELYE-EEYNELVDI 183
DLK N+F++G VK+GD GLA + T A++ +GTP +M+PE YNE DI
Sbjct: 139 DLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI 197
Query: 184 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-AS 242
+S G + E+ P+ + ++ K+ G K + ++ I + L
Sbjct: 198 WSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDY 255
Query: 243 ERLSAKDLLKDPFL 256
R S +++L++P +
Sbjct: 256 HRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-51
Identities = 52/246 (21%), Positives = 113/246 (45%), Gaps = 11/246 (4%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y A ++ + +A + + + G +L EV + L+ N+++ Y + D +
Sbjct: 23 YLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR- 80
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
V +I E G + + +K D + + ++ + L Y HS +IHRD+K +N+
Sbjct: 81 -VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENL 137
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 192
+ GE+KI D G ++ ++ GT +++ PE + ++E VD++S G+ E
Sbjct: 138 LLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLL 251
+ + P+ E + +K+++ + + I + L S+R +++L
Sbjct: 197 FLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
Query: 252 KDPFLQ 257
+ P++
Sbjct: 254 EHPWIT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 175 bits (445), Expect = 1e-50
Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 14/272 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y A D VA ++ Q Q + EV L+ L+ N +++ ++ +
Sbjct: 32 YFARDVRNSEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT- 89
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
++ E K + I L GL YLHSHN +IHRD+K NI
Sbjct: 90 -AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNI 146
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMC 189
++ G VK+GD G A M A S +GTP +MAPE+ E +Y+ VD++S G+
Sbjct: 147 LLSEP-GLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK 248
+E+ + P N + PA + + F++ CL +R +++
Sbjct: 204 CIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262
Query: 249 DLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 280
LLK F+ E I D ++ +++ L
Sbjct: 263 VLLKHRFVLRERPPTVIMDLIQRTKDAVRELD 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-49
Identities = 69/251 (27%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y A D G EVA ++ + + + +E+ +++ K+ N+V + S++ +
Sbjct: 37 YTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE- 91
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ ++ E G+L + D I R+ L L +LHS+ +IHRD+K DNI
Sbjct: 92 -LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNI 147
Query: 134 FVNGNHGEVKIGDLGLA--IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 190
+ + G VK+ D G I +Q +++GTP +MAPE + + Y VDI+S G+
Sbjct: 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMA 206
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 249
+EM+ E PY ++ T+G + + F+ +CL +R SAK+
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266
Query: 250 LLKDPFLQVEN 260
LL+ FL++
Sbjct: 267 LLQHQFLKIAK 277
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-48
Identities = 64/293 (21%), Positives = 121/293 (41%), Gaps = 50/293 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+K + +G+ +A K+ + P ++ E+ +L +V FY ++ D +
Sbjct: 23 FKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE- 78
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+++ E G+L Q KK + +++ + ++ GL YL + I+HRD+K NI
Sbjct: 79 -ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH-KIMHRDVKPSNI 136
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 192
VN GE+K+ D G++ + A S +GT +M+PE L Y+ DI+S G+ ++E
Sbjct: 137 LVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 193 MVTFEYPYS-----------------------------------------ECKNPAQIFK 211
M YP ++
Sbjct: 196 MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLD 255
Query: 212 KVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKE 263
+ + P + V + + F+ KCL+ +ER K L+ F++ + +E
Sbjct: 256 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-48
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 24/274 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA ++ + A + +L+ E+ +L S N+VK ++ +
Sbjct: 29 YKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN- 83
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ ++ E G + + + + I+ +Q L L YLH + IIHRDLK N
Sbjct: 84 -LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGN 140
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY------EEEYNELVDIY 184
I + G++K+ D G++ + R S IGTP +MAPE+ + Y+ D++
Sbjct: 141 ILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 185 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASE 243
S G+ ++EM E P+ E + K S + K F++KCL
Sbjct: 200 SLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDA 259
Query: 244 RLSAKDLLKDPFLQVENQKEPICDPLKLPIQSLK 277
R + LL+ PF+ V++ K P++ I K
Sbjct: 260 RWTTSQLLQHPFVTVDSNK-----PIRELIAEAK 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-48
Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 15/251 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
A + VA VKI D+ + + + E+ + K L +NVVKFY +
Sbjct: 22 QLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI- 77
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ E + G L + + + + Q++ G+VYLH I HRD+K +N+
Sbjct: 78 -QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENL 134
Query: 134 FVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFG 187
++ +KI D GLA ++ + GT ++APEL + + E VD++S G
Sbjct: 135 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ + M+ E P+ + + Q + + K D + K LV S R++
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT 253
Query: 247 AKDLLKDPFLQ 257
D+ KD +
Sbjct: 254 IPDIKKDRWYN 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (403), Expect = 3e-44
Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 19/274 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ + G A V D + + E+ + L+ +V + ++ DD +
Sbjct: 43 HRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE- 97
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ MI E + G L + +H + + RQ+ GL ++H +N +H DLK +N
Sbjct: 98 -MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPEN 154
Query: 133 IFVNGNH-GEVKIGDLGLAIAMQ-QPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 189
I E+K+ D GL + + + + GT EF APE+ E + D++S G+
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLS 246
+++ P+ +N + + V S + + K FI K L+ + R++
Sbjct: 215 SYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273
Query: 247 AKDLLKDPFLQVENQKEPICDPLKLPIQSLKMLR 280
L+ P+L N ++P +R
Sbjct: 274 IHQALEHPWLTPGNAP---GRDSQIPSSRYTKIR 304
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 159 bits (403), Expect = 3e-44
Identities = 54/277 (19%), Positives = 113/277 (40%), Gaps = 18/277 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ ++ G + P D + +E+ ++ L ++ + ++ D +
Sbjct: 46 HRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE- 100
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ +I E + G L + + + N+ RQ GL ++H H+ I+H D+K +N
Sbjct: 101 -MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPEN 157
Query: 133 IFVNGNH-GEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMC 189
I VKI D GLA + + T EF APE+ + E D+++ G+
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASERLSA 247
+++ P++ + + + A + P+ K FI+ L +RL+
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 277
Query: 248 KDLLKDPFLQVENQKEPICDPLKLPIQSLKMLRLPMS 284
D L+ P+L+ ++ ++P +R +
Sbjct: 278 HDALEHPWLKGDHSNL----TSRIPSSRYNKIRQKIK 310
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 21/242 (8%)
Query: 24 EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFT 83
+VA + + P LQ +EV +L+ + N++ F + + ++T+
Sbjct: 32 DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCE 86
Query: 84 SGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEV 142
+L + ++ + + ARQ G+ YLH+ + IIHRDLK +NIF++ + V
Sbjct: 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTV 143
Query: 143 KIGDLGLAIAMQQPTA----RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMV 194
KIGD GLA + + + G+ +MAPE+ + Y+ D+Y+FG+ + E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 195 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFIEKCLVP-ASERLSAKDL 250
T + PYS N QI V G L+KV +K + +CL ER +
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 251 LK 252
L
Sbjct: 264 LA 265
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 3e-43
Identities = 54/257 (21%), Positives = 107/257 (41%), Gaps = 15/257 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
A D+ VA +K L G + +E+ +L +K N+V +
Sbjct: 26 ILAEDKRTQKLVA---IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH- 81
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ +I +L + G L + + Q+L + YLH I+HRDLK +N+
Sbjct: 82 -LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENL 138
Query: 134 FVN--GNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAP-ELYEEEYNELVDIYSFGMC 189
++ I D GL+ + + GTP ++AP L ++ Y++ VD +S G+
Sbjct: 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 198
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASERLS 246
++ P+ + +N A++F+++ +D K FI + +R +
Sbjct: 199 AYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257
Query: 247 AKDLLKDPFLQVENQKE 263
+ L+ P++ + +
Sbjct: 258 CEQALQHPWIAGDTALD 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-43
Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 27/269 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
A + E A ++ +++ + + E ++ L VK Y ++ DD+K
Sbjct: 25 VLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK- 82
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ +G L +Y +K + D + + +I+ L YLH IIHRDLK +NI
Sbjct: 83 -LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENI 139
Query: 134 FVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 188
+N + ++I D G A + +Q A S +GT ++++PE L E+ + D+++ G
Sbjct: 140 LLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGC 198
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 247
I ++V P+ N IF+K+ + P+ + +EK LV A++RL
Sbjct: 199 IIYQLVAGLPPF-RAGNEYLIFQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGC 255
Query: 248 K------DLLKDPFLQ------VENQKEP 264
+ L PF + + Q P
Sbjct: 256 EEMEGYGPLKAHPFFESVTWENLHQQTPP 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 1e-42
Identities = 54/261 (20%), Positives = 111/261 (42%), Gaps = 23/261 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVL-----QLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSW 67
+ + E A + + ++ + EV +L+ + N+++ ++
Sbjct: 20 RRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79
Query: 68 VDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 127
+ ++ +L G L Y + + K + R +L + LH N I+HRD
Sbjct: 80 ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRD 135
Query: 128 LKCDNIFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEE-------YNE 179
LK +NI ++ + +K+ D G + + R V GTP ++APE+ E Y +
Sbjct: 136 LKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 180 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKC 237
VD++S G+ + ++ P+ + + + + SG + +D +K + +
Sbjct: 195 EVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 253
Query: 238 LVP-ASERLSAKDLLKDPFLQ 257
LV +R +A++ L PF Q
Sbjct: 254 LVVQPQKRYTAEEALAHPFFQ 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-42
Identities = 52/284 (18%), Positives = 122/284 (42%), Gaps = 19/284 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ + + VK+ D + E+ +L + N++ ++S+ ++
Sbjct: 22 HRCVETSSKKTYMAKFVKVKGT-----DQVLVKKEISILNIARHRNILHLHESFESMEE- 75
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ MI E + ++ + ++ + I ++ Q+ L +LHSHN I H D++ +N
Sbjct: 76 -LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPEN 132
Query: 133 IFV-NGNHGEVKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMC 189
I +KI + G A ++ R + PE+ APE+++ + + D++S G
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSG--IKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ +++ P+ + QI + + + K + F+++ LV R++
Sbjct: 193 VYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 247 AKDLLKDPFLQ--VENQKEPICDPLKLPIQSLKMLRLPMSGPSS 288
A + L+ P+L+ +E + LK +++ ++ S
Sbjct: 252 ASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVS 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-40
Identities = 51/243 (20%), Positives = 102/243 (41%), Gaps = 18/243 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ G +VA VK ++ Q +E ++ L+ N+V+ V++K
Sbjct: 24 MLG--DYRGNKVA---VK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 75
Query: 74 TVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ ++TE G+L Y + + + ++ + + YL +N +HRDL
Sbjct: 76 -LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAAR 132
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 190
N+ V+ + K+ D GL T + ++ APE L E++++ D++SFG+ +
Sbjct: 133 NVLVSED-NVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKD 249
E+ +F + +V G K + P + ++ C A+ R S
Sbjct: 191 WEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQ 249
Query: 250 LLK 252
L +
Sbjct: 250 LRE 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 62/269 (23%), Positives = 122/269 (45%), Gaps = 15/269 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVL--QLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
K ++ G++ A +K + + + EV +LK ++ NV+ ++ + +
Sbjct: 27 KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
V +I EL G L + + +++ + + +QIL+G+ YLHS I H DLK +
Sbjct: 87 D--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPE 142
Query: 132 NIFV---NGNHGEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPELYE-EEYNELVDIYSF 186
NI + N +KI D GLA + + GTPEF+APE+ E D++S
Sbjct: 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 202
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVND--PQIKGFIEKCLVP-ASE 243
G+ +++ P+ + V++ ++ K FI + LV +
Sbjct: 203 GVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKK 261
Query: 244 RLSAKDLLKDPFLQVENQKEPICDPLKLP 272
R++ +D L+ P+++ ++ ++ + P
Sbjct: 262 RMTIQDSLQHPWIKPKDTQQALSSAWSHP 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-40
Identities = 45/251 (17%), Positives = 101/251 (40%), Gaps = 19/251 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDD--NVVKFYKSWVD 69
Y + VA V+ D + + ++ EV LLK + V++ W +
Sbjct: 21 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL-DWFE 79
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
V ++ +L + + + ++ +++ Q+L + + H+ ++HRD+K
Sbjct: 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIK 137
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFG 187
+NI ++ N GE+K+ D G ++ GT + PE + ++S G
Sbjct: 138 DENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ + +MV + P+ + + + + + I CL S+R +
Sbjct: 198 ILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------SSECQHLIRWCLALRPSDRPT 248
Query: 247 AKDLLKDPFLQ 257
+++ P++Q
Sbjct: 249 FEEIQNHPWMQ 259
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (359), Expect = 8e-39
Identities = 52/257 (20%), Positives = 97/257 (37%), Gaps = 14/257 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK- 72
+ A D +VA ++ D + + P + E +L +V Y + +
Sbjct: 24 HLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82
Query: 73 -KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
++ E LR + K L + H + IIHRD+K
Sbjct: 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPA 140
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPELYE-EEYNELVDIYS 185
NI ++ + VK+ D G+A A+ +VIGT ++++PE + + D+YS
Sbjct: 141 NIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 199
Query: 186 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN-DPQIKGFIEKCLVP-ASE 243
G + E++T E P++ + ++ V P S + + K L
Sbjct: 200 LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259
Query: 244 RLSAKDLLKDPFLQVEN 260
R ++ ++V N
Sbjct: 260 RYQTAAEMRADLVRVHN 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 52/256 (20%), Positives = 100/256 (39%), Gaps = 23/256 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ + +VA +K + +E +L+K L+ +V+ Y +
Sbjct: 30 WMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-- 81
Query: 74 TVNMITELFTSGNLRQYRKKHKNV--DIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ +ITE +G+L + K + I + + A QI G+ ++ N IHRDL+
Sbjct: 82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAA 138
Query: 132 NIFVNGNHGEVKIGDLGLAIAM---QQPTARSVIGTPEFMAP-ELYEEEYNELVDIYSFG 187
NI V+ + KI D GLA + + ++ AP + + D++SFG
Sbjct: 139 NILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 197
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ + E+VT ++ + + G + ++ + C +R +
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDRPT 256
Query: 247 AKDL---LKDPFLQVE 259
L L+D F E
Sbjct: 257 FDYLRSVLEDFFTATE 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 47/262 (17%), Positives = 103/262 (39%), Gaps = 21/262 (8%)
Query: 14 YKAF--DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
K + + VA +K + P +L +E ++++ L + +V+ +
Sbjct: 24 KKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES 81
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
++ E+ G L +Y +++++V K I Q+ G+ YL N +HRDL
Sbjct: 82 ---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAAR 136
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYS 185
N+ + KI D GL+ A++ ++ APE + +++ D++S
Sbjct: 137 NVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 195
Query: 186 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 244
FG+ + E ++ +++ + G + A ++ + C R
Sbjct: 196 FGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENR 254
Query: 245 LSAKDL---LKDPFLQVENQKE 263
+ L++ + V N+
Sbjct: 255 PGFAAVELRLRNYYYDVVNEGH 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (356), Expect = 5e-38
Identities = 57/251 (22%), Positives = 118/251 (47%), Gaps = 17/251 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ G A +K + V++ ++ E +L + +++ + ++ D ++
Sbjct: 21 HLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ- 78
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ MI + G L +K + V K +A ++ L YLHS + II+RDLK +NI
Sbjct: 79 -IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENI 135
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 192
++ N G +KI D G A + T ++ GTP+++APE + + YN+ +D +SFG+ I E
Sbjct: 136 LLDKN-GHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV------PASERLS 246
M+ P+ + N + ++K+ + + +K + + + + +
Sbjct: 194 MLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250
Query: 247 AKDLLKDPFLQ 257
+D+ P+ +
Sbjct: 251 TEDVKNHPWFK 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (351), Expect = 1e-37
Identities = 44/259 (16%), Positives = 88/259 (33%), Gaps = 18/259 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ G + +K + SE ++ NV+
Sbjct: 43 CSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP- 101
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
V +ITE +G+L + R+ + + R I G+ YL N +HRDL N
Sbjct: 102 -VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARN 158
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTARSV-------IGTPEFMAPELYE-EEYNELVDIY 184
I VN N K+ D GL+ ++ T+ + APE + ++ D++
Sbjct: 159 ILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 217
Query: 185 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASE 243
S+G+ + E++++ + + + + + C +
Sbjct: 218 SYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDCWQKDRNH 276
Query: 244 RLSAKDLLK--DPFLQVEN 260
R ++ D ++ N
Sbjct: 277 RPKFGQIVNTLDKMIRNPN 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 53/261 (20%), Positives = 104/261 (39%), Gaps = 23/261 (8%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ VA +K + + E ++K L+ + +V+ Y ++
Sbjct: 34 WMGTWN-GTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-- 85
Query: 74 TVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ ++TE + G+L + + K + + + + A QI G+ Y+ N +HRDL+
Sbjct: 86 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAA 142
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQP---TARSVIGTPEFMAPE-LYEEEYNELVDIYSFG 187
NI V N K+ D GLA ++ + ++ APE + D++SFG
Sbjct: 143 NILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 201
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ + E+ T ++ +V G + + + + +C ER +
Sbjct: 202 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEERPT 260
Query: 247 AKDL---LKDPFLQVENQKEP 264
+ L L+D F E Q +P
Sbjct: 261 FEYLQAFLEDYFTSTEPQYQP 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 61/293 (20%), Positives = 107/293 (36%), Gaps = 39/293 (13%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQL-PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
YKA D+ VA ++K+ + G + E+ LL+ L N++ ++
Sbjct: 15 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
++++ + + + + IK + L GL YLH H I+HRDLK +N
Sbjct: 75 --ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNN 130
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELY--EEEYNELVDIYSFGM 188
+ ++ N G +K+ D GLA + P + T + APEL Y VD+++ G
Sbjct: 131 LLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 189
Query: 189 CILEMVTFEYPYS-------------------------ECKNPAQIFKKVTSGIKPASLA 223
+ E++ C P + K GI +
Sbjct: 190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249
Query: 224 KVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPLKLPIQS 275
+ I+ + R++A LK + P C LP +
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ---LPRPN 299
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-37
Identities = 38/245 (15%), Positives = 93/245 (37%), Gaps = 18/245 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ + +VA ++ + + + E ++ L +V+ Y ++
Sbjct: 22 HLGYWL-NKDKVAIKTIREGAMSE-----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP- 74
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ ++ E G L Y R + + + + G+ YL +IHRDL N
Sbjct: 75 -ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARN 131
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYSFGM 188
V + +K+ D G+ + ++ +PE Y+ D++SFG+
Sbjct: 132 CLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 190
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 247
+ E+ + E ++ +++ + +++G + ++ + + C +R +
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAF 249
Query: 248 KDLLK 252
LL+
Sbjct: 250 SRLLR 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 51/269 (18%), Positives = 117/269 (43%), Gaps = 18/269 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ G A ++ + ++ ++ +E +L++ + + ++ +
Sbjct: 22 ILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR- 79
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ + E G L + + + + + + +I+ L YLHS + +++RD+K +N+
Sbjct: 80 -LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENL 136
Query: 134 FVNGNHGEVKIGDLGLAIAMQQP--TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCI 190
++ G +KI D GL T ++ GTPE++APE+ E +Y VD + G+ +
Sbjct: 137 MLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS--- 246
EM+ P+ ++ ++F+ + + P+ K + L +RL
Sbjct: 196 YEMMCGRLPF-YNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 247 --AKDLLKDPFLQVENQKEPICDPLKLPI 273
AK++++ F N ++ + L P
Sbjct: 253 SDAKEVMEHRFFLSINWQDVVQKKLLPPF 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 9e-37
Identities = 52/249 (20%), Positives = 99/249 (39%), Gaps = 19/249 (7%)
Query: 14 YKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
++ E + VA +K +K E ++ ++VK ++
Sbjct: 24 HQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 80
Query: 71 KKKTVNMITELFTSGNLRQYR-KKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
V +I EL T G LR + + ++D+ + +A Q+ L YL S +HRD+
Sbjct: 81 P---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIA 135
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTAR---SVIGTPEFMAPE-LYEEEYNELVDIYS 185
N+ V+ + VK+GD GL+ M+ T ++MAPE + + D++
Sbjct: 136 ARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 186 FGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASER 244
FG+C+ E++ + + ++ +G + P + + KC S R
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSRR 253
Query: 245 LSAKDLLKD 253
+L
Sbjct: 254 PRFTELKAQ 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 40/264 (15%), Positives = 103/264 (39%), Gaps = 23/264 (8%)
Query: 14 YKAFDEFA--GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
+ I+VA +K+ D +++ E ++ L + +V+ +
Sbjct: 26 RQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA 82
Query: 72 KKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ ++ E+ G L ++ K + + + + Q+ G+ YL N +HRDL
Sbjct: 83 ---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAA 137
Query: 131 DNIFVNGNHGEVKIGDLGLAIAM-----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIY 184
N+ + KI D GL+ A+ + ++ APE + +++ D++
Sbjct: 138 RNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
Query: 185 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASE 243
S+G+ + E +++ + ++ + G + + P++ + C + +
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMSDCWIYKWED 255
Query: 244 RLSAKDL---LKDPFLQVENQKEP 264
R + ++ + + ++ E
Sbjct: 256 RPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 58/249 (23%), Positives = 111/249 (44%), Gaps = 13/249 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ A + A +K D VL + + L + + + + ++ +
Sbjct: 19 FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
M E G+L + + D+ +A +I+ GL +LHS I++RDLK DNI
Sbjct: 79 FFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNI 134
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCI 190
++ G +KI D G+ A+ + GTP+++APE L ++YN VD +SFG+ +
Sbjct: 135 LLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 193
Query: 191 LEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAK- 248
EM+ + P+ ++ ++F + + + + K + K V +RL +
Sbjct: 194 YEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
Query: 249 DLLKDPFLQ 257
D+ + P +
Sbjct: 251 DIRQHPLFR 259
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 53/314 (16%), Positives = 125/314 (39%), Gaps = 31/314 (9%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVH-LLKSLKDDNVVKFYKSWVD--D 70
+ F++ + A ++ D K EV ++ + ++V+ + +
Sbjct: 29 LQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRIVDVYENLYA 79
Query: 71 KKKTVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128
+K + ++ E G L + + + + I + YLHS N I HRD+
Sbjct: 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDV 137
Query: 129 KCDNIFVN--GNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELYE-EEYNELVDIY 184
K +N+ + +K+ D G A + + TP ++APE+ E+Y++ D++
Sbjct: 138 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 197
Query: 185 SFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK------PASLAKVNDPQIKGFIEKCL 238
S G+ + ++ P+ + I + + I+ P ++K I L
Sbjct: 198 SLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 256
Query: 239 VP-ASERLSAKDLLKDPFLQ--VENQKEPICDPLKLPIQSLKMLRLPMSGPSSM-DIDSD 294
++R++ + + P++ + + P+ L + + S++ + D
Sbjct: 257 KTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVD 316
Query: 295 YKQLSLSTCTESNN 308
Y+Q+ + +++N
Sbjct: 317 YEQIKIKKIEDASN 330
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 7e-36
Identities = 47/246 (19%), Positives = 96/246 (39%), Gaps = 18/246 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+VA +K + + + E ++ +L + +V+ Y +
Sbjct: 21 KYGKWR-GQYDVAIKMIKEGSMSE-----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP- 73
Query: 74 TVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ +ITE +G L Y R+ + + + + + YL S +HRDL N
Sbjct: 74 -IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARN 130
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTARS---VIGTPEFMAPELYE-EEYNELVDIYSFGM 188
VN + G VK+ D GL+ + S + PE+ +++ DI++FG+
Sbjct: 131 CLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGV 189
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSA 247
+ E+ + E ++ + + G++ + ++ + C A ER +
Sbjct: 190 LMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTF 248
Query: 248 KDLLKD 253
K LL +
Sbjct: 249 KILLSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 15/248 (6%)
Query: 14 YKAFDEFAGIEVAWSR-VKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
YK G +V +K P +++ E +++ S+ + +V + +
Sbjct: 26 YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 83
Query: 73 KTVNMITELFTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
TV +IT+L G L Y ++HK N+ + + NW QI G+ YL ++HRDL
Sbjct: 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAAR 140
Query: 132 NIFVNGNHGEVKIGDLGLAIAM----QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSF 186
N+ V VKI D GLA + ++ A ++MA E + Y D++S+
Sbjct: 141 NVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY 199
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERL 245
G+ + E++TF + ++I + G + + + KC + A R
Sbjct: 200 GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC-TIDVYMIMVKCWMIDADSRP 258
Query: 246 SAKDLLKD 253
++L+ +
Sbjct: 259 KFRELIIE 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (334), Expect = 2e-35
Identities = 54/261 (20%), Positives = 105/261 (40%), Gaps = 20/261 (7%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y+ + + VA +K D ++++ E ++K +K N+V+ +
Sbjct: 34 YEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88
Query: 74 TVNMITELFTSGNLRQY--RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
+ E T GNL Y + V V+ A QI + YL N IHRDL
Sbjct: 89 YIIT--EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAAR 144
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGT---PEFMAP-ELYEEEYNELVDIYSFG 187
N V N VK+ D GL+ M T + G ++ AP L +++ D+++FG
Sbjct: 145 NCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG 203
Query: 188 MCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS 246
+ + E+ T+ + +Q+++ + + ++ + C S+R S
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC-PEKVYELMRACWQWNPSDRPS 262
Query: 247 AKDLLK--DPFLQVENQKEPI 265
++ + + Q + + +
Sbjct: 263 FAEIHQAFETMFQESSISDEV 283
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (338), Expect = 4e-35
Identities = 54/254 (21%), Positives = 110/254 (43%), Gaps = 15/254 (5%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKL--YSEVHLLKSLKDDNVVKFYKSWVDDK 71
Y G A + + G+ L + L+ + +V ++
Sbjct: 21 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
K ++ I +L G+L + +H ++ +A +I+ GL ++H+ +++RDLK
Sbjct: 81 K--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPA 136
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMC 189
NI ++ HG V+I DLGLA + + +GT +MAPE+ ++ Y+ D +S G
Sbjct: 137 NILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 195
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLS-- 246
+ +++ P+ + K + + L P+++ +E L + RL
Sbjct: 196 LFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255
Query: 247 ---AKDLLKDPFLQ 257
A+++ + PF +
Sbjct: 256 GRGAQEVKESPFFR 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 5e-35
Identities = 56/275 (20%), Positives = 102/275 (37%), Gaps = 45/275 (16%)
Query: 14 YKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSW 67
A I+VA VK+ + + L SE+ ++ L +N+V +
Sbjct: 54 MNATAYGISKTGVSIQVA---VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110
Query: 68 VDDKKKTVNMITELFTSGNLRQYRKKHKN-----------------------VDIKVIKN 104
+ +I E G+L Y + + + + +
Sbjct: 111 TLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 168
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARS 160
+A Q+ G+ +L + +HRDL N+ V VKI D GLA + +
Sbjct: 169 FAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGN 225
Query: 161 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIK 218
++MAPE L+E Y D++S+G+ + E+ + PY A +K + +G K
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 285
Query: 219 PASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 252
+I ++ C + +R S +L
Sbjct: 286 MDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 8e-35
Identities = 59/239 (24%), Positives = 97/239 (40%), Gaps = 15/239 (6%)
Query: 22 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81
+ VA +K D + Q P + EV+ + SL N+++ Y + + M+TEL
Sbjct: 36 TVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTEL 91
Query: 82 FTSGNLRQYRKKHKN-VDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHG 140
G+L +KH+ + + +A Q+ G+ YL S IHRDL N+ +
Sbjct: 92 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-D 148
Query: 141 EVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 194
VKIGD GL A+ Q + APE L ++ D + FG+ + EM
Sbjct: 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208
Query: 195 TFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 252
T+ N +QI K+ + + I + +C +R + L
Sbjct: 209 TYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 53/251 (21%), Positives = 99/251 (39%), Gaps = 20/251 (7%)
Query: 14 YKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD 70
Y + I A VK + + G++ + +E ++K NV+ +
Sbjct: 44 YHGTLLDNDGKKIHCA---VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 71 KKKTVNMITELFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+ + ++ G+LR + + + N +K + + Q+ G+ + +HRDL
Sbjct: 101 EGSPL-VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLA 157
Query: 130 CDNIFVNGNHGEVKIGDLGLAIAMQQPTARS------VIGTPEFMAPE-LYEEEYNELVD 182
N ++ VK+ D GLA M S ++MA E L +++ D
Sbjct: 158 ARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 216
Query: 183 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-A 241
++SFG+ + E++T P N I + G + DP + + KC P A
Sbjct: 217 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP-LYEVMLKCWHPKA 275
Query: 242 SERLSAKDLLK 252
R S +L+
Sbjct: 276 EMRPSFSELVS 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 2e-34
Identities = 50/268 (18%), Positives = 98/268 (36%), Gaps = 23/268 (8%)
Query: 14 YKAF----DEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVD 69
YK + VA +K E ++ N+++
Sbjct: 24 YKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80
Query: 70 DKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128
K + +ITE +G L ++ R+K + + R I G + N +HRDL
Sbjct: 81 YKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG--MKYLANMNYVHRDL 136
Query: 129 KCDNIFVNGNHGEVKIGDLGLAIAMQQP-----TARSVIGTPEFMAPE-LYEEEYNELVD 182
NI VN N K+ D GL+ ++ T + APE + ++ D
Sbjct: 137 AARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 195
Query: 183 IYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP-A 241
++SFG+ + E++T+ + ++ K + G + + I + +C
Sbjct: 196 VWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQER 254
Query: 242 SERLSAKDLLK--DPFLQVENQKEPICD 267
+ R D++ D ++ + + + D
Sbjct: 255 ARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 53/301 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK-- 71
+KA G +VA +V +++ + G E+ +L+ LK +NVV +
Sbjct: 27 FKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84
Query: 72 ----KKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRD 127
K ++ ++ + + IK + +L+GL Y+H + I+HRD
Sbjct: 85 YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRD 142
Query: 128 LKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA------RSVIGTPEFMAPE--LYEEEYNE 179
+K N+ + + G +K+ D GLA A + + T + PE L E +Y
Sbjct: 143 MKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP 201
Query: 180 LVDIYSFGMCILEMVTFEYPYS-----------------------------ECKNPAQIF 210
+D++ G + EM T E ++
Sbjct: 202 PIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 261
Query: 211 KKVTSGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEPICDPL 269
K +K A V DP I+K LV ++R+ + D L F +P+ L
Sbjct: 262 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF----WSDPMPSDL 317
Query: 270 K 270
K
Sbjct: 318 K 318
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-34
Identities = 51/259 (19%), Positives = 98/259 (37%), Gaps = 27/259 (10%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
KA + G+ + + +K D + E+ +L L N++ +
Sbjct: 27 LKARIKKDGLRMDAA-IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85
Query: 73 KTVNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYL 116
+ + E GNL + +K + + + ++A + G+ YL
Sbjct: 86 --LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143
Query: 117 HSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVI-GTPEFMAPE-LYE 174
IHRDL NI V N+ KI D GL+ + +++ +MA E L
Sbjct: 144 SQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY 200
Query: 175 EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234
Y D++S+G+ + E+V+ A++++K+ G + D ++ +
Sbjct: 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-DDEVYDLM 259
Query: 235 EKCLVP-ASERLSAKDLLK 252
+C ER S +L
Sbjct: 260 RQCWREKPYERPSFAQILV 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 8e-34
Identities = 76/286 (26%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 14 YKAFD-EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD---DNVVKFYKSWVD 69
+KA D + G VA RV++ + G EV +L+ L+ NVV+ +
Sbjct: 24 FKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81
Query: 70 ---DKKKTVNMITELFTSGNLRQY-RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIH 125
D++ + ++ E + V + IK+ Q+L GL +LHSH ++H
Sbjct: 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVH 139
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLA-IAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDI 183
RDLK NI V + G++K+ D GLA I Q SV+ T + APE L + Y VD+
Sbjct: 140 RDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDL 198
Query: 184 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---------------------- 221
+S G EM + + + Q+ K + P
Sbjct: 199 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPI 258
Query: 222 --LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ-VENQKE 263
D K + KCL ++R+SA L P+ Q +E KE
Sbjct: 259 EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 9e-34
Identities = 66/315 (20%), Positives = 116/315 (36%), Gaps = 57/315 (18%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--- 70
A+D + VA +K + Q+ E+ +L + +N++
Sbjct: 25 CSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81
Query: 71 KKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
+ K V ++T L + + + +H + I + QIL GL Y+HS N ++HRDLK
Sbjct: 82 QMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKP 137
Query: 131 DNIFVNGNHGEVKIGDLGLAIAM-----QQPTARSVIGTPEFMAPELYEEE--YNELVDI 183
N+ +N ++KI D GLA + T + APE+ Y + +DI
Sbjct: 138 SNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 196
Query: 184 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP------------------------ 219
+S G + EM++ + Q+ + P
Sbjct: 197 WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 256
Query: 220 ----ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPL--- 269
L D + ++K L +R+ + L P+L+ + EPI +
Sbjct: 257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKF 316
Query: 270 -----KLPIQSLKML 279
LP + LK L
Sbjct: 317 DMELDDLPKEKLKEL 331
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 51/281 (18%), Positives = 102/281 (36%), Gaps = 47/281 (16%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----FYKSWVD 69
Y+A +G VA +V D + E+ +++ L N+V+ FY S
Sbjct: 37 YQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEK 88
Query: 70 DKKKTVNMITELFTSGN---LRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHR 126
+ +N++ + R Y + + + + +K + Q+ L Y+HS I HR
Sbjct: 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHR 146
Query: 127 DLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA-RSVIGTPEFMAPELY--EEEYNELVDI 183
D+K N+ ++ + +K+ D G A + + S I + + APEL +Y +D+
Sbjct: 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 184 YSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPAS---------------------- 221
+S G + E++ + + Q+ + + P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 222 ----LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
P+ + L + RL+ + F
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-33
Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 39/283 (13%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA ++ G VA ++++D + G E+ LLK L N+VK + K
Sbjct: 19 YKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK- 75
Query: 74 TVNMITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+ ++ E + + + +IK++ Q+L GL + HSH ++HRDLK N
Sbjct: 76 -LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQN 132
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELY--EEEYNELVDIYSFGM 188
+ +N G +K+ D GLA A P + T + APE+ + Y+ VDI+S G
Sbjct: 133 LLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVN---------------------- 226
EMVT + Q+F+ + P +
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251
Query: 227 ----DPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVENQKEP 264
D + + + L ++R+SAK L PF Q + P
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 1e-33
Identities = 55/251 (21%), Positives = 110/251 (43%), Gaps = 17/251 (6%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+ +G A + V++ ++ +E +L+++ +VK S+ D+
Sbjct: 58 MLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN- 115
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ M+ E G + + ++ + +A QI+ YLHS + +I+RDLK +N+
Sbjct: 116 -LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENL 172
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 192
++ G +++ D G A ++ T ++ GTPE +APE + + YN+ VD ++ G+ I E
Sbjct: 173 LIDQQ-GYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 193 MVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV------PASERLS 246
M P+ P QI++K+ SG +K + L + +
Sbjct: 231 MAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNG 287
Query: 247 AKDLLKDPFLQ 257
D+ +
Sbjct: 288 VNDIKNHKWFA 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (319), Expect = 2e-33
Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 39/275 (14%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
YKA + + G A +++++ + G E+ +LK LK N+VK Y K+
Sbjct: 19 YKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR- 74
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
+ ++ E + ++ K++ Q+L+G+ Y H ++HRDLK N+
Sbjct: 75 -LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNL 131
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTAR--SVIGTPEFMAPELYEEE--YNELVDIYSFGMC 189
+N GE+KI D GLA A P + I T + AP++ Y+ +DI+S G
Sbjct: 132 LINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 190 ILEMVTFEYPYSECKNPAQIFK--------------------------KVTSGIKPASLA 223
EMV + Q+ + V + S
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 224 KVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
K D + K L ++R++AK L+ + +
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (316), Expect = 8e-33
Identities = 45/265 (16%), Positives = 96/265 (36%), Gaps = 30/265 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
Y D AG EVA +K+ + +L+ E + K ++ + + W +
Sbjct: 24 YLGTDIAAGEEVA---IKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIR-WCGAEGD 76
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
M+ EL + + +K + A Q++ + Y+HS N IHRD+K DN
Sbjct: 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNF 134
Query: 134 FV--NGNHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYE-EEYNELV 181
+ V I D GLA + +++ GT + + + E +
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
Query: 182 DIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFIEK 236
D+ S G ++ + + Q +++++ + + + ++
Sbjct: 195 DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 237 CLVP-ASERLSA---KDLLKDPFLQ 257
C ++ + L ++ F +
Sbjct: 255 CRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 2e-32
Identities = 60/276 (21%), Positives = 116/276 (42%), Gaps = 39/276 (14%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
+KA + VA RV++DD G E+ LLK LK N+V+ + DKK
Sbjct: 19 FKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
++ E + + + ++D +++K++ Q+L GL + HS N ++HRDLK N+
Sbjct: 77 --TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNL 132
Query: 134 FVNGNHGEVKIGDLGLAIAMQQPTARS--VIGTPEFMAPELY--EEEYNELVDIYSFGMC 189
+N +GE+K+ + GLA A P + T + P++ + Y+ +D++S G
Sbjct: 133 LIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGI---------------------------KPASL 222
E+ P + K++ + ++
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 223 AKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
+ + ++ L +R+SA++ L+ P+
Sbjct: 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 7e-32
Identities = 49/284 (17%), Positives = 109/284 (38%), Gaps = 52/284 (18%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
++A + +V +K P +K+ E+ +L++L+ N++ D
Sbjct: 52 FEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVS 104
Query: 73 KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132
+T ++ E + + +Q ++ + I+ + +IL L Y HS I+HRD+K N
Sbjct: 105 RTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHN 159
Query: 133 IFVNGNHGEVKIGDLGLAIAMQQ-PTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMC 189
+ ++ H ++++ D GLA + + F PEL + Y+ +D++S G
Sbjct: 160 VMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVT----------------------------------- 214
+ M+ + P+ + ++
Sbjct: 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 279
Query: 215 SGIKPASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ 257
+ + P+ F++K L RL+A++ ++ P+
Sbjct: 280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-31
Identities = 52/264 (19%), Positives = 104/264 (39%), Gaps = 33/264 (12%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKK 72
Y A + VA VK+ + + L SE+ +L L + N+V +
Sbjct: 45 YGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101
Query: 73 KTVNMITELFTSGNLRQYRKKHKN------------------VDIKVIKNWARQILHGLV 114
+ITE G+L + ++ ++ +D++ + +++ Q+ G+
Sbjct: 102 --TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 115 YLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV----IGTPEFMAP 170
+L S N IHRDL NI + KI D GLA ++ + V ++MAP
Sbjct: 160 FLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP 216
Query: 171 E-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229
E ++ Y D++S+G+ + E+ + F K+ + +
Sbjct: 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE 276
Query: 230 IKGFIEKCLVP-ASERLSAKDLLK 252
+ ++ C +R + K +++
Sbjct: 277 MYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-31
Identities = 58/280 (20%), Positives = 122/280 (43%), Gaps = 23/280 (8%)
Query: 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVD 69
F K G A +K ++Q + +E +L+ ++ +V + ++
Sbjct: 41 FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100
Query: 70 DKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLK 129
+ K + + + G L + + + ++ + +I+ L +LH II+RD+K
Sbjct: 101 ETKLHLIL--DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIK 156
Query: 130 CDNIFVNGNHGEVKIGDLGLA---IAMQQPTARSVIGTPEFMAPELY---EEEYNELVDI 183
+NI ++ N G V + D GL+ +A + A GT E+MAP++ + +++ VD
Sbjct: 157 LENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 215
Query: 184 YSFGMCILEMVTFEYPY---SECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLVP 240
+S G+ + E++T P+ E + A+I +++ P + K I++ L+
Sbjct: 216 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMK 273
Query: 241 -ASERLS-----AKDLLKDPFLQVENQKEPICDPLKLPIQ 274
+RL A ++ + F Q N + + P +
Sbjct: 274 DPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFK 313
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 2e-31
Identities = 46/274 (16%), Positives = 87/274 (31%), Gaps = 44/274 (16%)
Query: 14 YKA-----FDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 68
++A VA VK+ E L+ + N+VK
Sbjct: 30 FQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86
Query: 69 DDKKKTVNMITELFTSGNLRQYRKKHKN------------------------VDIKVIKN 104
K + ++ E G+L ++ + +
Sbjct: 87 VGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 144
Query: 105 WARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR----S 160
ARQ+ G+ YL +HRDL N V N VKI D GL+ + +
Sbjct: 145 IARQVAAGMAYLSERK--FVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGN 201
Query: 161 VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP 219
+M PE ++ Y D++++G+ + E+ ++ ++ V G
Sbjct: 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL 261
Query: 220 ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLK 252
A ++ + C ++R S + +
Sbjct: 262 ACPENC-PLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 59/280 (21%), Positives = 105/280 (37%), Gaps = 50/280 (17%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ G EVA VKI + ++ +E++ L+ +N++ F + D
Sbjct: 20 WRGKWR--GEEVA---VKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGT 72
Query: 74 TVNM--ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS------HNPPIIH 125
+ +++ G+L Y ++ V ++ + A GL +LH P I H
Sbjct: 73 WTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131
Query: 126 RDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT------ARSVIGTPEFMAPELYEE---- 175
RDLK NI V N G I DLGLA+ T +GT +MAPE+ ++
Sbjct: 132 RDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM 190
Query: 176 ---EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG------IKPASLAKVN 226
E + DIY+ G+ E+ ++ + + ++ +
Sbjct: 191 KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL 250
Query: 227 DPQIKG-------------FIEKCLVP-ASERLSAKDLLK 252
P I + +C + RL+A + K
Sbjct: 251 RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 22 GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMITE 80
+VA VK+ DL L SE+ ++K + N++ + D + +I E
Sbjct: 45 VTKVA---VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVE 99
Query: 81 LFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPII 124
+ GNLR+Y + + + K + + A Q+ G+ YL S I
Sbjct: 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CI 157
Query: 125 HRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEEEYNE 179
HRDL N+ V + +KI D GLA + + ++MAPE L++ Y
Sbjct: 158 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 216
Query: 180 LVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239
D++SFG+ + E+ T ++FK + G + + ++ + C
Sbjct: 217 QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC-TNELYMMMRDCWH 275
Query: 240 P-ASERLSAKDLLKD 253
S+R + K L++D
Sbjct: 276 AVPSQRPTFKQLVED 290
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-31
Identities = 69/291 (23%), Positives = 113/291 (38%), Gaps = 41/291 (14%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
A D G +VA ++ Q ++ Y E+ LLK ++ +NV+ + D+
Sbjct: 35 CSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92
Query: 74 TVNMITELFTS--GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131
L G KH+ + I+ Q+L GL Y+H+ HRDLK
Sbjct: 93 DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPG 150
Query: 132 NIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMC 189
N+ VN + E+KI D GLA + T + APE+ Y + VDI+S G
Sbjct: 151 NLAVNED-CELKILDFGLARQADSEM-TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208
Query: 190 ILEMVTFEYPYSECKNPAQIFKKVTSGIKP----------------------------AS 221
+ EM+T + + + Q+ + + P AS
Sbjct: 209 MAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS 268
Query: 222 LAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPL 269
+ P +EK LV A +R++A + L P+ + + + EP
Sbjct: 269 ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKY 319
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 2e-30
Identities = 50/269 (18%), Positives = 102/269 (37%), Gaps = 28/269 (10%)
Query: 14 YKAFDEFAGIEVAWSRV--KIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK 71
Y+ + + +RV K + + + +E ++K +VV+ +
Sbjct: 37 YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96
Query: 72 KKTVNMITELFTSGNLRQYRKKHKNV----------DIKVIKNWARQILHGLVYLHSHNP 121
+I EL T G+L+ Y + + + + A +I G+ YL+++
Sbjct: 97 P--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK- 153
Query: 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPE-LYEEE 176
+HRDL N V + VKIGD G+ + + + +M+PE L +
Sbjct: 154 -FVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 211
Query: 177 YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236
+ D++SFG+ + E+ T + + Q+ + V G + +
Sbjct: 212 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC-PDMLFELMRM 270
Query: 237 CLVP-ASERLSAKDLLKDPFLQVENQKEP 264
C R S +++ ++ + EP
Sbjct: 271 CWQYNPKMRPSFLEIIS----SIKEEMEP 295
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 52/267 (19%), Positives = 100/267 (37%), Gaps = 35/267 (13%)
Query: 14 YKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWV 68
+A VA VK+ + + L SE+ +L + V
Sbjct: 30 IEADAFGIDKTATCRTVA---VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86
Query: 69 DDKKKTVNMITELFTSGNLRQYRKKHKN----------------VDIKVIKNWARQILHG 112
+ +I E GNL Y + +N + ++ + ++ Q+ G
Sbjct: 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146
Query: 113 LVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFM 168
+ +L S IHRDL NI ++ VKI D GLA + + ++M
Sbjct: 147 MEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 203
Query: 169 A-PELYEEEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPASLAKVN 226
A +++ Y D++SFG+ + E+ + PY K + +++ G +
Sbjct: 204 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYT 262
Query: 227 DPQIKGFIEKCLVP-ASERLSAKDLLK 252
P++ + C S+R + +L++
Sbjct: 263 TPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 114 bits (285), Expect = 1e-28
Identities = 32/244 (13%), Positives = 84/244 (34%), Gaps = 28/244 (11%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKK 73
++ + +VA +K D +L E K L + + +
Sbjct: 22 FEGTNLLNNQQVA---IKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75
Query: 74 TVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNI 133
V ++ +L + +K + A+Q+L + +H + +++RD+K DN
Sbjct: 76 NV-LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNF 132
Query: 134 FVN----GNHGEVKIGDLGLAIAMQQP---------TARSVIGTPEFMAPELYE-EEYNE 179
+ N + + D G+ + P +++ GT +M+ + E +
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192
Query: 180 LVDIYSFGMCILEMVT--FEYPYSECKNPAQIFKKVTSGIKPASLAKVND---PQIKGFI 234
D+ + G + + + + Q ++++ + L ++ + ++
Sbjct: 193 RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 235 EKCL 238
Sbjct: 253 HYAR 256
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 74/303 (24%), Positives = 119/303 (39%), Gaps = 43/303 (14%)
Query: 14 YKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
AFD G+ VA VK + Q ++ Y E+ LLK +K +NV+ + +
Sbjct: 35 CAAFDTKTGLRVA---VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91
Query: 73 KT--VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKC 130
++ G K + + ++ QIL GL Y+HS + IIHRDLK
Sbjct: 92 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKP 149
Query: 131 DNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGM 188
N+ VN E+KI D GLA + T + APE+ YN+ VDI+S G
Sbjct: 150 SNLAVN-EDCELKILDFGLARHTDDEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207
Query: 189 CILEMVTFEYPYSECKNPAQIFKKVTSGIKP----------------------------A 220
+ E++T + + Q+ + P A
Sbjct: 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267
Query: 221 SLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQ--VENQKEPICDPLKLPIQSLK 277
++ +P +EK LV + +R++A L + + EP+ DP +S
Sbjct: 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRD 327
Query: 278 MLR 280
+L
Sbjct: 328 LLI 330
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-27
Identities = 68/318 (21%), Positives = 117/318 (36%), Gaps = 57/318 (17%)
Query: 14 YKAFDEFAGIEVAWSRVK-IDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK 72
A+D VA +K + Q ++ Y E+ L+K + N++ + K
Sbjct: 34 CAAYDAVLDRNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90
Query: 73 ----KTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDL 128
+ V ++ EL + + + + D + + Q+L G+ +LHS IHRDL
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGI--IHRDL 145
Query: 129 KCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS-VIGTPEFMAPE-LYEEEYNELVDIYSF 186
K NI V + +KI D GLA + + T + APE + Y E VDI+S
Sbjct: 146 KPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 187 GMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--------------------------- 219
G + EMV + + Q K + P
Sbjct: 205 GCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264
Query: 220 ------------ASLAKVNDPQIKGFIEKCLVP-ASERLSAKDLLKDPFLQVE-NQKEPI 265
+ K+ Q + + K LV ++R+S D L+ P++ V + E
Sbjct: 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE 324
Query: 266 CDPLKLPIQSLKMLRLPM 283
P ++ + L +
Sbjct: 325 APPPQIYDKQLDEREHTI 342
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.2 bits (230), Expect = 4e-21
Identities = 65/321 (20%), Positives = 114/321 (35%), Gaps = 73/321 (22%)
Query: 14 YKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVK----------- 62
+ A D VA V+ D V + E+ LL+ + D + K
Sbjct: 30 WLAKDMVNNTHVAMKIVRGDKVYT-----EAAEDEIKLLQRVNDADNTKEDSMGANHILK 84
Query: 63 ---FYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH 119
+ + V + L + + +H+ + + +K ++Q+L GL Y+H
Sbjct: 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH-R 143
Query: 120 NPPIIHRDLKCDNIFVN-----GNHGEVKIGDLGLAIAMQQPTARSVIGTPEFMAPE-LY 173
IIH D+K +N+ + N ++KI DLG A + + I T E+ +PE L
Sbjct: 144 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TNSIQTREYRSPEVLL 202
Query: 174 EEEYNELVDIYSFGMCILEMVTFEYPYS---------ECKNPAQIFK------------- 211
+ DI+S I E++T ++ + + + AQI +
Sbjct: 203 GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 262
Query: 212 -------------KVTSGIKPASLAKV----------NDPQIKGFIEKCLVP-ASERLSA 247
+ S +K L V +I F+ L +R A
Sbjct: 263 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322
Query: 248 KDLLKDPFLQVENQKEPICDP 268
L+ P+L+ E I P
Sbjct: 323 GGLVNHPWLKDTLGMEEIRVP 343
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.3 bits (148), Expect = 2e-11
Identities = 26/144 (18%), Positives = 49/144 (34%), Gaps = 17/144 (11%)
Query: 49 VHLLKSLKDDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQ 108
L+ L+ V K Y + ++ EL + L + R ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNA------VLMELIDAKELYRVRVEN-------PDEVLDM 111
Query: 109 ILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSVIGTPEFM 168
IL + + I+H DL N+ V+ + I D ++ + + R ++
Sbjct: 112 ILEEVAKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 169 APELYEEEYNELVDIYSFGMCILE 192
+ Y DI S IL+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 639 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.6 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.57 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.95 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 82.16 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-58 Score=471.04 Aligned_cols=251 Identities=52% Similarity=0.940 Sum_probs=231.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD--KKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~--~~~~l~lV~ 79 (639)
||+|||| +||+|.+..+|+.||+|.+..... .....+.+.+|+++|++|+|||||++|++|.+. ....+|+||
T Consensus 17 iG~G~fg---~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 17 IGRGSFK---TVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EecCcCc---EEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 7888888 899999999999999999987653 456678899999999999999999999998753 345789999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
|||++|+|.+++++.+.+++..++.|++||+.||.|||+++++|+||||||+|||+++.+|.+||+|||+|+........
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~ 171 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 171 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBE
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccC
Confidence 99999999999999899999999999999999999999999889999999999999766789999999999877666667
Q ss_pred cccCCCCcCCcccccccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 160 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
+.+|||.|||||++.+.|+.++|||||||++|||++|+.||.+..+..++++.+..+..+..++...++++++||.+||.
T Consensus 172 ~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (270)
T d1t4ha_ 172 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251 (270)
T ss_dssp ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSC
T ss_pred CcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHcc
Confidence 78999999999999999999999999999999999999999988888999999999988888888889999999999999
Q ss_pred -CCCCCCCHHHHhcCcccc
Q 006593 240 -PASERLSAKDLLKDPFLQ 257 (639)
Q Consensus 240 -dP~~RpSa~ELL~Hpff~ 257 (639)
+|.+|||++|||+||||+
T Consensus 252 ~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 252 QNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp SSGGGSCCHHHHHTSGGGC
T ss_pred CCHhHCcCHHHHhCCcccC
Confidence 899999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-55 Score=445.26 Aligned_cols=246 Identities=22% Similarity=0.392 Sum_probs=218.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.++.+|+.||+|++....... ....+.+.+|+.+|++++|||||++|+++.++ ..+|+||||
T Consensus 14 iG~G~fg---~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~ivmEy 87 (263)
T d2j4za1 14 LGKGKFG---NVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDA--TRVYLILEY 87 (263)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCCCc---EEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--CEEEEEEee
Confidence 7888887 89999999999999999998654322 23456789999999999999999999998765 469999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 161 (639)
|.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ ..|.+||+|||+|...........
T Consensus 88 ~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~ 164 (263)
T d2j4za1 88 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTL 164 (263)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCCCCEET
T ss_pred cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCCccccc
Confidence 999999999999899999999999999999999999999 99999999999998 557999999999987766666678
Q ss_pred cCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-
Q 006593 162 IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV- 239 (639)
Q Consensus 162 ~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~- 239 (639)
+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+ .+..+++..+..+.. .++...++++++||.+||.
T Consensus 165 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp TEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHHccC
Confidence 99999999999875 589999999999999999999999976 567788888877543 3556678999999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 006593 240 PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 240 dP~~RpSa~ELL~Hpff~~~ 259 (639)
+|.+|||++|+|+||||+..
T Consensus 242 dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 242 NPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp SGGGSCCHHHHHTCHHHHHH
T ss_pred CHhHCcCHHHHHcCcCcCCc
Confidence 89999999999999999743
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-55 Score=448.50 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=210.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.++.+|+.||+|+++.... .+..+.+.+|+++|++|+|||||++|+++.+. ..+|+|||
T Consensus 12 ~lG~G~fg---~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--~~~~ivmE 83 (271)
T d1nvra_ 12 TLGEGAYG---EVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREG--NIQYLFLE 83 (271)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred EEecCcCe---EEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC--ceeEEEEe
Confidence 37888887 899999999999999999986643 23456789999999999999999999999876 46999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
||.||+|.+++++.+.+++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccCCccc
Confidence 9999999999988889999999999999999999999999 99999999999997 4579999999999866422
Q ss_pred CCccccCCCCcCCcccccc-c-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.....+||+.|||||++.+ . ++.++|||||||++|||+||++||.........+..+.............++++++||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 2456789999999998864 3 4678999999999999999999998765555566666555544444556689999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCccccc
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
.+||+ +|.+|||++|+|+||||+.
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCc
Confidence 99999 8999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=446.16 Aligned_cols=244 Identities=28% Similarity=0.489 Sum_probs=213.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||+|+++.... ...+.+.+|+.+|++++|||||+++++|.+.+ .+|+||||
T Consensus 28 iG~G~fg---~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~ivmEy 98 (293)
T d1yhwa1 28 IGQGASG---TVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWVVMEY 98 (293)
T ss_dssp CCCSSSC---EEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred EecCcCc---EEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC--EEEEEEEe
Confidence 6788887 899999999999999999987653 23567899999999999999999999998764 59999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
|.||+|.+++.+ +.+++..++.|++||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.+... ...
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhheeecccccccc
Confidence 999999998876 46999999999999999999999999 99999999999997 4589999999999876432 345
Q ss_pred cccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhc
Q 006593 160 SVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCL 238 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL 238 (639)
..+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+......+...+..+..+...+...++++++||.+||
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 254 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence 6689999999998875 589999999999999999999999988555555555555655555566777899999999999
Q ss_pred C-CCCCCCCHHHHhcCccccc
Q 006593 239 V-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 239 ~-dP~~RpSa~ELL~Hpff~~ 258 (639)
. +|.+|||+.|+|+||||+.
T Consensus 255 ~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 255 DMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp CSSTTTSCCHHHHTTCGGGGG
T ss_pred cCChhHCcCHHHHhcCHhhCC
Confidence 9 8999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=441.88 Aligned_cols=248 Identities=27% Similarity=0.466 Sum_probs=205.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.++.+|+.||+|+++.... .....+.+.+|+++|++++|||||++|++|.+.....+|+|||
T Consensus 11 ~iG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 11 TIGTGSYG---RCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred EEecCCCe---EEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 37888888 899999999999999999987654 4566788999999999999999999999998776677999999
Q ss_pred cCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 81 LFTSGNLRQYRKK----HKNVDIKVIKNWARQILHGLVYLHSHN---PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 81 y~~gGsL~d~lkk----~~~l~e~~i~~i~~QIl~aL~yLHs~g---ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
||++|+|.+++.+ .+.+++..++.|+.||+.||.|||+++ .+|+||||||+|||++ .+|.+||+|||+|+.+
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARIL 164 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHHHC
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccceeec
Confidence 9999999999864 467999999999999999999999865 2499999999999998 4589999999999877
Q ss_pred cCC--CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 154 QQP--TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 154 ~~~--~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
... .....+|||.|||||++.+ .|+.++|||||||++|||+||..||.+ .+..++...+..+..+ .++...++++
T Consensus 165 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~~l 242 (269)
T d2java1 165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDEL 242 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHHH
T ss_pred ccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHH
Confidence 543 3456789999999998864 699999999999999999999999986 5677888888877554 3556678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCccc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKDPFL 256 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~Hpff 256 (639)
++||.+||. ||.+|||+.|||+|||+
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999 89999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=451.47 Aligned_cols=249 Identities=25% Similarity=0.460 Sum_probs=209.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||+|+++... .+...+++.+|+.+|++|+|||||+++++|.++ ..+|+||||
T Consensus 14 iG~G~fg---~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~iVmEy 85 (322)
T d1s9ja_ 14 LGAGNGG---VVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEH 85 (322)
T ss_dssp EECCSSC---CEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCCCe---EEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEEc
Confidence 7888888 79999999999999999998653 345567899999999999999999999999766 459999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|.||+|.+++.+.+.+++..++.++.||+.||.|||+ +| |+||||||+|||++ ..|.+||+|||+|+........+
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~ 162 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 162 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHTC--
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccCCCcccc
Confidence 9999999999998999999999999999999999997 58 99999999999997 55899999999998776655667
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHH-------------------------------
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQ------------------------------- 208 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~------------------------------- 208 (639)
.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+......
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 899999999998875 699999999999999999999999975332211
Q ss_pred ----------HHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 209 ----------IFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 209 ----------i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
....+.....+.......++++++||.+||+ ||.+|||++|+|+||||+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111222222222334457899999999999 9999999999999999986544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-53 Score=443.82 Aligned_cols=246 Identities=28% Similarity=0.436 Sum_probs=216.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||||+++.... ......+.+.+|+++|++|+|||||+++++|.+. ..+|+||||
T Consensus 23 lG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~iv~E~ 96 (309)
T d1u5ra_ 23 IGHGSFG---AVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEY 96 (309)
T ss_dssp EEECSSS---EEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred EecCCCe---EEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEEEEEe
Confidence 7888888 899999999999999999987653 2345567899999999999999999999999876 459999999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCccc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARSV 161 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~~ 161 (639)
|.+|+|..++...+.+++..++.|++||+.||.|||++| |+||||||+|||++ ++|.+||+|||+|..... ....
T Consensus 97 ~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~--~~~~ 171 (309)
T d1u5ra_ 97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSF 171 (309)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--BCCC
T ss_pred cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecccccccCC--CCcc
Confidence 999999988888889999999999999999999999999 99999999999998 558999999999976543 3467
Q ss_pred cCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 162 IGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 162 ~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
+||+.|||||++. ..|+.++|||||||++|||++|..||.+. +..+.+..+..+..+...+...++++++||.+|
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~ 250 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHH
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 8999999999874 35899999999999999999999999874 455666666666666555667789999999999
Q ss_pred cC-CCCCCCCHHHHhcCcccccc
Q 006593 238 LV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
|+ ||.+|||++|+|+||||+..
T Consensus 251 L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 251 LQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp TCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CcCChhHCcCHHHHHhCHHhcCC
Confidence 99 89999999999999999753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=440.52 Aligned_cols=245 Identities=27% Similarity=0.480 Sum_probs=209.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|..||+|+++... ....+.+.+|+++|++|+|||||+++++|.+.+ .+|+||||
T Consensus 20 iG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lvmEy 90 (288)
T d2jfla1 20 LGDGAFG---KVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIEF 90 (288)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEEC
T ss_pred EeeCCCc---EEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC--eEEEEEec
Confidence 6777776 89999999999999999998653 345677899999999999999999999998764 59999999
Q ss_pred CCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CC
Q 006593 82 FTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~ 158 (639)
|.||+|.+++.+ .+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+..... ..
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECHHHHHHH
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechhhhccCCCcccc
Confidence 999999999765 567999999999999999999999999 99999999999998 5579999999998654322 23
Q ss_pred ccccCCCCcCCccccc------ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC-CCcccCCCChHHH
Q 006593 159 RSVIGTPEFMAPELYE------EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK-PASLAKVNDPQIK 231 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~------~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~-p~~l~~~~s~~l~ 231 (639)
.+.+||+.|||||++. ..|+.++|||||||++|||+||++||.+. ++.+++..+..+.. ....+...+++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 4578999999999873 34899999999999999999999999874 45556666665543 3344566789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 232 GFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+||.+||+ ||.+|||+.|+|+||||+..
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999 89999999999999999743
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=439.99 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=218.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|||| +||+|.++.+|+.||+|+++..... .....+.+.+|+++|++|+|||||++|++|.++ ..+|+|||
T Consensus 15 ~lG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~ivmE 88 (288)
T d1uu3a_ 15 ILGEGSFS---TVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD--EKLYFGLS 88 (288)
T ss_dssp EEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC--CEEEEEEE
Confidence 47888888 8999999999999999999865432 224567799999999999999999999998765 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC----
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP---- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~---- 156 (639)
||.||+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.+...
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccCCccc
Confidence 9999999999999999999999999999999999999999 99999999999998 5579999999999876422
Q ss_pred CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
...+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++..+..+.. .++...++++++||.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARDLVE 242 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHHHHH
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHHHHH
Confidence 2345689999999998864 599999999999999999999999987 577888888877643 345667899999999
Q ss_pred HhcC-CCCCCCCHHH------HhcCcccccccCCCC
Q 006593 236 KCLV-PASERLSAKD------LLKDPFLQVENQKEP 264 (639)
Q Consensus 236 kcL~-dP~~RpSa~E------LL~Hpff~~~~~~~~ 264 (639)
+||+ ||.+|||++| +++||||+..+|...
T Consensus 243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 9999 8999999987 688999998777643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-53 Score=439.77 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=199.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|.++.+|+.||+|++...... .....+.+|+.+|++|+|||||+++++|.++ ..+|+|||
T Consensus 16 ~lG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lvmE 87 (307)
T d1a06a_ 16 VLGTGAFS---EVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESG--GHLYLIMQ 87 (307)
T ss_dssp ESBSGGGG---GEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEeeccCe---EEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEe
Confidence 48999998 7999999999999999999866532 2345688999999999999999999998765 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhccCC-C
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP-T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~~~-~ 157 (639)
||.||+|.+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||+.. ++|.+||+|||+|+..... .
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 9999999999999999999999999999999999999999 999999999999952 4579999999999866533 3
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC--cccCCCChHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA--SLAKVNDPQIKGFI 234 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~--~l~~~~s~~l~~LI 234 (639)
..+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+ .+..++...+..+..+. ......++++++||
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence 456789999999998875 599999999999999999999999987 45677777777765432 33455689999999
Q ss_pred HHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 235 EKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.+||. +|.+|||+.|+|+||||+..
T Consensus 245 ~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999 89999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=433.61 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=216.7
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL--PGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|.++.+|+.||+|+++....... ....+.+.+|+.+|++|+|||||++|++|.+. ..+|+||
T Consensus 18 lG~G~fg---~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv~ 92 (293)
T d1jksa_ 18 LGSGQFA---VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--TDVILIL 92 (293)
T ss_dssp EEECSSE---EEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--SEEEEEE
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 7888887 899999999999999999987654322 23467899999999999999999999998765 5699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCC---CcEEEeecchhhhccCC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNH---GEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~---g~VKL~DFGlA~~l~~~ 156 (639)
|||.||+|.+++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++.++ +.+||+|||+|......
T Consensus 93 E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~ 170 (293)
T d1jksa_ 93 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170 (293)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS
T ss_pred EcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhcCCC
Confidence 99999999999998889999999999999999999999999 99999999999997432 25999999999876543
Q ss_pred -CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHH
Q 006593 157 -TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKG 232 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~ 232 (639)
...+..||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+.+..+..+... ...+...++++++
T Consensus 171 ~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 249 (293)
T d1jksa_ 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKD 249 (293)
T ss_dssp CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence 3456789999999999875 599999999999999999999999987 5677777777776443 3344567889999
Q ss_pred HHHHhcC-CCCCCCCHHHHhcCcccccccCCC
Q 006593 233 FIEKCLV-PASERLSAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~~~ 263 (639)
||.+||. ||.+|||++|+|+||||+...+..
T Consensus 250 li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 250 FIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence 9999999 899999999999999998765543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=444.32 Aligned_cols=251 Identities=20% Similarity=0.390 Sum_probs=221.1
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
+||+|+|| +||+|+++.+|+.||+|++++..... ....+.+.+|+.+|++++|||||+++++|.+. ..+|+|||
T Consensus 12 ~lG~G~fg---~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~~~iv~e 85 (337)
T d1o6la_ 12 LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTH--DRLCFVME 85 (337)
T ss_dssp EEEECSSE---EEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred EEecCcCe---EEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc--ccccccee
Confidence 47888888 89999999999999999998654322 34567889999999999999999999999765 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CCC
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PTA 158 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~~ 158 (639)
||+||+|.+++.+.+.+++..++.+++||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.... ...
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCB
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccCCccc
Confidence 9999999999999999999999999999999999999999 99999999999998 458999999999986543 344
Q ss_pred ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 159 RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+|||.|||||++. ..|+.++|||||||++|||++|++||.+ .+..++++.+..+.. .++...++++++||.+|
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~~ 239 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHH
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHHhh
Confidence 5679999999999887 4699999999999999999999999987 567888888877653 35667899999999999
Q ss_pred cC-CCCCCCC-----HHHHhcCcccccccCCC
Q 006593 238 LV-PASERLS-----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 238 L~-dP~~RpS-----a~ELL~Hpff~~~~~~~ 263 (639)
|+ ||.+|++ +.|+++||||+..++..
T Consensus 240 L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~ 271 (337)
T d1o6la_ 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred ccCCchhhcccccccHHHHHcCcccccCCHHH
Confidence 99 9999994 99999999998766543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-51 Score=433.18 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=219.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.++.+|+.||+|+++..... .....+.+.+|+.+|++++|||||++++++.+. ..+|+|||
T Consensus 11 ~lG~G~fg---~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivmE 84 (316)
T d1fota_ 11 TLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA--QQIFMIMD 84 (316)
T ss_dssp EEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS--SEEEEEEC
T ss_pred EEecCcCc---EEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC--CeeeeEee
Confidence 37888888 8999999999999999999865432 224567899999999999999999999998765 56999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
||.||+|..++.....+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+..... ..+
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~-~~~ 160 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV-TYT 160 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC-BCC
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc-ccc
Confidence 9999999999999999999999999999999999999999 99999999999998 5589999999999876543 356
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++..+..+.. .++...+++++++|.+||.
T Consensus 161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTC
T ss_pred ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhh
Confidence 789999999999875 599999999999999999999999987 567788888877643 3455678999999999998
Q ss_pred -CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 240 -PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 240 -dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
+|.+|+ |++++|+||||+...|..
T Consensus 238 ~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~ 267 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred hCHHhccccchhhHHHHHcCcccccCCHHH
Confidence 899996 999999999999876653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-51 Score=437.77 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=215.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|||| +||+|.+..+|..||+|++.... ....+.+.+|+.+|++|+|||||+++++|.+. ..+|+||||
T Consensus 34 lG~G~fg---~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivmE~ 104 (350)
T d1koaa2 34 LGTGAFG---VVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD--NEMVMIYEF 104 (350)
T ss_dssp EEEETTE---EEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET--TEEEEEECC
T ss_pred EecCcCe---EEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEEc
Confidence 7888887 89999999999999999997553 35567899999999999999999999999876 469999999
Q ss_pred CCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC-CCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lk-k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~-~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
|+||+|.+++. ..+.+++..++.|++||+.||.|||++| ||||||||+|||++. ..|.+||+|||+|+.+... ..
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99999999985 4567999999999999999999999999 999999999999963 3478999999999876543 34
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~LI~ 235 (639)
.+.+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++..+..+.. +.......++++++||.
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 261 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 46789999999998875 589999999999999999999999986 567777777776543 33344556889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
+||. ||.+|||++|+|+||||+....
T Consensus 262 ~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 262 KLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHccCChhHCcCHHHHhcCcccCCCCC
Confidence 9999 8999999999999999986654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-51 Score=440.80 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=211.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccC--ChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQ--LPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~--~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
+||+|||| +||+|.+..+|+.||+|++....... ......+...|+.+++.++|||||+++++|.+. ..+|+|
T Consensus 11 ~lG~G~fg---~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--~~~~iv 85 (364)
T d1omwa3 11 IIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFI 85 (364)
T ss_dssp EEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS--SEEEEE
T ss_pred EEecCCCe---EEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--CEEEEE
Confidence 48999998 89999999999999999997654311 112223334557788888999999999998765 469999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
||||.||+|.+++.+++.+++..++.|++||+.||.|||++| ||||||||+|||++ ..|.+||+|||+|+.+.....
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~~~~ 162 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP 162 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECSSSCC
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecCCCcc
Confidence 999999999999999999999999999999999999999999 99999999999997 558999999999988776666
Q ss_pred ccccCCCCcCCccccc-c-cCCccccccchhhhhhhhhhccCCCCCCCC--HHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 159 RSVIGTPEFMAPELYE-E-EYNELVDIYSFGMCILEMVTFEYPYSECKN--PAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~-~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~--~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
...+||+.|||||++. + .|+.++|||||||++|||+||+.||.+... ...+...+.. .+..++...++++++||
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li 240 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLL 240 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--CCCCCCSSSCHHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CCCCCCCCCCHHHHHHH
Confidence 7789999999999885 3 489999999999999999999999976432 2233333222 33445667789999999
Q ss_pred HHhcC-CCCCCCC-----HHHHhcCcccccccCCC
Q 006593 235 EKCLV-PASERLS-----AKDLLKDPFLQVENQKE 263 (639)
Q Consensus 235 ~kcL~-dP~~RpS-----a~ELL~Hpff~~~~~~~ 263 (639)
.+||. ||.+||| |+|+|+||||+..+|..
T Consensus 241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~ 275 (364)
T d1omwa3 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275 (364)
T ss_dssp HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred HHHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence 99999 9999999 89999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-51 Score=437.14 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=214.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|||| +||+|.+..+|+.||+|+++... ....+.+.+|+.+|++|+|||||++|++|.++ ..+|+||||
T Consensus 37 lG~G~fg---~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~ivmE~ 107 (352)
T d1koba_ 37 LGSGAFG---VVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLILEF 107 (352)
T ss_dssp EEEETTE---EEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEEEc
Confidence 7888887 89999999999999999998653 34567789999999999999999999998765 569999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC-CCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~-~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
|.||+|.+++.+.+ ++++..++.|+.||+.||.|||++| |+||||||+|||++. ..|.+||+|||+|+.+... ..
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 99999999876654 6999999999999999999999999 999999999999973 4579999999999877543 34
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~~~s~~l~~LI~ 235 (639)
...+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+..+++..+..+.. +.......++++++||.
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 264 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 56789999999998875 599999999999999999999999987 456666777766543 33445567899999999
Q ss_pred HhcC-CCCCCCCHHHHhcCccccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
+||. +|.+|||+.|+|+||||+...
T Consensus 265 ~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 265 NLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999 899999999999999998654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=429.20 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=202.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh-hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP-GDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~-~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.+..+|+.||||+++........ ...+.+.+|+.+|++++|||||+++++|.+++ .+|+||
T Consensus 5 ~lG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--~~~ivm 79 (299)
T d1ua2a_ 5 FLGEGQFA---TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--NISLVF 79 (299)
T ss_dssp EEEEETTE---EEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT--CCEEEE
T ss_pred EeccCcCe---EEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC--ceeehh
Confidence 48888888 8999999999999999999866543222 22356899999999999999999999986654 589999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
|||.++++..++...+.+++..++.|++||+.||+|||++| |+||||||+|||++ ..|.+||+|||+|+..... .
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCccc
Confidence 99999988888777788999999999999999999999999 99999999999998 5589999999999776543 3
Q ss_pred CccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CCC--------------
Q 006593 158 ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP-------------- 219 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~p-------------- 219 (639)
....+||+.|||||++. ..|+.++|||||||++|||+||.+||.+.. ..+.+..+... ...
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-HHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 34568999999999875 348999999999999999999999998744 44443333221 000
Q ss_pred ----------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 220 ----------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 220 ----------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
.......++++++||.+||+ ||.+||||+|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 00112347899999999999 999999999999999998544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-51 Score=437.15 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=219.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.++.+|+.||||++...... .....+.+.+|+++|++++|||||+++++|.+. ..+++|||
T Consensus 48 ~lG~G~fg---~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~~~v~e 121 (350)
T d1rdqe_ 48 TLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN--SNLYMVME 121 (350)
T ss_dssp EEEECSSC---EEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEE
T ss_pred EeecCcCc---EEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeecccccccc--cccccccc
Confidence 37888888 8999999999999999999865432 234567889999999999999999999998765 46899999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCcc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTARS 160 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~~ 160 (639)
|+.+|+|.+++.+.+.+++..++.|+.||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|+.+... ..+
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~-~~~ 197 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-TWT 197 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-BCC
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeecccc-ccc
Confidence 9999999999999899999999999999999999999999 99999999999998 4589999999999876543 346
Q ss_pred ccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC
Q 006593 161 VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV 239 (639)
Q Consensus 161 ~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~ 239 (639)
.+||+.|||||++.+ .|+.++|||||||++|||+||..||.+ .++..++..+..+... ++...++++++||.+||.
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTCCHHHHHHHHHHSC
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCCC--CCccCCHHHHHHHHHHhh
Confidence 789999999998875 599999999999999999999999987 5677888888776543 355678999999999999
Q ss_pred -CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 240 -PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 240 -dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
||.+|+ |+++||+||||+..+|..
T Consensus 275 ~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~ 304 (350)
T d1rdqe_ 275 VDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred hCHHhccccccccHHHHHcCccccCCCHHH
Confidence 899984 999999999999877654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-50 Score=414.78 Aligned_cols=249 Identities=22% Similarity=0.383 Sum_probs=214.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCC-----hhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQL-----PGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~-----~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~ 74 (639)
+||+|+|| +||+|++..+|+.||+|+++....... ....+.+.+|+.+|++|+ |||||+++++|.++ +.
T Consensus 10 ~iG~G~~g---~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--~~ 84 (277)
T d1phka_ 10 ILGRGVSS---VVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN--TF 84 (277)
T ss_dssp EEEECSSE---EEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred EEecCcCe---EEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC--cc
Confidence 37888887 899999999999999999987654322 223457889999999996 99999999998755 57
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhcc
Q 006593 75 VNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~ 154 (639)
+|||||||+||+|.++++.++.+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECC
T ss_pred eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchheeEcc
Confidence 9999999999999999999999999999999999999999999999 99999999999997 56899999999998765
Q ss_pred CC-CCccccCCCCcCCcccccc-------cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCC--CCcccC
Q 006593 155 QP-TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIK--PASLAK 224 (639)
Q Consensus 155 ~~-~~~~~~GTp~ymAPE~l~~-------~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~--p~~l~~ 224 (639)
.. ......||+.|+|||.+.. .|+.++||||+||++|+|+||..||.+ .+.......+..+.. +.....
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGG
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCCcccc
Confidence 33 3455789999999998752 378899999999999999999999987 566777777776643 233344
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 225 VNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 225 ~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
..++++++||.+||+ +|.+|||++|+|+||||+.
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 578999999999999 8999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-51 Score=427.37 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=215.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLK-SLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk-~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
+||+|+|| +||+|.++.+|+.||+|+++...... ....+.+..|..++. .++|||||++|++|.+. ..+|+||
T Consensus 9 ~iG~G~fg---~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~yivm 82 (320)
T d1xjda_ 9 MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLFFVM 82 (320)
T ss_dssp EEEECSSS---EEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEEEEE
T ss_pred EEecCCCc---EEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--CceeEEE
Confidence 47888888 89999999999999999998654322 234566777777765 68999999999998765 4699999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC--CC
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ--PT 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~--~~ 157 (639)
|||++|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|+.... ..
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCC
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhccccccc
Confidence 99999999999999999999999999999999999999999 99999999999998 558999999999976543 23
Q ss_pred CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+ .++.+++..+..+.. .++...++++++||.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVK 236 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHH
Confidence 445689999999998875 699999999999999999999999987 567888888877643 4556778999999999
Q ss_pred hcC-CCCCCCCHH-HHhcCcccccccCC
Q 006593 237 CLV-PASERLSAK-DLLKDPFLQVENQK 262 (639)
Q Consensus 237 cL~-dP~~RpSa~-ELL~Hpff~~~~~~ 262 (639)
||. +|.+||++. +|++||||+..++.
T Consensus 237 ~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 237 LFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred hcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 999 899999995 89999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=423.25 Aligned_cols=245 Identities=20% Similarity=0.322 Sum_probs=212.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.++.+|+.||+|+++... .....+.+|+++|++++|||||+++++|.+. ..+|+||||
T Consensus 13 lG~G~fg---~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~lvmE~ 82 (321)
T d1tkia_ 13 LGRGEFG---IVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESM--EELVMIFEF 82 (321)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET--TEEEEEECC
T ss_pred EecCCCe---EEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--CEEEEEEec
Confidence 6777777 89999999999999999997653 3445688999999999999999999999876 459999999
Q ss_pred CCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC-CCCcEEEeecchhhhccCC-CC
Q 006593 82 FTSGNLRQYRKKHK-NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG-NHGEVKIGDLGLAIAMQQP-TA 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~~-~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~-~~g~VKL~DFGlA~~l~~~-~~ 158 (639)
|.||+|.++++..+ .+++..++.|+.||+.||.|||++| |+||||||+|||++. +.+.+||+|||++...... ..
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 99999999998765 6999999999999999999999999 999999999999964 2358999999999766543 34
Q ss_pred ccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCC--CcccCCCChHHHHHHH
Q 006593 159 RSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKP--ASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p--~~l~~~~s~~l~~LI~ 235 (639)
...+||+.|+|||.+.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+... .......++++++||.
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 239 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence 45689999999998764 589999999999999999999999987 5677788888776543 2333456889999999
Q ss_pred HhcC-CCCCCCCHHHHhcCcccccc
Q 006593 236 KCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+||. ||.+|||+.|+|+||||+..
T Consensus 240 ~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 240 RLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHccCChhHCcCHHHHhcCHhhccC
Confidence 9999 89999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=413.72 Aligned_cols=242 Identities=20% Similarity=0.337 Sum_probs=206.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCCh--hhHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLP--GDLQKLYSEVHLLKSLK--DDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~--~~~~~l~~Ei~iLk~L~--HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|+|| +||+|.+..+|+.||||+++........ ....++.+|+.+|++++ |||||+++++|.+. ..++
T Consensus 11 ~lG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~--~~~~ 85 (273)
T d1xwsa_ 11 LLGSGGFG---SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP--DSFV 85 (273)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS--SEEE
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC--CeEE
Confidence 47888888 8999999999999999999865432211 12234678999999996 89999999998765 4689
Q ss_pred EEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTS-GNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~g-GsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+||||+.+ +++.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++.+.+.+||+|||+|+....
T Consensus 86 lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceeccc
Confidence 99999976 789999998899999999999999999999999999 999999999999987778999999999987766
Q ss_pred CCCccccCCCCcCCcccccc-c-CCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHH
Q 006593 156 PTARSVIGTPEFMAPELYEE-E-YNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGF 233 (639)
Q Consensus 156 ~~~~~~~GTp~ymAPE~l~~-~-ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~L 233 (639)
....+.+||+.|||||++.+ . ++.++|||||||++|+|+||+.||.. ... +..+. ..++...++++++|
T Consensus 164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~----i~~~~--~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEE----IIRGQ--VFFRQRVSSECQHL 234 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS---HHH----HHHCC--CCCSSCCCHHHHHH
T ss_pred ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC---chH----Hhhcc--cCCCCCCCHHHHHH
Confidence 66677899999999998864 3 46789999999999999999999975 222 33332 23455678999999
Q ss_pred HHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 234 IEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 234 I~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
|.+||. ||.+|||++|+|+||||+.
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999 9999999999999999974
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=423.50 Aligned_cols=245 Identities=19% Similarity=0.299 Sum_probs=200.2
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEe--CCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVD--DKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~--~~~~~l~l 77 (639)
+||+|+|| +||+|.+..+|+.||+|+++.. ..+.+|+.++.++ +|||||++|++|.+ ....++|+
T Consensus 19 ~lG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 19 VLGLGING---KVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp EEEECSSC---EEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred EeeeccCe---EEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 36777777 8999999999999999998643 3467899987654 89999999999865 34467999
Q ss_pred EEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhc
Q 006593 78 ITELFTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAM 153 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l 153 (639)
|||||+||+|.+++++. ..+++..++.|++||+.||.|||++| |+||||||+|||++. +.+.+||+|||+|+..
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccceeeec
Confidence 99999999999999875 46999999999999999999999999 999999999999974 3467999999999866
Q ss_pred cC-CCCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHH---HHHHHHHcCCC--CCcccCCC
Q 006593 154 QQ-PTARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPA---QIFKKVTSGIK--PASLAKVN 226 (639)
Q Consensus 154 ~~-~~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~---~i~~~i~~g~~--p~~l~~~~ 226 (639)
.. ......+|||.|||||++.+ .|+.++|||||||++|+|+||.+||.+..... .+...+..+.. |.......
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp CCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred cCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 53 34456789999999999875 59999999999999999999999997633222 12222222211 12222346
Q ss_pred ChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 227 DPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 227 s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 7899999999999 89999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=407.29 Aligned_cols=244 Identities=20% Similarity=0.318 Sum_probs=205.0
Q ss_pred cccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|+|| +||+|.+. .+++.||||+++.... .+...+.+.+|+.+|++|+|||||++++++..+ .+++||
T Consensus 15 iG~G~fG---~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---~~~lvm 86 (277)
T d1xbba_ 15 LGSGNFG---TVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVM 86 (277)
T ss_dssp EEECSSE---EEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEE
T ss_pred cccCCCe---EEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---CEEEEE
Confidence 7888888 89999853 4678999999875432 345667899999999999999999999987543 368999
Q ss_pred ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 80 ELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|||++|+|.+++++.+.+++..+..|+.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||+|+.+....
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSE
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhccccccc
Confidence 99999999999999999999999999999999999999999 99999999999998 45799999999997654321
Q ss_pred ---CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHH
Q 006593 158 ---ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKG 232 (639)
Q Consensus 158 ---~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~ 232 (639)
.....||+.|||||++. ..|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+...++++++
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~ 241 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYD 241 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHH
Confidence 23457899999999886 569999999999999999998 8999987 4567788888877554 345667899999
Q ss_pred HHHHhcC-CCCCCCCHHHH---hcCccccc
Q 006593 233 FIEKCLV-PASERLSAKDL---LKDPFLQV 258 (639)
Q Consensus 233 LI~kcL~-dP~~RpSa~EL---L~Hpff~~ 258 (639)
||.+||. +|.+|||+.+| |+|+|++.
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 9999999 89999999998 56777653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=405.40 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=198.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|+.||+|+++.... .....+.+.+|+++|++++|||||++|++|.+.+ .+|+|||
T Consensus 9 ~lG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~--~~~iv~e 81 (298)
T d1gz8a_ 9 KIGEGTYG---VVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--KLYLVFE 81 (298)
T ss_dssp EEEECSSS---EEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--EEEEEEE
T ss_pred EEecCcCe---EEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--ceeEEEe
Confidence 37888888 899999999999999999976542 2334567899999999999999999999998764 5999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--C
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--T 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~ 157 (639)
|+.++.+...... .+.+++..++.++.||+.||.|||++| ||||||||+|||++ .++.+||+|||+|+..... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccCCccc
Confidence 9976544433333 457999999999999999999999999 99999999999998 4579999999999877543 3
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CCCCC--------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GIKPA-------------- 220 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~~p~-------------- 220 (639)
.....||+.|+|||++.. .++.++|||||||++|+|++|+.||.+......+.+.+.. +....
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 445689999999997653 3688999999999999999999999875444444433321 11000
Q ss_pred -----------cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 221 -----------SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 221 -----------~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
......++++++||.+||+ ||.+|||+.|||+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0012346789999999999 89999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=403.50 Aligned_cols=239 Identities=28% Similarity=0.416 Sum_probs=200.8
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|... ..||||+++.... .....+.+.+|+.+|++++|||||++++++.. ..+++|||
T Consensus 15 ~lG~G~fg---~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv~E 83 (276)
T d1uwha_ 15 RIGSGSFG---TVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQ 83 (276)
T ss_dssp EEEECSSC---EEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEE
T ss_pred EEeeCCCc---EEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEEEEe
Confidence 37888888 89999764 3599999876643 34667889999999999999999999997532 34789999
Q ss_pred cCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 81 LFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 81 y~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
||++|+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceeeccccCCc
Confidence 99999999999765 56999999999999999999999999 99999999999998 4579999999999765432
Q ss_pred -CCccccCCCCcCCccccc----ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCC---cccCCCCh
Q 006593 157 -TARSVIGTPEFMAPELYE----EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPA---SLAKVNDP 228 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~----~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~---~l~~~~s~ 228 (639)
......||+.|||||++. ..|+.++|||||||++|||+||+.||.+......+...+..+..++ ..+...++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 234568999999999875 2489999999999999999999999998777777777777765543 34455678
Q ss_pred HHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 229 QIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 229 ~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
++++||.+||. +|.+|||+.||+++
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999 89999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-48 Score=399.80 Aligned_cols=245 Identities=27% Similarity=0.394 Sum_probs=200.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.++ +|+.||||+++.... .....+++.+|+.+|++++|||||+++++|.+.+ .++++|||
T Consensus 10 iG~G~fg---~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--~~~i~~e~ 81 (286)
T d1ob3a_ 10 IGEGTYG---VVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKK--RLVLVFEH 81 (286)
T ss_dssp EEEETTE---EEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--CEEEEEEC
T ss_pred EecCCCc---EEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--ceeEEEEe
Confidence 6777766 89999995 789999999987653 2344578999999999999999999999998765 48899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--Cc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--AR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--~~ 159 (639)
+.++.+..+.+..+.+++..++.+++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|....... ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceecccCccccc
Confidence 999888888887889999999999999999999999999 99999999999998 45899999999998765432 34
Q ss_pred cccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CCC-----------------
Q 006593 160 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GIK----------------- 218 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~~----------------- 218 (639)
...|++.|+|||.+.+ .++.++|||||||++|||++|++||.+.. ..+.+..+.. +..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-HHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 4579999999998753 47999999999999999999999998744 4333333221 000
Q ss_pred --------CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 219 --------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 219 --------p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
........++.+++||.+||+ ||.+|||++|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 011233457899999999999 9999999999999999973
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-48 Score=401.80 Aligned_cols=237 Identities=23% Similarity=0.354 Sum_probs=205.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||||+++... ...+.+.+|+++|++|+|||||++|++|.+. ..+++||||
T Consensus 25 iG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~iv~E~ 94 (287)
T d1opja_ 25 LGGGQYG---EVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYIITEF 94 (287)
T ss_dssp TTTTTTS---SEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEEEEC
T ss_pred EeeCCCe---EEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeC--CeeEEEeec
Confidence 7889998 79999999999999999987543 3456789999999999999999999998655 458899999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC-
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA- 158 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~- 158 (639)
|++|+|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccccceeecCCCCce
Confidence 9999999999764 56899999999999999999999999 99999999999998 457999999999987654332
Q ss_pred --ccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 159 --RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 159 --~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
....||+.|||||++. ..|+.++|||||||++|||++|..||....+..++++.+..+..+ ..+...++++++||.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPEKVYELMR 250 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHH
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCCccchHHHHHHHH
Confidence 2345789999999876 569999999999999999999887776667788888888776544 345667899999999
Q ss_pred HhcC-CCCCCCCHHHHhc
Q 006593 236 KCLV-PASERLSAKDLLK 252 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~ 252 (639)
+||. +|.+|||+.||++
T Consensus 251 ~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 251 ACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 9999 8999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=400.43 Aligned_cols=243 Identities=18% Similarity=0.347 Sum_probs=206.4
Q ss_pred cccccccCcEEEEEEEec--CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDE--FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~--~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~ 79 (639)
||+|||| +||+|.+. .++..||||+++... .....+++.+|+++|++|+|||||++|+++..+ .+|+||
T Consensus 17 iG~G~fg---~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~~lvm 87 (285)
T d1u59a_ 17 LGCGNFG---SVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---ALMLVM 87 (285)
T ss_dssp EECCTTE---EEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEE
T ss_pred EecccCe---EEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eEEEEE
Confidence 7888888 89999775 356689999987543 456678899999999999999999999987543 388999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 80 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
|||++|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhccccccc
Confidence 999999999998654 57999999999999999999999999 99999999999998 4579999999999866432
Q ss_pred ---CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 ---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 ---~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
......||+.|||||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+..+..+. .+...++++.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-~~~~~~~~i~~~~~~~-~p~~~~~~l~ 242 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQGKRME-CPPECPPELY 242 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CTHHHHHHHHTTCCCC-CCTTCCHHHH
T ss_pred ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCcCCHHHH
Confidence 223457899999999886 569999999999999999998 89999875 4567777888776543 4566789999
Q ss_pred HHHHHhcC-CCCCCCCHHHH---hcCccccc
Q 006593 232 GFIEKCLV-PASERLSAKDL---LKDPFLQV 258 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~EL---L~Hpff~~ 258 (639)
+||.+||. +|.+|||+.++ |+|+|+..
T Consensus 243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999 89999999888 67888754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.8e-48 Score=397.87 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=202.3
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC--ceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--KTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~--~~l~lV 78 (639)
.||+|+|| +||+|.+..+|+.||+|+++.... ......+++.+|+++|++++|||||++++++...+. ..+|+|
T Consensus 14 ~lG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv 89 (277)
T d1o6ya_ 14 ILGFGGMS---EVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 89 (277)
T ss_dssp EEEECSSE---EEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEeeCCCe---EEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEE
Confidence 37888888 899999999999999999986543 345667789999999999999999999999876543 468999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
||||.||+|.+++...+.+++..++.|++||+.||.|||++| |+||||||+|||++ ..+.++|+|||++......
T Consensus 90 mE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEECC----
T ss_pred EECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhhhccccc
Confidence 999999999999999999999999999999999999999999 99999999999998 4579999999988654322
Q ss_pred ---CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHH-HHcCCCC-CcccCCCChHH
Q 006593 157 ---TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKK-VTSGIKP-ASLAKVNDPQI 230 (639)
Q Consensus 157 ---~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~-i~~g~~p-~~l~~~~s~~l 230 (639)
.....+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+. ++.++... +.....+ .......++++
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l 245 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSARHEGLSADL 245 (277)
T ss_dssp ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHCCCCCGGGTSSSCCHHH
T ss_pred cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-CHHHHHHHHHhcCCCCCchhccCCCHHH
Confidence 2345689999999998875 5999999999999999999999999874 45554444 4444333 23445678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
++||.+||. ||.+||+..+.|.|+|++.
T Consensus 246 ~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 246 DAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 999999999 8999995444445677653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=399.09 Aligned_cols=250 Identities=28% Similarity=0.394 Sum_probs=198.2
Q ss_pred cccccccCcEEEEEEEecCC-CeEEEEEEEecccccCChhhHHHHHHHHHHHHhC---CCCCcceEEEEEEeC---CCce
Q 006593 2 VLTGLYMTPFSSYKAFDEFA-GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL---KDDNVVKFYKSWVDD---KKKT 74 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~t-G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~~~~~---~~~~ 74 (639)
||+|+|| +||+|.+..+ ++.||+|+++..... ......+.+|+.+|+.| +||||++++++|... ....
T Consensus 15 LG~G~fg---~V~~a~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 15 IGEGAYG---KVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEETTE---EEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EecccCe---EEEEEEEECCCCEEEEEEEEehhhcc--chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 6777776 8999999766 678999999865432 12223456777777666 899999999998643 3357
Q ss_pred EEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 75 VNMITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
++++|||+.+|.+...... .+.+++..++.+++||+.||+|||+++ |+||||||+|||++ ..|.+||+|||++...
T Consensus 90 ~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCCC
T ss_pred EEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecchhhhhhh
Confidence 8999999998877655543 456999999999999999999999999 99999999999998 5579999999998755
Q ss_pred cC-CCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc--CC------------
Q 006593 154 QQ-PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS--GI------------ 217 (639)
Q Consensus 154 ~~-~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~--g~------------ 217 (639)
.. ......+||+.|||||++. ..|+.++|||||||++|||+||.+||.+. +..+.+..+.. +.
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS-SDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC-CHHHHHHHHHHhhCCCchhcccccccc
Confidence 43 2345678999999999875 56999999999999999999999999874 44444443321 00
Q ss_pred -----------CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 218 -----------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 218 -----------~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
....+....++.+++||.+||+ ||.+||||.|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0112234457889999999999 999999999999999998543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=406.97 Aligned_cols=241 Identities=22% Similarity=0.325 Sum_probs=200.2
Q ss_pred CcccccccCcEEEEEEEecCCC-----eEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG-----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG-----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
+||+|||| +||+|.+..++ ..||+|.+.... .......+.+|+.+|+++ +|||||++|++|.+.+ .
T Consensus 44 ~lG~G~fG---~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~ 115 (325)
T d1rjba_ 44 VLGSGAFG---KVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG--P 115 (325)
T ss_dssp EEEECSSE---EEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--S
T ss_pred EEeeCCCe---EEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC--e
Confidence 37888888 89999986554 479999887543 234556789999999998 8999999999987654 5
Q ss_pred EEEEEecCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCC
Q 006593 75 VNMITELFTSGNLRQYRKKHK-----------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCD 131 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~-----------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~ 131 (639)
+|+|||||++|+|.++++..+ .+++..++.|+.||+.||.|||+++ ||||||||+
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~ 193 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAAR 193 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchh
Confidence 899999999999999997642 4889999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCC
Q 006593 132 NIFVNGNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKN 205 (639)
Q Consensus 132 NILl~~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~ 205 (639)
|||++ .+|.+||+|||+|+...... ..+..||+.|||||++. +.|+.++|||||||++|||+| |..||.+...
T Consensus 194 Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99998 45899999999997665432 23456899999999775 569999999999999999998 8999988666
Q ss_pred HHHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 206 PAQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 206 ~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
...+.+.+..+.. ...+...++++++||.+||+ +|.+|||++||++|
T Consensus 273 ~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCC-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6666666666544 34566778999999999999 89999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=393.06 Aligned_cols=237 Identities=16% Similarity=0.330 Sum_probs=192.8
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+. ++..||||+++... ...+.+.+|+++|++++|||||++++++...+ .+++||||
T Consensus 13 iG~G~fg---~Vy~~~~~-~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~--~~~lv~E~ 81 (263)
T d1sm2a_ 13 IGSGQFG---LVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA--PICLVFEF 81 (263)
T ss_dssp EECCSSC---CEEEEEET-TTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEEC
T ss_pred EeeCCCe---EEEEEEEC-CCCEEEEEEECCCc-----CcHHHHHHHHHHHHhcCCCCcccccceeccCC--ceEEEEEe
Confidence 7888888 79999985 57889999987543 23356899999999999999999999986654 48899999
Q ss_pred CCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC---
Q 006593 82 FTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT--- 157 (639)
Q Consensus 82 ~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~--- 157 (639)
|.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccCCCcee
Confidence 9999999998765 56899999999999999999999999 99999999999998 45799999999998764332
Q ss_pred CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHH
Q 006593 158 ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEK 236 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~k 236 (639)
.....||+.|||||++. ..|+.++|||||||++|||+|+..|+....+..++...+..+..+ ..+...++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHH
Confidence 23457899999999887 469999999999999999999654544446777888888877554 3456678999999999
Q ss_pred hcC-CCCCCCCHHHHhcC
Q 006593 237 CLV-PASERLSAKDLLKD 253 (639)
Q Consensus 237 cL~-dP~~RpSa~ELL~H 253 (639)
||+ +|.+|||++|+|+|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999 89999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=406.01 Aligned_cols=247 Identities=20% Similarity=0.310 Sum_probs=199.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----CCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----KKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~----~~~~l~ 76 (639)
+||+|||| +||+|.+..+|+.||||+++..... +.+|+++|++|+|||||+++++|... +..++|
T Consensus 27 ~LG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 27 VIGNGSFG---VVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEETTE---EEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred EEeeCcCe---EEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 48999888 8999999999999999999865421 24799999999999999999998653 345789
Q ss_pred EEEecCCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhc
Q 006593 77 MITELFTSGNLRQY---RKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAM 153 (639)
Q Consensus 77 lV~Ey~~gGsL~d~---lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l 153 (639)
+|||||++|.+..+ ......+++..++.|++||+.||+|||++| |+||||||+|||++.+...+||+|||++...
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999987644433 344567999999999999999999999999 9999999999999866568999999999766
Q ss_pred cC-CCCccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-C-------------
Q 006593 154 QQ-PTARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G------------- 216 (639)
Q Consensus 154 ~~-~~~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g------------- 216 (639)
.. ....+.+||+.|+|||.+. ..|+.++|||||||++|||++|++||.......++...+.. |
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 43 3445678999999999764 35899999999999999999999999875443333322210 0
Q ss_pred ----CCC--------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 217 ----IKP--------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 217 ----~~p--------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
..+ .......++++++||.+||. ||.+||||.|+|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 01123457899999999999 999999999999999997543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-47 Score=399.31 Aligned_cols=240 Identities=20% Similarity=0.324 Sum_probs=193.5
Q ss_pred CcccccccCcEEEEEEEecCCCe---EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI---EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~---~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| +||+|.+..+|. .||||.+.... .....+.+.+|+++|++|+|||||++++++... ..+++
T Consensus 33 ~lG~G~fg---~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~i 104 (299)
T d1jpaa_ 33 VIGAGEFG---EVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--TPVMI 104 (299)
T ss_dssp EEEECSSS---EEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--SSCEE
T ss_pred EEeeCCCe---EEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--CEEEE
Confidence 48999999 899999977664 58888776432 456677899999999999999999999988655 45899
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|||||++|+|.+++.+. +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCcccceEccCC
Confidence 99999999999998874 56999999999999999999999999 99999999999998 5589999999999866432
Q ss_pred C-------CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCC
Q 006593 157 T-------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVND 227 (639)
Q Consensus 157 ~-------~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s 227 (639)
. .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+. .+...+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~ 259 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-PPMDCP 259 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccch
Confidence 1 11245799999999886 469999999999999999998 8999987 45677778887775543 345568
Q ss_pred hHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 228 PQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+++++||.+||. +|.+|||+.||+++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 899999999998 89999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=396.21 Aligned_cols=240 Identities=21% Similarity=0.360 Sum_probs=203.9
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|||| +||+|.+. ++..||||+++... ...+.+.+|+.+|++++|||||++++++.+ ..+++||||
T Consensus 21 iG~G~fg---~Vy~~~~~-~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv~Ey 88 (272)
T d1qpca_ 21 LGAGQFG---EVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEY 88 (272)
T ss_dssp EEEETTE---EEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEEC
T ss_pred EecCCCc---EEEEEEEC-CCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEEEEe
Confidence 7888888 89999985 67899999987543 234678999999999999999999997643 237899999
Q ss_pred CCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 82 FTSGNLRQYRKKH--KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk~--~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
|.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+|+.+...
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceEEccCCccc
Confidence 9999999987543 35999999999999999999999999 99999999999998 5579999999999876533
Q ss_pred CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
......||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+..+..+. .+...++++++||.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEELYQLMR 244 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHH
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHHHHHHH
Confidence 233467899999999886 5699999999999999999997666655577888888888775543 45567889999999
Q ss_pred HhcC-CCCCCCCHHHHhc--Ccccc
Q 006593 236 KCLV-PASERLSAKDLLK--DPFLQ 257 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~--Hpff~ 257 (639)
+||. +|.+|||++||++ |+||.
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 9999 8999999999998 78885
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-47 Score=399.31 Aligned_cols=245 Identities=21% Similarity=0.345 Sum_probs=202.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEe
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
||+|+|| +||+|.+..+|+.||+|+++... .+++.+|+.+|+.+. ||||++++++|.......+++|||
T Consensus 43 LG~G~fg---~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 43 LGRGKYS---EVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred EecCcCe---EEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 6777776 89999999999999999987432 356889999999995 999999999998777778999999
Q ss_pred cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC-CCc
Q 006593 81 LFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-TAR 159 (639)
Q Consensus 81 y~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-~~~ 159 (639)
||.+|+|..+ .+.+++..++.+++||+.||.|||++| |+||||||+|||++.+++.+||+|||+|+..... ...
T Consensus 113 ~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 113 HVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp CCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred ecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 9999999875 356999999999999999999999999 9999999999999866667999999999876533 445
Q ss_pred cccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-------------C-C------
Q 006593 160 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-------------G-I------ 217 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-------------g-~------ 217 (639)
..+||+.|+|||.+.+ .|+.++|||||||++|+|++|..||....+.......+.. . .
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 6789999999998753 4899999999999999999999999765554332222110 0 0
Q ss_pred ---------------CCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccccC
Q 006593 218 ---------------KPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVENQ 261 (639)
Q Consensus 218 ---------------~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~~ 261 (639)
.+.......++++++||.+||+ ||.+|||++|+|+||||+...+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0111223357899999999999 9999999999999999986543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=387.73 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=209.4
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+|+.||||+++.... ......++.+|+.+|+.++|||||+++++|.+. ..+++|+++
T Consensus 10 LG~G~fg---~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~iv~~~ 82 (292)
T d1unla_ 10 IGEGTYG---TVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLTLVFEF 82 (292)
T ss_dssp EEECSSS---EEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--SEEEEEEEC
T ss_pred EecCcCe---EEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccc--cceeEEeee
Confidence 7888887 899999999999999999987653 345678899999999999999999999998766 458899999
Q ss_pred CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--CCc
Q 006593 82 FTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--TAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--~~~ 159 (639)
+.+++|..++..++.+++..++.+++|++.||+|||++| |+||||||+|||++. .+.+||+|||.|...... ...
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECT-TCCEEECCCTTCEECCSCCSCCC
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCccccccc-CCceeeeecchhhcccCCCccce
Confidence 999999999999999999999999999999999999999 999999999999984 579999999999876543 233
Q ss_pred cccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC---------------------
Q 006593 160 SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--------------------- 216 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--------------------- 216 (639)
...+++.|+|||++.. .++.++|||||||++|||++|..||....+..+.+..+...
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 4567889999998764 37899999999999999999999987666766666554321
Q ss_pred ------CCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 217 ------IKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 217 ------~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
..........++.+++||.+||+ ||.+||||+|+|+||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 01112223446889999999999 9999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=400.57 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=199.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----CceEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK----KKTVNM 77 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~----~~~l~l 77 (639)
||+|+|| +||+|.+..+|+.||||+++... ......+++.+|+++|++|+|||||+++++|...+ ...+|+
T Consensus 26 lG~G~fg---~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 26 VGSGAYG---AVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp C---------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence 6777777 79999999999999999997543 34566788999999999999999999999987653 235799
Q ss_pred EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 78 ITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||| +++|..+++. +.+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+.....
T Consensus 101 v~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~~- 174 (346)
T d1cm8a_ 101 VMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSE- 174 (346)
T ss_dssp EEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSS-
T ss_pred EEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccceeccCCc-
Confidence 99999 6788887764 67999999999999999999999999 99999999999998 5579999999999766543
Q ss_pred CccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-CC-----------------
Q 006593 158 ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-GI----------------- 217 (639)
Q Consensus 158 ~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g~----------------- 217 (639)
.....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+...... +.
T Consensus 175 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (346)
T d1cm8a_ 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254 (346)
T ss_dssp CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhh
Confidence 356789999999998753 4789999999999999999999999875433322221110 00
Q ss_pred -------C---CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccccc
Q 006593 218 -------K---PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVEN 260 (639)
Q Consensus 218 -------~---p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~~ 260 (639)
. ........++++++||.+||. ||.+|||+.|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 112234457899999999999 999999999999999998643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=385.57 Aligned_cols=237 Identities=20% Similarity=0.358 Sum_probs=204.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+ .++..||||+++.... ..+.+.+|+.++++++|||||++|+++.+. ..+++|||
T Consensus 11 ~iG~G~fg---~Vy~~~~-~~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--~~~~iv~E 79 (258)
T d1k2pa_ 11 ELGTGQFG---VVKYGKW-RGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--RPIFIITE 79 (258)
T ss_dssp CCCEETTE---EEEEEEE-TTTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--SSEEEEEE
T ss_pred EEecCCCe---EEEEEEE-CCCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--CceEEEEE
Confidence 37888888 8999998 4788999999986542 335689999999999999999999988655 45999999
Q ss_pred cCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC--
Q 006593 81 LFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT-- 157 (639)
Q Consensus 81 y~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~-- 157 (639)
|+.+|+|.+++.. ...+++..+++|+.||+.||.|||++| |+||||||+|||++ +++.+||+|||+++.+....
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccCCCce
Confidence 9999999999765 467999999999999999999999999 99999999999998 55799999999997654332
Q ss_pred -CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHH
Q 006593 158 -ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFI 234 (639)
Q Consensus 158 -~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI 234 (639)
.....||+.|||||++. ..|+.++|||||||++|||+| |+.||.+. +..++...+..+..+ ..+...++++++||
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRL-YRPHLASEKVYTIM 234 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhCCCC-CCcccccHHHHHHH
Confidence 22457899999999886 569999999999999999998 79999874 567788888887544 45677789999999
Q ss_pred HHhcC-CCCCCCCHHHHhcC
Q 006593 235 EKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 235 ~kcL~-dP~~RpSa~ELL~H 253 (639)
.+||+ +|.+|||+.+||+|
T Consensus 235 ~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999 89999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=388.29 Aligned_cols=240 Identities=20% Similarity=0.327 Sum_probs=198.1
Q ss_pred CcccccccCcEEEEEEEecCCC----eEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAG----IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG----~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|||| +||+|.+..++ ..||||+++... .......+.+|+.+|++|+|||||++|+++... ..++
T Consensus 14 ~iG~G~fG---~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~~~~ 85 (283)
T d1mqba_ 14 VIGAGEFG---EVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--KPMM 85 (283)
T ss_dssp EEEECSSS---EEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSEE
T ss_pred EEeeCCCe---EEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--CceE
Confidence 58999999 79999987654 579999987543 445667799999999999999999999988655 4589
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
+|||||.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEcccchhhcccC
Confidence 999999999999988765 67999999999999999999999999 99999999999998 558999999999987643
Q ss_pred CC-----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PT-----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~-----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. .....||+.|||||++. +.|+.++|||||||++|||++|..||....+..+++..+..+..+. .+...++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~ 241 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSA 241 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTCBHH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-CchhhHHH
Confidence 21 22346899999999886 4699999999999999999997767666577888888888876554 34556789
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+++||.+||. +|.+|||+.||++
T Consensus 242 l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 242 IYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999 8999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=394.17 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=197.6
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------CceE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK------KKTV 75 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~------~~~l 75 (639)
||+|+|| +||+|.+..+|+.||||++..... ......++.+|+.+|++++||||+++++++.... ...+
T Consensus 18 LG~G~fg---~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 18 IGQGTFG---EVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEECSSS---EEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred EecCcCe---EEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence 6777777 899999999999999999877653 2345567889999999999999999999986532 3458
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 76 NMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 76 ~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
|+|||||.++.+..+......+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 93 ~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~~~~~~~ 169 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSL 169 (318)
T ss_dssp EEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCC
T ss_pred EEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEeeecceeeeccc
Confidence 999999998888777666778999999999999999999999999 99999999999998 457999999999965542
Q ss_pred C------CCccccCCCCcCCccccc--ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc---CCCCCccc-
Q 006593 156 P------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS---GIKPASLA- 223 (639)
Q Consensus 156 ~------~~~~~~GTp~ymAPE~l~--~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~---g~~p~~l~- 223 (639)
. .....+||+.|+|||++. ..|+.++|||||||++|||++|.+||.+. +.......+.. ...+....
T Consensus 170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-TEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp -----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-CHHHHHHHHHHhcCCCChhhccc
Confidence 1 234467999999999875 35899999999999999999999999863 44443333321 11111111
Q ss_pred --------------------------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCccccc
Q 006593 224 --------------------------KVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQV 258 (639)
Q Consensus 224 --------------------------~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~ 258 (639)
...++++++||.+||+ ||.+||||+|+|+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 1136788999999999 9999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=399.80 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=208.7
Q ss_pred CcccccccCcEEEEEEEe---cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFD---EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d---~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~~~~~~~~~l~ 76 (639)
.||+|+|| +||+|.+ ..+|+.||+|+++...........+++.+|+++|++++| |||+++++++.+.. .++
T Consensus 31 ~IG~G~fg---~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~--~~~ 105 (322)
T d1vzoa_ 31 VLGTGAYG---KVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET--KLH 105 (322)
T ss_dssp EEEETTTE---EEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT--EEE
T ss_pred EEecCCCe---EEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC--cee
Confidence 37888888 7888886 557999999999765543333445668899999999966 89999999987764 599
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
++|||+.+|+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++. .|.+||+|||+|+.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~-~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDS-NGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT-TSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecC-CCCEEEeeccchhhhccc
Confidence 99999999999999999999999999999999999999999999 999999999999984 589999999999765322
Q ss_pred ---CCccccCCCCcCCcccccc---cCCccccccchhhhhhhhhhccCCCCCC---CCHHHHHHHHHcCCCCCcccCCCC
Q 006593 157 ---TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTFEYPYSEC---KNPAQIFKKVTSGIKPASLAKVND 227 (639)
Q Consensus 157 ---~~~~~~GTp~ymAPE~l~~---~ys~ksDIwSlGiil~ELltG~~Pf~~~---~~~~~i~~~i~~g~~p~~l~~~~s 227 (639)
...+..||+.|+|||.+.. .++.++|||||||++|+|+||+.||.+. .....+.+....... .++...+
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~~s 260 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMS 260 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSC
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--CCcccCC
Confidence 2345689999999998853 4788999999999999999999999653 223444444444432 3455678
Q ss_pred hHHHHHHHHhcC-CCCCCC-----CHHHHhcCcccccccCCC
Q 006593 228 PQIKGFIEKCLV-PASERL-----SAKDLLKDPFLQVENQKE 263 (639)
Q Consensus 228 ~~l~~LI~kcL~-dP~~Rp-----Sa~ELL~Hpff~~~~~~~ 263 (639)
+++++||.+||. +|.+|| +++|+|+||||+..++..
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~ 302 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence 999999999999 899999 589999999998766543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=394.23 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=196.3
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC---ceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK---KTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~---~~l~lV 78 (639)
||+|+|| +||+|.+..+|+.||||+++... .....+++.+|+.+|++|+||||+++++++..... ..+++
T Consensus 16 LG~G~fg---~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l- 88 (345)
T d1pmea_ 16 IGEGAYG---MVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL- 88 (345)
T ss_dssp CC---CC---CEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE-
T ss_pred EeeccCe---EEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE-
Confidence 6777777 79999999999999999997543 35667789999999999999999999999865432 23445
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC--
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP-- 156 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~-- 156 (639)
++|+.+|+|.++++.+ .+++..++.++.||+.||.|||++| ||||||||+|||++ +.|.+||+|||+|......
T Consensus 89 ~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCceeeccCCCc
Confidence 4566689999999764 6999999999999999999999999 99999999999998 5589999999999754322
Q ss_pred ---CCccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-C--------------
Q 006593 157 ---TARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS-G-------------- 216 (639)
Q Consensus 157 ---~~~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~-g-------------- 216 (639)
.....+||+.|+|||++.. .|+.++||||+||++|+|++|..||............+.. .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 2345689999999998743 4789999999999999999999999864433222221110 0
Q ss_pred -------C---CC---CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 217 -------I---KP---ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 217 -------~---~p---~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
. .. .......++++++||.+||. ||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0 00 01123456789999999999 99999999999999999743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=384.53 Aligned_cols=239 Identities=22% Similarity=0.375 Sum_probs=193.3
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
.||+|+|| +||+|.+..+ +..||||.++... .....+.+.+|+.+|++++|||||++|+++.+ ..+|+
T Consensus 14 ~iG~G~fg---~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~i 84 (273)
T d1mp8a_ 14 CIGEGQFG---DVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWI 84 (273)
T ss_dssp EEEECSSS---EEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCEE
T ss_pred EEeeCCCc---EEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeEEE
Confidence 38899998 8999998654 5678888875432 45567789999999999999999999998743 35889
Q ss_pred EEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKK-HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk-~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|||||.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||+|+.+...
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhheeccCC
Confidence 9999999999998765 457999999999999999999999999 99999999999998 4579999999999876432
Q ss_pred ---CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHH
Q 006593 157 ---TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIK 231 (639)
Q Consensus 157 ---~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~ 231 (639)
......||+.|+|||++. ..|+.++|||||||++|||+| |.+||.+ .+..+++..+..+..+ ..+...+++++
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~ 239 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPTLY 239 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHH
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 223457899999999886 569999999999999999998 8899977 4567777888877654 34566789999
Q ss_pred HHHHHhcC-CCCCCCCHHHHhcC
Q 006593 232 GFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 232 ~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+||.+||. +|.+|||+.||++|
T Consensus 240 ~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 240 SLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999 89999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=389.26 Aligned_cols=240 Identities=25% Similarity=0.393 Sum_probs=197.0
Q ss_pred CcccccccCcEEEEEEEecCCCe----EEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGI----EVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~----~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
+||+|||| +||+|.+..+|+ .||+|+++... .....+.+.+|+.+|++|+|||||++|+++.++ ..+
T Consensus 16 ~lG~G~fG---~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~~~ 86 (317)
T d1xkka_ 16 VLGSGAFG---TVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TVQ 86 (317)
T ss_dssp EEEECSSE---EEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEE
T ss_pred EEecCCCe---EEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---Cee
Confidence 47888888 899999988876 57888776432 344567899999999999999999999998754 367
Q ss_pred EEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccC
Q 006593 77 MITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQ 155 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~ 155 (639)
++++|+.+|+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+|+....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~-~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKT-PQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEE-TTEEEECCCSHHHHTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCC-CCCeEeeccccceeccc
Confidence 889999999999988764 57999999999999999999999999 999999999999984 57999999999987653
Q ss_pred CC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 156 PT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 156 ~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
.. .....||+.|||||++. +.|+.++|||||||++|||+| |.+||.+ .+..++...+..+..+. .+...+++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~ 241 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPICTID 241 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTBCHH
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccCHH
Confidence 22 23346899999999776 569999999999999999998 7888876 45666777777776543 44567889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
+++||.+||. +|.+|||+.||+.|.
T Consensus 242 ~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 242 VYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 9999999999 899999999999984
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=383.65 Aligned_cols=241 Identities=20% Similarity=0.324 Sum_probs=199.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| +||+|.+..+ ..||||+++.... ..+.+.+|+.+|++++|||||++|+++.+ + .+++||||
T Consensus 25 iG~G~fg---~Vy~~~~~~~-~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~--~~~lv~Ey 92 (285)
T d1fmka3 25 LGQGCFG---EVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIYIVTEY 92 (285)
T ss_dssp EEECSSC---EEEEEEETTT-EEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCEEEECC
T ss_pred EeeCCCe---EEEEEEECCC-CEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEEec-C--CeEEEEEe
Confidence 7888888 8999998655 6799999875532 23668999999999999999999998743 2 37899999
Q ss_pred CCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC---
Q 006593 82 FTSGNLRQYRKK--HKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP--- 156 (639)
Q Consensus 82 ~~gGsL~d~lkk--~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~--- 156 (639)
|.+|+|..++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ++|.+||+|||+|+.....
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccchhhhccCCCce
Confidence 999999998854 457999999999999999999999999 99999999999997 4579999999999765432
Q ss_pred CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHH
Q 006593 157 TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIE 235 (639)
Q Consensus 157 ~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~ 235 (639)
......||+.|+|||++. +.++.++|||||||++|||+||..||.......+++..+..+..+. .+...++++++||.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMC 248 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHHHHHHH
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHHHHHHH
Confidence 223467999999999886 5699999999999999999997767665577888888888776544 45667889999999
Q ss_pred HhcC-CCCCCCCHHHHhc--Cccccc
Q 006593 236 KCLV-PASERLSAKDLLK--DPFLQV 258 (639)
Q Consensus 236 kcL~-dP~~RpSa~ELL~--Hpff~~ 258 (639)
+||+ +|.+||++++|+. ++||..
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999 8999999999987 788864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=385.56 Aligned_cols=242 Identities=23% Similarity=0.334 Sum_probs=195.1
Q ss_pred CcccccccCcEEEEEEEecC-----CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFDEF-----AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~-----tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
.||+|||| .||+|.+.. +++.||+|+++... .....+.+.+|..++.++ +|+|||++++++...+ ..
T Consensus 20 ~iG~G~fG---~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-~~ 92 (299)
T d1ywna1 20 PLGRGAFG---QVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GP 92 (299)
T ss_dssp EEEECSSC---EEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-SC
T ss_pred EEeecCCe---EEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-Ce
Confidence 37899988 799999643 56789999987543 345667788888888887 6899999999875543 46
Q ss_pred EEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCC
Q 006593 75 VNMITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGN 138 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~ 138 (639)
+++|||||++|+|.++++.. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~-~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-E 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-G
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeEC-C
Confidence 88999999999999999753 24889999999999999999999999 99999999999998 4
Q ss_pred CCcEEEeecchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhc-cCCCCCCCCHHHHHHH
Q 006593 139 HGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKK 212 (639)
Q Consensus 139 ~g~VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG-~~Pf~~~~~~~~i~~~ 212 (639)
+|.+||+|||+|+..... ......||+.|||||++. +.|+.++|||||||++|||+|| .+||.+......+...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 579999999999865432 233568999999999886 4599999999999999999987 5688876667777777
Q ss_pred HHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 213 VTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 213 i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+..+..+ ..+...++++++||.+||. +|.+|||+.|+++|
T Consensus 250 ~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7777654 3556678999999999999 89999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=390.44 Aligned_cols=247 Identities=28% Similarity=0.373 Sum_probs=197.2
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---CceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDK---KKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~---~~~l~lV 78 (639)
||+|||| +||+|.+..+|+.||||+++... ......+++.+|+++|++|+|||||+++++|.... ....++|
T Consensus 26 LG~G~fg---~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 26 VGSGAYG---SVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp CGGGTTS---SEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EecCCCe---EEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence 6777777 79999999999999999988654 24556678999999999999999999999986432 2234566
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCC
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTA 158 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~ 158 (639)
++|+.||+|.+++.. +++++..++.+++||+.||.|||++| |+||||||+|||++ .+|.+|++|||++...... .
T Consensus 101 ~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~~~-~ 175 (348)
T d2gfsa1 101 VTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDE-M 175 (348)
T ss_dssp EEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----CCTGG-G
T ss_pred EEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhcccCcc-c
Confidence 777889999999864 57999999999999999999999999 99999999999998 5589999999999765432 3
Q ss_pred ccccCCCCcCCcccccc--cCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcC--CCC---------------
Q 006593 159 RSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSG--IKP--------------- 219 (639)
Q Consensus 159 ~~~~GTp~ymAPE~l~~--~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g--~~p--------------- 219 (639)
.+..||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.. .......+... ..+
T Consensus 176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 45689999999997654 36899999999999999999999998743 33333333211 000
Q ss_pred ------------CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 220 ------------ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 220 ------------~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
.......++++++||.+||. ||.+||||.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00113457899999999999 99999999999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=391.68 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=190.0
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeC----CCceEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDD----KKKTVN 76 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~----~~~~l~ 76 (639)
+||+|+|| +||+|.|..+|+.||||+++.... ......++.+|+.+|++++|||||+++++|... ....+|
T Consensus 24 ~LG~G~fg---~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 24 PIGSGAQG---IVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp ECSCC--C---EEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EeecCcCe---EEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 36777777 899999999999999999986643 456677899999999999999999999998654 336899
Q ss_pred EEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 77 MITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
+|||||.++.+.. + .+.+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||+++.....
T Consensus 99 iv~Ey~~~~l~~~-~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 99 LVMELMDANLCQV-I--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEECCSEEHHHH-H--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-------
T ss_pred EEEeccchHHHHh-h--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhhccccc
Confidence 9999997765543 3 457999999999999999999999999 99999999999998 4578999999998766543
Q ss_pred -CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHc-------------------
Q 006593 157 -TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTS------------------- 215 (639)
Q Consensus 157 -~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~------------------- 215 (639)
.....+||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+.. ......++..
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 344568999999999876 458999999999999999999999998743 3332222211
Q ss_pred ---CCCCC-----------c-------ccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCcccccc
Q 006593 216 ---GIKPA-----------S-------LAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDPFLQVE 259 (639)
Q Consensus 216 ---g~~p~-----------~-------l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hpff~~~ 259 (639)
+..+. . .....++++++||.+||. ||.+||||+|||+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 10000 0 001124678999999999 99999999999999999853
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=384.38 Aligned_cols=240 Identities=23% Similarity=0.340 Sum_probs=199.4
Q ss_pred CcccccccCcEEEEEEEecCCCeE--EEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIE--VAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~--VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| +||+|.++.+|.. ||||+++... ..+..+.+.+|+++|+++ +|||||++|+++.++ ..+++
T Consensus 17 ~iG~G~fg---~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~~i 88 (309)
T d1fvra_ 17 VIGEGNFG---QVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYL 88 (309)
T ss_dssp EEECGGGC---EEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEEEE
T ss_pred EEeeCCCc---EEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--CeeEE
Confidence 48999999 7999999888875 6677765332 334567799999999999 799999999999876 45999
Q ss_pred EEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCc
Q 006593 78 ITELFTSGNLRQYRKKH----------------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGE 141 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~----------------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~ 141 (639)
|||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~-~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE-NYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG-GGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcC-CCc
Confidence 99999999999999754 56899999999999999999999999 999999999999984 579
Q ss_pred EEEeecchhhhccCC-CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhcc-CCCCCCCCHHHHHHHHHcCCC
Q 006593 142 VKIGDLGLAIAMQQP-TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFE-YPYSECKNPAQIFKKVTSGIK 218 (639)
Q Consensus 142 VKL~DFGlA~~l~~~-~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~-~Pf~~~~~~~~i~~~i~~g~~ 218 (639)
+||+|||+|+..... ......||+.|+|||.+. ..|+.++|||||||++|||++|. +||.+ .+..+++..+..+..
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYR 244 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCC
T ss_pred eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhcCC
Confidence 999999999765432 233557999999999886 56999999999999999999975 56655 678888888888765
Q ss_pred CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 219 PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 219 p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+. .+...++++++||.+||. +|.+|||+.||++|
T Consensus 245 ~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 43 455668899999999999 89999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-45 Score=378.88 Aligned_cols=238 Identities=19% Similarity=0.285 Sum_probs=201.2
Q ss_pred cccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|||| +||+|.+. .++..||||+++... .....+++.+|+.+|++++||||++++++|... ..++
T Consensus 21 lG~G~fG---~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~ 92 (301)
T d1lufa_ 21 IGEGAFG---RVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCAVG--KPMC 92 (301)
T ss_dssp EEECSSC---EEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--SSCE
T ss_pred EeeCCCe---EEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--CceE
Confidence 7888888 89999864 467899999987543 455677899999999999999999999988665 4588
Q ss_pred EEEecCCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCc
Q 006593 77 MITELFTSGNLRQYRKKHK------------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDN 132 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~~------------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~N 132 (639)
+||||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~N 170 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRN 170 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcccc
Confidence 9999999999999997532 3889999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEeecchhhhccCC----CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhcc-CCCCCCCCH
Q 006593 133 IFVNGNHGEVKIGDLGLAIAMQQP----TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFE-YPYSECKNP 206 (639)
Q Consensus 133 ILl~~~~g~VKL~DFGlA~~l~~~----~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~-~Pf~~~~~~ 206 (639)
||+++ ++.+||+|||+|+.+... ...+..||+.|||||++.. .|+.++|||||||++|||++|. +||.+ .+.
T Consensus 171 ILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-~~~ 248 (301)
T d1lufa_ 171 CLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAH 248 (301)
T ss_dssp EEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCH
T ss_pred eEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-CCH
Confidence 99985 579999999999866432 2335678999999998864 6999999999999999999996 56765 677
Q ss_pred HHHHHHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 207 AQIFKKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 207 ~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.++...+..+..+ ..+...++++.+||.+||. +|.+|||+.||++
T Consensus 249 ~e~~~~v~~~~~~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7888888887654 3456678899999999999 8999999999965
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=380.56 Aligned_cols=242 Identities=20% Similarity=0.289 Sum_probs=201.4
Q ss_pred CcccccccCcEEEEEEEecCC---CeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFA---GIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNM 77 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~t---G~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~l 77 (639)
+||+|+|| +||+|.+..+ ...||||+++.. ......+++.+|+++|++|+|||||++++++...+ ..+++
T Consensus 34 ~iG~G~fg---~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~l 106 (311)
T d1r0pa_ 34 VIGRGHFG---CVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLV 106 (311)
T ss_dssp EEEEETTE---EEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEE
T ss_pred EEeecCCe---EEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceEE
Confidence 47999999 8999998554 357999998643 25677788999999999999999999999987653 46889
Q ss_pred EEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCC
Q 006593 78 ITELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQP 156 (639)
Q Consensus 78 V~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~ 156 (639)
|||||.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ ..+.+||+|||+++.+...
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccchhhcccc
Confidence 99999999999998854 45788889999999999999999999 99999999999998 4579999999999765432
Q ss_pred C------CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChH
Q 006593 157 T------ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQ 229 (639)
Q Consensus 157 ~------~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~ 229 (639)
. .....||+.|+|||.+. ..|+.++|||||||++|||+||..||....+..++...+..+..+. .+...+++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~-~p~~~~~~ 262 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-QPEYCPDP 262 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC-CCTTCCHH
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-CcccCcHH
Confidence 1 22356899999999876 5699999999999999999998888876666777778888776543 45667889
Q ss_pred HHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 230 IKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 230 l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
+.+||.+||. ||.+||++.|+++|
T Consensus 263 l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 263 LYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999 89999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=375.69 Aligned_cols=240 Identities=25% Similarity=0.355 Sum_probs=190.0
Q ss_pred cccccccCcEEEEEEEecC---CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEE
Q 006593 2 VLTGLYMTPFSSYKAFDEF---AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~---tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV 78 (639)
||+|||| .||+|.+.. .+..||||+++.... ...+..+.+.+|+.+|++++|||||++|+++.++ .+++|
T Consensus 16 iG~G~fg---~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~~~lv 88 (273)
T d1u46a_ 16 LGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PMKMV 88 (273)
T ss_dssp CC----C---CCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEEE
T ss_pred EecCCCe---EEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---chhee
Confidence 7999999 689997543 245799999876553 2345667899999999999999999999988543 47899
Q ss_pred EecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCC
Q 006593 79 TELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPT 157 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~ 157 (639)
||||.+|+|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~-~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEE-TTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhcccc-ccceeeccchhhhhcccCC
Confidence 9999999999887654 57999999999999999999999999 999999999999985 4799999999998764332
Q ss_pred -----CccccCCCCcCCcccccc-cCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHH
Q 006593 158 -----ARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQI 230 (639)
Q Consensus 158 -----~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l 230 (639)
.....||+.|+|||++.. .|+.++|||||||++|||+| |..||.+ .+..++...+.........+...++.+
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 233467889999998864 58999999999999999998 8999987 566667677766544445566678999
Q ss_pred HHHHHHhcC-CCCCCCCHHHHhc
Q 006593 231 KGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 231 ~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
++||.+||. +|.+|||+.||++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999 8999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=375.44 Aligned_cols=234 Identities=22% Similarity=0.362 Sum_probs=193.1
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEec
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITEL 81 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~Ey 81 (639)
||+|+|| .||+|.+ +|..||+|+++.. ...+.+.+|+++|++|+|||||++|+++.+.. ..+|+||||
T Consensus 15 lG~G~fg---~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ey 82 (262)
T d1byga_ 15 IGKGEFG---DVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEY 82 (262)
T ss_dssp EEECSSC---EEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECC
T ss_pred EecCCCe---EEEEEEE--CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEEEec
Confidence 7888888 7999998 4789999998643 23467899999999999999999999886543 357999999
Q ss_pred CCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEeecchhhhccCCCCc
Q 006593 82 FTSGNLRQYRKKHK--NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIAMQQPTAR 159 (639)
Q Consensus 82 ~~gGsL~d~lkk~~--~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~l~~~~~~ 159 (639)
+++|+|.+++.+.+ .+++..++.|+.||+.||.|||+.+ |+||||||+|||++ .+|.+||+|||+++.... ...
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~-~~~ 158 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASS-TQD 158 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecCC-CCc
Confidence 99999999997643 5899999999999999999999999 99999999999998 558999999999976543 334
Q ss_pred cccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHHHHHcCCCCCcccCCCChHHHHHHHHh
Q 006593 160 SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFKKVTSGIKPASLAKVNDPQIKGFIEKC 237 (639)
Q Consensus 160 ~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~~i~~g~~p~~l~~~~s~~l~~LI~kc 237 (639)
...+|+.|+|||++. ..|+.++|||||||++|||+| |.+||.. .+..++...+..+..+. ++...++++++||.+|
T Consensus 159 ~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMKNC 236 (262)
T ss_dssp ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHHHHH
T ss_pred cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence 567899999999875 569999999999999999998 6777766 56778888888776654 4566789999999999
Q ss_pred cC-CCCCCCCHHHHhcC
Q 006593 238 LV-PASERLSAKDLLKD 253 (639)
Q Consensus 238 L~-dP~~RpSa~ELL~H 253 (639)
|. ||.+|||+.+|+++
T Consensus 237 l~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 237 WHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cccCHhHCcCHHHHHHH
Confidence 99 89999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=373.79 Aligned_cols=238 Identities=26% Similarity=0.385 Sum_probs=198.4
Q ss_pred cccccccCcEEEEEEEecCCC-------eEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCc
Q 006593 2 VLTGLYMTPFSSYKAFDEFAG-------IEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKK 73 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG-------~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~ 73 (639)
||+|||| .||+|.+..++ ..||+|+++... .......+.+|...++++ +|||||+++++|.++ .
T Consensus 21 iG~G~fg---~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~--~ 92 (299)
T d1fgka_ 21 LGEGAFG---QVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD--G 92 (299)
T ss_dssp CC--------CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred EeecCCc---EEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC--C
Confidence 7888888 78999876554 579999987543 455677899999999999 899999999998765 4
Q ss_pred eEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC
Q 006593 74 TVNMITELFTSGNLRQYRKKHK----------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG 137 (639)
Q Consensus 74 ~l~lV~Ey~~gGsL~d~lkk~~----------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~ 137 (639)
.+++|||||.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~- 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT- 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeec-
Confidence 5899999999999999997553 4899999999999999999999999 99999999999998
Q ss_pred CCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHHH
Q 006593 138 NHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIFK 211 (639)
Q Consensus 138 ~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~~ 211 (639)
.+|.+||+|||+++...... .....||+.|+|||++. +.|+.++|||||||++|||++ |.+||.+ .+..+++.
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~~ 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFK 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CCHHHHHH
Confidence 55799999999997664332 33467899999999876 569999999999999999998 6888876 56778888
Q ss_pred HHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 212 KVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 212 ~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.+..+..+ ..+...++++++||.+||+ +|.+|||+.|||+
T Consensus 249 ~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 88877555 3456678999999999999 8999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=374.21 Aligned_cols=240 Identities=22% Similarity=0.341 Sum_probs=201.1
Q ss_pred CcccccccCcEEEEEEEe-----cCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCCce
Q 006593 1 MVLTGLYMTPFSSYKAFD-----EFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSL-KDDNVVKFYKSWVDDKKKT 74 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d-----~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~~~~~~~~~ 74 (639)
.||+|||| .||+|.+ ..++..||||+++... .......+.+|+.+++.+ +|||||++|+++...+ .
T Consensus 30 ~iG~G~fg---~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~--~ 101 (311)
T d1t46a_ 30 TLGAGAFG---KVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG--P 101 (311)
T ss_dssp EEEECSSE---EEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--S
T ss_pred EEeecCCe---EEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC--E
Confidence 37888888 7999975 4678899999998654 356677899999999999 7999999999986554 4
Q ss_pred EEEEEecCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEe
Q 006593 75 VNMITELFTSGNLRQYRKKHK------------------NVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVN 136 (639)
Q Consensus 75 l~lV~Ey~~gGsL~d~lkk~~------------------~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~ 136 (639)
+++|||||.+|+|.+++.+.. .+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT 179 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccccccc
Confidence 899999999999999997653 5899999999999999999999999 99999999999998
Q ss_pred CCCCcEEEeecchhhhccCCC----CccccCCCCcCCccccc-ccCCccccccchhhhhhhhhh-ccCCCCCCCCHHHHH
Q 006593 137 GNHGEVKIGDLGLAIAMQQPT----ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT-FEYPYSECKNPAQIF 210 (639)
Q Consensus 137 ~~~g~VKL~DFGlA~~l~~~~----~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELlt-G~~Pf~~~~~~~~i~ 210 (639)
..+.+||+|||+++...... ....+||+.|+|||++. +.++.++|||||||++|||+| |.+||........+.
T Consensus 180 -~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 -HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp -TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred -ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 45799999999998765332 23467899999999886 568999999999999999999 566666655555555
Q ss_pred HHHHcCCCCCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 211 KKVTSGIKPASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 211 ~~i~~g~~p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
+.+..+..+ ..+...++.+++||.+||. ||.+|||+.|||+
T Consensus 259 ~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 666665544 3456678899999999999 8999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=370.87 Aligned_cols=238 Identities=21% Similarity=0.345 Sum_probs=201.2
Q ss_pred cccccccCcEEEEEEEec-----CCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEE
Q 006593 2 VLTGLYMTPFSSYKAFDE-----FAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVN 76 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~-----~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~ 76 (639)
||+|||| +||+|.+. .++..||||+++... .......+.+|+++|++++|||||++++++..+. .++
T Consensus 28 lG~G~fG---~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~ 99 (308)
T d1p4oa_ 28 LGQGSFG---MVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--PTL 99 (308)
T ss_dssp EEECSSS---EEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--SCE
T ss_pred EeeCCCe---EEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC--cee
Confidence 7888888 79999875 346789999987543 4456678999999999999999999999886554 588
Q ss_pred EEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEee
Q 006593 77 MITELFTSGNLRQYRKKH----------KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 146 (639)
Q Consensus 77 lV~Ey~~gGsL~d~lkk~----------~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~D 146 (639)
+|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld-~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeec-CCceEEEee
Confidence 999999999999998643 34788999999999999999999999 99999999999998 457999999
Q ss_pred cchhhhccCC----CCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhc-cCCCCCCCCHHHHHHHHHcCCCCC
Q 006593 147 LGLAIAMQQP----TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTF-EYPYSECKNPAQIFKKVTSGIKPA 220 (639)
Q Consensus 147 FGlA~~l~~~----~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG-~~Pf~~~~~~~~i~~~i~~g~~p~ 220 (639)
||+|+.+... ......||+.|+|||.+. ..|+.++|||||||++|||+|| .+||.+ .+..+++..+.++..+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCCC
Confidence 9999766432 223457899999999876 4589999999999999999998 477765 67788888888776543
Q ss_pred cccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 221 SLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 221 ~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
.+...++.+.++|.+||+ +|.+|||+.+|++
T Consensus 256 -~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 -KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 455677899999999999 8999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-43 Score=362.09 Aligned_cols=241 Identities=23% Similarity=0.311 Sum_probs=184.5
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCC--ceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKK--KTVNMI 78 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~--~~l~lV 78 (639)
.||+|||| +||+|.+ +|..||||+++... ........|+..+++++|||||++|+++.+.+. ..+|+|
T Consensus 10 ~iG~G~fg---~Vy~~~~--~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 10 SIGKGRFG---EVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEECCSSS---EEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEeeCCCe---EEEEEEE--CCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 37999999 7999986 68999999986443 222223345666678899999999999987653 368999
Q ss_pred EecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeeccCCCcEEEeCCCCcEEEeecchhhh
Q 006593 79 TELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSH------NPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIA 152 (639)
Q Consensus 79 ~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~------gppIIHRDLKp~NILl~~~~g~VKL~DFGlA~~ 152 (639)
||||.+|+|.+++++. .+++..+..++.|++.||.|||+. .++|+||||||+|||++ .+|.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecCcccc
Confidence 9999999999999875 589999999999999999999974 12399999999999998 558999999999976
Q ss_pred ccCC------CCccccCCCCcCCcccccc-------cCCccccccchhhhhhhhhhccCCCCCC--------------CC
Q 006593 153 MQQP------TARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTFEYPYSEC--------------KN 205 (639)
Q Consensus 153 l~~~------~~~~~~GTp~ymAPE~l~~-------~ys~ksDIwSlGiil~ELltG~~Pf~~~--------------~~ 205 (639)
.... .....+||+.|||||++.. .++.++|||||||++|||+||..||... ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6432 2235689999999998864 2678999999999999999998776321 12
Q ss_pred HHHHHHHHHcCCCCCcccCCC-----ChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 006593 206 PAQIFKKVTSGIKPASLAKVN-----DPQIKGFIEKCLV-PASERLSAKDLLKD 253 (639)
Q Consensus 206 ~~~i~~~i~~g~~p~~l~~~~-----s~~l~~LI~kcL~-dP~~RpSa~ELL~H 253 (639)
...+...+..+...+.++... ...+.+|+.+||+ +|.+|||+.||+++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 333444443333222222221 1358899999999 89999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-42 Score=357.69 Aligned_cols=244 Identities=20% Similarity=0.263 Sum_probs=188.7
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCCceEEEEEe
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNVVKFYKSWVDDKKKTVNMITE 80 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~~~~~~~~~l~lV~E 80 (639)
.||+|+|| +||+|.+..+|+.||+|++...... +.+..|+++++.++|+|++.++..+... ....++|||
T Consensus 14 ~iG~G~fG---~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivme 83 (299)
T d1ckia_ 14 KIGSGSFG---DIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVME 83 (299)
T ss_dssp EEEECSSS---EEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEEE
T ss_pred EEeeCCCc---EEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEEEE
Confidence 37888888 8999999999999999998865421 2378899999999887766655544333 356889999
Q ss_pred cCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC--CCCcEEEeecchhhhccCC-
Q 006593 81 LFTSGNLRQYRK-KHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG--NHGEVKIGDLGLAIAMQQP- 156 (639)
Q Consensus 81 y~~gGsL~d~lk-k~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~--~~g~VKL~DFGlA~~l~~~- 156 (639)
|+. |+|.+++. ..+.+++..+..++.||+.||+|||++| ||||||||+|||++. ....+||+|||+|+.+...
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 995 56655554 4568999999999999999999999999 999999999999852 3457999999999866432
Q ss_pred --------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCCCHHHH--HHHHHc---CCCCCcc
Q 006593 157 --------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECKNPAQI--FKKVTS---GIKPASL 222 (639)
Q Consensus 157 --------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~~~i--~~~i~~---g~~p~~l 222 (639)
......||+.|||||++.+ .|+.++|||||||++|||+||..||......... +..... ......+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 1235689999999998875 5999999999999999999999999764332221 111111 1222334
Q ss_pred cCCCChHHHHHHHHhcC-CCCCCCCHH---HHhcCcccc
Q 006593 223 AKVNDPQIKGFIEKCLV-PASERLSAK---DLLKDPFLQ 257 (639)
Q Consensus 223 ~~~~s~~l~~LI~kcL~-dP~~RpSa~---ELL~Hpff~ 257 (639)
....++++.+||.+||. +|.+||++. ++|+|+|.+
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 45667899999999998 999999986 557787754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-40 Score=343.59 Aligned_cols=238 Identities=15% Similarity=0.195 Sum_probs=192.9
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCCceEEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD-DNVVKFYKSWVDDKKKTVNMIT 79 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~~~~~~~~~l~lV~ 79 (639)
.||+|||| +||+|.+..+|+.||+|++..... ...+.+|++.++.|.| +||+++++++... ...++||
T Consensus 12 ~iG~G~fG---~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~vm 80 (293)
T d1csna_ 12 RIGEGSFG---VIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLVI 80 (293)
T ss_dssp EEEECSSC---EEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEEE
T ss_pred EEecCCCe---EEEEEEECCCCCEEEEEEEccccC------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEEEE
Confidence 37889888 899999999999999998865432 2346789999999965 8999999988665 4689999
Q ss_pred ecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeC----CCCcEEEeecchhhhcc
Q 006593 80 ELFTSGNLRQYRKKH-KNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNG----NHGEVKIGDLGLAIAMQ 154 (639)
Q Consensus 80 Ey~~gGsL~d~lkk~-~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~----~~g~VKL~DFGlA~~l~ 154 (639)
||+ +|+|.++++.. +.+++..+..++.|++.||+|||++| |+||||||+|||++. ..+.+||+|||+|+...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 999 68999998775 46999999999999999999999999 999999999999963 34689999999997654
Q ss_pred CC---------CCccccCCCCcCCcccccc-cCCccccccchhhhhhhhhhccCCCCCCC--CHHHHHHHHHc---CCCC
Q 006593 155 QP---------TARSVIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTFEYPYSECK--NPAQIFKKVTS---GIKP 219 (639)
Q Consensus 155 ~~---------~~~~~~GTp~ymAPE~l~~-~ys~ksDIwSlGiil~ELltG~~Pf~~~~--~~~~i~~~i~~---g~~p 219 (639)
.. .....+|||.|||||++.+ .|+.++|||||||++|||+||..||.+.. +....+..+.. ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 32 2335689999999998875 59999999999999999999999997532 33344443332 1223
Q ss_pred CcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 006593 220 ASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLK 252 (639)
Q Consensus 220 ~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~ 252 (639)
..+....++++.+|+..|+. +|.+||+...+.+
T Consensus 238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 33445567899999999998 8999999776643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-40 Score=349.51 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=185.5
Q ss_pred cccccccCcEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-----------CCCcceEEEEEEeC
Q 006593 2 VLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-----------DDNVVKFYKSWVDD 70 (639)
Q Consensus 2 LG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-----------HpNIVkl~~~~~~~ 70 (639)
||+|+|| +||+|.+..+|+.||||+++... ...+.+.+|+.+|+.++ |+||+++++++...
T Consensus 21 LG~G~fg---~Vy~~~~~~~g~~vAvKvi~~~~-----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 21 LGWGHFS---TVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEECSSE---EEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EeeCCCe---EEEEEEECCCCCEEEEEEEeccc-----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5666666 89999999999999999997543 34567788999998885 47899999998766
Q ss_pred CCceEEEEEecCCCCCH-HHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeccCCCcEEEeCCC-----Cc
Q 006593 71 KKKTVNMITELFTSGNL-RQYRK--KHKNVDIKVIKNWARQILHGLVYLHS-HNPPIIHRDLKCDNIFVNGNH-----GE 141 (639)
Q Consensus 71 ~~~~l~lV~Ey~~gGsL-~d~lk--k~~~l~e~~i~~i~~QIl~aL~yLHs-~gppIIHRDLKp~NILl~~~~-----g~ 141 (639)
.....++++.++..+.. ..+.. ....+++..++.+++||+.||.|||+ +| |+||||||+|||++.++ ..
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccce
Confidence 55667777777655543 33332 34579999999999999999999998 78 99999999999997332 14
Q ss_pred EEEeecchhhhccCCCCccccCCCCcCCccccc-ccCCccccccchhhhhhhhhhccCCCCCCCCH------HHHHHHHH
Q 006593 142 VKIGDLGLAIAMQQPTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTFEYPYSECKNP------AQIFKKVT 214 (639)
Q Consensus 142 VKL~DFGlA~~l~~~~~~~~~GTp~ymAPE~l~-~~ys~ksDIwSlGiil~ELltG~~Pf~~~~~~------~~i~~~i~ 214 (639)
+||+|||.+...... ....+||+.|+|||++. ..|+.++||||+||++++|++|+.||...... ..+...+.
T Consensus 171 ~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp EEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eeEeecccccccccc-cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 999999998765433 35678999999999776 46999999999999999999999999643211 11111100
Q ss_pred -cCCC--------------------------------------CCcccCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCc
Q 006593 215 -SGIK--------------------------------------PASLAKVNDPQIKGFIEKCLV-PASERLSAKDLLKDP 254 (639)
Q Consensus 215 -~g~~--------------------------------------p~~l~~~~s~~l~~LI~kcL~-dP~~RpSa~ELL~Hp 254 (639)
-|.. ........++++++||.+||. ||.+||||+|+|+||
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0000 000111224679999999999 999999999999999
Q ss_pred ccccc
Q 006593 255 FLQVE 259 (639)
Q Consensus 255 ff~~~ 259 (639)
||+..
T Consensus 330 ~f~~~ 334 (362)
T d1q8ya_ 330 WLKDT 334 (362)
T ss_dssp GGTTC
T ss_pred ccCCC
Confidence 99843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=9.1e-23 Score=196.15 Aligned_cols=167 Identities=17% Similarity=0.161 Sum_probs=119.6
Q ss_pred CcccccccCcEEEEEEEecCCCeEEEEEEEeccccc-----C---------ChhhHHHHHHHHHHHHhCCCCCcceEEEE
Q 006593 1 MVLTGLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL-----Q---------LPGDLQKLYSEVHLLKSLKDDNVVKFYKS 66 (639)
Q Consensus 1 iLG~GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~-----~---------~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 66 (639)
.||+|||| +||+|.+. +|+.||+|+++..... . ..........|+..|.++.|+++++.+++
T Consensus 7 ~IG~G~~g---~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 7 LMGEGKES---AVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEECSSE---EEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred EeeeCcce---EEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 37888888 89999984 7999999987642210 0 01122345678999999999999999874
Q ss_pred EEeCCCceEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeccCCCcEEEeCCCCcEEEee
Q 006593 67 WVDDKKKTVNMITELFTSGNLRQYRKKHKNVDIKVIKNWARQILHGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGD 146 (639)
Q Consensus 67 ~~~~~~~~l~lV~Ey~~gGsL~d~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~gppIIHRDLKp~NILl~~~~g~VKL~D 146 (639)
. . .+++|||+.++.+.+ +++..+..++.||+.+|.|||++| |+||||||+|||++ + +.++|+|
T Consensus 83 ~--~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~liD 145 (191)
T d1zara2 83 E--G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIID 145 (191)
T ss_dssp E--T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECC
T ss_pred c--C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEEE
Confidence 2 2 268999999866542 455667889999999999999999 99999999999998 4 3599999
Q ss_pred cchhhhccCCCCccccC-CCCcCCcccccccCCccccccchhhh
Q 006593 147 LGLAIAMQQPTARSVIG-TPEFMAPELYEEEYNELVDIYSFGMC 189 (639)
Q Consensus 147 FGlA~~l~~~~~~~~~G-Tp~ymAPE~l~~~ys~ksDIwSlGii 189 (639)
||+|.....+....+.. ... --.+.+...|+.++|+||+.--
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~-~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVR-NIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHH-HHHHHHHHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHH-HHHHHHcCCCCCcccHHHHHHH
Confidence 99997655433221110 000 0012344678999999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.60 E-value=0.00014 Score=70.04 Aligned_cols=127 Identities=17% Similarity=0.038 Sum_probs=79.2
Q ss_pred EEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEEEecCCCCCHHH
Q 006593 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMITELFTSGNLRQ 89 (639)
Q Consensus 11 ~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL~d 89 (639)
..||+.. ..+..+++|....... .....+.+|..+|..|. +-.+.+++.+..++ ...++||++++|.++.+
T Consensus 28 ~~v~rv~--~~~~~~vlk~~~~~~~----~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 28 AKVYKLV--GENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMSEADGVLCSE 99 (263)
T ss_dssp SEEEEEE--CSSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCSSEEHHH
T ss_pred CcEEEEE--eCCCeEEEEEcCCCcc----cchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEEEecccccccc
Confidence 4788875 3456677887764432 12234678998888773 43456777655444 46789999999988865
Q ss_pred HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 006593 90 YRKKHKNVDIKVIKNWARQILHGLVYLHSHN------------------------------------------------- 120 (639)
Q Consensus 90 ~lkk~~~l~e~~i~~i~~QIl~aL~yLHs~g------------------------------------------------- 120 (639)
.... ......++.++...|..||+..
T Consensus 100 ~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 100 EYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp HTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred cccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 4311 1112223344444444444311
Q ss_pred --------CCeeeeccCCCcEEEeCCCCcEEEeecchhh
Q 006593 121 --------PPIIHRDLKCDNIFVNGNHGEVKIGDLGLAI 151 (639)
Q Consensus 121 --------ppIIHRDLKp~NILl~~~~g~VKL~DFGlA~ 151 (639)
+.++|+|+.|.||++++ ++.+-|+||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecC-CceEEEeechhcc
Confidence 12799999999999984 3445699998663
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.57 E-value=0.0001 Score=76.60 Aligned_cols=78 Identities=9% Similarity=-0.020 Sum_probs=48.6
Q ss_pred ccccCcEEEEEEEecCCCeEEEEEEEeccccc---CChhhHHHHHHHHHHHHhC-CC--CCcceEEEEEEeCCCceEEEE
Q 006593 5 GLYMTPFSSYKAFDEFAGIEVAWSRVKIDDVL---QLPGDLQKLYSEVHLLKSL-KD--DNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 5 GGfG~v~tVykA~d~~tG~~VAIK~v~~~~~~---~~~~~~~~l~~Ei~iLk~L-~H--pNIVkl~~~~~~~~~~~l~lV 78 (639)
.|-|....||+..+...|+.|++|+-...-.. ..+....+...|.+.|+.+ .+ ..++++|. .++.. .++|
T Consensus 34 ig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--~~lv 109 (392)
T d2pula1 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--AVTV 109 (392)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT--TEEE
T ss_pred eCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC--CEEE
Confidence 35577889999998888889999985432110 1223345677899988877 33 34667775 34543 4589
Q ss_pred EecCCCCC
Q 006593 79 TELFTSGN 86 (639)
Q Consensus 79 ~Ey~~gGs 86 (639)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.28 E-value=0.00047 Score=65.79 Aligned_cols=67 Identities=9% Similarity=-0.041 Sum_probs=45.2
Q ss_pred EEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCCceEEEEEecCCCCCH
Q 006593 11 FSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKD--DNVVKFYKSWVDDKKKTVNMITELFTSGNL 87 (639)
Q Consensus 11 ~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~~~~~~~~~l~lV~Ey~~gGsL 87 (639)
..||+... ..|..+++|...... ...+..|..+|+.|.. -.+.+++.+..+. ...++||++++|-++
T Consensus 25 ~~v~r~~~-~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 25 AAVFRLSA-QGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL 93 (255)
T ss_dssp CEEEEEEC-TTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred CeEEEEEe-CCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeecccc
Confidence 46898875 456668888755332 1236788888888743 3356777755443 457899999988665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.64 E-value=0.0083 Score=59.80 Aligned_cols=69 Identities=9% Similarity=0.001 Sum_probs=41.5
Q ss_pred cEEEEEEEecCCCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCc--ceEEE----EEEeCCCceEEEEEecCC
Q 006593 10 PFSSYKAFDEFAGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLKDDNV--VKFYK----SWVDDKKKTVNMITELFT 83 (639)
Q Consensus 10 v~tVykA~d~~tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI--Vkl~~----~~~~~~~~~l~lV~Ey~~ 83 (639)
-..||++.. ..|..|++|+.+.... ..+.+..|+..|..|...+| +.... ... ......+.+++++.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~-~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL-NHQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE-EETTEEEEEEECCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeee-eeeeEEEEEEeecC
Confidence 357999987 5688899998664321 23457789998888843222 11111 001 11245778899998
Q ss_pred CC
Q 006593 84 SG 85 (639)
Q Consensus 84 gG 85 (639)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 73
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.95 E-value=0.052 Score=55.24 Aligned_cols=69 Identities=13% Similarity=-0.020 Sum_probs=43.4
Q ss_pred ccCcEEEEEEEecC-------CCeEEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCCceEEEE
Q 006593 7 YMTPFSSYKAFDEF-------AGIEVAWSRVKIDDVLQLPGDLQKLYSEVHLLKSLK-DDNVVKFYKSWVDDKKKTVNMI 78 (639)
Q Consensus 7 fG~v~tVykA~d~~-------tG~~VAIK~v~~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~~~~~~~~~l~lV 78 (639)
-|....+|+..... .+..|.+++.-.. ... ....+|..+++.+. +.-..++|+++ .+ .+|
T Consensus 52 GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~--~~----g~I 119 (395)
T d1nw1a_ 52 GGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETE-SHLVAESVIFTLLSERHLGPKLYGIF--SG----GRL 119 (395)
T ss_dssp CCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEE
T ss_pred CccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chh-hHHHHHHHHHHHHHhCCCCCeEEEEc--CC----ceE
Confidence 45667899987643 2455766654311 122 34568999999884 43346888765 32 478
Q ss_pred EecCCCCCH
Q 006593 79 TELFTSGNL 87 (639)
Q Consensus 79 ~Ey~~gGsL 87 (639)
+||+.|.+|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=82.16 E-value=0.22 Score=48.31 Aligned_cols=28 Identities=36% Similarity=0.455 Sum_probs=23.7
Q ss_pred CeeeeccCCCcEEEeCCCCcEEEeecchh
Q 006593 122 PIIHRDLKCDNIFVNGNHGEVKIGDLGLA 150 (639)
Q Consensus 122 pIIHRDLKp~NILl~~~~g~VKL~DFGlA 150 (639)
++||+|+.++||+++++ +..-|.||+.+
T Consensus 184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~ 211 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGD-ELSGLIDFYFA 211 (316)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTC
T ss_pred ccccCCcchhhhhcccc-cceeEeccccc
Confidence 49999999999999854 35579999876
|